data_1xs3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xs3 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.716 0.294 . . . . 74.319999999999993 111.046 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -71.5 -40.84 69.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 72.439999999999998 110.866 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 p -61.06 -52.86 63.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 73.310000000000002 111.134 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.467 HD13 ' CG2' ' A' ' 35' ' ' VAL . 4.6 pt -67.2 -45.07 87.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 74.439999999999998 111.148 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.1 ttt-85 -58.96 -45.06 91.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 72.340000000000003 110.846 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -65.37 -44.65 86.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 75.230000000000004 110.88 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.5 mt -56.01 -49.54 73.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 65.120000000000005 110.935 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.48 ' CG2' HG22 ' A' ' 33' ' ' VAL . 8.8 mt -67.33 -44.28 87.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 74.129999999999995 111.129 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -54.03 -39.1 65.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 62.119999999999997 110.852 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.78 -41.21 45.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 74.120000000000005 110.873 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.48 -58.33 10.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 63.109999999999999 112.502 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.453 ' CB ' ' HB2' ' A' ' 31' ' ' ALA . 32.0 mt -73.05 154.69 90.68 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.638 0.732 . . . . 75.010000000000005 110.896 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -90.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.267 . . . . 73.219999999999999 112.315 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -104.41 34.51 3.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 74.030000000000001 110.89 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.453 ' HB2' ' CB ' ' A' ' 28' ' ' LEU . . . -87.52 139.6 30.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 73.140000000000001 111.119 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.465 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 31.3 ttt180 -109.3 125.65 52.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 74.010000000000005 110.865 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.48 HG22 ' CG2' ' A' ' 24' ' ' ILE . 6.0 t -123.15 133.26 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 75.109999999999999 111.128 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -135.09 118.86 17.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 71.129999999999995 110.83 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.468 ' CG2' ' HB1' ' A' ' 45' ' ' ALA . 40.1 t -124.56 130.85 73.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 71.230000000000004 111.115 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -132.77 120.18 21.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 63.509999999999998 110.912 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.471 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 149.44 -122.75 1.49 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.757 -0.735 . . . . 72.219999999999999 112.516 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -175.32 160.71 2.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.783 0.325 . . . . 75.099999999999994 110.918 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -73.65 146.58 44.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 71.299999999999997 110.905 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.427 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.7 18.39 78.69 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.784 -0.722 . . . . 72.099999999999994 112.451 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.0 t -149.23 165.44 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 74.439999999999998 111.168 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.451 ' CB ' ' HB1' ' A' ' 78' ' ' ALA . 36.0 p-80 -74.21 112.27 10.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 74.230000000000004 110.849 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.571 ' CZ ' HD22 ' A' ' 79' ' ' LEU . 27.8 p90 -129.23 167.44 17.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 75.430000000000007 110.931 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -116.63 120.04 37.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 74.230000000000004 110.86 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.468 ' HB1' ' CG2' ' A' ' 35' ' ' VAL . . . -127.73 116.83 20.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 72.319999999999993 111.07 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.6 m -106.89 117.89 35.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 64.420000000000002 111.115 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.456 ' CG2' HG13 ' A' ' 33' ' ' VAL . 55.0 t -113.93 141.22 30.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 74.040000000000006 111.126 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.508 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 3.7 p -131.42 118.75 41.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 70.530000000000001 111.105 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.548 ' OG ' ' CE2' ' A' ' 52' ' ' PHE . 10.8 p -158.58 158.62 29.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.651 0.738 . . . . 62.439999999999998 110.862 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.57 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.1 Cg_endo -69.69 -22.71 32.01 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.697 2.265 . . . . 73.239999999999995 112.385 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.0 -39.2 40.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 73.420000000000002 111.116 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.572 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 3.3 m-85 -84.51 27.77 0.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 74.319999999999993 110.915 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 55' ' ' LYS . 2.1 p -52.25 138.65 10.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.113 -0.494 . . . . 74.409999999999997 111.147 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 54.85 -82.25 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.738 -0.744 . . . . 71.120000000000005 112.482 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 53' ' ' VAL . 16.6 pttm -119.23 135.69 54.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.328 . . . . 73.340000000000003 110.919 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.97 100.78 10.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.611 0.719 . . . . 74.519999999999996 111.068 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.86 173.82 10.5 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.643 2.229 . . . . 63.340000000000003 112.339 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.38 -26.62 63.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 72.439999999999998 110.927 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.01 -52.96 63.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 73.25 111.128 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.572 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 3.7 mmt180 -71.57 -42.62 67.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 73.019999999999996 110.915 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.557 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 0.7 OUTLIER -57.92 -53.17 61.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.095 -0.502 . . . . 74.109999999999999 110.912 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 -67.35 -37.67 83.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 74.109999999999999 110.912 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 40.0 mmm -55.1 -47.71 74.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 63.229999999999997 110.935 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.486 HG21 ' N ' ' A' ' 65' ' ' TYR . 19.6 m -69.58 -42.66 80.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.435 . . . . 75.120000000000005 111.151 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.557 ' OH ' ' CE1' ' A' ' 61' ' ' HIS . 13.3 m-85 -62.41 -36.98 84.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 110.891 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.48 -45.71 44.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 74.510000000000005 111.125 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.473 HG21 ' CD1' ' A' ' 24' ' ' ILE . 1.2 t -66.5 -26.62 67.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 75.510000000000005 111.16 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.46 ' N ' HG22 ' A' ' 67' ' ' THR . 7.5 mp -86.91 4.49 41.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 73.340000000000003 110.886 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.53 78.68 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.791 -0.719 . . . . 52.219999999999999 112.479 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -99.44 -48.25 4.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 74.329999999999998 110.896 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.0 mp -85.96 1.0 51.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.16 -0.473 . . . . 71.319999999999993 110.947 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 tpt -80.86 -13.31 59.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 75.25 110.861 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -123.0 -28.29 1.4 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 63.219999999999999 112.501 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.427 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.685 -0.769 . . . . 73.0 112.479 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.451 ' HB1' ' CB ' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.819 0.342 . . . . 73.239999999999995 111.08 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.571 HD22 ' CZ ' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -97.97 126.83 43.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.436 . . . . 72.409999999999997 110.902 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -106.75 114.76 29.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 74.150000000000006 110.917 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.556 HD12 ' CE1' ' A' ' 65' ' ' TYR . 9.0 tt -140.04 129.38 23.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 73.420000000000002 110.952 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -122.49 132.21 54.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 73.230000000000004 110.874 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.526 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 27.2 p -112.16 107.09 15.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 75.329999999999998 111.107 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.5 mt -124.04 162.07 24.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.26 -0.427 . . . . 64.109999999999999 110.959 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.66 164.65 56.34 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.619 0.723 . . . . 73.349999999999994 111.111 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.57 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.0 Cg_endo -69.81 -18.85 36.53 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.67 2.247 . . . . 75.329999999999998 112.331 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -77.64 -25.64 49.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 71.150000000000006 110.91 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -83.01 18.77 1.55 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 64.200000000000003 110.891 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 63.020000000000003 111.104 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.796 0.331 . . . . 73.209999999999994 111.084 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -71.14 -31.06 67.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 72.140000000000001 110.911 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.3 p -67.22 -53.37 30.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 75.200000000000003 111.132 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.505 ' CD1' ' CG1' ' A' ' 35' ' ' VAL . 2.0 pp -70.06 -37.62 72.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 75.219999999999999 111.13 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.476 ' N ' HD13 ' A' ' 20' ' ' ILE . 38.0 ttp180 -61.32 -50.46 72.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 70.030000000000001 110.938 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.8 ptpp? -67.08 -40.0 86.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.140000000000001 110.878 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.8 mt -56.6 -49.86 73.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 75.030000000000001 110.893 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.484 ' CG2' HG22 ' A' ' 33' ' ' VAL . 12.3 mt -68.47 -43.8 83.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 75.450000000000003 111.113 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -55.58 -36.9 67.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 73.319999999999993 110.84 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.72 -43.0 32.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 71.219999999999999 110.845 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.8 -50.68 61.81 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.733 . . . . 75.319999999999993 112.463 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.486 HD13 ' CB ' ' A' ' 31' ' ' ALA . 5.0 mt -82.44 160.24 62.53 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.599 0.714 . . . . 74.439999999999998 110.884 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -91.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.729 2.286 . . . . 65.530000000000001 112.393 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -106.71 25.6 11.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 74.430000000000007 110.876 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.486 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -69.78 131.86 45.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 75.030000000000001 111.073 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.481 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 3.3 tpp85 -99.69 113.64 26.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 75.219999999999999 110.879 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.484 HG22 ' CG2' ' A' ' 24' ' ' ILE . 21.5 t -115.81 130.47 70.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 73.0 111.178 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -131.43 118.63 20.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 74.019999999999996 110.861 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.505 ' CG1' ' CD1' ' A' ' 20' ' ' ILE . 2.0 p -128.31 130.59 69.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 74.030000000000001 111.151 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -133.2 120.37 21.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 70.530000000000001 110.921 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.421 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 150.2 -125.14 1.88 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 64.310000000000002 112.505 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -175.1 162.48 3.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.817 0.342 . . . . 72.239999999999995 110.894 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -71.58 144.42 49.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 74.299999999999997 110.837 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.408 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.74 22.31 79.12 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.786 -0.721 . . . . 75.140000000000001 112.481 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -150.66 164.8 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.819 0.343 . . . . 75.439999999999998 111.173 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.402 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 45.8 p-80 -75.14 106.69 6.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 64.019999999999996 110.919 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.567 ' CE2' HD22 ' A' ' 79' ' ' LEU . 4.7 p90 -121.67 167.75 12.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 75.540000000000006 110.911 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -113.48 121.06 43.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 73.439999999999998 110.874 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.36 121.88 30.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 75.0 111.072 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.4 m -119.76 115.02 23.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 72.140000000000001 111.164 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.424 ' CG2' HG13 ' A' ' 33' ' ' VAL . 44.5 t -110.26 138.54 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 70.25 111.165 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.481 ' CG1' ' HB3' ' A' ' 32' ' ' ARG . 8.9 p -135.33 118.78 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 64.219999999999999 111.142 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.439 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.7 OUTLIER -161.19 165.72 16.44 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.614 0.721 . . . . 71.25 110.883 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.472 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.0 Cg_endo -69.74 -21.01 34.16 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.643 2.229 . . . . 64.319999999999993 112.362 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.31 -46.52 25.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 72.549999999999997 111.072 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.592 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -85.22 34.97 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.425 . . . . 75.430000000000007 110.889 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 55' ' ' LYS . 2.6 p -51.99 130.96 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 71.200000000000003 111.146 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 59.65 -76.08 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.804 -0.712 . . . . 62.340000000000003 112.498 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 53' ' ' VAL . 16.5 pttm -120.38 137.48 54.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 74.420000000000002 110.936 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.58 99.9 9.67 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.504 0.669 . . . . 73.530000000000001 111.118 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 171.25 14.87 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.695 2.263 . . . . 73.230000000000004 112.34 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.93 -27.97 61.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 72.340000000000003 110.945 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.459 ' O ' ' CG ' ' A' ' 63' ' ' MET . . . -58.15 -52.26 66.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 72.349999999999994 111.082 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.592 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 44.1 mmt-85 -70.37 -43.47 70.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 110.852 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.451 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 0.8 OUTLIER -57.74 -53.59 56.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 72.340000000000003 110.844 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -66.12 -36.15 82.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 71.209999999999994 110.864 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.459 ' CG ' ' O ' ' A' ' 59' ' ' ALA . 23.4 mmm -57.14 -46.49 82.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 74.129999999999995 110.881 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.501 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 17.1 m -69.82 -40.21 78.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 74.400000000000006 111.152 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.566 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 13.7 m-85 -65.94 -34.44 78.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.145 -0.48 . . . . 74.219999999999999 110.882 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.14 -46.6 33.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 64.420000000000002 111.079 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.42 HG21 ' O ' ' A' ' 64' ' ' VAL . 13.0 t -66.56 -28.46 68.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 74.340000000000003 111.14 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.501 ' CD1' ' O ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -82.47 -2.45 53.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 72.010000000000005 110.915 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.88 78.41 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.78 -0.724 . . . . 72.409999999999997 112.537 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 71' ' ' LEU . 12.1 pt-20 -90.02 -42.15 11.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.902 0.382 . . . . 74.430000000000007 110.883 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.459 ' N ' ' HG3' ' A' ' 70' ' ' GLU . 18.0 tp -89.45 7.94 33.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 72.329999999999998 110.9 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -13.02 60.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.446 . . . . 75.409999999999997 110.951 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.05 -30.27 0.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.708 -0.758 . . . . 52.439999999999998 112.446 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.408 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.362 0 C-N-CA 120.722 -0.751 . . . . 72.319999999999993 112.499 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.83 0.348 . . . . 74.129999999999995 111.084 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.567 HD22 ' CE2' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -98.77 128.48 45.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.318 -0.401 . . . . 75.109999999999999 110.934 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.453 ' N ' HD12 ' A' ' 79' ' ' LEU . 4.8 mt-30 -97.53 116.84 30.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 73.25 110.872 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.566 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 1.7 tm? -139.04 117.92 12.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 73.200000000000003 110.906 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -122.21 133.01 54.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 74.310000000000002 110.963 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.541 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 68.4 p -117.24 107.63 14.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 73.319999999999993 111.132 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.421 HD22 ' CD ' ' A' ' 88' ' ' GLU . 21.9 mt -127.76 161.04 29.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 73.209999999999994 110.903 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.471 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.15 163.8 64.28 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.631 0.729 . . . . 74.230000000000004 111.097 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.2 Cg_endo -69.81 -4.73 14.65 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.722 2.281 . . . . 74.109999999999999 112.304 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -94.18 -27.92 15.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 74.219999999999999 110.829 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.421 ' CD ' HD22 ' A' ' 84' ' ' LEU . 2.0 pt-20 -105.31 39.72 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 73.129999999999995 110.853 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 74.439999999999998 111.084 179.92 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.477 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.762 0.315 . . . . 74.420000000000002 111.145 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -40.53 94.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 73.329999999999998 110.872 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.577 ' CG2' ' N ' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -60.74 -47.89 84.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 71.400000000000006 111.118 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.577 ' N ' ' CG2' ' A' ' 19' ' ' THR . 43.6 pt -66.36 -39.26 83.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 75.530000000000001 111.122 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.464 ' N ' HG13 ' A' ' 20' ' ' ILE . 20.9 ttp85 -61.62 -42.22 98.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 73.540000000000006 110.85 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.62 -46.2 69.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 72.430000000000007 110.896 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -56.28 -49.06 75.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 74.409999999999997 110.957 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.473 ' CG2' HG22 ' A' ' 33' ' ' VAL . 7.9 mt -65.77 -45.31 92.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 74.239999999999995 111.117 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -53.86 -39.75 65.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 73.140000000000001 110.945 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -79.8 -32.47 40.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 72.430000000000007 110.798 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.24 -60.73 4.96 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.828 -0.701 . . . . 75.209999999999994 112.441 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.478 HD12 ' CB ' ' A' ' 31' ' ' ALA . 10.2 mt -72.65 159.29 85.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.569 0.7 . . . . 72.329999999999998 110.926 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -91.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.66 2.24 . . . . 71.549999999999997 112.347 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -105.38 38.9 1.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 64.329999999999998 110.846 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.478 ' CB ' HD12 ' A' ' 28' ' ' LEU . . . -91.35 125.75 36.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 71.5 111.072 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.458 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 8.0 tpp180 -95.67 109.65 21.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 73.310000000000002 110.881 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.473 HG22 ' CG2' ' A' ' 24' ' ' ILE . 39.0 t -109.12 125.4 66.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 62.409999999999997 111.101 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -135.35 117.53 15.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 64.129999999999995 110.831 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.477 ' CG1' ' HB2' ' A' ' 17' ' ' ALA . 5.1 p -126.88 139.78 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 74.519999999999996 111.13 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -129.19 120.99 26.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.461 . . . . 74.439999999999998 110.92 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.474 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 144.16 -135.07 6.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 72.530000000000001 112.488 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -168.67 172.05 8.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 71.430000000000007 110.915 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -77.15 150.63 35.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 73.109999999999999 110.861 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.58 1.25 52.28 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.741 -0.742 . . . . 72.129999999999995 112.442 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 p -131.23 164.55 33.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.855 0.36 . . . . 73.239999999999995 111.151 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.525 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 10.0 p80 -75.21 107.35 7.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 73.439999999999998 110.876 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.535 ' CE2' HD12 ' A' ' 79' ' ' LEU . 48.8 p90 -125.37 167.52 14.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 74.239999999999995 110.884 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -114.02 124.61 52.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 74.439999999999998 110.887 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 81' ' ' LEU . . . -117.74 115.4 24.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 73.299999999999997 111.081 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 m -114.92 106.65 14.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 72.010000000000005 111.217 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.442 HG21 ' CG1' ' A' ' 33' ' ' VAL . 59.9 t -112.54 125.95 69.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 71.349999999999994 111.102 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.503 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 3.9 p -114.4 118.57 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 75.299999999999997 111.173 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.476 ' OG ' ' CE2' ' A' ' 52' ' ' PHE . 14.9 p -159.33 158.66 28.38 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.663 0.744 . . . . 72.120000000000005 110.859 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.557 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.4 Cg_endo -69.68 -21.26 34.1 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.699 2.266 . . . . 75.019999999999996 112.352 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.53 -42.16 43.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 63.520000000000003 111.129 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.575 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 2.5 m-85 -84.04 30.18 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 74.510000000000005 110.838 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 55' ' ' LYS . 2.9 p -52.02 135.58 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 73.099999999999994 111.1 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.45 ' N ' HG22 ' A' ' 53' ' ' VAL . . . 55.18 -82.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.745 -0.74 . . . . 53.409999999999997 112.46 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 53' ' ' VAL . 30.9 mmmt -115.62 135.97 53.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.824 0.345 . . . . 71.019999999999996 110.891 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.14 100.55 10.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.623 0.725 . . . . 75.310000000000002 111.092 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 171.03 15.11 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.718 2.279 . . . . 75.430000000000007 112.333 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.478 ' CD2' ' CD ' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -55.62 -27.82 51.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 74.310000000000002 110.956 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.18 -52.64 64.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 74.209999999999994 111.135 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.575 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 7.7 mmt180 -70.98 -42.13 70.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 71.319999999999993 110.839 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.507 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 0.6 OUTLIER -57.61 -52.02 67.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 75.409999999999997 110.863 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.478 ' CD ' ' CD2' ' A' ' 58' ' ' LEU . 44.8 mtt180 -68.16 -37.48 81.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 74.439999999999998 110.801 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.1 mmt -55.51 -49.0 73.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 74.209999999999994 110.875 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.47 HG21 ' N ' ' A' ' 65' ' ' TYR . 18.6 m -67.89 -45.1 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 71.109999999999999 111.111 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.572 ' CE1' HD13 ' A' ' 81' ' ' LEU . 13.2 m-85 -57.75 -36.77 72.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.45 . . . . 73.219999999999999 110.894 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.55 -46.03 41.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 72.530000000000001 111.093 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.465 HG21 ' CD1' ' A' ' 24' ' ' ILE . 1.7 t -72.58 -12.89 61.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 73.040000000000006 111.136 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.429 HD13 ' C ' ' A' ' 64' ' ' VAL . 27.1 mt -93.76 3.29 55.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 75.25 110.887 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 55.57 66.97 2.46 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 72.120000000000005 112.524 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -81.04 -39.41 25.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.912 0.387 . . . . 73.400000000000006 110.908 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.9 mt -90.18 10.08 25.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 75.329999999999998 110.894 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 22.9 mmt -71.79 -9.0 57.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 65.040000000000006 110.832 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.54 -31.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 75.129999999999995 112.52 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.761 -0.733 . . . . 72.450000000000003 112.533 -179.923 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.851 0.358 . . . . 74.430000000000007 111.137 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.535 HD12 ' CE2' ' A' ' 43' ' ' PHE . 2.2 mm? -99.16 134.36 42.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 74.150000000000006 110.907 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -120.31 115.67 24.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 71.530000000000001 110.87 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.572 HD13 ' CE1' ' A' ' 65' ' ' TYR . 4.5 tt -127.94 140.61 51.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 74.200000000000003 110.957 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.39 115.69 12.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 62.520000000000003 110.979 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.535 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 11.8 p -105.46 106.87 17.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 72.310000000000002 111.086 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.5 mt -122.97 162.08 22.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 73.030000000000001 110.977 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.33 165.82 44.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.61 0.719 . . . . 71.420000000000002 111.119 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.557 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.7 Cg_endo -69.69 -24.71 29.69 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.697 2.265 . . . . 74.019999999999996 112.393 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.28 -31.77 72.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 70.140000000000001 110.897 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -70.56 -32.39 69.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 72.219999999999999 110.903 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 71.510000000000005 111.134 179.912 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.472 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . . . . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.803 0.335 . . . . 64.299999999999997 111.161 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -70.86 -47.94 56.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 75.209999999999994 110.844 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.9 t -61.34 -45.1 95.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 71.230000000000004 111.112 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.473 HD12 ' CB ' ' A' ' 35' ' ' VAL . 6.4 pt -71.55 -42.5 72.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 65.409999999999997 111.165 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -60.5 -48.0 83.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 73.430000000000007 110.855 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -66.08 -42.85 88.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 75.439999999999998 110.872 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.1 mt -56.07 -48.31 76.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.452 . . . . 72.219999999999999 110.912 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.469 ' CG2' HG23 ' A' ' 33' ' ' VAL . 13.3 mt -68.41 -45.22 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 74.420000000000002 111.106 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -54.58 -37.12 65.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 70.219999999999999 110.879 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.91 -42.97 31.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 71.439999999999998 110.885 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.38 -49.9 73.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 65.209999999999994 112.499 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.457 HD12 ' CG2' ' A' ' 24' ' ' ILE . 5.8 mp -89.57 154.06 48.26 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.7 0.762 . . . . 73.409999999999997 110.845 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 -91.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.725 2.283 . . . . 63.329999999999998 112.317 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -100.16 54.74 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 72.5 110.897 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.97 137.66 42.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 70.239999999999995 111.143 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.458 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 4.7 tmm_? -106.43 117.38 33.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 74.439999999999998 110.852 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.469 HG23 ' CG2' ' A' ' 24' ' ' ILE . 38.0 t -122.2 130.27 74.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 73.5 111.181 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -135.26 118.52 16.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 71.319999999999993 110.949 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.483 HG23 ' CD2' ' A' ' 68' ' ' LEU . 7.6 t -122.79 131.55 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 65.230000000000004 111.124 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -133.53 120.0 20.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 75.219999999999999 110.937 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.08 -141.62 9.81 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 72.209999999999994 112.47 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -155.05 179.95 8.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 74.239999999999995 110.832 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -86.96 144.25 27.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 73.310000000000002 110.85 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.418 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.69 22.3 79.1 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.757 -0.735 . . . . 73.219999999999999 112.455 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.5 p -148.84 164.93 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.808 0.337 . . . . 73.299999999999997 111.166 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.43 ' CD2' ' O ' ' A' ' 42' ' ' HIS . 8.6 p-80 -74.95 106.75 6.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 64.329999999999998 110.862 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.496 ' CE2' HD22 ' A' ' 79' ' ' LEU . 8.1 p90 -120.5 167.39 12.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 73.129999999999995 110.881 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -118.29 119.18 33.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 73.140000000000001 110.836 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.99 115.57 18.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 63.350000000000001 111.148 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.7 m -103.86 125.64 50.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.479 . . . . 74.120000000000005 111.084 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.439 ' CG2' HG11 ' A' ' 33' ' ' VAL . 88.1 t -122.3 133.82 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 61.509999999999998 111.136 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.504 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 4.1 p -130.11 118.61 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 71.310000000000002 111.138 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.431 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.5 OUTLIER -158.64 168.06 13.19 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.629 0.728 . . . . 62.329999999999998 110.797 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.508 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.1 Cg_endo -69.75 -28.52 25.2 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.604 2.203 . . . . 73.319999999999993 112.388 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.65 -42.17 33.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 70.510000000000005 111.126 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.552 ' CD2' ' HB ' ' A' ' 83' ' ' THR . 1.4 m-85 -83.86 31.38 0.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 74.25 110.89 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 55' ' ' LYS . 1.8 p -54.36 132.1 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 72.239999999999995 111.177 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.406 ' N ' HG21 ' A' ' 53' ' ' VAL . . . 55.93 -80.2 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.74 -0.743 . . . . 72.140000000000001 112.511 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -116.91 136.52 52.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.757 0.313 . . . . 74.030000000000001 110.92 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.07 100.5 10.15 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.579 0.704 . . . . 72.120000000000005 111.099 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 172.48 12.57 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.696 2.264 . . . . 65.230000000000004 112.309 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 tp -55.99 -25.07 42.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 73.25 110.909 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.26 -53.31 59.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 64.310000000000002 111.116 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.519 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 8.7 mmt180 -71.77 -40.43 69.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 73.319999999999993 110.915 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.555 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 0.8 OUTLIER -59.84 -51.91 67.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 75.25 110.885 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -67.4 -39.05 85.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 71.540000000000006 110.891 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -54.89 -52.11 63.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 74.450000000000003 110.858 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.491 HG21 ' N ' ' A' ' 65' ' ' TYR . 25.5 m -63.83 -44.9 98.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.303 -0.408 . . . . 74.400000000000006 111.072 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.555 ' OH ' ' CE1' ' A' ' 61' ' ' HIS . 12.8 m-85 -60.37 -31.24 70.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 73.0 110.885 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.04 -46.66 33.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 62.310000000000002 111.099 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.417 HG22 ' O ' ' A' ' 64' ' ' VAL . 3.8 t -67.12 -26.6 66.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 74.019999999999996 111.134 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.483 ' CD2' HG23 ' A' ' 35' ' ' VAL . 12.9 mt -83.0 8.88 11.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 72.150000000000006 110.887 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.14 66.94 1.33 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.736 . . . . 74.219999999999999 112.508 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -70.39 -42.8 71.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.875 0.369 . . . . 75.530000000000001 110.845 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.01 7.62 36.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 75.140000000000001 110.93 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.0 ttm -71.92 -12.99 61.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 74.349999999999994 110.877 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.26 -33.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.777 -0.725 . . . . 73.439999999999998 112.501 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.418 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.276 0 C-N-CA 120.643 -0.789 . . . . 73.340000000000003 112.449 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.754 0.311 . . . . 54.439999999999998 111.065 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.496 HD22 ' CE2' ' A' ' 43' ' ' PHE . 8.8 mt -104.24 126.9 51.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 73.349999999999994 110.914 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -96.93 115.4 27.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.462 . . . . 71.409999999999997 110.903 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 tp -139.22 144.19 38.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 75.019999999999996 110.937 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.27 114.48 11.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 64.109999999999999 110.901 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.552 ' HB ' ' CD2' ' A' ' 52' ' ' PHE . 44.5 p -99.41 107.72 20.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 65.239999999999995 111.17 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.419 HD21 ' CD ' ' A' ' 88' ' ' GLU . 26.9 mt -130.78 160.35 34.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.176 -0.466 . . . . 74.219999999999999 110.915 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.479 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -73.63 164.11 63.49 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.633 0.73 . . . . 71.209999999999994 111.142 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.8 Cg_endo -69.72 -8.79 24.5 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.689 2.259 . . . . 65.420000000000002 112.318 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -77.58 -35.96 52.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 63.520000000000003 110.918 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.419 ' CD ' HD21 ' A' ' 84' ' ' LEU . 18.0 mt-10 -70.36 -32.57 70.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 74.340000000000003 110.796 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 71.219999999999999 111.17 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.463 ' CB ' HG13 ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.679 0.276 . . . . 71.030000000000001 111.093 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -71.61 -41.14 69.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 71.310000000000002 110.866 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.5 p -61.03 -53.0 62.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 73.549999999999997 111.15 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.476 HG13 ' N ' ' A' ' 21' ' ' ARG . 12.3 pt -68.3 -42.72 84.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 72.530000000000001 111.155 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.476 ' N ' HG13 ' A' ' 20' ' ' ILE . 39.9 ttp85 -59.56 -46.49 88.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 75.540000000000006 110.88 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -66.82 -41.21 87.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 74.549999999999997 110.918 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.3 mt -56.64 -49.46 74.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 71.140000000000001 110.867 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.47 ' CG2' HG23 ' A' ' 33' ' ' VAL . 10.6 mt -67.56 -41.95 86.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 75.310000000000002 111.131 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -55.7 -41.1 73.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 73.109999999999999 110.913 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.72 -43.28 55.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 75.329999999999998 110.876 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.35 -51.86 53.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.747 . . . . 73.430000000000007 112.406 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.465 HD23 ' CB ' ' A' ' 31' ' ' ALA . 7.3 mp -80.71 156.31 72.92 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.594 0.712 . . . . 74.549999999999997 110.88 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -90.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.657 2.238 . . . . 73.409999999999997 112.375 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -105.96 27.36 8.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 74.150000000000006 110.863 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.465 ' CB ' HD23 ' A' ' 28' ' ' LEU . . . -75.81 144.45 41.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 74.439999999999998 111.048 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.472 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 58.2 ttt180 -110.96 124.83 52.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 74.439999999999998 110.849 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.47 HG23 ' CG2' ' A' ' 24' ' ' ILE . 5.9 t -124.17 129.44 74.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 65.430000000000007 111.153 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -131.44 118.98 20.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 60.140000000000001 110.846 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.475 HG11 ' CD1' ' A' ' 20' ' ' ILE . 1.6 p -126.73 134.34 66.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 72.439999999999998 111.105 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.438 ' N ' HG23 ' A' ' 35' ' ' VAL . 12.6 mt-30 -133.45 120.3 20.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 74.129999999999995 110.897 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.56 -130.39 4.55 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.731 -0.747 . . . . 71.409999999999997 112.529 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -174.06 160.98 3.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.919 0.39 . . . . 72.510000000000005 110.871 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -67.69 151.95 46.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 70.530000000000001 110.887 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.416 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.74 10.12 75.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.752 -0.737 . . . . 75.430000000000007 112.533 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.3 t -143.95 165.15 14.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.834 0.35 . . . . 61.329999999999998 111.159 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.437 ' CB ' ' HB1' ' A' ' 78' ' ' ALA . 12.7 p80 -74.52 108.85 7.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 73.430000000000007 110.783 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.573 ' CE2' HD12 ' A' ' 79' ' ' LEU . 40.0 p90 -125.09 167.47 14.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 74.010000000000005 110.826 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -119.43 120.11 35.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 75.230000000000004 110.903 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.2 115.28 18.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 65.430000000000007 111.126 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.7 m -108.41 119.42 39.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 61.219999999999999 111.181 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 96.8 t -112.74 136.59 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 71.230000000000004 111.183 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.472 ' CG1' ' HB3' ' A' ' 32' ' ' ARG . 2.7 p -128.76 125.55 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 73.409999999999997 111.084 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.449 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.8 OUTLIER -172.45 164.84 3.81 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.648 0.737 . . . . 73.219999999999999 110.863 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.495 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.4 Cg_endo -69.74 -22.43 32.2 Favored 'Trans proline' 0 N--CA 1.466 -0.127 0 C-N-CA 122.705 2.27 . . . . 71.140000000000001 112.362 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.44 ' HB2' ' NE ' ' A' ' 60' ' ' ARG . . . -47.72 -41.99 24.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 73.219999999999999 111.043 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.581 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 0.6 OUTLIER -89.27 35.9 0.82 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 73.140000000000001 110.904 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.486 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 6.7 p -52.41 139.33 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 64.140000000000001 111.138 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.482 ' N ' HG22 ' A' ' 53' ' ' VAL . . . 56.38 -89.28 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.756 -0.735 . . . . 70.420000000000002 112.5 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.427 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -117.9 111.16 18.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.732 0.301 . . . . 74.409999999999997 110.919 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' A' ' 52' ' ' PHE . . . -60.03 108.48 1.43 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.635 0.731 . . . . 63.119999999999997 111.09 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 54.2 Cg_endo -69.71 160.76 48.52 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.67 2.247 . . . . 74.510000000000005 112.374 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tp -54.81 -26.76 36.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 74.109999999999999 110.86 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.02 -52.39 65.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 111.071 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.581 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 30.7 mmt-85 -69.46 -41.07 76.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 74.420000000000002 110.857 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.415 ' NE2' ' OH ' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -59.07 -53.46 58.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 63.450000000000003 110.808 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 52.0 mtt-85 -67.1 -35.05 78.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 75.030000000000001 110.924 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.0 tpp -58.37 -51.6 69.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 65.450000000000003 110.875 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.475 HG21 ' N ' ' A' ' 65' ' ' TYR . 20.7 m -64.05 -44.66 97.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 71.340000000000003 111.204 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.542 ' CE1' HD12 ' A' ' 81' ' ' LEU . 14.1 m-85 -59.17 -38.85 80.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 75.310000000000002 110.955 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.72 -32.85 60.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 70.040000000000006 111.096 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.506 HG23 ' N ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -71.57 -27.09 62.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 74.5 111.142 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.506 ' N ' HG23 ' A' ' 67' ' ' THR . 3.5 pp -88.66 -10.5 48.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 72.209999999999994 110.95 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.69 75.1 0.25 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.705 -0.76 . . . . 74.420000000000002 112.505 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -91.38 -42.51 10.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.858 0.361 . . . . 72.239999999999995 110.88 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.491 ' O ' ' CD1' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -84.44 -10.11 57.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 63.310000000000002 110.891 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.5 mmt -72.51 -13.72 61.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 54.549999999999997 110.896 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -126.72 -14.08 2.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.8 -0.714 . . . . 40.020000000000003 112.499 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.416 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.689 -0.767 . . . . 74.540000000000006 112.475 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.437 ' HB1' ' CB ' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.847 0.356 . . . . 73.299999999999997 111.155 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.573 HD12 ' CE2' ' A' ' 43' ' ' PHE . 7.9 tp -105.0 133.14 50.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 73.209999999999994 110.912 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -111.47 115.46 29.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 74.400000000000006 110.929 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.542 HD12 ' CE1' ' A' ' 65' ' ' TYR . 8.4 tt -139.43 129.41 24.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 74.549999999999997 110.99 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -123.58 135.95 54.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 74.049999999999997 110.91 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.533 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 14.0 p -119.43 106.94 12.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.302 -0.408 . . . . 61.130000000000003 111.163 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.7 mp -124.9 161.59 26.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 74.310000000000002 110.902 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.486 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.3 OUTLIER -71.99 164.74 56.31 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.694 0.759 . . . . 75.230000000000004 111.035 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.4 Cg_endo -69.84 -12.32 32.5 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.684 2.256 . . . . 73.049999999999997 112.302 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -75.45 -35.81 60.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 74.349999999999994 110.876 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.45 -39.86 77.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 61.229999999999997 110.903 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 73.400000000000006 111.116 179.961 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.466 ' O ' ' CB ' ' A' ' 21' ' ' ARG . . . . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.743 0.306 . . . . 72.140000000000001 111.102 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.77 -48.69 63.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 75.040000000000006 110.883 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.2 t -62.0 -48.32 80.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 74.25 111.181 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.458 HD13 ' CG2' ' A' ' 35' ' ' VAL . 2.3 pp -69.3 -39.73 79.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 72.439999999999998 111.169 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.466 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 33.0 ttp85 -59.39 -45.96 90.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 73.299999999999997 110.862 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -68.95 -41.26 78.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 74.409999999999997 110.86 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.0 mt -56.3 -49.19 74.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 73.430000000000007 110.884 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.48 ' CG2' HG21 ' A' ' 33' ' ' VAL . 16.2 mt -69.88 -41.68 79.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 73.299999999999997 111.11 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -56.26 -37.03 69.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 75.310000000000002 110.851 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.31 -42.86 24.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 43.32 110.905 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.95 -52.03 51.06 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.776 -0.726 . . . . 74.439999999999998 112.453 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.407 ' CB ' ' HB3' ' A' ' 31' ' ' ALA . 4.1 mm? -79.53 158.02 74.15 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.645 0.736 . . . . 73.230000000000004 110.872 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -90.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.709 2.273 . . . . 73.129999999999995 112.354 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -105.18 27.71 7.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 65.030000000000001 110.873 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.407 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . . . -78.22 129.41 35.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 74.129999999999995 111.103 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.453 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 7.6 tpt180 -101.42 113.52 26.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 74.099999999999994 110.892 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.48 HG21 ' CG2' ' A' ' 24' ' ' ILE . 11.6 t -113.44 127.69 70.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 72.230000000000004 111.131 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -134.08 118.24 17.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 70.120000000000005 110.888 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.458 ' CG2' HD13 ' A' ' 20' ' ' ILE . 61.7 t -122.71 137.53 55.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 64.319999999999993 111.131 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -133.9 119.39 19.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 71.120000000000005 110.987 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 146.1 -132.54 4.55 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 73.439999999999998 112.459 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.465 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 0.4 OUTLIER -171.68 162.37 6.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 74.030000000000001 110.915 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.41 145.7 53.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 62.439999999999998 110.817 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.9 -15.97 9.33 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.703 -0.761 . . . . 41.450000000000003 112.471 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' A' ' 38' ' ' GLU . 13.1 m -112.96 164.86 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.919 0.39 . . . . 71.319999999999993 111.112 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.606 ' CD2' ' O ' ' A' ' 78' ' ' ALA . 4.9 t-160 -74.94 106.9 6.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 74.129999999999995 110.886 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.69 ' CZ ' ' CD1' ' A' ' 79' ' ' LEU . 4.4 p90 -120.94 167.21 12.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 75.510000000000005 110.85 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -119.47 123.62 44.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 73.540000000000006 110.836 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.479 ' CB ' HD23 ' A' ' 68' ' ' LEU . . . -117.66 115.97 26.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 74.150000000000006 111.085 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.2 m -110.8 108.05 17.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 75.540000000000006 111.17 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.2 t -109.76 141.27 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 73.129999999999995 111.152 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.477 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 5.1 p -134.65 118.49 26.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 74.450000000000003 111.117 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.431 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.8 OUTLIER -164.03 165.98 12.67 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.67 0.748 . . . . 73.219999999999999 110.817 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.519 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.8 Cg_endo -69.78 -28.57 25.01 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.693 2.262 . . . . 72.319999999999993 112.33 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.27 -34.05 31.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 73.430000000000007 111.06 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.579 ' CD2' ' HB ' ' A' ' 83' ' ' THR . 3.9 m-85 -90.78 31.06 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 75.299999999999997 110.893 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.48 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 8.4 p -61.21 143.55 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 75.129999999999995 111.143 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.471 ' N ' HG22 ' A' ' 53' ' ' VAL . . . 52.41 -90.99 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.728 -0.749 . . . . 75.109999999999999 112.496 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.9 OUTLIER -120.06 104.77 10.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.774 0.321 . . . . 72.310000000000002 110.934 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.49 109.22 1.76 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.624 0.726 . . . . 64.409999999999997 111.064 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.9 Cg_endo -69.81 168.81 20.56 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.67 2.247 . . . . 74.099999999999994 112.334 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tp -53.86 -26.62 25.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 71.299999999999997 110.925 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.35 -53.05 62.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 75.140000000000001 111.106 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.577 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 21.3 mmt180 -69.88 -41.67 74.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 64.549999999999997 110.926 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.557 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -59.49 -53.4 58.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 74.129999999999995 110.845 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.6 mtp180 -66.53 -35.85 81.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 72.409999999999997 110.837 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 10.9 tpt -58.35 -45.86 87.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 75.400000000000006 110.933 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.506 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 19.6 m -70.19 -40.38 78.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 72.150000000000006 111.13 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.564 ' CE1' HD13 ' A' ' 81' ' ' LEU . 13.6 m-85 -65.71 -34.76 78.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 73.040000000000006 110.949 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.61 -46.29 32.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 71.239999999999995 111.045 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.48 ' CG2' HD12 ' A' ' 68' ' ' LEU . 3.5 t -66.91 -28.37 68.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 75.030000000000001 111.109 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.506 ' CD1' ' O ' ' A' ' 64' ' ' VAL . 3.8 mp -82.57 -8.82 59.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 71.540000000000006 110.91 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.27 80.01 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.687 -0.768 . . . . 53.450000000000003 112.552 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -91.22 -25.31 19.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.897 0.38 . . . . 74.400000000000006 110.889 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.1 mp -89.96 9.98 25.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.098 -0.501 . . . . 71.420000000000002 110.965 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 7.0 ptp -74.42 -13.22 60.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 74.010000000000005 110.83 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.3 -32.93 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.748 -0.739 . . . . 65.0 112.503 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.761 -0.733 . . . . 51.25 112.487 -179.869 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.606 ' O ' ' CD2' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.793 0.33 . . . . 73.109999999999999 111.091 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.69 ' CD1' ' CZ ' ' A' ' 43' ' ' PHE . 1.1 mm? -115.47 133.85 55.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 75.150000000000006 110.97 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -114.35 115.61 27.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 75.099999999999994 110.883 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.564 HD13 ' CE1' ' A' ' 65' ' ' TYR . 1.4 tt -126.33 144.99 50.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 75.340000000000003 110.937 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -136.26 123.84 22.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 72.510000000000005 110.866 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.579 ' HB ' ' CD2' ' A' ' 52' ' ' PHE . 30.1 p -116.06 107.75 15.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.25 111.131 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mp -128.3 160.67 31.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 75.030000000000001 110.92 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.48 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.3 OUTLIER -72.5 164.94 55.91 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.606 0.717 . . . . 73.219999999999999 111.139 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.1 Cg_endo -69.77 -16.37 37.5 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 2.245 . . . . 71.420000000000002 112.375 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -73.03 -35.9 66.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 72.420000000000002 110.817 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -67.82 -38.03 82.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 75.230000000000004 110.839 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 71.239999999999995 111.144 179.925 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.794 0.331 . . . . 45.329999999999998 111.139 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -72.83 -48.04 41.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 72.5 110.906 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.7 t -57.8 -50.15 74.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 72.340000000000003 111.139 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.477 HG13 ' N ' ' A' ' 21' ' ' ARG . 25.9 pt -68.01 -42.16 85.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 73.219999999999999 111.152 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.477 ' N ' HG13 ' A' ' 20' ' ' ILE . 54.3 ttt-85 -55.01 -53.16 59.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 74.349999999999994 110.834 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.5 mttt -66.15 -35.86 81.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 74.129999999999995 110.94 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.37 -49.18 75.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 53.439999999999998 110.945 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.476 HD12 ' CG1' ' A' ' 33' ' ' VAL . 5.8 mt -70.9 -44.34 76.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 74.310000000000002 111.135 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -53.89 -36.85 63.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 72.209999999999994 110.869 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.51 -41.48 21.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 75.109999999999999 110.818 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.61 -55.5 24.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.798 -0.715 . . . . 63.240000000000002 112.481 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.89 159.36 85.51 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.641 0.734 . . . . 75.340000000000003 110.945 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -90.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.649 2.233 . . . . 65.299999999999997 112.368 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -107.29 27.24 9.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.423 . . . . 73.219999999999999 110.895 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.07 126.77 31.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 75.109999999999999 111.058 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -93.86 109.01 20.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 73.310000000000002 110.905 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.483 ' CG1' HG22 ' A' ' 47' ' ' VAL . 53.0 t -113.65 121.45 65.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 72.25 111.102 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -132.34 118.11 18.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 75.329999999999998 110.897 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 36' ' ' GLN . 2.2 p -127.08 135.63 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 71.0 111.162 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.46 ' N ' HG22 ' A' ' 35' ' ' VAL . 30.5 mm-40 -133.57 120.14 20.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 75.510000000000005 110.903 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.88 -128.19 2.92 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.727 -0.749 . . . . 61.420000000000002 112.436 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.432 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 11.8 pt-20 -175.27 171.17 2.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.811 0.339 . . . . 74.420000000000002 110.838 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -75.29 147.42 40.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.132 -0.485 . . . . 71.129999999999995 110.819 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.71 16.72 77.9 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.716 -0.754 . . . . 73.140000000000001 112.435 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.432 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 1.8 t -146.62 164.01 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 73.140000000000001 111.161 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 42' ' ' HIS . 19.7 p-80 -75.98 106.62 7.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 110.835 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.569 ' CD1' HD11 ' A' ' 79' ' ' LEU . 4.5 p90 -119.26 166.22 13.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 75.030000000000001 110.836 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -115.4 121.17 41.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 72.219999999999999 110.892 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.17 115.09 17.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 72.120000000000005 111.072 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.1 m -111.81 116.16 30.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 74.030000000000001 111.1 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.483 HG22 ' CG1' ' A' ' 33' ' ' VAL . 28.6 t -120.58 126.11 74.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 74.239999999999995 111.148 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 p -124.06 118.8 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 75.040000000000006 111.174 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.431 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.8 OUTLIER -160.61 166.63 15.17 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.611 0.719 . . . . 72.040000000000006 110.8 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.505 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.3 Cg_endo -69.82 -21.82 32.66 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.687 2.258 . . . . 74.340000000000003 112.297 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 60' ' ' ARG . . . -46.65 -45.19 19.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 75.409999999999997 111.12 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.582 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -87.47 36.92 0.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 75.530000000000001 110.936 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.481 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 4.1 p -52.34 124.37 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 74.349999999999994 111.128 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.57 -89.05 0.73 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.791 -0.719 . . . . 34.350000000000001 112.47 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.423 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -119.52 111.24 17.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.82 0.343 . . . . 61.119999999999997 110.934 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.511 ' CB ' ' HB3' ' A' ' 52' ' ' PHE . . . -58.38 108.0 1.15 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.536 0.684 . . . . 71.319999999999993 111.149 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.5 Cg_endo -69.83 162.59 41.51 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.65 2.234 . . . . 74.299999999999997 112.366 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -58.0 -27.05 63.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 70.140000000000001 110.916 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.82 -52.39 65.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 71.230000000000004 111.079 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.582 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 16.5 mmt180 -69.09 -41.18 77.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.473 . . . . 74.140000000000001 110.908 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.409 ' NE2' ' OH ' ' A' ' 65' ' ' TYR . 1.0 OUTLIER -60.66 -53.54 56.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 74.349999999999994 110.836 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.9 mtp85 -66.68 -33.35 75.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 75.25 110.87 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.3 mmt -60.81 -49.69 76.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 74.299999999999997 110.833 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.481 HG21 ' N ' ' A' ' 65' ' ' TYR . 19.2 m -65.21 -43.0 95.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 75.120000000000005 111.166 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.58 ' CE1' HD13 ' A' ' 81' ' ' LEU . 15.0 m-85 -61.9 -37.92 86.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 75.109999999999999 110.887 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.24 -33.16 59.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 71.120000000000005 111.088 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.52 HG23 ' N ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -72.15 -29.63 64.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.264 -0.425 . . . . 73.150000000000006 111.115 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.52 ' N ' HG23 ' A' ' 67' ' ' THR . 3.9 pp -83.33 -6.78 59.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.448 . . . . 75.219999999999999 110.913 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.47 69.62 1.09 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.782 -0.723 . . . . 65.129999999999995 112.433 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.495 ' CB ' ' CD1' ' A' ' 68' ' ' LEU . 2.4 tp10 -98.75 -23.51 15.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.956 0.408 . . . . 75.099999999999994 110.957 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.45 ' N ' HD22 ' A' ' 71' ' ' LEU . 4.6 mm? -90.31 3.39 53.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 74.209999999999994 110.916 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.7 mtp -71.93 -13.31 61.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 74.409999999999997 110.865 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.27 -31.5 0.12 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.738 -0.744 . . . . 74.200000000000003 112.505 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 C-N-CA 120.804 -0.712 . . . . 65.239999999999995 112.523 -179.931 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.448 ' HB2' ' CB ' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.82 0.343 . . . . 71.329999999999998 111.13 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.569 HD11 ' CD1' ' A' ' 43' ' ' PHE . 8.5 tp -97.58 133.25 42.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 73.349999999999994 110.937 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -111.35 115.18 28.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 74.319999999999993 110.946 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.58 HD13 ' CE1' ' A' ' 65' ' ' TYR . 7.4 tt -139.77 137.74 35.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 75.25 110.88 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 82' ' ' LYS . 2.3 mppt? -136.35 128.16 29.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 74.010000000000005 110.907 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.527 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 63.9 p -113.48 106.95 15.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 71.209999999999994 111.103 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.9 mt -125.99 161.69 26.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 73.219999999999999 110.946 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.481 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.94 163.99 62.29 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.608 0.718 . . . . 75.120000000000005 111.171 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.505 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.4 Cg_endo -69.66 -21.96 33.2 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.787 2.325 . . . . 74.450000000000003 112.288 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -70.66 -35.94 73.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 74.439999999999998 110.905 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.7 -33.89 76.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 63.149999999999999 110.916 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 74.019999999999996 111.106 179.948 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.462 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.767 0.318 . . . . 71.25 111.089 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -70.22 -48.43 57.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 72.140000000000001 110.888 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 t -59.17 -51.13 71.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 73.340000000000003 111.143 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.508 ' CG2' ' O ' ' A' ' 67' ' ' THR . 2.6 pp -64.83 -40.7 89.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 75.319999999999993 111.187 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.499 ' N ' HD11 ' A' ' 20' ' ' ILE . 73.9 ttt180 -60.92 -46.26 91.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 72.129999999999995 110.87 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -63.51 -42.66 98.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 73.329999999999998 110.888 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.5 mt -57.53 -49.11 77.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 74.200000000000003 110.939 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.455 ' CG2' HG22 ' A' ' 33' ' ' VAL . 49.2 mm -63.18 -46.71 95.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 72.409999999999997 111.147 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -55.11 -40.23 70.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 75.049999999999997 110.846 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.04 -43.24 71.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 73.209999999999994 110.867 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.99 -49.13 60.3 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.726 . . . . 74.140000000000001 112.525 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.55 157.16 72.77 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.53 0.681 . . . . 72.230000000000004 110.972 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -90.62 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.685 2.256 . . . . 64.519999999999996 112.323 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -107.41 29.57 7.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 74.310000000000002 110.882 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.02 133.09 41.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 72.140000000000001 111.084 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.471 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 7.0 tpp180 -99.98 111.14 23.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 73.439999999999998 110.927 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.496 ' O ' ' NE ' ' A' ' 21' ' ' ARG . 32.3 t -113.86 124.98 71.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 74.409999999999997 111.107 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -134.69 118.15 16.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 75.209999999999994 110.889 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.462 ' CG1' ' HB2' ' A' ' 17' ' ' ALA . 4.9 p -130.43 136.33 58.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 71.239999999999995 111.134 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.444 ' N ' HG23 ' A' ' 35' ' ' VAL . 13.3 pt20 -133.32 120.21 20.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 74.430000000000007 110.928 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.466 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 149.67 -145.19 13.09 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.703 -0.761 . . . . 72.519999999999996 112.461 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -156.1 176.98 11.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.825 0.345 . . . . 71.0 110.939 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -80.06 139.87 36.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 74.030000000000001 110.895 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.419 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.67 25.7 73.38 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.772 -0.727 . . . . 64.519999999999996 112.463 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.2 p -148.91 164.7 4.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.895 0.379 . . . . 75.540000000000006 111.079 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.423 ' CD2' ' O ' ' A' ' 42' ' ' HIS . 7.4 p-80 -74.97 107.44 7.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 72.230000000000004 110.853 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.578 ' CE2' HD12 ' A' ' 79' ' ' LEU . 4.4 p90 -123.88 167.14 14.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.3 -0.409 . . . . 74.140000000000001 110.92 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -118.75 121.73 40.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 71.329999999999998 110.894 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -126.42 114.9 18.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 64.340000000000003 111.103 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 m -111.58 117.19 32.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 71.120000000000005 111.182 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.8 t -115.65 132.99 63.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 73.129999999999995 111.169 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.471 ' CG1' ' HB3' ' A' ' 32' ' ' ARG . 5.6 p -128.79 120.37 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 73.140000000000001 111.149 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.446 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.9 OUTLIER -167.31 164.82 9.31 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.711 0.767 . . . . 74.510000000000005 110.803 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.505 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.6 Cg_endo -69.78 -19.1 36.48 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.685 2.256 . . . . 71.329999999999998 112.363 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 60' ' ' ARG . . . -47.19 -41.61 18.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 73.510000000000005 111.043 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.58 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -91.87 38.23 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.895 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.48 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 4.8 p -53.03 123.27 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 73.25 111.156 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.92 -90.61 0.68 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.689 -0.767 . . . . 75.310000000000002 112.532 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.45 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 1.3 mptp? -117.11 110.29 18.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.815 0.341 . . . . 74.299999999999997 110.855 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.517 ' CB ' ' HB3' ' A' ' 52' ' ' PHE . . . -58.52 107.44 0.95 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.526 0.679 . . . . 61.530000000000001 111.092 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.1 Cg_endo -69.85 166.01 29.15 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.676 2.251 . . . . 75.310000000000002 112.312 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.34 -26.75 65.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 74.519999999999996 110.929 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.61 -52.22 66.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 74.230000000000004 111.099 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.58 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 18.9 mmt180 -69.59 -41.09 76.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 72.329999999999998 110.829 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.498 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -58.78 -52.59 65.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.421 . . . . 74.209999999999994 110.836 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -66.42 -37.26 84.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 74.230000000000004 110.916 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 20.2 mmm -56.44 -52.07 66.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 71.120000000000005 110.895 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.474 HG23 ' N ' ' A' ' 65' ' ' TYR . 17.4 m -62.95 -44.44 99.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 65.219999999999999 111.072 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.576 ' CE1' HD12 ' A' ' 81' ' ' LEU . 14.3 m-85 -60.98 -30.81 70.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 71.450000000000003 110.938 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.02 -46.76 32.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 73.409999999999997 111.08 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.508 ' O ' ' CG2' ' A' ' 20' ' ' ILE . 3.8 t -63.9 -28.8 70.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 70.400000000000006 111.115 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.451 ' O ' ' C ' ' A' ' 69' ' ' GLY . 9.9 mt -82.17 5.58 19.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 75.010000000000005 110.854 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 34.07 67.59 0.24 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 72.230000000000004 112.484 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.483 ' HG3' ' N ' ' A' ' 71' ' ' LEU . 5.8 pt-20 -85.41 -39.48 17.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 75.200000000000003 110.847 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.556 ' CD2' ' C ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -91.03 7.38 40.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 73.239999999999995 110.904 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.416 ' N ' HD21 ' A' ' 71' ' ' LEU . 19.8 mtt -73.06 -12.93 61.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 74.219999999999999 110.889 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.15 -32.15 0.1 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.725 -0.75 . . . . 74.010000000000005 112.49 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.419 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.778 -0.725 . . . . 41.020000000000003 112.514 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.801 0.334 . . . . 62.439999999999998 111.039 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.578 HD12 ' CE2' ' A' ' 43' ' ' PHE . 7.8 tp -107.96 128.18 54.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 74.219999999999999 110.902 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -102.45 115.0 29.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 73.450000000000003 110.957 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.576 HD12 ' CE1' ' A' ' 65' ' ' TYR . 8.6 tt -139.76 135.86 33.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.241 -0.436 . . . . 74.230000000000004 110.899 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -136.49 131.63 34.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 73.439999999999998 110.949 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.537 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 67.1 p -116.69 106.8 13.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 55.219999999999999 111.155 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.05 161.81 24.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 75.099999999999994 110.96 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.48 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -71.8 163.41 66.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.546 0.689 . . . . 73.129999999999995 111.175 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.505 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.2 Cg_endo -69.78 -10.32 28.25 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.749 2.3 . . . . 72.040000000000006 112.349 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -76.0 -35.89 59.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 72.329999999999998 110.821 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -68.19 -36.06 78.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.426 . . . . 71.329999999999998 110.898 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.154 -0.475 . . . . 71.140000000000001 111.122 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.498 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . . . . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.736 0.303 . . . . 73.340000000000003 111.062 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.501 ' OE1' ' NE ' ' A' ' 21' ' ' ARG . 4.3 mm-40 -68.65 -26.55 65.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 73.310000000000002 110.854 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.7 p -61.4 -56.91 15.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 73.420000000000002 111.1 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.498 ' CD1' ' HA ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -74.06 -29.91 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 73.420000000000002 111.1 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.501 ' NE ' ' OE1' ' A' ' 18' ' ' GLU . 23.7 ttp85 -63.37 -50.86 68.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 60.43 110.851 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -72.79 -36.13 67.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 74.549999999999997 110.897 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.471 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -57.91 -51.04 71.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 73.400000000000006 110.851 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.471 ' CG2' HG23 ' A' ' 33' ' ' VAL . 8.6 mt -73.5 -44.16 54.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 74.019999999999996 111.17 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.444 ' CG ' ' O ' ' A' ' 21' ' ' ARG . 68.0 mt-10 -56.51 -32.22 64.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 74.120000000000005 110.874 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.27 -43.23 17.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 74.010000000000005 110.83 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.44 -41.89 97.29 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.737 -0.744 . . . . 73.420000000000002 112.548 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -122.94 102.41 37.88 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.648 0.737 . . . . 65.120000000000005 110.915 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -15.02 37.09 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.687 2.258 . . . . 73.349999999999994 112.3 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -100.16 0.83 41.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.411 . . . . 73.549999999999997 110.86 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -120.58 135.7 55.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 71.200000000000003 111.108 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.462 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 47.1 ttt-85 -110.44 123.73 50.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 74.200000000000003 110.926 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.471 HG23 ' CG2' ' A' ' 24' ' ' ILE . 4.8 t -122.37 134.3 66.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 74.519999999999996 111.139 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.35 118.08 16.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 75.420000000000002 110.912 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.4 t -123.62 130.4 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 75.510000000000005 111.104 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -133.34 120.15 20.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 71.400000000000006 110.889 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.07 -119.97 1.12 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.712 -0.756 . . . . 73.340000000000003 112.437 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -172.19 170.43 5.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 74.420000000000002 110.903 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -80.35 145.55 32.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 72.120000000000005 110.908 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.474 ' CA ' ' O ' ' A' ' 73' ' ' GLY . . . 72.7 -0.94 40.69 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.747 -0.739 . . . . 65.230000000000004 112.487 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.13 165.19 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 75.340000000000003 111.186 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.447 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . 53.9 p-80 -74.67 106.45 6.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 72.510000000000005 110.857 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.571 ' CE2' HD12 ' A' ' 79' ' ' LEU . 8.6 p90 -120.55 168.06 11.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 73.239999999999995 110.912 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -113.2 121.22 43.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 74.349999999999994 110.859 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.67 126.99 45.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.103 -0.499 . . . . 64.310000000000002 111.093 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.7 m -120.96 120.64 36.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 73.140000000000001 111.146 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 78.2 t -119.45 136.76 55.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 72.319999999999993 111.119 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.462 ' CG1' ' HB3' ' A' ' 32' ' ' ARG . 7.2 p -136.17 124.28 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 74.400000000000006 111.156 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.406 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.9 OUTLIER -174.62 164.74 2.45 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.624 0.725 . . . . 73.019999999999996 110.879 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.524 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.2 Cg_endo -69.71 -19.96 35.68 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.653 2.236 . . . . 64.120000000000005 112.369 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.47 -40.51 18.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 111.08 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.574 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 0.5 OUTLIER -92.22 37.64 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 74.420000000000002 110.907 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.484 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 2.6 p -52.82 136.0 14.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 63.32 111.136 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.459 ' N ' HG21 ' A' ' 53' ' ' VAL . . . 60.37 -89.09 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.765 -0.731 . . . . 64.109999999999999 112.455 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.432 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 3.6 mptp? -119.28 111.08 17.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.746 0.308 . . . . 70.310000000000002 110.932 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.505 ' CB ' ' HB3' ' A' ' 52' ' ' PHE . . . -58.46 107.99 1.15 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.607 0.718 . . . . 73.200000000000003 111.071 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.76 164.23 35.33 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.665 2.244 . . . . 74.019999999999996 112.375 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.6 tt -57.64 -24.85 58.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 73.219999999999999 110.887 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.406 ' O ' ' SD ' ' A' ' 63' ' ' MET . . . -61.91 -52.75 62.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 63.32 111.099 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.574 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 0.5 OUTLIER -69.08 -40.7 78.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 74.450000000000003 110.875 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.561 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 1.1 t60 -58.85 -53.98 52.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 75.349999999999994 110.826 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -66.2 -35.53 80.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.209999999999994 110.868 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.406 ' SD ' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -58.33 -46.22 86.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 72.150000000000006 110.88 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.482 HG22 ' N ' ' A' ' 65' ' ' TYR . 17.1 m -69.15 -40.22 80.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 72.150000000000006 111.185 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.569 ' CE1' HD21 ' A' ' 81' ' ' LEU . 14.2 m-85 -64.93 -35.89 82.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 75.409999999999997 110.92 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.3 -46.63 39.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 74.209999999999994 111.115 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.479 ' CG2' ' HA ' ' A' ' 64' ' ' VAL . 6.0 t -66.04 -28.47 68.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 75.230000000000004 111.107 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.461 ' CD1' HD12 ' A' ' 24' ' ' ILE . 5.2 mp -82.32 7.66 13.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 75.510000000000005 110.917 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 35.71 68.79 0.26 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.786 -0.721 . . . . 71.219999999999999 112.402 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.43 ' CD ' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -102.38 -24.62 13.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.879 0.371 . . . . 72.239999999999995 110.845 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.43 HD22 ' CD ' ' A' ' 70' ' ' GLU . 3.0 mm? -86.75 -21.0 26.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 70.420000000000002 110.902 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.2 ttm -76.22 -12.59 60.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 74.540000000000006 110.867 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.474 ' O ' ' CA ' ' A' ' 40' ' ' GLY . . . -120.47 -9.19 7.95 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.746 -0.74 . . . . 71.140000000000001 112.455 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.762 -0.733 . . . . 74.129999999999995 112.483 -179.903 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.447 ' HB3' ' CB ' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.85 0.357 . . . . 65.239999999999995 111.138 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.571 HD12 ' CE2' ' A' ' 43' ' ' PHE . 8.8 tp -110.2 138.43 46.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 75.519999999999996 110.928 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -104.62 117.07 33.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 61.509999999999998 110.891 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.569 HD21 ' CE1' ' A' ' 65' ' ' TYR . 1.9 tp -139.33 123.51 17.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 63.109999999999999 110.886 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -126.87 123.3 36.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 75.209999999999994 110.891 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.526 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 4.9 p -113.22 107.25 15.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 64.420000000000002 111.186 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.7 mp -129.81 161.59 30.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 72.510000000000005 110.924 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.484 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.9 164.04 61.8 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.614 0.721 . . . . 71.219999999999999 111.102 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.9 Cg_endo -69.71 -23.75 30.67 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.714 2.276 . . . . 72.409999999999997 112.296 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.44 -34.9 78.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 73.150000000000006 110.891 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.08 -33.18 75.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 71.439999999999998 110.876 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 73.519999999999996 111.09 179.941 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.732 0.301 . . . . 74.439999999999998 111.048 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -71.54 -48.01 51.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 72.299999999999997 110.92 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 t -57.96 -51.7 68.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 74.239999999999995 111.177 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.2 pt -66.06 -41.9 90.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 73.510000000000005 111.168 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -60.45 -53.58 55.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 74.420000000000002 110.912 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.456 ' CG ' ' N ' ' A' ' 23' ' ' LEU . 23.2 pttt -59.43 -44.83 92.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 75.310000000000002 110.861 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.456 ' N ' ' CG ' ' A' ' 22' ' ' LYS . 2.1 mm? -55.96 -49.12 74.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 64.319999999999993 110.867 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.481 ' CG2' HG22 ' A' ' 33' ' ' VAL . 7.1 mt -68.17 -44.12 84.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 64.400000000000006 111.113 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -54.79 -37.85 66.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 75.439999999999998 110.874 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.1 -41.31 35.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 71.129999999999995 110.866 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.31 -53.82 33.7 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.701 -0.761 . . . . 72.230000000000004 112.483 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.94 159.13 79.29 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.533 0.682 . . . . 74.450000000000003 110.985 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -87.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.676 2.25 . . . . 71.430000000000007 112.369 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -111.02 26.12 11.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 75.340000000000003 110.889 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.31 125.85 28.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 74.239999999999995 111.085 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -91.77 107.52 19.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 72.400000000000006 110.984 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.481 HG22 ' CG2' ' A' ' 24' ' ' ILE . 61.6 t -109.83 121.33 62.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 72.310000000000002 111.132 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -132.38 118.88 19.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 73.230000000000004 110.876 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 44.8 t -126.79 136.98 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 72.310000000000002 111.146 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -130.67 120.5 24.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.159 -0.473 . . . . 71.409999999999997 110.886 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.435 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 140.63 -142.08 11.99 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.672 -0.775 . . . . 71.120000000000005 112.491 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -165.29 156.04 13.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.886 0.374 . . . . 72.239999999999995 110.84 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -62.26 154.51 27.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 75.530000000000001 110.863 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.85 -2.59 40.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.676 -0.773 . . . . 75.120000000000005 112.524 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.3 t -132.52 164.76 34.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.328 . . . . 71.299999999999997 111.174 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.598 ' CD2' ' O ' ' A' ' 42' ' ' HIS . 0.6 OUTLIER -75.02 106.72 6.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 74.030000000000001 110.825 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.55 ' CZ ' HD12 ' A' ' 79' ' ' LEU . 39.7 p90 -121.98 167.79 12.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 74.329999999999998 110.846 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -113.26 133.52 55.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 74.140000000000001 110.89 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.478 ' CB ' HD23 ' A' ' 68' ' ' LEU . . . -128.09 118.84 24.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 65.219999999999999 111.17 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.2 m -121.4 111.5 17.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 72.430000000000007 111.149 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.47 HG21 ' CG1' ' A' ' 33' ' ' VAL . 94.9 t -120.74 134.73 63.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 71.120000000000005 111.097 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.6 p -131.05 122.72 52.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 75.510000000000005 111.111 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.423 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.9 OUTLIER -161.83 165.6 15.91 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.628 0.728 . . . . 73.5 110.874 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.512 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 52.9 Cg_endo -69.93 -22.14 31.7 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.728 2.285 . . . . 71.340000000000003 112.215 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 60' ' ' ARG . . . -47.04 -44.29 20.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 75.519999999999996 111.079 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.576 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -87.11 35.56 0.7 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 73.420000000000002 110.902 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.47 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 12.4 p -52.26 125.86 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 73.25 111.138 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.5 -89.4 0.73 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.712 -0.756 . . . . 55.130000000000003 112.51 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.422 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 3.3 mptp? -120.3 110.23 16.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.809 0.338 . . . . 73.329999999999998 110.871 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.551 ' CB ' ' HB3' ' A' ' 52' ' ' PHE . . . -58.64 108.15 1.21 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.563 0.697 . . . . 62.420000000000002 111.08 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.83 161.59 45.36 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.728 2.285 . . . . 64.329999999999998 112.36 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.417 HD21 ' NH1' ' A' ' 62' ' ' ARG . 1.1 tp -57.87 -27.25 63.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.28 -0.418 . . . . 74.310000000000002 110.925 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.27 -52.16 66.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 64.510000000000005 111.092 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.576 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 23.2 mmt180 -69.18 -43.0 75.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 75.209999999999994 110.856 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.511 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 0.2 OUTLIER -59.17 -51.49 69.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 75.230000000000004 110.849 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.417 ' NH1' HD21 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -66.15 -38.64 88.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 74.439999999999998 110.902 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 21.8 mmt -56.29 -48.27 76.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 74.549999999999997 110.919 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 61' ' ' HIS . 16.3 m -65.31 -39.54 85.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 72.340000000000003 111.117 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.562 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 12.4 m-85 -59.58 -39.81 85.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 72.439999999999998 110.91 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.06 -46.96 31.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 74.450000000000003 111.133 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 64' ' ' VAL . 0.9 OUTLIER -61.66 -31.32 71.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 74.420000000000002 111.145 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.478 HD23 ' CB ' ' A' ' 45' ' ' ALA . 7.3 mp -83.04 -4.3 58.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 72.510000000000005 110.929 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.75 69.37 1.28 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.705 -0.76 . . . . 71.230000000000004 112.535 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -85.31 -40.5 16.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 75.120000000000005 110.911 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 mp -87.87 9.87 20.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 75.219999999999999 110.916 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.6 mmt -72.01 -13.14 61.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 72.230000000000004 110.909 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.92 -32.91 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.77 -0.729 . . . . 73.310000000000002 112.528 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.745 -0.74 . . . . 64.230000000000004 112.465 -179.88 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.463 ' HB3' ' CB ' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.833 0.349 . . . . 61.140000000000001 111.075 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.55 HD12 ' CZ ' ' A' ' 43' ' ' PHE . 1.6 mm? -97.83 140.43 32.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 72.430000000000007 110.939 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -118.21 115.62 25.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 75.019999999999996 111.016 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.562 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 0.6 OUTLIER -130.85 116.57 18.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 74.299999999999997 110.862 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.465 ' HD3' ' N ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -126.01 122.19 35.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 75.049999999999997 110.944 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.521 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 69.2 p -115.62 107.34 14.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.289 -0.414 . . . . 71.209999999999994 111.172 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -127.75 162.06 27.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 74.310000000000002 110.894 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.47 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.02 163.29 68.17 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-O 121.639 0.733 . . . . 73.549999999999997 111.12 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.512 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.9 Cg_endo -69.72 -7.49 21.18 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.693 2.262 . . . . 74.540000000000006 112.363 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -84.58 -30.77 24.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 61.539999999999999 110.828 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -84.79 28.24 0.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 62.119999999999997 110.876 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 72.400000000000006 111.072 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.47 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . . . . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.67 0.271 . . . . 55.130000000000003 111.091 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -72.65 -48.8 36.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 72.340000000000003 110.856 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.408 HG23 ' N ' ' A' ' 20' ' ' ILE . 2.9 t -61.59 -47.63 84.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 71.319999999999993 111.151 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.47 ' CD1' ' HA ' ' A' ' 17' ' ' ALA . 10.8 pt -67.8 -43.13 86.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 73.120000000000005 111.149 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.1 ttt-85 -54.97 -52.91 61.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 74.310000000000002 110.838 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -65.42 -37.05 85.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 74.349999999999994 110.838 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.76 -50.26 72.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.47 . . . . 73.239999999999995 110.844 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.481 ' CD1' HG11 ' A' ' 33' ' ' VAL . 7.9 mt -72.51 -36.31 53.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 73.120000000000005 111.131 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -58.92 -38.3 78.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 70.430000000000007 110.845 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -80.84 -42.11 22.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 71.200000000000003 110.846 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.37 -42.48 99.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.738 . . . . 64.150000000000006 112.525 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -89.88 157.29 46.3 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.556 0.693 . . . . 73.329999999999998 110.962 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -91.22 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.662 2.241 . . . . 55.520000000000003 112.306 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -104.58 27.11 8.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.252 -0.431 . . . . 74.099999999999994 110.907 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.61 132.25 38.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 75.409999999999997 111.053 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.406 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 7.9 ttm-85 -101.35 112.12 24.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 75.540000000000006 110.873 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.481 HG11 ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -107.32 129.32 61.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.202 -0.454 . . . . 73.049999999999997 111.093 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.73 118.53 16.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 74.329999999999998 110.895 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.9 t -127.66 129.86 70.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 73.310000000000002 111.205 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -133.25 120.15 20.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.933 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.467 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 151.0 -125.97 2.01 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.726 -0.75 . . . . 74.230000000000004 112.483 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -174.66 157.76 2.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 74.099999999999994 110.909 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -68.41 144.16 54.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 74.430000000000007 110.854 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.76 22.26 79.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.759 . . . . 61.100000000000001 112.56 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -150.63 164.79 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.866 0.365 . . . . 71.329999999999998 111.111 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.455 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . 28.1 p80 -75.09 106.66 6.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 74.439999999999998 110.831 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.556 ' CE2' HD23 ' A' ' 79' ' ' LEU . 8.7 p90 -122.43 167.4 13.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 64.140000000000001 110.903 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -113.72 120.33 40.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 65.209999999999994 110.903 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.25 115.77 22.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 71.200000000000003 111.019 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.6 m -113.62 123.5 50.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 75.140000000000001 111.153 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.429 ' CG2' HG12 ' A' ' 33' ' ' VAL . 27.1 t -123.59 140.72 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 72.549999999999997 111.134 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.412 ' O ' ' CG1' ' A' ' 48' ' ' VAL . 8.1 p -130.52 117.83 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 73.420000000000002 111.165 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.411 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.9 OUTLIER -162.0 164.49 17.47 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.679 0.752 . . . . 72.349999999999994 110.855 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.541 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.3 Cg_endo -69.88 -22.05 32.06 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.631 2.221 . . . . 74.510000000000005 112.309 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.69 -44.53 38.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 72.140000000000001 111.133 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.523 ' CG ' ' HB ' ' A' ' 83' ' ' THR . 0.5 OUTLIER -87.63 34.19 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 71.450000000000003 110.898 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 55' ' ' LYS . 7.6 p -52.41 131.63 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 73.310000000000002 111.109 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 56.08 -81.02 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.726 -0.75 . . . . 74.439999999999998 112.517 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 53' ' ' VAL . 69.6 mmtt -113.3 134.27 54.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.796 0.331 . . . . 75.010000000000005 110.876 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.56 99.96 9.77 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.608 0.718 . . . . 74.430000000000007 111.1 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 172.58 12.32 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.695 2.263 . . . . 73.510000000000005 112.333 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tp -57.01 -27.49 61.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 74.040000000000006 110.913 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.3 -53.35 59.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 61.130000000000003 111.016 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.509 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 12.2 mmm180 -70.57 -42.24 71.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 72.109999999999999 110.838 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.566 ' CE1' HD23 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -57.12 -53.1 61.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 73.340000000000003 110.874 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -67.49 -38.86 84.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 73.239999999999995 110.903 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.463 ' C ' ' SD ' ' A' ' 63' ' ' MET . 0.7 OUTLIER -54.08 -48.02 71.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 75.209999999999994 110.853 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.512 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 24.4 m -68.77 -40.64 81.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 74.230000000000004 111.156 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.57 ' CE1' HD12 ' A' ' 81' ' ' LEU . 10.5 m-85 -64.93 -34.84 79.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 65.239999999999995 110.936 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.75 -46.24 32.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 75.530000000000001 111.193 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.47 ' CG2' HD13 ' A' ' 68' ' ' LEU . 3.8 t -67.58 -25.67 65.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 74.409999999999997 111.108 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.512 ' CD1' ' O ' ' A' ' 64' ' ' VAL . 5.9 mp -82.48 -0.47 46.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.246 -0.434 . . . . 73.239999999999995 110.919 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.6 68.37 1.02 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.75 -0.738 . . . . 70.120000000000005 112.439 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.466 ' C ' ' OE1' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -88.06 -25.57 22.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.339 . . . . 73.209999999999994 110.817 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.416 HD21 ' CD ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -89.64 7.12 38.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 73.049999999999997 110.963 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.4 mmt -73.15 -7.18 50.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 72.409999999999997 110.899 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.94 -35.04 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.703 -0.761 . . . . 74.200000000000003 112.492 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.767 -0.73 . . . . 71.319999999999993 112.517 -179.924 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.455 ' HB3' ' CB ' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.79 0.329 . . . . 72.329999999999998 111.092 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.556 HD23 ' CE2' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -97.68 134.41 40.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 74.129999999999995 110.894 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -106.95 118.67 37.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 71.430000000000007 110.984 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.57 HD12 ' CE1' ' A' ' 65' ' ' TYR . 4.5 tp -123.05 138.9 54.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 74.5 110.873 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -132.36 118.46 19.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 75.219999999999999 110.933 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.523 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 11.8 p -118.91 107.35 13.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 73.010000000000005 111.133 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.22 161.42 28.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.92 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.466 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -76.35 164.92 56.81 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.545 0.688 . . . . 74.519999999999996 111.166 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.5 Cg_endo -69.8 -0.15 6.52 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.695 2.264 . . . . 71.540000000000006 112.36 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.09 -27.43 26.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 73.010000000000005 110.869 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -82.2 24.81 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 72.150000000000006 110.884 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 65.200000000000003 111.137 179.918 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.413 ' O ' ' CB ' ' A' ' 21' ' ' ARG . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.687 0.28 . . . . 73.329999999999998 111.096 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.557 ' CD ' ' N ' ' A' ' 19' ' ' THR . 3.0 pp20? -66.77 -48.14 69.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 72.099999999999994 110.83 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.557 ' N ' ' CD ' ' A' ' 18' ' ' GLU . 3.7 t -57.74 -52.45 65.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 74.349999999999994 111.089 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.469 HD11 ' CG2' ' A' ' 35' ' ' VAL . 5.9 pt -67.84 -41.95 85.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 72.219999999999999 111.176 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 54.4 ttp180 -58.67 -51.47 69.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 62.219999999999999 110.868 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.1 pttp -63.79 -40.24 96.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.499 . . . . 75.0 110.892 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 20.6 mt -56.32 -50.27 71.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 72.310000000000002 110.898 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.486 ' CG2' HG22 ' A' ' 33' ' ' VAL . 10.5 mt -69.53 -43.86 80.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 74.409999999999997 111.112 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -55.64 -35.07 65.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.462 . . . . 71.439999999999998 110.868 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -79.18 -43.2 24.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 74.230000000000004 110.905 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.65 -34.38 88.77 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.695 -0.764 . . . . 73.209999999999994 112.524 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.63 158.98 32.76 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.545 0.688 . . . . 65.450000000000003 110.924 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -90.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.695 2.263 . . . . 64.329999999999998 112.4 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -107.87 33.46 4.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 70.209999999999994 110.912 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.67 133.87 34.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 72.239999999999995 111.138 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.469 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 39.8 ttt-85 -106.4 125.56 51.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 75.430000000000007 110.845 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.486 HG22 ' CG2' ' A' ' 24' ' ' ILE . 3.9 t -124.0 135.45 63.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 74.329999999999998 111.149 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -135.26 118.46 16.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 72.010000000000005 110.889 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.469 ' CG2' HD11 ' A' ' 20' ' ' ILE . 39.6 t -125.85 136.7 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 73.299999999999997 111.143 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.3 mm-40 -133.33 120.36 20.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 71.340000000000003 110.893 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.84 -143.21 13.46 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 75.219999999999999 112.461 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -151.19 -174.98 4.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.889 0.376 . . . . 75.219999999999999 110.845 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -87.77 146.79 25.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 73.209999999999994 110.888 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.431 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 73.24 1.14 56.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.73 . . . . 62.310000000000002 112.476 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 m -125.21 165.19 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 73.439999999999998 111.1 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.454 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 23.6 p80 -74.86 107.01 6.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 62.530000000000001 110.821 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.579 ' CE2' HD12 ' A' ' 79' ' ' LEU . 39.6 p90 -121.99 167.75 12.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 74.120000000000005 110.898 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -113.48 124.74 53.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 73.120000000000005 110.86 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.18 115.88 19.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 63.25 111.099 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.8 m -117.72 112.71 20.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 72.319999999999993 111.131 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.428 ' CG2' HG11 ' A' ' 33' ' ' VAL . 22.6 t -110.5 141.44 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 74.299999999999997 111.133 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.492 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 4.0 p -130.42 118.95 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 75.209999999999994 111.127 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.42 ' OG ' ' CE2' ' A' ' 52' ' ' PHE . 24.1 p -168.7 160.01 8.4 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.654 0.74 . . . . 74.430000000000007 110.923 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.573 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.4 Cg_endo -69.74 -18.65 36.96 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.659 2.239 . . . . 72.030000000000001 112.383 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.83 -38.47 35.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 61.240000000000002 111.077 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.601 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 1.3 m-85 -90.86 33.5 0.93 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 73.510000000000005 110.904 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.464 HG22 ' N ' ' A' ' 54' ' ' GLY . 10.9 p -52.18 146.82 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 74.299999999999997 111.122 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.464 ' N ' HG22 ' A' ' 53' ' ' VAL . . . 52.17 -89.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.719 . . . . 71.430000000000007 112.467 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -121.62 111.03 16.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.333 . . . . 74.209999999999994 110.87 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.494 ' CB ' ' HB3' ' A' ' 52' ' ' PHE . . . -59.67 108.28 1.33 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.58 0.705 . . . . 73.120000000000005 111.097 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.6 Cg_endo -69.76 161.55 45.48 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.695 2.263 . . . . 63.5 112.344 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -55.14 -24.76 27.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 61.439999999999998 110.921 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.33 -52.57 64.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 55.310000000000002 111.06 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.601 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 21.1 mmt180 -69.78 -41.01 75.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 75.420000000000002 110.84 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.557 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 1.0 OUTLIER -59.77 -53.01 62.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 73.530000000000001 110.908 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -66.2 -35.64 80.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 75.420000000000002 110.813 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.2 ttt -59.09 -49.86 76.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 73.319999999999993 110.852 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.49 HG21 ' N ' ' A' ' 65' ' ' TYR . 22.1 m -65.08 -41.43 91.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 71.439999999999998 111.136 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.569 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 12.8 m-85 -62.83 -36.89 84.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 74.450000000000003 110.921 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.73 -35.27 60.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 64.140000000000001 111.107 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.516 HG22 ' N ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -70.95 -30.17 66.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 74.230000000000004 111.121 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.516 ' N ' HG22 ' A' ' 67' ' ' THR . 4.0 pp -83.6 -3.79 58.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 74.439999999999998 110.912 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.68 63.4 3.72 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.799 -0.715 . . . . 74.340000000000003 112.422 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.459 ' N ' HD11 ' A' ' 68' ' ' LEU . 26.0 tt0 -70.03 -57.43 5.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.387 . . . . 74.409999999999997 110.875 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -84.79 8.65 16.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 74.209999999999994 110.888 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.7 ttt -78.17 -13.2 59.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 72.540000000000006 110.89 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.47 -32.2 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.708 -0.758 . . . . 51.229999999999997 112.506 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.431 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.764 -0.731 . . . . 74.120000000000005 112.533 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.423 ' HB2' ' CB ' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.815 0.341 . . . . 74.099999999999994 111.082 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.579 HD12 ' CE2' ' A' ' 43' ' ' PHE . 8.3 tp -113.04 147.53 37.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 74.129999999999995 110.99 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -113.71 119.33 37.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 72.549999999999997 110.837 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.569 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 0.5 OUTLIER -128.61 117.62 21.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 75.0 110.889 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -119.33 114.52 22.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 73.400000000000006 110.874 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.526 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 17.3 p -117.1 106.54 13.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 62.130000000000003 111.147 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mp -132.42 162.76 30.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 75.519999999999996 110.973 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.404 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -71.12 165.39 48.34 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.615 0.721 . . . . 73.329999999999998 111.147 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.1 Cg_endo -69.8 -24.8 29.09 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.729 2.286 . . . . 73.120000000000005 112.285 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -65.77 -32.31 73.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 63.520000000000003 110.83 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -70.03 -35.03 74.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 71.430000000000007 110.874 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 61.32 111.071 179.965 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.467 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.744 0.306 . . . . 73.340000000000003 111.122 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -72.01 -47.83 49.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 74.219999999999999 110.934 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.7 t -61.68 -47.04 87.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 75.010000000000005 111.115 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.492 HD13 ' N ' ' A' ' 21' ' ' ARG . 2.0 pp -69.51 -36.84 73.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 73.340000000000003 111.119 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.492 ' N ' HD13 ' A' ' 20' ' ' ILE . 35.9 ttt180 -63.58 -49.99 71.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.400000000000006 110.871 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.414 ' CG ' HD22 ' A' ' 23' ' ' LEU . 34.1 pttt -64.45 -41.99 96.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 71.420000000000002 110.929 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.453 ' N ' HD22 ' A' ' 23' ' ' LEU . 3.2 mm? -56.48 -50.79 70.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 75.219999999999999 110.937 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.485 ' CG2' HG21 ' A' ' 33' ' ' VAL . 12.7 mt -68.0 -43.83 85.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 71.450000000000003 111.127 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -56.53 -34.85 67.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 73.239999999999995 110.794 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.98 -43.38 35.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 72.409999999999997 110.874 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.66 -49.01 77.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 70.310000000000002 112.476 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.6 mt -118.93 102.31 49.37 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.628 0.728 . . . . 74.150000000000006 110.944 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -15.03 36.87 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.701 2.268 . . . . 73.340000000000003 112.294 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -96.18 -10.21 28.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 63.399999999999999 110.862 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.454 ' CB ' ' HB3' ' A' ' 49' ' ' SER . . . -111.04 126.83 55.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 71.510000000000005 111.105 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.498 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 24.5 ttp180 -103.06 117.17 33.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 63.350000000000001 110.874 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.485 HG21 ' CG2' ' A' ' 24' ' ' ILE . 18.5 t -111.75 131.17 63.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 74.010000000000005 111.092 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -135.4 117.65 15.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 73.030000000000001 110.884 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 17' ' ' ALA . 4.6 p -126.91 139.4 51.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 52.229999999999997 111.11 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.44 ' N ' HG21 ' A' ' 35' ' ' VAL . 35.9 mt-30 -132.2 120.63 22.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 72.340000000000003 110.945 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 149.99 -139.45 7.37 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.751 -0.737 . . . . 53.43 112.467 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.84 153.62 8.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.859 0.361 . . . . 74.439999999999998 110.906 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -58.61 147.48 32.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 74.239999999999995 110.893 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.29 -11.16 13.25 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.741 -0.742 . . . . 72.239999999999995 112.556 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.5 t -118.14 164.05 14.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 73.349999999999994 111.099 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.469 ' HB3' ' CB ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -75.79 107.67 8.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 73.340000000000003 110.889 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.656 ' CZ ' ' CD1' ' A' ' 79' ' ' LEU . 3.6 p90 -119.37 167.22 12.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 74.030000000000001 110.824 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.418 ' OE2' ' C ' ' A' ' 45' ' ' ALA . 1.0 OUTLIER -113.52 135.19 54.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 64.209999999999994 110.902 -179.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.418 ' C ' ' OE2' ' A' ' 44' ' ' GLU . . . -127.25 121.25 30.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 74.349999999999994 111.064 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.7 m -121.3 110.96 16.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 73.439999999999998 111.168 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.469 ' CG1' HG13 ' A' ' 33' ' ' VAL . 3.8 m -112.77 140.05 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 74.239999999999995 111.152 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.498 ' CG1' ' HB3' ' A' ' 32' ' ' ARG . 3.0 p -134.4 118.81 28.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 70.219999999999999 111.175 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.454 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 12.2 p -169.64 161.65 7.17 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.682 0.753 . . . . 70.319999999999993 110.859 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.571 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.6 Cg_endo -69.78 -23.4 30.74 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.664 2.242 . . . . 64.430000000000007 112.262 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.12 -41.59 17.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.307 -0.406 . . . . 61.530000000000001 111.085 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.614 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 1.6 m-85 -86.45 32.38 0.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 75.510000000000005 110.844 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 55' ' ' LYS . 10.8 p -52.38 146.79 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.491 . . . . 64.439999999999998 111.16 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.461 ' N ' HG23 ' A' ' 53' ' ' VAL . . . 50.5 -88.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.747 -0.74 . . . . 73.340000000000003 112.424 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -121.06 112.25 18.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.792 0.33 . . . . 74.439999999999998 110.898 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.17 108.24 1.28 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.564 0.697 . . . . 74.049999999999997 111.101 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.64 162.43 42.05 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.66 2.24 . . . . 74.209999999999994 112.416 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -56.36 -26.12 51.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 75.150000000000006 110.966 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.82 -52.64 64.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 72.239999999999995 111.084 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.614 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 11.6 mmp_? -69.57 -42.77 74.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 75.140000000000001 110.889 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.453 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -58.59 -52.99 63.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 75.450000000000003 110.864 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -65.41 -36.49 84.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 63.329999999999998 110.903 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -57.09 -48.25 79.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 75.25 110.889 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 65' ' ' TYR . 17.2 m -67.68 -40.88 84.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 73.239999999999995 111.146 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.502 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 14.8 m-85 -65.74 -33.39 75.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 75.519999999999996 110.897 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.36 -46.03 43.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.096 -0.502 . . . . 74.109999999999999 111.069 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.423 ' CG2' ' HA ' ' A' ' 64' ' ' VAL . 4.7 t -63.81 -33.66 76.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 61.409999999999997 111.161 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.467 ' O ' ' C ' ' A' ' 69' ' ' GLY . 3.4 mp -81.9 -1.95 49.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.447 . . . . 53.520000000000003 110.91 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 32.48 82.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.806 -0.711 . . . . 55.310000000000002 112.51 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.55 -20.17 34.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.357 . . . . 75.120000000000005 110.887 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.96 9.36 22.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 75.239999999999995 110.871 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.87 -13.2 61.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 75.450000000000003 110.867 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.58 -33.15 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.772 -0.727 . . . . 70.409999999999997 112.511 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 C-N-CA 120.694 -0.765 . . . . 74.420000000000002 112.497 -179.94 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.469 ' CB ' ' HB3' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.865 0.364 . . . . 70.530000000000001 111.12 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.656 ' CD1' ' CZ ' ' A' ' 43' ' ' PHE . 3.7 mm? -97.02 143.67 27.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 75.329999999999998 110.888 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -118.79 115.25 24.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 72.010000000000005 110.919 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.502 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 0.4 OUTLIER -123.9 116.7 23.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 75.099999999999994 110.92 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.07 114.85 23.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 73.439999999999998 110.899 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.548 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 40.2 p -115.78 106.49 13.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.236 -0.438 . . . . 64.230000000000004 111.174 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.4 mt -131.68 162.82 29.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 63.140000000000001 110.894 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.457 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -70.79 164.53 54.94 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.592 0.71 . . . . 71.209999999999994 111.128 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.4 Cg_endo -69.76 -24.53 29.58 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.726 2.284 . . . . 74.129999999999995 112.301 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.54 -36.0 82.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 70.230000000000004 110.882 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.63 -41.66 87.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 71.010000000000005 110.876 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.426 ' CB ' HG23 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 73.430000000000007 111.108 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.793 0.33 . . . . 72.219999999999999 111.075 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -70.69 -37.98 73.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 64.519999999999996 110.815 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 6.2 p -59.21 -54.02 51.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 73.310000000000002 111.144 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.48 -47.34 77.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 74.310000000000002 111.152 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -53.29 -50.42 64.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 72.040000000000006 110.897 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 ptmm? -66.96 -35.39 79.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 70.319999999999993 110.868 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.32 -49.27 74.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.433 . . . . 75.430000000000007 110.908 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.468 ' CG2' HG22 ' A' ' 33' ' ' VAL . 7.4 mm -72.79 -42.81 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 74.519999999999996 111.191 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -54.7 -37.19 65.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.075 -0.511 . . . . 73.530000000000001 110.858 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -82.88 -42.49 17.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 73.299999999999997 110.894 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.99 -47.58 90.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.688 -0.768 . . . . 64.319999999999993 112.463 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.492 ' CB ' ' HB2' ' A' ' 31' ' ' ALA . 2.5 mm? -76.19 157.06 83.51 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.57 0.7 . . . . 74.430000000000007 110.91 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -58.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.63 2.22 . . . . 64.219999999999999 112.377 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -134.99 20.81 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 50.149999999999999 110.942 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.492 ' HB2' ' CB ' ' A' ' 28' ' ' LEU . . . -74.4 126.52 30.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 75.540000000000006 111.087 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.457 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 4.3 tpt180 -100.68 109.7 21.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 73.140000000000001 110.858 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.468 HG22 ' CG2' ' A' ' 24' ' ' ILE . 41.1 t -114.14 135.34 54.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 73.230000000000004 111.088 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -135.23 118.81 16.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 71.430000000000007 110.85 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.477 HG21 ' CD2' ' A' ' 68' ' ' LEU . 61.4 t -121.49 131.33 73.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 74.049999999999997 111.119 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -132.83 120.35 21.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 74.430000000000007 110.895 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 142.45 -163.68 27.12 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.809 -0.71 . . . . 53.149999999999999 112.514 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -135.39 176.23 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.871 0.367 . . . . 73.340000000000003 110.888 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -78.65 146.52 34.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 62.130000000000003 110.841 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.73 18.43 78.75 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.763 -0.732 . . . . 75.519999999999996 112.402 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.42 ' CG2' ' N ' ' A' ' 42' ' ' HIS . 12.5 p -144.63 164.39 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 72.109999999999999 111.143 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.497 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 8.1 p80 -75.52 108.09 8.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 74.129999999999995 110.935 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.68 ' CZ ' ' CD1' ' A' ' 79' ' ' LEU . 9.7 p90 -114.96 167.11 11.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 73.340000000000003 110.926 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -116.59 126.76 53.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 74.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.415 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -128.33 125.35 38.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 51.420000000000002 111.132 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.3 m -121.21 111.17 17.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 70.030000000000001 111.132 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.468 HG22 ' CG1' ' A' ' 33' ' ' VAL . 92.7 t -112.13 138.01 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 74.519999999999996 111.166 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 32' ' ' ARG . 9.9 p -136.21 121.8 28.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 71.140000000000001 111.111 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.412 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.7 OUTLIER -170.25 166.01 5.34 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.588 0.708 . . . . 75.439999999999998 110.917 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.544 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.5 Cg_endo -69.72 -21.66 33.36 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.719 2.279 . . . . 74.129999999999995 112.327 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 60' ' ' ARG . . . -46.73 -46.26 20.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 64.0 111.136 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.573 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -84.72 35.14 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 73.430000000000007 110.873 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.487 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 7.7 p -52.46 133.84 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 71.430000000000007 111.142 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.94 -88.88 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.761 -0.733 . . . . 72.140000000000001 112.484 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.428 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 0.3 OUTLIER -120.64 113.39 20.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.769 0.319 . . . . 74.140000000000001 110.922 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.3 107.8 1.08 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.544 0.688 . . . . 63.299999999999997 111.071 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.7 Cg_endo -69.83 164.9 32.88 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.623 2.215 . . . . 64.319999999999993 112.393 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.457 HD22 ' NE ' ' A' ' 62' ' ' ARG . 1.8 tt -59.66 -25.6 64.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 74.099999999999994 110.892 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.26 -52.15 65.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 111.146 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.573 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 20.4 mmt180 -69.69 -41.08 75.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 75.219999999999999 110.874 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.431 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -58.44 -53.49 57.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 72.409999999999997 110.848 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.457 ' NE ' HD22 ' A' ' 58' ' ' LEU . 51.8 mtt180 -66.47 -36.88 83.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 73.120000000000005 110.874 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.6 mmm -56.61 -47.56 79.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 70.140000000000001 110.819 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.485 HG22 ' N ' ' A' ' 65' ' ' TYR . 19.2 m -68.8 -40.78 81.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 73.310000000000002 111.065 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.485 ' N ' HG22 ' A' ' 64' ' ' VAL . 12.0 m-85 -62.09 -36.09 80.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 75.040000000000006 110.953 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.18 -46.78 31.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 74.010000000000005 111.069 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.505 HG22 ' N ' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -61.7 -33.28 73.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 70.150000000000006 111.135 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.505 ' N ' HG22 ' A' ' 67' ' ' THR . 4.0 mp -84.49 -6.25 59.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 64.549999999999997 110.904 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 34.46 85.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.672 -0.775 . . . . 61.219999999999999 112.534 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.09 -35.11 11.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.841 0.353 . . . . 71.530000000000001 110.882 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.454 ' N ' HD22 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -87.91 5.98 37.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 72.450000000000003 110.867 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.404 ' N ' HD22 ' A' ' 71' ' ' LEU . 1.5 tpt -71.93 -10.65 60.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.432 . . . . 72.120000000000005 110.942 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.83 -32.68 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.777 -0.725 . . . . 71.400000000000006 112.534 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.741 . . . . 61.340000000000003 112.478 -179.936 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.891 0.376 . . . . 64.530000000000001 111.187 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.68 ' CD1' ' CZ ' ' A' ' 43' ' ' PHE . 1.9 mm? -97.62 140.47 31.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 73.120000000000005 110.964 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -116.98 115.71 25.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 63.119999999999997 110.875 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 tp -130.64 138.7 50.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 72.109999999999999 110.957 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -136.33 114.82 11.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 73.200000000000003 110.858 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.509 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 8.8 p -112.02 106.58 15.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.461 . . . . 75.219999999999999 111.119 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.0 mt -133.55 162.02 33.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 70.120000000000005 110.94 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.487 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.72 164.53 57.42 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.642 0.734 . . . . 72.519999999999996 111.056 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.7 Cg_endo -69.78 -11.53 31.0 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.651 2.234 . . . . 74.299999999999997 112.339 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.47 -23.06 26.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 71.030000000000001 110.832 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -108.04 38.44 2.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 75.219999999999999 110.919 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 75.340000000000003 111.048 179.98 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.409 ' O ' ' CB ' ' A' ' 21' ' ' ARG . . . . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.757 0.313 . . . . 55.130000000000003 111.129 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -74.06 -33.51 63.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 75.030000000000001 110.939 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.422 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 18.6 p -57.55 -57.63 11.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 74.329999999999998 111.131 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.445 HG21 ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -73.87 -35.26 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 75.230000000000004 111.135 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.409 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 68.7 ttt-85 -61.8 -45.07 95.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 71.430000000000007 110.895 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp -71.09 -41.09 71.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 73.519999999999996 110.933 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 23' ' ' LEU . 3.4 mm? -55.63 -49.15 73.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 72.200000000000003 110.928 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.481 ' CG2' HG23 ' A' ' 33' ' ' VAL . 14.9 mt -69.28 -43.33 81.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 75.299999999999997 111.113 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -53.67 -38.26 63.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 71.150000000000006 110.897 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -78.28 -43.05 29.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 71.310000000000002 110.833 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.69 -51.11 60.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 71.129999999999995 112.454 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.69 158.17 76.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.623 0.725 . . . . 72.329999999999998 110.889 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -90.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.71 2.274 . . . . 73.120000000000005 112.337 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -107.28 33.2 4.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 71.109999999999999 110.885 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.05 125.84 32.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 75.430000000000007 111.112 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -92.8 108.92 20.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 71.040000000000006 110.862 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.481 HG23 ' CG2' ' A' ' 24' ' ' ILE . 76.3 t -109.76 122.74 64.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 55.32 111.116 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -134.07 118.38 17.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 53.43 110.822 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.412 HG21 ' N ' ' A' ' 36' ' ' GLN . 2.4 p -128.25 132.78 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 74.420000000000002 111.17 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.412 ' N ' HG21 ' A' ' 35' ' ' VAL . 3.4 tp-100 -132.89 120.45 21.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 74.420000000000002 110.92 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 150.29 -140.16 7.8 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 61.229999999999997 112.439 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -157.68 178.77 9.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.87 0.367 . . . . 64.430000000000007 110.887 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.07 142.47 30.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 54.520000000000003 110.866 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.85 17.81 78.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.731 . . . . 70.010000000000005 112.468 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 p -142.08 164.33 18.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.884 0.373 . . . . 75.340000000000003 111.117 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.49 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 5.9 p80 -75.7 107.05 7.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 75.120000000000005 110.865 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.66 ' CZ ' ' CD1' ' A' ' 79' ' ' LEU . 4.7 p90 -119.06 167.25 11.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 72.430000000000007 110.863 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.409 ' HG3' ' CB ' ' A' ' 80' ' ' GLN . 26.5 tt0 -117.03 122.07 43.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 71.209999999999994 110.926 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.59 115.9 18.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 74.150000000000006 111.139 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.5 m -110.78 120.07 41.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 75.510000000000005 111.172 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 86.9 t -123.47 128.24 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 73.340000000000003 111.157 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.9 p -125.33 122.67 63.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 75.109999999999999 111.115 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.435 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.6 OUTLIER -163.33 168.01 10.67 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.655 0.74 . . . . 74.510000000000005 110.893 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.482 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.6 Cg_endo -69.82 -21.19 33.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.68 2.253 . . . . 74.549999999999997 112.314 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -46.48 -46.76 19.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 72.209999999999994 111.097 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.575 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 0.7 OUTLIER -86.1 36.41 0.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 74.209999999999994 110.93 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.49 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 6.9 p -52.24 124.27 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 74.420000000000002 111.12 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.46 -74.69 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.796 -0.716 . . . . 64.430000000000007 112.464 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 53' ' ' VAL . 22.9 pttm -119.89 140.47 50.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.761 0.315 . . . . 75.340000000000003 110.89 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.25 97.92 8.11 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.59 0.709 . . . . 71.129999999999995 111.054 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 173.42 11.01 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.703 2.269 . . . . 72.540000000000006 112.348 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.433 HD23 ' NE ' ' A' ' 62' ' ' ARG . 1.1 tp -57.79 -26.83 62.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 74.109999999999999 110.907 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.84 -52.94 63.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 64.430000000000007 111.162 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.575 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 11.6 mmt180 -69.51 -43.13 73.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 75.239999999999995 110.898 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.553 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -58.34 -53.35 59.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 75.530000000000001 110.9 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.433 ' NE ' HD23 ' A' ' 58' ' ' LEU . 43.8 mtt180 -65.99 -35.82 81.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 73.430000000000007 110.887 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.9 ttt -57.91 -46.0 85.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 74.109999999999999 110.875 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 61' ' ' HIS . 15.8 m -69.61 -39.96 78.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 74.530000000000001 111.152 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.553 ' OH ' ' CE1' ' A' ' 61' ' ' HIS . 15.8 m-85 -67.72 -34.99 77.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 73.510000000000005 111.028 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.18 -47.19 29.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 74.510000000000005 111.086 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.445 ' O ' HG21 ' A' ' 20' ' ' ILE . 15.4 t -61.65 -39.59 91.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 72.239999999999995 111.138 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 69' ' ' GLY . 1.0 OUTLIER -82.0 0.73 38.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 73.400000000000006 110.975 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 35.04 91.22 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 64.150000000000006 112.416 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -96.86 -32.26 12.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.902 0.382 . . . . 65.049999999999997 110.852 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.53 10.25 3.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 75.040000000000006 110.903 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 37.9 mtm -73.56 -13.19 60.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 74.530000000000001 110.937 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.12 -33.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 74.340000000000003 112.479 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.786 -0.721 . . . . 74.340000000000003 112.489 -179.921 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.806 0.336 . . . . 74.409999999999997 111.105 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.66 ' CD1' ' CZ ' ' A' ' 43' ' ' PHE . 3.6 mm? -97.79 133.86 41.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 74.349999999999994 110.972 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.409 ' CB ' ' HG3' ' A' ' 44' ' ' GLU . 25.9 mt-30 -109.7 115.6 30.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 74.200000000000003 110.906 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.0 tp -133.46 139.63 46.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 73.129999999999995 110.852 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.53 115.36 12.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 75.010000000000005 110.842 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.519 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 10.5 p -108.44 106.68 16.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 72.430000000000007 111.147 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -129.61 161.49 30.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 75.420000000000002 110.838 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.49 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.5 162.92 71.54 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.623 0.725 . . . . 73.129999999999995 111.089 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.6 Cg_endo -69.64 -19.18 37.05 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.733 2.289 . . . . 65.150000000000006 112.402 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -68.82 -35.99 77.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 74.349999999999994 110.899 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -66.53 -40.19 88.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 73.310000000000002 110.918 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 75.219999999999999 111.097 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.491 ' CB ' ' CG1' ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.755 0.312 . . . . 74.430000000000007 111.101 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -70.1 -38.45 75.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 60.439999999999998 110.84 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.421 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 25.8 p -63.43 -53.57 50.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 72.310000000000002 111.139 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.621 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 1.7 pp -65.06 -42.61 94.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 62.299999999999997 111.079 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.621 ' N ' ' CD1' ' A' ' 20' ' ' ILE . 39.9 ttp180 -60.37 -46.23 90.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 75.540000000000006 110.889 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.12 -42.4 99.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 75.120000000000005 110.969 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 23' ' ' LEU . 4.2 mm? -58.08 -49.3 77.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 75.109999999999999 110.913 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.473 ' CG2' HG22 ' A' ' 33' ' ' VAL . 46.7 mm -63.31 -46.38 95.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 73.099999999999994 111.152 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -54.37 -43.71 71.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 74.150000000000006 110.851 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.31 -42.93 78.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 74.049999999999997 110.797 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.35 -57.04 12.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.725 -0.75 . . . . 74.109999999999999 112.45 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.475 ' CB ' ' HB3' ' A' ' 31' ' ' ALA . 3.3 mm? -72.65 155.86 90.57 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.537 0.684 . . . . 75.340000000000003 110.958 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -90.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.615 2.21 . . . . 73.510000000000005 112.352 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -103.32 31.89 4.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 73.230000000000004 110.902 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.475 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . . . -80.48 131.65 35.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 74.230000000000004 111.095 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.467 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 6.4 tpp180 -102.42 113.99 27.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 75.430000000000007 110.878 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.473 HG22 ' CG2' ' A' ' 24' ' ' ILE . 36.8 t -116.03 127.31 73.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 72.140000000000001 111.137 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -135.4 118.37 16.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.248 -0.433 . . . . 72.239999999999995 110.864 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.491 ' CG1' ' CB ' ' A' ' 17' ' ' ALA . 4.3 p -127.28 136.91 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 73.319999999999993 111.142 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.433 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.9 OUTLIER -133.05 120.4 21.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 73.129999999999995 110.918 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 142.37 -134.43 6.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.741 . . . . 64.209999999999994 112.469 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.412 ' OE2' ' CG ' ' A' ' 39' ' ' ASP . 5.3 tm-20 -170.2 166.53 8.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 72.219999999999999 110.866 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.412 ' CG ' ' OE2' ' A' ' 38' ' ' GLU . 7.8 p30 -72.95 153.55 40.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 70.340000000000003 110.905 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.421 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.84 -2.62 32.06 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 73.219999999999999 112.489 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.4 m -130.41 164.9 32.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.867 0.365 . . . . 74.120000000000005 111.124 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.419 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 12.6 p80 -74.78 109.98 8.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 73.120000000000005 110.859 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.572 ' CE2' HD12 ' A' ' 79' ' ' LEU . 34.1 p90 -127.43 167.36 16.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 75.140000000000001 110.9 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -118.1 126.72 52.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 73.430000000000007 110.837 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.27 115.32 18.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 72.219999999999999 111.052 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.7 m -110.37 110.78 21.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.469 . . . . 74.209999999999994 111.108 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 91.5 t -110.68 140.8 28.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.49 . . . . 74.340000000000003 111.091 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.496 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 4.3 p -133.34 118.31 31.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 74.0 111.168 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.4 p -162.08 159.17 21.55 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.671 0.748 . . . . 72.109999999999999 110.853 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.57 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.1 Cg_endo -69.78 -14.67 36.34 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.643 2.229 . . . . 75.439999999999998 112.318 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.07 -48.45 22.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 74.0 111.134 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.53 ' CG ' ' HB ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -84.19 35.07 0.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 71.450000000000003 110.874 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 p -50.84 131.1 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 72.519999999999996 111.099 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.73 -78.04 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.728 -0.749 . . . . 71.340000000000003 112.509 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.49 140.87 52.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.8 0.334 . . . . 75.439999999999998 110.849 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.45 ' CB ' ' HB3' ' A' ' 52' ' ' PHE . . . -104.19 99.11 15.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.606 0.717 . . . . 64.430000000000007 111.114 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.81 169.4 19.05 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.677 2.251 . . . . 65.230000000000004 112.309 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.474 HD23 ' NE ' ' A' ' 62' ' ' ARG . 1.6 tt -56.43 -27.56 56.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 74.310000000000002 110.888 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.69 -52.75 63.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 73.25 111.097 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -69.84 -43.64 71.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 75.530000000000001 110.906 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.411 ' NE2' ' OH ' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -56.57 -53.44 57.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.14 -0.482 . . . . 55.340000000000003 110.857 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.474 ' NE ' HD23 ' A' ' 58' ' ' LEU . 51.0 mtt180 -66.73 -37.93 85.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 70.530000000000001 110.852 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.5 mmt -54.13 -50.15 67.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 74.230000000000004 110.844 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.469 HG22 ' N ' ' A' ' 65' ' ' TYR . 17.1 m -66.96 -42.91 89.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 64.310000000000002 111.154 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.578 ' CE1' HD11 ' A' ' 81' ' ' LEU . 15.2 m-85 -62.29 -36.82 83.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 71.150000000000006 110.936 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.2 -35.88 61.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 75.530000000000001 111.046 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.526 HG21 ' N ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -69.93 -31.22 68.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 73.319999999999993 111.122 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.526 ' N ' HG21 ' A' ' 67' ' ' THR . 2.9 pp -88.03 -10.44 50.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 64.439999999999998 110.933 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 46.86 87.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.681 -0.771 . . . . 52.5 112.506 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.47 ' CG ' HD11 ' A' ' 68' ' ' LEU . 8.2 pt-20 -111.02 -48.14 3.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.847 0.356 . . . . 73.230000000000004 110.868 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.483 ' O ' ' CD1' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -78.88 -2.19 38.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.199 -0.455 . . . . 74.349999999999994 110.963 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.1 mmt -85.14 -13.7 49.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 72.319999999999993 110.888 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.6 -30.88 3.37 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.724 -0.75 . . . . 74.040000000000006 112.423 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.421 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.785 -0.722 . . . . 64.0 112.527 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.833 0.349 . . . . 70.409999999999997 111.068 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.572 HD12 ' CE2' ' A' ' 43' ' ' PHE . 4.1 mm? -97.44 131.83 43.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 73.319999999999993 110.943 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -112.58 114.94 27.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 75.219999999999999 110.896 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.578 HD11 ' CE1' ' A' ' 65' ' ' TYR . 6.7 tt -139.53 138.44 36.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 75.230000000000004 110.883 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -136.54 114.96 11.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 74.0 110.868 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.53 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 59.0 p -100.87 106.82 18.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 73.25 111.172 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -125.27 162.5 24.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 74.400000000000006 110.92 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.09 164.49 56.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.606 0.717 . . . . 64.209999999999994 111.131 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.57 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.2 Cg_endo -69.83 -18.25 36.78 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.613 2.209 . . . . 61.210000000000001 112.333 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -76.51 -29.56 56.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 63.200000000000003 110.885 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -80.28 5.37 14.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.172 -0.467 . . . . 75.420000000000002 110.87 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 74.219999999999999 111.118 179.925 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.716 0.293 . . . . 65.329999999999998 111.135 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.64 -47.19 49.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 74.25 110.967 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.406 HG23 ' N ' ' A' ' 20' ' ' ILE . 3.1 t -62.4 -45.14 94.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 43.399999999999999 111.155 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.431 HG13 ' N ' ' A' ' 21' ' ' ARG . 14.6 pt -69.91 -40.03 78.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 71.329999999999998 111.124 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.431 ' N ' HG13 ' A' ' 20' ' ' ILE . 32.5 ttt-85 -60.0 -48.23 82.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 74.540000000000006 110.861 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -69.29 -39.62 78.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 73.319999999999993 110.917 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.465 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 17.8 mt -57.12 -49.32 76.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 110.881 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.479 ' CD1' HG22 ' A' ' 67' ' ' THR . 5.7 mt -70.06 -45.86 74.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 73.109999999999999 111.127 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -53.96 -36.86 63.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 63.229999999999997 110.898 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -79.48 -40.82 28.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 74.239999999999995 110.861 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.92 -55.56 21.43 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.732 -0.747 . . . . 64.239999999999995 112.473 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.46 HD13 ' CG2' ' A' ' 24' ' ' ILE . 5.8 mt -76.5 159.62 79.17 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.572 0.701 . . . . 75.120000000000005 111.005 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -91.29 0.01 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.104 0 C-N-CA 122.73 2.286 . . . . 71.25 112.361 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -106.96 29.61 6.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 74.400000000000006 110.87 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.42 ' CB ' HD12 ' A' ' 28' ' ' LEU . . . -77.58 131.28 37.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 64.299999999999997 111.113 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.6 mmm-85 -97.11 114.42 26.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 74.439999999999998 110.881 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.473 HG22 ' CG2' ' A' ' 24' ' ' ILE . 56.3 t -117.98 126.05 74.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 74.239999999999995 111.179 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -135.28 118.63 16.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 73.349999999999994 110.822 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.2 t -125.01 135.21 64.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 72.340000000000003 111.108 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 -133.25 123.17 25.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 73.140000000000001 110.884 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.78 -134.48 6.23 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.698 -0.763 . . . . 73.319999999999993 112.511 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -163.67 160.23 22.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 62.200000000000003 110.896 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.453 ' OD2' ' C ' ' A' ' 72' ' ' MET . 24.5 t0 -67.49 147.63 52.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 72.200000000000003 110.901 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.0 -7.29 16.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.815 -0.707 . . . . 62.130000000000003 112.391 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 t -118.81 165.8 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.871 0.367 . . . . 64.219999999999999 111.158 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.454 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 5.3 p80 -73.95 106.54 5.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 64.329999999999998 110.853 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.486 ' CZ ' HD13 ' A' ' 79' ' ' LEU . 41.7 p90 -122.6 167.33 13.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 64.209999999999994 110.918 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -114.3 128.1 56.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 75.010000000000005 110.916 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.39 121.94 36.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 72.109999999999999 111.133 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.8 m -121.11 110.41 16.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 73.25 111.14 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.47 HG23 ' CG1' ' A' ' 33' ' ' VAL . 65.4 t -120.6 129.64 75.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 72.349999999999994 111.18 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.4 118.86 52.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 75.439999999999998 111.112 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.424 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.4 OUTLIER -161.84 169.36 9.63 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.657 0.741 . . . . 71.120000000000005 110.862 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.508 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 52.9 Cg_endo -69.79 -20.87 34.15 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.692 2.261 . . . . 73.400000000000006 112.326 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.407 ' CB ' ' HE ' ' A' ' 60' ' ' ARG . . . -43.74 -53.58 5.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 75.140000000000001 111.195 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 0.7 OUTLIER -81.55 38.46 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 72.109999999999999 110.884 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.504 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 2.9 p -51.37 127.23 7.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 72.030000000000001 111.118 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.39 -78.36 0.12 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.714 -0.755 . . . . 73.340000000000003 112.481 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.97 141.68 51.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.765 0.316 . . . . 72.25 110.91 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.67 99.28 8.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.575 0.702 . . . . 50.340000000000003 111.101 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 165.75 29.91 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.696 2.264 . . . . 74.239999999999995 112.332 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 tt -54.53 -24.09 19.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 71.319999999999993 110.916 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.36 -51.65 67.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 75.319999999999993 111.14 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.577 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 0.1 OUTLIER -72.05 -37.45 69.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 71.120000000000005 110.918 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.514 ' CD2' ' CD2' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -61.46 -49.99 74.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 74.239999999999995 110.879 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -70.39 -39.8 74.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 75.439999999999998 110.95 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 10.1 tpt -54.58 -50.84 67.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 71.239999999999995 110.912 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 61' ' ' HIS . 30.3 m -66.12 -44.21 91.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 73.230000000000004 111.142 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.551 ' CZ ' HD23 ' A' ' 81' ' ' LEU . 10.0 m-85 -55.45 -40.17 71.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 65.430000000000007 110.943 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.32 -38.93 59.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 75.340000000000003 111.102 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.481 HG23 ' N ' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -66.18 -24.03 66.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 74.230000000000004 111.123 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.481 ' N ' HG23 ' A' ' 67' ' ' THR . 3.8 pp -95.47 -1.57 50.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 55.240000000000002 110.889 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.441 ' HA2' ' CG ' ' A' ' 72' ' ' MET . . . 82.06 66.01 1.6 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.773 -0.727 . . . . 73.430000000000007 112.446 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -74.75 -65.62 0.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.838 0.351 . . . . 73.239999999999995 110.914 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.6 tp -86.48 10.08 16.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 75.230000000000004 110.91 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' MET . . . . . 0.453 ' C ' ' OD2' ' A' ' 39' ' ' ASP . 19.7 mmt -72.22 -14.08 61.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 61.200000000000003 110.854 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.422 ' HA3' ' CG ' ' A' ' 39' ' ' ASP . . . -149.46 -34.54 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.755 -0.736 . . . . 60.439999999999998 112.509 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 72.439999999999998 112.482 -179.892 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.448 ' HB3' ' CB ' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.82 0.343 . . . . 75.219999999999999 111.096 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.486 HD13 ' CZ ' ' A' ' 43' ' ' PHE . 1.2 mm? -113.54 145.78 40.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 73.450000000000003 110.951 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -124.7 115.96 21.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 74.120000000000005 110.861 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.551 HD23 ' CZ ' ' A' ' 65' ' ' TYR . 2.8 tp -123.94 141.67 51.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 75.219999999999999 110.895 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -133.13 114.39 13.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 75.219999999999999 110.916 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.519 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 24.7 p -118.5 106.12 12.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 74.219999999999999 111.145 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mp -134.62 161.23 35.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 64.150000000000006 110.934 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.504 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.48 163.59 66.52 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.639 0.733 . . . . 74.239999999999995 111.152 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.3 Cg_endo -69.76 -19.04 36.64 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.693 2.262 . . . . 71.040000000000006 112.328 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -68.87 -36.07 77.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 71.5 110.891 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -64.48 -38.12 89.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 62.530000000000001 110.925 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 74.329999999999998 111.136 179.893 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.797 0.332 . . . . 70.519999999999996 111.124 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -70.54 -39.13 74.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 110.879 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.1 p -62.32 -53.55 53.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 75.200000000000003 111.104 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.475 ' CD1' HG12 ' A' ' 35' ' ' VAL . 9.1 pt -66.88 -45.9 86.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 74.510000000000005 111.147 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.435 ' N ' ' CG1' ' A' ' 20' ' ' ILE . 37.7 ttp85 -53.58 -51.45 62.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 73.129999999999995 110.828 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -67.43 -34.85 78.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 71.310000000000002 110.987 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.64 -49.65 74.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 74.109999999999999 110.885 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.483 ' CG2' HG23 ' A' ' 33' ' ' VAL . 46.8 mt -72.44 -43.05 64.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 74.420000000000002 111.109 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -54.61 -36.49 64.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 65.209999999999994 110.92 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -81.44 -43.14 19.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.487 . . . . 71.120000000000005 110.865 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 -37.88 95.45 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 55.240000000000002 112.485 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.471 HD22 ' CB ' ' A' ' 31' ' ' ALA . 8.2 mp -92.99 160.94 32.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.537 0.684 . . . . 72.109999999999999 110.937 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -90.99 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.657 2.238 . . . . 75.510000000000005 112.36 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -107.43 25.55 11.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 73.409999999999997 110.907 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.471 ' CB ' HD22 ' A' ' 28' ' ' LEU . . . -72.36 129.51 38.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 74.319999999999993 111.042 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.464 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 3.3 ttm180 -97.03 112.01 23.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 70.099999999999994 110.879 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.483 HG23 ' CG2' ' A' ' 24' ' ' ILE . 21.4 t -113.94 130.08 68.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 74.109999999999999 111.143 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -135.12 118.08 16.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 75.019999999999996 110.898 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.475 HG12 ' CD1' ' A' ' 20' ' ' ILE . 5.8 p -129.69 137.44 56.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 73.349999999999994 111.17 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.467 ' N ' HG23 ' A' ' 35' ' ' VAL . 47.2 tt0 -133.25 120.3 20.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 74.219999999999999 110.868 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.424 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 144.12 -149.06 21.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 74.340000000000003 112.571 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -155.69 177.7 11.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 74.519999999999996 110.91 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.95 147.04 35.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 75.319999999999993 110.889 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.84 7.86 71.3 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.78 -0.724 . . . . 72.310000000000002 112.521 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.7 t -134.87 163.87 35.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 74.129999999999995 111.105 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 49.3 p-80 -75.9 106.85 7.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 75.420000000000002 110.879 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.558 ' CZ ' HD13 ' A' ' 79' ' ' LEU . 7.4 p90 -119.76 166.76 12.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 75.319999999999993 110.866 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.02 129.59 56.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.019999999999996 110.899 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.05 116.28 19.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 72.230000000000004 111.108 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.0 m -121.29 112.11 18.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 74.310000000000002 111.132 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.471 HG21 ' CG1' ' A' ' 33' ' ' VAL . 79.6 t -114.06 138.92 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 65.450000000000003 111.143 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' A' ' 32' ' ' ARG . 8.6 p -132.08 123.84 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 75.310000000000002 111.126 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.427 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.6 OUTLIER -170.37 167.52 4.59 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.7 0.762 . . . . 60.119999999999997 110.855 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.506 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.4 Cg_endo -69.77 -22.78 31.55 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.693 2.262 . . . . 70.329999999999998 112.357 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.471 ' HB3' ' NE ' ' A' ' 60' ' ' ARG . . . -44.27 -47.02 9.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 62.049999999999997 111.091 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.562 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 0.4 OUTLIER -86.69 39.85 0.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 72.5 110.814 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.484 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 4.3 p -55.92 123.11 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 74.349999999999994 111.139 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.46 -91.68 0.86 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.75 -0.738 . . . . 74.109999999999999 112.41 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.484 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 11.8 mptt -118.06 108.88 15.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.797 0.332 . . . . 70.439999999999998 110.878 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.503 ' CB ' ' HB3' ' A' ' 52' ' ' PHE . . . -57.82 106.65 0.73 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.549 0.69 . . . . 71.109999999999999 111.1 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 54.5 Cg_endo -69.79 170.5 16.45 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.645 2.23 . . . . 73.239999999999995 112.381 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tp -63.54 -23.78 67.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 74.519999999999996 110.943 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.87 -54.14 49.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.219999999999999 111.116 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.562 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 8.2 mmm180 -71.83 -40.84 68.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 74.239999999999995 110.82 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.464 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -58.25 -50.34 73.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 73.5 110.855 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -69.05 -40.18 78.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 72.230000000000004 110.819 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.417 ' O ' ' CG2' ' A' ' 67' ' ' THR . 10.5 tpt -53.47 -52.79 58.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 72.430000000000007 110.856 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.472 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 16.6 m -61.75 -49.56 83.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 72.230000000000004 111.141 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.566 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 12.8 m-85 -55.61 -31.19 62.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 74.310000000000002 110.995 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.49 -43.33 56.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 74.140000000000001 111.151 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.417 ' CG2' ' O ' ' A' ' 63' ' ' MET . 1.1 p -64.44 -33.83 76.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 75.510000000000005 111.179 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.484 ' O ' ' C ' ' A' ' 69' ' ' GLY . 12.6 mt -81.74 7.07 13.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 75.310000000000002 110.925 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 31.58 73.14 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.7 -0.762 . . . . 71.25 112.48 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.423 ' CD ' ' HG ' ' A' ' 79' ' ' LEU . 26.7 mt-10 -77.34 -38.95 49.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.861 0.362 . . . . 74.329999999999998 110.894 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.4 tp -89.83 10.36 23.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 64.319999999999993 110.876 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.3 ttt -77.23 -13.52 59.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 72.450000000000003 110.904 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.1 -32.33 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.737 . . . . 72.129999999999995 112.508 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.718 -0.754 . . . . 62.409999999999997 112.528 -179.918 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.798 0.332 . . . . 74.340000000000003 111.123 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.558 HD13 ' CZ ' ' A' ' 43' ' ' PHE . 4.0 mm? -97.61 146.54 25.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 74.310000000000002 110.954 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -121.3 115.79 23.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 72.340000000000003 110.901 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.566 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 0.4 OUTLIER -125.01 117.64 24.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 61.219999999999999 110.869 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -120.83 114.87 22.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 73.510000000000005 110.853 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.527 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 28.6 p -116.15 107.06 14.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 74.129999999999995 111.188 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.5 mt -132.48 161.42 33.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 72.239999999999995 110.935 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.484 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.1 163.04 70.27 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.608 0.718 . . . . 75.0 111.109 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.506 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.2 Cg_endo -69.77 -7.97 22.42 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.681 2.254 . . . . 72.200000000000003 112.354 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -86.62 -28.83 23.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.446 . . . . 74.430000000000007 110.824 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -84.53 18.31 2.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 71.5 110.894 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 63.119999999999997 111.118 179.93 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.465 ' HB3' ' CG2' ' A' ' 35' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.736 0.303 . . . . 64.040000000000006 111.078 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -57.64 -37.1 72.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 62.439999999999998 110.898 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.56 ' CG2' ' N ' ' A' ' 20' ' ' ILE . 1.2 t -60.86 -47.53 85.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 72.439999999999998 111.045 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.56 ' N ' ' CG2' ' A' ' 19' ' ' THR . 9.4 pt -70.24 -30.8 44.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 75.109999999999999 111.086 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.54 ' N ' HG13 ' A' ' 20' ' ' ILE . 39.0 ttt-85 -65.22 -48.02 74.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 74.310000000000002 110.814 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -71.46 -39.74 70.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 72.439999999999998 110.92 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.0 mt -58.26 -50.21 74.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 75.409999999999997 110.899 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.47 ' CG2' HG22 ' A' ' 33' ' ' VAL . 6.6 mt -71.32 -45.78 68.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 70.019999999999996 111.176 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -54.2 -35.82 62.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 74.329999999999998 110.903 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.97 -43.15 22.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 75.310000000000002 110.852 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.79 -52.22 52.12 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.78 -0.724 . . . . 71.299999999999997 112.518 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.06 101.67 54.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 74.409999999999997 110.938 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.64 -14.76 36.95 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.723 2.282 . . . . 73.219999999999999 112.302 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -97.65 1.1 48.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 75.319999999999993 110.88 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.427 ' CB ' ' CB ' ' A' ' 49' ' ' SER . . . -119.24 135.89 54.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 64.019999999999996 111.123 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -106.85 114.32 28.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 74.120000000000005 110.878 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.47 HG22 ' CG2' ' A' ' 24' ' ' ILE . 18.4 t -116.79 124.69 73.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 72.530000000000001 111.065 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.62 117.65 15.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 63.399999999999999 110.806 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.493 HG22 ' CD1' ' A' ' 43' ' ' PHE . 4.4 p -123.64 138.6 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 74.239999999999995 111.098 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -132.12 120.52 22.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 72.409999999999997 110.904 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.53 -150.81 23.1 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.667 -0.778 . . . . 74.439999999999998 112.474 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -150.94 165.68 32.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 75.430000000000007 110.883 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -68.56 142.75 55.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 64.349999999999994 110.851 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.61 19.56 79.17 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 74.540000000000006 112.478 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.8 t -144.1 164.98 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.853 0.359 . . . . 74.140000000000001 111.099 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.453 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 17.3 p80 -74.81 107.73 7.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 71.109999999999999 110.923 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.598 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 7.7 p90 -119.43 167.43 11.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 74.200000000000003 110.904 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.1 pm0 -115.27 133.72 55.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 64.310000000000002 110.889 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.54 123.93 40.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 63.25 111.097 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.8 m -121.72 107.32 12.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 73.549999999999997 111.194 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 m -116.8 128.95 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 60.420000000000002 111.178 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 p -133.48 118.62 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 74.510000000000005 111.184 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.431 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.4 OUTLIER -165.19 168.22 8.7 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.611 0.72 . . . . 74.219999999999999 110.828 -179.788 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.498 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.9 Cg_endo -69.7 -23.94 30.5 Favored 'Trans proline' 0 N--CA 1.465 -0.147 0 C-N-CA 122.747 2.298 . . . . 63.0 112.38 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.471 ' HB3' ' NE ' ' A' ' 60' ' ' ARG . . . -47.35 -44.45 23.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 72.540000000000006 111.053 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.582 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 0.7 OUTLIER -85.3 34.25 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 61.340000000000003 110.865 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.5 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 14.6 p -52.3 144.67 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 74.140000000000001 111.109 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.462 ' N ' HG21 ' A' ' 53' ' ' VAL . . . 50.7 -88.12 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.772 -0.728 . . . . 74.420000000000002 112.512 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -118.21 112.51 20.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 75.299999999999997 110.922 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.59 108.05 1.18 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.607 0.718 . . . . 73.140000000000001 111.136 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 52.9 Cg_endo -69.8 162.27 42.74 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.715 2.277 . . . . 73.420000000000002 112.317 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.8 tp -57.89 -25.95 61.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.225 -0.443 . . . . 74.230000000000004 110.831 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.22 -53.53 57.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 75.209999999999994 111.105 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.582 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 29.5 mmt180 -69.92 -44.97 68.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 75.239999999999995 110.885 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.478 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 1.5 t-160 -56.24 -53.77 53.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 72.129999999999995 110.821 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.9 mtp85 -65.33 -35.89 82.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 71.329999999999998 110.87 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.4 ttt -56.24 -48.38 76.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 65.129999999999995 110.835 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 61' ' ' HIS . 11.4 m -67.83 -40.64 83.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 74.310000000000002 111.116 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.494 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 16.7 m-85 -67.35 -34.18 76.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 71.420000000000002 110.908 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.06 -44.46 26.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 64.209999999999994 111.114 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.457 ' CG2' ' N ' ' A' ' 68' ' ' LEU . 1.2 t -60.32 -40.99 92.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 72.519999999999996 111.158 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.587 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -88.66 -10.92 46.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 74.230000000000004 110.921 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.521 ' N ' HD13 ' A' ' 68' ' ' LEU . . . 31.32 87.82 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.757 -0.735 . . . . 75.040000000000006 112.506 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.467 ' N ' HD13 ' A' ' 68' ' ' LEU . 1.1 pm0 -79.53 -35.25 40.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.993 0.425 . . . . 74.439999999999998 110.938 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.11 7.3 4.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 73.430000000000007 110.929 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 63.4 mtp -84.52 -13.05 52.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 71.400000000000006 110.854 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.39 -22.1 1.11 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.772 -0.728 . . . . 55.100000000000001 112.448 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.722 -0.751 . . . . 74.349999999999994 112.501 -179.881 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.812 0.339 . . . . 72.439999999999998 111.107 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.598 ' CD1' ' CE2' ' A' ' 43' ' ' PHE . 3.9 mm? -97.66 132.49 43.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 73.230000000000004 110.882 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -111.46 114.94 28.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 71.109999999999999 110.935 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 tp -133.65 124.72 27.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 64.120000000000005 110.915 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -126.48 114.47 18.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 72.049999999999997 110.834 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.578 ' HB ' ' CD2' ' A' ' 52' ' ' PHE . 66.8 p -109.39 107.19 17.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 72.299999999999997 111.189 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.6 mp -131.56 162.8 29.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 73.430000000000007 110.88 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.5 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.11 164.1 59.8 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.59 0.71 . . . . 72.439999999999998 111.103 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.498 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.6 Cg_endo -69.79 -12.8 33.58 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.633 2.222 . . . . 74.540000000000006 112.374 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -78.66 -28.72 45.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 72.239999999999995 110.905 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -85.04 28.79 0.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 74.400000000000006 110.877 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 64.510000000000005 111.18 179.837 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.476 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.704 0.288 . . . . 74.239999999999995 111.042 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 19' ' ' THR . 4.0 pt-20 -71.49 -28.91 64.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.26 -0.427 . . . . 74.439999999999998 110.873 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.409 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 17.1 p -59.07 -56.66 19.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 74.510000000000005 111.166 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.476 ' CD1' ' HA ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -73.92 -35.29 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 74.150000000000006 111.098 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -62.41 -48.57 79.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 73.230000000000004 110.862 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -69.56 -40.27 76.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 75.420000000000002 110.872 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.8 mt -56.18 -49.19 74.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.302 -0.408 . . . . 74.239999999999995 110.931 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.471 ' CG2' HG23 ' A' ' 33' ' ' VAL . 11.7 mt -68.07 -45.84 82.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 74.430000000000007 111.161 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -54.21 -36.8 63.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.116 -0.493 . . . . 74.340000000000003 110.898 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m -77.4 -43.02 34.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 60.5 110.881 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.47 -46.46 92.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.768 -0.729 . . . . 54.409999999999997 112.472 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.44 HD21 ' CB ' ' A' ' 31' ' ' ALA . 6.8 mp -85.61 161.09 52.02 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.567 0.699 . . . . 75.099999999999994 110.938 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -90.76 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.656 2.237 . . . . 74.120000000000005 112.373 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -107.26 25.89 10.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 72.409999999999997 110.909 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.44 ' CB ' HD21 ' A' ' 28' ' ' LEU . . . -71.64 125.71 27.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 73.010000000000005 111.118 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.444 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 2.2 tpm_? -93.71 108.75 20.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 71.219999999999999 110.865 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.471 HG23 ' CG2' ' A' ' 24' ' ' ILE . 41.7 t -113.28 127.46 70.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 73.040000000000006 111.196 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -135.22 118.56 16.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 70.120000000000005 110.828 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.466 HG11 ' CG1' ' A' ' 20' ' ' ILE . 3.9 p -126.26 136.7 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 65.150000000000006 111.089 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -132.69 120.1 21.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 73.439999999999998 110.912 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 149.18 -124.92 1.9 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 72.420000000000002 112.444 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' CG1' ' A' ' 41' ' ' VAL . 2.2 tt0 -175.44 163.04 2.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 65.200000000000003 110.895 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.02 148.16 46.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 75.310000000000002 110.9 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.61 8.99 73.4 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.739 -0.743 . . . . 73.049999999999997 112.508 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.41 ' CG1' ' O ' ' A' ' 38' ' ' GLU . 14.7 p -139.14 165.17 23.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.827 0.346 . . . . 72.420000000000002 111.152 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.401 ' N ' ' CG2' ' A' ' 41' ' ' VAL . 32.6 p80 -74.49 110.7 9.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 73.219999999999999 110.851 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.565 ' CZ ' HD12 ' A' ' 79' ' ' LEU . 4.9 p90 -126.91 167.65 15.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.273 -0.422 . . . . 74.310000000000002 110.866 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -113.5 124.98 53.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 64.150000000000006 110.873 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.22 119.99 26.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 64.510000000000005 111.148 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.4 m -118.26 114.99 23.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 74.510000000000005 111.117 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.457 HG12 ' CG2' ' A' ' 33' ' ' VAL . 24.7 t -113.47 141.25 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 74.129999999999995 111.128 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 32' ' ' ARG . 5.1 p -134.95 122.2 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 73.329999999999998 111.133 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.426 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.9 OUTLIER -167.61 166.26 7.97 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.704 0.764 . . . . 73.540000000000006 110.874 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.503 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.8 Cg_endo -69.74 -18.22 37.21 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.681 2.254 . . . . 74.030000000000001 112.317 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -43.76 -50.79 7.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 74.129999999999995 111.157 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.582 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -86.94 40.58 0.92 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.248 -0.433 . . . . 71.400000000000006 110.891 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.487 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 4.7 p -51.24 119.1 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 74.200000000000003 111.089 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.69 -72.88 1.01 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.748 -0.739 . . . . 70.549999999999997 112.495 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -121.62 138.59 54.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.809 0.338 . . . . 73.209999999999994 110.876 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.483 ' CB ' ' HB3' ' A' ' 52' ' ' PHE . . . -99.73 100.11 10.33 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.538 0.685 . . . . 75.530000000000001 111.093 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 163.49 38.11 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.633 2.222 . . . . 75.230000000000004 112.374 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.49 -26.76 55.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 55.43 110.928 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 63' ' ' MET . . . -58.6 -49.95 75.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 75.099999999999994 111.13 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.582 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 21.6 mmt180 -71.7 -46.47 58.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.275 -0.42 . . . . 71.239999999999995 110.818 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.513 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -58.0 -50.0 74.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 63.219999999999999 110.833 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -67.34 -39.65 85.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 75.319999999999993 110.883 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' MET . . . . . 0.407 ' CG ' ' O ' ' A' ' 59' ' ' ALA . 4.3 mmt -54.54 -48.02 72.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 75.409999999999997 110.898 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' A' ' 61' ' ' HIS . 13.5 m -65.43 -42.51 93.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 72.450000000000003 111.165 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . 0.448 ' N ' HG23 ' A' ' 64' ' ' VAL . 12.1 m-85 -54.8 -42.09 71.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 74.319999999999993 110.853 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.53 -44.37 62.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 74.109999999999999 111.109 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.438 HG23 ' CG1' ' A' ' 24' ' ' ILE . 0.6 OUTLIER -69.64 -14.76 62.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 72.430000000000007 111.201 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.426 HD13 ' C ' ' A' ' 64' ' ' VAL . 18.0 mt -94.61 -10.54 31.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 72.319999999999993 110.929 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.71 72.71 0.47 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.712 -0.756 . . . . 62.219999999999999 112.505 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 71' ' ' LEU . 10.0 pt-20 -114.65 -38.47 3.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.869 0.366 . . . . 72.340000000000003 110.924 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.503 ' O ' ' CD1' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -88.38 -11.17 46.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 75.329999999999998 110.907 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.8 ptm -80.63 -13.14 59.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 75.239999999999995 110.921 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.36 -25.28 5.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 64.5 112.471 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 C-N-CA 120.731 -0.747 . . . . 60.109999999999999 112.478 -179.91 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.84 0.353 . . . . 72.230000000000004 111.08 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.565 HD12 ' CZ ' ' A' ' 43' ' ' PHE . 3.9 mm? -98.16 136.36 38.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 73.010000000000005 110.958 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -105.79 115.73 30.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 74.140000000000001 110.913 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.58 118.47 22.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 74.340000000000003 110.892 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 47' ' ' VAL . 2.2 mptp? -119.0 114.5 22.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.467 . . . . 75.400000000000006 110.953 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.532 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 33.5 p -109.79 107.32 17.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 73.019999999999996 111.163 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.6 mt -131.07 160.83 33.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 75.109999999999999 110.883 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.487 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.36 162.86 71.71 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.597 0.713 . . . . 62.299999999999997 111.128 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.7 Cg_endo -69.65 -17.94 37.81 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.689 2.259 . . . . 75.409999999999997 112.394 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -71.83 -34.76 69.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 73.430000000000007 110.904 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -68.32 -31.24 70.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.173 -0.467 . . . . 74.239999999999995 110.854 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 74.409999999999997 111.063 179.977 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 39.1 mtt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.788 0.328 . . . . 75.329999999999998 110.892 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.84 -35.88 3.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 75.219999999999999 110.853 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -148.98 111.58 4.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 75.040000000000006 110.922 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.439 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 7.2 ttt180 -47.25 -59.67 5.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.571 0.7 . . . . 74.439999999999998 110.844 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 13' ' ' ARG . 54.3 Cg_endo -69.72 176.75 6.32 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.649 2.232 . . . . 73.340000000000003 112.363 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.9 tp -173.5 157.14 3.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 53.439999999999998 110.923 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -58.99 -63.82 1.16 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 72.209999999999994 110.896 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.52 -25.7 17.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 74.319999999999993 111.046 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -71.5 -40.84 69.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 72.439999999999998 110.866 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.2 p -61.06 -52.86 63.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 73.310000000000002 111.134 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.467 HD13 ' CG2' ' A' ' 35' ' ' VAL . 4.6 pt -67.2 -45.07 87.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 74.439999999999998 111.148 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.1 ttt-85 -58.96 -45.06 91.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 72.340000000000003 110.846 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -65.37 -44.65 86.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 75.230000000000004 110.88 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.5 mt -56.01 -49.54 73.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 65.120000000000005 110.935 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.48 ' CG2' HG22 ' A' ' 33' ' ' VAL . 8.8 mt -67.33 -44.28 87.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 74.129999999999995 111.129 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -54.03 -39.1 65.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 62.119999999999997 110.852 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.78 -41.21 45.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 74.120000000000005 110.873 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.48 -58.33 10.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 63.109999999999999 112.502 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.453 ' CB ' ' HB2' ' A' ' 31' ' ' ALA . 32.0 mt -73.05 154.69 90.68 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.638 0.732 . . . . 75.010000000000005 110.896 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -90.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.267 . . . . 73.219999999999999 112.315 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -104.41 34.51 3.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 74.030000000000001 110.89 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.453 ' HB2' ' CB ' ' A' ' 28' ' ' LEU . . . -87.52 139.6 30.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 73.140000000000001 111.119 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.465 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 31.3 ttt180 -109.3 125.65 52.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 74.010000000000005 110.865 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.48 HG22 ' CG2' ' A' ' 24' ' ' ILE . 6.0 t -123.15 133.26 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 75.109999999999999 111.128 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -135.09 118.86 17.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 71.129999999999995 110.83 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.468 ' CG2' ' HB1' ' A' ' 45' ' ' ALA . 40.1 t -124.56 130.85 73.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 71.230000000000004 111.115 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -132.77 120.18 21.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 63.509999999999998 110.912 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.471 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 149.44 -122.75 1.49 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.757 -0.735 . . . . 72.219999999999999 112.516 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -175.32 160.71 2.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.783 0.325 . . . . 75.099999999999994 110.918 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -73.65 146.58 44.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 71.299999999999997 110.905 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.427 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.7 18.39 78.69 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.784 -0.722 . . . . 72.099999999999994 112.451 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 21.0 t -149.23 165.44 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 74.439999999999998 111.168 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.451 ' CB ' ' HB1' ' A' ' 78' ' ' ALA . 36.0 p-80 -74.21 112.27 10.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 74.230000000000004 110.849 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.571 ' CZ ' HD22 ' A' ' 79' ' ' LEU . 27.8 p90 -129.23 167.44 17.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 75.430000000000007 110.931 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -116.63 120.04 37.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 74.230000000000004 110.86 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.468 ' HB1' ' CG2' ' A' ' 35' ' ' VAL . . . -127.73 116.83 20.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 72.319999999999993 111.07 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.6 m -106.89 117.89 35.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 64.420000000000002 111.115 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.456 ' CG2' HG13 ' A' ' 33' ' ' VAL . 55.0 t -113.93 141.22 30.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 74.040000000000006 111.126 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.508 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 3.7 p -131.42 118.75 41.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 70.530000000000001 111.105 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.548 ' OG ' ' CE2' ' A' ' 52' ' ' PHE . 10.8 p -158.58 158.62 29.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.651 0.738 . . . . 62.439999999999998 110.862 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.57 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.1 Cg_endo -69.69 -22.71 32.01 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.697 2.265 . . . . 73.239999999999995 112.385 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.0 -39.2 40.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 73.420000000000002 111.116 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.572 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 3.3 m-85 -84.51 27.77 0.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 74.319999999999993 110.915 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 55' ' ' LYS . 2.1 p -52.25 138.65 10.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.113 -0.494 . . . . 74.409999999999997 111.147 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 54.85 -82.25 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.738 -0.744 . . . . 71.120000000000005 112.482 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 53' ' ' VAL . 16.6 pttm -119.23 135.69 54.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.328 . . . . 73.340000000000003 110.919 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -98.97 100.78 10.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.611 0.719 . . . . 74.519999999999996 111.068 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.86 173.82 10.5 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.643 2.229 . . . . 63.340000000000003 112.339 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.38 -26.62 63.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 72.439999999999998 110.927 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.01 -52.96 63.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 73.25 111.128 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.572 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 3.7 mmt180 -71.57 -42.62 67.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 73.019999999999996 110.915 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.557 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 0.7 OUTLIER -57.92 -53.17 61.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.095 -0.502 . . . . 74.109999999999999 110.912 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 -67.35 -37.67 83.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 74.109999999999999 110.912 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 40.0 mmm -55.1 -47.71 74.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 63.229999999999997 110.935 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.486 HG21 ' N ' ' A' ' 65' ' ' TYR . 19.6 m -69.58 -42.66 80.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.435 . . . . 75.120000000000005 111.151 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.557 ' OH ' ' CE1' ' A' ' 61' ' ' HIS . 13.3 m-85 -62.41 -36.98 84.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 110.891 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.48 -45.71 44.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 74.510000000000005 111.125 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.473 HG21 ' CD1' ' A' ' 24' ' ' ILE . 1.2 t -66.5 -26.62 67.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 75.510000000000005 111.16 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.46 ' N ' HG22 ' A' ' 67' ' ' THR . 7.5 mp -86.91 4.49 41.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 73.340000000000003 110.886 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.53 78.68 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.791 -0.719 . . . . 52.219999999999999 112.479 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -99.44 -48.25 4.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 74.329999999999998 110.896 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.0 mp -85.96 1.0 51.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.16 -0.473 . . . . 71.319999999999993 110.947 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 tpt -80.86 -13.31 59.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 75.25 110.861 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -123.0 -28.29 1.4 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 63.219999999999999 112.501 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.427 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . 106.62 35.3 2.87 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.685 -0.769 . . . . 73.0 112.479 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.4 ' N ' ' HA2' ' A' ' 40' ' ' GLY . . . -59.69 155.67 15.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.73 0.3 . . . . 70.230000000000004 111.09 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 7.9 mt -84.33 163.28 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 65.420000000000002 111.181 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -60.16 -9.34 3.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 74.230000000000004 110.909 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.451 ' HB1' ' CB ' ' A' ' 42' ' ' HIS . . . -77.43 45.72 0.49 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 73.239999999999995 111.08 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.571 HD22 ' CZ ' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -97.97 126.83 43.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.436 . . . . 72.409999999999997 110.902 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -106.75 114.76 29.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 74.150000000000006 110.917 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.556 HD12 ' CE1' ' A' ' 65' ' ' TYR . 9.0 tt -140.04 129.38 23.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 73.420000000000002 110.952 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -122.49 132.21 54.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 73.230000000000004 110.874 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.526 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 27.2 p -112.16 107.09 15.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 75.329999999999998 111.107 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.5 mt -124.04 162.07 24.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.26 -0.427 . . . . 64.109999999999999 110.959 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -71.66 164.65 56.34 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.619 0.723 . . . . 73.349999999999994 111.111 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.57 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.0 Cg_endo -69.81 -18.85 36.53 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.67 2.247 . . . . 75.329999999999998 112.331 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -77.64 -25.64 49.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 71.150000000000006 110.91 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -83.01 18.77 1.55 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 64.200000000000003 110.891 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 63.020000000000003 111.104 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 18.3 mtt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.766 0.317 . . . . 75.349999999999994 110.856 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 86.5 mtt-85 -58.16 176.64 0.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 74.239999999999995 110.882 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -156.02 175.33 14.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 72.540000000000006 110.926 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -118.7 153.96 52.48 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.58 0.705 . . . . 71.030000000000001 110.844 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -172.72 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.651 2.234 . . . . 65.200000000000003 112.331 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.43 ' O ' ' CG2' ' A' ' 19' ' ' THR . 1.6 mp -104.05 -35.66 8.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 64.049999999999997 110.872 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -38.7 -71.08 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 74.319999999999993 110.84 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -56.72 -28.59 61.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 73.209999999999994 111.084 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -71.14 -31.06 67.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 72.140000000000001 110.911 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.43 ' CG2' ' O ' ' A' ' 15' ' ' LEU . 1.3 p -67.22 -53.37 30.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 75.200000000000003 111.132 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.505 ' CD1' ' CG1' ' A' ' 35' ' ' VAL . 2.0 pp -70.06 -37.62 72.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 75.219999999999999 111.13 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.476 ' N ' HD13 ' A' ' 20' ' ' ILE . 38.0 ttp180 -61.32 -50.46 72.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 70.030000000000001 110.938 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.8 ptpp? -67.08 -40.0 86.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 72.140000000000001 110.878 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.8 mt -56.6 -49.86 73.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 75.030000000000001 110.893 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.484 ' CG2' HG22 ' A' ' 33' ' ' VAL . 12.3 mt -68.47 -43.8 83.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 75.450000000000003 111.113 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -55.58 -36.9 67.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 73.319999999999993 110.84 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.72 -43.0 32.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 71.219999999999999 110.845 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.8 -50.68 61.81 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.733 . . . . 75.319999999999993 112.463 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.486 HD13 ' CB ' ' A' ' 31' ' ' ALA . 5.0 mt -82.44 160.24 62.53 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.599 0.714 . . . . 74.439999999999998 110.884 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -91.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.729 2.286 . . . . 65.530000000000001 112.393 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -106.71 25.6 11.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 74.430000000000007 110.876 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.486 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -69.78 131.86 45.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 75.030000000000001 111.073 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.481 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 3.3 tpp85 -99.69 113.64 26.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 75.219999999999999 110.879 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.484 HG22 ' CG2' ' A' ' 24' ' ' ILE . 21.5 t -115.81 130.47 70.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 73.0 111.178 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -131.43 118.63 20.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 74.019999999999996 110.861 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.505 ' CG1' ' CD1' ' A' ' 20' ' ' ILE . 2.0 p -128.31 130.59 69.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 74.030000000000001 111.151 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -133.2 120.37 21.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 70.530000000000001 110.921 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.421 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 150.2 -125.14 1.88 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 64.310000000000002 112.505 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -175.1 162.48 3.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.817 0.342 . . . . 72.239999999999995 110.894 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -71.58 144.42 49.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 74.299999999999997 110.837 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.408 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.74 22.31 79.12 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.786 -0.721 . . . . 75.140000000000001 112.481 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -150.66 164.8 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.819 0.343 . . . . 75.439999999999998 111.173 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.402 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 45.8 p-80 -75.14 106.69 6.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 64.019999999999996 110.919 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.567 ' CE2' HD22 ' A' ' 79' ' ' LEU . 4.7 p90 -121.67 167.75 12.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 75.540000000000006 110.911 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -113.48 121.06 43.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 73.439999999999998 110.874 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.36 121.88 30.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 75.0 111.072 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.4 m -119.76 115.02 23.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 72.140000000000001 111.164 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.424 ' CG2' HG13 ' A' ' 33' ' ' VAL . 44.5 t -110.26 138.54 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 70.25 111.165 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.481 ' CG1' ' HB3' ' A' ' 32' ' ' ARG . 8.9 p -135.33 118.78 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 64.219999999999999 111.142 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.439 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.7 OUTLIER -161.19 165.72 16.44 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.614 0.721 . . . . 71.25 110.883 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.472 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.0 Cg_endo -69.74 -21.01 34.16 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.643 2.229 . . . . 64.319999999999993 112.362 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.31 -46.52 25.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 72.549999999999997 111.072 179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.592 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -85.22 34.97 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.425 . . . . 75.430000000000007 110.889 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 55' ' ' LYS . 2.6 p -51.99 130.96 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 71.200000000000003 111.146 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 59.65 -76.08 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.804 -0.712 . . . . 62.340000000000003 112.498 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 53' ' ' VAL . 16.5 pttm -120.38 137.48 54.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 74.420000000000002 110.936 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.58 99.9 9.67 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.504 0.669 . . . . 73.530000000000001 111.118 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 171.25 14.87 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.695 2.263 . . . . 73.230000000000004 112.34 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.93 -27.97 61.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 72.340000000000003 110.945 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.459 ' O ' ' CG ' ' A' ' 63' ' ' MET . . . -58.15 -52.26 66.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 72.349999999999994 111.082 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.592 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 44.1 mmt-85 -70.37 -43.47 70.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 110.852 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.451 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 0.8 OUTLIER -57.74 -53.59 56.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 72.340000000000003 110.844 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -66.12 -36.15 82.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 71.209999999999994 110.864 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.459 ' CG ' ' O ' ' A' ' 59' ' ' ALA . 23.4 mmm -57.14 -46.49 82.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 74.129999999999995 110.881 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.501 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 17.1 m -69.82 -40.21 78.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 74.400000000000006 111.152 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.566 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 13.7 m-85 -65.94 -34.44 78.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.145 -0.48 . . . . 74.219999999999999 110.882 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.14 -46.6 33.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 64.420000000000002 111.079 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.42 HG21 ' O ' ' A' ' 64' ' ' VAL . 13.0 t -66.56 -28.46 68.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 74.340000000000003 111.14 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.501 ' CD1' ' O ' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -82.47 -2.45 53.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 72.010000000000005 110.915 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.88 78.41 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.78 -0.724 . . . . 72.409999999999997 112.537 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.459 ' HG3' ' N ' ' A' ' 71' ' ' LEU . 12.1 pt-20 -90.02 -42.15 11.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.902 0.382 . . . . 74.430000000000007 110.883 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.459 ' N ' ' HG3' ' A' ' 70' ' ' GLU . 18.0 tp -89.45 7.94 33.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 72.329999999999998 110.9 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -13.02 60.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.446 . . . . 75.409999999999997 110.951 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.05 -30.27 0.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.708 -0.758 . . . . 52.439999999999998 112.446 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.408 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . 130.27 48.86 0.12 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.722 -0.751 . . . . 72.319999999999993 112.499 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.53 140.87 55.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.347 . . . . 72.120000000000005 111.132 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.47 HG21 ' N ' ' A' ' 77' ' ' HIS . 4.0 mp -99.77 160.46 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 73.219999999999999 111.092 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.47 ' N ' HG21 ' A' ' 76' ' ' ILE . 52.6 t60 -53.66 -14.81 0.97 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 73.420000000000002 110.897 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.94 40.06 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 74.129999999999995 111.084 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.567 HD22 ' CE2' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -98.77 128.48 45.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.318 -0.401 . . . . 75.109999999999999 110.934 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.453 ' N ' HD12 ' A' ' 79' ' ' LEU . 4.8 mt-30 -97.53 116.84 30.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 73.25 110.872 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.566 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 1.7 tm? -139.04 117.92 12.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 73.200000000000003 110.906 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -122.21 133.01 54.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 74.310000000000002 110.963 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.541 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 68.4 p -117.24 107.63 14.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 73.319999999999993 111.132 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.421 HD22 ' CD ' ' A' ' 88' ' ' GLU . 21.9 mt -127.76 161.04 29.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 73.209999999999994 110.903 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.471 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.15 163.8 64.28 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.631 0.729 . . . . 74.230000000000004 111.097 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.2 Cg_endo -69.81 -4.73 14.65 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.722 2.281 . . . . 74.109999999999999 112.304 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -94.18 -27.92 15.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 74.219999999999999 110.829 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.421 ' CD ' HD22 ' A' ' 84' ' ' LEU . 2.0 pt-20 -105.31 39.72 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 73.129999999999995 110.853 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 74.439999999999998 111.084 179.92 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.728 0.299 . . . . 74.420000000000002 110.836 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -105.01 -55.67 2.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 74.329999999999998 110.964 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -105.11 137.38 42.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 71.409999999999997 110.901 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -129.27 144.66 53.63 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.584 0.706 . . . . 72.030000000000001 110.951 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.78 -164.64 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.634 2.223 . . . . 72.049999999999997 112.341 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.8 pp -106.35 24.0 13.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.231 -0.44 . . . . 74.439999999999998 110.958 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -66.8 179.69 1.04 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 75.400000000000006 110.864 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.477 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . . . -46.52 -26.03 0.8 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 74.420000000000002 111.145 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -40.53 94.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 73.329999999999998 110.872 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.577 ' CG2' ' N ' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -60.74 -47.89 84.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 71.400000000000006 111.118 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.577 ' N ' ' CG2' ' A' ' 19' ' ' THR . 43.6 pt -66.36 -39.26 83.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 75.530000000000001 111.122 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.464 ' N ' HG13 ' A' ' 20' ' ' ILE . 20.9 ttp85 -61.62 -42.22 98.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 73.540000000000006 110.85 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.62 -46.2 69.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 72.430000000000007 110.896 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -56.28 -49.06 75.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 74.409999999999997 110.957 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.473 ' CG2' HG22 ' A' ' 33' ' ' VAL . 7.9 mt -65.77 -45.31 92.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 74.239999999999995 111.117 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -53.86 -39.75 65.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 73.140000000000001 110.945 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -79.8 -32.47 40.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 72.430000000000007 110.798 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.24 -60.73 4.96 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.828 -0.701 . . . . 75.209999999999994 112.441 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.478 HD12 ' CB ' ' A' ' 31' ' ' ALA . 10.2 mt -72.65 159.29 85.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.569 0.7 . . . . 72.329999999999998 110.926 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -91.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.66 2.24 . . . . 71.549999999999997 112.347 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -105.38 38.9 1.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 64.329999999999998 110.846 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.478 ' CB ' HD12 ' A' ' 28' ' ' LEU . . . -91.35 125.75 36.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 71.5 111.072 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.458 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 8.0 tpp180 -95.67 109.65 21.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 73.310000000000002 110.881 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.473 HG22 ' CG2' ' A' ' 24' ' ' ILE . 39.0 t -109.12 125.4 66.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 62.409999999999997 111.101 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -135.35 117.53 15.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 64.129999999999995 110.831 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.477 ' CG1' ' HB2' ' A' ' 17' ' ' ALA . 5.1 p -126.88 139.78 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 74.519999999999996 111.13 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -129.19 120.99 26.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.461 . . . . 74.439999999999998 110.92 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.474 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 144.16 -135.07 6.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 72.530000000000001 112.488 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -168.67 172.05 8.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 71.430000000000007 110.915 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -77.15 150.63 35.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 73.109999999999999 110.861 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.58 1.25 52.28 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.741 -0.742 . . . . 72.129999999999995 112.442 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 p -131.23 164.55 33.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.855 0.36 . . . . 73.239999999999995 111.151 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.525 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 10.0 p80 -75.21 107.35 7.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 73.439999999999998 110.876 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.535 ' CE2' HD12 ' A' ' 79' ' ' LEU . 48.8 p90 -125.37 167.52 14.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 74.239999999999995 110.884 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -114.02 124.61 52.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 74.439999999999998 110.887 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 81' ' ' LEU . . . -117.74 115.4 24.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 73.299999999999997 111.081 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 m -114.92 106.65 14.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 72.010000000000005 111.217 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.442 HG21 ' CG1' ' A' ' 33' ' ' VAL . 59.9 t -112.54 125.95 69.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 71.349999999999994 111.102 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.503 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 3.9 p -114.4 118.57 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 75.299999999999997 111.173 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.476 ' OG ' ' CE2' ' A' ' 52' ' ' PHE . 14.9 p -159.33 158.66 28.38 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.663 0.744 . . . . 72.120000000000005 110.859 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.557 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.4 Cg_endo -69.68 -21.26 34.1 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.699 2.266 . . . . 75.019999999999996 112.352 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.53 -42.16 43.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 63.520000000000003 111.129 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.575 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 2.5 m-85 -84.04 30.18 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 74.510000000000005 110.838 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 55' ' ' LYS . 2.9 p -52.02 135.58 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 73.099999999999994 111.1 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.45 ' N ' HG22 ' A' ' 53' ' ' VAL . . . 55.18 -82.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.745 -0.74 . . . . 53.409999999999997 112.46 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 53' ' ' VAL . 30.9 mmmt -115.62 135.97 53.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.824 0.345 . . . . 71.019999999999996 110.891 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.14 100.55 10.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.623 0.725 . . . . 75.310000000000002 111.092 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.67 171.03 15.11 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.718 2.279 . . . . 75.430000000000007 112.333 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.478 ' CD2' ' CD ' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -55.62 -27.82 51.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 74.310000000000002 110.956 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.18 -52.64 64.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 74.209999999999994 111.135 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.575 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 7.7 mmt180 -70.98 -42.13 70.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 71.319999999999993 110.839 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.507 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 0.6 OUTLIER -57.61 -52.02 67.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 75.409999999999997 110.863 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.478 ' CD ' ' CD2' ' A' ' 58' ' ' LEU . 44.8 mtt180 -68.16 -37.48 81.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 74.439999999999998 110.801 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.1 mmt -55.51 -49.0 73.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 74.209999999999994 110.875 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.47 HG21 ' N ' ' A' ' 65' ' ' TYR . 18.6 m -67.89 -45.1 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 71.109999999999999 111.111 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.572 ' CE1' HD13 ' A' ' 81' ' ' LEU . 13.2 m-85 -57.75 -36.77 72.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.45 . . . . 73.219999999999999 110.894 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.55 -46.03 41.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 72.530000000000001 111.093 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.465 HG21 ' CD1' ' A' ' 24' ' ' ILE . 1.7 t -72.58 -12.89 61.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 73.040000000000006 111.136 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.429 HD13 ' C ' ' A' ' 64' ' ' VAL . 27.1 mt -93.76 3.29 55.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 75.25 110.887 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 55.57 66.97 2.46 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 72.120000000000005 112.524 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -81.04 -39.41 25.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.912 0.387 . . . . 73.400000000000006 110.908 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.9 mt -90.18 10.08 25.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 75.329999999999998 110.894 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 22.9 mmt -71.79 -9.0 57.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 65.040000000000006 110.832 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.54 -31.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 75.129999999999995 112.52 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.85 107.3 0.61 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.761 -0.733 . . . . 72.450000000000003 112.533 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.16 123.58 29.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.725 0.297 . . . . 64.530000000000001 111.156 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.7 mp -113.24 163.16 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 73.310000000000002 111.102 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -60.47 -9.45 3.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 71.340000000000003 110.872 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.52 26.84 0.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 74.430000000000007 111.137 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.535 HD12 ' CE2' ' A' ' 43' ' ' PHE . 2.2 mm? -99.16 134.36 42.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 74.150000000000006 110.907 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -120.31 115.67 24.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 71.530000000000001 110.87 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.572 HD13 ' CE1' ' A' ' 65' ' ' TYR . 4.5 tt -127.94 140.61 51.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 74.200000000000003 110.957 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.39 115.69 12.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 62.520000000000003 110.979 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.535 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 11.8 p -105.46 106.87 17.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 72.310000000000002 111.086 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.5 mt -122.97 162.08 22.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 73.030000000000001 110.977 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.33 165.82 44.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.61 0.719 . . . . 71.420000000000002 111.119 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.557 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.7 Cg_endo -69.69 -24.71 29.69 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.697 2.265 . . . . 74.019999999999996 112.393 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.28 -31.77 72.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 70.140000000000001 110.897 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -70.56 -32.39 69.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 72.219999999999999 110.903 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 71.510000000000005 111.134 179.912 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 7.2 mtm . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.811 0.339 . . . . 74.140000000000001 110.891 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -45.59 140.44 3.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 75.150000000000006 110.838 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -142.9 111.78 6.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 72.409999999999997 110.84 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -105.1 93.8 7.0 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.563 0.697 . . . . 74.430000000000007 110.866 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 101.97 0.98 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.647 2.231 . . . . 71.329999999999998 112.311 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.1 mt -88.98 168.62 12.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 72.329999999999998 110.957 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.441 ' O ' ' CG2' ' A' ' 19' ' ' THR . 11.6 t0 -53.53 -53.5 50.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.458 . . . . 73.510000000000005 110.832 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.472 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . . . -67.91 -24.77 65.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.424 . . . . 64.299999999999997 111.161 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -70.86 -47.94 56.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 75.209999999999994 110.844 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.441 ' CG2' ' O ' ' A' ' 16' ' ' ASP . 1.9 t -61.34 -45.1 95.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 71.230000000000004 111.112 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.473 HD12 ' CB ' ' A' ' 35' ' ' VAL . 6.4 pt -71.55 -42.5 72.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 65.409999999999997 111.165 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -60.5 -48.0 83.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 73.430000000000007 110.855 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -66.08 -42.85 88.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 75.439999999999998 110.872 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 12.1 mt -56.07 -48.31 76.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.452 . . . . 72.219999999999999 110.912 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.469 ' CG2' HG23 ' A' ' 33' ' ' VAL . 13.3 mt -68.41 -45.22 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 74.420000000000002 111.106 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -54.58 -37.12 65.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 70.219999999999999 110.879 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.91 -42.97 31.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 71.439999999999998 110.885 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.38 -49.9 73.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 65.209999999999994 112.499 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.457 HD12 ' CG2' ' A' ' 24' ' ' ILE . 5.8 mp -89.57 154.06 48.26 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.7 0.762 . . . . 73.409999999999997 110.845 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 -91.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.725 2.283 . . . . 63.329999999999998 112.317 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -100.16 54.74 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 72.5 110.897 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.97 137.66 42.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 70.239999999999995 111.143 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.458 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 4.7 tmm_? -106.43 117.38 33.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 74.439999999999998 110.852 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.469 HG23 ' CG2' ' A' ' 24' ' ' ILE . 38.0 t -122.2 130.27 74.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 73.5 111.181 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -135.26 118.52 16.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 71.319999999999993 110.949 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.483 HG23 ' CD2' ' A' ' 68' ' ' LEU . 7.6 t -122.79 131.55 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 65.230000000000004 111.124 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -133.53 120.0 20.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 75.219999999999999 110.937 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.08 -141.62 9.81 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 72.209999999999994 112.47 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -155.05 179.95 8.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 74.239999999999995 110.832 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -86.96 144.25 27.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 73.310000000000002 110.85 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.418 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.69 22.3 79.1 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.757 -0.735 . . . . 73.219999999999999 112.455 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.5 p -148.84 164.93 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.808 0.337 . . . . 73.299999999999997 111.166 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.43 ' CD2' ' O ' ' A' ' 42' ' ' HIS . 8.6 p-80 -74.95 106.75 6.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 64.329999999999998 110.862 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.496 ' CE2' HD22 ' A' ' 79' ' ' LEU . 8.1 p90 -120.5 167.39 12.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 73.129999999999995 110.881 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -118.29 119.18 33.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 73.140000000000001 110.836 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.99 115.57 18.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 63.350000000000001 111.148 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.7 m -103.86 125.64 50.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.479 . . . . 74.120000000000005 111.084 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.439 ' CG2' HG11 ' A' ' 33' ' ' VAL . 88.1 t -122.3 133.82 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 61.509999999999998 111.136 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.504 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 4.1 p -130.11 118.61 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 71.310000000000002 111.138 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.431 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.5 OUTLIER -158.64 168.06 13.19 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.629 0.728 . . . . 62.329999999999998 110.797 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.508 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.1 Cg_endo -69.75 -28.52 25.2 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.604 2.203 . . . . 73.319999999999993 112.388 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.65 -42.17 33.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 70.510000000000005 111.126 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.552 ' CD2' ' HB ' ' A' ' 83' ' ' THR . 1.4 m-85 -83.86 31.38 0.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 74.25 110.89 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 55' ' ' LYS . 1.8 p -54.36 132.1 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 72.239999999999995 111.177 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.406 ' N ' HG21 ' A' ' 53' ' ' VAL . . . 55.93 -80.2 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.74 -0.743 . . . . 72.140000000000001 112.511 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -116.91 136.52 52.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.757 0.313 . . . . 74.030000000000001 110.92 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.07 100.5 10.15 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.579 0.704 . . . . 72.120000000000005 111.099 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 172.48 12.57 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.696 2.264 . . . . 65.230000000000004 112.309 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 tp -55.99 -25.07 42.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 73.25 110.909 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.26 -53.31 59.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 64.310000000000002 111.116 179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.519 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 8.7 mmt180 -71.77 -40.43 69.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 73.319999999999993 110.915 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.555 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 0.8 OUTLIER -59.84 -51.91 67.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 75.25 110.885 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -67.4 -39.05 85.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 71.540000000000006 110.891 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 4.9 tmm? -54.89 -52.11 63.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 74.450000000000003 110.858 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.491 HG21 ' N ' ' A' ' 65' ' ' TYR . 25.5 m -63.83 -44.9 98.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.303 -0.408 . . . . 74.400000000000006 111.072 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.555 ' OH ' ' CE1' ' A' ' 61' ' ' HIS . 12.8 m-85 -60.37 -31.24 70.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 73.0 110.885 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.04 -46.66 33.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 62.310000000000002 111.099 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.417 HG22 ' O ' ' A' ' 64' ' ' VAL . 3.8 t -67.12 -26.6 66.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 74.019999999999996 111.134 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.483 ' CD2' HG23 ' A' ' 35' ' ' VAL . 12.9 mt -83.0 8.88 11.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 72.150000000000006 110.887 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.14 66.94 1.33 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.736 . . . . 74.219999999999999 112.508 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -70.39 -42.8 71.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.875 0.369 . . . . 75.530000000000001 110.845 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -90.01 7.62 36.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 75.140000000000001 110.93 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.0 ttm -71.92 -12.99 61.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 74.349999999999994 110.877 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.26 -33.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.777 -0.725 . . . . 73.439999999999998 112.501 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.418 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . 130.3 59.3 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.643 -0.789 . . . . 73.340000000000003 112.449 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.02 147.17 35.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.73 0.3 . . . . 75.519999999999996 111.097 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 76' ' ' ILE . 4.0 mp -113.11 152.91 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 65.450000000000003 111.111 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -46.38 -20.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 75.340000000000003 110.877 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.63 47.73 0.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 54.439999999999998 111.065 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.496 HD22 ' CE2' ' A' ' 43' ' ' PHE . 8.8 mt -104.24 126.9 51.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 73.349999999999994 110.914 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -96.93 115.4 27.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.462 . . . . 71.409999999999997 110.903 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 tp -139.22 144.19 38.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 75.019999999999996 110.937 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.27 114.48 11.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 64.109999999999999 110.901 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.552 ' HB ' ' CD2' ' A' ' 52' ' ' PHE . 44.5 p -99.41 107.72 20.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 65.239999999999995 111.17 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.419 HD21 ' CD ' ' A' ' 88' ' ' GLU . 26.9 mt -130.78 160.35 34.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.176 -0.466 . . . . 74.219999999999999 110.915 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.479 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -73.63 164.11 63.49 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.633 0.73 . . . . 71.209999999999994 111.142 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.8 Cg_endo -69.72 -8.79 24.5 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.689 2.259 . . . . 65.420000000000002 112.318 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -77.58 -35.96 52.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 63.520000000000003 110.918 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.419 ' CD ' HD21 ' A' ' 84' ' ' LEU . 18.0 mt-10 -70.36 -32.57 70.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 74.340000000000003 110.796 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 71.219999999999999 111.17 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 14.2 mtt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.838 0.351 . . . . 75.430000000000007 110.906 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -53.54 -51.91 61.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 71.150000000000006 110.849 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.04 100.49 7.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 74.409999999999997 110.881 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -115.39 80.73 7.94 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.653 0.739 . . . . 75.099999999999994 110.893 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -172.67 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.711 2.274 . . . . 63.539999999999999 112.431 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.402 ' C ' HG23 ' A' ' 19' ' ' THR . 2.5 pp -117.31 25.04 10.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.286 -0.415 . . . . 64.120000000000005 110.94 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -120.72 -70.56 0.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.155 -0.475 . . . . 75.310000000000002 110.914 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.463 ' CB ' HG13 ' A' ' 35' ' ' VAL . . . -67.18 -32.58 73.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 71.030000000000001 111.093 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -71.61 -41.14 69.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 71.310000000000002 110.866 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.402 HG23 ' C ' ' A' ' 15' ' ' LEU . 82.5 p -61.03 -53.0 62.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 73.549999999999997 111.15 -179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.476 HG13 ' N ' ' A' ' 21' ' ' ARG . 12.3 pt -68.3 -42.72 84.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 72.530000000000001 111.155 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.476 ' N ' HG13 ' A' ' 20' ' ' ILE . 39.9 ttp85 -59.56 -46.49 88.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 75.540000000000006 110.88 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -66.82 -41.21 87.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 74.549999999999997 110.918 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.3 mt -56.64 -49.46 74.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 71.140000000000001 110.867 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.47 ' CG2' HG23 ' A' ' 33' ' ' VAL . 10.6 mt -67.56 -41.95 86.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 75.310000000000002 111.131 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -55.7 -41.1 73.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 73.109999999999999 110.913 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.72 -43.28 55.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 75.329999999999998 110.876 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.35 -51.86 53.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.747 . . . . 73.430000000000007 112.406 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.465 HD23 ' CB ' ' A' ' 31' ' ' ALA . 7.3 mp -80.71 156.31 72.92 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.594 0.712 . . . . 74.549999999999997 110.88 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -90.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.657 2.238 . . . . 73.409999999999997 112.375 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -105.96 27.36 8.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 74.150000000000006 110.863 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.465 ' CB ' HD23 ' A' ' 28' ' ' LEU . . . -75.81 144.45 41.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 74.439999999999998 111.048 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.472 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 58.2 ttt180 -110.96 124.83 52.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 74.439999999999998 110.849 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.47 HG23 ' CG2' ' A' ' 24' ' ' ILE . 5.9 t -124.17 129.44 74.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 65.430000000000007 111.153 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -131.44 118.98 20.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 60.140000000000001 110.846 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.475 HG11 ' CD1' ' A' ' 20' ' ' ILE . 1.6 p -126.73 134.34 66.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 72.439999999999998 111.105 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.438 ' N ' HG23 ' A' ' 35' ' ' VAL . 12.6 mt-30 -133.45 120.3 20.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 74.129999999999995 110.897 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.56 -130.39 4.55 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.731 -0.747 . . . . 71.409999999999997 112.529 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -174.06 160.98 3.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.919 0.39 . . . . 72.510000000000005 110.871 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -67.69 151.95 46.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 70.530000000000001 110.887 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.416 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.74 10.12 75.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.752 -0.737 . . . . 75.430000000000007 112.533 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.3 t -143.95 165.15 14.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.834 0.35 . . . . 61.329999999999998 111.159 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.437 ' CB ' ' HB1' ' A' ' 78' ' ' ALA . 12.7 p80 -74.52 108.85 7.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 73.430000000000007 110.783 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.573 ' CE2' HD12 ' A' ' 79' ' ' LEU . 40.0 p90 -125.09 167.47 14.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 74.010000000000005 110.826 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -119.43 120.11 35.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 75.230000000000004 110.903 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.2 115.28 18.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 65.430000000000007 111.126 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.7 m -108.41 119.42 39.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 61.219999999999999 111.181 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 96.8 t -112.74 136.59 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 71.230000000000004 111.183 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.472 ' CG1' ' HB3' ' A' ' 32' ' ' ARG . 2.7 p -128.76 125.55 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 73.409999999999997 111.084 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.449 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.8 OUTLIER -172.45 164.84 3.81 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.648 0.737 . . . . 73.219999999999999 110.863 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.495 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.4 Cg_endo -69.74 -22.43 32.2 Favored 'Trans proline' 0 N--CA 1.466 -0.127 0 C-N-CA 122.705 2.27 . . . . 71.140000000000001 112.362 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.44 ' HB2' ' NE ' ' A' ' 60' ' ' ARG . . . -47.72 -41.99 24.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 73.219999999999999 111.043 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.581 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 0.6 OUTLIER -89.27 35.9 0.82 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 73.140000000000001 110.904 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.486 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 6.7 p -52.41 139.33 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 64.140000000000001 111.138 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.482 ' N ' HG22 ' A' ' 53' ' ' VAL . . . 56.38 -89.28 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.756 -0.735 . . . . 70.420000000000002 112.5 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.427 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -117.9 111.16 18.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.732 0.301 . . . . 74.409999999999997 110.919 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.5 ' CB ' ' HB3' ' A' ' 52' ' ' PHE . . . -60.03 108.48 1.43 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.635 0.731 . . . . 63.119999999999997 111.09 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 54.2 Cg_endo -69.71 160.76 48.52 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.67 2.247 . . . . 74.510000000000005 112.374 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tp -54.81 -26.76 36.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 74.109999999999999 110.86 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.02 -52.39 65.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 73.340000000000003 111.071 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.581 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 30.7 mmt-85 -69.46 -41.07 76.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 74.420000000000002 110.857 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.415 ' NE2' ' OH ' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -59.07 -53.46 58.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 63.450000000000003 110.808 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 52.0 mtt-85 -67.1 -35.05 78.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 75.030000000000001 110.924 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.0 tpp -58.37 -51.6 69.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 65.450000000000003 110.875 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.475 HG21 ' N ' ' A' ' 65' ' ' TYR . 20.7 m -64.05 -44.66 97.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 71.340000000000003 111.204 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.542 ' CE1' HD12 ' A' ' 81' ' ' LEU . 14.1 m-85 -59.17 -38.85 80.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 75.310000000000002 110.955 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.72 -32.85 60.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 70.040000000000006 111.096 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.506 HG23 ' N ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -71.57 -27.09 62.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 74.5 111.142 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.506 ' N ' HG23 ' A' ' 67' ' ' THR . 3.5 pp -88.66 -10.5 48.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 72.209999999999994 110.95 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.69 75.1 0.25 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.705 -0.76 . . . . 74.420000000000002 112.505 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -91.38 -42.51 10.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.858 0.361 . . . . 72.239999999999995 110.88 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.491 ' O ' ' CD1' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -84.44 -10.11 57.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 63.310000000000002 110.891 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.5 mmt -72.51 -13.72 61.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 54.549999999999997 110.896 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -126.72 -14.08 2.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.8 -0.714 . . . . 40.020000000000003 112.499 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.416 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . 99.52 35.81 4.54 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.689 -0.767 . . . . 74.540000000000006 112.475 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.76 142.31 53.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 74.310000000000002 111.11 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.468 HG21 ' N ' ' A' ' 77' ' ' HIS . 3.6 mp -82.66 160.83 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 74.519999999999996 111.168 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.544 ' CD2' ' O ' ' A' ' 77' ' ' HIS . 15.2 t60 -58.19 -10.67 2.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 73.040000000000006 110.852 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.437 ' HB1' ' CB ' ' A' ' 42' ' ' HIS . . . -75.73 47.61 0.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 73.299999999999997 111.155 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.573 HD12 ' CE2' ' A' ' 43' ' ' PHE . 7.9 tp -105.0 133.14 50.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 73.209999999999994 110.912 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -111.47 115.46 29.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 74.400000000000006 110.929 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.542 HD12 ' CE1' ' A' ' 65' ' ' TYR . 8.4 tt -139.43 129.41 24.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 74.549999999999997 110.99 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -123.58 135.95 54.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 74.049999999999997 110.91 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.533 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 14.0 p -119.43 106.94 12.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.302 -0.408 . . . . 61.130000000000003 111.163 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.7 mp -124.9 161.59 26.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 74.310000000000002 110.902 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.486 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.3 OUTLIER -71.99 164.74 56.31 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.694 0.759 . . . . 75.230000000000004 111.035 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.4 Cg_endo -69.84 -12.32 32.5 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.684 2.256 . . . . 73.049999999999997 112.302 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -75.45 -35.81 60.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 74.349999999999994 110.876 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.45 -39.86 77.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 61.229999999999997 110.903 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 73.400000000000006 111.116 179.961 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.472 ' O ' ' C ' ' A' ' 11' ' ' ARG . 22.3 ptp . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.735 0.302 . . . . 74.200000000000003 110.869 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.472 ' C ' ' O ' ' A' ' 10' ' ' MET . 0.0 OUTLIER 32.45 41.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 74.409999999999997 110.873 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.424 ' CB ' HD12 ' A' ' 15' ' ' LEU . 29.6 mtpt -78.15 98.34 5.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 65.430000000000007 110.889 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.496 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 6.3 ttt85 -68.34 -51.52 24.37 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.582 0.706 . . . . 75.530000000000001 110.831 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.496 ' CD ' ' N ' ' A' ' 13' ' ' ARG . 53.3 Cg_endo -69.79 14.43 0.26 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.693 2.262 . . . . 74.219999999999999 112.311 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.481 ' H ' ' C ' ' A' ' 13' ' ' ARG . 5.9 tp -39.26 161.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 53.32 110.865 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -85.24 -50.01 7.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.479 . . . . 65.530000000000001 110.922 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.466 ' O ' ' CB ' ' A' ' 21' ' ' ARG . . . -68.37 -30.47 69.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 72.140000000000001 111.102 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.77 -48.69 63.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 75.040000000000006 110.883 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.2 t -62.0 -48.32 80.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 74.25 111.181 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.458 HD13 ' CG2' ' A' ' 35' ' ' VAL . 2.3 pp -69.3 -39.73 79.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 72.439999999999998 111.169 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.466 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 33.0 ttp85 -59.39 -45.96 90.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 73.299999999999997 110.862 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -68.95 -41.26 78.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 74.409999999999997 110.86 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.0 mt -56.3 -49.19 74.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 73.430000000000007 110.884 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.48 ' CG2' HG21 ' A' ' 33' ' ' VAL . 16.2 mt -69.88 -41.68 79.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 73.299999999999997 111.11 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -56.26 -37.03 69.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 75.310000000000002 110.851 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.31 -42.86 24.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 43.32 110.905 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.95 -52.03 51.06 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.776 -0.726 . . . . 74.439999999999998 112.453 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.407 ' CB ' ' HB3' ' A' ' 31' ' ' ALA . 4.1 mm? -79.53 158.02 74.15 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.645 0.736 . . . . 73.230000000000004 110.872 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -90.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.709 2.273 . . . . 73.129999999999995 112.354 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -105.18 27.71 7.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 65.030000000000001 110.873 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.407 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . . . -78.22 129.41 35.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 74.129999999999995 111.103 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.453 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 7.6 tpt180 -101.42 113.52 26.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 74.099999999999994 110.892 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.48 HG21 ' CG2' ' A' ' 24' ' ' ILE . 11.6 t -113.44 127.69 70.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 72.230000000000004 111.131 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -134.08 118.24 17.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 70.120000000000005 110.888 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.458 ' CG2' HD13 ' A' ' 20' ' ' ILE . 61.7 t -122.71 137.53 55.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 64.319999999999993 111.131 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -133.9 119.39 19.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 71.120000000000005 110.987 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 146.1 -132.54 4.55 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 73.439999999999998 112.459 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.465 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 0.4 OUTLIER -171.68 162.37 6.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 74.030000000000001 110.915 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.41 145.7 53.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 62.439999999999998 110.817 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.9 -15.97 9.33 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.703 -0.761 . . . . 41.450000000000003 112.471 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' A' ' 38' ' ' GLU . 13.1 m -112.96 164.86 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.919 0.39 . . . . 71.319999999999993 111.112 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.606 ' CD2' ' O ' ' A' ' 78' ' ' ALA . 4.9 t-160 -74.94 106.9 6.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 74.129999999999995 110.886 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.69 ' CZ ' ' CD1' ' A' ' 79' ' ' LEU . 4.4 p90 -120.94 167.21 12.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 75.510000000000005 110.85 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -119.47 123.62 44.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 73.540000000000006 110.836 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.479 ' CB ' HD23 ' A' ' 68' ' ' LEU . . . -117.66 115.97 26.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 74.150000000000006 111.085 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.2 m -110.8 108.05 17.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 75.540000000000006 111.17 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.2 t -109.76 141.27 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 73.129999999999995 111.152 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.477 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 5.1 p -134.65 118.49 26.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 74.450000000000003 111.117 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.431 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.8 OUTLIER -164.03 165.98 12.67 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.67 0.748 . . . . 73.219999999999999 110.817 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.519 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.8 Cg_endo -69.78 -28.57 25.01 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.693 2.262 . . . . 72.319999999999993 112.33 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.27 -34.05 31.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 73.430000000000007 111.06 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.579 ' CD2' ' HB ' ' A' ' 83' ' ' THR . 3.9 m-85 -90.78 31.06 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 75.299999999999997 110.893 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.48 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 8.4 p -61.21 143.55 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 75.129999999999995 111.143 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.471 ' N ' HG22 ' A' ' 53' ' ' VAL . . . 52.41 -90.99 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.728 -0.749 . . . . 75.109999999999999 112.496 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.9 OUTLIER -120.06 104.77 10.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.774 0.321 . . . . 72.310000000000002 110.934 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.49 109.22 1.76 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.624 0.726 . . . . 64.409999999999997 111.064 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.9 Cg_endo -69.81 168.81 20.56 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.67 2.247 . . . . 74.099999999999994 112.334 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tp -53.86 -26.62 25.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 71.299999999999997 110.925 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.35 -53.05 62.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 75.140000000000001 111.106 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.577 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 21.3 mmt180 -69.88 -41.67 74.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 64.549999999999997 110.926 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.557 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -59.49 -53.4 58.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 74.129999999999995 110.845 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.6 mtp180 -66.53 -35.85 81.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 72.409999999999997 110.837 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 10.9 tpt -58.35 -45.86 87.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 75.400000000000006 110.933 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.506 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 19.6 m -70.19 -40.38 78.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 72.150000000000006 111.13 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.564 ' CE1' HD13 ' A' ' 81' ' ' LEU . 13.6 m-85 -65.71 -34.76 78.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 73.040000000000006 110.949 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.61 -46.29 32.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 71.239999999999995 111.045 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.48 ' CG2' HD12 ' A' ' 68' ' ' LEU . 3.5 t -66.91 -28.37 68.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 75.030000000000001 111.109 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.506 ' CD1' ' O ' ' A' ' 64' ' ' VAL . 3.8 mp -82.57 -8.82 59.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 71.540000000000006 110.91 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.27 80.01 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.687 -0.768 . . . . 53.450000000000003 112.552 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.44 ' CB ' ' HB2' ' A' ' 75' ' ' ALA . 56.1 mt-10 -91.22 -25.31 19.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.897 0.38 . . . . 74.400000000000006 110.889 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.1 mp -89.96 9.98 25.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.098 -0.501 . . . . 71.420000000000002 110.965 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 7.0 ptp -74.42 -13.22 60.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 74.010000000000005 110.83 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.3 -32.93 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.748 -0.739 . . . . 65.0 112.503 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.88 73.9 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.761 -0.733 . . . . 51.25 112.487 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.44 ' HB2' ' CB ' ' A' ' 70' ' ' GLU . . . -59.35 123.54 17.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.828 0.346 . . . . 75.230000000000004 111.061 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 18.6 mm -113.56 163.42 10.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.479 . . . . 74.450000000000003 111.102 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -65.2 -4.88 5.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.186 -0.461 . . . . 72.040000000000006 110.823 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.606 ' O ' ' CD2' ' A' ' 42' ' ' HIS . . . -88.47 47.21 1.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 73.109999999999999 111.091 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.69 ' CD1' ' CZ ' ' A' ' 43' ' ' PHE . 1.1 mm? -115.47 133.85 55.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 75.150000000000006 110.97 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -114.35 115.61 27.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 75.099999999999994 110.883 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.564 HD13 ' CE1' ' A' ' 65' ' ' TYR . 1.4 tt -126.33 144.99 50.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 75.340000000000003 110.937 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -136.26 123.84 22.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 72.510000000000005 110.866 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.579 ' HB ' ' CD2' ' A' ' 52' ' ' PHE . 30.1 p -116.06 107.75 15.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.25 111.131 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mp -128.3 160.67 31.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 75.030000000000001 110.92 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.48 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.3 OUTLIER -72.5 164.94 55.91 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.606 0.717 . . . . 73.219999999999999 111.139 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.519 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.1 Cg_endo -69.77 -16.37 37.5 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 2.245 . . . . 71.420000000000002 112.375 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -73.03 -35.9 66.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 72.420000000000002 110.817 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -67.82 -38.03 82.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 75.230000000000004 110.839 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 71.239999999999995 111.144 179.925 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 14.9 ptp . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.761 0.315 . . . . 74.25 110.941 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -84.01 145.05 28.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 71.349999999999994 110.894 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -98.75 35.6 1.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 73.239999999999995 110.874 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -115.15 65.37 1.9 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.596 0.713 . . . . 74.400000000000006 110.876 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 150.92 68.69 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.668 2.245 . . . . 73.0 112.319 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.1 mt -128.15 -69.73 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 74.409999999999997 110.927 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.4 ' O ' HG21 ' A' ' 19' ' ' THR . 5.4 m-20 -125.83 -69.05 0.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.469 . . . . 73.430000000000007 110.914 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.61 -31.9 71.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 45.329999999999998 111.139 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -72.83 -48.04 41.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 72.5 110.906 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.4 HG21 ' O ' ' A' ' 16' ' ' ASP . 2.7 t -57.8 -50.15 74.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 72.340000000000003 111.139 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.477 HG13 ' N ' ' A' ' 21' ' ' ARG . 25.9 pt -68.01 -42.16 85.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 73.219999999999999 111.152 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.477 ' N ' HG13 ' A' ' 20' ' ' ILE . 54.3 ttt-85 -55.01 -53.16 59.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 74.349999999999994 110.834 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.5 mttt -66.15 -35.86 81.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 74.129999999999995 110.94 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.37 -49.18 75.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 53.439999999999998 110.945 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.476 HD12 ' CG1' ' A' ' 33' ' ' VAL . 5.8 mt -70.9 -44.34 76.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 74.310000000000002 111.135 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -53.89 -36.85 63.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 72.209999999999994 110.869 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.51 -41.48 21.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 75.109999999999999 110.818 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.61 -55.5 24.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.798 -0.715 . . . . 63.240000000000002 112.481 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -72.89 159.36 85.51 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.641 0.734 . . . . 75.340000000000003 110.945 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -90.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.649 2.233 . . . . 65.299999999999997 112.368 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -107.29 27.24 9.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.423 . . . . 73.219999999999999 110.895 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -79.07 126.77 31.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 75.109999999999999 111.058 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -93.86 109.01 20.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 73.310000000000002 110.905 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.483 ' CG1' HG22 ' A' ' 47' ' ' VAL . 53.0 t -113.65 121.45 65.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 72.25 111.102 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -132.34 118.11 18.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 75.329999999999998 110.897 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 36' ' ' GLN . 2.2 p -127.08 135.63 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 71.0 111.162 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.46 ' N ' HG22 ' A' ' 35' ' ' VAL . 30.5 mm-40 -133.57 120.14 20.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 75.510000000000005 110.903 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.88 -128.19 2.92 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.727 -0.749 . . . . 61.420000000000002 112.436 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.432 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 11.8 pt-20 -175.27 171.17 2.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.811 0.339 . . . . 74.420000000000002 110.838 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -75.29 147.42 40.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.132 -0.485 . . . . 71.129999999999995 110.819 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.71 16.72 77.9 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.716 -0.754 . . . . 73.140000000000001 112.435 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.432 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 1.8 t -146.62 164.01 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 73.140000000000001 111.161 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 42' ' ' HIS . 19.7 p-80 -75.98 106.62 7.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 110.835 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.569 ' CD1' HD11 ' A' ' 79' ' ' LEU . 4.5 p90 -119.26 166.22 13.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 75.030000000000001 110.836 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -115.4 121.17 41.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 72.219999999999999 110.892 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.17 115.09 17.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 72.120000000000005 111.072 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.1 m -111.81 116.16 30.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 74.030000000000001 111.1 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.483 HG22 ' CG1' ' A' ' 33' ' ' VAL . 28.6 t -120.58 126.11 74.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 74.239999999999995 111.148 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.4 p -124.06 118.8 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 75.040000000000006 111.174 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.431 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.8 OUTLIER -160.61 166.63 15.17 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.611 0.719 . . . . 72.040000000000006 110.8 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.505 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.3 Cg_endo -69.82 -21.82 32.66 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.687 2.258 . . . . 74.340000000000003 112.297 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.476 ' HB3' ' CZ ' ' A' ' 60' ' ' ARG . . . -46.65 -45.19 19.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 75.409999999999997 111.12 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.582 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -87.47 36.92 0.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 75.530000000000001 110.936 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.481 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 4.1 p -52.34 124.37 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 74.349999999999994 111.128 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.57 -89.05 0.73 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.791 -0.719 . . . . 34.350000000000001 112.47 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.423 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -119.52 111.24 17.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.82 0.343 . . . . 61.119999999999997 110.934 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.511 ' CB ' ' HB3' ' A' ' 52' ' ' PHE . . . -58.38 108.0 1.15 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.536 0.684 . . . . 71.319999999999993 111.149 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.423 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.5 Cg_endo -69.83 162.59 41.51 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.65 2.234 . . . . 74.299999999999997 112.366 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -58.0 -27.05 63.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 70.140000000000001 110.916 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.82 -52.39 65.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 71.230000000000004 111.079 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.582 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 16.5 mmt180 -69.09 -41.18 77.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.473 . . . . 74.140000000000001 110.908 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.409 ' NE2' ' OH ' ' A' ' 65' ' ' TYR . 1.0 OUTLIER -60.66 -53.54 56.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 74.349999999999994 110.836 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.9 mtp85 -66.68 -33.35 75.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 75.25 110.87 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.3 mmt -60.81 -49.69 76.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 74.299999999999997 110.833 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.481 HG21 ' N ' ' A' ' 65' ' ' TYR . 19.2 m -65.21 -43.0 95.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 75.120000000000005 111.166 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.58 ' CE1' HD13 ' A' ' 81' ' ' LEU . 15.0 m-85 -61.9 -37.92 86.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 75.109999999999999 110.887 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.24 -33.16 59.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 71.120000000000005 111.088 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.52 HG23 ' N ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -72.15 -29.63 64.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.264 -0.425 . . . . 73.150000000000006 111.115 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.52 ' N ' HG23 ' A' ' 67' ' ' THR . 3.9 pp -83.33 -6.78 59.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.448 . . . . 75.219999999999999 110.913 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.47 69.62 1.09 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.782 -0.723 . . . . 65.129999999999995 112.433 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.495 ' CB ' ' CD1' ' A' ' 68' ' ' LEU . 2.4 tp10 -98.75 -23.51 15.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.956 0.408 . . . . 75.099999999999994 110.957 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.454 ' CD2' ' HB1' ' A' ' 75' ' ' ALA . 4.6 mm? -90.31 3.39 53.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 74.209999999999994 110.916 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.7 mtp -71.93 -13.31 61.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 74.409999999999997 110.865 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.27 -31.5 0.12 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.738 -0.744 . . . . 74.200000000000003 112.505 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 154.26 109.14 0.34 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.804 -0.712 . . . . 65.239999999999995 112.523 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.473 ' CB ' ' HG3' ' A' ' 70' ' ' GLU . . . -87.56 123.19 32.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 73.340000000000003 111.088 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.404 ' CG2' ' N ' ' A' ' 77' ' ' HIS . 4.5 mp -113.89 163.25 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 74.430000000000007 111.109 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.404 ' N ' ' CG2' ' A' ' 76' ' ' ILE . 35.4 p-80 -72.11 2.76 5.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.329999999999998 110.848 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.448 ' HB2' ' CB ' ' A' ' 42' ' ' HIS . . . -88.94 21.52 3.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 71.329999999999998 111.13 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.569 HD11 ' CD1' ' A' ' 43' ' ' PHE . 8.5 tp -97.58 133.25 42.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 73.349999999999994 110.937 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -111.35 115.18 28.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 74.319999999999993 110.946 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.58 HD13 ' CE1' ' A' ' 65' ' ' TYR . 7.4 tt -139.77 137.74 35.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 75.25 110.88 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 82' ' ' LYS . 2.3 mppt? -136.35 128.16 29.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 74.010000000000005 110.907 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.527 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 63.9 p -113.48 106.95 15.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 71.209999999999994 111.103 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.9 mt -125.99 161.69 26.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 73.219999999999999 110.946 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.481 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.94 163.99 62.29 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.608 0.718 . . . . 75.120000000000005 111.171 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.505 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.4 Cg_endo -69.66 -21.96 33.2 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.787 2.325 . . . . 74.450000000000003 112.288 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -70.66 -35.94 73.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 74.439999999999998 110.905 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.7 -33.89 76.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 63.149999999999999 110.916 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 74.019999999999996 111.106 179.948 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.3 tpt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.714 0.292 . . . . 75.109999999999999 110.926 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -81.52 -49.85 10.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 74.420000000000002 110.86 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -161.22 146.5 13.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 74.439999999999998 110.908 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.6 mtm180 -120.7 81.99 33.71 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.577 0.703 . . . . 75.349999999999994 110.91 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.73 -51.4 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.663 2.242 . . . . 75.150000000000006 112.335 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.0 tp 61.53 53.12 3.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 75.430000000000007 110.956 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -134.94 -70.01 0.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 72.219999999999999 110.905 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.462 ' HB2' ' CG1' ' A' ' 35' ' ' VAL . . . -68.29 -34.5 76.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 71.25 111.089 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -70.22 -48.43 57.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 72.140000000000001 110.888 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 2.8 t -59.17 -51.13 71.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 73.340000000000003 111.143 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.508 ' CG2' ' O ' ' A' ' 67' ' ' THR . 2.6 pp -64.83 -40.7 89.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 75.319999999999993 111.187 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.499 ' N ' HD11 ' A' ' 20' ' ' ILE . 73.9 ttt180 -60.92 -46.26 91.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 72.129999999999995 110.87 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -63.51 -42.66 98.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 73.329999999999998 110.888 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.5 mt -57.53 -49.11 77.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 74.200000000000003 110.939 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.455 ' CG2' HG22 ' A' ' 33' ' ' VAL . 49.2 mm -63.18 -46.71 95.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 72.409999999999997 111.147 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -55.11 -40.23 70.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 75.049999999999997 110.846 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.04 -43.24 71.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 73.209999999999994 110.867 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.99 -49.13 60.3 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.726 . . . . 74.140000000000001 112.525 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.55 157.16 72.77 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.53 0.681 . . . . 72.230000000000004 110.972 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -90.62 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.685 2.256 . . . . 64.519999999999996 112.323 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -107.41 29.57 7.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 74.310000000000002 110.882 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -75.02 133.09 41.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 72.140000000000001 111.084 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.471 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 7.0 tpp180 -99.98 111.14 23.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 73.439999999999998 110.927 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.496 ' O ' ' NE ' ' A' ' 21' ' ' ARG . 32.3 t -113.86 124.98 71.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 74.409999999999997 111.107 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -134.69 118.15 16.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 75.209999999999994 110.889 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.462 ' CG1' ' HB2' ' A' ' 17' ' ' ALA . 4.9 p -130.43 136.33 58.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 71.239999999999995 111.134 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.444 ' N ' HG23 ' A' ' 35' ' ' VAL . 13.3 pt20 -133.32 120.21 20.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 74.430000000000007 110.928 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.466 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 149.67 -145.19 13.09 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.703 -0.761 . . . . 72.519999999999996 112.461 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -156.1 176.98 11.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.825 0.345 . . . . 71.0 110.939 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -80.06 139.87 36.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 74.030000000000001 110.895 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.419 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.67 25.7 73.38 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.772 -0.727 . . . . 64.519999999999996 112.463 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.457 ' HA ' ' CD1' ' A' ' 76' ' ' ILE . 1.2 p -148.91 164.7 4.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.895 0.379 . . . . 75.540000000000006 111.079 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.423 ' CD2' ' O ' ' A' ' 42' ' ' HIS . 7.4 p-80 -74.97 107.44 7.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 72.230000000000004 110.853 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.578 ' CE2' HD12 ' A' ' 79' ' ' LEU . 4.4 p90 -123.88 167.14 14.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.3 -0.409 . . . . 74.140000000000001 110.92 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -118.75 121.73 40.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 71.329999999999998 110.894 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -126.42 114.9 18.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 64.340000000000003 111.103 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 m -111.58 117.19 32.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 71.120000000000005 111.182 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 84.8 t -115.65 132.99 63.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 73.129999999999995 111.169 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.471 ' CG1' ' HB3' ' A' ' 32' ' ' ARG . 5.6 p -128.79 120.37 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 73.140000000000001 111.149 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.446 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.9 OUTLIER -167.31 164.82 9.31 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.711 0.767 . . . . 74.510000000000005 110.803 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.505 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.6 Cg_endo -69.78 -19.1 36.48 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.685 2.256 . . . . 71.329999999999998 112.363 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 60' ' ' ARG . . . -47.19 -41.61 18.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 73.510000000000005 111.043 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.58 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -91.87 38.23 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 74.25 110.895 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.48 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 4.8 p -53.03 123.27 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 73.25 111.156 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.92 -90.61 0.68 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.689 -0.767 . . . . 75.310000000000002 112.532 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.45 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 1.3 mptp? -117.11 110.29 18.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.815 0.341 . . . . 74.299999999999997 110.855 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.517 ' CB ' ' HB3' ' A' ' 52' ' ' PHE . . . -58.52 107.44 0.95 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.526 0.679 . . . . 61.530000000000001 111.092 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.1 Cg_endo -69.85 166.01 29.15 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.676 2.251 . . . . 75.310000000000002 112.312 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.34 -26.75 65.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 74.519999999999996 110.929 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.61 -52.22 66.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 74.230000000000004 111.099 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.58 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 18.9 mmt180 -69.59 -41.09 76.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 72.329999999999998 110.829 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.498 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -58.78 -52.59 65.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.421 . . . . 74.209999999999994 110.836 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -66.42 -37.26 84.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 74.230000000000004 110.916 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 20.2 mmm -56.44 -52.07 66.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 71.120000000000005 110.895 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.474 HG23 ' N ' ' A' ' 65' ' ' TYR . 17.4 m -62.95 -44.44 99.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 65.219999999999999 111.072 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.576 ' CE1' HD12 ' A' ' 81' ' ' LEU . 14.3 m-85 -60.98 -30.81 70.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 71.450000000000003 110.938 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.02 -46.76 32.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 73.409999999999997 111.08 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.508 ' O ' ' CG2' ' A' ' 20' ' ' ILE . 3.8 t -63.9 -28.8 70.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 70.400000000000006 111.115 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.451 ' O ' ' C ' ' A' ' 69' ' ' GLY . 9.9 mt -82.17 5.58 19.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 75.010000000000005 110.854 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 34.07 67.59 0.24 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 72.230000000000004 112.484 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.483 ' HG3' ' N ' ' A' ' 71' ' ' LEU . 5.8 pt-20 -85.41 -39.48 17.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 75.200000000000003 110.847 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.556 ' CD2' ' C ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -91.03 7.38 40.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 73.239999999999995 110.904 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.416 ' N ' HD21 ' A' ' 71' ' ' LEU . 19.8 mtt -73.06 -12.93 61.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 74.219999999999999 110.889 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.15 -32.15 0.1 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.725 -0.75 . . . . 74.010000000000005 112.49 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.419 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . 135.52 54.48 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.778 -0.725 . . . . 41.020000000000003 112.514 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.81 145.16 41.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.715 0.293 . . . . 70.239999999999995 111.104 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.457 ' CD1' ' HA ' ' A' ' 41' ' ' VAL . 3.0 mp -97.11 148.42 5.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 73.129999999999995 111.164 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -48.07 -17.34 0.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 74.409999999999997 110.843 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.417 ' N ' ' C ' ' A' ' 76' ' ' ILE . . . -74.78 48.7 0.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 62.439999999999998 111.039 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.578 HD12 ' CE2' ' A' ' 43' ' ' PHE . 7.8 tp -107.96 128.18 54.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 74.219999999999999 110.902 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -102.45 115.0 29.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 73.450000000000003 110.957 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.576 HD12 ' CE1' ' A' ' 65' ' ' TYR . 8.6 tt -139.76 135.86 33.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.241 -0.436 . . . . 74.230000000000004 110.899 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -136.49 131.63 34.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 73.439999999999998 110.949 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.537 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 67.1 p -116.69 106.8 13.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 55.219999999999999 111.155 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.05 161.81 24.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 75.099999999999994 110.96 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.48 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -71.8 163.41 66.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.546 0.689 . . . . 73.129999999999995 111.175 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.505 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.2 Cg_endo -69.78 -10.32 28.25 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.749 2.3 . . . . 72.040000000000006 112.349 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -76.0 -35.89 59.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 72.329999999999998 110.821 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -68.19 -36.06 78.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.426 . . . . 71.329999999999998 110.898 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.154 -0.475 . . . . 71.140000000000001 111.122 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.8 ttt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.739 0.304 . . . . 75.109999999999999 110.913 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -151.96 116.86 5.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 73.549999999999997 110.897 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -63.51 111.8 2.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 72.510000000000005 110.876 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -76.13 114.86 41.62 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.619 0.723 . . . . 75.519999999999996 110.843 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 174.0 10.12 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.658 2.239 . . . . 75.219999999999999 112.389 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -121.18 -11.51 8.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.272 -0.422 . . . . 75.109999999999999 110.918 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -102.78 -53.61 2.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 72.430000000000007 110.874 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.498 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . . . -63.23 -27.95 69.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 73.340000000000003 111.062 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.501 ' OE1' ' NE ' ' A' ' 21' ' ' ARG . 4.3 mm-40 -68.65 -26.55 65.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 73.310000000000002 110.854 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.7 p -61.4 -56.91 15.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 73.420000000000002 111.1 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.498 ' CD1' ' HA ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -74.06 -29.91 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 73.420000000000002 111.1 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.501 ' NE ' ' OE1' ' A' ' 18' ' ' GLU . 23.7 ttp85 -63.37 -50.86 68.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 60.43 110.851 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -72.79 -36.13 67.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 74.549999999999997 110.897 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.471 ' C ' ' CD1' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -57.91 -51.04 71.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 73.400000000000006 110.851 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.471 ' CG2' HG23 ' A' ' 33' ' ' VAL . 8.6 mt -73.5 -44.16 54.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 74.019999999999996 111.17 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.444 ' CG ' ' O ' ' A' ' 21' ' ' ARG . 68.0 mt-10 -56.51 -32.22 64.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 74.120000000000005 110.874 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.27 -43.23 17.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 74.010000000000005 110.83 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.44 -41.89 97.29 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.737 -0.744 . . . . 73.420000000000002 112.548 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -122.94 102.41 37.88 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.648 0.737 . . . . 65.120000000000005 110.915 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.7 -15.02 37.09 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.687 2.258 . . . . 73.349999999999994 112.3 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -100.16 0.83 41.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.411 . . . . 73.549999999999997 110.86 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -120.58 135.7 55.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 71.200000000000003 111.108 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.462 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 47.1 ttt-85 -110.44 123.73 50.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 74.200000000000003 110.926 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.471 HG23 ' CG2' ' A' ' 24' ' ' ILE . 4.8 t -122.37 134.3 66.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 74.519999999999996 111.139 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.35 118.08 16.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 75.420000000000002 110.912 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.4 t -123.62 130.4 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 75.510000000000005 111.104 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -133.34 120.15 20.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 71.400000000000006 110.889 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.07 -119.97 1.12 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.712 -0.756 . . . . 73.340000000000003 112.437 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -172.19 170.43 5.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 74.420000000000002 110.903 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -80.35 145.55 32.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 72.120000000000005 110.908 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.474 ' CA ' ' O ' ' A' ' 73' ' ' GLY . . . 72.7 -0.94 40.69 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.747 -0.739 . . . . 65.230000000000004 112.487 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.3 t -123.13 165.19 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 75.340000000000003 111.186 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.447 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . 53.9 p-80 -74.67 106.45 6.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 72.510000000000005 110.857 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.571 ' CE2' HD12 ' A' ' 79' ' ' LEU . 8.6 p90 -120.55 168.06 11.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 73.239999999999995 110.912 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -113.2 121.22 43.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 74.349999999999994 110.859 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.67 126.99 45.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.103 -0.499 . . . . 64.310000000000002 111.093 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.7 m -120.96 120.64 36.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 73.140000000000001 111.146 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 78.2 t -119.45 136.76 55.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 72.319999999999993 111.119 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.462 ' CG1' ' HB3' ' A' ' 32' ' ' ARG . 7.2 p -136.17 124.28 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 74.400000000000006 111.156 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.406 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.9 OUTLIER -174.62 164.74 2.45 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.624 0.725 . . . . 73.019999999999996 110.879 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.524 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.2 Cg_endo -69.71 -19.96 35.68 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.653 2.236 . . . . 64.120000000000005 112.369 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.47 -40.51 18.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 111.08 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.574 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 0.5 OUTLIER -92.22 37.64 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 74.420000000000002 110.907 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.484 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 2.6 p -52.82 136.0 14.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 63.32 111.136 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.459 ' N ' HG21 ' A' ' 53' ' ' VAL . . . 60.37 -89.09 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.765 -0.731 . . . . 64.109999999999999 112.455 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.432 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 3.6 mptp? -119.28 111.08 17.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.746 0.308 . . . . 70.310000000000002 110.932 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.505 ' CB ' ' HB3' ' A' ' 52' ' ' PHE . . . -58.46 107.99 1.15 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.607 0.718 . . . . 73.200000000000003 111.071 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.76 164.23 35.33 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.665 2.244 . . . . 74.019999999999996 112.375 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.6 tt -57.64 -24.85 58.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 73.219999999999999 110.887 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.406 ' O ' ' SD ' ' A' ' 63' ' ' MET . . . -61.91 -52.75 62.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 63.32 111.099 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.574 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 0.5 OUTLIER -69.08 -40.7 78.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 74.450000000000003 110.875 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.561 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 1.1 t60 -58.85 -53.98 52.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 75.349999999999994 110.826 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -66.2 -35.53 80.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.209999999999994 110.868 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.406 ' SD ' ' O ' ' A' ' 59' ' ' ALA . 0.0 OUTLIER -58.33 -46.22 86.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 72.150000000000006 110.88 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.482 HG22 ' N ' ' A' ' 65' ' ' TYR . 17.1 m -69.15 -40.22 80.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 72.150000000000006 111.185 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.569 ' CE1' HD21 ' A' ' 81' ' ' LEU . 14.2 m-85 -64.93 -35.89 82.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 75.409999999999997 110.92 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.3 -46.63 39.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 74.209999999999994 111.115 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.479 ' CG2' ' HA ' ' A' ' 64' ' ' VAL . 6.0 t -66.04 -28.47 68.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 75.230000000000004 111.107 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.461 ' CD1' HD12 ' A' ' 24' ' ' ILE . 5.2 mp -82.32 7.66 13.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 75.510000000000005 110.917 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 35.71 68.79 0.26 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.786 -0.721 . . . . 71.219999999999999 112.402 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.43 ' CD ' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -102.38 -24.62 13.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.879 0.371 . . . . 72.239999999999995 110.845 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.43 HD22 ' CD ' ' A' ' 70' ' ' GLU . 3.0 mm? -86.75 -21.0 26.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 70.420000000000002 110.902 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.2 ttm -76.22 -12.59 60.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 74.540000000000006 110.867 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.474 ' O ' ' CA ' ' A' ' 40' ' ' GLY . . . -120.47 -9.19 7.95 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.746 -0.74 . . . . 71.140000000000001 112.455 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.53 43.03 10.69 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.762 -0.733 . . . . 74.129999999999995 112.483 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.89 127.6 33.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.732 0.301 . . . . 74.019999999999996 111.096 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.401 ' CG2' ' N ' ' A' ' 77' ' ' HIS . 26.1 mm -71.25 163.32 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 75.129999999999995 111.077 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.401 ' N ' ' CG2' ' A' ' 76' ' ' ILE . 80.3 m-70 -55.69 -12.63 1.31 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 74.329999999999998 110.897 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.447 ' HB3' ' CB ' ' A' ' 42' ' ' HIS . . . -75.31 47.94 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 65.239999999999995 111.138 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.571 HD12 ' CE2' ' A' ' 43' ' ' PHE . 8.8 tp -110.2 138.43 46.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 75.519999999999996 110.928 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -104.62 117.07 33.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 61.509999999999998 110.891 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.569 HD21 ' CE1' ' A' ' 65' ' ' TYR . 1.9 tp -139.33 123.51 17.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 63.109999999999999 110.886 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -126.87 123.3 36.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 75.209999999999994 110.891 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.526 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 4.9 p -113.22 107.25 15.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 64.420000000000002 111.186 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.7 mp -129.81 161.59 30.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 72.510000000000005 110.924 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.484 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.9 164.04 61.8 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.614 0.721 . . . . 71.219999999999999 111.102 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.9 Cg_endo -69.71 -23.75 30.67 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.714 2.276 . . . . 72.409999999999997 112.296 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.44 -34.9 78.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 73.150000000000006 110.891 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.08 -33.18 75.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 71.439999999999998 110.876 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 73.519999999999996 111.09 179.941 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.714 0.292 . . . . 73.349999999999994 110.863 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.408 ' HD3' ' N ' ' A' ' 11' ' ' ARG . 1.7 mpp_? -109.02 163.59 13.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 73.420000000000002 110.864 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -169.03 177.91 4.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 74.099999999999994 110.94 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.449 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 11.8 mmp_? 51.5 53.45 13.36 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.616 0.722 . . . . 73.409999999999997 110.864 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 13' ' ' ARG . 54.0 Cg_endo -69.7 108.22 2.02 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.71 2.274 . . . . 73.319999999999993 112.411 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.2 tp -113.5 -72.53 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 74.409999999999997 110.915 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -128.63 -66.54 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 74.349999999999994 110.87 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.1 -36.28 79.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 74.439999999999998 111.048 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -71.54 -48.01 51.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 72.299999999999997 110.92 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 3.0 t -57.96 -51.7 68.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 74.239999999999995 111.177 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.2 pt -66.06 -41.9 90.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 73.510000000000005 111.168 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 67.3 ttt180 -60.45 -53.58 55.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 74.420000000000002 110.912 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.456 ' CG ' ' N ' ' A' ' 23' ' ' LEU . 23.2 pttt -59.43 -44.83 92.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 75.310000000000002 110.861 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.456 ' N ' ' CG ' ' A' ' 22' ' ' LYS . 2.1 mm? -55.96 -49.12 74.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 64.319999999999993 110.867 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.481 ' CG2' HG22 ' A' ' 33' ' ' VAL . 7.1 mt -68.17 -44.12 84.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 64.400000000000006 111.113 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -54.79 -37.85 66.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 75.439999999999998 110.874 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.1 -41.31 35.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 71.129999999999995 110.866 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.31 -53.82 33.7 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.701 -0.761 . . . . 72.230000000000004 112.483 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.94 159.13 79.29 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.533 0.682 . . . . 74.450000000000003 110.985 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -87.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.676 2.25 . . . . 71.430000000000007 112.369 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -111.02 26.12 11.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 75.340000000000003 110.889 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -73.31 125.85 28.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 74.239999999999995 111.085 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -91.77 107.52 19.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 72.400000000000006 110.984 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.481 HG22 ' CG2' ' A' ' 24' ' ' ILE . 61.6 t -109.83 121.33 62.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 72.310000000000002 111.132 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -132.38 118.88 19.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 73.230000000000004 110.876 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 44.8 t -126.79 136.98 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 72.310000000000002 111.146 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -130.67 120.5 24.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.159 -0.473 . . . . 71.409999999999997 110.886 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.435 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 140.63 -142.08 11.99 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.672 -0.775 . . . . 71.120000000000005 112.491 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -165.29 156.04 13.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.886 0.374 . . . . 72.239999999999995 110.84 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -62.26 154.51 27.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 75.530000000000001 110.863 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.85 -2.59 40.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.676 -0.773 . . . . 75.120000000000005 112.524 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.3 t -132.52 164.76 34.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.328 . . . . 71.299999999999997 111.174 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.598 ' CD2' ' O ' ' A' ' 42' ' ' HIS . 0.6 OUTLIER -75.02 106.72 6.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 74.030000000000001 110.825 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.55 ' CZ ' HD12 ' A' ' 79' ' ' LEU . 39.7 p90 -121.98 167.79 12.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 74.329999999999998 110.846 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -113.26 133.52 55.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 74.140000000000001 110.89 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.478 ' CB ' HD23 ' A' ' 68' ' ' LEU . . . -128.09 118.84 24.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 65.219999999999999 111.17 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.2 m -121.4 111.5 17.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 72.430000000000007 111.149 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.47 HG21 ' CG1' ' A' ' 33' ' ' VAL . 94.9 t -120.74 134.73 63.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 71.120000000000005 111.097 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.6 p -131.05 122.72 52.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 75.510000000000005 111.111 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.423 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.9 OUTLIER -161.83 165.6 15.91 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.628 0.728 . . . . 73.5 110.874 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.512 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 52.9 Cg_endo -69.93 -22.14 31.7 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.728 2.285 . . . . 71.340000000000003 112.215 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 60' ' ' ARG . . . -47.04 -44.29 20.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 75.519999999999996 111.079 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.576 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -87.11 35.56 0.7 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 73.420000000000002 110.902 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.47 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 12.4 p -52.26 125.86 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 73.25 111.138 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.5 -89.4 0.73 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.712 -0.756 . . . . 55.130000000000003 112.51 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.422 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 3.3 mptp? -120.3 110.23 16.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.809 0.338 . . . . 73.329999999999998 110.871 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.551 ' CB ' ' HB3' ' A' ' 52' ' ' PHE . . . -58.64 108.15 1.21 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.563 0.697 . . . . 62.420000000000002 111.08 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.83 161.59 45.36 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.728 2.285 . . . . 64.329999999999998 112.36 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.417 HD21 ' NH1' ' A' ' 62' ' ' ARG . 1.1 tp -57.87 -27.25 63.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.28 -0.418 . . . . 74.310000000000002 110.925 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.27 -52.16 66.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 64.510000000000005 111.092 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.576 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 23.2 mmt180 -69.18 -43.0 75.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 75.209999999999994 110.856 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.511 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 0.2 OUTLIER -59.17 -51.49 69.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 75.230000000000004 110.849 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.417 ' NH1' HD21 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -66.15 -38.64 88.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 74.439999999999998 110.902 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 21.8 mmt -56.29 -48.27 76.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 74.549999999999997 110.919 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 61' ' ' HIS . 16.3 m -65.31 -39.54 85.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 72.340000000000003 111.117 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.562 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 12.4 m-85 -59.58 -39.81 85.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 72.439999999999998 110.91 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.06 -46.96 31.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 74.450000000000003 111.133 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 64' ' ' VAL . 0.9 OUTLIER -61.66 -31.32 71.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 74.420000000000002 111.145 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.478 HD23 ' CB ' ' A' ' 45' ' ' ALA . 7.3 mp -83.04 -4.3 58.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 72.510000000000005 110.929 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.75 69.37 1.28 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.705 -0.76 . . . . 71.230000000000004 112.535 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -85.31 -40.5 16.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 75.120000000000005 110.911 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.4 mp -87.87 9.87 20.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 75.219999999999999 110.916 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.6 mmt -72.01 -13.14 61.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 72.230000000000004 110.909 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.92 -32.91 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.77 -0.729 . . . . 73.310000000000002 112.528 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.76 106.23 0.31 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.745 -0.74 . . . . 64.230000000000004 112.465 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.69 123.76 31.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.718 0.294 . . . . 70.5 111.113 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.419 ' CG2' ' N ' ' A' ' 77' ' ' HIS . 4.7 mp -113.36 163.26 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 75.200000000000003 111.083 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.419 ' N ' ' CG2' ' A' ' 76' ' ' ILE . 43.8 m-70 -60.86 -9.07 3.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.088 -0.506 . . . . 73.349999999999994 110.871 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.463 ' HB3' ' CB ' ' A' ' 42' ' ' HIS . . . -83.86 27.1 0.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 61.140000000000001 111.075 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.55 HD12 ' CZ ' ' A' ' 43' ' ' PHE . 1.6 mm? -97.83 140.43 32.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 72.430000000000007 110.939 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -118.21 115.62 25.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 75.019999999999996 111.016 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.562 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 0.6 OUTLIER -130.85 116.57 18.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 74.299999999999997 110.862 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.465 ' HD3' ' N ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -126.01 122.19 35.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 75.049999999999997 110.944 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.521 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 69.2 p -115.62 107.34 14.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.289 -0.414 . . . . 71.209999999999994 111.172 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -127.75 162.06 27.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 74.310000000000002 110.894 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.47 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.02 163.29 68.17 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-O 121.639 0.733 . . . . 73.549999999999997 111.12 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.512 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.9 Cg_endo -69.72 -7.49 21.18 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.693 2.262 . . . . 74.540000000000006 112.363 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -84.58 -30.77 24.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 61.539999999999999 110.828 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -84.79 28.24 0.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 62.119999999999997 110.876 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 72.400000000000006 111.072 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.771 0.32 . . . . 74.439999999999998 110.905 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -119.1 93.3 4.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 72.549999999999997 110.864 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -99.58 -48.93 4.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 75.439999999999998 110.923 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.472 ' O ' ' CD2' ' A' ' 15' ' ' LEU . 8.8 ptt-85 -116.21 86.25 17.03 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.639 0.733 . . . . 74.239999999999995 110.918 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.456 ' HA ' ' CB ' ' A' ' 18' ' ' GLU . 53.8 Cg_endo -69.74 136.4 32.96 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.628 2.219 . . . . 64.530000000000001 112.362 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.472 ' CD2' ' O ' ' A' ' 13' ' ' ARG . 3.7 mm? -116.5 -68.22 0.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 72.340000000000003 110.948 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.29 -68.06 0.6 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 70.099999999999994 110.814 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.47 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . . . -68.0 -25.06 65.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 55.130000000000003 111.091 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.456 ' CB ' ' HA ' ' A' ' 14' ' ' PRO . 12.6 mt-10 -72.65 -48.8 36.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 72.340000000000003 110.856 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.408 HG23 ' N ' ' A' ' 20' ' ' ILE . 2.9 t -61.59 -47.63 84.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 71.319999999999993 111.151 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.47 ' CD1' ' HA ' ' A' ' 17' ' ' ALA . 10.8 pt -67.8 -43.13 86.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 73.120000000000005 111.149 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 55.1 ttt-85 -54.97 -52.91 61.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 74.310000000000002 110.838 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -65.42 -37.05 85.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 74.349999999999994 110.838 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.76 -50.26 72.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.47 . . . . 73.239999999999995 110.844 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.481 ' CD1' HG11 ' A' ' 33' ' ' VAL . 7.9 mt -72.51 -36.31 53.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 73.120000000000005 111.131 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -58.92 -38.3 78.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 70.430000000000007 110.845 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -80.84 -42.11 22.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 71.200000000000003 110.846 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.37 -42.48 99.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.738 . . . . 64.150000000000006 112.525 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -89.88 157.29 46.3 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.556 0.693 . . . . 73.329999999999998 110.962 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -91.22 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.662 2.241 . . . . 55.520000000000003 112.306 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -104.58 27.11 8.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.252 -0.431 . . . . 74.099999999999994 110.907 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -77.61 132.25 38.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 75.409999999999997 111.053 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.406 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 7.9 ttm-85 -101.35 112.12 24.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 75.540000000000006 110.873 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.481 HG11 ' CD1' ' A' ' 24' ' ' ILE . 0.0 OUTLIER -107.32 129.32 61.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.202 -0.454 . . . . 73.049999999999997 111.093 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.73 118.53 16.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 74.329999999999998 110.895 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.9 t -127.66 129.86 70.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 73.310000000000002 111.205 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -133.25 120.15 20.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.933 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.467 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 151.0 -125.97 2.01 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.726 -0.75 . . . . 74.230000000000004 112.483 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -174.66 157.76 2.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 74.099999999999994 110.909 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -68.41 144.16 54.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 74.430000000000007 110.854 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.76 22.26 79.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.759 . . . . 61.100000000000001 112.56 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -150.63 164.79 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.866 0.365 . . . . 71.329999999999998 111.111 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.455 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . 28.1 p80 -75.09 106.66 6.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 74.439999999999998 110.831 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.556 ' CE2' HD23 ' A' ' 79' ' ' LEU . 8.7 p90 -122.43 167.4 13.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 64.140000000000001 110.903 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -113.72 120.33 40.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 65.209999999999994 110.903 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -123.25 115.77 22.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 71.200000000000003 111.019 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.6 m -113.62 123.5 50.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 75.140000000000001 111.153 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.429 ' CG2' HG12 ' A' ' 33' ' ' VAL . 27.1 t -123.59 140.72 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 72.549999999999997 111.134 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.412 ' O ' ' CG1' ' A' ' 48' ' ' VAL . 8.1 p -130.52 117.83 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 73.420000000000002 111.165 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.411 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.9 OUTLIER -162.0 164.49 17.47 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.679 0.752 . . . . 72.349999999999994 110.855 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.541 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.3 Cg_endo -69.88 -22.05 32.06 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.631 2.221 . . . . 74.510000000000005 112.309 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.69 -44.53 38.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 72.140000000000001 111.133 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.523 ' CG ' ' HB ' ' A' ' 83' ' ' THR . 0.5 OUTLIER -87.63 34.19 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 71.450000000000003 110.898 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 55' ' ' LYS . 7.6 p -52.41 131.63 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 73.310000000000002 111.109 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 56.08 -81.02 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.726 -0.75 . . . . 74.439999999999998 112.517 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 53' ' ' VAL . 69.6 mmtt -113.3 134.27 54.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.796 0.331 . . . . 75.010000000000005 110.876 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.56 99.96 9.77 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.608 0.718 . . . . 74.430000000000007 111.1 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.71 172.58 12.32 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.695 2.263 . . . . 73.510000000000005 112.333 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tp -57.01 -27.49 61.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 74.040000000000006 110.913 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.3 -53.35 59.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 61.130000000000003 111.016 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.509 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 12.2 mmm180 -70.57 -42.24 71.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 72.109999999999999 110.838 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.566 ' CE1' HD23 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -57.12 -53.1 61.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 73.340000000000003 110.874 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -67.49 -38.86 84.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 73.239999999999995 110.903 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.463 ' C ' ' SD ' ' A' ' 63' ' ' MET . 0.7 OUTLIER -54.08 -48.02 71.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 75.209999999999994 110.853 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.512 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 24.4 m -68.77 -40.64 81.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 74.230000000000004 111.156 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.57 ' CE1' HD12 ' A' ' 81' ' ' LEU . 10.5 m-85 -64.93 -34.84 79.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 65.239999999999995 110.936 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.75 -46.24 32.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 75.530000000000001 111.193 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.47 ' CG2' HD13 ' A' ' 68' ' ' LEU . 3.8 t -67.58 -25.67 65.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 74.409999999999997 111.108 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.512 ' CD1' ' O ' ' A' ' 64' ' ' VAL . 5.9 mp -82.48 -0.47 46.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.246 -0.434 . . . . 73.239999999999995 110.919 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.6 68.37 1.02 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.75 -0.738 . . . . 70.120000000000005 112.439 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.466 ' C ' ' OE1' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -88.06 -25.57 22.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.339 . . . . 73.209999999999994 110.817 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.416 HD21 ' CD ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -89.64 7.12 38.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 73.049999999999997 110.963 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.4 mmt -73.15 -7.18 50.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 72.409999999999997 110.899 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.94 -35.04 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.703 -0.761 . . . . 74.200000000000003 112.492 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 131.63 64.26 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.767 -0.73 . . . . 71.319999999999993 112.517 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.0 129.1 40.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 52.020000000000003 111.109 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 77' ' ' HIS . 4.3 mp -88.89 163.22 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 75.530000000000001 111.094 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.45 ' N ' HG22 ' A' ' 76' ' ' ILE . 11.5 m80 -57.08 -12.27 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 73.25 110.822 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.455 ' HB3' ' CB ' ' A' ' 42' ' ' HIS . . . -82.79 39.61 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 72.329999999999998 111.092 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.556 HD23 ' CE2' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -97.68 134.41 40.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 74.129999999999995 110.894 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -106.95 118.67 37.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 71.430000000000007 110.984 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.57 HD12 ' CE1' ' A' ' 65' ' ' TYR . 4.5 tp -123.05 138.9 54.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 74.5 110.873 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.5 mptt -132.36 118.46 19.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 75.219999999999999 110.933 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.523 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 11.8 p -118.91 107.35 13.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 73.010000000000005 111.133 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -127.22 161.42 28.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.92 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.466 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -76.35 164.92 56.81 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.545 0.688 . . . . 74.519999999999996 111.166 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.5 Cg_endo -69.8 -0.15 6.52 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.695 2.264 . . . . 71.540000000000006 112.36 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.09 -27.43 26.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 73.010000000000005 110.869 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -82.2 24.81 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 72.150000000000006 110.884 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 65.200000000000003 111.137 179.918 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.0 mtt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.769 0.318 . . . . 75.239999999999995 110.827 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -124.03 32.21 5.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.301 -0.409 . . . . 72.420000000000002 110.83 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.3 tptt -80.59 42.56 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 75.319999999999993 110.919 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.458 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 15.5 mtt85 -72.54 -60.45 2.06 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.597 0.713 . . . . 74.439999999999998 110.885 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' A' ' 13' ' ' ARG . 53.2 Cg_endo -69.73 -173.92 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.683 2.256 . . . . 64.340000000000003 112.317 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.467 ' N ' HD23 ' A' ' 15' ' ' LEU . 4.0 mm? -120.99 -58.18 1.82 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.435 . . . . 73.129999999999995 110.931 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.473 ' HA ' ' CG2' ' A' ' 19' ' ' THR . 17.6 t0 -78.55 -34.65 46.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 72.530000000000001 110.88 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.413 ' O ' ' CB ' ' A' ' 21' ' ' ARG . . . -68.43 -42.96 78.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 73.329999999999998 111.096 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.557 ' CD ' ' N ' ' A' ' 19' ' ' THR . 3.0 pp20? -66.77 -48.14 69.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 72.099999999999994 110.83 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.557 ' N ' ' CD ' ' A' ' 18' ' ' GLU . 3.7 t -57.74 -52.45 65.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 74.349999999999994 111.089 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.469 HD11 ' CG2' ' A' ' 35' ' ' VAL . 5.9 pt -67.84 -41.95 85.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 72.219999999999999 111.176 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 54.4 ttp180 -58.67 -51.47 69.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 62.219999999999999 110.868 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.1 pttp -63.79 -40.24 96.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.499 . . . . 75.0 110.892 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 20.6 mt -56.32 -50.27 71.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 72.310000000000002 110.898 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.486 ' CG2' HG22 ' A' ' 33' ' ' VAL . 10.5 mt -69.53 -43.86 80.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 74.409999999999997 111.112 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -55.64 -35.07 65.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.462 . . . . 71.439999999999998 110.868 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -79.18 -43.2 24.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 74.230000000000004 110.905 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.65 -34.38 88.77 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.695 -0.764 . . . . 73.209999999999994 112.524 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.63 158.98 32.76 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.545 0.688 . . . . 65.450000000000003 110.924 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -90.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.695 2.263 . . . . 64.329999999999998 112.4 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -107.87 33.46 4.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 70.209999999999994 110.912 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.67 133.87 34.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 72.239999999999995 111.138 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.469 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 39.8 ttt-85 -106.4 125.56 51.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 75.430000000000007 110.845 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.486 HG22 ' CG2' ' A' ' 24' ' ' ILE . 3.9 t -124.0 135.45 63.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 74.329999999999998 111.149 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -135.26 118.46 16.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 72.010000000000005 110.889 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.469 ' CG2' HD11 ' A' ' 20' ' ' ILE . 39.6 t -125.85 136.7 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 73.299999999999997 111.143 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.3 mm-40 -133.33 120.36 20.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 71.340000000000003 110.893 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.84 -143.21 13.46 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 75.219999999999999 112.461 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -151.19 -174.98 4.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.889 0.376 . . . . 75.219999999999999 110.845 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -87.77 146.79 25.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 73.209999999999994 110.888 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.431 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 73.24 1.14 56.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.73 . . . . 62.310000000000002 112.476 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.6 m -125.21 165.19 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 73.439999999999998 111.1 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.454 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 23.6 p80 -74.86 107.01 6.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 62.530000000000001 110.821 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.579 ' CE2' HD12 ' A' ' 79' ' ' LEU . 39.6 p90 -121.99 167.75 12.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 74.120000000000005 110.898 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -113.48 124.74 53.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 73.120000000000005 110.86 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.18 115.88 19.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 63.25 111.099 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.8 m -117.72 112.71 20.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 72.319999999999993 111.131 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.428 ' CG2' HG11 ' A' ' 33' ' ' VAL . 22.6 t -110.5 141.44 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 74.299999999999997 111.133 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.492 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 4.0 p -130.42 118.95 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 75.209999999999994 111.127 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.42 ' OG ' ' CE2' ' A' ' 52' ' ' PHE . 24.1 p -168.7 160.01 8.4 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.654 0.74 . . . . 74.430000000000007 110.923 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.573 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.4 Cg_endo -69.74 -18.65 36.96 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.659 2.239 . . . . 72.030000000000001 112.383 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.83 -38.47 35.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 61.240000000000002 111.077 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.601 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 1.3 m-85 -90.86 33.5 0.93 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 73.510000000000005 110.904 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.464 HG22 ' N ' ' A' ' 54' ' ' GLY . 10.9 p -52.18 146.82 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 74.299999999999997 111.122 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.464 ' N ' HG22 ' A' ' 53' ' ' VAL . . . 52.17 -89.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.719 . . . . 71.430000000000007 112.467 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -121.62 111.03 16.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.333 . . . . 74.209999999999994 110.87 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.494 ' CB ' ' HB3' ' A' ' 52' ' ' PHE . . . -59.67 108.28 1.33 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.58 0.705 . . . . 73.120000000000005 111.097 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.6 Cg_endo -69.76 161.55 45.48 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.695 2.263 . . . . 63.5 112.344 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -55.14 -24.76 27.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 61.439999999999998 110.921 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.33 -52.57 64.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 55.310000000000002 111.06 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.601 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 21.1 mmt180 -69.78 -41.01 75.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 75.420000000000002 110.84 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.557 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 1.0 OUTLIER -59.77 -53.01 62.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 73.530000000000001 110.908 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -66.2 -35.64 80.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 75.420000000000002 110.813 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.2 ttt -59.09 -49.86 76.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 73.319999999999993 110.852 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.49 HG21 ' N ' ' A' ' 65' ' ' TYR . 22.1 m -65.08 -41.43 91.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 71.439999999999998 111.136 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.569 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 12.8 m-85 -62.83 -36.89 84.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 74.450000000000003 110.921 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.73 -35.27 60.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 64.140000000000001 111.107 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.516 HG22 ' N ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -70.95 -30.17 66.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 74.230000000000004 111.121 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.516 ' N ' HG22 ' A' ' 67' ' ' THR . 4.0 pp -83.6 -3.79 58.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 74.439999999999998 110.912 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.68 63.4 3.72 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.799 -0.715 . . . . 74.340000000000003 112.422 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.459 ' N ' HD11 ' A' ' 68' ' ' LEU . 26.0 tt0 -70.03 -57.43 5.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.387 . . . . 74.409999999999997 110.875 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -84.79 8.65 16.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 74.209999999999994 110.888 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.7 ttt -78.17 -13.2 59.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 72.540000000000006 110.89 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.47 -32.2 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.708 -0.758 . . . . 51.229999999999997 112.506 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.431 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . 121.67 48.85 0.27 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.764 -0.731 . . . . 74.120000000000005 112.533 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.87 124.43 19.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.754 0.311 . . . . 71.120000000000005 111.115 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.9 mm -83.29 163.29 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 73.329999999999998 111.165 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -50.61 -16.96 0.44 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 73.25 110.874 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.423 ' HB2' ' CB ' ' A' ' 42' ' ' HIS . . . -75.38 48.3 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 74.099999999999994 111.082 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.579 HD12 ' CE2' ' A' ' 43' ' ' PHE . 8.3 tp -113.04 147.53 37.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 74.129999999999995 110.99 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -113.71 119.33 37.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 72.549999999999997 110.837 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.569 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 0.5 OUTLIER -128.61 117.62 21.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 75.0 110.889 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 15.4 mmtp -119.33 114.52 22.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 73.400000000000006 110.874 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.526 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 17.3 p -117.1 106.54 13.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 62.130000000000003 111.147 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mp -132.42 162.76 30.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 75.519999999999996 110.973 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.404 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -71.12 165.39 48.34 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.615 0.721 . . . . 73.329999999999998 111.147 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.573 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.1 Cg_endo -69.8 -24.8 29.09 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.729 2.286 . . . . 73.120000000000005 112.285 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -65.77 -32.31 73.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 63.520000000000003 110.83 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -70.03 -35.03 74.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 71.430000000000007 110.874 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 61.32 111.071 179.965 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.792 0.329 . . . . 74.219999999999999 110.884 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -141.14 105.91 4.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 71.230000000000004 110.873 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -107.71 -41.09 5.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 74.120000000000005 110.926 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.434 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 12.4 mmt85 58.09 55.0 6.36 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.562 0.696 . . . . 72.340000000000003 110.815 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 13' ' ' ARG . 53.9 Cg_endo -69.84 170.68 16.1 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.673 2.249 . . . . 73.219999999999999 112.374 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 pp -109.98 36.28 3.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 74.109999999999999 110.915 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.4 ' O ' HG21 ' A' ' 19' ' ' THR . 1.3 m-20 -127.6 -74.04 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 74.530000000000001 110.906 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.467 ' HB2' ' CG2' ' A' ' 35' ' ' VAL . . . -68.08 -26.61 65.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.340000000000003 111.122 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -72.01 -47.83 49.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 74.219999999999999 110.934 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.4 HG21 ' O ' ' A' ' 16' ' ' ASP . 2.7 t -61.68 -47.04 87.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 75.010000000000005 111.115 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.492 HD13 ' N ' ' A' ' 21' ' ' ARG . 2.0 pp -69.51 -36.84 73.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 73.340000000000003 111.119 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.492 ' N ' HD13 ' A' ' 20' ' ' ILE . 35.9 ttt180 -63.58 -49.99 71.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.400000000000006 110.871 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.414 ' CG ' HD22 ' A' ' 23' ' ' LEU . 34.1 pttt -64.45 -41.99 96.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 71.420000000000002 110.929 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.453 ' N ' HD22 ' A' ' 23' ' ' LEU . 3.2 mm? -56.48 -50.79 70.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 75.219999999999999 110.937 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.485 ' CG2' HG21 ' A' ' 33' ' ' VAL . 12.7 mt -68.0 -43.83 85.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 71.450000000000003 111.127 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -56.53 -34.85 67.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 73.239999999999995 110.794 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.98 -43.38 35.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 72.409999999999997 110.874 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.66 -49.01 77.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 70.310000000000002 112.476 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.6 mt -118.93 102.31 49.37 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.628 0.728 . . . . 74.150000000000006 110.944 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -15.03 36.87 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.701 2.268 . . . . 73.340000000000003 112.294 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -96.18 -10.21 28.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 63.399999999999999 110.862 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.454 ' CB ' ' HB3' ' A' ' 49' ' ' SER . . . -111.04 126.83 55.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 71.510000000000005 111.105 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.498 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 24.5 ttp180 -103.06 117.17 33.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 63.350000000000001 110.874 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.485 HG21 ' CG2' ' A' ' 24' ' ' ILE . 18.5 t -111.75 131.17 63.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 74.010000000000005 111.092 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -135.4 117.65 15.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 73.030000000000001 110.884 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 17' ' ' ALA . 4.6 p -126.91 139.4 51.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 52.229999999999997 111.11 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.44 ' N ' HG21 ' A' ' 35' ' ' VAL . 35.9 mt-30 -132.2 120.63 22.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 72.340000000000003 110.945 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 149.99 -139.45 7.37 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.751 -0.737 . . . . 53.43 112.467 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.84 153.62 8.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.859 0.361 . . . . 74.439999999999998 110.906 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -58.61 147.48 32.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 74.239999999999995 110.893 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.29 -11.16 13.25 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.741 -0.742 . . . . 72.239999999999995 112.556 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.5 t -118.14 164.05 14.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 73.349999999999994 111.099 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.469 ' HB3' ' CB ' ' A' ' 78' ' ' ALA . 0.2 OUTLIER -75.79 107.67 8.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 73.340000000000003 110.889 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.656 ' CZ ' ' CD1' ' A' ' 79' ' ' LEU . 3.6 p90 -119.37 167.22 12.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 74.030000000000001 110.824 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.418 ' OE2' ' C ' ' A' ' 45' ' ' ALA . 1.0 OUTLIER -113.52 135.19 54.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 64.209999999999994 110.902 -179.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.418 ' C ' ' OE2' ' A' ' 44' ' ' GLU . . . -127.25 121.25 30.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 74.349999999999994 111.064 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.7 m -121.3 110.96 16.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 73.439999999999998 111.168 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.469 ' CG1' HG13 ' A' ' 33' ' ' VAL . 3.8 m -112.77 140.05 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 74.239999999999995 111.152 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.498 ' CG1' ' HB3' ' A' ' 32' ' ' ARG . 3.0 p -134.4 118.81 28.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 70.219999999999999 111.175 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.454 ' HB3' ' CB ' ' A' ' 31' ' ' ALA . 12.2 p -169.64 161.65 7.17 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.682 0.753 . . . . 70.319999999999993 110.859 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.571 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.6 Cg_endo -69.78 -23.4 30.74 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.664 2.242 . . . . 64.430000000000007 112.262 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.12 -41.59 17.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.307 -0.406 . . . . 61.530000000000001 111.085 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.614 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 1.6 m-85 -86.45 32.38 0.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 75.510000000000005 110.844 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.472 ' O ' ' N ' ' A' ' 55' ' ' LYS . 10.8 p -52.38 146.79 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.491 . . . . 64.439999999999998 111.16 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.461 ' N ' HG23 ' A' ' 53' ' ' VAL . . . 50.5 -88.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.747 -0.74 . . . . 73.340000000000003 112.424 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -121.06 112.25 18.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.792 0.33 . . . . 74.439999999999998 110.898 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.17 108.24 1.28 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.564 0.697 . . . . 74.049999999999997 111.101 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.64 162.43 42.05 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.66 2.24 . . . . 74.209999999999994 112.416 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -56.36 -26.12 51.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 75.150000000000006 110.966 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.82 -52.64 64.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 72.239999999999995 111.084 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.614 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 11.6 mmp_? -69.57 -42.77 74.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 75.140000000000001 110.889 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.453 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -58.59 -52.99 63.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 75.450000000000003 110.864 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -65.41 -36.49 84.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 63.329999999999998 110.903 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -57.09 -48.25 79.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 75.25 110.889 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.48 HG23 ' N ' ' A' ' 65' ' ' TYR . 17.2 m -67.68 -40.88 84.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 73.239999999999995 111.146 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.502 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 14.8 m-85 -65.74 -33.39 75.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 75.519999999999996 110.897 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.36 -46.03 43.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.096 -0.502 . . . . 74.109999999999999 111.069 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.423 ' CG2' ' HA ' ' A' ' 64' ' ' VAL . 4.7 t -63.81 -33.66 76.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 61.409999999999997 111.161 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.467 ' O ' ' C ' ' A' ' 69' ' ' GLY . 3.4 mp -81.9 -1.95 49.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.447 . . . . 53.520000000000003 110.91 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 32.48 82.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.806 -0.711 . . . . 55.310000000000002 112.51 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.55 -20.17 34.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.357 . . . . 75.120000000000005 110.887 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -87.96 9.36 22.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 75.239999999999995 110.871 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.87 -13.2 61.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 75.450000000000003 110.867 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.58 -33.15 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.772 -0.727 . . . . 70.409999999999997 112.511 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.93 102.36 0.27 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.694 -0.765 . . . . 74.420000000000002 112.497 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -66.55 122.52 17.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.735 0.302 . . . . 75.430000000000007 111.116 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.457 ' C ' ' H ' ' A' ' 78' ' ' ALA . 6.4 mm -114.11 157.46 14.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 74.109999999999999 111.115 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -73.97 41.39 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 71.230000000000004 110.843 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.469 ' CB ' ' HB3' ' A' ' 42' ' ' HIS . . . -135.04 29.36 3.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 70.530000000000001 111.12 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.656 ' CD1' ' CZ ' ' A' ' 43' ' ' PHE . 3.7 mm? -97.02 143.67 27.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 75.329999999999998 110.888 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -118.79 115.25 24.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 72.010000000000005 110.919 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.502 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 0.4 OUTLIER -123.9 116.7 23.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 75.099999999999994 110.92 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.07 114.85 23.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 73.439999999999998 110.899 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.548 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 40.2 p -115.78 106.49 13.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.236 -0.438 . . . . 64.230000000000004 111.174 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.4 mt -131.68 162.82 29.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 63.140000000000001 110.894 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.457 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -70.79 164.53 54.94 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.592 0.71 . . . . 71.209999999999994 111.128 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.4 Cg_endo -69.76 -24.53 29.58 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.726 2.284 . . . . 74.129999999999995 112.301 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.54 -36.0 82.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 70.230000000000004 110.882 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.63 -41.66 87.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 71.010000000000005 110.876 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.426 ' CB ' HG23 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 73.430000000000007 111.108 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.771 0.319 . . . . 72.329999999999998 110.867 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.483 ' O ' ' CG ' ' A' ' 11' ' ' ARG . 0.1 OUTLIER -132.73 106.23 7.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 74.299999999999997 110.872 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.418 ' O ' ' CG ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -116.95 115.76 26.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 74.329999999999998 110.884 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.418 ' CG ' ' O ' ' A' ' 12' ' ' LYS . 84.9 mtm180 -159.71 120.85 1.77 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.596 0.712 . . . . 74.519999999999996 110.9 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 153.6 68.52 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.729 2.286 . . . . 71.040000000000006 112.355 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.418 ' O ' ' CG2' ' A' ' 19' ' ' THR . 3.2 mm? -89.97 172.48 8.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 75.010000000000005 110.884 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -55.03 -70.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 73.349999999999994 110.801 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.16 -26.19 16.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 72.219999999999999 111.075 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -70.69 -37.98 73.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 64.519999999999996 110.815 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.418 ' CG2' ' O ' ' A' ' 15' ' ' LEU . 6.2 p -59.21 -54.02 51.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 73.310000000000002 111.144 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.48 -47.34 77.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 74.310000000000002 111.152 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -53.29 -50.42 64.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 72.040000000000006 110.897 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 ptmm? -66.96 -35.39 79.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 70.319999999999993 110.868 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.32 -49.27 74.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.433 . . . . 75.430000000000007 110.908 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.468 ' CG2' HG22 ' A' ' 33' ' ' VAL . 7.4 mm -72.79 -42.81 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 74.519999999999996 111.191 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -54.7 -37.19 65.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.075 -0.511 . . . . 73.530000000000001 110.858 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -82.88 -42.49 17.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 73.299999999999997 110.894 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.99 -47.58 90.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.688 -0.768 . . . . 64.319999999999993 112.463 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.492 ' CB ' ' HB2' ' A' ' 31' ' ' ALA . 2.5 mm? -76.19 157.06 83.51 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.57 0.7 . . . . 74.430000000000007 110.91 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -58.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.63 2.22 . . . . 64.219999999999999 112.377 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -134.99 20.81 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 50.149999999999999 110.942 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.492 ' HB2' ' CB ' ' A' ' 28' ' ' LEU . . . -74.4 126.52 30.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 75.540000000000006 111.087 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.457 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 4.3 tpt180 -100.68 109.7 21.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 73.140000000000001 110.858 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.468 HG22 ' CG2' ' A' ' 24' ' ' ILE . 41.1 t -114.14 135.34 54.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 73.230000000000004 111.088 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -135.23 118.81 16.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 71.430000000000007 110.85 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.477 HG21 ' CD2' ' A' ' 68' ' ' LEU . 61.4 t -121.49 131.33 73.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 74.049999999999997 111.119 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -132.83 120.35 21.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 74.430000000000007 110.895 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 142.45 -163.68 27.12 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.809 -0.71 . . . . 53.149999999999999 112.514 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -135.39 176.23 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.871 0.367 . . . . 73.340000000000003 110.888 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -78.65 146.52 34.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 62.130000000000003 110.841 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.73 18.43 78.75 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.763 -0.732 . . . . 75.519999999999996 112.402 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.42 ' CG2' ' N ' ' A' ' 42' ' ' HIS . 12.5 p -144.63 164.39 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 72.109999999999999 111.143 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.497 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 8.1 p80 -75.52 108.09 8.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 74.129999999999995 110.935 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.68 ' CZ ' ' CD1' ' A' ' 79' ' ' LEU . 9.7 p90 -114.96 167.11 11.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 73.340000000000003 110.926 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -116.59 126.76 53.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 74.0 110.844 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.415 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -128.33 125.35 38.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 51.420000000000002 111.132 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.3 m -121.21 111.17 17.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 70.030000000000001 111.132 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.468 HG22 ' CG1' ' A' ' 33' ' ' VAL . 92.7 t -112.13 138.01 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 74.519999999999996 111.166 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 32' ' ' ARG . 9.9 p -136.21 121.8 28.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 71.140000000000001 111.111 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.412 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.7 OUTLIER -170.25 166.01 5.34 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.588 0.708 . . . . 75.439999999999998 110.917 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.544 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.5 Cg_endo -69.72 -21.66 33.36 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.719 2.279 . . . . 74.129999999999995 112.327 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 60' ' ' ARG . . . -46.73 -46.26 20.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 64.0 111.136 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.573 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 0.9 OUTLIER -84.72 35.14 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 73.430000000000007 110.873 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.487 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 7.7 p -52.46 133.84 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 71.430000000000007 111.142 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.94 -88.88 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.761 -0.733 . . . . 72.140000000000001 112.484 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.428 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 0.3 OUTLIER -120.64 113.39 20.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.769 0.319 . . . . 74.140000000000001 110.922 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.3 107.8 1.08 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.544 0.688 . . . . 63.299999999999997 111.071 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.7 Cg_endo -69.83 164.9 32.88 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.623 2.215 . . . . 64.319999999999993 112.393 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.457 HD22 ' NE ' ' A' ' 62' ' ' ARG . 1.8 tt -59.66 -25.6 64.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 74.099999999999994 110.892 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.26 -52.15 65.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 74.409999999999997 111.146 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.573 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 20.4 mmt180 -69.69 -41.08 75.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 75.219999999999999 110.874 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.431 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -58.44 -53.49 57.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 72.409999999999997 110.848 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.457 ' NE ' HD22 ' A' ' 58' ' ' LEU . 51.8 mtt180 -66.47 -36.88 83.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 73.120000000000005 110.874 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.6 mmm -56.61 -47.56 79.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 70.140000000000001 110.819 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.485 HG22 ' N ' ' A' ' 65' ' ' TYR . 19.2 m -68.8 -40.78 81.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 73.310000000000002 111.065 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.485 ' N ' HG22 ' A' ' 64' ' ' VAL . 12.0 m-85 -62.09 -36.09 80.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 75.040000000000006 110.953 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.18 -46.78 31.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 74.010000000000005 111.069 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.505 HG22 ' N ' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -61.7 -33.28 73.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 70.150000000000006 111.135 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.505 ' N ' HG22 ' A' ' 67' ' ' THR . 4.0 mp -84.49 -6.25 59.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 64.549999999999997 110.904 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 34.46 85.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.672 -0.775 . . . . 61.219999999999999 112.534 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -96.09 -35.11 11.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.841 0.353 . . . . 71.530000000000001 110.882 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.454 ' N ' HD22 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -87.91 5.98 37.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 72.450000000000003 110.867 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.404 ' N ' HD22 ' A' ' 71' ' ' LEU . 1.5 tpt -71.93 -10.65 60.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.432 . . . . 72.120000000000005 110.942 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.83 -32.68 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.777 -0.725 . . . . 71.400000000000006 112.534 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 164.12 93.48 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.741 . . . . 61.340000000000003 112.478 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.48 123.48 30.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.72 0.295 . . . . 63.420000000000002 111.093 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.414 ' C ' ' H ' ' A' ' 78' ' ' ALA . 3.8 mp -113.45 164.17 9.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 75.409999999999997 111.123 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -77.2 40.41 0.27 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 74.120000000000005 110.847 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 76' ' ' ILE . . . -134.11 36.97 3.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 64.530000000000001 111.187 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.68 ' CD1' ' CZ ' ' A' ' 43' ' ' PHE . 1.9 mm? -97.62 140.47 31.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 73.120000000000005 110.964 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -116.98 115.71 25.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 63.119999999999997 110.875 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 tp -130.64 138.7 50.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 72.109999999999999 110.957 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -136.33 114.82 11.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 73.200000000000003 110.858 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.509 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 8.8 p -112.02 106.58 15.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.461 . . . . 75.219999999999999 111.119 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.0 mt -133.55 162.02 33.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 70.120000000000005 110.94 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.487 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.72 164.53 57.42 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.642 0.734 . . . . 72.519999999999996 111.056 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.7 Cg_endo -69.78 -11.53 31.0 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.651 2.234 . . . . 74.299999999999997 112.339 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.47 -23.06 26.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 71.030000000000001 110.832 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -108.04 38.44 2.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 75.219999999999999 110.919 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 75.340000000000003 111.048 179.98 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 7.9 tpt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.746 0.308 . . . . 74.219999999999999 110.916 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -123.6 93.8 4.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 74.299999999999997 110.863 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.456 ' CG ' ' HD3' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -128.56 -49.28 1.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 71.299999999999997 110.848 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.451 ' C ' ' O ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER 34.34 54.97 1.71 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.542 0.687 . . . . 72.019999999999996 110.813 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.456 ' HD3' ' CG ' ' A' ' 12' ' ' LYS . 54.2 Cg_endo -69.67 -166.24 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.698 2.265 . . . . 74.420000000000002 112.39 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.514 ' C ' ' CD2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -130.82 -3.8 4.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.421 . . . . 74.209999999999994 110.893 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.451 ' N ' HD22 ' A' ' 15' ' ' LEU . 68.3 m-20 -112.74 -74.85 0.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 73.219999999999999 110.865 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.409 ' O ' ' CB ' ' A' ' 21' ' ' ARG . . . -46.25 -28.4 1.27 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 55.130000000000003 111.129 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -74.06 -33.51 63.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 75.030000000000001 110.939 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.422 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 18.6 p -57.55 -57.63 11.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 74.329999999999998 111.131 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.445 HG21 ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -73.87 -35.26 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 75.230000000000004 111.135 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.409 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 68.7 ttt-85 -61.8 -45.07 95.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 71.430000000000007 110.895 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp -71.09 -41.09 71.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 73.519999999999996 110.933 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.472 HD23 ' N ' ' A' ' 23' ' ' LEU . 3.4 mm? -55.63 -49.15 73.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 72.200000000000003 110.928 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.481 ' CG2' HG23 ' A' ' 33' ' ' VAL . 14.9 mt -69.28 -43.33 81.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 75.299999999999997 111.113 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -53.67 -38.26 63.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 71.150000000000006 110.897 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -78.28 -43.05 29.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 71.310000000000002 110.833 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.69 -51.11 60.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 71.129999999999995 112.454 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -78.69 158.17 76.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.623 0.725 . . . . 72.329999999999998 110.889 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -90.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.71 2.274 . . . . 73.120000000000005 112.337 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -107.28 33.2 4.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 71.109999999999999 110.885 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -84.05 125.84 32.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 75.430000000000007 111.112 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -92.8 108.92 20.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 71.040000000000006 110.862 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.481 HG23 ' CG2' ' A' ' 24' ' ' ILE . 76.3 t -109.76 122.74 64.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 55.32 111.116 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -134.07 118.38 17.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 53.43 110.822 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.412 HG21 ' N ' ' A' ' 36' ' ' GLN . 2.4 p -128.25 132.78 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 74.420000000000002 111.17 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.412 ' N ' HG21 ' A' ' 35' ' ' VAL . 3.4 tp-100 -132.89 120.45 21.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 74.420000000000002 110.92 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 150.29 -140.16 7.8 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 61.229999999999997 112.439 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -157.68 178.77 9.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.87 0.367 . . . . 64.430000000000007 110.887 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.07 142.47 30.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 54.520000000000003 110.866 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.85 17.81 78.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.731 . . . . 70.010000000000005 112.468 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 p -142.08 164.33 18.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.884 0.373 . . . . 75.340000000000003 111.117 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.49 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 5.9 p80 -75.7 107.05 7.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 75.120000000000005 110.865 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.66 ' CZ ' ' CD1' ' A' ' 79' ' ' LEU . 4.7 p90 -119.06 167.25 11.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 72.430000000000007 110.863 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.409 ' HG3' ' CB ' ' A' ' 80' ' ' GLN . 26.5 tt0 -117.03 122.07 43.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 71.209999999999994 110.926 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.59 115.9 18.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 74.150000000000006 111.139 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.5 m -110.78 120.07 41.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 75.510000000000005 111.172 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 86.9 t -123.47 128.24 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 73.340000000000003 111.157 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.9 p -125.33 122.67 63.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 75.109999999999999 111.115 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.435 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.6 OUTLIER -163.33 168.01 10.67 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.655 0.74 . . . . 74.510000000000005 110.893 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.482 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.6 Cg_endo -69.82 -21.19 33.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.68 2.253 . . . . 74.549999999999997 112.314 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -46.48 -46.76 19.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 72.209999999999994 111.097 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.575 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 0.7 OUTLIER -86.1 36.41 0.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 74.209999999999994 110.93 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.49 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 6.9 p -52.24 124.27 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 74.420000000000002 111.12 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.46 -74.69 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.796 -0.716 . . . . 64.430000000000007 112.464 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 53' ' ' VAL . 22.9 pttm -119.89 140.47 50.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.761 0.315 . . . . 75.340000000000003 110.89 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -101.25 97.92 8.11 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.59 0.709 . . . . 71.129999999999995 111.054 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 173.42 11.01 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.703 2.269 . . . . 72.540000000000006 112.348 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.433 HD23 ' NE ' ' A' ' 62' ' ' ARG . 1.1 tp -57.79 -26.83 62.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 74.109999999999999 110.907 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.84 -52.94 63.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 64.430000000000007 111.162 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.575 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 11.6 mmt180 -69.51 -43.13 73.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 75.239999999999995 110.898 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.553 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -58.34 -53.35 59.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 75.530000000000001 110.9 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.433 ' NE ' HD23 ' A' ' 58' ' ' LEU . 43.8 mtt180 -65.99 -35.82 81.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 73.430000000000007 110.887 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.9 ttt -57.91 -46.0 85.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 74.109999999999999 110.875 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 61' ' ' HIS . 15.8 m -69.61 -39.96 78.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 74.530000000000001 111.152 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.553 ' OH ' ' CE1' ' A' ' 61' ' ' HIS . 15.8 m-85 -67.72 -34.99 77.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 73.510000000000005 111.028 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.18 -47.19 29.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 74.510000000000005 111.086 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.445 ' O ' HG21 ' A' ' 20' ' ' ILE . 15.4 t -61.65 -39.59 91.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 72.239999999999995 111.138 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 69' ' ' GLY . 1.0 OUTLIER -82.0 0.73 38.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 73.400000000000006 110.975 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 35.04 91.22 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 64.150000000000006 112.416 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -96.86 -32.26 12.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.902 0.382 . . . . 65.049999999999997 110.852 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.53 10.25 3.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 75.040000000000006 110.903 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 37.9 mtm -73.56 -13.19 60.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 74.530000000000001 110.937 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.12 -33.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 74.340000000000003 112.479 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.53 101.02 0.21 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.786 -0.721 . . . . 74.340000000000003 112.489 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.5 123.68 29.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.805 0.336 . . . . 50.350000000000001 111.127 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.2 mp -113.35 163.13 10.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 72.420000000000002 111.161 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -66.56 -3.84 7.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 75.230000000000004 110.902 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -87.37 29.83 0.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 74.409999999999997 111.105 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.66 ' CD1' ' CZ ' ' A' ' 43' ' ' PHE . 3.6 mm? -97.79 133.86 41.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 74.349999999999994 110.972 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.409 ' CB ' ' HG3' ' A' ' 44' ' ' GLU . 25.9 mt-30 -109.7 115.6 30.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 74.200000000000003 110.906 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.0 tp -133.46 139.63 46.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 73.129999999999995 110.852 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.53 115.36 12.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 75.010000000000005 110.842 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.519 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 10.5 p -108.44 106.68 16.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 72.430000000000007 111.147 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -129.61 161.49 30.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 75.420000000000002 110.838 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.49 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.5 162.92 71.54 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.623 0.725 . . . . 73.129999999999995 111.089 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.6 Cg_endo -69.64 -19.18 37.05 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.733 2.289 . . . . 65.150000000000006 112.402 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -68.82 -35.99 77.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 74.349999999999994 110.899 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -66.53 -40.19 88.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 73.310000000000002 110.918 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 75.219999999999999 111.097 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.792 0.329 . . . . 72.310000000000002 110.845 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 63.39 54.27 2.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 70.140000000000001 110.864 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.13 48.28 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 75.329999999999998 110.889 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -141.57 143.35 29.23 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.56 0.695 . . . . 72.120000000000005 110.86 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 146.74 60.78 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.732 2.288 . . . . 62.450000000000003 112.297 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.484 ' CD2' ' CD ' ' A' ' 18' ' ' GLU . 4.3 mp -109.89 -175.6 2.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 75.519999999999996 110.93 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -129.76 -73.4 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 75.430000000000007 110.844 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.491 ' CB ' ' CG1' ' A' ' 35' ' ' VAL . . . -59.26 -30.57 68.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 74.430000000000007 111.101 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.484 ' CD ' ' CD2' ' A' ' 15' ' ' LEU . 5.9 mt-10 -70.1 -38.45 75.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 60.439999999999998 110.84 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.421 ' O ' ' CD2' ' A' ' 23' ' ' LEU . 25.8 p -63.43 -53.57 50.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 72.310000000000002 111.139 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.621 ' CD1' ' N ' ' A' ' 21' ' ' ARG . 1.7 pp -65.06 -42.61 94.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 62.299999999999997 111.079 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.621 ' N ' ' CD1' ' A' ' 20' ' ' ILE . 39.9 ttp180 -60.37 -46.23 90.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 75.540000000000006 110.889 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.12 -42.4 99.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 75.120000000000005 110.969 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 23' ' ' LEU . 4.2 mm? -58.08 -49.3 77.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 75.109999999999999 110.913 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.473 ' CG2' HG22 ' A' ' 33' ' ' VAL . 46.7 mm -63.31 -46.38 95.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 73.099999999999994 111.152 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -54.37 -43.71 71.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 74.150000000000006 110.851 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.31 -42.93 78.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 74.049999999999997 110.797 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.35 -57.04 12.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.725 -0.75 . . . . 74.109999999999999 112.45 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.475 ' CB ' ' HB3' ' A' ' 31' ' ' ALA . 3.3 mm? -72.65 155.86 90.57 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.537 0.684 . . . . 75.340000000000003 110.958 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -90.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.615 2.21 . . . . 73.510000000000005 112.352 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -103.32 31.89 4.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 73.230000000000004 110.902 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.475 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . . . -80.48 131.65 35.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 74.230000000000004 111.095 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.467 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 6.4 tpp180 -102.42 113.99 27.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 75.430000000000007 110.878 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.473 HG22 ' CG2' ' A' ' 24' ' ' ILE . 36.8 t -116.03 127.31 73.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 72.140000000000001 111.137 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -135.4 118.37 16.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.248 -0.433 . . . . 72.239999999999995 110.864 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.491 ' CG1' ' CB ' ' A' ' 17' ' ' ALA . 4.3 p -127.28 136.91 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 73.319999999999993 111.142 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.433 ' N ' HG22 ' A' ' 35' ' ' VAL . 0.9 OUTLIER -133.05 120.4 21.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 73.129999999999995 110.918 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.43 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 142.37 -134.43 6.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.741 . . . . 64.209999999999994 112.469 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.412 ' OE2' ' CG ' ' A' ' 39' ' ' ASP . 5.3 tm-20 -170.2 166.53 8.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 72.219999999999999 110.866 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.412 ' CG ' ' OE2' ' A' ' 38' ' ' GLU . 7.8 p30 -72.95 153.55 40.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 70.340000000000003 110.905 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.421 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.84 -2.62 32.06 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 73.219999999999999 112.489 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.4 m -130.41 164.9 32.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.867 0.365 . . . . 74.120000000000005 111.124 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.419 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 12.6 p80 -74.78 109.98 8.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 73.120000000000005 110.859 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.572 ' CE2' HD12 ' A' ' 79' ' ' LEU . 34.1 p90 -127.43 167.36 16.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 75.140000000000001 110.9 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -118.1 126.72 52.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 73.430000000000007 110.837 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.27 115.32 18.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 72.219999999999999 111.052 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.7 m -110.37 110.78 21.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.469 . . . . 74.209999999999994 111.108 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 91.5 t -110.68 140.8 28.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.49 . . . . 74.340000000000003 111.091 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.496 ' CG1' ' O ' ' A' ' 48' ' ' VAL . 4.3 p -133.34 118.31 31.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 74.0 111.168 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 38.4 p -162.08 159.17 21.55 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.671 0.748 . . . . 72.109999999999999 110.853 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.57 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.1 Cg_endo -69.78 -14.67 36.34 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.643 2.229 . . . . 75.439999999999998 112.318 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.07 -48.45 22.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 74.0 111.134 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.53 ' CG ' ' HB ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -84.19 35.07 0.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 71.450000000000003 110.874 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 p -50.84 131.1 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 72.519999999999996 111.099 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.73 -78.04 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.728 -0.749 . . . . 71.340000000000003 112.509 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.49 140.87 52.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.8 0.334 . . . . 75.439999999999998 110.849 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.45 ' CB ' ' HB3' ' A' ' 52' ' ' PHE . . . -104.19 99.11 15.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.606 0.717 . . . . 64.430000000000007 111.114 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.81 169.4 19.05 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.677 2.251 . . . . 65.230000000000004 112.309 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.474 HD23 ' NE ' ' A' ' 62' ' ' ARG . 1.6 tt -56.43 -27.56 56.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 74.310000000000002 110.888 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.69 -52.75 63.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 73.25 111.097 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 mmm180 -69.84 -43.64 71.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 75.530000000000001 110.906 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.411 ' NE2' ' OH ' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -56.57 -53.44 57.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.14 -0.482 . . . . 55.340000000000003 110.857 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.474 ' NE ' HD23 ' A' ' 58' ' ' LEU . 51.0 mtt180 -66.73 -37.93 85.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 70.530000000000001 110.852 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.5 mmt -54.13 -50.15 67.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 74.230000000000004 110.844 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.469 HG22 ' N ' ' A' ' 65' ' ' TYR . 17.1 m -66.96 -42.91 89.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 64.310000000000002 111.154 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.578 ' CE1' HD11 ' A' ' 81' ' ' LEU . 15.2 m-85 -62.29 -36.82 83.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 71.150000000000006 110.936 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.2 -35.88 61.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 75.530000000000001 111.046 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.526 HG21 ' N ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -69.93 -31.22 68.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 73.319999999999993 111.122 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.526 ' N ' HG21 ' A' ' 67' ' ' THR . 2.9 pp -88.03 -10.44 50.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 64.439999999999998 110.933 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 46.86 87.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.681 -0.771 . . . . 52.5 112.506 179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.47 ' CG ' HD11 ' A' ' 68' ' ' LEU . 8.2 pt-20 -111.02 -48.14 3.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.847 0.356 . . . . 73.230000000000004 110.868 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.483 ' O ' ' CD1' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -78.88 -2.19 38.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.199 -0.455 . . . . 74.349999999999994 110.963 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.1 mmt -85.14 -13.7 49.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 72.319999999999993 110.888 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.6 -30.88 3.37 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.724 -0.75 . . . . 74.040000000000006 112.423 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.421 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . 103.53 53.25 0.88 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.785 -0.722 . . . . 64.0 112.527 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.402 ' HA ' ' C ' ' A' ' 40' ' ' GLY . . . -86.84 157.91 19.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.843 0.354 . . . . 63.329999999999998 111.08 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.2 mp -70.91 165.25 2.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 72.120000000000005 111.148 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -74.22 49.37 0.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 110.814 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -131.37 51.85 2.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 70.409999999999997 111.068 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.572 HD12 ' CE2' ' A' ' 43' ' ' PHE . 4.1 mm? -97.44 131.83 43.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 73.319999999999993 110.943 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -112.58 114.94 27.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 75.219999999999999 110.896 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.578 HD11 ' CE1' ' A' ' 65' ' ' TYR . 6.7 tt -139.53 138.44 36.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 75.230000000000004 110.883 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -136.54 114.96 11.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 74.0 110.868 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.53 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 59.0 p -100.87 106.82 18.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 73.25 111.172 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -125.27 162.5 24.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 74.400000000000006 110.92 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -71.09 164.49 56.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.606 0.717 . . . . 64.209999999999994 111.131 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.57 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.2 Cg_endo -69.83 -18.25 36.78 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.613 2.209 . . . . 61.210000000000001 112.333 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -76.51 -29.56 56.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 63.200000000000003 110.885 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -80.28 5.37 14.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.172 -0.467 . . . . 75.420000000000002 110.87 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 74.219999999999999 111.118 179.925 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.45 ' O ' ' NH1' ' A' ' 11' ' ' ARG . 1.6 tpt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.705 0.288 . . . . 75.230000000000004 110.867 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.45 ' NH1' ' O ' ' A' ' 10' ' ' MET . 15.1 mmt-85 -127.31 159.0 35.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 75.209999999999994 110.805 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -83.8 144.38 29.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 74.150000000000006 110.876 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -102.56 96.35 7.31 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.62 0.724 . . . . 73.230000000000004 110.853 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.73 160.56 49.26 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.731 2.287 . . . . 63.539999999999999 112.327 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.29 -75.13 0.5 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 75.219999999999999 110.934 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -128.77 -68.72 0.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 73.129999999999995 110.89 179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.4 -27.78 67.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 65.329999999999998 111.135 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.64 -47.19 49.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 74.25 110.967 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.406 HG23 ' N ' ' A' ' 20' ' ' ILE . 3.1 t -62.4 -45.14 94.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 43.399999999999999 111.155 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.431 HG13 ' N ' ' A' ' 21' ' ' ARG . 14.6 pt -69.91 -40.03 78.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 71.329999999999998 111.124 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.431 ' N ' HG13 ' A' ' 20' ' ' ILE . 32.5 ttt-85 -60.0 -48.23 82.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 74.540000000000006 110.861 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -69.29 -39.62 78.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 73.319999999999993 110.917 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.465 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 17.8 mt -57.12 -49.32 76.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 74.340000000000003 110.881 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.479 ' CD1' HG22 ' A' ' 67' ' ' THR . 5.7 mt -70.06 -45.86 74.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 73.109999999999999 111.127 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -53.96 -36.86 63.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 63.229999999999997 110.898 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -79.48 -40.82 28.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 74.239999999999995 110.861 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.92 -55.56 21.43 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.732 -0.747 . . . . 64.239999999999995 112.473 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.46 HD13 ' CG2' ' A' ' 24' ' ' ILE . 5.8 mt -76.5 159.62 79.17 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.572 0.701 . . . . 75.120000000000005 111.005 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -91.29 0.01 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.104 0 C-N-CA 122.73 2.286 . . . . 71.25 112.361 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -106.96 29.61 6.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 74.400000000000006 110.87 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.42 ' CB ' HD12 ' A' ' 28' ' ' LEU . . . -77.58 131.28 37.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 64.299999999999997 111.113 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.6 mmm-85 -97.11 114.42 26.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 74.439999999999998 110.881 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.473 HG22 ' CG2' ' A' ' 24' ' ' ILE . 56.3 t -117.98 126.05 74.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 74.239999999999995 111.179 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -135.28 118.63 16.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 73.349999999999994 110.822 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.2 t -125.01 135.21 64.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 72.340000000000003 111.108 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 -133.25 123.17 25.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 73.140000000000001 110.884 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.78 -134.48 6.23 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.698 -0.763 . . . . 73.319999999999993 112.511 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -163.67 160.23 22.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 62.200000000000003 110.896 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.453 ' OD2' ' C ' ' A' ' 72' ' ' MET . 24.5 t0 -67.49 147.63 52.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 72.200000000000003 110.901 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.0 -7.29 16.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.815 -0.707 . . . . 62.130000000000003 112.391 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.6 t -118.81 165.8 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.871 0.367 . . . . 64.219999999999999 111.158 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.454 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 5.3 p80 -73.95 106.54 5.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 64.329999999999998 110.853 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.486 ' CZ ' HD13 ' A' ' 79' ' ' LEU . 41.7 p90 -122.6 167.33 13.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 64.209999999999994 110.918 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -114.3 128.1 56.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 75.010000000000005 110.916 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.39 121.94 36.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 72.109999999999999 111.133 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.8 m -121.11 110.41 16.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 73.25 111.14 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.47 HG23 ' CG1' ' A' ' 33' ' ' VAL . 65.4 t -120.6 129.64 75.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 72.349999999999994 111.18 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.7 p -126.4 118.86 52.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 75.439999999999998 111.112 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.424 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.4 OUTLIER -161.84 169.36 9.63 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.657 0.741 . . . . 71.120000000000005 110.862 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.508 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 52.9 Cg_endo -69.79 -20.87 34.15 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.692 2.261 . . . . 73.400000000000006 112.326 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.407 ' CB ' ' HE ' ' A' ' 60' ' ' ARG . . . -43.74 -53.58 5.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 75.140000000000001 111.195 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.577 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 0.7 OUTLIER -81.55 38.46 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 72.109999999999999 110.884 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.504 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 2.9 p -51.37 127.23 7.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 72.030000000000001 111.118 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.39 -78.36 0.12 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.714 -0.755 . . . . 73.340000000000003 112.481 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.97 141.68 51.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.765 0.316 . . . . 72.25 110.91 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.67 99.28 8.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.575 0.702 . . . . 50.340000000000003 111.101 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.74 165.75 29.91 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.696 2.264 . . . . 74.239999999999995 112.332 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 tt -54.53 -24.09 19.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 71.319999999999993 110.916 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.36 -51.65 67.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 75.319999999999993 111.14 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.577 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 0.1 OUTLIER -72.05 -37.45 69.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 71.120000000000005 110.918 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.514 ' CD2' ' CD2' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -61.46 -49.99 74.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 74.239999999999995 110.879 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -70.39 -39.8 74.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 75.439999999999998 110.95 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 10.1 tpt -54.58 -50.84 67.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 71.239999999999995 110.912 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 61' ' ' HIS . 30.3 m -66.12 -44.21 91.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 73.230000000000004 111.142 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.551 ' CZ ' HD23 ' A' ' 81' ' ' LEU . 10.0 m-85 -55.45 -40.17 71.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 65.430000000000007 110.943 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.32 -38.93 59.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 75.340000000000003 111.102 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.481 HG23 ' N ' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -66.18 -24.03 66.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 74.230000000000004 111.123 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.481 ' N ' HG23 ' A' ' 67' ' ' THR . 3.8 pp -95.47 -1.57 50.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 55.240000000000002 110.889 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.441 ' HA2' ' CG ' ' A' ' 72' ' ' MET . . . 82.06 66.01 1.6 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.773 -0.727 . . . . 73.430000000000007 112.446 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -74.75 -65.62 0.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.838 0.351 . . . . 73.239999999999995 110.914 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.6 tp -86.48 10.08 16.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 75.230000000000004 110.91 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' MET . . . . . 0.453 ' C ' ' OD2' ' A' ' 39' ' ' ASP . 19.7 mmt -72.22 -14.08 61.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 61.200000000000003 110.854 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.422 ' HA3' ' CG ' ' A' ' 39' ' ' ASP . . . -149.46 -34.54 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.755 -0.736 . . . . 60.439999999999998 112.509 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 131.57 68.67 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 72.439999999999998 112.482 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.21 132.25 53.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.822 0.344 . . . . 55.140000000000001 111.059 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 77' ' ' HIS . 4.7 mp -110.69 163.25 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 74.010000000000005 111.178 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.423 ' N ' ' CG2' ' A' ' 76' ' ' ILE . 84.3 t60 -48.42 -18.8 0.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 70.430000000000007 110.891 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.448 ' HB3' ' CB ' ' A' ' 42' ' ' HIS . . . -79.01 44.79 0.58 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 75.219999999999999 111.096 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.486 HD13 ' CZ ' ' A' ' 43' ' ' PHE . 1.2 mm? -113.54 145.78 40.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 73.450000000000003 110.951 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -124.7 115.96 21.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 74.120000000000005 110.861 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.551 HD23 ' CZ ' ' A' ' 65' ' ' TYR . 2.8 tp -123.94 141.67 51.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 75.219999999999999 110.895 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -133.13 114.39 13.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 75.219999999999999 110.916 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.519 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 24.7 p -118.5 106.12 12.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 74.219999999999999 111.145 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mp -134.62 161.23 35.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 64.150000000000006 110.934 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.504 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.48 163.59 66.52 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.639 0.733 . . . . 74.239999999999995 111.152 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.3 Cg_endo -69.76 -19.04 36.64 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.693 2.262 . . . . 71.040000000000006 112.328 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -68.87 -36.07 77.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 71.5 110.891 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -64.48 -38.12 89.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 62.530000000000001 110.925 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 74.329999999999998 111.136 179.893 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.833 0.349 . . . . 64.430000000000007 110.885 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.6 ttt85 -90.31 141.34 28.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 75.140000000000001 110.855 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.63 -62.91 1.41 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.310000000000002 110.914 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -47.45 115.46 3.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.656 0.741 . . . . 75.299999999999997 110.918 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 162.59 41.45 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.651 2.234 . . . . 71.239999999999995 112.407 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.432 ' O ' ' CG2' ' A' ' 19' ' ' THR . 28.1 mt -110.71 -68.01 0.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 75.109999999999999 110.924 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -61.88 -57.4 11.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 64.340000000000003 110.841 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.38 -26.22 64.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 70.519999999999996 111.124 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -70.54 -39.13 74.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 74.340000000000003 110.879 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.432 ' CG2' ' O ' ' A' ' 15' ' ' LEU . 1.1 p -62.32 -53.55 53.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 75.200000000000003 111.104 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.475 ' CD1' HG12 ' A' ' 35' ' ' VAL . 9.1 pt -66.88 -45.9 86.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 74.510000000000005 111.147 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.435 ' N ' ' CG1' ' A' ' 20' ' ' ILE . 37.7 ttp85 -53.58 -51.45 62.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 73.129999999999995 110.828 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -67.43 -34.85 78.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 71.310000000000002 110.987 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.64 -49.65 74.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 74.109999999999999 110.885 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.483 ' CG2' HG23 ' A' ' 33' ' ' VAL . 46.8 mt -72.44 -43.05 64.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 74.420000000000002 111.109 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -54.61 -36.49 64.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 65.209999999999994 110.92 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -81.44 -43.14 19.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.487 . . . . 71.120000000000005 110.865 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 -37.88 95.45 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 55.240000000000002 112.485 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.471 HD22 ' CB ' ' A' ' 31' ' ' ALA . 8.2 mp -92.99 160.94 32.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.537 0.684 . . . . 72.109999999999999 110.937 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -90.99 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.657 2.238 . . . . 75.510000000000005 112.36 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -107.43 25.55 11.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 73.409999999999997 110.907 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.471 ' CB ' HD22 ' A' ' 28' ' ' LEU . . . -72.36 129.51 38.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 74.319999999999993 111.042 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.464 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 3.3 ttm180 -97.03 112.01 23.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 70.099999999999994 110.879 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.483 HG23 ' CG2' ' A' ' 24' ' ' ILE . 21.4 t -113.94 130.08 68.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 74.109999999999999 111.143 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -135.12 118.08 16.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 75.019999999999996 110.898 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.475 HG12 ' CD1' ' A' ' 20' ' ' ILE . 5.8 p -129.69 137.44 56.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 73.349999999999994 111.17 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.467 ' N ' HG23 ' A' ' 35' ' ' VAL . 47.2 tt0 -133.25 120.3 20.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 74.219999999999999 110.868 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.424 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 144.12 -149.06 21.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 74.340000000000003 112.571 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -155.69 177.7 11.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 74.519999999999996 110.91 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.95 147.04 35.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 75.319999999999993 110.889 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.84 7.86 71.3 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.78 -0.724 . . . . 72.310000000000002 112.521 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.7 t -134.87 163.87 35.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 74.129999999999995 111.105 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 49.3 p-80 -75.9 106.85 7.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 75.420000000000002 110.879 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.558 ' CZ ' HD13 ' A' ' 79' ' ' LEU . 7.4 p90 -119.76 166.76 12.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 75.319999999999993 110.866 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.02 129.59 56.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.019999999999996 110.899 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.05 116.28 19.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 72.230000000000004 111.108 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.0 m -121.29 112.11 18.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 74.310000000000002 111.132 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.471 HG21 ' CG1' ' A' ' 33' ' ' VAL . 79.6 t -114.06 138.92 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 65.450000000000003 111.143 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' A' ' 32' ' ' ARG . 8.6 p -132.08 123.84 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 75.310000000000002 111.126 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.427 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.6 OUTLIER -170.37 167.52 4.59 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.7 0.762 . . . . 60.119999999999997 110.855 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.506 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.4 Cg_endo -69.77 -22.78 31.55 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.693 2.262 . . . . 70.329999999999998 112.357 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.471 ' HB3' ' NE ' ' A' ' 60' ' ' ARG . . . -44.27 -47.02 9.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 62.049999999999997 111.091 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.562 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 0.4 OUTLIER -86.69 39.85 0.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 72.5 110.814 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.484 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 4.3 p -55.92 123.11 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 74.349999999999994 111.139 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.46 -91.68 0.86 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.75 -0.738 . . . . 74.109999999999999 112.41 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.484 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 11.8 mptt -118.06 108.88 15.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.797 0.332 . . . . 70.439999999999998 110.878 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.503 ' CB ' ' HB3' ' A' ' 52' ' ' PHE . . . -57.82 106.65 0.73 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.549 0.69 . . . . 71.109999999999999 111.1 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 54.5 Cg_endo -69.79 170.5 16.45 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.645 2.23 . . . . 73.239999999999995 112.381 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tp -63.54 -23.78 67.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 74.519999999999996 110.943 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.87 -54.14 49.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 74.219999999999999 111.116 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.562 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 8.2 mmm180 -71.83 -40.84 68.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 74.239999999999995 110.82 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.464 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -58.25 -50.34 73.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 73.5 110.855 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -69.05 -40.18 78.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 72.230000000000004 110.819 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.417 ' O ' ' CG2' ' A' ' 67' ' ' THR . 10.5 tpt -53.47 -52.79 58.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 72.430000000000007 110.856 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.472 ' O ' ' HG ' ' A' ' 68' ' ' LEU . 16.6 m -61.75 -49.56 83.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 72.230000000000004 111.141 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.566 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 12.8 m-85 -55.61 -31.19 62.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 74.310000000000002 110.995 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.49 -43.33 56.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 74.140000000000001 111.151 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.417 ' CG2' ' O ' ' A' ' 63' ' ' MET . 1.1 p -64.44 -33.83 76.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 75.510000000000005 111.179 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.484 ' O ' ' C ' ' A' ' 69' ' ' GLY . 12.6 mt -81.74 7.07 13.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 75.310000000000002 110.925 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 31.58 73.14 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.7 -0.762 . . . . 71.25 112.48 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.423 ' CD ' ' HG ' ' A' ' 79' ' ' LEU . 26.7 mt-10 -77.34 -38.95 49.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.861 0.362 . . . . 74.329999999999998 110.894 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.4 tp -89.83 10.36 23.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 64.319999999999993 110.876 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.3 ttt -77.23 -13.52 59.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 72.450000000000003 110.904 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.1 -32.33 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.737 . . . . 72.129999999999995 112.508 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.88 100.53 0.17 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.718 -0.754 . . . . 62.409999999999997 112.528 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.28 122.81 28.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 44.450000000000003 111.079 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.416 ' C ' ' H ' ' A' ' 78' ' ' ALA . 2.6 mp -114.02 163.82 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 73.030000000000001 111.205 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 39.5 m-70 -76.9 41.52 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 60.109999999999999 110.867 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.416 ' H ' ' C ' ' A' ' 76' ' ' ILE . . . -135.01 33.21 3.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 74.340000000000003 111.123 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.558 HD13 ' CZ ' ' A' ' 43' ' ' PHE . 4.0 mm? -97.61 146.54 25.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 74.310000000000002 110.954 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -121.3 115.79 23.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 72.340000000000003 110.901 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.566 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 0.4 OUTLIER -125.01 117.64 24.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 61.219999999999999 110.869 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -120.83 114.87 22.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 73.510000000000005 110.853 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.527 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 28.6 p -116.15 107.06 14.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 74.129999999999995 111.188 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.5 mt -132.48 161.42 33.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 72.239999999999995 110.935 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.484 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.1 163.04 70.27 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.608 0.718 . . . . 75.0 111.109 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.506 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.2 Cg_endo -69.77 -7.97 22.42 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.681 2.254 . . . . 72.200000000000003 112.354 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -86.62 -28.83 23.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.446 . . . . 74.430000000000007 110.824 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -84.53 18.31 2.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 71.5 110.894 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 63.119999999999997 111.118 179.93 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.4 mmt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.823 0.344 . . . . 73.019999999999996 110.856 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.0 mtm180 -104.74 -58.47 1.88 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 73.310000000000002 110.917 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.84 139.06 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 73.230000000000004 110.885 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -125.63 113.22 25.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.582 0.706 . . . . 73.400000000000006 110.898 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 87.22 0.55 Allowed 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.688 2.259 . . . . 71.209999999999994 112.312 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tp -132.23 -32.17 1.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.289 -0.414 . . . . 75.030000000000001 110.91 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.95 -175.28 3.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 70.019999999999996 110.853 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.465 ' HB3' ' CG2' ' A' ' 35' ' ' VAL . . . -46.55 -30.03 2.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 64.040000000000006 111.078 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -57.64 -37.1 72.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 62.439999999999998 110.898 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.56 ' CG2' ' N ' ' A' ' 20' ' ' ILE . 1.2 t -60.86 -47.53 85.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 72.439999999999998 111.045 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.56 ' N ' ' CG2' ' A' ' 19' ' ' THR . 9.4 pt -70.24 -30.8 44.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 75.109999999999999 111.086 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.54 ' N ' HG13 ' A' ' 20' ' ' ILE . 39.0 ttt-85 -65.22 -48.02 74.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 74.310000000000002 110.814 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -71.46 -39.74 70.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 72.439999999999998 110.92 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.0 mt -58.26 -50.21 74.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 75.409999999999997 110.899 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.47 ' CG2' HG22 ' A' ' 33' ' ' VAL . 6.6 mt -71.32 -45.78 68.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 70.019999999999996 111.176 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -54.2 -35.82 62.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 74.329999999999998 110.903 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.97 -43.15 22.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 75.310000000000002 110.852 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.79 -52.22 52.12 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.78 -0.724 . . . . 71.299999999999997 112.518 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.06 101.67 54.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 74.409999999999997 110.938 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.64 -14.76 36.95 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.723 2.282 . . . . 73.219999999999999 112.302 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -97.65 1.1 48.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 75.319999999999993 110.88 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.427 ' CB ' ' CB ' ' A' ' 49' ' ' SER . . . -119.24 135.89 54.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 64.019999999999996 111.123 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 9.8 mmt180 -106.85 114.32 28.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 74.120000000000005 110.878 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.47 HG22 ' CG2' ' A' ' 24' ' ' ILE . 18.4 t -116.79 124.69 73.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 72.530000000000001 111.065 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.62 117.65 15.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 63.399999999999999 110.806 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.493 HG22 ' CD1' ' A' ' 43' ' ' PHE . 4.4 p -123.64 138.6 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 74.239999999999995 111.098 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -132.12 120.52 22.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 72.409999999999997 110.904 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.53 -150.81 23.1 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.667 -0.778 . . . . 74.439999999999998 112.474 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -150.94 165.68 32.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 75.430000000000007 110.883 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -68.56 142.75 55.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 64.349999999999994 110.851 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.42 ' C ' ' HA ' ' A' ' 75' ' ' ALA . . . 72.61 19.56 79.17 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 74.540000000000006 112.478 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 9.8 t -144.1 164.98 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.853 0.359 . . . . 74.140000000000001 111.099 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.453 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 17.3 p80 -74.81 107.73 7.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 71.109999999999999 110.923 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.598 ' CE2' ' CD1' ' A' ' 79' ' ' LEU . 7.7 p90 -119.43 167.43 11.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 74.200000000000003 110.904 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.1 pm0 -115.27 133.72 55.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 64.310000000000002 110.889 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.54 123.93 40.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 63.25 111.097 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.8 m -121.72 107.32 12.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 73.549999999999997 111.194 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.9 m -116.8 128.95 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 60.420000000000002 111.178 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.4 p -133.48 118.62 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 74.510000000000005 111.184 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.431 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.4 OUTLIER -165.19 168.22 8.7 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.611 0.72 . . . . 74.219999999999999 110.828 -179.788 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.498 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.9 Cg_endo -69.7 -23.94 30.5 Favored 'Trans proline' 0 N--CA 1.465 -0.147 0 C-N-CA 122.747 2.298 . . . . 63.0 112.38 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.471 ' HB3' ' NE ' ' A' ' 60' ' ' ARG . . . -47.35 -44.45 23.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 72.540000000000006 111.053 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.582 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 0.7 OUTLIER -85.3 34.25 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 61.340000000000003 110.865 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.5 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 14.6 p -52.3 144.67 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 74.140000000000001 111.109 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.462 ' N ' HG21 ' A' ' 53' ' ' VAL . . . 50.7 -88.12 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.772 -0.728 . . . . 74.420000000000002 112.512 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -118.21 112.51 20.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 75.299999999999997 110.922 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -58.59 108.05 1.18 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.607 0.718 . . . . 73.140000000000001 111.136 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 52.9 Cg_endo -69.8 162.27 42.74 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.715 2.277 . . . . 73.420000000000002 112.317 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.8 tp -57.89 -25.95 61.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.225 -0.443 . . . . 74.230000000000004 110.831 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.22 -53.53 57.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 75.209999999999994 111.105 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.582 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 29.5 mmt180 -69.92 -44.97 68.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 75.239999999999995 110.885 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.478 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 1.5 t-160 -56.24 -53.77 53.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 72.129999999999995 110.821 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.9 mtp85 -65.33 -35.89 82.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 71.329999999999998 110.87 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.4 ttt -56.24 -48.38 76.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 65.129999999999995 110.835 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 61' ' ' HIS . 11.4 m -67.83 -40.64 83.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 74.310000000000002 111.116 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.494 ' O ' ' CD1' ' A' ' 68' ' ' LEU . 16.7 m-85 -67.35 -34.18 76.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 71.420000000000002 110.908 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.06 -44.46 26.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 64.209999999999994 111.114 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.457 ' CG2' ' N ' ' A' ' 68' ' ' LEU . 1.2 t -60.32 -40.99 92.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 72.519999999999996 111.158 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.587 ' C ' ' CD1' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -88.66 -10.92 46.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 74.230000000000004 110.921 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.521 ' N ' HD13 ' A' ' 68' ' ' LEU . . . 31.32 87.82 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.757 -0.735 . . . . 75.040000000000006 112.506 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.467 ' N ' HD13 ' A' ' 68' ' ' LEU . 1.1 pm0 -79.53 -35.25 40.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.993 0.425 . . . . 74.439999999999998 110.938 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -76.11 7.3 4.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 73.430000000000007 110.929 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 63.4 mtp -84.52 -13.05 52.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 71.400000000000006 110.854 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.39 -22.1 1.11 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.772 -0.728 . . . . 55.100000000000001 112.448 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.08 42.9 4.23 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.722 -0.751 . . . . 74.349999999999994 112.501 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.42 ' HA ' ' C ' ' A' ' 40' ' ' GLY . . . -58.78 156.09 11.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.766 0.317 . . . . 72.200000000000003 111.063 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 21.5 mm -70.82 164.99 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 75.310000000000002 111.134 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 30.2 m170 -74.48 46.46 0.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 72.140000000000001 110.839 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -134.95 58.63 1.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 72.439999999999998 111.107 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.598 ' CD1' ' CE2' ' A' ' 43' ' ' PHE . 3.9 mm? -97.66 132.49 43.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 73.230000000000004 110.882 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -111.46 114.94 28.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 71.109999999999999 110.935 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 tp -133.65 124.72 27.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 64.120000000000005 110.915 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.4 mptt -126.48 114.47 18.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 72.049999999999997 110.834 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.578 ' HB ' ' CD2' ' A' ' 52' ' ' PHE . 66.8 p -109.39 107.19 17.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 72.299999999999997 111.189 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.6 mp -131.56 162.8 29.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 73.430000000000007 110.88 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.5 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.11 164.1 59.8 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.59 0.71 . . . . 72.439999999999998 111.103 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.498 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.6 Cg_endo -69.79 -12.8 33.58 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.633 2.222 . . . . 74.540000000000006 112.374 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -78.66 -28.72 45.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 72.239999999999995 110.905 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -85.04 28.79 0.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 74.400000000000006 110.877 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 64.510000000000005 111.18 179.837 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.6 ptp . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.747 0.308 . . . . 72.010000000000005 110.944 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -113.85 90.91 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 74.129999999999995 110.876 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.74 43.94 2.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 74.420000000000002 110.933 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.439 ' CB ' ' CD ' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -71.35 -59.87 2.99 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.563 0.697 . . . . 74.319999999999993 110.852 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 13' ' ' ARG . 54.0 Cg_endo -69.8 165.32 31.4 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.662 2.241 . . . . 65.209999999999994 112.379 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.7 tp -121.22 -36.96 3.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 63.509999999999998 110.901 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.52 -49.25 6.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 74.549999999999997 110.911 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.476 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . . . -63.37 -27.73 69.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 74.239999999999995 111.042 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 19' ' ' THR . 4.0 pt-20 -71.49 -28.91 64.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.26 -0.427 . . . . 74.439999999999998 110.873 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.409 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 17.1 p -59.07 -56.66 19.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 74.510000000000005 111.166 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.476 ' CD1' ' HA ' ' A' ' 17' ' ' ALA . 0.2 OUTLIER -73.92 -35.29 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 74.150000000000006 111.098 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -62.41 -48.57 79.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 73.230000000000004 110.862 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -69.56 -40.27 76.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 75.420000000000002 110.872 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.8 mt -56.18 -49.19 74.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.302 -0.408 . . . . 74.239999999999995 110.931 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.471 ' CG2' HG23 ' A' ' 33' ' ' VAL . 11.7 mt -68.07 -45.84 82.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 74.430000000000007 111.161 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -54.21 -36.8 63.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.116 -0.493 . . . . 74.340000000000003 110.898 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m -77.4 -43.02 34.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 60.5 110.881 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.47 -46.46 92.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.768 -0.729 . . . . 54.409999999999997 112.472 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.44 HD21 ' CB ' ' A' ' 31' ' ' ALA . 6.8 mp -85.61 161.09 52.02 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.567 0.699 . . . . 75.099999999999994 110.938 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -90.76 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.656 2.237 . . . . 74.120000000000005 112.373 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -107.26 25.89 10.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 72.409999999999997 110.909 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.44 ' CB ' HD21 ' A' ' 28' ' ' LEU . . . -71.64 125.71 27.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 73.010000000000005 111.118 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.444 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 2.2 tpm_? -93.71 108.75 20.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 71.219999999999999 110.865 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.471 HG23 ' CG2' ' A' ' 24' ' ' ILE . 41.7 t -113.28 127.46 70.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 73.040000000000006 111.196 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -135.22 118.56 16.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 70.120000000000005 110.828 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.466 HG11 ' CG1' ' A' ' 20' ' ' ILE . 3.9 p -126.26 136.7 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 65.150000000000006 111.089 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -132.69 120.1 21.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 73.439999999999998 110.912 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 149.18 -124.92 1.9 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 72.420000000000002 112.444 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.41 ' O ' ' CG1' ' A' ' 41' ' ' VAL . 2.2 tt0 -175.44 163.04 2.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 65.200000000000003 110.895 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.02 148.16 46.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 75.310000000000002 110.9 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.61 8.99 73.4 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.739 -0.743 . . . . 73.049999999999997 112.508 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.41 ' CG1' ' O ' ' A' ' 38' ' ' GLU . 14.7 p -139.14 165.17 23.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.827 0.346 . . . . 72.420000000000002 111.152 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.401 ' N ' ' CG2' ' A' ' 41' ' ' VAL . 32.6 p80 -74.49 110.7 9.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 73.219999999999999 110.851 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.565 ' CZ ' HD12 ' A' ' 79' ' ' LEU . 4.9 p90 -126.91 167.65 15.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.273 -0.422 . . . . 74.310000000000002 110.866 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -113.5 124.98 53.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 64.150000000000006 110.873 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.22 119.99 26.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 64.510000000000005 111.148 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.4 m -118.26 114.99 23.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 74.510000000000005 111.117 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.457 HG12 ' CG2' ' A' ' 33' ' ' VAL . 24.7 t -113.47 141.25 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 74.129999999999995 111.128 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.444 ' CG1' ' HB3' ' A' ' 32' ' ' ARG . 5.1 p -134.95 122.2 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 73.329999999999998 111.133 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.426 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.9 OUTLIER -167.61 166.26 7.97 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.704 0.764 . . . . 73.540000000000006 110.874 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.503 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.8 Cg_endo -69.74 -18.22 37.21 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.681 2.254 . . . . 74.030000000000001 112.317 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -43.76 -50.79 7.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 74.129999999999995 111.157 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.582 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 0.1 OUTLIER -86.94 40.58 0.92 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.248 -0.433 . . . . 71.400000000000006 110.891 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.487 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 4.7 p -51.24 119.1 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 74.200000000000003 111.089 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.69 -72.88 1.01 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.748 -0.739 . . . . 70.549999999999997 112.495 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -121.62 138.59 54.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.809 0.338 . . . . 73.209999999999994 110.876 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.483 ' CB ' ' HB3' ' A' ' 52' ' ' PHE . . . -99.73 100.11 10.33 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.538 0.685 . . . . 75.530000000000001 111.093 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 163.49 38.11 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.633 2.222 . . . . 75.230000000000004 112.374 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.49 -26.76 55.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 55.43 110.928 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 63' ' ' MET . . . -58.6 -49.95 75.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 75.099999999999994 111.13 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.582 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 21.6 mmt180 -71.7 -46.47 58.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.275 -0.42 . . . . 71.239999999999995 110.818 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.513 ' O ' ' CG2' ' A' ' 64' ' ' VAL . 1.0 OUTLIER -58.0 -50.0 74.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 63.219999999999999 110.833 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -67.34 -39.65 85.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 75.319999999999993 110.883 -179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.407 ' CG ' ' O ' ' A' ' 59' ' ' ALA . 4.3 mmt -54.54 -48.02 72.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 75.409999999999997 110.898 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' A' ' 61' ' ' HIS . 13.5 m -65.43 -42.51 93.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 72.450000000000003 111.165 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.448 ' N ' HG23 ' A' ' 64' ' ' VAL . 12.1 m-85 -54.8 -42.09 71.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 74.319999999999993 110.853 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.53 -44.37 62.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 74.109999999999999 111.109 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.438 HG23 ' CG1' ' A' ' 24' ' ' ILE . 0.6 OUTLIER -69.64 -14.76 62.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 72.430000000000007 111.201 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.426 HD13 ' C ' ' A' ' 64' ' ' VAL . 18.0 mt -94.61 -10.54 31.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 72.319999999999993 110.929 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.71 72.71 0.47 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.712 -0.756 . . . . 62.219999999999999 112.505 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.405 ' HG3' ' N ' ' A' ' 71' ' ' LEU . 10.0 pt-20 -114.65 -38.47 3.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.869 0.366 . . . . 72.340000000000003 110.924 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.503 ' O ' ' CD1' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -88.38 -11.17 46.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 75.329999999999998 110.907 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.8 ptm -80.63 -13.14 59.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 75.239999999999995 110.921 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.36 -25.28 5.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 64.5 112.471 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.82 52.64 1.63 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.731 -0.747 . . . . 60.109999999999999 112.478 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.88 162.13 22.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 74.219999999999999 111.093 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.408 ' C ' ' H ' ' A' ' 78' ' ' ALA . 10.9 mt -73.35 165.0 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 74.5 111.156 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -74.41 45.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.813 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 76' ' ' ILE . . . -132.01 53.66 1.98 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 72.230000000000004 111.08 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.565 HD12 ' CZ ' ' A' ' 43' ' ' PHE . 3.9 mm? -98.16 136.36 38.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 73.010000000000005 110.958 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -105.79 115.73 30.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 74.140000000000001 110.913 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.58 118.47 22.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 74.340000000000003 110.892 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 47' ' ' VAL . 2.2 mptp? -119.0 114.5 22.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.467 . . . . 75.400000000000006 110.953 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.532 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 33.5 p -109.79 107.32 17.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 73.019999999999996 111.163 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.6 mt -131.07 160.83 33.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 75.109999999999999 110.883 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.487 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.36 162.86 71.71 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.597 0.713 . . . . 62.299999999999997 111.128 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.7 Cg_endo -69.65 -17.94 37.81 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.689 2.259 . . . . 75.409999999999997 112.394 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -71.83 -34.76 69.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 73.430000000000007 110.904 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -68.32 -31.24 70.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.173 -0.467 . . . . 74.239999999999995 110.854 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 74.409999999999997 111.063 179.977 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.716 0.294 . . . . 74.32 111.046 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -71.5 -40.84 69.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 70.01 110.866 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.415 ' H ' HG23 ' A' ' 19' ' ' THR . 2.2 p -61.06 -52.86 63.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 71.44 111.134 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.561 HD11 HG11 ' A' ' 35' ' ' VAL . 4.6 pt -67.2 -45.07 87.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 73.42 111.148 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.1 ttt-85 -58.96 -45.06 91.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 72.34 110.846 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -65.37 -44.65 86.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 74.3 110.88 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.5 mt -56.01 -49.54 73.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 55.43 110.935 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.829 HG22 HD12 ' A' ' 28' ' ' LEU . 8.8 mt -67.33 -44.28 87.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 53.53 111.129 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -54.03 -39.1 65.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 55.54 110.852 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.78 -41.21 45.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 74.12 110.873 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.48 -58.33 10.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 63.11 112.502 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.829 HD12 HG22 ' A' ' 24' ' ' ILE . 32.0 mt -73.05 154.69 90.68 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.638 0.732 . . . . 75.01 110.896 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -90.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.267 . . . . 61.34 112.315 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -104.41 34.51 3.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 73.21 110.89 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.513 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -87.52 139.6 30.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 73.14 111.119 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.644 ' HB3' HG12 ' A' ' 48' ' ' VAL . 31.3 ttt180 -109.3 125.65 52.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 74.01 110.865 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.045 HG13 HG22 ' A' ' 47' ' ' VAL . 6.0 t -123.15 133.26 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 70.32 111.128 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -135.09 118.86 17.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 71.13 110.83 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.741 HG22 ' HB1' ' A' ' 45' ' ' ALA . 40.1 t -124.56 130.85 73.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 64.21 111.115 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 2.0 tp-100 -132.77 120.18 21.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 63.51 110.912 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.478 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 149.44 -122.75 1.49 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.757 -0.735 . . . . 65.52 112.516 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -175.32 160.71 2.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.783 0.325 . . . . 71.25 110.918 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -73.65 146.58 44.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 54.34 110.905 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.435 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.7 18.39 78.69 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.784 -0.722 . . . . 72.1 112.451 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 42' ' ' HIS . 21.0 t -149.23 165.44 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 74.44 111.168 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.574 ' N ' HG12 ' A' ' 41' ' ' VAL . 36.0 p-80 -74.21 112.27 10.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 74.23 110.849 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.765 ' CZ ' HD21 ' A' ' 79' ' ' LEU . 27.8 p90 -129.23 167.44 17.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 75.43 110.931 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -116.63 120.04 37.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 73.22 110.86 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.741 ' HB1' HG22 ' A' ' 35' ' ' VAL . . . -127.73 116.83 20.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 72.32 111.07 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.6 m -106.89 117.89 35.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 45.53 111.115 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.045 HG22 HG13 ' A' ' 33' ' ' VAL . 55.0 t -113.93 141.22 30.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 63.01 111.126 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.644 HG12 ' HB3' ' A' ' 32' ' ' ARG . 3.7 p -131.42 118.75 41.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 63.04 111.105 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.545 ' OG ' ' CE2' ' A' ' 52' ' ' PHE . 10.8 p -158.58 158.62 29.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.651 0.738 . . . . 62.44 110.862 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.577 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.1 Cg_endo -69.69 -22.71 32.01 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.697 2.265 . . . . 63.1 112.385 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.0 -39.2 40.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 73.42 111.116 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.596 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 3.3 m-85 -84.51 27.77 0.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 74.32 110.915 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 55' ' ' LYS . 2.1 p -52.25 138.65 10.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.113 -0.494 . . . . 44.13 111.147 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 54.85 -82.25 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.738 -0.744 . . . . 70.42 112.482 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 53' ' ' VAL . 16.6 pttm -119.23 135.69 54.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.328 . . . . 72.44 110.919 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.57 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -98.97 100.78 10.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.611 0.719 . . . . 70.54 111.068 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.5 Cg_endo -69.86 173.82 10.5 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.643 2.229 . . . . 63.34 112.339 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.38 -26.62 63.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 61.2 110.927 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.01 -52.96 63.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 53.21 111.128 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.596 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 3.7 mmt180 -71.57 -42.62 67.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 53.52 110.915 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.469 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -57.92 -53.17 61.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.095 -0.502 . . . . 74.11 110.912 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 -67.35 -37.67 83.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 74.11 110.912 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 40.0 mmm -55.1 -47.71 74.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 63.23 110.935 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 61' ' ' HIS . 19.6 m -69.58 -42.66 80.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.435 . . . . 70.34 111.151 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.679 ' CE1' HD13 ' A' ' 81' ' ' LEU . 13.3 m-85 -62.41 -36.98 84.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 74.23 110.891 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.48 -45.71 44.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 74.51 111.125 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.624 HG23 HD12 ' A' ' 68' ' ' LEU . 1.2 t -66.5 -26.62 67.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 74.42 111.16 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.647 HD12 HD11 ' A' ' 24' ' ' ILE . 7.5 mp -86.91 4.49 41.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 70.14 110.886 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.53 78.68 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.791 -0.719 . . . . 52.22 112.479 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -99.44 -48.25 4.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 74.33 110.896 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.0 mp -85.96 1.0 51.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.16 -0.473 . . . . 55.24 110.947 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 tpt -80.86 -13.31 59.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 72.32 110.861 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -123.0 -28.29 1.4 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 63.22 112.501 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.435 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.685 -0.769 . . . . 60.31 112.479 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.819 0.342 . . . . 73.24 111.08 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.765 HD21 ' CZ ' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -97.97 126.83 43.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.436 . . . . 51.24 110.902 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.4 ' N ' HD13 ' A' ' 79' ' ' LEU . 20.8 mp0 -106.75 114.76 29.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 72.41 110.917 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.679 HD13 ' CE1' ' A' ' 65' ' ' TYR . 9.0 tt -140.04 129.38 23.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 73.33 110.952 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -122.49 132.21 54.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 65.01 110.874 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.533 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 27.2 p -112.16 107.09 15.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 72.21 111.107 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.5 mt -124.04 162.07 24.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.26 -0.427 . . . . 34.41 110.959 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.414 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 0.5 OUTLIER -71.66 164.65 56.34 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.619 0.723 . . . . 43.52 111.111 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.577 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.0 Cg_endo -69.81 -18.85 36.53 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.67 2.247 . . . . 75.33 112.331 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -77.64 -25.64 49.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 71.15 110.91 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -83.01 18.77 1.55 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 62.45 110.891 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 63.02 111.104 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.76 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.796 0.331 . . . . 73.21 111.084 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -71.14 -31.06 67.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 72.14 110.911 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 19' ' ' THR . 1.3 p -67.22 -53.37 30.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 75.2 111.132 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.058 HD11 HG11 ' A' ' 35' ' ' VAL . 2.0 pp -70.06 -37.62 72.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 75.22 111.13 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.578 ' N ' HD12 ' A' ' 20' ' ' ILE . 38.0 ttp180 -61.32 -50.46 72.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 70.03 110.938 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.404 ' NZ ' ' HA ' ' A' ' 19' ' ' THR . 4.8 ptpp? -67.08 -40.0 86.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 64.22 110.878 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.8 mt -56.6 -49.86 73.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 75.03 110.893 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.714 ' CG2' HG21 ' A' ' 33' ' ' VAL . 12.3 mt -68.47 -43.8 83.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 75.45 111.113 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -55.58 -36.9 67.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 72.34 110.84 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.72 -43.0 32.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 71.22 110.845 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.8 -50.68 61.81 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.733 . . . . 63.22 112.463 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.501 HD13 ' CB ' ' A' ' 31' ' ' ALA . 5.0 mt -82.44 160.24 62.53 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.599 0.714 . . . . 64.34 110.884 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.424 ' HD2' ' CD2' ' A' ' 28' ' ' LEU . 54.3 Cg_endo -69.68 -91.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.729 2.286 . . . . 65.53 112.393 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -106.71 25.6 11.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 74.43 110.876 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.501 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -69.78 131.86 45.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 75.03 111.073 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.581 ' HB3' HG12 ' A' ' 48' ' ' VAL . 3.3 tpp85 -99.69 113.64 26.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 75.22 110.879 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.982 HG13 HG22 ' A' ' 47' ' ' VAL . 21.5 t -115.81 130.47 70.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 62.0 111.178 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -131.43 118.63 20.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 71.21 110.861 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.058 HG11 HD11 ' A' ' 20' ' ' ILE . 2.0 p -128.31 130.59 69.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 74.03 111.151 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.404 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 48.3 mt-30 -133.2 120.37 21.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 70.53 110.921 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 150.2 -125.14 1.88 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 64.31 112.505 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.647 ' O ' HG12 ' A' ' 41' ' ' VAL . 17.4 tt0 -175.1 162.48 3.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.817 0.342 . . . . 72.24 110.894 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -71.58 144.42 49.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 72.31 110.837 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.416 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.74 22.31 79.12 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.786 -0.721 . . . . 75.14 112.481 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -150.66 164.8 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.819 0.343 . . . . 72.35 111.173 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.402 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 45.8 p-80 -75.14 106.69 6.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 64.02 110.919 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.922 ' CE1' HD11 ' A' ' 79' ' ' LEU . 4.7 p90 -121.67 167.75 12.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 75.54 110.911 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -113.48 121.06 43.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 73.44 110.874 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.518 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -128.36 121.88 30.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 64.32 111.072 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.4 m -119.76 115.02 23.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 44.11 111.164 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.982 HG22 HG13 ' A' ' 33' ' ' VAL . 44.5 t -110.26 138.54 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 70.25 111.165 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.997 HG21 ' HB2' ' A' ' 89' ' ' ALA . 8.9 p -135.33 118.78 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 64.22 111.142 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.447 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.7 OUTLIER -161.19 165.72 16.44 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.614 0.721 . . . . 71.1 110.883 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.471 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.0 Cg_endo -69.74 -21.01 34.16 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.643 2.229 . . . . 54.21 112.362 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.723 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -47.31 -46.52 25.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 70.32 111.072 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.709 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -85.22 34.97 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.425 . . . . 75.43 110.889 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 55' ' ' LYS . 2.6 p -51.99 130.96 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 63.3 111.146 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 59.65 -76.08 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.804 -0.712 . . . . 60.55 112.498 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 53' ' ' VAL . 16.5 pttm -120.38 137.48 54.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 63.25 110.936 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.709 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -99.58 99.9 9.67 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.504 0.669 . . . . 73.53 111.118 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.82 171.25 14.87 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.695 2.263 . . . . 64.52 112.34 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.93 -27.97 61.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 72.34 110.945 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.459 ' O ' ' CG ' ' A' ' 63' ' ' MET . . . -58.15 -52.26 66.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 72.35 111.082 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.723 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 44.1 mmt-85 -70.37 -43.47 70.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 73.11 110.852 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.529 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.8 OUTLIER -57.74 -53.59 56.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 72.25 110.844 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -66.12 -36.15 82.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 71.21 110.864 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.459 ' CG ' ' O ' ' A' ' 59' ' ' ALA . 23.4 mmm -57.14 -46.49 82.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 74.13 110.881 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 61' ' ' HIS . 17.1 m -69.82 -40.21 78.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 74.4 111.152 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.58 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 13.7 m-85 -65.94 -34.44 78.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.145 -0.48 . . . . 72.11 110.882 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.14 -46.6 33.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 64.42 111.079 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.473 HG21 HG12 ' A' ' 24' ' ' ILE . 13.0 t -66.56 -28.46 68.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 74.34 111.14 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.621 ' HG ' HD13 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -82.47 -2.45 53.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 53.25 110.915 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.88 78.41 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.78 -0.724 . . . . 52.52 112.537 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 71' ' ' LEU . 12.1 pt-20 -90.02 -42.15 11.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.902 0.382 . . . . 74.43 110.883 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.469 ' N ' ' HG3' ' A' ' 70' ' ' GLU . 18.0 tp -89.45 7.94 33.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 72.33 110.9 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -13.02 60.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.446 . . . . 73.43 110.951 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.05 -30.27 0.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.708 -0.758 . . . . 35.03 112.446 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.416 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.362 0 C-N-CA 120.722 -0.751 . . . . 4.33 112.499 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.83 0.348 . . . . 74.13 111.084 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.922 HD11 ' CE1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -98.77 128.48 45.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.318 -0.401 . . . . 74.52 110.934 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.406 ' N ' HD13 ' A' ' 79' ' ' LEU . 4.8 mt-30 -97.53 116.84 30.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 34.1 110.872 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.58 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 1.7 tm? -139.04 117.92 12.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 73.2 110.906 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.566 ' N ' HD13 ' A' ' 81' ' ' LEU . 4.0 mptp? -122.21 133.01 54.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 74.31 110.963 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.55 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 68.4 p -117.24 107.63 14.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 73.32 111.132 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.9 mt -127.76 161.04 29.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 62.42 110.903 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.483 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.15 163.8 64.28 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.631 0.729 . . . . 63.33 111.097 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.471 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.2 Cg_endo -69.81 -4.73 14.65 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.722 2.281 . . . . 74.11 112.304 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -94.18 -27.92 15.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 63.13 110.829 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -105.31 39.72 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 73.13 110.853 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.997 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 74.44 111.084 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.112 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.762 0.315 . . . . 52.51 111.145 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -40.53 94.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 73.33 110.872 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.577 ' CG2' ' N ' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -60.74 -47.89 84.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 43.14 111.118 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.794 HD11 HG11 ' A' ' 35' ' ' VAL . 43.6 pt -66.36 -39.26 83.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 52.34 111.122 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.484 ' N ' HG13 ' A' ' 20' ' ' ILE . 20.9 ttp85 -61.62 -42.22 98.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 63.22 110.85 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.62 -46.2 69.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 72.43 110.896 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -56.28 -49.06 75.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 74.41 110.957 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.813 ' CG2' HG21 ' A' ' 33' ' ' VAL . 7.9 mt -65.77 -45.31 92.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 74.24 111.117 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -53.86 -39.75 65.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 73.14 110.945 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -79.8 -32.47 40.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 70.31 110.798 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.24 -60.73 4.96 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.828 -0.701 . . . . 24.32 112.441 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.491 HD13 ' CB ' ' A' ' 31' ' ' ALA . 10.2 mt -72.65 159.29 85.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.569 0.7 . . . . 72.33 110.926 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -91.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.66 2.24 . . . . 54.35 112.347 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -105.38 38.9 1.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 64.33 110.846 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.491 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -91.35 125.75 36.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 71.5 111.072 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.624 ' HB3' HG12 ' A' ' 48' ' ' VAL . 8.0 tpp180 -95.67 109.65 21.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 71.34 110.881 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.027 HG22 HG13 ' A' ' 47' ' ' VAL . 39.0 t -109.12 125.4 66.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 62.41 111.101 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -135.35 117.53 15.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 64.13 110.831 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.112 HG13 ' HB1' ' A' ' 17' ' ' ALA . 5.1 p -126.88 139.78 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 74.52 111.13 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -129.19 120.99 26.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.461 . . . . 70.24 110.92 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.478 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 144.16 -135.07 6.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 72.53 112.488 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.517 ' O ' HG12 ' A' ' 41' ' ' VAL . 10.9 tt0 -168.67 172.05 8.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 71.43 110.915 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -77.15 150.63 35.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 73.11 110.861 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.58 1.25 52.28 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.741 -0.742 . . . . 71.44 112.442 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 38' ' ' GLU . 2.0 p -131.23 164.55 33.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.855 0.36 . . . . 65.32 111.151 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.525 ' CG ' ' O ' ' A' ' 42' ' ' HIS . 10.0 p80 -75.21 107.35 7.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 73.22 110.876 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.513 ' CE2' HD11 ' A' ' 79' ' ' LEU . 48.8 p90 -125.37 167.52 14.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 74.24 110.884 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -114.02 124.61 52.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 42.11 110.887 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 81' ' ' LEU . . . -117.74 115.4 24.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 61.41 111.081 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 m -114.92 106.65 14.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 62.51 111.217 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.027 HG13 HG22 ' A' ' 33' ' ' VAL . 59.9 t -112.54 125.95 69.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 53.42 111.102 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 89' ' ' ALA . 3.9 p -114.4 118.57 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 75.3 111.173 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.499 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 14.9 p -159.33 158.66 28.38 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.663 0.744 . . . . 72.12 110.859 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.564 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.4 Cg_endo -69.68 -21.26 34.1 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.699 2.266 . . . . 75.02 112.352 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.53 -42.16 43.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 63.52 111.129 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.598 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 2.5 m-85 -84.04 30.18 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 74.51 110.838 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 55' ' ' LYS . 2.9 p -52.02 135.58 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 65.14 111.1 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.18 -82.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.745 -0.74 . . . . 53.41 112.46 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 53' ' ' VAL . 30.9 mmmt -115.62 135.97 53.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.824 0.345 . . . . 65.23 110.891 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.538 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -99.14 100.55 10.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.623 0.725 . . . . 75.31 111.092 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 54.3 Cg_endo -69.67 171.03 15.11 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.718 2.279 . . . . 75.43 112.333 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.491 HD21 ' NE ' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -55.62 -27.82 51.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 74.31 110.956 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.18 -52.64 64.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 74.21 111.135 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.598 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 7.7 mmt180 -70.98 -42.13 70.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 65.11 110.839 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.432 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -57.61 -52.02 67.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 75.41 110.863 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.491 ' NE ' HD21 ' A' ' 58' ' ' LEU . 44.8 mtt180 -68.16 -37.48 81.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 64.52 110.801 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.1 mmt -55.51 -49.0 73.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 64.45 110.875 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.491 ' HA ' HG22 ' A' ' 67' ' ' THR . 18.6 m -67.89 -45.1 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 60.02 111.111 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.851 ' CE1' HD13 ' A' ' 81' ' ' LEU . 13.2 m-85 -57.75 -36.77 72.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.45 . . . . 73.22 110.894 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.55 -46.03 41.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 43.12 111.093 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.536 HG21 HG12 ' A' ' 24' ' ' ILE . 1.7 t -72.58 -12.89 61.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 72.12 111.136 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.741 HD23 HD12 ' A' ' 20' ' ' ILE . 27.1 mt -93.76 3.29 55.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 61.13 110.887 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 55.57 66.97 2.46 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 54.14 112.524 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -81.04 -39.41 25.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.912 0.387 . . . . 54.04 110.908 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.9 mt -90.18 10.08 25.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 73.22 110.894 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 22.9 mmt -71.79 -9.0 57.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 65.04 110.832 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.54 -31.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 75.13 112.52 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.761 -0.733 . . . . 64.41 112.533 -179.923 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.851 0.358 . . . . 74.13 111.137 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.513 HD11 ' CE2' ' A' ' 43' ' ' PHE . 2.2 mm? -99.16 134.36 42.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 70.41 110.907 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -120.31 115.67 24.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 55.51 110.87 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.851 HD13 ' CE1' ' A' ' 65' ' ' TYR . 4.5 tt -127.94 140.61 51.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 74.2 110.957 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.39 115.69 12.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 61.22 110.979 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.542 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 11.8 p -105.46 106.87 17.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 64.12 111.086 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.5 mt -122.97 162.08 22.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 73.03 110.977 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.435 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 0.2 OUTLIER -71.33 165.82 44.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.61 0.719 . . . . 71.35 111.119 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.7 Cg_endo -69.69 -24.71 29.69 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.697 2.265 . . . . 74.02 112.393 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.28 -31.77 72.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 70.14 110.897 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -70.56 -32.39 69.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 72.22 110.903 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.664 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 71.51 111.134 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.581 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.803 0.335 . . . . 34.34 111.161 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -70.86 -47.94 56.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 73.11 110.844 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.9 t -61.34 -45.1 95.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 62.42 111.112 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.74 HD12 HD23 ' A' ' 68' ' ' LEU . 6.4 pt -71.55 -42.5 72.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 64.45 111.165 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 58.9 ttt180 -60.5 -48.0 83.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 73.43 110.855 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -66.08 -42.85 88.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 75.44 110.872 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 23' ' ' LEU . 12.1 mt -56.07 -48.31 76.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.452 . . . . 71.33 110.912 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.791 HG21 HG21 ' A' ' 33' ' ' VAL . 13.3 mt -68.41 -45.22 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 71.24 111.106 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -54.58 -37.12 65.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 70.22 110.879 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.91 -42.97 31.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 71.44 110.885 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.38 -49.9 73.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 65.21 112.499 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.608 HD13 ' CG2' ' A' ' 24' ' ' ILE . 5.8 mp -89.57 154.06 48.26 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.7 0.762 . . . . 70.44 110.845 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 -91.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.725 2.283 . . . . 63.33 112.317 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -100.16 54.74 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 72.5 110.897 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.97 137.66 42.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 54.42 111.143 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.645 ' HB3' HG12 ' A' ' 48' ' ' VAL . 4.7 tmm_? -106.43 117.38 33.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 74.44 110.852 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.948 HG13 HG22 ' A' ' 47' ' ' VAL . 38.0 t -122.2 130.27 74.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 64.4 111.181 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -135.26 118.52 16.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 71.32 110.949 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.884 HG13 ' HB2' ' A' ' 45' ' ' ALA . 7.6 t -122.79 131.55 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 65.23 111.124 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.403 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 1.9 tp60 -133.53 120.0 20.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 63.34 110.937 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.08 -141.62 9.81 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 53.22 112.47 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -155.05 179.95 8.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 74.24 110.832 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -86.96 144.25 27.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 63.33 110.85 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.425 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.69 22.3 79.1 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.757 -0.735 . . . . 73.22 112.455 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 42' ' ' HIS . 2.5 p -148.84 164.93 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.808 0.337 . . . . 63.5 111.166 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.415 ' H ' HG22 ' A' ' 41' ' ' VAL . 15.8 p80 -74.95 106.75 6.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 64.33 110.862 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.418 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 8.1 p90 -120.5 167.39 12.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 63.12 110.881 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -118.29 119.18 33.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 73.14 110.836 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.884 ' HB2' HG13 ' A' ' 35' ' ' VAL . . . -128.99 115.57 18.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 63.35 111.148 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.461 HG23 ' HB2' ' A' ' 82' ' ' LYS . 38.7 m -103.86 125.64 50.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.479 . . . . 74.12 111.084 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.948 HG22 HG13 ' A' ' 33' ' ' VAL . 88.1 t -122.3 133.82 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 61.51 111.136 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.645 HG12 ' HB3' ' A' ' 32' ' ' ARG . 4.1 p -130.11 118.61 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 65.34 111.138 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.464 ' CB ' ' HD2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -158.64 168.06 13.19 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.629 0.728 . . . . 62.33 110.797 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.515 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.1 Cg_endo -69.75 -28.52 25.2 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.604 2.203 . . . . 71.45 112.388 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.731 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -48.65 -42.17 33.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 61.01 111.126 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.559 ' CD2' ' HB ' ' A' ' 83' ' ' THR . 1.4 m-85 -83.86 31.38 0.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 72.32 110.89 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.591 ' HA ' HG23 ' A' ' 85' ' ' THR . 1.8 p -54.36 132.1 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 61.54 111.177 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.93 -80.2 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.74 -0.743 . . . . 32.13 112.511 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -116.91 136.52 52.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.757 0.313 . . . . 51.51 110.92 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.426 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -99.07 100.5 10.15 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.579 0.704 . . . . 71.23 111.099 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.76 172.48 12.57 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.696 2.264 . . . . 65.23 112.309 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 tp -55.99 -25.07 42.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 71.12 110.909 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 63' ' ' MET . . . -59.26 -53.31 59.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 64.31 111.116 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.731 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 8.7 mmt180 -71.77 -40.43 69.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 73.32 110.915 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.44 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.1 t-160 -59.84 -51.91 67.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 74.24 110.885 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -67.4 -39.05 85.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 71.54 110.891 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 4.9 tmm? -54.89 -52.11 63.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 74.45 110.858 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.538 ' O ' HG22 ' A' ' 67' ' ' THR . 25.5 m -63.83 -44.9 98.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.303 -0.408 . . . . 72.13 111.072 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.475 ' N ' HG23 ' A' ' 64' ' ' VAL . 12.8 m-85 -60.37 -31.24 70.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 73.0 110.885 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.04 -46.66 33.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 61.11 111.099 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.538 HG22 ' O ' ' A' ' 64' ' ' VAL . 3.8 t -67.12 -26.6 66.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 74.02 111.134 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.74 HD23 HD12 ' A' ' 20' ' ' ILE . 12.9 mt -83.0 8.88 11.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 72.15 110.887 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.14 66.94 1.33 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.736 . . . . 60.34 112.508 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.478 ' HG3' HD23 ' A' ' 71' ' ' LEU . 10.0 pt-20 -70.39 -42.8 71.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.875 0.369 . . . . 73.43 110.845 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.478 HD23 ' HG3' ' A' ' 70' ' ' GLU . 4.4 mm? -90.01 7.62 36.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 64.13 110.93 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.0 ttm -71.92 -12.99 61.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 74.21 110.877 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.26 -33.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.777 -0.725 . . . . 72.3 112.501 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.425 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.276 0 C-N-CA 120.643 -0.789 . . . . 63.14 112.449 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.754 0.311 . . . . 54.44 111.065 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 79' ' ' LEU . 8.8 mt -104.24 126.9 51.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.914 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -96.93 115.4 27.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.462 . . . . 61.03 110.903 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 tp -139.22 144.19 38.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 75.02 110.937 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HB2' HG23 ' A' ' 46' ' ' THR . 0.6 OUTLIER -136.27 114.48 11.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 64.11 110.901 179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.559 ' HB ' ' CD2' ' A' ' 52' ' ' PHE . 44.5 p -99.41 107.72 20.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 65.24 111.17 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.778 HD22 ' OE1' ' A' ' 88' ' ' GLU . 26.9 mt -130.78 160.35 34.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.176 -0.466 . . . . 71.01 110.915 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.591 HG23 ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -73.63 164.11 63.49 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.633 0.73 . . . . 71.21 111.142 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.8 Cg_endo -69.72 -8.79 24.5 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.689 2.259 . . . . 65.42 112.318 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -77.58 -35.96 52.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 63.52 110.918 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.778 ' OE1' HD22 ' A' ' 84' ' ' LEU . 18.0 mt-10 -70.36 -32.57 70.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 74.34 110.796 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 52.15 111.17 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.793 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.679 0.276 . . . . 71.03 111.093 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -71.61 -41.14 69.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 71.31 110.866 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.5 p -61.03 -53.0 62.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 73.55 111.15 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.714 HD11 HG11 ' A' ' 35' ' ' VAL . 12.3 pt -68.3 -42.72 84.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 72.53 111.155 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.501 ' N ' HG13 ' A' ' 20' ' ' ILE . 39.9 ttp85 -59.56 -46.49 88.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 75.54 110.88 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -66.82 -41.21 87.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 62.54 110.918 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.3 mt -56.64 -49.46 74.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 71.14 110.867 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.76 ' CG2' HG21 ' A' ' 33' ' ' VAL . 10.6 mt -67.56 -41.95 86.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 71.2 111.131 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -55.7 -41.1 73.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 73.11 110.913 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.72 -43.28 55.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 75.33 110.876 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.35 -51.86 53.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.747 . . . . 73.43 112.406 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.599 HD23 ' CB ' ' A' ' 31' ' ' ALA . 7.3 mp -80.71 156.31 72.92 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.594 0.712 . . . . 74.55 110.88 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -90.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.657 2.238 . . . . 64.44 112.375 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -105.96 27.36 8.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 74.15 110.863 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.599 ' CB ' HD23 ' A' ' 28' ' ' LEU . . . -75.81 144.45 41.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 74.44 111.048 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.692 ' HB3' HG12 ' A' ' 48' ' ' VAL . 58.2 ttt180 -110.96 124.83 52.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 74.44 110.849 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.1 HG13 HG22 ' A' ' 47' ' ' VAL . 5.9 t -124.17 129.44 74.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 62.34 111.153 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -131.44 118.98 20.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 53.13 110.846 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.793 HG13 ' HB1' ' A' ' 17' ' ' ALA . 1.6 p -126.73 134.34 66.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 64.12 111.105 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -133.45 120.3 20.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 74.13 110.897 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.56 -130.39 4.55 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.731 -0.747 . . . . 71.41 112.529 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -174.06 160.98 3.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.919 0.39 . . . . 72.51 110.871 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -67.69 151.95 46.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 70.53 110.887 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.419 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.74 10.12 75.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.752 -0.737 . . . . 75.43 112.533 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 42' ' ' HIS . 7.3 t -143.95 165.15 14.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.834 0.35 . . . . 54.14 111.159 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.524 ' N ' HG12 ' A' ' 41' ' ' VAL . 12.7 p80 -74.52 108.85 7.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 62.43 110.783 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.808 ' CE1' HD11 ' A' ' 79' ' ' LEU . 40.0 p90 -125.09 167.47 14.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 74.01 110.826 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -119.43 120.11 35.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 75.23 110.903 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.2 115.28 18.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 63.25 111.126 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.7 m -108.41 119.42 39.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 54.55 111.181 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.1 HG22 HG13 ' A' ' 33' ' ' VAL . 96.8 t -112.74 136.59 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 64.21 111.183 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.725 HG21 ' HB2' ' A' ' 89' ' ' ALA . 2.7 p -128.76 125.55 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 73.41 111.084 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.453 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.8 OUTLIER -172.45 164.84 3.81 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.648 0.737 . . . . 73.22 110.863 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.495 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.4 Cg_endo -69.74 -22.43 32.2 Favored 'Trans proline' 0 N--CA 1.466 -0.127 0 C-N-CA 122.705 2.27 . . . . 71.14 112.362 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.778 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -47.72 -41.99 24.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 73.22 111.043 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.768 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -89.27 35.9 0.82 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 63.13 110.904 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.5 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 6.7 p -52.41 139.33 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 64.14 111.138 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 56.38 -89.28 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.756 -0.735 . . . . 70.42 112.5 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HD2' ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -117.9 111.16 18.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.732 0.301 . . . . 70.22 110.919 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.768 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -60.03 108.48 1.43 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.635 0.731 . . . . 63.12 111.09 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 54.2 Cg_endo -69.71 160.76 48.52 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.67 2.247 . . . . 74.5 112.374 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tp -54.81 -26.76 36.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 74.11 110.86 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.02 -52.39 65.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 55.22 111.071 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.778 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 30.7 mmt-85 -69.46 -41.07 76.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 74.3 110.857 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.426 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.9 OUTLIER -59.07 -53.46 58.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 63.45 110.808 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 52.0 mtt-85 -67.1 -35.05 78.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 75.03 110.924 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.0 tpp -58.37 -51.6 69.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 65.45 110.875 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.659 ' O ' HG22 ' A' ' 67' ' ' THR . 20.7 m -64.05 -44.66 97.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 70.52 111.204 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.76 ' CE1' HD13 ' A' ' 81' ' ' LEU . 14.1 m-85 -59.17 -38.85 80.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 75.31 110.955 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.72 -32.85 60.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 70.04 111.096 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 64' ' ' VAL . 0.6 OUTLIER -71.57 -27.09 62.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 72.04 111.142 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.527 ' C ' HD12 ' A' ' 68' ' ' LEU . 3.5 pp -88.66 -10.5 48.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 72.21 110.95 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.523 ' N ' HD12 ' A' ' 68' ' ' LEU . . . 53.69 75.1 0.25 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.705 -0.76 . . . . 44.23 112.505 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.526 ' HG2' HD11 ' A' ' 68' ' ' LEU . 4.6 pt-20 -91.38 -42.51 10.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.858 0.361 . . . . 63.14 110.88 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.686 HD13 ' O ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -84.44 -10.11 57.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 63.31 110.891 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.5 mmt -72.51 -13.72 61.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 53.41 110.896 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -126.72 -14.08 2.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.8 -0.714 . . . . 40.02 112.499 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.419 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.689 -0.767 . . . . 74.54 112.475 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.847 0.356 . . . . 73.3 111.155 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.808 HD11 ' CE1' ' A' ' 43' ' ' PHE . 7.9 tp -105.0 133.14 50.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 64.31 110.912 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -111.47 115.46 29.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 74.4 110.929 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.76 HD13 ' CE1' ' A' ' 65' ' ' TYR . 8.4 tt -139.43 129.41 24.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 74.55 110.99 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -123.58 135.95 54.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 74.05 110.91 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.54 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 14.0 p -119.43 106.94 12.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.302 -0.408 . . . . 43.02 111.163 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.7 mp -124.9 161.59 26.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 74.31 110.902 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.5 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.3 OUTLIER -71.99 164.74 56.31 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.694 0.759 . . . . 65.53 111.035 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.4 Cg_endo -69.84 -12.32 32.5 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.684 2.256 . . . . 63.14 112.302 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -75.45 -35.81 60.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 72.12 110.876 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.45 -39.86 77.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 61.23 110.903 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.725 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 63.01 111.116 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.466 ' O ' ' CB ' ' A' ' 21' ' ' ARG . . . . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.743 0.306 . . . . 63.42 111.102 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.77 -48.69 63.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 75.04 110.883 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.454 HG23 ' N ' ' A' ' 20' ' ' ILE . 3.2 t -62.0 -48.32 80.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 74.25 111.181 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.706 HD12 ' N ' ' A' ' 21' ' ' ARG . 2.3 pp -69.3 -39.73 79.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 72.34 111.169 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.706 ' N ' HD12 ' A' ' 20' ' ' ILE . 33.0 ttp85 -59.39 -45.96 90.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 73.3 110.862 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -68.95 -41.26 78.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 62.54 110.86 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 23' ' ' LEU . 16.0 mt -56.3 -49.19 74.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 54.43 110.884 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.754 ' CG2' HG21 ' A' ' 33' ' ' VAL . 16.2 mt -69.88 -41.68 79.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 72.32 111.11 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -56.26 -37.03 69.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 75.31 110.851 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.31 -42.86 24.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 43.32 110.905 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.95 -52.03 51.06 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.776 -0.726 . . . . 62.35 112.453 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.517 HD23 ' CG2' ' A' ' 24' ' ' ILE . 4.1 mm? -79.53 158.02 74.15 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.645 0.736 . . . . 61.42 110.872 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -90.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.709 2.273 . . . . 73.13 112.354 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -105.18 27.71 7.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 65.03 110.873 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.485 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . . . -78.22 129.41 35.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 71.53 111.103 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.627 ' HB3' HG12 ' A' ' 48' ' ' VAL . 7.6 tpt180 -101.42 113.52 26.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 62.33 110.892 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.059 HG13 HG22 ' A' ' 47' ' ' VAL . 11.6 t -113.44 127.69 70.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 63.44 111.131 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -134.08 118.24 17.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 70.12 110.888 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.561 ' CG2' HD11 ' A' ' 20' ' ' ILE . 61.7 t -122.71 137.53 55.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 60.41 111.131 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 4.2 tt0 -133.9 119.39 19.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 71.12 110.987 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.466 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 146.1 -132.54 4.55 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 42.41 112.459 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.465 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 0.4 OUTLIER -171.68 162.37 6.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 74.03 110.915 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.41 145.7 53.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 51.32 110.817 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.9 -15.97 9.33 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.703 -0.761 . . . . 34.33 112.471 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' A' ' 38' ' ' GLU . 13.1 m -112.96 164.86 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.919 0.39 . . . . 71.32 111.112 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.94 106.9 6.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 74.13 110.886 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.788 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 4.4 p90 -120.94 167.21 12.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 75.21 110.85 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -119.47 123.62 44.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 73.54 110.836 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.594 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -117.66 115.97 26.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 74.15 111.085 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.2 m -110.8 108.05 17.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 72.41 111.17 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.059 HG22 HG13 ' A' ' 33' ' ' VAL . 95.2 t -109.76 141.27 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 72.32 111.152 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.747 HG21 ' HB2' ' A' ' 89' ' ' ALA . 5.1 p -134.65 118.49 26.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 60.43 111.117 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -164.03 165.98 12.67 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.67 0.748 . . . . 73.22 110.817 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.526 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.8 Cg_endo -69.78 -28.57 25.01 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.693 2.262 . . . . 72.32 112.33 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.663 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -51.27 -34.05 31.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 73.43 111.06 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.599 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 3.9 m-85 -90.78 31.06 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 75.3 110.893 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.681 ' HA ' HG23 ' A' ' 85' ' ' THR . 8.4 p -61.21 143.55 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 75.13 111.143 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 52.41 -90.99 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.728 -0.749 . . . . 71.3 112.496 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.9 OUTLIER -120.06 104.77 10.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.774 0.321 . . . . 62.1 110.934 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -59.49 109.22 1.76 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.624 0.726 . . . . 64.41 111.064 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.9 Cg_endo -69.81 168.81 20.56 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.67 2.247 . . . . 74.1 112.334 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tp -53.86 -26.62 25.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 71.3 110.925 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.35 -53.05 62.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 75.14 111.106 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.663 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 21.3 mmt180 -69.88 -41.67 74.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 64.55 110.926 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.534 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.2 t-160 -59.49 -53.4 58.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 74.13 110.845 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.6 mtp180 -66.53 -35.85 81.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 72.41 110.837 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 10.9 tpt -58.35 -45.86 87.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 75.4 110.933 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.626 ' O ' HD13 ' A' ' 68' ' ' LEU . 19.6 m -70.19 -40.38 78.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 72.15 111.13 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.704 ' CE1' HD13 ' A' ' 81' ' ' LEU . 13.6 m-85 -65.71 -34.76 78.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 73.04 110.949 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.61 -46.29 32.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 71.24 111.045 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.562 HG23 HD11 ' A' ' 24' ' ' ILE . 3.5 t -66.91 -28.37 68.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 74.0 111.109 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.626 HD13 ' O ' ' A' ' 64' ' ' VAL . 3.8 mp -82.57 -8.82 59.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 63.45 110.91 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.27 80.01 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.687 -0.768 . . . . 53.45 112.552 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -91.22 -25.31 19.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.897 0.38 . . . . 72.03 110.889 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.1 mp -89.96 9.98 25.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.098 -0.501 . . . . 71.42 110.965 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 7.0 ptp -74.42 -13.22 60.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 74.01 110.83 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.3 -32.93 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.748 -0.739 . . . . 65.0 112.503 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.761 -0.733 . . . . 51.25 112.487 -179.869 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.793 0.33 . . . . 70.33 111.091 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.788 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 1.1 mm? -115.47 133.85 55.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 72.03 110.97 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -114.35 115.61 27.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 75.1 110.883 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.704 HD13 ' CE1' ' A' ' 65' ' ' TYR . 1.4 tt -126.33 144.99 50.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 75.23 110.937 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -136.26 123.84 22.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 52.12 110.866 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.585 ' HB ' ' CD2' ' A' ' 52' ' ' PHE . 30.1 p -116.06 107.75 15.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 65.23 111.131 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mp -128.3 160.67 31.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 75.03 110.92 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.681 HG23 ' HA ' ' A' ' 53' ' ' VAL . 0.3 OUTLIER -72.5 164.94 55.91 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.606 0.717 . . . . 73.22 111.139 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.1 Cg_endo -69.77 -16.37 37.5 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 2.245 . . . . 71.42 112.375 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -73.03 -35.9 66.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 72.42 110.817 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -67.82 -38.03 82.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 75.11 110.839 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.747 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 71.24 111.144 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.473 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.794 0.331 . . . . 45.33 111.139 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -72.83 -48.04 41.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 72.5 110.906 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.462 HG23 ' N ' ' A' ' 20' ' ' ILE . 2.7 t -57.8 -50.15 74.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 64.15 111.139 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 21' ' ' ARG . 25.9 pt -68.01 -42.16 85.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 72.33 111.152 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.5 ' N ' HG13 ' A' ' 20' ' ' ILE . 54.3 ttt-85 -55.01 -53.16 59.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 74.33 110.834 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.5 mttt -66.15 -35.86 81.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.94 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -56.37 -49.18 75.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 53.44 110.945 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.825 ' CG2' HG21 ' A' ' 33' ' ' VAL . 5.8 mt -70.9 -44.34 76.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 61.53 111.135 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -53.89 -36.85 63.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 72.21 110.869 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.51 -41.48 21.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 75.11 110.818 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.61 -55.5 24.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.798 -0.715 . . . . 63.24 112.481 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 4.3 mm? -72.89 159.36 85.51 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.641 0.734 . . . . 75.34 110.945 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -90.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.649 2.233 . . . . 65.3 112.368 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -107.29 27.24 9.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.423 . . . . 73.22 110.895 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . . . -79.07 126.77 31.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 71.34 111.058 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.512 ' HB2' ' CG1' ' A' ' 48' ' ' VAL . 3.7 mmm180 -93.86 109.01 20.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 73.31 110.905 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.825 HG21 ' CG2' ' A' ' 24' ' ' ILE . 53.0 t -113.65 121.45 65.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 72.25 111.102 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -132.34 118.11 18.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 75.33 110.897 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.473 HG13 ' HB1' ' A' ' 17' ' ' ALA . 2.2 p -127.08 135.63 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 70.21 111.162 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -133.57 120.14 20.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 72.14 110.903 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.88 -128.19 2.92 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.727 -0.749 . . . . 23.4 112.436 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.439 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 11.8 pt-20 -175.27 171.17 2.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.811 0.339 . . . . 74.42 110.838 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -75.29 147.42 40.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.132 -0.485 . . . . 71.13 110.819 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.71 16.72 77.9 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.716 -0.754 . . . . 53.13 112.435 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.439 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 1.8 t -146.62 164.01 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 65.02 111.161 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 32.5 p80 -75.98 106.62 7.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 73.31 110.835 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.764 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 4.5 p90 -119.26 166.22 13.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 75.03 110.836 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -115.4 121.17 41.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 72.22 110.892 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 81' ' ' LEU . . . -128.17 115.09 17.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 72.12 111.072 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.1 m -111.81 116.16 30.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 73.45 111.1 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.771 ' CG2' HG13 ' A' ' 33' ' ' VAL . 28.6 t -120.58 126.11 74.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 74.24 111.148 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.512 ' CG1' ' HB2' ' A' ' 32' ' ' ARG . 6.4 p -124.06 118.8 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 75.04 111.174 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.446 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -160.61 166.63 15.17 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.611 0.719 . . . . 53.13 110.8 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.517 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.3 Cg_endo -69.82 -21.82 32.66 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.687 2.258 . . . . 74.34 112.297 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.67 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -46.65 -45.19 19.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 74.34 111.12 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.639 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -87.47 36.92 0.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 75.53 110.936 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.492 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 4.1 p -52.34 124.37 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 74.35 111.128 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.57 -89.05 0.73 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.791 -0.719 . . . . 34.35 112.47 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.426 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -119.52 111.24 17.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.82 0.343 . . . . 43.3 110.934 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.639 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -58.38 108.0 1.15 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.536 0.684 . . . . 60.0 111.149 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.5 Cg_endo -69.83 162.59 41.51 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.65 2.234 . . . . 74.3 112.366 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -58.0 -27.05 63.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 62.33 110.916 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.82 -52.39 65.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 71.23 111.079 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.67 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 16.5 mmt180 -69.09 -41.18 77.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.473 . . . . 71.55 110.908 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.467 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -60.66 -53.54 56.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 65.15 110.836 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.9 mtp85 -66.68 -33.35 75.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 75.25 110.87 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.3 mmt -60.81 -49.69 76.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 73.42 110.833 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.605 ' O ' HG22 ' A' ' 67' ' ' THR . 19.2 m -65.21 -43.0 95.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 75.12 111.166 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.98 ' CE1' HD13 ' A' ' 81' ' ' LEU . 15.0 m-85 -61.9 -37.92 86.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 75.11 110.887 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.24 -33.16 59.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 52.43 111.088 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 64' ' ' VAL . 0.6 OUTLIER -72.15 -29.63 64.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.264 -0.425 . . . . 73.15 111.115 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.565 HD21 ' HA ' ' A' ' 65' ' ' TYR . 3.9 pp -83.33 -6.78 59.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.448 . . . . 75.22 110.913 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.47 69.62 1.09 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.782 -0.723 . . . . 64.32 112.433 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.499 ' HB2' ' CD1' ' A' ' 68' ' ' LEU . 2.4 tp10 -98.75 -23.51 15.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.956 0.408 . . . . 75.1 110.957 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -90.31 3.39 53.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 74.21 110.916 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.7 mtp -71.93 -13.31 61.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 74.41 110.865 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.27 -31.5 0.12 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.738 -0.744 . . . . 64.34 112.505 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 C-N-CA 120.804 -0.712 . . . . 44.45 112.523 -179.931 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.82 0.343 . . . . 71.33 111.13 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.764 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 8.5 tp -97.58 133.25 42.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 73.12 110.937 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -111.35 115.18 28.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.52 110.946 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.98 HD13 ' CE1' ' A' ' 65' ' ' TYR . 7.4 tt -139.77 137.74 35.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 71.33 110.88 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 82' ' ' LYS . 2.3 mppt? -136.35 128.16 29.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 74.01 110.907 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.535 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 63.9 p -113.48 106.95 15.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 71.21 111.103 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.9 mt -125.99 161.69 26.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 73.22 110.946 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.492 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.94 163.99 62.29 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.608 0.718 . . . . 75.12 111.171 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.4 Cg_endo -69.66 -21.96 33.2 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.787 2.325 . . . . 74.45 112.288 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -70.66 -35.94 73.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 74.44 110.905 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.7 -33.89 76.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 63.15 110.916 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.47 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 62.43 111.106 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.092 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.767 0.318 . . . . 55.41 111.089 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -70.22 -48.43 57.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 72.14 110.888 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.489 HG23 ' N ' ' A' ' 20' ' ' ILE . 2.8 t -59.17 -51.13 71.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 63.23 111.143 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.025 HD11 HG11 ' A' ' 35' ' ' VAL . 2.6 pp -64.83 -40.7 89.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 72.45 111.187 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.632 ' N ' HD12 ' A' ' 20' ' ' ILE . 73.9 ttt180 -60.92 -46.26 91.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 63.54 110.87 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -63.51 -42.66 98.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 64.33 110.888 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 23' ' ' LEU . 16.5 mt -57.53 -49.11 77.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 74.2 110.939 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.792 ' CG2' HG21 ' A' ' 33' ' ' VAL . 49.2 mm -63.18 -46.71 95.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 72.41 111.147 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -55.11 -40.23 70.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 73.23 110.846 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.04 -43.24 71.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 72.4 110.867 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.99 -49.13 60.3 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.726 . . . . 73.44 112.525 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.55 157.16 72.77 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.53 0.681 . . . . 64.22 110.972 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -90.62 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.685 2.256 . . . . 54.33 112.323 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -107.41 29.57 7.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 64.42 110.882 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' A' ' 49' ' ' SER . . . -75.02 133.09 41.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 72.14 111.084 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.702 ' HB3' HG12 ' A' ' 48' ' ' VAL . 7.0 tpp180 -99.98 111.14 23.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 73.44 110.927 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.852 HG13 HG22 ' A' ' 47' ' ' VAL . 32.3 t -113.86 124.98 71.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 62.52 111.107 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -134.69 118.15 16.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 63.33 110.889 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.092 HG13 ' HB1' ' A' ' 17' ' ' ALA . 4.9 p -130.43 136.33 58.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 35.41 111.134 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -133.32 120.21 20.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.23 110.928 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.47 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 149.67 -145.19 13.09 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.703 -0.761 . . . . 72.21 112.461 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.403 ' O ' HG12 ' A' ' 41' ' ' VAL . 18.9 mt-10 -156.1 176.98 11.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.825 0.345 . . . . 71.0 110.939 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -80.06 139.87 36.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 74.03 110.895 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.432 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.67 25.7 73.38 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.772 -0.727 . . . . 54.02 112.463 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 38' ' ' GLU . 1.2 p -148.91 164.7 4.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.895 0.379 . . . . 75.54 111.079 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -74.97 107.44 7.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 71.23 110.853 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.83 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 4.4 p90 -123.88 167.14 14.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.3 -0.409 . . . . 74.14 110.92 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -118.75 121.73 40.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 53.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 81' ' ' LEU . . . -126.42 114.9 18.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 61.13 111.103 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 m -111.58 117.19 32.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 71.12 111.182 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.852 HG22 HG13 ' A' ' 33' ' ' VAL . 84.8 t -115.65 132.99 63.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 73.13 111.169 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.702 HG12 ' HB3' ' A' ' 32' ' ' ARG . 5.6 p -128.79 120.37 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 73.05 111.149 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.448 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.9 OUTLIER -167.31 164.82 9.31 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.711 0.767 . . . . 74.51 110.803 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.515 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.6 Cg_endo -69.78 -19.1 36.48 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.685 2.256 . . . . 63.2 112.363 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.798 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -47.19 -41.61 18.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 63.0 111.043 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.657 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -91.87 38.23 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 71.32 110.895 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.492 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 4.8 p -53.03 123.27 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 71.14 111.156 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.92 -90.61 0.68 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.689 -0.767 . . . . 75.31 112.532 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.452 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 1.3 mptp? -117.11 110.29 18.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.815 0.341 . . . . 72.02 110.855 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.657 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -58.52 107.44 0.95 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.526 0.679 . . . . 61.34 111.092 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.1 Cg_endo -69.85 166.01 29.15 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.676 2.251 . . . . 71.4 112.312 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.34 -26.75 65.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 74.52 110.929 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.61 -52.22 66.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 74.23 111.099 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.798 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 18.9 mmt180 -69.59 -41.09 76.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 72.33 110.829 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.446 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.9 OUTLIER -58.78 -52.59 65.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.421 . . . . 74.21 110.836 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -66.42 -37.26 84.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 62.23 110.916 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 20.2 mmm -56.44 -52.07 66.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 71.12 110.895 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.632 ' O ' HG22 ' A' ' 67' ' ' THR . 17.4 m -62.95 -44.44 99.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 65.22 111.072 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 1.055 ' CE1' HD13 ' A' ' 81' ' ' LEU . 14.3 m-85 -60.98 -30.81 70.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 71.45 110.938 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.02 -46.76 32.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 73.41 111.08 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 64' ' ' VAL . 3.8 t -63.9 -28.8 70.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 60.12 111.115 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.863 HD23 HD13 ' A' ' 20' ' ' ILE . 9.9 mt -82.17 5.58 19.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 64.24 110.854 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 34.07 67.59 0.24 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 72.23 112.484 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.639 ' HG3' HD13 ' A' ' 71' ' ' LEU . 5.8 pt-20 -85.41 -39.48 17.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 72.31 110.847 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.639 HD13 ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -91.03 7.38 40.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 71.43 110.904 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.412 ' N ' HD22 ' A' ' 71' ' ' LEU . 19.8 mtt -73.06 -12.93 61.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 54.42 110.889 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.15 -32.15 0.1 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.725 -0.75 . . . . 74.01 112.49 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.432 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.778 -0.725 . . . . 31.34 112.514 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.801 0.334 . . . . 62.44 111.039 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.83 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 7.8 tp -107.96 128.18 54.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 72.21 110.902 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -102.45 115.0 29.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 73.45 110.957 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.055 HD13 ' CE1' ' A' ' 65' ' ' TYR . 8.6 tt -139.76 135.86 33.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.241 -0.436 . . . . 64.34 110.899 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -136.49 131.63 34.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 73.44 110.949 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.544 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 67.1 p -116.69 106.8 13.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 43.01 111.155 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.05 161.81 24.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 72.32 110.96 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.492 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -71.8 163.41 66.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.546 0.689 . . . . 72.41 111.175 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.2 Cg_endo -69.78 -10.32 28.25 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.749 2.3 . . . . 72.04 112.349 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -76.0 -35.89 59.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 63.45 110.821 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -68.19 -36.06 78.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.426 . . . . 71.33 110.898 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.452 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.154 -0.475 . . . . 71.14 111.122 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.736 0.303 . . . . 73.34 111.062 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.501 ' OE1' ' NE ' ' A' ' 21' ' ' ARG . 4.3 mm-40 -68.65 -26.55 65.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 73.31 110.854 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.7 p -61.4 -56.91 15.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 73.42 111.1 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.58 HG12 ' N ' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -74.06 -29.91 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 55.14 111.1 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.58 ' N ' HG12 ' A' ' 20' ' ' ILE . 23.7 ttp85 -63.37 -50.86 68.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 60.43 110.851 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -72.79 -36.13 67.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 71.41 110.897 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.648 HD13 ' O ' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -57.91 -51.04 71.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 71.24 110.851 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.795 HG21 HG21 ' A' ' 33' ' ' VAL . 8.6 mt -73.5 -44.16 54.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 72.04 111.17 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.444 ' CG ' ' O ' ' A' ' 21' ' ' ARG . 68.0 mt-10 -56.51 -32.22 64.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 71.43 110.874 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.27 -43.23 17.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 74.01 110.83 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.44 -41.89 97.29 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.737 -0.744 . . . . 73.42 112.548 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 28' ' ' LEU . 3.8 mm? -122.94 102.41 37.88 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.648 0.737 . . . . 64.23 110.915 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 28' ' ' LEU . 53.9 Cg_endo -69.7 -15.02 37.09 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.687 2.258 . . . . 71.21 112.3 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -100.16 0.83 41.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.411 . . . . 73.55 110.86 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.505 ' HB2' ' HB2' ' A' ' 49' ' ' SER . . . -120.58 135.7 55.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 64.43 111.108 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.476 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 47.1 ttt-85 -110.44 123.73 50.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 74.2 110.926 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.142 HG13 HG22 ' A' ' 47' ' ' VAL . 4.8 t -122.37 134.3 66.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 74.04 111.139 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.35 118.08 16.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 75.42 110.912 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.6 ' O ' ' HB1' ' A' ' 17' ' ' ALA . 43.4 t -123.62 130.4 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 75.51 111.104 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 20.8 mm100 -133.34 120.15 20.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 71.4 110.889 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.07 -119.97 1.12 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.712 -0.756 . . . . 73.34 112.437 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -172.19 170.43 5.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 74.42 110.903 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -80.35 145.55 32.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 72.12 110.908 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.474 ' CA ' ' O ' ' A' ' 73' ' ' GLY . . . 72.7 -0.94 40.69 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.747 -0.739 . . . . 65.23 112.487 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 42' ' ' HIS . 2.3 t -123.13 165.19 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 75.34 111.186 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.454 ' H ' HG12 ' A' ' 41' ' ' VAL . 53.9 p-80 -74.67 106.45 6.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 72.4 110.857 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.796 ' CE2' HD11 ' A' ' 79' ' ' LEU . 8.6 p90 -120.55 168.06 11.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 73.24 110.912 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -113.2 121.22 43.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 74.35 110.859 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.67 126.99 45.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.103 -0.499 . . . . 61.02 111.093 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.7 m -120.96 120.64 36.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 63.24 111.146 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.142 HG22 HG13 ' A' ' 33' ' ' VAL . 78.2 t -119.45 136.76 55.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 54.43 111.119 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.476 ' CG1' ' HB3' ' A' ' 32' ' ' ARG . 7.2 p -136.17 124.28 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 74.4 111.156 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -174.62 164.74 2.45 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.624 0.725 . . . . 55.12 110.879 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.524 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.2 Cg_endo -69.71 -19.96 35.68 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.653 2.236 . . . . 54.0 112.369 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.743 ' HB1' ' HD3' ' A' ' 60' ' ' ARG . . . -47.47 -40.51 18.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 72.24 111.08 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.748 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.5 OUTLIER -92.22 37.64 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 74.42 110.907 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.495 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 2.6 p -52.82 136.0 14.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 54.22 111.136 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 60.37 -89.09 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.765 -0.731 . . . . 64.11 112.455 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.431 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 3.6 mptp? -119.28 111.08 17.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.746 0.308 . . . . 70.31 110.932 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.748 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -58.46 107.99 1.15 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.607 0.718 . . . . 72.02 111.071 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.8 Cg_endo -69.76 164.23 35.33 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.665 2.244 . . . . 74.02 112.375 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.415 ' O ' HD23 ' A' ' 58' ' ' LEU . 1.6 tt -57.64 -24.85 58.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 63.1 110.887 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.406 ' O ' ' SD ' ' A' ' 63' ' ' MET . . . -61.91 -52.75 62.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 63.32 111.099 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.743 ' HD3' ' HB1' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -69.08 -40.7 78.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 74.45 110.875 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.538 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.4 t-160 -58.85 -53.98 52.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 73.43 110.826 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -66.2 -35.53 80.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.21 110.868 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.609 ' O ' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -58.33 -46.22 86.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 44.31 110.88 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.715 HG21 HD21 ' A' ' 81' ' ' LEU . 17.1 m -69.15 -40.22 80.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 72.15 111.185 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 1.059 ' CE1' HD22 ' A' ' 81' ' ' LEU . 14.2 m-85 -64.93 -35.89 82.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 75.41 110.92 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.3 -46.63 39.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 71.53 111.115 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.62 HG23 HD13 ' A' ' 68' ' ' LEU . 6.0 t -66.04 -28.47 68.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 75.23 111.107 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.62 HD13 HG23 ' A' ' 67' ' ' THR . 5.2 mp -82.32 7.66 13.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 72.33 110.917 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 35.71 68.79 0.26 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.786 -0.721 . . . . 65.11 112.402 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.712 ' HG3' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -102.38 -24.62 13.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.879 0.371 . . . . 72.24 110.845 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.712 HD22 ' HG3' ' A' ' 70' ' ' GLU . 3.0 mm? -86.75 -21.0 26.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 63.25 110.902 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.2 ttm -76.22 -12.59 60.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 74.04 110.867 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.474 ' O ' ' CA ' ' A' ' 40' ' ' GLY . . . -120.47 -9.19 7.95 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.746 -0.74 . . . . 40.33 112.455 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.762 -0.733 . . . . 74.13 112.483 -179.903 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.85 0.357 . . . . 53.44 111.138 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.796 HD11 ' CE2' ' A' ' 43' ' ' PHE . 8.8 tp -110.2 138.43 46.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 75.52 110.928 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -104.62 117.07 33.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 61.51 110.891 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.059 HD22 ' CE1' ' A' ' 65' ' ' TYR . 1.9 tp -139.33 123.51 17.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 63.11 110.886 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -126.87 123.3 36.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 75.21 110.891 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.533 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 4.9 p -113.22 107.25 15.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 64.03 111.186 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.7 mp -129.81 161.59 30.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 51.54 110.924 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.495 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.9 164.04 61.8 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.614 0.721 . . . . 71.22 111.102 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.9 Cg_endo -69.71 -23.75 30.67 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.714 2.276 . . . . 63.21 112.296 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.44 -34.9 78.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 72.22 110.891 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.08 -33.18 75.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 71.22 110.876 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 64.24 111.09 179.941 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.732 0.301 . . . . 74.44 111.048 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -71.54 -48.01 51.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 70.41 110.92 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.572 ' O ' HD23 ' A' ' 23' ' ' LEU . 3.0 t -57.96 -51.7 68.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 52.32 111.177 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.866 HD12 ' HG ' ' A' ' 68' ' ' LEU . 16.2 pt -66.06 -41.9 90.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 73.01 111.168 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.425 ' N ' HG13 ' A' ' 20' ' ' ILE . 67.3 ttt180 -60.45 -53.58 55.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 73.43 110.912 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.456 ' CG ' ' N ' ' A' ' 23' ' ' LEU . 23.2 pttt -59.43 -44.83 92.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 75.31 110.861 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.572 HD23 ' O ' ' A' ' 19' ' ' THR . 2.1 mm? -55.96 -49.12 74.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 53.32 110.867 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.797 ' CG2' HG21 ' A' ' 33' ' ' VAL . 7.1 mt -68.17 -44.12 84.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 63.35 111.113 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -54.79 -37.85 66.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 75.44 110.874 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.1 -41.31 35.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 70.34 110.866 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.31 -53.82 33.7 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.701 -0.761 . . . . 72.23 112.483 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.402 ' CB ' ' HB3' ' A' ' 31' ' ' ALA . 4.2 mm? -76.94 159.13 79.29 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.533 0.682 . . . . 74.45 110.985 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -87.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.676 2.25 . . . . 71.43 112.369 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -111.02 26.12 11.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 75.2 110.889 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 49' ' ' SER . . . -73.31 125.85 28.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 54.04 111.085 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.61 ' HB2' HG13 ' A' ' 48' ' ' VAL . 2.4 mmt180 -91.77 107.52 19.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 65.13 110.984 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.814 HG13 HG22 ' A' ' 47' ' ' VAL . 61.6 t -109.83 121.33 62.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 55.33 111.132 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -132.38 118.88 19.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 73.23 110.876 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 44.8 t -126.79 136.98 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 72.31 111.146 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 34.9 mt-30 -130.67 120.5 24.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.159 -0.473 . . . . 71.41 110.886 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.438 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 140.63 -142.08 11.99 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.672 -0.775 . . . . 71.12 112.491 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.484 ' HG2' ' CG2' ' A' ' 41' ' ' VAL . 1.0 OUTLIER -165.29 156.04 13.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.886 0.374 . . . . 72.24 110.84 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -62.26 154.51 27.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 75.53 110.863 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.85 -2.59 40.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.676 -0.773 . . . . 75.12 112.524 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.484 ' CG2' ' HG2' ' A' ' 38' ' ' GLU . 1.3 t -132.52 164.76 34.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.328 . . . . 71.3 111.174 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.449 ' HB2' ' HB1' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -75.02 106.72 6.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 72.15 110.825 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.551 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 39.7 p90 -121.98 167.79 12.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 74.11 110.846 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -113.26 133.52 55.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 74.14 110.89 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.466 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -128.09 118.84 24.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 60.3 111.17 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.2 m -121.4 111.5 17.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 72.43 111.149 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.814 HG22 HG13 ' A' ' 33' ' ' VAL . 94.9 t -120.74 134.73 63.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 71.12 111.097 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.61 HG13 ' HB2' ' A' ' 32' ' ' ARG . 3.6 p -131.05 122.72 52.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 74.12 111.111 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -161.83 165.6 15.91 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.628 0.728 . . . . 73.5 110.874 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.515 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 52.9 Cg_endo -69.93 -22.14 31.7 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.728 2.285 . . . . 65.15 112.215 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.614 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -47.04 -44.29 20.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 43.11 111.079 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.676 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -87.11 35.56 0.7 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 73.42 110.902 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.481 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 12.4 p -52.26 125.86 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 73.25 111.138 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.5 -89.4 0.73 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.712 -0.756 . . . . 55.13 112.51 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.423 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 3.3 mptp? -120.3 110.23 16.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.809 0.338 . . . . 73.33 110.871 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.676 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -58.64 108.15 1.21 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.563 0.697 . . . . 62.42 111.08 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.8 Cg_endo -69.83 161.59 45.36 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.728 2.285 . . . . 62.43 112.36 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.87 -27.25 63.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.28 -0.418 . . . . 61.04 110.925 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.27 -52.16 66.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 54.42 111.092 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.614 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 23.2 mmt180 -69.18 -43.0 75.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 60.24 110.856 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.571 ' CE1' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -59.17 -51.49 69.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 75.23 110.849 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.15 -38.64 88.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 74.44 110.902 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 21.8 mmt -56.29 -48.27 76.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 74.55 110.919 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 61' ' ' HIS . 16.3 m -65.31 -39.54 85.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 34.25 111.117 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.572 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 12.4 m-85 -59.58 -39.81 85.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 65.24 110.91 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.06 -46.96 31.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 74.45 111.133 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.556 HG23 HD12 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -61.66 -31.32 71.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 74.42 111.145 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.866 ' HG ' HD12 ' A' ' 20' ' ' ILE . 7.3 mp -83.04 -4.3 58.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 72.51 110.929 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.75 69.37 1.28 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.705 -0.76 . . . . 62.2 112.535 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -85.31 -40.5 16.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 64.21 110.911 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 71' ' ' LEU . 8.4 mp -87.87 9.87 20.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 64.23 110.916 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.6 mmt -72.01 -13.14 61.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 65.33 110.909 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.92 -32.91 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.77 -0.729 . . . . 73.31 112.528 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.745 -0.74 . . . . 64.23 112.465 -179.88 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.833 0.349 . . . . 43.14 111.075 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.551 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 1.6 mm? -97.83 140.43 32.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 71.31 110.939 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -118.21 115.62 25.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 75.02 111.016 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.572 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 0.6 OUTLIER -130.85 116.57 18.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 74.3 110.862 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -126.01 122.19 35.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 75.05 110.944 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.528 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 69.2 p -115.62 107.34 14.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.289 -0.414 . . . . 71.21 111.172 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 84' ' ' LEU . 1.6 mm? -127.75 162.06 27.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 63.15 110.894 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.481 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.02 163.29 68.17 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-O 121.639 0.733 . . . . 63.03 111.12 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.9 Cg_endo -69.72 -7.49 21.18 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.693 2.262 . . . . 74.54 112.363 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -84.58 -30.77 24.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 43.11 110.828 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -84.79 28.24 0.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 62.03 110.876 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 72.4 111.072 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.484 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . . . . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.67 0.271 . . . . 55.13 111.091 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -72.65 -48.8 36.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 72.34 110.856 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.438 HG23 ' N ' ' A' ' 20' ' ' ILE . 2.9 t -61.59 -47.63 84.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 51.31 111.151 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.491 HD11 HG11 ' A' ' 35' ' ' VAL . 10.8 pt -67.8 -43.13 86.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 72.54 111.149 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.403 ' N ' HG13 ' A' ' 20' ' ' ILE . 55.1 ttt-85 -54.97 -52.91 61.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 74.31 110.838 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -65.42 -37.05 85.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 61.4 110.838 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.76 -50.26 72.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.47 . . . . 72.05 110.844 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.644 ' HB ' HG21 ' A' ' 33' ' ' VAL . 7.9 mt -72.51 -36.31 53.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 73.12 111.131 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.496 ' HG3' HG23 ' A' ' 33' ' ' VAL . 19.7 mt-10 -58.92 -38.3 78.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 70.43 110.845 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -80.84 -42.11 22.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 71.2 110.846 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.37 -42.48 99.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.738 . . . . 62.12 112.525 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.487 ' CB ' ' HB3' ' A' ' 31' ' ' ALA . 3.6 mm? -89.88 157.29 46.3 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.556 0.693 . . . . 73.33 110.962 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -91.22 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.662 2.241 . . . . 55.52 112.306 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -104.58 27.11 8.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.252 -0.431 . . . . 74.1 110.907 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 49' ' ' SER . . . -77.61 132.25 38.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 75.41 111.053 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.656 ' HB3' HG12 ' A' ' 48' ' ' VAL . 7.9 ttm-85 -101.35 112.12 24.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 75.54 110.873 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.707 HG12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -107.32 129.32 61.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.202 -0.454 . . . . 73.05 111.093 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.73 118.53 16.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 74.1 110.895 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.491 HG11 HD11 ' A' ' 20' ' ' ILE . 28.9 t -127.66 129.86 70.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 71.4 111.205 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.409 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 31.4 mt-30 -133.25 120.15 20.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 65.11 110.933 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.474 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 151.0 -125.97 2.01 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.726 -0.75 . . . . 42.23 112.483 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -174.66 157.76 2.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 74.1 110.909 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -68.41 144.16 54.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 74.43 110.854 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.76 22.26 79.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.759 . . . . 54.31 112.56 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -150.63 164.79 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.866 0.365 . . . . 71.33 111.111 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 28.1 p80 -75.09 106.66 6.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 74.44 110.831 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.895 ' CZ ' HD21 ' A' ' 79' ' ' LEU . 8.7 p90 -122.43 167.4 13.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 64.14 110.903 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -113.72 120.33 40.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 65.21 110.903 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.591 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -123.25 115.77 22.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 71.2 111.019 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.658 HG23 ' HB2' ' A' ' 82' ' ' LYS . 81.6 m -113.62 123.5 50.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 75.14 111.153 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.707 HG22 HG12 ' A' ' 33' ' ' VAL . 27.1 t -123.59 140.72 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 62.41 111.134 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.656 HG12 ' HB3' ' A' ' 32' ' ' ARG . 8.1 p -130.52 117.83 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 73.42 111.165 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.49 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -162.0 164.49 17.47 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.679 0.752 . . . . 72.35 110.855 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.544 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.3 Cg_endo -69.88 -22.05 32.06 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.631 2.221 . . . . 61.05 112.309 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.615 ' HB1' ' HE ' ' A' ' 60' ' ' ARG . . . -48.69 -44.53 38.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 61.12 111.133 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.659 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.5 OUTLIER -87.63 34.19 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 71.11 110.898 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 55' ' ' LYS . 7.6 p -52.41 131.63 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 71.33 111.109 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 56.08 -81.02 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.726 -0.75 . . . . 74.44 112.517 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 53' ' ' VAL . 69.6 mmtt -113.3 134.27 54.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.796 0.331 . . . . 62.01 110.876 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.659 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -99.56 99.96 9.77 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.608 0.718 . . . . 73.32 111.1 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.4 Cg_endo -69.71 172.58 12.32 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.695 2.263 . . . . 51.12 112.333 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tp -57.01 -27.49 61.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 52.15 110.913 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 63' ' ' MET . . . -57.3 -53.35 59.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 60.12 111.016 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.615 ' HE ' ' HB1' ' A' ' 51' ' ' ALA . 12.2 mmm180 -70.57 -42.24 71.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 60.24 110.838 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.516 ' CE1' HD23 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -57.12 -53.1 61.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 71.54 110.874 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -67.49 -38.86 84.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 73.24 110.903 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.463 ' SD ' ' C ' ' A' ' 63' ' ' MET . 0.7 OUTLIER -54.08 -48.02 71.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 75.21 110.853 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.772 ' O ' HD13 ' A' ' 68' ' ' LEU . 24.4 m -68.77 -40.64 81.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 62.21 111.156 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.891 ' CE1' HD13 ' A' ' 81' ' ' LEU . 10.5 m-85 -64.93 -34.84 79.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 65.24 110.936 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.75 -46.24 32.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 75.33 111.193 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.604 HG21 HG12 ' A' ' 24' ' ' ILE . 3.8 t -67.58 -25.67 65.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 54.01 111.108 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.772 HD13 ' O ' ' A' ' 64' ' ' VAL . 5.9 mp -82.48 -0.47 46.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.246 -0.434 . . . . 73.24 110.919 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.6 68.37 1.02 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.75 -0.738 . . . . 70.12 112.439 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.845 ' HG3' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -88.06 -25.57 22.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.339 . . . . 73.21 110.817 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.845 HD23 ' HG3' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -89.64 7.12 38.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 73.05 110.963 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.4 mmt -73.15 -7.18 50.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 72.41 110.899 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.94 -35.04 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.703 -0.761 . . . . 73.2 112.492 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.767 -0.73 . . . . 71.32 112.517 -179.924 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.79 0.329 . . . . 64.52 111.092 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.895 HD21 ' CZ ' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -97.68 134.41 40.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 73.31 110.894 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.511 ' N ' HD13 ' A' ' 79' ' ' LEU . 8.5 mm-40 -106.95 118.67 37.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 71.43 110.984 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.891 HD13 ' CE1' ' A' ' 65' ' ' TYR . 4.5 tp -123.05 138.9 54.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 74.5 110.873 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.658 ' HB2' HG23 ' A' ' 46' ' ' THR . 2.5 mptt -132.36 118.46 19.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 64.42 110.933 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.53 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 11.8 p -118.91 107.35 13.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 54.11 111.133 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.537 ' N ' HD23 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -127.22 161.42 28.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 74.33 110.92 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.479 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -76.35 164.92 56.81 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.545 0.688 . . . . 74.52 111.166 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.5 Cg_endo -69.8 -0.15 6.52 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.695 2.264 . . . . 71.54 112.36 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.09 -27.43 26.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 73.01 110.869 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -82.2 24.81 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 60.42 110.884 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 65.2 111.137 179.918 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.687 0.28 . . . . 63.24 111.096 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.557 ' CD ' ' N ' ' A' ' 19' ' ' THR . 3.0 pp20? -66.77 -48.14 69.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 50.33 110.83 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.557 ' N ' ' CD ' ' A' ' 18' ' ' GLU . 3.7 t -57.74 -52.45 65.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 74.35 111.089 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.526 ' N ' HG23 ' A' ' 19' ' ' THR . 5.9 pt -67.84 -41.95 85.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 72.04 111.176 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 54.4 ttp180 -58.67 -51.47 69.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 53.44 110.868 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.1 pttp -63.79 -40.24 96.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.499 . . . . 64.41 110.892 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 20.6 mt -56.32 -50.27 71.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 71.23 110.898 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.662 HD11 ' CG2' ' A' ' 67' ' ' THR . 10.5 mt -69.53 -43.86 80.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 52.13 111.112 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -55.64 -35.07 65.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.462 . . . . 71.44 110.868 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -79.18 -43.2 24.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 55.02 110.905 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.65 -34.38 88.77 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.695 -0.764 . . . . 73.21 112.524 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.63 158.98 32.76 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.545 0.688 . . . . 52.12 110.924 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -90.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.695 2.263 . . . . 64.33 112.4 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -107.87 33.46 4.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 55.31 110.912 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.67 133.87 34.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 72.24 111.138 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.654 ' HB3' HG12 ' A' ' 48' ' ' VAL . 39.8 ttt-85 -106.4 125.56 51.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 72.23 110.845 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.035 HG13 HG22 ' A' ' 47' ' ' VAL . 3.9 t -124.0 135.45 63.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 74.33 111.149 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -135.26 118.46 16.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 72.01 110.889 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.437 ' O ' ' HB1' ' A' ' 17' ' ' ALA . 39.6 t -125.85 136.7 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 73.3 111.143 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 50.3 mm-40 -133.33 120.36 20.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 53.24 110.893 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.84 -143.21 13.46 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 64.12 112.461 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.422 ' HB2' HG21 ' A' ' 41' ' ' VAL . 17.8 mt-10 -151.19 -174.98 4.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.889 0.376 . . . . 75.22 110.845 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -87.77 146.79 25.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 73.21 110.888 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.437 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 73.24 1.14 56.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.73 . . . . 62.31 112.476 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' A' ' 38' ' ' GLU . 2.6 m -125.21 165.19 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 71.45 111.1 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.454 ' CG ' ' O ' ' A' ' 42' ' ' HIS . 23.6 p80 -74.86 107.01 6.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 53.34 110.821 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.833 ' CE1' HD11 ' A' ' 79' ' ' LEU . 39.6 p90 -121.99 167.75 12.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 74.12 110.898 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -113.48 124.74 53.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 63.54 110.86 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.18 115.88 19.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 44.33 111.099 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.8 m -117.72 112.71 20.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 72.21 111.131 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.035 HG22 HG13 ' A' ' 33' ' ' VAL . 22.6 t -110.5 141.44 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 71.1 111.133 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.753 HG21 ' HB2' ' A' ' 89' ' ' ALA . 4.0 p -130.42 118.95 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 74.41 111.127 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.539 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 24.1 p -168.7 160.01 8.4 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.654 0.74 . . . . 74.43 110.923 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.581 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.4 Cg_endo -69.74 -18.65 36.96 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.659 2.239 . . . . 71.2 112.383 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.878 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -49.83 -38.47 35.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 61.24 111.077 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.811 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 1.3 m-85 -90.86 33.5 0.93 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 73.51 110.904 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.539 ' HA ' HG23 ' A' ' 85' ' ' THR . 10.9 p -52.18 146.82 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 74.3 111.122 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 52.17 -89.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.719 . . . . 60.41 112.467 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -121.62 111.03 16.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.333 . . . . 74.21 110.87 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.811 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -59.67 108.28 1.33 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.58 0.705 . . . . 52.33 111.097 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.6 Cg_endo -69.76 161.55 45.48 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.695 2.263 . . . . 63.5 112.344 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -55.14 -24.76 27.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 61.44 110.921 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.33 -52.57 64.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 51.22 111.06 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.878 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 21.1 mmt180 -69.78 -41.01 75.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 75.42 110.84 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.497 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.2 t-160 -59.77 -53.01 62.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 73.53 110.908 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -66.2 -35.64 80.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 71.25 110.813 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.2 ttt -59.09 -49.86 76.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 65.42 110.852 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.587 ' O ' HG22 ' A' ' 67' ' ' THR . 22.1 m -65.08 -41.43 91.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 71.44 111.136 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.595 ' HD1' HD21 ' A' ' 68' ' ' LEU . 12.8 m-85 -62.83 -36.89 84.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 72.12 110.921 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.73 -35.27 60.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 51.15 111.107 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.662 ' CG2' HD11 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -70.95 -30.17 66.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 74.23 111.121 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.595 HD21 ' HD1' ' A' ' 65' ' ' TYR . 4.0 pp -83.6 -3.79 58.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 73.23 110.912 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.68 63.4 3.72 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.799 -0.715 . . . . 74.34 112.422 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -70.03 -57.43 5.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.387 . . . . 72.13 110.875 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -84.79 8.65 16.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 73.14 110.888 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.7 ttt -78.17 -13.2 59.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 72.54 110.89 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.47 -32.2 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.708 -0.758 . . . . 51.23 112.506 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.437 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.764 -0.731 . . . . 74.12 112.533 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.815 0.341 . . . . 65.41 111.082 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.833 HD11 ' CE1' ' A' ' 43' ' ' PHE . 8.3 tp -113.04 147.53 37.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 74.13 110.99 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -113.71 119.33 37.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 72.55 110.837 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.58 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 0.5 OUTLIER -128.61 117.62 21.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 75.0 110.889 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.419 ' N ' HD13 ' A' ' 81' ' ' LEU . 15.4 mmtp -119.33 114.52 22.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 72.1 110.874 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.532 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 17.3 p -117.1 106.54 13.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 40.34 111.147 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mp -132.42 162.76 30.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 75.52 110.973 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.539 HG23 ' HA ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -71.12 165.39 48.34 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.615 0.721 . . . . 72.25 111.147 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.1 Cg_endo -69.8 -24.8 29.09 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.729 2.286 . . . . 71.33 112.285 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -65.77 -32.31 73.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 63.52 110.83 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -70.03 -35.03 74.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 71.43 110.874 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.753 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 61.32 111.071 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 1.007 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.744 0.306 . . . . 41.55 111.122 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -72.01 -47.83 49.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 74.22 110.934 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.833 ' O ' HD23 ' A' ' 23' ' ' LEU . 2.7 t -61.68 -47.04 87.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 75.01 111.115 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.937 HD11 HG11 ' A' ' 35' ' ' VAL . 2.0 pp -69.51 -36.84 73.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 73.11 111.119 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.447 ' N ' HD12 ' A' ' 20' ' ' ILE . 35.9 ttt180 -63.58 -49.99 71.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.33 110.871 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.408 ' CG ' ' N ' ' A' ' 23' ' ' LEU . 34.1 pttt -64.45 -41.99 96.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 71.42 110.929 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.833 HD23 ' O ' ' A' ' 19' ' ' THR . 3.2 mm? -56.48 -50.79 70.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 72.41 110.937 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.814 HG21 HG21 ' A' ' 33' ' ' VAL . 12.7 mt -68.0 -43.83 85.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 71.45 111.127 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -56.53 -34.85 67.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 72.34 110.794 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.98 -43.38 35.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 72.41 110.874 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.66 -49.01 77.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 70.31 112.476 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.6 mt -118.93 102.31 49.37 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.628 0.728 . . . . 74.15 110.944 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -15.03 36.87 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.701 2.268 . . . . 73.34 112.294 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -96.18 -10.21 28.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 63.4 110.862 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.477 ' CB ' ' HB3' ' A' ' 49' ' ' SER . . . -111.04 126.83 55.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 51.33 111.105 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.504 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 24.5 ttp180 -103.06 117.17 33.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 63.35 110.874 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.814 HG21 HG21 ' A' ' 24' ' ' ILE . 18.5 t -111.75 131.17 63.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 74.01 111.092 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -135.4 117.65 15.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 73.03 110.884 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 1.007 HG13 ' HB1' ' A' ' 17' ' ' ALA . 4.6 p -126.91 139.4 51.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 52.23 111.11 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -132.2 120.63 22.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 72.34 110.945 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 149.99 -139.45 7.37 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.751 -0.737 . . . . 52.32 112.467 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.84 153.62 8.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.859 0.361 . . . . 74.44 110.906 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -58.61 147.48 32.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 74.24 110.893 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.29 -11.16 13.25 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.741 -0.742 . . . . 72.24 112.556 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 42' ' ' HIS . 20.5 t -118.14 164.05 14.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 73.35 111.099 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.556 ' N ' HG12 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -75.79 107.67 8.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 73.34 110.889 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.819 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 3.6 p90 -119.37 167.22 12.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 74.03 110.824 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.418 ' OE2' ' C ' ' A' ' 45' ' ' ALA . 1.0 OUTLIER -113.52 135.19 54.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 63.23 110.902 -179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.418 ' C ' ' OE2' ' A' ' 44' ' ' GLU . . . -127.25 121.25 30.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 72.44 111.064 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.7 m -121.3 110.96 16.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 61.25 111.168 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.776 ' CG1' HG13 ' A' ' 33' ' ' VAL . 3.8 m -112.77 140.05 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 34.21 111.152 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.61 HG21 ' HB2' ' A' ' 89' ' ' ALA . 3.0 p -134.4 118.81 28.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 64.34 111.175 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.562 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 12.2 p -169.64 161.65 7.17 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.682 0.753 . . . . 70.32 110.859 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.578 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.6 Cg_endo -69.78 -23.4 30.74 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.664 2.242 . . . . 63.32 112.262 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.751 ' HB1' ' CD ' ' A' ' 60' ' ' ARG . . . -47.12 -41.59 17.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.307 -0.406 . . . . 54.12 111.085 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.695 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 1.6 m-85 -86.45 32.38 0.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 71.23 110.844 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.571 ' HA ' HG23 ' A' ' 85' ' ' THR . 10.8 p -52.38 146.79 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.491 . . . . 55.24 111.16 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 50.5 -88.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.747 -0.74 . . . . 73.34 112.424 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -121.06 112.25 18.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.792 0.33 . . . . 74.44 110.898 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.695 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -59.17 108.24 1.28 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.564 0.697 . . . . 74.05 111.101 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.64 162.43 42.05 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.66 2.24 . . . . 74.21 112.416 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -56.36 -26.12 51.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 64.24 110.966 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 63' ' ' MET . . . -59.82 -52.64 64.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 43.22 111.084 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.751 ' CD ' ' HB1' ' A' ' 51' ' ' ALA . 11.6 mmp_? -69.57 -42.77 74.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 75.14 110.889 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.529 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -58.59 -52.99 63.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 71.11 110.864 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -65.41 -36.49 84.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 52.32 110.903 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.475 ' O ' HG22 ' A' ' 67' ' ' THR . 0.3 OUTLIER -57.09 -48.25 79.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 65.35 110.889 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 61' ' ' HIS . 17.2 m -67.68 -40.88 84.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 53.23 111.146 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.514 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 14.8 m-85 -65.74 -33.39 75.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 75.52 110.897 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.36 -46.03 43.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.096 -0.502 . . . . 74.11 111.069 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.518 HG23 HD12 ' A' ' 68' ' ' LEU . 4.7 t -63.81 -33.66 76.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 51.4 111.161 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.751 ' HG ' HD13 ' A' ' 20' ' ' ILE . 3.4 mp -81.9 -1.95 49.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.447 . . . . 53.52 110.91 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 32.48 82.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.806 -0.711 . . . . 55.31 112.51 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.59 ' HG2' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -83.55 -20.17 34.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.357 . . . . 75.12 110.887 -179.876 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.59 HD22 ' HG2' ' A' ' 70' ' ' GLU . 4.0 mm? -87.96 9.36 22.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 64.34 110.871 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.87 -13.2 61.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 75.45 110.867 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.58 -33.15 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.772 -0.727 . . . . 51.11 112.511 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 C-N-CA 120.694 -0.765 . . . . 74.42 112.497 -179.94 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.543 ' HB3' ' HB3' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.865 0.364 . . . . 70.53 111.12 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.819 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 3.7 mm? -97.02 143.67 27.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 72.12 110.888 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -118.79 115.25 24.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 72.01 110.919 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.514 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 0.4 OUTLIER -123.9 116.7 23.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 75.1 110.92 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.07 114.85 23.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 65.41 110.899 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.556 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 40.2 p -115.78 106.49 13.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.236 -0.438 . . . . 64.23 111.174 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.4 mt -131.68 162.82 29.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 61.13 110.894 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.571 HG23 ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -70.79 164.53 54.94 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.592 0.71 . . . . 64.2 111.128 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.578 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.4 Cg_endo -69.76 -24.53 29.58 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.726 2.284 . . . . 74.13 112.301 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.54 -36.0 82.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 70.23 110.882 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.63 -41.66 87.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 53.33 110.876 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.61 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 50.21 111.108 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.793 0.33 . . . . 72.22 111.075 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -70.69 -37.98 73.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 64.52 110.815 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 19' ' ' THR . 6.2 p -59.21 -54.02 51.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 51.34 111.144 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.545 HD11 HG11 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -68.48 -47.34 77.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 74.31 111.152 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -53.29 -50.42 64.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 71.54 110.897 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 ptmm? -66.96 -35.39 79.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 62.02 110.868 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.32 -49.27 74.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.433 . . . . 73.4 110.908 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.721 HD11 ' OG1' ' A' ' 67' ' ' THR . 7.4 mm -72.79 -42.81 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 63.1 111.191 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -54.7 -37.19 65.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.075 -0.511 . . . . 73.53 110.858 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -82.88 -42.49 17.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 64.3 110.894 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.99 -47.58 90.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.688 -0.768 . . . . 64.32 112.463 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.738 ' CB ' ' HB3' ' A' ' 31' ' ' ALA . 2.5 mm? -76.19 157.06 83.51 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.57 0.7 . . . . 74.43 110.91 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -58.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.63 2.22 . . . . 64.22 112.377 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -134.99 20.81 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 44.41 110.942 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.738 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . . . -74.4 126.52 30.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 72.21 111.087 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.654 ' HB3' HG12 ' A' ' 48' ' ' VAL . 4.3 tpt180 -100.68 109.7 21.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 62.13 110.858 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.038 HG13 HG22 ' A' ' 47' ' ' VAL . 41.1 t -114.14 135.34 54.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 60.31 111.088 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -135.23 118.81 16.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 71.43 110.85 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.545 HG11 HD11 ' A' ' 20' ' ' ILE . 61.4 t -121.49 131.33 73.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 53.25 111.119 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -132.83 120.35 21.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 74.43 110.895 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 142.45 -163.68 27.12 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.809 -0.71 . . . . 53.15 112.514 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 41' ' ' VAL . 27.1 mt-10 -135.39 176.23 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.871 0.367 . . . . 73.34 110.888 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -78.65 146.52 34.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 62.13 110.841 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.4 ' HA2' ' CA ' ' A' ' 74' ' ' GLY . . . 72.73 18.43 78.75 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.763 -0.732 . . . . 75.52 112.402 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.586 HG22 ' N ' ' A' ' 42' ' ' HIS . 12.5 p -144.63 164.39 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 72.11 111.143 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.586 ' N ' HG22 ' A' ' 41' ' ' VAL . 8.1 p80 -75.52 108.09 8.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 52.41 110.935 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.81 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 9.7 p90 -114.96 167.11 11.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 73.34 110.926 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -116.59 126.76 53.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 64.13 110.844 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.447 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -128.33 125.35 38.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 35.44 111.132 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.3 m -121.21 111.17 17.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 70.03 111.132 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.038 HG22 HG13 ' A' ' 33' ' ' VAL . 92.7 t -112.13 138.01 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 74.52 111.166 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.746 HG21 ' HB2' ' A' ' 89' ' ' ALA . 9.9 p -136.21 121.8 28.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 71.14 111.111 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.43 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -170.25 166.01 5.34 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.588 0.708 . . . . 75.44 110.917 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.548 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.5 Cg_endo -69.72 -21.66 33.36 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.719 2.279 . . . . 74.13 112.327 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.801 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -46.73 -46.26 20.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 64.0 111.136 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.623 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.9 OUTLIER -84.72 35.14 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 73.43 110.873 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.547 ' HA ' HG23 ' A' ' 85' ' ' THR . 7.7 p -52.46 133.84 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 64.12 111.142 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.94 -88.88 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.761 -0.733 . . . . 72.14 112.484 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 0.3 OUTLIER -120.64 113.39 20.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.769 0.319 . . . . 74.14 110.922 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.623 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -58.3 107.8 1.08 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.544 0.688 . . . . 53.22 111.071 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.7 Cg_endo -69.83 164.9 32.88 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.623 2.215 . . . . 64.32 112.393 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.507 HD21 ' NE ' ' A' ' 62' ' ' ARG . 1.8 tt -59.66 -25.6 64.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 63.4 110.892 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.26 -52.15 65.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 74.14 111.146 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.801 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 20.4 mmt180 -69.69 -41.08 75.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 72.45 110.874 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.52 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -58.44 -53.49 57.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 72.41 110.848 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.507 ' NE ' HD21 ' A' ' 58' ' ' LEU . 51.8 mtt180 -66.47 -36.88 83.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 63.52 110.874 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.6 mmm -56.61 -47.56 79.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 70.14 110.819 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 61' ' ' HIS . 19.2 m -68.8 -40.78 81.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 70.22 111.065 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.497 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 12.0 m-85 -62.09 -36.09 80.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 75.04 110.953 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.18 -46.78 31.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 73.33 111.069 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.721 ' OG1' HD11 ' A' ' 24' ' ' ILE . 0.7 OUTLIER -61.7 -33.28 73.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 65.02 111.135 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.57 HD12 HG23 ' A' ' 67' ' ' THR . 4.0 mp -84.49 -6.25 59.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 64.4 110.904 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 34.46 85.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.672 -0.775 . . . . 43.11 112.534 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -96.09 -35.11 11.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.841 0.353 . . . . 71.53 110.882 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.496 ' C ' HD23 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -87.91 5.98 37.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 72.45 110.867 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.492 ' N ' HD23 ' A' ' 71' ' ' LEU . 1.5 tpt -71.93 -10.65 60.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.432 . . . . 72.12 110.942 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.83 -32.68 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.777 -0.725 . . . . 34.21 112.534 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.4 ' CA ' ' HA2' ' A' ' 40' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.741 . . . . 61.34 112.478 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.445 ' HB3' ' CB ' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.891 0.376 . . . . 44.42 111.187 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.81 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 1.9 mm? -97.62 140.47 31.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 61.42 110.964 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -116.98 115.71 25.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 63.12 110.875 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.497 HD22 ' CZ ' ' A' ' 65' ' ' TYR . 5.2 tp -130.64 138.7 50.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 62.43 110.957 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -136.33 114.82 11.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 65.13 110.858 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.518 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 8.8 p -112.02 106.58 15.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.461 . . . . 75.22 111.119 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.0 mt -133.55 162.02 33.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 64.43 110.94 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.547 HG23 ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.72 164.53 57.42 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.642 0.734 . . . . 72.52 111.056 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.7 Cg_endo -69.78 -11.53 31.0 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.651 2.234 . . . . 74.3 112.339 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.47 -23.06 26.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 71.03 110.832 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -108.04 38.44 2.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 51.13 110.919 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.746 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 65.3 111.048 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.689 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.757 0.313 . . . . 55.13 111.129 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -74.06 -33.51 63.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 75.03 110.939 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.94 ' O ' HD23 ' A' ' 23' ' ' LEU . 18.6 p -57.55 -57.63 11.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 74.33 111.131 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.748 ' H ' HD13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -73.87 -35.26 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 64.21 111.135 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.409 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 68.7 ttt-85 -61.8 -45.07 95.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 71.43 110.895 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp -71.09 -41.09 71.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 65.21 110.933 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.94 HD23 ' O ' ' A' ' 19' ' ' THR . 3.4 mm? -55.63 -49.15 73.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 63.14 110.928 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.762 ' CG2' HG21 ' A' ' 33' ' ' VAL . 14.9 mt -69.28 -43.33 81.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 52.21 111.113 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -53.67 -38.26 63.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 54.43 110.897 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -78.28 -43.05 29.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 63.21 110.833 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.69 -51.11 60.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 64.23 112.454 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.512 HD23 HG23 ' A' ' 24' ' ' ILE . 4.2 mm? -78.69 158.17 76.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.623 0.725 . . . . 64.44 110.889 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -90.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.71 2.274 . . . . 73.12 112.337 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -107.28 33.2 4.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 60.44 110.885 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 49' ' ' SER . . . -84.05 125.84 32.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 72.34 111.112 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.519 ' HB2' ' CG1' ' A' ' 48' ' ' VAL . 3.7 mmt180 -92.8 108.92 20.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 61.53 110.862 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.762 HG21 ' CG2' ' A' ' 24' ' ' ILE . 76.3 t -109.76 122.74 64.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 51.31 111.116 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -134.07 118.38 17.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 53.43 110.822 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.689 HG13 ' HB1' ' A' ' 17' ' ' ALA . 2.4 p -128.25 132.78 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 61.15 111.17 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -132.89 120.45 21.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 74.42 110.92 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.413 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 150.29 -140.16 7.8 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 53.11 112.439 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -157.68 178.77 9.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.87 0.367 . . . . 64.43 110.887 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.07 142.47 30.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 54.52 110.866 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.85 17.81 78.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.731 . . . . 15.32 112.468 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 p -142.08 164.33 18.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.884 0.373 . . . . 75.34 111.117 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.49 ' CG ' ' O ' ' A' ' 42' ' ' HIS . 26.9 p-80 -75.7 107.05 7.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 75.12 110.865 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.779 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 4.7 p90 -119.06 167.25 11.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 63.44 110.863 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.409 ' HG3' ' CB ' ' A' ' 80' ' ' GLN . 26.5 tt0 -117.03 122.07 43.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 71.21 110.926 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.59 115.9 18.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 74.15 111.139 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.406 HG23 ' HB2' ' A' ' 82' ' ' LYS . 10.5 m -110.78 120.07 41.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 65.31 111.172 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.404 HG13 HG22 ' A' ' 33' ' ' VAL . 86.9 t -123.47 128.24 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 73.34 111.157 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 32' ' ' ARG . 4.9 p -125.33 122.67 63.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 75.11 111.115 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -163.33 168.01 10.67 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.655 0.74 . . . . 72.31 110.893 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.483 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.6 Cg_endo -69.82 -21.19 33.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.68 2.253 . . . . 73.04 112.314 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -46.48 -46.76 19.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 71.12 111.097 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.603 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.7 OUTLIER -86.1 36.41 0.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 74.21 110.93 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.503 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 6.9 p -52.24 124.27 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 72.31 111.12 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.46 -74.69 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.796 -0.716 . . . . 61.24 112.464 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 53' ' ' VAL . 22.9 pttm -119.89 140.47 50.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.761 0.315 . . . . 75.34 110.89 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.603 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -101.25 97.92 8.11 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.59 0.709 . . . . 71.13 111.054 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.6 Cg_endo -69.77 173.42 11.01 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.703 2.269 . . . . 72.54 112.348 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.79 -26.83 62.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 74.11 110.907 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.84 -52.94 63.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 64.32 111.162 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.597 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 11.6 mmt180 -69.51 -43.13 73.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 64.51 110.898 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.533 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.2 t-160 -58.34 -53.35 59.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 75.53 110.9 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.8 mtt180 -65.99 -35.82 81.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 73.43 110.887 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.9 ttt -57.91 -46.0 85.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 74.11 110.875 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 61' ' ' HIS . 15.8 m -69.61 -39.96 78.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 74.3 111.152 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -67.72 -34.99 77.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 64.21 111.028 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.18 -47.19 29.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 74.51 111.086 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.703 HG23 HD12 ' A' ' 68' ' ' LEU . 15.4 t -61.65 -39.59 91.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 72.24 111.138 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.703 HD12 HG23 ' A' ' 67' ' ' THR . 1.0 OUTLIER -82.0 0.73 38.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 41.21 110.975 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 35.04 91.22 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 62.34 112.416 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -96.86 -32.26 12.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.902 0.382 . . . . 51.41 110.852 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.53 10.25 3.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 75.04 110.903 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 37.9 mtm -73.56 -13.19 60.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 62.44 110.937 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.12 -33.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 74.34 112.479 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.786 -0.721 . . . . 74.34 112.489 -179.921 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.806 0.336 . . . . 70.34 111.105 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.779 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 3.6 mm? -97.79 133.86 41.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 62.21 110.972 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.409 ' CB ' ' HG3' ' A' ' 44' ' ' GLU . 25.9 mt-30 -109.7 115.6 30.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 72.41 110.906 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.4 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 5.0 tp -133.46 139.63 46.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 64.1 110.852 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HB2' HG23 ' A' ' 46' ' ' THR . 0.6 OUTLIER -136.53 115.36 12.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 74.11 110.842 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.527 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 10.5 p -108.44 106.68 16.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 72.43 111.147 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.504 HD22 ' C ' ' A' ' 83' ' ' THR . 3.9 mm? -129.61 161.49 30.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 75.42 110.838 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.503 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.5 162.92 71.54 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.623 0.725 . . . . 73.13 111.089 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.6 Cg_endo -69.64 -19.18 37.05 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.733 2.289 . . . . 63.34 112.402 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -68.82 -35.99 77.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 74.35 110.899 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -66.53 -40.19 88.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 72.51 110.918 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 75.22 111.097 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.94 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.755 0.312 . . . . 53.15 111.101 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -70.1 -38.45 75.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 60.44 110.84 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.9 ' O ' HD23 ' A' ' 23' ' ' LEU . 25.8 p -63.43 -53.57 50.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 72.31 111.139 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.935 HD12 ' N ' ' A' ' 21' ' ' ARG . 1.7 pp -65.06 -42.61 94.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 61.33 111.079 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.935 ' N ' HD12 ' A' ' 20' ' ' ILE . 39.9 ttp180 -60.37 -46.23 90.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 64.03 110.889 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.12 -42.4 99.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 75.12 110.969 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.9 HD23 ' O ' ' A' ' 19' ' ' THR . 4.2 mm? -58.08 -49.3 77.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 74.24 110.913 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.776 ' CG2' HG21 ' A' ' 33' ' ' VAL . 46.7 mm -63.31 -46.38 95.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 73.1 111.152 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -54.37 -43.71 71.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 74.15 110.851 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.31 -42.93 78.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 74.05 110.797 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.35 -57.04 12.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.725 -0.75 . . . . 14.42 112.45 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.477 ' CB ' ' HB3' ' A' ' 31' ' ' ALA . 3.3 mm? -72.65 155.86 90.57 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.537 0.684 . . . . 63.41 110.958 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -90.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.615 2.21 . . . . 73.51 112.352 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -103.32 31.89 4.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 70.33 110.902 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.477 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . . . -80.48 131.65 35.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 74.23 111.095 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.634 ' HB3' HG12 ' A' ' 48' ' ' VAL . 6.4 tpp180 -102.42 113.99 27.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 75.43 110.878 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.075 HG13 HG22 ' A' ' 47' ' ' VAL . 36.8 t -116.03 127.31 73.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 72.14 111.137 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -135.4 118.37 16.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.248 -0.433 . . . . 72.24 110.864 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.94 HG13 ' HB1' ' A' ' 17' ' ' ALA . 4.3 p -127.28 136.91 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 65.15 111.142 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.418 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 0.9 OUTLIER -133.05 120.4 21.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 61.55 110.918 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.435 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 142.37 -134.43 6.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.741 . . . . 55.44 112.469 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.412 ' OE2' ' CG ' ' A' ' 39' ' ' ASP . 5.3 tm-20 -170.2 166.53 8.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 72.22 110.866 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.412 ' CG ' ' OE2' ' A' ' 38' ' ' GLU . 7.8 p30 -72.95 153.55 40.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 70.34 110.905 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.432 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.84 -2.62 32.06 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 73.22 112.489 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.4 m -130.41 164.9 32.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.867 0.365 . . . . 62.52 111.124 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.419 ' CG ' ' O ' ' A' ' 42' ' ' HIS . 12.6 p80 -74.78 109.98 8.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 63.35 110.859 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.606 ' CE2' HD11 ' A' ' 79' ' ' LEU . 34.1 p90 -127.43 167.36 16.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 71.13 110.9 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -118.1 126.72 52.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 63.23 110.837 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.27 115.32 18.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 72.22 111.052 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.7 m -110.37 110.78 21.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.469 . . . . 55.2 111.108 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.075 HG22 HG13 ' A' ' 33' ' ' VAL . 91.5 t -110.68 140.8 28.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.49 . . . . 64.33 111.091 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.634 HG12 ' HB3' ' A' ' 32' ' ' ARG . 4.3 p -133.34 118.31 31.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 60.34 111.168 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.534 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 38.4 p -162.08 159.17 21.55 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.671 0.748 . . . . 72.11 110.853 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.574 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.1 Cg_endo -69.78 -14.67 36.34 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.643 2.229 . . . . 51.53 112.318 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.07 -48.45 22.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 74.0 111.134 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.77 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -84.19 35.07 0.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 64.33 110.874 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 p -50.84 131.1 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 54.13 111.099 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.73 -78.04 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.728 -0.749 . . . . 71.34 112.509 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -122.49 140.87 52.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.8 0.334 . . . . 75.44 110.849 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.77 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -104.19 99.11 15.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.606 0.717 . . . . 64.43 111.114 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 52.7 Cg_endo -69.81 169.4 19.05 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.677 2.251 . . . . 52.22 112.309 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.484 HD21 ' NE ' ' A' ' 62' ' ' ARG . 1.6 tt -56.43 -27.56 56.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 61.21 110.888 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.69 -52.75 63.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 73.25 111.097 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.458 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 3.4 mmm180 -69.84 -43.64 71.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 73.31 110.906 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.453 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.9 OUTLIER -56.57 -53.44 57.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.14 -0.482 . . . . 55.34 110.857 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.484 ' NE ' HD21 ' A' ' 58' ' ' LEU . 51.0 mtt180 -66.73 -37.93 85.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 64.1 110.852 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.5 mmt -54.13 -50.15 67.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 74.14 110.844 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.587 ' O ' HG22 ' A' ' 67' ' ' THR . 17.1 m -66.96 -42.91 89.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 60.02 111.154 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.889 ' CE1' HD13 ' A' ' 81' ' ' LEU . 15.2 m-85 -62.29 -36.82 83.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 71.15 110.936 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.2 -35.88 61.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 73.02 111.046 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.587 HG22 ' O ' ' A' ' 64' ' ' VAL . 0.6 OUTLIER -69.93 -31.22 68.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 73.32 111.122 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.657 ' C ' HD12 ' A' ' 68' ' ' LEU . 2.9 pp -88.03 -10.44 50.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 55.41 110.933 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.613 ' N ' HD12 ' A' ' 68' ' ' LEU . . . 46.86 87.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.681 -0.771 . . . . 52.5 112.506 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.638 ' HG2' HD11 ' A' ' 68' ' ' LEU . 8.2 pt-20 -111.02 -48.14 3.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.847 0.356 . . . . 73.23 110.868 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.73 HD13 ' O ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -78.88 -2.19 38.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.199 -0.455 . . . . 73.32 110.963 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.1 mmt -85.14 -13.7 49.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 54.03 110.888 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.6 -30.88 3.37 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.724 -0.75 . . . . 50.1 112.423 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.432 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.785 -0.722 . . . . 64.0 112.527 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.833 0.349 . . . . 70.41 111.068 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.606 HD11 ' CE2' ' A' ' 43' ' ' PHE . 4.1 mm? -97.44 131.83 43.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 63.53 110.943 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -112.58 114.94 27.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 75.22 110.896 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.889 HD13 ' CE1' ' A' ' 65' ' ' TYR . 6.7 tt -139.53 138.44 36.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 51.13 110.883 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -136.54 114.96 11.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 74.0 110.868 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.536 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 59.0 p -100.87 106.82 18.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 72.15 111.172 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 84' ' ' LEU . 2.5 mm? -125.27 162.5 24.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 74.4 110.92 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.408 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 0.6 OUTLIER -71.09 164.49 56.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.606 0.717 . . . . 64.03 111.131 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.2 Cg_endo -69.83 -18.25 36.78 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.613 2.209 . . . . 61.21 112.333 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -76.51 -29.56 56.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 63.2 110.885 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -80.28 5.37 14.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.172 -0.467 . . . . 75.42 110.87 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 63.03 111.118 179.925 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 35' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.716 0.293 . . . . 65.33 111.135 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.64 -47.19 49.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 62.01 110.967 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.403 HG23 ' N ' ' A' ' 20' ' ' ILE . 3.1 t -62.4 -45.14 94.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 43.4 111.155 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.568 ' CD1' HG21 ' A' ' 35' ' ' VAL . 14.6 pt -69.91 -40.03 78.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 54.42 111.124 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.455 ' N ' HG13 ' A' ' 20' ' ' ILE . 32.5 ttt-85 -60.0 -48.23 82.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 51.2 110.861 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.449 ' HG3' ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -69.29 -39.62 78.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 73.32 110.917 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.449 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 17.8 mt -57.12 -49.32 76.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 73.42 110.881 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.803 ' CG2' HG21 ' A' ' 33' ' ' VAL . 5.7 mt -70.06 -45.86 74.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 61.3 111.127 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -53.96 -36.86 63.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 62.44 110.898 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -79.48 -40.82 28.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 74.24 110.861 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.92 -55.56 21.43 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.732 -0.747 . . . . 64.24 112.473 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.596 HD12 ' CG2' ' A' ' 24' ' ' ILE . 5.8 mt -76.5 159.62 79.17 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.572 0.701 . . . . 72.24 111.005 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -91.29 0.01 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.104 0 C-N-CA 122.73 2.286 . . . . 71.25 112.361 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -106.96 29.61 6.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 74.4 110.87 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.46 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -77.58 131.28 37.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 64.3 111.113 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.516 ' HB2' ' CG1' ' A' ' 48' ' ' VAL . 13.6 mmm-85 -97.11 114.42 26.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 74.44 110.881 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.872 HG13 HG22 ' A' ' 47' ' ' VAL . 56.3 t -117.98 126.05 74.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 63.33 111.179 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -135.28 118.63 16.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 73.35 110.822 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.568 HG21 ' CD1' ' A' ' 20' ' ' ILE . 43.2 t -125.01 135.21 64.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 72.34 111.108 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 -133.25 123.17 25.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 71.22 110.884 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.78 -134.48 6.23 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.698 -0.763 . . . . 62.24 112.511 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -163.67 160.23 22.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 54.42 110.896 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.453 ' OD2' ' C ' ' A' ' 72' ' ' MET . 24.5 t0 -67.49 147.63 52.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 65.41 110.901 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.0 -7.29 16.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.815 -0.707 . . . . 62.13 112.391 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.573 HG12 ' N ' ' A' ' 42' ' ' HIS . 14.6 t -118.81 165.8 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.871 0.367 . . . . 64.22 111.158 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.573 ' N ' HG12 ' A' ' 41' ' ' VAL . 22.9 p-80 -73.95 106.54 5.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 64.33 110.853 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.573 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 41.7 p90 -122.6 167.33 13.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 64.21 110.918 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -114.3 128.1 56.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 75.01 110.916 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.39 121.94 36.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 72.11 111.133 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.8 m -121.11 110.41 16.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 71.41 111.14 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.872 HG22 HG13 ' A' ' 33' ' ' VAL . 65.4 t -120.6 129.64 75.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 65.2 111.18 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.516 ' CG1' ' HB2' ' A' ' 32' ' ' ARG . 3.7 p -126.4 118.86 52.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 51.45 111.112 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.478 ' CB ' ' HD2' ' A' ' 50' ' ' PRO . 0.4 OUTLIER -161.84 169.36 9.63 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.657 0.741 . . . . 61.22 110.862 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.515 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 52.9 Cg_endo -69.79 -20.87 34.15 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.692 2.261 . . . . 72.35 112.326 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.68 ' HB1' ' NE ' ' A' ' 60' ' ' ARG . . . -43.74 -53.58 5.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 75.14 111.195 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.626 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.7 OUTLIER -81.55 38.46 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 72.11 110.884 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.514 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 2.9 p -51.37 127.23 7.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 64.31 111.118 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.39 -78.36 0.12 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.714 -0.755 . . . . 72.12 112.481 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -121.97 141.68 51.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.765 0.316 . . . . 72.25 110.91 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.626 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -99.67 99.28 8.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.575 0.702 . . . . 50.34 111.101 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.6 Cg_endo -69.74 165.75 29.91 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.696 2.264 . . . . 74.24 112.332 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.469 ' O ' HD23 ' A' ' 58' ' ' LEU . 2.8 tt -54.53 -24.09 19.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 63.02 110.916 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 63' ' ' MET . . . -61.36 -51.65 67.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 75.32 111.14 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.68 ' NE ' ' HB1' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -72.05 -37.45 69.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 71.12 110.918 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.514 ' CD2' ' CD2' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -61.46 -49.99 74.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 74.24 110.879 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.439 ' HD2' HD21 ' A' ' 58' ' ' LEU . 18.5 mtp180 -70.39 -39.8 74.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 63.45 110.95 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 10.1 tpt -54.58 -50.84 67.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 71.24 110.912 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.649 ' O ' HG22 ' A' ' 67' ' ' THR . 30.3 m -66.12 -44.21 91.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 70.3 111.142 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.65 ' CE1' HD13 ' A' ' 81' ' ' LEU . 10.0 m-85 -55.45 -40.17 71.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 62.34 110.943 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.32 -38.93 59.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 62.33 111.102 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.649 HG22 ' O ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -66.18 -24.03 66.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 74.23 111.123 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.597 ' C ' HD12 ' A' ' 68' ' ' LEU . 3.8 pp -95.47 -1.57 50.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 55.24 110.889 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.459 ' HA2' ' CG ' ' A' ' 72' ' ' MET . . . 82.06 66.01 1.6 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.773 -0.727 . . . . 73.43 112.446 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -74.75 -65.62 0.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.838 0.351 . . . . 73.24 110.914 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.6 tp -86.48 10.08 16.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 75.23 110.91 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' MET . . . . . 0.459 ' CG ' ' HA2' ' A' ' 69' ' ' GLY . 19.7 mmt -72.22 -14.08 61.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 53.33 110.854 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.423 ' HA3' ' CG ' ' A' ' 39' ' ' ASP . . . -149.46 -34.54 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.755 -0.736 . . . . 60.44 112.509 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 53.34 112.482 -179.892 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.82 0.343 . . . . 62.33 111.096 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.573 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 1.2 mm? -113.54 145.78 40.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 73.45 110.951 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -124.7 115.96 21.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 65.13 110.861 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.65 HD13 ' CE1' ' A' ' 65' ' ' TYR . 2.8 tp -123.94 141.67 51.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 75.22 110.895 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -133.13 114.39 13.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 75.22 110.916 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.527 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 24.7 p -118.5 106.12 12.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 54.13 111.145 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mp -134.62 161.23 35.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 64.15 110.934 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.514 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.48 163.59 66.52 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.639 0.733 . . . . 64.42 111.152 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.3 Cg_endo -69.76 -19.04 36.64 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.693 2.262 . . . . 71.04 112.328 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -68.87 -36.07 77.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 71.5 110.891 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -64.48 -38.12 89.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 62.53 110.925 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 54.13 111.136 179.893 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.853 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.797 0.332 . . . . 60.22 111.124 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -70.54 -39.13 74.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 74.31 110.879 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.442 ' H ' HG23 ' A' ' 19' ' ' THR . 1.1 p -62.32 -53.55 53.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 75.2 111.104 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.073 HD12 HD22 ' A' ' 68' ' ' LEU . 9.1 pt -66.88 -45.9 86.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 74.51 111.147 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.435 ' N ' ' CG1' ' A' ' 20' ' ' ILE . 37.7 ttp85 -53.58 -51.45 62.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 73.13 110.828 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -67.43 -34.85 78.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 64.43 110.987 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.491 HD13 ' O ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -56.64 -49.65 74.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 55.22 110.885 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.663 HD12 HG11 ' A' ' 33' ' ' VAL . 46.8 mt -72.44 -43.05 64.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 74.42 111.109 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -54.61 -36.49 64.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 65.21 110.92 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -81.44 -43.14 19.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.487 . . . . 65.13 110.865 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 -37.88 95.45 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 55.24 112.485 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.801 HD23 ' CB ' ' A' ' 31' ' ' ALA . 8.2 mp -92.99 160.94 32.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.537 0.684 . . . . 72.11 110.937 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -90.99 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.657 2.238 . . . . 74.15 112.36 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -107.43 25.55 11.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 62.25 110.907 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.801 ' CB ' HD23 ' A' ' 28' ' ' LEU . . . -72.36 129.51 38.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 74.32 111.042 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.651 ' HB3' HG12 ' A' ' 48' ' ' VAL . 3.3 ttm180 -97.03 112.01 23.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 70.1 110.879 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.022 HG13 HG22 ' A' ' 47' ' ' VAL . 21.4 t -113.94 130.08 68.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 74.11 111.143 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -135.12 118.08 16.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 75.02 110.898 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.853 HG13 ' HB1' ' A' ' 17' ' ' ALA . 5.8 p -129.69 137.44 56.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 70.33 111.17 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.4 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 47.2 tt0 -133.25 120.3 20.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 74.22 110.868 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 144.12 -149.06 21.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 74.34 112.571 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -155.69 177.7 11.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 74.52 110.91 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.95 147.04 35.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 75.32 110.889 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.84 7.86 71.3 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.78 -0.724 . . . . 72.31 112.521 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.548 HG12 ' N ' ' A' ' 42' ' ' HIS . 17.7 t -134.87 163.87 35.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 52.14 111.105 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.548 ' N ' HG12 ' A' ' 41' ' ' VAL . 49.3 p-80 -75.9 106.85 7.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 75.42 110.879 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.654 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 7.4 p90 -119.76 166.76 12.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 75.32 110.866 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.02 129.59 56.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.02 110.899 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.05 116.28 19.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 62.32 111.108 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.691 HG23 ' HB2' ' A' ' 82' ' ' LYS . 12.0 m -121.29 112.11 18.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 71.33 111.132 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.022 HG22 HG13 ' A' ' 33' ' ' VAL . 79.6 t -114.06 138.92 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 45.22 111.143 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.651 HG12 ' HB3' ' A' ' 32' ' ' ARG . 8.6 p -132.08 123.84 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 73.21 111.126 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.44 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 0.6 OUTLIER -170.37 167.52 4.59 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.7 0.762 . . . . 60.12 110.855 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.518 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.4 Cg_endo -69.77 -22.78 31.55 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.693 2.262 . . . . 70.33 112.357 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HB1' ' NE ' ' A' ' 60' ' ' ARG . . . -44.27 -47.02 9.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 54.14 111.091 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.724 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -86.69 39.85 0.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 72.5 110.814 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.494 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 4.3 p -55.92 123.11 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 74.35 111.139 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.46 -91.68 0.86 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.75 -0.738 . . . . 52.25 112.41 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.485 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 11.8 mptt -118.06 108.88 15.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.797 0.332 . . . . 70.44 110.878 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.724 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -57.82 106.65 0.73 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.549 0.69 . . . . 63.44 111.1 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 54.5 Cg_endo -69.79 170.5 16.45 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.645 2.23 . . . . 73.24 112.381 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tp -63.54 -23.78 67.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 64.3 110.943 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.87 -54.14 49.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 64.3 111.116 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.583 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 8.2 mmm180 -71.83 -40.84 68.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 74.24 110.82 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.406 ' CD2' ' HE2' ' A' ' 65' ' ' TYR . 1.0 OUTLIER -58.25 -50.34 73.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 64.53 110.855 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -69.05 -40.18 78.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 71.23 110.819 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.812 ' O ' HG23 ' A' ' 67' ' ' THR . 10.5 tpt -53.47 -52.79 58.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 71.11 110.856 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.523 HG23 ' N ' ' A' ' 65' ' ' TYR . 16.6 m -61.75 -49.56 83.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 72.23 111.141 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.577 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 12.8 m-85 -55.61 -31.19 62.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 74.31 110.995 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.49 -43.33 56.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 74.14 111.151 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 63' ' ' MET . 1.1 p -64.44 -33.83 76.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 75.51 111.179 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.073 HD22 HD12 ' A' ' 20' ' ' ILE . 12.6 mt -81.74 7.07 13.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 74.12 110.925 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 31.58 73.14 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.7 -0.762 . . . . 70.11 112.48 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.427 ' CD ' ' HG ' ' A' ' 79' ' ' LEU . 26.7 mt-10 -77.34 -38.95 49.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.861 0.362 . . . . 51.32 110.894 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.4 tp -89.83 10.36 23.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 51.24 110.876 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.3 ttt -77.23 -13.52 59.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 72.11 110.904 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.1 -32.33 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.737 . . . . 53.12 112.508 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.718 -0.754 . . . . 32.24 112.528 -179.918 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.415 ' HB3' ' HB3' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.798 0.332 . . . . 74.34 111.123 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.654 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 4.0 mm? -97.61 146.54 25.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 64.42 110.954 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -121.3 115.79 23.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 72.34 110.901 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.577 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 0.4 OUTLIER -125.01 117.64 24.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 54.33 110.869 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.691 ' HB2' HG23 ' A' ' 46' ' ' THR . 2.3 mptp? -120.83 114.87 22.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 73.51 110.853 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.536 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 28.6 p -116.15 107.06 14.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 40.14 111.188 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.5 mt -132.48 161.42 33.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 72.24 110.935 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.494 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.1 163.04 70.27 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.608 0.718 . . . . 75.0 111.109 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.2 Cg_endo -69.77 -7.97 22.42 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.681 2.254 . . . . 72.2 112.354 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -86.62 -28.83 23.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.446 . . . . 74.43 110.824 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -84.53 18.31 2.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 71.5 110.894 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 63.12 111.118 179.93 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.77 ' HB1' ' CG1' ' A' ' 35' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.736 0.303 . . . . 64.04 111.078 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -57.64 -37.1 72.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 62.01 110.898 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.56 ' CG2' ' N ' ' A' ' 20' ' ' ILE . 1.2 t -60.86 -47.53 85.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 44.51 111.045 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.857 HD13 ' HB2' ' A' ' 68' ' ' LEU . 9.4 pt -70.24 -30.8 44.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 74.2 111.086 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.556 ' N ' HG13 ' A' ' 20' ' ' ILE . 39.0 ttt-85 -65.22 -48.02 74.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 74.31 110.814 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -71.46 -39.74 70.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 72.24 110.92 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.0 mt -58.26 -50.21 74.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 75.41 110.899 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.778 HG21 HG21 ' A' ' 33' ' ' VAL . 6.6 mt -71.32 -45.78 68.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 62.32 111.176 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -54.2 -35.82 62.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 74.33 110.903 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.97 -43.15 22.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 75.31 110.852 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.79 -52.22 52.12 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.78 -0.724 . . . . 71.3 112.518 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.06 101.67 54.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 74.41 110.938 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.64 -14.76 36.95 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.723 2.282 . . . . 73.22 112.302 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -97.65 1.1 48.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 74.44 110.88 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' A' ' 49' ' ' SER . . . -119.24 135.89 54.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 61.45 111.123 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.609 ' HB2' HG13 ' A' ' 48' ' ' VAL . 9.8 mmt180 -106.85 114.32 28.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 74.12 110.878 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 24' ' ' ILE . 18.4 t -116.79 124.69 73.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 72.12 111.065 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.62 117.65 15.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 63.4 110.806 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.77 ' CG1' ' HB1' ' A' ' 17' ' ' ALA . 4.4 p -123.64 138.6 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 71.51 111.098 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 3.1 tp-100 -132.12 120.52 22.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 72.41 110.904 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.53 -150.81 23.1 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.667 -0.778 . . . . 74.44 112.474 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -150.94 165.68 32.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 75.24 110.883 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -68.56 142.75 55.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 64.35 110.851 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.61 19.56 79.17 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 74.54 112.478 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 42' ' ' HIS . 9.8 t -144.1 164.98 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.853 0.359 . . . . 74.14 111.099 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.54 ' N ' HG12 ' A' ' 41' ' ' VAL . 17.3 p80 -74.81 107.73 7.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 71.11 110.923 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.928 ' CE2' HD11 ' A' ' 79' ' ' LEU . 7.7 p90 -119.43 167.43 11.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 72.21 110.904 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.1 pm0 -115.27 133.72 55.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 61.41 110.889 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.829 ' HB2' ' HE1' ' A' ' 43' ' ' PHE . . . -125.54 123.93 40.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 52.54 111.097 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.8 m -121.72 107.32 12.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 63.34 111.194 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.768 ' CG1' HG13 ' A' ' 33' ' ' VAL . 2.9 m -116.8 128.95 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 60.42 111.178 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.609 HG13 ' HB2' ' A' ' 32' ' ' ARG . 4.4 p -133.48 118.62 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 73.12 111.184 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.466 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -165.19 168.22 8.7 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.611 0.72 . . . . 74.22 110.828 -179.788 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.508 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.9 Cg_endo -69.7 -23.94 30.5 Favored 'Trans proline' 0 N--CA 1.465 -0.147 0 C-N-CA 122.747 2.298 . . . . 35.2 112.38 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -47.35 -44.45 23.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 72.54 111.053 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.635 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.7 OUTLIER -85.3 34.25 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 61.34 110.865 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.555 ' HA ' HG23 ' A' ' 85' ' ' THR . 14.6 p -52.3 144.67 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 71.44 111.109 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 50.7 -88.12 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.772 -0.728 . . . . 74.42 112.512 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -118.21 112.51 20.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 73.24 110.922 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.635 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -58.59 108.05 1.18 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.607 0.718 . . . . 63.33 111.136 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 52.9 Cg_endo -69.8 162.27 42.74 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.715 2.277 . . . . 73.42 112.317 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.8 tp -57.89 -25.95 61.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.225 -0.443 . . . . 74.23 110.831 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.22 -53.53 57.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 73.21 111.105 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.6 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 29.5 mmt180 -69.92 -44.97 68.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 75.24 110.885 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.485 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.5 t-160 -56.24 -53.77 53.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 61.44 110.821 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.9 mtp85 -65.33 -35.89 82.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 70.44 110.87 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.4 ttt -56.24 -48.38 76.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 65.13 110.835 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.594 HG21 HD21 ' A' ' 81' ' ' LEU . 11.4 m -67.83 -40.64 83.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 74.31 111.116 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.605 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 16.7 m-85 -67.35 -34.18 76.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 71.42 110.908 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.06 -44.46 26.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 64.02 111.114 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.505 HG22 ' O ' ' A' ' 64' ' ' VAL . 1.2 t -60.32 -40.99 92.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 72.52 111.158 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.048 HD22 ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -88.66 -10.92 46.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 60.34 110.921 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 1.014 ' N ' HD13 ' A' ' 68' ' ' LEU . . . 31.32 87.82 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.757 -0.735 . . . . 75.04 112.506 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.456 ' HG2' HD23 ' A' ' 71' ' ' LEU . 1.1 pm0 -79.53 -35.25 40.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.993 0.425 . . . . 74.44 110.938 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.456 HD23 ' HG2' ' A' ' 70' ' ' GLU . 3.9 mm? -76.11 7.3 4.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 40.21 110.929 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 63.4 mtp -84.52 -13.05 52.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 71.11 110.854 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.39 -22.1 1.11 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.772 -0.728 . . . . 55.1 112.448 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.722 -0.751 . . . . 74.35 112.501 -179.881 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.812 0.339 . . . . 61.0 111.107 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.928 HD11 ' CE2' ' A' ' 43' ' ' PHE . 3.9 mm? -97.66 132.49 43.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 63.23 110.882 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -111.46 114.94 28.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 71.11 110.935 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.605 HD22 ' CZ ' ' A' ' 65' ' ' TYR . 3.4 tp -133.65 124.72 27.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 64.12 110.915 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' A' ' 81' ' ' LEU . 9.4 mptt -126.48 114.47 18.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 72.05 110.834 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.583 ' HB ' ' CD2' ' A' ' 52' ' ' PHE . 66.8 p -109.39 107.19 17.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 72.3 111.189 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.412 HD12 ' C ' ' A' ' 83' ' ' THR . 6.6 mp -131.56 162.8 29.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 65.25 110.88 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.555 HG23 ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.11 164.1 59.8 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.59 0.71 . . . . 72.44 111.103 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.6 Cg_endo -69.79 -12.8 33.58 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.633 2.222 . . . . 74.54 112.374 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -78.66 -28.72 45.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 72.24 110.905 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -85.04 28.79 0.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 74.4 110.877 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 53.44 111.18 179.837 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.869 ' HA ' HD11 ' A' ' 20' ' ' ILE . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.704 0.288 . . . . 74.24 111.042 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' A' ' 19' ' ' THR . 4.0 pt-20 -71.49 -28.91 64.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.26 -0.427 . . . . 74.44 110.873 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.421 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 17.1 p -59.07 -56.66 19.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 74.51 111.166 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.892 ' H ' HD13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -73.92 -35.29 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 74.15 111.098 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.52 ' N ' HG12 ' A' ' 20' ' ' ILE . 30.8 ttp180 -62.41 -48.57 79.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 73.23 110.862 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -69.56 -40.27 76.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 75.42 110.872 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.8 mt -56.18 -49.19 74.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.302 -0.408 . . . . 74.24 110.931 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.811 ' CG2' HG21 ' A' ' 33' ' ' VAL . 11.7 mt -68.07 -45.84 82.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 70.04 111.161 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -54.21 -36.8 63.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.116 -0.493 . . . . 74.34 110.898 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m -77.4 -43.02 34.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 40.15 110.881 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.47 -46.46 92.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.768 -0.729 . . . . 54.41 112.472 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.789 HD23 ' CB ' ' A' ' 31' ' ' ALA . 6.8 mp -85.61 161.09 52.02 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.567 0.699 . . . . 63.32 110.938 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -90.76 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.656 2.237 . . . . 74.12 112.373 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -107.26 25.89 10.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 72.41 110.909 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.789 ' CB ' HD23 ' A' ' 28' ' ' LEU . . . -71.64 125.71 27.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 73.01 111.118 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.717 ' HB3' HG12 ' A' ' 48' ' ' VAL . 2.2 tpm_? -93.71 108.75 20.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 71.22 110.865 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 1.071 HG22 HG13 ' A' ' 47' ' ' VAL . 41.7 t -113.28 127.46 70.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 73.04 111.196 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -135.22 118.56 16.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 70.12 110.828 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.683 HG13 ' HB1' ' A' ' 17' ' ' ALA . 3.9 p -126.26 136.7 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 64.33 111.089 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 24.7 mt-30 -132.69 120.1 21.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 73.44 110.912 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 149.18 -124.92 1.9 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 72.42 112.444 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.62 ' O ' HG12 ' A' ' 41' ' ' VAL . 2.2 tt0 -175.44 163.04 2.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 61.52 110.895 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.02 148.16 46.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 75.31 110.9 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.61 8.99 73.4 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.739 -0.743 . . . . 41.25 112.508 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 38' ' ' GLU . 14.7 p -139.14 165.17 23.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.827 0.346 . . . . 70.52 111.152 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.6 ' N ' HG22 ' A' ' 41' ' ' VAL . 32.6 p80 -74.49 110.7 9.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 73.22 110.851 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.536 ' CE2' HD11 ' A' ' 79' ' ' LEU . 4.9 p90 -126.91 167.65 15.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.273 -0.422 . . . . 71.21 110.866 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -113.5 124.98 53.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 64.15 110.873 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.22 119.99 26.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 64.51 111.148 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.4 m -118.26 114.99 23.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 74.51 111.117 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.071 HG13 HG22 ' A' ' 33' ' ' VAL . 24.7 t -113.47 141.25 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 74.13 111.128 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.717 HG12 ' HB3' ' A' ' 32' ' ' ARG . 5.1 p -134.95 122.2 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 70.24 111.133 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.449 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -167.61 166.26 7.97 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.704 0.764 . . . . 73.54 110.874 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.504 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.8 Cg_endo -69.74 -18.22 37.21 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.681 2.254 . . . . 74.03 112.317 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -43.76 -50.79 7.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 64.04 111.157 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.63 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -86.94 40.58 0.92 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.248 -0.433 . . . . 71.23 110.891 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.498 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 4.7 p -51.24 119.1 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 74.2 111.089 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.69 -72.88 1.01 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.748 -0.739 . . . . 70.55 112.495 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.404 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 23.3 mtpt -121.62 138.59 54.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.809 0.338 . . . . 72.23 110.876 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -99.73 100.11 10.33 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.538 0.685 . . . . 75.53 111.093 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.8 163.49 38.11 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.633 2.222 . . . . 75.23 112.374 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -56.49 -26.76 55.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 50.2 110.928 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 63' ' ' MET . . . -58.6 -49.95 75.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 63.41 111.13 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.605 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 21.6 mmt180 -71.7 -46.47 58.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.275 -0.42 . . . . 64.51 110.818 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.583 ' CD2' ' HH ' ' A' ' 65' ' ' TYR . 1.0 OUTLIER -58.0 -50.0 74.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 62.24 110.833 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 1.2 ttm180 -67.34 -39.65 85.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 55.34 110.883 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' MET . . . . . 0.407 ' CG ' ' O ' ' A' ' 59' ' ' ALA . 4.3 mmt -54.54 -48.02 72.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 75.41 110.898 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' A' ' 61' ' ' HIS . 13.5 m -65.43 -42.51 93.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 72.44 111.165 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . 0.583 ' HH ' ' CD2' ' A' ' 61' ' ' HIS . 12.1 m-85 -54.8 -42.09 71.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 74.13 110.853 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.53 -44.37 62.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 54.2 111.109 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.569 HG21 HG12 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -69.64 -14.76 62.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 72.43 111.201 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.525 ' O ' HG21 ' A' ' 20' ' ' ILE . 18.0 mt -94.61 -10.54 31.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 72.32 110.929 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.71 72.71 0.47 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.712 -0.756 . . . . 43.04 112.505 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 71' ' ' LEU . 10.0 pt-20 -114.65 -38.47 3.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.869 0.366 . . . . 72.34 110.924 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.637 HD13 ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -88.38 -11.17 46.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 71.31 110.907 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.8 ptm -80.63 -13.14 59.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 75.24 110.921 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.36 -25.28 5.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 64.5 112.471 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 C-N-CA 120.731 -0.747 . . . . 54.34 112.478 -179.91 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.84 0.353 . . . . 72.23 111.08 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.536 HD11 ' CE2' ' A' ' 43' ' ' PHE . 3.9 mm? -98.16 136.36 38.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 71.52 110.958 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -105.79 115.73 30.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 74.14 110.913 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.438 HD12 HG23 ' A' ' 83' ' ' THR . 0.2 OUTLIER -129.58 118.47 22.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 64.14 110.892 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 47' ' ' VAL . 2.2 mptp? -119.0 114.5 22.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.467 . . . . 75.4 110.953 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.539 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 33.5 p -109.79 107.32 17.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 62.0 111.163 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.6 mt -131.07 160.83 33.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 75.11 110.883 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.498 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.36 162.86 71.71 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.597 0.713 . . . . 62.3 111.128 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.7 Cg_endo -69.65 -17.94 37.81 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.689 2.259 . . . . 75.41 112.394 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -71.83 -34.76 69.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 73.43 110.904 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -68.32 -31.24 70.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.173 -0.467 . . . . 74.24 110.854 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 74.41 111.063 179.977 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 39.1 mtt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.788 0.328 . . . . 73.24 110.892 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.84 -35.88 3.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 72.24 110.853 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -148.98 111.58 4.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 55.04 110.922 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.498 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 7.2 ttt180 -47.25 -59.67 5.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.571 0.7 . . . . 74.44 110.844 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 13' ' ' ARG . 54.3 Cg_endo -69.72 176.75 6.32 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.649 2.232 . . . . 73.34 112.363 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.708 ' O ' HG23 ' A' ' 19' ' ' THR . 8.9 tp -173.5 157.14 3.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 53.44 110.923 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -58.99 -63.82 1.16 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 72.21 110.896 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.52 -25.7 17.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 74.32 111.046 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -71.5 -40.84 69.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 70.01 110.866 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 15' ' ' LEU . 2.2 p -61.06 -52.86 63.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 71.44 111.134 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.561 HD11 HG11 ' A' ' 35' ' ' VAL . 4.6 pt -67.2 -45.07 87.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 73.42 111.148 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.1 ttt-85 -58.96 -45.06 91.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 72.34 110.846 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -65.37 -44.65 86.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 74.3 110.88 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.5 mt -56.01 -49.54 73.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 55.43 110.935 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.829 HG22 HD12 ' A' ' 28' ' ' LEU . 8.8 mt -67.33 -44.28 87.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 53.53 111.129 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -54.03 -39.1 65.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 55.54 110.852 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.78 -41.21 45.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 74.12 110.873 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.48 -58.33 10.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 63.11 112.502 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.829 HD12 HG22 ' A' ' 24' ' ' ILE . 32.0 mt -73.05 154.69 90.68 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.638 0.732 . . . . 75.01 110.896 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -90.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.267 . . . . 61.34 112.315 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -104.41 34.51 3.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 73.21 110.89 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.513 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -87.52 139.6 30.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 73.14 111.119 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.644 ' HB3' HG12 ' A' ' 48' ' ' VAL . 31.3 ttt180 -109.3 125.65 52.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 74.01 110.865 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.045 HG13 HG22 ' A' ' 47' ' ' VAL . 6.0 t -123.15 133.26 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 70.32 111.128 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -135.09 118.86 17.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 71.13 110.83 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.741 HG22 ' HB1' ' A' ' 45' ' ' ALA . 40.1 t -124.56 130.85 73.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 64.21 111.115 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 2.0 tp-100 -132.77 120.18 21.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 63.51 110.912 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.478 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 149.44 -122.75 1.49 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.757 -0.735 . . . . 65.52 112.516 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -175.32 160.71 2.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.783 0.325 . . . . 71.25 110.918 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -73.65 146.58 44.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 54.34 110.905 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.435 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.7 18.39 78.69 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.784 -0.722 . . . . 72.1 112.451 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 42' ' ' HIS . 21.0 t -149.23 165.44 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 74.44 111.168 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.574 ' N ' HG12 ' A' ' 41' ' ' VAL . 36.0 p-80 -74.21 112.27 10.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 74.23 110.849 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.765 ' CZ ' HD21 ' A' ' 79' ' ' LEU . 27.8 p90 -129.23 167.44 17.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 75.43 110.931 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -116.63 120.04 37.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 73.22 110.86 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.741 ' HB1' HG22 ' A' ' 35' ' ' VAL . . . -127.73 116.83 20.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 72.32 111.07 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.6 m -106.89 117.89 35.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 45.53 111.115 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.045 HG22 HG13 ' A' ' 33' ' ' VAL . 55.0 t -113.93 141.22 30.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 63.01 111.126 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.644 HG12 ' HB3' ' A' ' 32' ' ' ARG . 3.7 p -131.42 118.75 41.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 63.04 111.105 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.545 ' OG ' ' CE2' ' A' ' 52' ' ' PHE . 10.8 p -158.58 158.62 29.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.651 0.738 . . . . 62.44 110.862 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.577 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.1 Cg_endo -69.69 -22.71 32.01 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.697 2.265 . . . . 63.1 112.385 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.0 -39.2 40.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 73.42 111.116 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.596 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 3.3 m-85 -84.51 27.77 0.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 74.32 110.915 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 55' ' ' LYS . 2.1 p -52.25 138.65 10.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.113 -0.494 . . . . 44.13 111.147 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 54.85 -82.25 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.738 -0.744 . . . . 70.42 112.482 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 53' ' ' VAL . 16.6 pttm -119.23 135.69 54.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.328 . . . . 72.44 110.919 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.57 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -98.97 100.78 10.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.611 0.719 . . . . 70.54 111.068 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.5 Cg_endo -69.86 173.82 10.5 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.643 2.229 . . . . 63.34 112.339 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.38 -26.62 63.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 61.2 110.927 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.01 -52.96 63.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 53.21 111.128 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.596 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 3.7 mmt180 -71.57 -42.62 67.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 53.52 110.915 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.469 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -57.92 -53.17 61.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.095 -0.502 . . . . 74.11 110.912 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 -67.35 -37.67 83.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 74.11 110.912 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 40.0 mmm -55.1 -47.71 74.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 63.23 110.935 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 61' ' ' HIS . 19.6 m -69.58 -42.66 80.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.435 . . . . 70.34 111.151 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.679 ' CE1' HD13 ' A' ' 81' ' ' LEU . 13.3 m-85 -62.41 -36.98 84.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 74.23 110.891 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.48 -45.71 44.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 74.51 111.125 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.624 HG23 HD12 ' A' ' 68' ' ' LEU . 1.2 t -66.5 -26.62 67.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 74.42 111.16 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.647 HD12 HD11 ' A' ' 24' ' ' ILE . 7.5 mp -86.91 4.49 41.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 70.14 110.886 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.53 78.68 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.791 -0.719 . . . . 52.22 112.479 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -99.44 -48.25 4.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 74.33 110.896 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.0 mp -85.96 1.0 51.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.16 -0.473 . . . . 55.24 110.947 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 tpt -80.86 -13.31 59.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 72.32 110.861 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -123.0 -28.29 1.4 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 63.22 112.501 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.435 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . 106.62 35.3 2.87 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.685 -0.769 . . . . 60.31 112.479 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.69 155.67 15.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.73 0.3 . . . . 61.33 111.09 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 77' ' ' HIS . 7.9 mt -84.33 163.28 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 64.53 111.181 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.55 ' N ' HG22 ' A' ' 76' ' ' ILE . 66.0 m80 -60.16 -9.34 3.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 71.23 110.909 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 42' ' ' HIS . . . -77.43 45.72 0.49 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 73.24 111.08 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.765 HD21 ' CZ ' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -97.97 126.83 43.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.436 . . . . 51.24 110.902 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.4 ' N ' HD13 ' A' ' 79' ' ' LEU . 20.8 mp0 -106.75 114.76 29.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 72.41 110.917 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.679 HD13 ' CE1' ' A' ' 65' ' ' TYR . 9.0 tt -140.04 129.38 23.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 73.33 110.952 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -122.49 132.21 54.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 65.01 110.874 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.533 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 27.2 p -112.16 107.09 15.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 72.21 111.107 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.5 mt -124.04 162.07 24.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.26 -0.427 . . . . 34.41 110.959 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.414 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 0.5 OUTLIER -71.66 164.65 56.34 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.619 0.723 . . . . 43.52 111.111 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.577 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.0 Cg_endo -69.81 -18.85 36.53 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.67 2.247 . . . . 75.33 112.331 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -77.64 -25.64 49.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 71.15 110.91 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -83.01 18.77 1.55 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 62.45 110.891 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 63.02 111.104 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 18.3 mtt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.766 0.317 . . . . 71.24 110.856 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 86.5 mtt-85 -58.16 176.64 0.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 74.22 110.882 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -156.02 175.33 14.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 71.3 110.926 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -118.7 153.96 52.48 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.58 0.705 . . . . 71.03 110.844 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -172.72 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.651 2.234 . . . . 65.2 112.331 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.774 ' O ' HG23 ' A' ' 19' ' ' THR . 1.6 mp -104.05 -35.66 8.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 64.05 110.872 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -38.7 -71.08 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 74.32 110.84 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.76 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . -56.72 -28.59 61.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 73.21 111.084 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -71.14 -31.06 67.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 72.14 110.911 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.774 HG23 ' O ' ' A' ' 15' ' ' LEU . 1.3 p -67.22 -53.37 30.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 75.2 111.132 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.058 HD11 HG11 ' A' ' 35' ' ' VAL . 2.0 pp -70.06 -37.62 72.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 75.22 111.13 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.578 ' N ' HD12 ' A' ' 20' ' ' ILE . 38.0 ttp180 -61.32 -50.46 72.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 70.03 110.938 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.404 ' NZ ' ' HA ' ' A' ' 19' ' ' THR . 4.8 ptpp? -67.08 -40.0 86.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 64.22 110.878 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.8 mt -56.6 -49.86 73.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 75.03 110.893 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.714 ' CG2' HG21 ' A' ' 33' ' ' VAL . 12.3 mt -68.47 -43.8 83.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 75.45 111.113 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -55.58 -36.9 67.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 72.34 110.84 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.72 -43.0 32.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 71.22 110.845 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.8 -50.68 61.81 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.733 . . . . 63.22 112.463 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.501 HD13 ' CB ' ' A' ' 31' ' ' ALA . 5.0 mt -82.44 160.24 62.53 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.599 0.714 . . . . 64.34 110.884 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.424 ' HD2' ' CD2' ' A' ' 28' ' ' LEU . 54.3 Cg_endo -69.68 -91.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.729 2.286 . . . . 65.53 112.393 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -106.71 25.6 11.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 74.43 110.876 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.501 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -69.78 131.86 45.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 75.03 111.073 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.581 ' HB3' HG12 ' A' ' 48' ' ' VAL . 3.3 tpp85 -99.69 113.64 26.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 75.22 110.879 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.982 HG13 HG22 ' A' ' 47' ' ' VAL . 21.5 t -115.81 130.47 70.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 62.0 111.178 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -131.43 118.63 20.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 71.21 110.861 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.058 HG11 HD11 ' A' ' 20' ' ' ILE . 2.0 p -128.31 130.59 69.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 74.03 111.151 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.404 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 48.3 mt-30 -133.2 120.37 21.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 70.53 110.921 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 150.2 -125.14 1.88 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 64.31 112.505 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.647 ' O ' HG12 ' A' ' 41' ' ' VAL . 17.4 tt0 -175.1 162.48 3.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.817 0.342 . . . . 72.24 110.894 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -71.58 144.42 49.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 72.31 110.837 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.416 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.74 22.31 79.12 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.786 -0.721 . . . . 75.14 112.481 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -150.66 164.8 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.819 0.343 . . . . 72.35 111.173 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.402 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 45.8 p-80 -75.14 106.69 6.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 64.02 110.919 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.922 ' CE1' HD11 ' A' ' 79' ' ' LEU . 4.7 p90 -121.67 167.75 12.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 75.54 110.911 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -113.48 121.06 43.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 73.44 110.874 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.518 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -128.36 121.88 30.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 64.32 111.072 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.4 m -119.76 115.02 23.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 44.11 111.164 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.982 HG22 HG13 ' A' ' 33' ' ' VAL . 44.5 t -110.26 138.54 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 70.25 111.165 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.997 HG21 ' HB2' ' A' ' 89' ' ' ALA . 8.9 p -135.33 118.78 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 64.22 111.142 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.447 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.7 OUTLIER -161.19 165.72 16.44 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.614 0.721 . . . . 71.1 110.883 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.471 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.0 Cg_endo -69.74 -21.01 34.16 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.643 2.229 . . . . 54.21 112.362 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.723 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -47.31 -46.52 25.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 70.32 111.072 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.709 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -85.22 34.97 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.425 . . . . 75.43 110.889 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 55' ' ' LYS . 2.6 p -51.99 130.96 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 63.3 111.146 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 59.65 -76.08 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.804 -0.712 . . . . 60.55 112.498 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 53' ' ' VAL . 16.5 pttm -120.38 137.48 54.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 63.25 110.936 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.709 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -99.58 99.9 9.67 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.504 0.669 . . . . 73.53 111.118 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.82 171.25 14.87 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.695 2.263 . . . . 64.52 112.34 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.93 -27.97 61.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 72.34 110.945 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.459 ' O ' ' CG ' ' A' ' 63' ' ' MET . . . -58.15 -52.26 66.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 72.35 111.082 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.723 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 44.1 mmt-85 -70.37 -43.47 70.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 73.11 110.852 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.529 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.8 OUTLIER -57.74 -53.59 56.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 72.25 110.844 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -66.12 -36.15 82.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 71.21 110.864 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.459 ' CG ' ' O ' ' A' ' 59' ' ' ALA . 23.4 mmm -57.14 -46.49 82.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 74.13 110.881 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 61' ' ' HIS . 17.1 m -69.82 -40.21 78.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 74.4 111.152 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.58 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 13.7 m-85 -65.94 -34.44 78.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.145 -0.48 . . . . 72.11 110.882 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.14 -46.6 33.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 64.42 111.079 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.473 HG21 HG12 ' A' ' 24' ' ' ILE . 13.0 t -66.56 -28.46 68.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 74.34 111.14 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.621 ' HG ' HD13 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -82.47 -2.45 53.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 53.25 110.915 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.88 78.41 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.78 -0.724 . . . . 52.52 112.537 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 71' ' ' LEU . 12.1 pt-20 -90.02 -42.15 11.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.902 0.382 . . . . 74.43 110.883 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.469 ' N ' ' HG3' ' A' ' 70' ' ' GLU . 18.0 tp -89.45 7.94 33.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 72.33 110.9 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -13.02 60.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.446 . . . . 73.43 110.951 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.05 -30.27 0.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.708 -0.758 . . . . 35.03 112.446 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.416 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . 130.27 48.86 0.12 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.722 -0.751 . . . . 4.33 112.499 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.53 140.87 55.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.347 . . . . 40.45 111.132 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.52 HG22 ' N ' ' A' ' 77' ' ' HIS . 4.0 mp -99.77 160.46 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 42.3 111.092 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.52 ' N ' HG22 ' A' ' 76' ' ' ILE . 52.6 t60 -53.66 -14.81 0.97 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 73.42 110.897 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.94 40.06 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 74.13 111.084 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.922 HD11 ' CE1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -98.77 128.48 45.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.318 -0.401 . . . . 74.52 110.934 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.406 ' N ' HD13 ' A' ' 79' ' ' LEU . 4.8 mt-30 -97.53 116.84 30.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 34.1 110.872 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.58 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 1.7 tm? -139.04 117.92 12.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 73.2 110.906 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.566 ' N ' HD13 ' A' ' 81' ' ' LEU . 4.0 mptp? -122.21 133.01 54.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 74.31 110.963 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.55 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 68.4 p -117.24 107.63 14.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 73.32 111.132 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.9 mt -127.76 161.04 29.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 62.42 110.903 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.483 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.15 163.8 64.28 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.631 0.729 . . . . 63.33 111.097 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.471 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.2 Cg_endo -69.81 -4.73 14.65 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.722 2.281 . . . . 74.11 112.304 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -94.18 -27.92 15.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 63.13 110.829 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -105.31 39.72 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 73.13 110.853 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.997 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 74.44 111.084 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.728 0.299 . . . . 74.42 110.836 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -105.01 -55.67 2.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 74.33 110.964 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -105.11 137.38 42.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 62.23 110.901 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -129.27 144.66 53.63 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.584 0.706 . . . . 63.53 110.951 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.78 -164.64 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.634 2.223 . . . . 72.05 112.341 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.485 ' C ' HD12 ' A' ' 15' ' ' LEU . 2.8 pp -106.35 24.0 13.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.231 -0.44 . . . . 63.33 110.958 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -66.8 179.69 1.04 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 75.4 110.864 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.112 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . -46.52 -26.03 0.8 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 52.51 111.145 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -40.53 94.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 73.33 110.872 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.577 ' CG2' ' N ' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -60.74 -47.89 84.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 43.14 111.118 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.794 HD11 HG11 ' A' ' 35' ' ' VAL . 43.6 pt -66.36 -39.26 83.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 52.34 111.122 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.484 ' N ' HG13 ' A' ' 20' ' ' ILE . 20.9 ttp85 -61.62 -42.22 98.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 63.22 110.85 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.62 -46.2 69.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 72.43 110.896 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -56.28 -49.06 75.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 74.41 110.957 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.813 ' CG2' HG21 ' A' ' 33' ' ' VAL . 7.9 mt -65.77 -45.31 92.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 74.24 111.117 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -53.86 -39.75 65.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 73.14 110.945 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -79.8 -32.47 40.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 70.31 110.798 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.24 -60.73 4.96 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.828 -0.701 . . . . 24.32 112.441 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.491 HD13 ' CB ' ' A' ' 31' ' ' ALA . 10.2 mt -72.65 159.29 85.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.569 0.7 . . . . 72.33 110.926 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -91.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.66 2.24 . . . . 54.35 112.347 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -105.38 38.9 1.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 64.33 110.846 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.491 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -91.35 125.75 36.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 71.5 111.072 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.624 ' HB3' HG12 ' A' ' 48' ' ' VAL . 8.0 tpp180 -95.67 109.65 21.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 71.34 110.881 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.027 HG22 HG13 ' A' ' 47' ' ' VAL . 39.0 t -109.12 125.4 66.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 62.41 111.101 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -135.35 117.53 15.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 64.13 110.831 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.112 HG13 ' HB1' ' A' ' 17' ' ' ALA . 5.1 p -126.88 139.78 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 74.52 111.13 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -129.19 120.99 26.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.461 . . . . 70.24 110.92 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.478 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 144.16 -135.07 6.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 72.53 112.488 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.517 ' O ' HG12 ' A' ' 41' ' ' VAL . 10.9 tt0 -168.67 172.05 8.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 71.43 110.915 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -77.15 150.63 35.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 73.11 110.861 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.58 1.25 52.28 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.741 -0.742 . . . . 71.44 112.442 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 38' ' ' GLU . 2.0 p -131.23 164.55 33.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.855 0.36 . . . . 65.32 111.151 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.525 ' CG ' ' O ' ' A' ' 42' ' ' HIS . 10.0 p80 -75.21 107.35 7.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 73.22 110.876 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.513 ' CE2' HD11 ' A' ' 79' ' ' LEU . 48.8 p90 -125.37 167.52 14.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 74.24 110.884 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -114.02 124.61 52.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 42.11 110.887 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 81' ' ' LEU . . . -117.74 115.4 24.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 61.41 111.081 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 m -114.92 106.65 14.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 62.51 111.217 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.027 HG13 HG22 ' A' ' 33' ' ' VAL . 59.9 t -112.54 125.95 69.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 53.42 111.102 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 89' ' ' ALA . 3.9 p -114.4 118.57 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 75.3 111.173 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.499 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 14.9 p -159.33 158.66 28.38 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.663 0.744 . . . . 72.12 110.859 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.564 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.4 Cg_endo -69.68 -21.26 34.1 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.699 2.266 . . . . 75.02 112.352 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.53 -42.16 43.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 63.52 111.129 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.598 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 2.5 m-85 -84.04 30.18 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 74.51 110.838 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 55' ' ' LYS . 2.9 p -52.02 135.58 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 65.14 111.1 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.18 -82.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.745 -0.74 . . . . 53.41 112.46 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 53' ' ' VAL . 30.9 mmmt -115.62 135.97 53.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.824 0.345 . . . . 65.23 110.891 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.538 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -99.14 100.55 10.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.623 0.725 . . . . 75.31 111.092 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 54.3 Cg_endo -69.67 171.03 15.11 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.718 2.279 . . . . 75.43 112.333 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.491 HD21 ' NE ' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -55.62 -27.82 51.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 74.31 110.956 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.18 -52.64 64.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 74.21 111.135 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.598 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 7.7 mmt180 -70.98 -42.13 70.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 65.11 110.839 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.432 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.5 OUTLIER -57.61 -52.02 67.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 75.41 110.863 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.491 ' NE ' HD21 ' A' ' 58' ' ' LEU . 44.8 mtt180 -68.16 -37.48 81.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 64.52 110.801 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.1 mmt -55.51 -49.0 73.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 64.45 110.875 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.491 ' HA ' HG22 ' A' ' 67' ' ' THR . 18.6 m -67.89 -45.1 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 60.02 111.111 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.851 ' CE1' HD13 ' A' ' 81' ' ' LEU . 13.2 m-85 -57.75 -36.77 72.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.45 . . . . 73.22 110.894 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.55 -46.03 41.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 43.12 111.093 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.536 HG21 HG12 ' A' ' 24' ' ' ILE . 1.7 t -72.58 -12.89 61.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 72.12 111.136 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.741 HD23 HD12 ' A' ' 20' ' ' ILE . 27.1 mt -93.76 3.29 55.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 61.13 110.887 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 55.57 66.97 2.46 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 54.14 112.524 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -81.04 -39.41 25.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.912 0.387 . . . . 54.04 110.908 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.9 mt -90.18 10.08 25.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 73.22 110.894 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 22.9 mmt -71.79 -9.0 57.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 65.04 110.832 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.54 -31.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 75.13 112.52 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.85 107.3 0.61 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.761 -0.733 . . . . 64.41 112.533 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.16 123.58 29.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.725 0.297 . . . . 63.42 111.156 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.571 ' O ' HD23 ' A' ' 79' ' ' LEU . 3.7 mp -113.24 163.16 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 65.25 111.102 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.536 ' N ' HG22 ' A' ' 76' ' ' ILE . 25.6 p-80 -60.47 -9.45 3.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 71.34 110.872 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.52 26.84 0.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 74.13 111.137 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 76' ' ' ILE . 2.2 mm? -99.16 134.36 42.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 70.41 110.907 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -120.31 115.67 24.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 55.51 110.87 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.851 HD13 ' CE1' ' A' ' 65' ' ' TYR . 4.5 tt -127.94 140.61 51.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 74.2 110.957 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.39 115.69 12.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 61.22 110.979 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.542 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 11.8 p -105.46 106.87 17.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 64.12 111.086 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.5 mt -122.97 162.08 22.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 73.03 110.977 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.435 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 0.2 OUTLIER -71.33 165.82 44.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.61 0.719 . . . . 71.35 111.119 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.7 Cg_endo -69.69 -24.71 29.69 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.697 2.265 . . . . 74.02 112.393 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.28 -31.77 72.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 70.14 110.897 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -70.56 -32.39 69.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 72.22 110.903 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.664 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 71.51 111.134 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 7.2 mtm . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.811 0.339 . . . . 63.4 110.891 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -45.59 140.44 3.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 75.15 110.838 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -142.9 111.78 6.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 72.41 110.84 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -105.1 93.8 7.0 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.563 0.697 . . . . 73.13 110.866 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 101.97 0.98 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.647 2.231 . . . . 63.05 112.311 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.1 mt -88.98 168.62 12.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 72.31 110.957 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.441 ' O ' ' CG2' ' A' ' 19' ' ' THR . 11.6 t0 -53.53 -53.5 50.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.458 . . . . 73.51 110.832 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.581 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -67.91 -24.77 65.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.424 . . . . 34.34 111.161 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -70.86 -47.94 56.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 73.11 110.844 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.441 ' CG2' ' O ' ' A' ' 16' ' ' ASP . 1.9 t -61.34 -45.1 95.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 62.42 111.112 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.74 HD12 HD23 ' A' ' 68' ' ' LEU . 6.4 pt -71.55 -42.5 72.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 64.45 111.165 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 58.9 ttt180 -60.5 -48.0 83.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 73.43 110.855 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -66.08 -42.85 88.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 75.44 110.872 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 23' ' ' LEU . 12.1 mt -56.07 -48.31 76.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.452 . . . . 71.33 110.912 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.791 HG21 HG21 ' A' ' 33' ' ' VAL . 13.3 mt -68.41 -45.22 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 71.24 111.106 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -54.58 -37.12 65.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 70.22 110.879 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.91 -42.97 31.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 71.44 110.885 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.38 -49.9 73.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 65.21 112.499 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.608 HD13 ' CG2' ' A' ' 24' ' ' ILE . 5.8 mp -89.57 154.06 48.26 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.7 0.762 . . . . 70.44 110.845 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 -91.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.725 2.283 . . . . 63.33 112.317 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -100.16 54.74 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 72.5 110.897 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.97 137.66 42.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 54.42 111.143 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.645 ' HB3' HG12 ' A' ' 48' ' ' VAL . 4.7 tmm_? -106.43 117.38 33.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 74.44 110.852 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.948 HG13 HG22 ' A' ' 47' ' ' VAL . 38.0 t -122.2 130.27 74.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 64.4 111.181 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -135.26 118.52 16.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 71.32 110.949 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.884 HG13 ' HB2' ' A' ' 45' ' ' ALA . 7.6 t -122.79 131.55 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 65.23 111.124 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.403 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 1.9 tp60 -133.53 120.0 20.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 63.34 110.937 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.08 -141.62 9.81 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 53.22 112.47 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -155.05 179.95 8.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 74.24 110.832 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -86.96 144.25 27.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 63.33 110.85 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.425 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.69 22.3 79.1 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.757 -0.735 . . . . 73.22 112.455 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 42' ' ' HIS . 2.5 p -148.84 164.93 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.808 0.337 . . . . 63.5 111.166 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.415 ' H ' HG22 ' A' ' 41' ' ' VAL . 15.8 p80 -74.95 106.75 6.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 64.33 110.862 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.418 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 8.1 p90 -120.5 167.39 12.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 63.12 110.881 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -118.29 119.18 33.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 73.14 110.836 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.884 ' HB2' HG13 ' A' ' 35' ' ' VAL . . . -128.99 115.57 18.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 63.35 111.148 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.461 HG23 ' HB2' ' A' ' 82' ' ' LYS . 38.7 m -103.86 125.64 50.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.479 . . . . 74.12 111.084 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.948 HG22 HG13 ' A' ' 33' ' ' VAL . 88.1 t -122.3 133.82 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 61.51 111.136 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.645 HG12 ' HB3' ' A' ' 32' ' ' ARG . 4.1 p -130.11 118.61 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 65.34 111.138 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.464 ' CB ' ' HD2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -158.64 168.06 13.19 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.629 0.728 . . . . 62.33 110.797 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.515 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.1 Cg_endo -69.75 -28.52 25.2 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.604 2.203 . . . . 71.45 112.388 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.731 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -48.65 -42.17 33.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 61.01 111.126 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.559 ' CD2' ' HB ' ' A' ' 83' ' ' THR . 1.4 m-85 -83.86 31.38 0.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 72.32 110.89 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.591 ' HA ' HG23 ' A' ' 85' ' ' THR . 1.8 p -54.36 132.1 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 61.54 111.177 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.93 -80.2 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.74 -0.743 . . . . 32.13 112.511 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -116.91 136.52 52.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.757 0.313 . . . . 51.51 110.92 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.426 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -99.07 100.5 10.15 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.579 0.704 . . . . 71.23 111.099 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.76 172.48 12.57 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.696 2.264 . . . . 65.23 112.309 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 tp -55.99 -25.07 42.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 71.12 110.909 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 63' ' ' MET . . . -59.26 -53.31 59.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 64.31 111.116 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.731 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 8.7 mmt180 -71.77 -40.43 69.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 73.32 110.915 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.44 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.1 t-160 -59.84 -51.91 67.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 74.24 110.885 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -67.4 -39.05 85.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 71.54 110.891 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 4.9 tmm? -54.89 -52.11 63.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 74.45 110.858 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.538 ' O ' HG22 ' A' ' 67' ' ' THR . 25.5 m -63.83 -44.9 98.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.303 -0.408 . . . . 72.13 111.072 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.475 ' N ' HG23 ' A' ' 64' ' ' VAL . 12.8 m-85 -60.37 -31.24 70.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 73.0 110.885 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.04 -46.66 33.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 61.11 111.099 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.538 HG22 ' O ' ' A' ' 64' ' ' VAL . 3.8 t -67.12 -26.6 66.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 74.02 111.134 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.74 HD23 HD12 ' A' ' 20' ' ' ILE . 12.9 mt -83.0 8.88 11.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 72.15 110.887 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.14 66.94 1.33 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.736 . . . . 60.34 112.508 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.478 ' HG3' HD23 ' A' ' 71' ' ' LEU . 10.0 pt-20 -70.39 -42.8 71.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.875 0.369 . . . . 73.43 110.845 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.478 HD23 ' HG3' ' A' ' 70' ' ' GLU . 4.4 mm? -90.01 7.62 36.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 64.13 110.93 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.0 ttm -71.92 -12.99 61.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 74.21 110.877 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.26 -33.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.777 -0.725 . . . . 72.3 112.501 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.425 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . 130.3 59.3 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.643 -0.789 . . . . 63.14 112.449 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.02 147.17 35.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.73 0.3 . . . . 74.21 111.097 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 76' ' ' ILE . 4.0 mp -113.11 152.91 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 51.42 111.111 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -46.38 -20.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 74.3 110.877 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.63 47.73 0.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 54.44 111.065 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 79' ' ' LEU . 8.8 mt -104.24 126.9 51.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 73.24 110.914 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -96.93 115.4 27.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.462 . . . . 61.03 110.903 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 tp -139.22 144.19 38.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 75.02 110.937 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HB2' HG23 ' A' ' 46' ' ' THR . 0.6 OUTLIER -136.27 114.48 11.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 64.11 110.901 179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.559 ' HB ' ' CD2' ' A' ' 52' ' ' PHE . 44.5 p -99.41 107.72 20.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 65.24 111.17 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.778 HD22 ' OE1' ' A' ' 88' ' ' GLU . 26.9 mt -130.78 160.35 34.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.176 -0.466 . . . . 71.01 110.915 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.591 HG23 ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -73.63 164.11 63.49 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.633 0.73 . . . . 71.21 111.142 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.8 Cg_endo -69.72 -8.79 24.5 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.689 2.259 . . . . 65.42 112.318 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -77.58 -35.96 52.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 63.52 110.918 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.778 ' OE1' HD22 ' A' ' 84' ' ' LEU . 18.0 mt-10 -70.36 -32.57 70.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 74.34 110.796 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 52.15 111.17 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 14.2 mtt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.838 0.351 . . . . 62.43 110.906 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -53.54 -51.91 61.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 55.43 110.849 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.04 100.49 7.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 74.41 110.881 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -115.39 80.73 7.94 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.653 0.739 . . . . 63.53 110.893 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -172.67 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.711 2.274 . . . . 63.54 112.431 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 pp -117.31 25.04 10.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.286 -0.415 . . . . 64.12 110.94 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -120.72 -70.56 0.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.155 -0.475 . . . . 75.31 110.914 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.793 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . -67.18 -32.58 73.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 71.03 111.093 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -71.61 -41.14 69.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 71.31 110.866 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.5 p -61.03 -53.0 62.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 73.55 111.15 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.714 HD11 HG11 ' A' ' 35' ' ' VAL . 12.3 pt -68.3 -42.72 84.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 72.53 111.155 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.501 ' N ' HG13 ' A' ' 20' ' ' ILE . 39.9 ttp85 -59.56 -46.49 88.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 75.54 110.88 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -66.82 -41.21 87.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 62.54 110.918 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.3 mt -56.64 -49.46 74.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 71.14 110.867 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.76 ' CG2' HG21 ' A' ' 33' ' ' VAL . 10.6 mt -67.56 -41.95 86.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 71.2 111.131 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -55.7 -41.1 73.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 73.11 110.913 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.72 -43.28 55.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 75.33 110.876 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.35 -51.86 53.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.747 . . . . 73.43 112.406 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.599 HD23 ' CB ' ' A' ' 31' ' ' ALA . 7.3 mp -80.71 156.31 72.92 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.594 0.712 . . . . 74.55 110.88 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -90.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.657 2.238 . . . . 64.44 112.375 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -105.96 27.36 8.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 74.15 110.863 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.599 ' CB ' HD23 ' A' ' 28' ' ' LEU . . . -75.81 144.45 41.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 74.44 111.048 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.692 ' HB3' HG12 ' A' ' 48' ' ' VAL . 58.2 ttt180 -110.96 124.83 52.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 74.44 110.849 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.1 HG13 HG22 ' A' ' 47' ' ' VAL . 5.9 t -124.17 129.44 74.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 62.34 111.153 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -131.44 118.98 20.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 53.13 110.846 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.793 HG13 ' HB1' ' A' ' 17' ' ' ALA . 1.6 p -126.73 134.34 66.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 64.12 111.105 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -133.45 120.3 20.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 74.13 110.897 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.56 -130.39 4.55 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.731 -0.747 . . . . 71.41 112.529 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -174.06 160.98 3.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.919 0.39 . . . . 72.51 110.871 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -67.69 151.95 46.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 70.53 110.887 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.419 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.74 10.12 75.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.752 -0.737 . . . . 75.43 112.533 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 42' ' ' HIS . 7.3 t -143.95 165.15 14.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.834 0.35 . . . . 54.14 111.159 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.524 ' N ' HG12 ' A' ' 41' ' ' VAL . 12.7 p80 -74.52 108.85 7.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 62.43 110.783 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.808 ' CE1' HD11 ' A' ' 79' ' ' LEU . 40.0 p90 -125.09 167.47 14.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 74.01 110.826 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -119.43 120.11 35.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 75.23 110.903 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.2 115.28 18.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 63.25 111.126 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.7 m -108.41 119.42 39.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 54.55 111.181 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.1 HG22 HG13 ' A' ' 33' ' ' VAL . 96.8 t -112.74 136.59 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 64.21 111.183 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.725 HG21 ' HB2' ' A' ' 89' ' ' ALA . 2.7 p -128.76 125.55 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 73.41 111.084 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.453 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.8 OUTLIER -172.45 164.84 3.81 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.648 0.737 . . . . 73.22 110.863 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.495 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.4 Cg_endo -69.74 -22.43 32.2 Favored 'Trans proline' 0 N--CA 1.466 -0.127 0 C-N-CA 122.705 2.27 . . . . 71.14 112.362 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.778 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -47.72 -41.99 24.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 73.22 111.043 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.768 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -89.27 35.9 0.82 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 63.13 110.904 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.5 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 6.7 p -52.41 139.33 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 64.14 111.138 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 56.38 -89.28 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.756 -0.735 . . . . 70.42 112.5 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HD2' ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -117.9 111.16 18.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.732 0.301 . . . . 70.22 110.919 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.768 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -60.03 108.48 1.43 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.635 0.731 . . . . 63.12 111.09 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 54.2 Cg_endo -69.71 160.76 48.52 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.67 2.247 . . . . 74.5 112.374 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tp -54.81 -26.76 36.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 74.11 110.86 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.02 -52.39 65.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 55.22 111.071 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.778 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 30.7 mmt-85 -69.46 -41.07 76.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 74.3 110.857 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.426 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.9 OUTLIER -59.07 -53.46 58.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 63.45 110.808 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 52.0 mtt-85 -67.1 -35.05 78.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 75.03 110.924 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.0 tpp -58.37 -51.6 69.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 65.45 110.875 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.659 ' O ' HG22 ' A' ' 67' ' ' THR . 20.7 m -64.05 -44.66 97.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 70.52 111.204 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.76 ' CE1' HD13 ' A' ' 81' ' ' LEU . 14.1 m-85 -59.17 -38.85 80.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 75.31 110.955 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.72 -32.85 60.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 70.04 111.096 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 64' ' ' VAL . 0.6 OUTLIER -71.57 -27.09 62.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 72.04 111.142 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.527 ' C ' HD12 ' A' ' 68' ' ' LEU . 3.5 pp -88.66 -10.5 48.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 72.21 110.95 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.523 ' N ' HD12 ' A' ' 68' ' ' LEU . . . 53.69 75.1 0.25 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.705 -0.76 . . . . 44.23 112.505 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.526 ' HG2' HD11 ' A' ' 68' ' ' LEU . 4.6 pt-20 -91.38 -42.51 10.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.858 0.361 . . . . 63.14 110.88 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.686 HD13 ' O ' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -84.44 -10.11 57.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 63.31 110.891 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.5 mmt -72.51 -13.72 61.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 53.41 110.896 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -126.72 -14.08 2.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.8 -0.714 . . . . 40.02 112.499 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.419 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . 99.52 35.81 4.54 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.689 -0.767 . . . . 74.54 112.475 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.76 142.31 53.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 74.31 111.11 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.709 ' H ' HD12 ' A' ' 76' ' ' ILE . 3.6 mp -82.66 160.83 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 65.4 111.168 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.513 ' N ' HG22 ' A' ' 76' ' ' ILE . 38.8 t-80 -58.19 -10.67 2.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 73.04 110.852 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.73 47.61 0.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 73.3 111.155 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.808 HD11 ' CE1' ' A' ' 43' ' ' PHE . 7.9 tp -105.0 133.14 50.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 64.31 110.912 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -111.47 115.46 29.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 74.4 110.929 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.76 HD13 ' CE1' ' A' ' 65' ' ' TYR . 8.4 tt -139.43 129.41 24.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 74.55 110.99 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -123.58 135.95 54.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 74.05 110.91 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.54 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 14.0 p -119.43 106.94 12.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.302 -0.408 . . . . 43.02 111.163 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.7 mp -124.9 161.59 26.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 74.31 110.902 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.5 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.3 OUTLIER -71.99 164.74 56.31 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.694 0.759 . . . . 65.53 111.035 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.4 Cg_endo -69.84 -12.32 32.5 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.684 2.256 . . . . 63.14 112.302 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -75.45 -35.81 60.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 72.12 110.876 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.45 -39.86 77.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 61.23 110.903 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.725 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 63.01 111.116 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.472 ' O ' ' C ' ' A' ' 11' ' ' ARG . 22.3 ptp . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.735 0.302 . . . . 74.2 110.869 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.472 ' C ' ' O ' ' A' ' 10' ' ' MET . 0.0 OUTLIER 32.45 41.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 74.41 110.873 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.485 ' HB2' HD13 ' A' ' 15' ' ' LEU . 29.6 mtpt -78.15 98.34 5.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 65.43 110.889 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.648 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 6.3 ttt85 -68.34 -51.52 24.37 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.582 0.706 . . . . 75.53 110.831 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.648 ' HD2' ' N ' ' A' ' 13' ' ' ARG . 53.3 Cg_endo -69.79 14.43 0.26 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.693 2.262 . . . . 74.22 112.311 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.485 HD13 ' HB2' ' A' ' 12' ' ' LYS . 5.9 tp -39.26 161.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 40.22 110.865 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -85.24 -50.01 7.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.479 . . . . 52.12 110.922 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.466 ' O ' ' CB ' ' A' ' 21' ' ' ARG . . . -68.37 -30.47 69.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 63.42 111.102 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.401 ' CB ' ' HB3' ' A' ' 15' ' ' LEU . 7.2 tp10 -68.77 -48.69 63.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 75.04 110.883 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 15' ' ' LEU . 3.2 t -62.0 -48.32 80.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 74.25 111.181 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.706 HD12 ' N ' ' A' ' 21' ' ' ARG . 2.3 pp -69.3 -39.73 79.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 72.34 111.169 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.706 ' N ' HD12 ' A' ' 20' ' ' ILE . 33.0 ttp85 -59.39 -45.96 90.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 73.3 110.862 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -68.95 -41.26 78.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 62.54 110.86 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 23' ' ' LEU . 16.0 mt -56.3 -49.19 74.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 54.43 110.884 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.754 ' CG2' HG21 ' A' ' 33' ' ' VAL . 16.2 mt -69.88 -41.68 79.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 72.32 111.11 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -56.26 -37.03 69.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 75.31 110.851 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.31 -42.86 24.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 43.32 110.905 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.95 -52.03 51.06 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.776 -0.726 . . . . 62.35 112.453 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.517 HD23 ' CG2' ' A' ' 24' ' ' ILE . 4.1 mm? -79.53 158.02 74.15 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.645 0.736 . . . . 61.42 110.872 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -90.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.709 2.273 . . . . 73.13 112.354 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -105.18 27.71 7.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 65.03 110.873 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.485 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . . . -78.22 129.41 35.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 71.53 111.103 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.627 ' HB3' HG12 ' A' ' 48' ' ' VAL . 7.6 tpt180 -101.42 113.52 26.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 62.33 110.892 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.059 HG13 HG22 ' A' ' 47' ' ' VAL . 11.6 t -113.44 127.69 70.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 63.44 111.131 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -134.08 118.24 17.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 70.12 110.888 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.561 ' CG2' HD11 ' A' ' 20' ' ' ILE . 61.7 t -122.71 137.53 55.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 60.41 111.131 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 4.2 tt0 -133.9 119.39 19.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 71.12 110.987 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.466 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 146.1 -132.54 4.55 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 42.41 112.459 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.465 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 0.4 OUTLIER -171.68 162.37 6.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 74.03 110.915 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.41 145.7 53.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 51.32 110.817 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.9 -15.97 9.33 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.703 -0.761 . . . . 34.33 112.471 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' A' ' 38' ' ' GLU . 13.1 m -112.96 164.86 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.919 0.39 . . . . 71.32 111.112 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.94 106.9 6.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 74.13 110.886 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.788 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 4.4 p90 -120.94 167.21 12.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 75.21 110.85 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -119.47 123.62 44.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 73.54 110.836 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.594 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -117.66 115.97 26.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 74.15 111.085 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.2 m -110.8 108.05 17.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 72.41 111.17 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.059 HG22 HG13 ' A' ' 33' ' ' VAL . 95.2 t -109.76 141.27 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 72.32 111.152 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.747 HG21 ' HB2' ' A' ' 89' ' ' ALA . 5.1 p -134.65 118.49 26.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 60.43 111.117 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -164.03 165.98 12.67 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.67 0.748 . . . . 73.22 110.817 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.526 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.8 Cg_endo -69.78 -28.57 25.01 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.693 2.262 . . . . 72.32 112.33 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.663 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -51.27 -34.05 31.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 73.43 111.06 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.599 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 3.9 m-85 -90.78 31.06 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 75.3 110.893 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.681 ' HA ' HG23 ' A' ' 85' ' ' THR . 8.4 p -61.21 143.55 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 75.13 111.143 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 52.41 -90.99 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.728 -0.749 . . . . 71.3 112.496 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.9 OUTLIER -120.06 104.77 10.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.774 0.321 . . . . 62.1 110.934 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -59.49 109.22 1.76 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.624 0.726 . . . . 64.41 111.064 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.9 Cg_endo -69.81 168.81 20.56 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.67 2.247 . . . . 74.1 112.334 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tp -53.86 -26.62 25.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 71.3 110.925 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.35 -53.05 62.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 75.14 111.106 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.663 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 21.3 mmt180 -69.88 -41.67 74.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 64.55 110.926 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.534 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.2 t-160 -59.49 -53.4 58.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 74.13 110.845 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.6 mtp180 -66.53 -35.85 81.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 72.41 110.837 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 10.9 tpt -58.35 -45.86 87.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 75.4 110.933 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.626 ' O ' HD13 ' A' ' 68' ' ' LEU . 19.6 m -70.19 -40.38 78.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 72.15 111.13 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.704 ' CE1' HD13 ' A' ' 81' ' ' LEU . 13.6 m-85 -65.71 -34.76 78.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 73.04 110.949 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.61 -46.29 32.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 71.24 111.045 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.562 HG23 HD11 ' A' ' 24' ' ' ILE . 3.5 t -66.91 -28.37 68.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 74.0 111.109 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.626 HD13 ' O ' ' A' ' 64' ' ' VAL . 3.8 mp -82.57 -8.82 59.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 63.45 110.91 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.27 80.01 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.687 -0.768 . . . . 53.45 112.552 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.443 ' C ' ' HB2' ' A' ' 75' ' ' ALA . 56.1 mt-10 -91.22 -25.31 19.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.897 0.38 . . . . 72.03 110.889 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.1 mp -89.96 9.98 25.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.098 -0.501 . . . . 71.42 110.965 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 7.0 ptp -74.42 -13.22 60.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 74.01 110.83 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.3 -32.93 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.748 -0.739 . . . . 65.0 112.503 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.88 73.9 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.761 -0.733 . . . . 51.25 112.487 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.443 ' HB2' ' C ' ' A' ' 70' ' ' GLU . . . -59.35 123.54 17.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.828 0.346 . . . . 55.42 111.061 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 77' ' ' HIS . 18.6 mm -113.56 163.42 10.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.479 . . . . 74.45 111.102 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.55 ' N ' HG22 ' A' ' 76' ' ' ILE . 74.0 m80 -65.2 -4.88 5.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.186 -0.461 . . . . 62.41 110.823 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.47 47.21 1.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 70.33 111.091 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.788 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 1.1 mm? -115.47 133.85 55.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 72.03 110.97 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -114.35 115.61 27.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 75.1 110.883 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.704 HD13 ' CE1' ' A' ' 65' ' ' TYR . 1.4 tt -126.33 144.99 50.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 75.23 110.937 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -136.26 123.84 22.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 52.12 110.866 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.585 ' HB ' ' CD2' ' A' ' 52' ' ' PHE . 30.1 p -116.06 107.75 15.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 65.23 111.131 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mp -128.3 160.67 31.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 75.03 110.92 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.681 HG23 ' HA ' ' A' ' 53' ' ' VAL . 0.3 OUTLIER -72.5 164.94 55.91 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.606 0.717 . . . . 73.22 111.139 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.1 Cg_endo -69.77 -16.37 37.5 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 2.245 . . . . 71.42 112.375 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -73.03 -35.9 66.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 72.42 110.817 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -67.82 -38.03 82.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 75.11 110.839 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.747 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 71.24 111.144 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 14.9 ptp . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.761 0.315 . . . . 74.25 110.941 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -84.01 145.05 28.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 71.35 110.894 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -98.75 35.6 1.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 73.24 110.874 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -115.15 65.37 1.9 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.596 0.713 . . . . 74.4 110.876 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 150.92 68.69 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.668 2.245 . . . . 53.04 112.319 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.1 mt -128.15 -69.73 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 73.11 110.927 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -125.83 -69.05 0.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.469 . . . . 73.43 110.914 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.473 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . -68.61 -31.9 71.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 45.33 111.139 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -72.83 -48.04 41.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 72.5 110.906 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.462 HG23 ' N ' ' A' ' 20' ' ' ILE . 2.7 t -57.8 -50.15 74.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 64.15 111.139 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 21' ' ' ARG . 25.9 pt -68.01 -42.16 85.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 72.33 111.152 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.5 ' N ' HG13 ' A' ' 20' ' ' ILE . 54.3 ttt-85 -55.01 -53.16 59.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 74.33 110.834 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.5 mttt -66.15 -35.86 81.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 74.13 110.94 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -56.37 -49.18 75.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 53.44 110.945 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.825 ' CG2' HG21 ' A' ' 33' ' ' VAL . 5.8 mt -70.9 -44.34 76.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 61.53 111.135 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -53.89 -36.85 63.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 72.21 110.869 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.51 -41.48 21.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 75.11 110.818 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.61 -55.5 24.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.798 -0.715 . . . . 63.24 112.481 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 4.3 mm? -72.89 159.36 85.51 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.641 0.734 . . . . 75.34 110.945 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -90.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.649 2.233 . . . . 65.3 112.368 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -107.29 27.24 9.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.423 . . . . 73.22 110.895 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . . . -79.07 126.77 31.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 71.34 111.058 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.512 ' HB2' ' CG1' ' A' ' 48' ' ' VAL . 3.7 mmm180 -93.86 109.01 20.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 73.31 110.905 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.825 HG21 ' CG2' ' A' ' 24' ' ' ILE . 53.0 t -113.65 121.45 65.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 72.25 111.102 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -132.34 118.11 18.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 75.33 110.897 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.473 HG13 ' HB1' ' A' ' 17' ' ' ALA . 2.2 p -127.08 135.63 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 70.21 111.162 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -133.57 120.14 20.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 72.14 110.903 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.88 -128.19 2.92 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.727 -0.749 . . . . 23.4 112.436 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.439 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 11.8 pt-20 -175.27 171.17 2.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.811 0.339 . . . . 74.42 110.838 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -75.29 147.42 40.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.132 -0.485 . . . . 71.13 110.819 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.71 16.72 77.9 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.716 -0.754 . . . . 53.13 112.435 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.439 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 1.8 t -146.62 164.01 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 65.02 111.161 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 32.5 p80 -75.98 106.62 7.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 73.31 110.835 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.764 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 4.5 p90 -119.26 166.22 13.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 75.03 110.836 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -115.4 121.17 41.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 72.22 110.892 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 81' ' ' LEU . . . -128.17 115.09 17.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 72.12 111.072 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.1 m -111.81 116.16 30.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 73.45 111.1 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.771 ' CG2' HG13 ' A' ' 33' ' ' VAL . 28.6 t -120.58 126.11 74.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 74.24 111.148 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.512 ' CG1' ' HB2' ' A' ' 32' ' ' ARG . 6.4 p -124.06 118.8 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 75.04 111.174 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.446 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -160.61 166.63 15.17 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.611 0.719 . . . . 53.13 110.8 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.517 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.3 Cg_endo -69.82 -21.82 32.66 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.687 2.258 . . . . 74.34 112.297 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.67 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -46.65 -45.19 19.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 74.34 111.12 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.639 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -87.47 36.92 0.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 75.53 110.936 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.492 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 4.1 p -52.34 124.37 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 74.35 111.128 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.57 -89.05 0.73 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.791 -0.719 . . . . 34.35 112.47 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.426 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -119.52 111.24 17.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.82 0.343 . . . . 43.3 110.934 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.639 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -58.38 108.0 1.15 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.536 0.684 . . . . 60.0 111.149 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.5 Cg_endo -69.83 162.59 41.51 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.65 2.234 . . . . 74.3 112.366 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -58.0 -27.05 63.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 62.33 110.916 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.82 -52.39 65.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 71.23 111.079 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.67 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 16.5 mmt180 -69.09 -41.18 77.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.473 . . . . 71.55 110.908 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.467 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -60.66 -53.54 56.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 65.15 110.836 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.9 mtp85 -66.68 -33.35 75.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 75.25 110.87 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.3 mmt -60.81 -49.69 76.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 73.42 110.833 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.605 ' O ' HG22 ' A' ' 67' ' ' THR . 19.2 m -65.21 -43.0 95.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 75.12 111.166 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.98 ' CE1' HD13 ' A' ' 81' ' ' LEU . 15.0 m-85 -61.9 -37.92 86.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 75.11 110.887 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.24 -33.16 59.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 52.43 111.088 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 64' ' ' VAL . 0.6 OUTLIER -72.15 -29.63 64.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.264 -0.425 . . . . 73.15 111.115 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.565 HD21 ' HA ' ' A' ' 65' ' ' TYR . 3.9 pp -83.33 -6.78 59.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.448 . . . . 75.22 110.913 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.47 69.62 1.09 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.782 -0.723 . . . . 64.32 112.433 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.726 ' HG3' ' HB2' ' A' ' 75' ' ' ALA . 2.4 tp10 -98.75 -23.51 15.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.956 0.408 . . . . 75.1 110.957 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.729 HD22 ' HB2' ' A' ' 75' ' ' ALA . 4.6 mm? -90.31 3.39 53.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 74.21 110.916 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.7 mtp -71.93 -13.31 61.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 74.41 110.865 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.27 -31.5 0.12 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.738 -0.744 . . . . 64.34 112.505 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 154.26 109.14 0.34 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.804 -0.712 . . . . 44.45 112.523 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.729 ' HB2' HD22 ' A' ' 71' ' ' LEU . . . -87.56 123.19 32.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 60.14 111.088 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 77' ' ' HIS . 4.5 mp -113.89 163.25 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 72.33 111.109 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.574 ' N ' HG22 ' A' ' 76' ' ' ILE . 35.4 p-80 -72.11 2.76 5.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.33 110.848 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 42' ' ' HIS . . . -88.94 21.52 3.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 71.33 111.13 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.764 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 8.5 tp -97.58 133.25 42.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 73.12 110.937 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -111.35 115.18 28.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.52 110.946 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.98 HD13 ' CE1' ' A' ' 65' ' ' TYR . 7.4 tt -139.77 137.74 35.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 71.33 110.88 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 82' ' ' LYS . 2.3 mppt? -136.35 128.16 29.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 74.01 110.907 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.535 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 63.9 p -113.48 106.95 15.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 71.21 111.103 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.9 mt -125.99 161.69 26.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 73.22 110.946 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.492 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.94 163.99 62.29 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.608 0.718 . . . . 75.12 111.171 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.4 Cg_endo -69.66 -21.96 33.2 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.787 2.325 . . . . 74.45 112.288 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -70.66 -35.94 73.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 74.44 110.905 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.7 -33.89 76.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 63.15 110.916 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.47 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 62.43 111.106 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.3 tpt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.714 0.292 . . . . 75.11 110.926 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -81.52 -49.85 10.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 70.04 110.86 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -161.22 146.5 13.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 72.21 110.908 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.6 mtm180 -120.7 81.99 33.71 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.577 0.703 . . . . 70.33 110.91 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.73 -51.4 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.663 2.242 . . . . 63.52 112.335 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.0 tp 61.53 53.12 3.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 75.43 110.956 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -134.94 -70.01 0.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 72.22 110.905 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.092 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . -68.29 -34.5 76.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 55.41 111.089 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -70.22 -48.43 57.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 72.14 110.888 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.489 HG23 ' N ' ' A' ' 20' ' ' ILE . 2.8 t -59.17 -51.13 71.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 63.23 111.143 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.025 HD11 HG11 ' A' ' 35' ' ' VAL . 2.6 pp -64.83 -40.7 89.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 72.45 111.187 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.632 ' N ' HD12 ' A' ' 20' ' ' ILE . 73.9 ttt180 -60.92 -46.26 91.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 63.54 110.87 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -63.51 -42.66 98.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 64.33 110.888 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 23' ' ' LEU . 16.5 mt -57.53 -49.11 77.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 74.2 110.939 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.792 ' CG2' HG21 ' A' ' 33' ' ' VAL . 49.2 mm -63.18 -46.71 95.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 72.41 111.147 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -55.11 -40.23 70.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 73.23 110.846 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.04 -43.24 71.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 72.4 110.867 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.99 -49.13 60.3 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.726 . . . . 73.44 112.525 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.55 157.16 72.77 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.53 0.681 . . . . 64.22 110.972 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -90.62 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.685 2.256 . . . . 54.33 112.323 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -107.41 29.57 7.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 64.42 110.882 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' A' ' 49' ' ' SER . . . -75.02 133.09 41.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 72.14 111.084 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.702 ' HB3' HG12 ' A' ' 48' ' ' VAL . 7.0 tpp180 -99.98 111.14 23.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 73.44 110.927 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.852 HG13 HG22 ' A' ' 47' ' ' VAL . 32.3 t -113.86 124.98 71.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 62.52 111.107 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -134.69 118.15 16.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 63.33 110.889 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.092 HG13 ' HB1' ' A' ' 17' ' ' ALA . 4.9 p -130.43 136.33 58.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 35.41 111.134 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -133.32 120.21 20.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.23 110.928 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.47 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 149.67 -145.19 13.09 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.703 -0.761 . . . . 72.21 112.461 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.403 ' O ' HG12 ' A' ' 41' ' ' VAL . 18.9 mt-10 -156.1 176.98 11.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.825 0.345 . . . . 71.0 110.939 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -80.06 139.87 36.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 74.03 110.895 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.432 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.67 25.7 73.38 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.772 -0.727 . . . . 54.02 112.463 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.471 ' HA ' ' CD1' ' A' ' 76' ' ' ILE . 1.2 p -148.91 164.7 4.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.895 0.379 . . . . 75.54 111.079 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -74.97 107.44 7.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 71.23 110.853 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.83 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 4.4 p90 -123.88 167.14 14.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.3 -0.409 . . . . 74.14 110.92 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -118.75 121.73 40.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 53.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 81' ' ' LEU . . . -126.42 114.9 18.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 61.13 111.103 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 m -111.58 117.19 32.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 71.12 111.182 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.852 HG22 HG13 ' A' ' 33' ' ' VAL . 84.8 t -115.65 132.99 63.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 73.13 111.169 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.702 HG12 ' HB3' ' A' ' 32' ' ' ARG . 5.6 p -128.79 120.37 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 73.05 111.149 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.448 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.9 OUTLIER -167.31 164.82 9.31 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.711 0.767 . . . . 74.51 110.803 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.515 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.6 Cg_endo -69.78 -19.1 36.48 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.685 2.256 . . . . 63.2 112.363 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.798 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -47.19 -41.61 18.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 63.0 111.043 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.657 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -91.87 38.23 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 71.32 110.895 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.492 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 4.8 p -53.03 123.27 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 71.14 111.156 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.92 -90.61 0.68 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.689 -0.767 . . . . 75.31 112.532 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.452 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 1.3 mptp? -117.11 110.29 18.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.815 0.341 . . . . 72.02 110.855 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.657 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -58.52 107.44 0.95 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.526 0.679 . . . . 61.34 111.092 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.1 Cg_endo -69.85 166.01 29.15 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.676 2.251 . . . . 71.4 112.312 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.34 -26.75 65.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 74.52 110.929 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.61 -52.22 66.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 74.23 111.099 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.798 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 18.9 mmt180 -69.59 -41.09 76.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 72.33 110.829 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.446 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.9 OUTLIER -58.78 -52.59 65.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.421 . . . . 74.21 110.836 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -66.42 -37.26 84.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 62.23 110.916 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 20.2 mmm -56.44 -52.07 66.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 71.12 110.895 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.632 ' O ' HG22 ' A' ' 67' ' ' THR . 17.4 m -62.95 -44.44 99.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 65.22 111.072 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 1.055 ' CE1' HD13 ' A' ' 81' ' ' LEU . 14.3 m-85 -60.98 -30.81 70.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 71.45 110.938 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.02 -46.76 32.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 73.41 111.08 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 64' ' ' VAL . 3.8 t -63.9 -28.8 70.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 60.12 111.115 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.863 HD23 HD13 ' A' ' 20' ' ' ILE . 9.9 mt -82.17 5.58 19.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 64.24 110.854 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 34.07 67.59 0.24 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 72.23 112.484 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.639 ' HG3' HD13 ' A' ' 71' ' ' LEU . 5.8 pt-20 -85.41 -39.48 17.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 72.31 110.847 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.639 HD13 ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -91.03 7.38 40.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 71.43 110.904 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.412 ' N ' HD22 ' A' ' 71' ' ' LEU . 19.8 mtt -73.06 -12.93 61.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 54.42 110.889 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.15 -32.15 0.1 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.725 -0.75 . . . . 74.01 112.49 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.432 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . 135.52 54.48 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.778 -0.725 . . . . 31.34 112.514 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 70' ' ' GLU . . . -58.81 145.16 41.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.715 0.293 . . . . 70.24 111.104 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.494 ' H ' HD12 ' A' ' 76' ' ' ILE . 3.0 mp -97.11 148.42 5.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 64.01 111.164 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -48.07 -17.34 0.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 74.41 110.843 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.417 ' N ' ' C ' ' A' ' 76' ' ' ILE . . . -74.78 48.7 0.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 62.44 111.039 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.83 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 7.8 tp -107.96 128.18 54.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 72.21 110.902 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -102.45 115.0 29.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 73.45 110.957 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.055 HD13 ' CE1' ' A' ' 65' ' ' TYR . 8.6 tt -139.76 135.86 33.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.241 -0.436 . . . . 64.34 110.899 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -136.49 131.63 34.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 73.44 110.949 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.544 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 67.1 p -116.69 106.8 13.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 43.01 111.155 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.05 161.81 24.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 72.32 110.96 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.492 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -71.8 163.41 66.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.546 0.689 . . . . 72.41 111.175 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.2 Cg_endo -69.78 -10.32 28.25 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.749 2.3 . . . . 72.04 112.349 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -76.0 -35.89 59.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 63.45 110.821 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -68.19 -36.06 78.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.426 . . . . 71.33 110.898 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.452 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.154 -0.475 . . . . 71.14 111.122 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.8 ttt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.739 0.304 . . . . 71.33 110.913 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -151.96 116.86 5.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 60.13 110.897 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -63.51 111.8 2.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 64.52 110.876 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -76.13 114.86 41.62 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.619 0.723 . . . . 75.52 110.843 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 174.0 10.12 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.658 2.239 . . . . 75.22 112.389 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.401 HD23 ' H ' ' A' ' 15' ' ' LEU . 1.3 pt? -121.18 -11.51 8.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.272 -0.422 . . . . 63.43 110.918 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -102.78 -53.61 2.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 72.43 110.874 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 35' ' ' VAL . . . -63.23 -27.95 69.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 73.34 111.062 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.501 ' OE1' ' NE ' ' A' ' 21' ' ' ARG . 4.3 mm-40 -68.65 -26.55 65.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 73.31 110.854 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.7 p -61.4 -56.91 15.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 73.42 111.1 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.58 HG12 ' N ' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -74.06 -29.91 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 55.14 111.1 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.58 ' N ' HG12 ' A' ' 20' ' ' ILE . 23.7 ttp85 -63.37 -50.86 68.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 60.43 110.851 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -72.79 -36.13 67.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 71.41 110.897 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.648 HD13 ' O ' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -57.91 -51.04 71.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 71.24 110.851 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.795 HG21 HG21 ' A' ' 33' ' ' VAL . 8.6 mt -73.5 -44.16 54.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 72.04 111.17 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.444 ' CG ' ' O ' ' A' ' 21' ' ' ARG . 68.0 mt-10 -56.51 -32.22 64.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 71.43 110.874 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.27 -43.23 17.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 74.01 110.83 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.44 -41.89 97.29 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.737 -0.744 . . . . 73.42 112.548 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 28' ' ' LEU . 3.8 mm? -122.94 102.41 37.88 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.648 0.737 . . . . 64.23 110.915 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 28' ' ' LEU . 53.9 Cg_endo -69.7 -15.02 37.09 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.687 2.258 . . . . 71.21 112.3 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -100.16 0.83 41.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.411 . . . . 73.55 110.86 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.505 ' HB2' ' HB2' ' A' ' 49' ' ' SER . . . -120.58 135.7 55.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 64.43 111.108 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.476 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 47.1 ttt-85 -110.44 123.73 50.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 74.2 110.926 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.142 HG13 HG22 ' A' ' 47' ' ' VAL . 4.8 t -122.37 134.3 66.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 74.04 111.139 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.35 118.08 16.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 75.42 110.912 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.6 ' O ' ' HB1' ' A' ' 17' ' ' ALA . 43.4 t -123.62 130.4 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 75.51 111.104 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 20.8 mm100 -133.34 120.15 20.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 71.4 110.889 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.07 -119.97 1.12 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.712 -0.756 . . . . 73.34 112.437 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -172.19 170.43 5.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 74.42 110.903 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -80.35 145.55 32.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 72.12 110.908 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.474 ' CA ' ' O ' ' A' ' 73' ' ' GLY . . . 72.7 -0.94 40.69 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.747 -0.739 . . . . 65.23 112.487 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 42' ' ' HIS . 2.3 t -123.13 165.19 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 75.34 111.186 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.454 ' H ' HG12 ' A' ' 41' ' ' VAL . 53.9 p-80 -74.67 106.45 6.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 72.4 110.857 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.796 ' CE2' HD11 ' A' ' 79' ' ' LEU . 8.6 p90 -120.55 168.06 11.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 73.24 110.912 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -113.2 121.22 43.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 74.35 110.859 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.67 126.99 45.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.103 -0.499 . . . . 61.02 111.093 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.7 m -120.96 120.64 36.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 63.24 111.146 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.142 HG22 HG13 ' A' ' 33' ' ' VAL . 78.2 t -119.45 136.76 55.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 54.43 111.119 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.476 ' CG1' ' HB3' ' A' ' 32' ' ' ARG . 7.2 p -136.17 124.28 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 74.4 111.156 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -174.62 164.74 2.45 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.624 0.725 . . . . 55.12 110.879 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.524 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.2 Cg_endo -69.71 -19.96 35.68 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.653 2.236 . . . . 54.0 112.369 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.743 ' HB1' ' HD3' ' A' ' 60' ' ' ARG . . . -47.47 -40.51 18.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 72.24 111.08 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.748 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.5 OUTLIER -92.22 37.64 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 74.42 110.907 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.495 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 2.6 p -52.82 136.0 14.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 54.22 111.136 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 60.37 -89.09 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.765 -0.731 . . . . 64.11 112.455 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 3.6 mptp? -119.28 111.08 17.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.746 0.308 . . . . 70.31 110.932 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.748 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -58.46 107.99 1.15 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.607 0.718 . . . . 72.02 111.071 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.8 Cg_endo -69.76 164.23 35.33 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.665 2.244 . . . . 74.02 112.375 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.415 ' O ' HD23 ' A' ' 58' ' ' LEU . 1.6 tt -57.64 -24.85 58.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 63.1 110.887 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.406 ' O ' ' SD ' ' A' ' 63' ' ' MET . . . -61.91 -52.75 62.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 63.32 111.099 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.743 ' HD3' ' HB1' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -69.08 -40.7 78.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 74.45 110.875 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.538 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.4 t-160 -58.85 -53.98 52.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 73.43 110.826 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -66.2 -35.53 80.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.21 110.868 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.609 ' O ' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -58.33 -46.22 86.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 44.31 110.88 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.715 HG21 HD21 ' A' ' 81' ' ' LEU . 17.1 m -69.15 -40.22 80.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 72.15 111.185 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 1.059 ' CE1' HD22 ' A' ' 81' ' ' LEU . 14.2 m-85 -64.93 -35.89 82.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 75.41 110.92 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.3 -46.63 39.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 71.53 111.115 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.62 HG23 HD13 ' A' ' 68' ' ' LEU . 6.0 t -66.04 -28.47 68.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 75.23 111.107 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.62 HD13 HG23 ' A' ' 67' ' ' THR . 5.2 mp -82.32 7.66 13.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 72.33 110.917 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 35.71 68.79 0.26 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.786 -0.721 . . . . 65.11 112.402 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.712 ' HG3' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -102.38 -24.62 13.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.879 0.371 . . . . 72.24 110.845 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.712 HD22 ' HG3' ' A' ' 70' ' ' GLU . 3.0 mm? -86.75 -21.0 26.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 63.25 110.902 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.2 ttm -76.22 -12.59 60.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 74.04 110.867 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.474 ' O ' ' CA ' ' A' ' 40' ' ' GLY . . . -120.47 -9.19 7.95 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.746 -0.74 . . . . 40.33 112.455 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.53 43.03 10.69 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.762 -0.733 . . . . 74.13 112.483 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.89 127.6 33.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.732 0.301 . . . . 62.14 111.096 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.584 HG22 ' N ' ' A' ' 77' ' ' HIS . 26.1 mm -71.25 163.32 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 75.13 111.077 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.584 ' N ' HG22 ' A' ' 76' ' ' ILE . 80.3 m-70 -55.69 -12.63 1.31 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 73.01 110.897 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.31 47.94 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 53.44 111.138 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.796 HD11 ' CE2' ' A' ' 43' ' ' PHE . 8.8 tp -110.2 138.43 46.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 75.52 110.928 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -104.62 117.07 33.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 61.51 110.891 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.059 HD22 ' CE1' ' A' ' 65' ' ' TYR . 1.9 tp -139.33 123.51 17.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 63.11 110.886 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -126.87 123.3 36.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 75.21 110.891 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.533 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 4.9 p -113.22 107.25 15.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 64.03 111.186 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.7 mp -129.81 161.59 30.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 51.54 110.924 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.495 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.9 164.04 61.8 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.614 0.721 . . . . 71.22 111.102 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.9 Cg_endo -69.71 -23.75 30.67 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.714 2.276 . . . . 63.21 112.296 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.44 -34.9 78.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 72.22 110.891 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.08 -33.18 75.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 71.22 110.876 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 64.24 111.09 179.941 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.714 0.292 . . . . 73.35 110.863 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.404 ' N ' ' HD3' ' A' ' 11' ' ' ARG . 1.7 mpp_? -109.02 163.59 13.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 73.42 110.864 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -169.03 177.91 4.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 74.1 110.94 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.449 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 11.8 mmp_? 51.5 53.45 13.36 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.616 0.722 . . . . 73.41 110.864 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 13' ' ' ARG . 54.0 Cg_endo -69.7 108.22 2.02 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.71 2.274 . . . . 73.32 112.411 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.2 tp -113.5 -72.53 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 74.41 110.915 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 20' ' ' ILE . 12.0 m-20 -128.63 -66.54 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 42.02 110.87 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.1 -36.28 79.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 74.44 111.048 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 14' ' ' PRO . 50.2 mm-40 -71.54 -48.01 51.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 70.41 110.92 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.572 ' O ' HD23 ' A' ' 23' ' ' LEU . 3.0 t -57.96 -51.7 68.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 52.32 111.177 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.866 HD12 ' HG ' ' A' ' 68' ' ' LEU . 16.2 pt -66.06 -41.9 90.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 73.01 111.168 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.425 ' N ' HG13 ' A' ' 20' ' ' ILE . 67.3 ttt180 -60.45 -53.58 55.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 73.43 110.912 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.456 ' CG ' ' N ' ' A' ' 23' ' ' LEU . 23.2 pttt -59.43 -44.83 92.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 75.31 110.861 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.572 HD23 ' O ' ' A' ' 19' ' ' THR . 2.1 mm? -55.96 -49.12 74.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 53.32 110.867 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.797 ' CG2' HG21 ' A' ' 33' ' ' VAL . 7.1 mt -68.17 -44.12 84.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 63.35 111.113 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -54.79 -37.85 66.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 75.44 110.874 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.1 -41.31 35.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 70.34 110.866 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.31 -53.82 33.7 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.701 -0.761 . . . . 72.23 112.483 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.402 ' CB ' ' HB3' ' A' ' 31' ' ' ALA . 4.2 mm? -76.94 159.13 79.29 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.533 0.682 . . . . 74.45 110.985 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -87.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.676 2.25 . . . . 71.43 112.369 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -111.02 26.12 11.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 75.2 110.889 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 49' ' ' SER . . . -73.31 125.85 28.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 54.04 111.085 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.61 ' HB2' HG13 ' A' ' 48' ' ' VAL . 2.4 mmt180 -91.77 107.52 19.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 65.13 110.984 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.814 HG13 HG22 ' A' ' 47' ' ' VAL . 61.6 t -109.83 121.33 62.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 55.33 111.132 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -132.38 118.88 19.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 73.23 110.876 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 44.8 t -126.79 136.98 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 72.31 111.146 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 34.9 mt-30 -130.67 120.5 24.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.159 -0.473 . . . . 71.41 110.886 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.438 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 140.63 -142.08 11.99 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.672 -0.775 . . . . 71.12 112.491 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.484 ' HG2' ' CG2' ' A' ' 41' ' ' VAL . 1.0 OUTLIER -165.29 156.04 13.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.886 0.374 . . . . 72.24 110.84 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -62.26 154.51 27.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 75.53 110.863 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.85 -2.59 40.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.676 -0.773 . . . . 75.12 112.524 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.484 ' CG2' ' HG2' ' A' ' 38' ' ' GLU . 1.3 t -132.52 164.76 34.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.328 . . . . 71.3 111.174 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.449 ' HB2' ' HB1' ' A' ' 78' ' ' ALA . 0.0 OUTLIER -75.02 106.72 6.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 72.15 110.825 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.551 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 39.7 p90 -121.98 167.79 12.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 74.11 110.846 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -113.26 133.52 55.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 74.14 110.89 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.466 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -128.09 118.84 24.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 60.3 111.17 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.2 m -121.4 111.5 17.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 72.43 111.149 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.814 HG22 HG13 ' A' ' 33' ' ' VAL . 94.9 t -120.74 134.73 63.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 71.12 111.097 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.61 HG13 ' HB2' ' A' ' 32' ' ' ARG . 3.6 p -131.05 122.72 52.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 74.12 111.111 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -161.83 165.6 15.91 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.628 0.728 . . . . 73.5 110.874 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.515 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 52.9 Cg_endo -69.93 -22.14 31.7 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.728 2.285 . . . . 65.15 112.215 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.614 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -47.04 -44.29 20.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 43.11 111.079 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.676 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -87.11 35.56 0.7 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 73.42 110.902 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.481 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 12.4 p -52.26 125.86 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 73.25 111.138 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.5 -89.4 0.73 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.712 -0.756 . . . . 55.13 112.51 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.423 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 3.3 mptp? -120.3 110.23 16.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.809 0.338 . . . . 73.33 110.871 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.676 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -58.64 108.15 1.21 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.563 0.697 . . . . 62.42 111.08 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.8 Cg_endo -69.83 161.59 45.36 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.728 2.285 . . . . 62.43 112.36 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.87 -27.25 63.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.28 -0.418 . . . . 61.04 110.925 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.27 -52.16 66.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 54.42 111.092 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.614 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 23.2 mmt180 -69.18 -43.0 75.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 60.24 110.856 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.571 ' CE1' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -59.17 -51.49 69.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 75.23 110.849 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.15 -38.64 88.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 74.44 110.902 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 21.8 mmt -56.29 -48.27 76.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 74.55 110.919 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 61' ' ' HIS . 16.3 m -65.31 -39.54 85.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 34.25 111.117 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.572 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 12.4 m-85 -59.58 -39.81 85.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 65.24 110.91 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.06 -46.96 31.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 74.45 111.133 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.556 HG23 HD12 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -61.66 -31.32 71.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 74.42 111.145 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.866 ' HG ' HD12 ' A' ' 20' ' ' ILE . 7.3 mp -83.04 -4.3 58.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 72.51 110.929 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.75 69.37 1.28 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.705 -0.76 . . . . 62.2 112.535 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -85.31 -40.5 16.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 64.21 110.911 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.408 HD12 ' N ' ' A' ' 71' ' ' LEU . 8.4 mp -87.87 9.87 20.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 64.23 110.916 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.6 mmt -72.01 -13.14 61.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 65.33 110.909 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.92 -32.91 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.77 -0.729 . . . . 73.31 112.528 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.76 106.23 0.31 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.745 -0.74 . . . . 64.23 112.465 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.69 123.76 31.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.718 0.294 . . . . 70.5 111.113 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.582 HG22 ' N ' ' A' ' 77' ' ' HIS . 4.7 mp -113.36 163.26 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 54.15 111.083 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.582 ' N ' HG22 ' A' ' 76' ' ' ILE . 43.8 m-70 -60.86 -9.07 3.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.088 -0.506 . . . . 73.35 110.871 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 42' ' ' HIS . . . -83.86 27.1 0.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 43.14 111.075 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.551 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 1.6 mm? -97.83 140.43 32.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 71.31 110.939 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -118.21 115.62 25.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 75.02 111.016 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.572 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 0.6 OUTLIER -130.85 116.57 18.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 74.3 110.862 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -126.01 122.19 35.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 75.05 110.944 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.528 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 69.2 p -115.62 107.34 14.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.289 -0.414 . . . . 71.21 111.172 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 84' ' ' LEU . 1.6 mm? -127.75 162.06 27.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 63.15 110.894 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.481 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.02 163.29 68.17 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-O 121.639 0.733 . . . . 63.03 111.12 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.9 Cg_endo -69.72 -7.49 21.18 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.693 2.262 . . . . 74.54 112.363 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -84.58 -30.77 24.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 43.11 110.828 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -84.79 28.24 0.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 62.03 110.876 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 72.4 111.072 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.771 0.32 . . . . 60.52 110.905 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 22' ' ' LYS . 18.8 ptt180 -119.1 93.3 4.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 65.52 110.864 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -99.58 -48.93 4.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 70.35 110.923 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.472 ' O ' ' CD2' ' A' ' 15' ' ' LEU . 8.8 ptt-85 -116.21 86.25 17.03 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.639 0.733 . . . . 74.24 110.918 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.556 ' C ' HD22 ' A' ' 15' ' ' LEU . 53.8 Cg_endo -69.74 136.4 32.96 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.628 2.219 . . . . 64.53 112.362 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.556 HD22 ' C ' ' A' ' 14' ' ' PRO . 3.7 mm? -116.5 -68.22 0.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 72.34 110.948 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.29 -68.06 0.6 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 70.1 110.814 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.484 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . . . -68.0 -25.06 65.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 55.13 111.091 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.432 ' CB ' ' HA ' ' A' ' 14' ' ' PRO . 12.6 mt-10 -72.65 -48.8 36.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 72.34 110.856 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.438 HG23 ' N ' ' A' ' 20' ' ' ILE . 2.9 t -61.59 -47.63 84.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 51.31 111.151 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.491 HD11 HG11 ' A' ' 35' ' ' VAL . 10.8 pt -67.8 -43.13 86.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 72.54 111.149 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.403 ' N ' HG13 ' A' ' 20' ' ' ILE . 55.1 ttt-85 -54.97 -52.91 61.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 74.31 110.838 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 11' ' ' ARG . 13.4 ptpt -65.42 -37.05 85.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 61.4 110.838 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.76 -50.26 72.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.47 . . . . 72.05 110.844 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.644 ' HB ' HG21 ' A' ' 33' ' ' VAL . 7.9 mt -72.51 -36.31 53.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 73.12 111.131 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.496 ' HG3' HG23 ' A' ' 33' ' ' VAL . 19.7 mt-10 -58.92 -38.3 78.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 70.43 110.845 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -80.84 -42.11 22.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 71.2 110.846 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.37 -42.48 99.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.738 . . . . 62.12 112.525 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.487 ' CB ' ' HB3' ' A' ' 31' ' ' ALA . 3.6 mm? -89.88 157.29 46.3 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.556 0.693 . . . . 73.33 110.962 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -91.22 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.662 2.241 . . . . 55.52 112.306 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -104.58 27.11 8.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.252 -0.431 . . . . 74.1 110.907 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 49' ' ' SER . . . -77.61 132.25 38.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 75.41 111.053 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.656 ' HB3' HG12 ' A' ' 48' ' ' VAL . 7.9 ttm-85 -101.35 112.12 24.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 75.54 110.873 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.707 HG12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -107.32 129.32 61.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.202 -0.454 . . . . 73.05 111.093 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.73 118.53 16.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 74.1 110.895 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.491 HG11 HD11 ' A' ' 20' ' ' ILE . 28.9 t -127.66 129.86 70.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 71.4 111.205 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.409 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 31.4 mt-30 -133.25 120.15 20.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 65.11 110.933 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.474 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 151.0 -125.97 2.01 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.726 -0.75 . . . . 42.23 112.483 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -174.66 157.76 2.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 74.1 110.909 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -68.41 144.16 54.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 74.43 110.854 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.76 22.26 79.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.759 . . . . 54.31 112.56 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -150.63 164.79 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.866 0.365 . . . . 71.33 111.111 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 28.1 p80 -75.09 106.66 6.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 74.44 110.831 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.895 ' CZ ' HD21 ' A' ' 79' ' ' LEU . 8.7 p90 -122.43 167.4 13.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 64.14 110.903 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -113.72 120.33 40.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 65.21 110.903 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.591 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -123.25 115.77 22.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 71.2 111.019 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.658 HG23 ' HB2' ' A' ' 82' ' ' LYS . 81.6 m -113.62 123.5 50.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 75.14 111.153 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.707 HG22 HG12 ' A' ' 33' ' ' VAL . 27.1 t -123.59 140.72 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 62.41 111.134 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.656 HG12 ' HB3' ' A' ' 32' ' ' ARG . 8.1 p -130.52 117.83 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 73.42 111.165 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.49 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -162.0 164.49 17.47 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.679 0.752 . . . . 72.35 110.855 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.544 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.3 Cg_endo -69.88 -22.05 32.06 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.631 2.221 . . . . 61.05 112.309 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.615 ' HB1' ' HE ' ' A' ' 60' ' ' ARG . . . -48.69 -44.53 38.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 61.12 111.133 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.659 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.5 OUTLIER -87.63 34.19 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 71.11 110.898 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 55' ' ' LYS . 7.6 p -52.41 131.63 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 71.33 111.109 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 56.08 -81.02 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.726 -0.75 . . . . 74.44 112.517 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 53' ' ' VAL . 69.6 mmtt -113.3 134.27 54.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.796 0.331 . . . . 62.01 110.876 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.659 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -99.56 99.96 9.77 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.608 0.718 . . . . 73.32 111.1 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.4 Cg_endo -69.71 172.58 12.32 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.695 2.263 . . . . 51.12 112.333 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tp -57.01 -27.49 61.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 52.15 110.913 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 63' ' ' MET . . . -57.3 -53.35 59.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 60.12 111.016 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.615 ' HE ' ' HB1' ' A' ' 51' ' ' ALA . 12.2 mmm180 -70.57 -42.24 71.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 60.24 110.838 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.516 ' CE1' HD23 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -57.12 -53.1 61.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 71.54 110.874 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -67.49 -38.86 84.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 73.24 110.903 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.463 ' SD ' ' C ' ' A' ' 63' ' ' MET . 0.7 OUTLIER -54.08 -48.02 71.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 75.21 110.853 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.772 ' O ' HD13 ' A' ' 68' ' ' LEU . 24.4 m -68.77 -40.64 81.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 62.21 111.156 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.891 ' CE1' HD13 ' A' ' 81' ' ' LEU . 10.5 m-85 -64.93 -34.84 79.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 65.24 110.936 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.75 -46.24 32.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 75.33 111.193 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.604 HG21 HG12 ' A' ' 24' ' ' ILE . 3.8 t -67.58 -25.67 65.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 54.01 111.108 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.772 HD13 ' O ' ' A' ' 64' ' ' VAL . 5.9 mp -82.48 -0.47 46.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.246 -0.434 . . . . 73.24 110.919 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.6 68.37 1.02 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.75 -0.738 . . . . 70.12 112.439 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.845 ' HG3' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -88.06 -25.57 22.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.339 . . . . 73.21 110.817 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.845 HD23 ' HG3' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -89.64 7.12 38.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 73.05 110.963 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.4 mmt -73.15 -7.18 50.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 72.41 110.899 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.94 -35.04 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.703 -0.761 . . . . 73.2 112.492 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 131.63 64.26 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.767 -0.73 . . . . 71.32 112.517 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.475 ' CB ' ' HB2' ' A' ' 70' ' ' GLU . . . -59.0 129.1 40.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 52.02 111.109 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 77' ' ' HIS . 4.3 mp -88.89 163.22 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 74.04 111.094 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.574 ' N ' HG22 ' A' ' 76' ' ' ILE . 11.5 m80 -57.08 -12.27 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 73.25 110.822 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 42' ' ' HIS . . . -82.79 39.61 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 64.52 111.092 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.895 HD21 ' CZ ' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -97.68 134.41 40.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 73.31 110.894 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.511 ' N ' HD13 ' A' ' 79' ' ' LEU . 8.5 mm-40 -106.95 118.67 37.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 71.43 110.984 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.891 HD13 ' CE1' ' A' ' 65' ' ' TYR . 4.5 tp -123.05 138.9 54.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 74.5 110.873 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.658 ' HB2' HG23 ' A' ' 46' ' ' THR . 2.5 mptt -132.36 118.46 19.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 64.42 110.933 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.53 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 11.8 p -118.91 107.35 13.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 54.11 111.133 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.537 ' N ' HD23 ' A' ' 84' ' ' LEU . 0.1 OUTLIER -127.22 161.42 28.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 74.33 110.92 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.479 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -76.35 164.92 56.81 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.545 0.688 . . . . 74.52 111.166 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.5 Cg_endo -69.8 -0.15 6.52 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.695 2.264 . . . . 71.54 112.36 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.09 -27.43 26.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 73.01 110.869 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -82.2 24.81 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 60.42 110.884 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 65.2 111.137 179.918 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.0 mtt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.769 0.318 . . . . 75.24 110.827 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -124.03 32.21 5.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.301 -0.409 . . . . 72.42 110.83 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.3 tptt -80.59 42.56 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 75.32 110.919 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.479 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 15.5 mtt85 -72.54 -60.45 2.06 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.597 0.713 . . . . 74.44 110.885 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.563 ' C ' HD22 ' A' ' 15' ' ' LEU . 53.2 Cg_endo -69.73 -173.92 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.683 2.256 . . . . 64.34 112.317 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.563 HD22 ' C ' ' A' ' 14' ' ' PRO . 4.0 mm? -120.99 -58.18 1.82 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.435 . . . . 73.13 110.931 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.524 ' O ' HG23 ' A' ' 20' ' ' ILE . 17.6 t0 -78.55 -34.65 46.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 72.53 110.88 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 35' ' ' VAL . . . -68.43 -42.96 78.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 63.24 111.096 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.557 ' CD ' ' N ' ' A' ' 19' ' ' THR . 3.0 pp20? -66.77 -48.14 69.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 50.33 110.83 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.557 ' N ' ' CD ' ' A' ' 18' ' ' GLU . 3.7 t -57.74 -52.45 65.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 74.35 111.089 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.526 ' N ' HG23 ' A' ' 19' ' ' THR . 5.9 pt -67.84 -41.95 85.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 72.04 111.176 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 54.4 ttp180 -58.67 -51.47 69.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 53.44 110.868 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.1 pttp -63.79 -40.24 96.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.499 . . . . 64.41 110.892 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 20.6 mt -56.32 -50.27 71.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 71.23 110.898 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.662 HD11 ' CG2' ' A' ' 67' ' ' THR . 10.5 mt -69.53 -43.86 80.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 52.13 111.112 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -55.64 -35.07 65.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.462 . . . . 71.44 110.868 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -79.18 -43.2 24.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 55.02 110.905 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.65 -34.38 88.77 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.695 -0.764 . . . . 73.21 112.524 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.63 158.98 32.76 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.545 0.688 . . . . 52.12 110.924 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -90.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.695 2.263 . . . . 64.33 112.4 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -107.87 33.46 4.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 55.31 110.912 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.67 133.87 34.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 72.24 111.138 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.654 ' HB3' HG12 ' A' ' 48' ' ' VAL . 39.8 ttt-85 -106.4 125.56 51.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 72.23 110.845 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.035 HG13 HG22 ' A' ' 47' ' ' VAL . 3.9 t -124.0 135.45 63.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 74.33 111.149 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -135.26 118.46 16.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 72.01 110.889 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.437 ' O ' ' HB1' ' A' ' 17' ' ' ALA . 39.6 t -125.85 136.7 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 73.3 111.143 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 50.3 mm-40 -133.33 120.36 20.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 53.24 110.893 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.84 -143.21 13.46 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 64.12 112.461 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.422 ' HB2' HG21 ' A' ' 41' ' ' VAL . 17.8 mt-10 -151.19 -174.98 4.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.889 0.376 . . . . 75.22 110.845 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -87.77 146.79 25.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 73.21 110.888 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.437 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 73.24 1.14 56.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.73 . . . . 62.31 112.476 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' A' ' 38' ' ' GLU . 2.6 m -125.21 165.19 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 71.45 111.1 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.454 ' CG ' ' O ' ' A' ' 42' ' ' HIS . 23.6 p80 -74.86 107.01 6.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 53.34 110.821 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.833 ' CE1' HD11 ' A' ' 79' ' ' LEU . 39.6 p90 -121.99 167.75 12.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 74.12 110.898 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -113.48 124.74 53.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 63.54 110.86 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.18 115.88 19.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 44.33 111.099 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.8 m -117.72 112.71 20.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 72.21 111.131 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.035 HG22 HG13 ' A' ' 33' ' ' VAL . 22.6 t -110.5 141.44 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 71.1 111.133 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.753 HG21 ' HB2' ' A' ' 89' ' ' ALA . 4.0 p -130.42 118.95 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 74.41 111.127 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.539 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 24.1 p -168.7 160.01 8.4 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.654 0.74 . . . . 74.43 110.923 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.581 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.4 Cg_endo -69.74 -18.65 36.96 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.659 2.239 . . . . 71.2 112.383 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.878 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -49.83 -38.47 35.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 61.24 111.077 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.811 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 1.3 m-85 -90.86 33.5 0.93 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 73.51 110.904 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.539 ' HA ' HG23 ' A' ' 85' ' ' THR . 10.9 p -52.18 146.82 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 74.3 111.122 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 52.17 -89.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.719 . . . . 60.41 112.467 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -121.62 111.03 16.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.333 . . . . 74.21 110.87 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.811 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -59.67 108.28 1.33 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.58 0.705 . . . . 52.33 111.097 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.6 Cg_endo -69.76 161.55 45.48 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.695 2.263 . . . . 63.5 112.344 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -55.14 -24.76 27.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 61.44 110.921 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.33 -52.57 64.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 51.22 111.06 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.878 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 21.1 mmt180 -69.78 -41.01 75.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 75.42 110.84 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.497 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.2 t-160 -59.77 -53.01 62.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 73.53 110.908 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -66.2 -35.64 80.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 71.25 110.813 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.2 ttt -59.09 -49.86 76.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 65.42 110.852 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.587 ' O ' HG22 ' A' ' 67' ' ' THR . 22.1 m -65.08 -41.43 91.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 71.44 111.136 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.595 ' HD1' HD21 ' A' ' 68' ' ' LEU . 12.8 m-85 -62.83 -36.89 84.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 72.12 110.921 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.73 -35.27 60.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 51.15 111.107 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.662 ' CG2' HD11 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -70.95 -30.17 66.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 74.23 111.121 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.595 HD21 ' HD1' ' A' ' 65' ' ' TYR . 4.0 pp -83.6 -3.79 58.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 73.23 110.912 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.68 63.4 3.72 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.799 -0.715 . . . . 74.34 112.422 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -70.03 -57.43 5.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.387 . . . . 72.13 110.875 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -84.79 8.65 16.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 73.14 110.888 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.7 ttt -78.17 -13.2 59.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 72.54 110.89 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.47 -32.2 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.708 -0.758 . . . . 51.23 112.506 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.437 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . 121.67 48.85 0.27 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.764 -0.731 . . . . 74.12 112.533 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.87 124.43 19.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.754 0.311 . . . . 71.12 111.115 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.523 HG22 ' N ' ' A' ' 77' ' ' HIS . 14.9 mm -83.29 163.29 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 54.1 111.165 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.523 ' N ' HG22 ' A' ' 76' ' ' ILE . 5.2 p80 -50.61 -16.96 0.44 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 73.25 110.874 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.38 48.3 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 65.41 111.082 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.833 HD11 ' CE1' ' A' ' 43' ' ' PHE . 8.3 tp -113.04 147.53 37.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 74.13 110.99 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -113.71 119.33 37.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 72.55 110.837 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.58 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 0.5 OUTLIER -128.61 117.62 21.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 75.0 110.889 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.419 ' N ' HD13 ' A' ' 81' ' ' LEU . 15.4 mmtp -119.33 114.52 22.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 72.1 110.874 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.532 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 17.3 p -117.1 106.54 13.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 40.34 111.147 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mp -132.42 162.76 30.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 75.52 110.973 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.539 HG23 ' HA ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -71.12 165.39 48.34 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.615 0.721 . . . . 72.25 111.147 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.1 Cg_endo -69.8 -24.8 29.09 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.729 2.286 . . . . 71.33 112.285 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -65.77 -32.31 73.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 63.52 110.83 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -70.03 -35.03 74.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 71.43 110.874 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.753 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 61.32 111.071 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.792 0.329 . . . . 73.41 110.884 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -141.14 105.91 4.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 70.45 110.873 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -107.71 -41.09 5.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 74.12 110.926 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.434 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 12.4 mmt85 58.09 55.0 6.36 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.562 0.696 . . . . 72.34 110.815 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 13' ' ' ARG . 53.9 Cg_endo -69.84 170.68 16.1 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.673 2.249 . . . . 73.22 112.374 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.44 ' O ' HD12 ' A' ' 15' ' ' LEU . 3.3 pp -109.98 36.28 3.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 74.01 110.915 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.405 ' O ' HG23 ' A' ' 20' ' ' ILE . 1.3 m-20 -127.6 -74.04 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 74.53 110.906 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 1.007 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . -68.08 -26.61 65.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 41.55 111.122 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -72.01 -47.83 49.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 74.22 110.934 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.833 ' O ' HD23 ' A' ' 23' ' ' LEU . 2.7 t -61.68 -47.04 87.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 75.01 111.115 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.937 HD11 HG11 ' A' ' 35' ' ' VAL . 2.0 pp -69.51 -36.84 73.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 73.11 111.119 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.447 ' N ' HD12 ' A' ' 20' ' ' ILE . 35.9 ttt180 -63.58 -49.99 71.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.33 110.871 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.408 ' CG ' ' N ' ' A' ' 23' ' ' LEU . 34.1 pttt -64.45 -41.99 96.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 71.42 110.929 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.833 HD23 ' O ' ' A' ' 19' ' ' THR . 3.2 mm? -56.48 -50.79 70.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 72.41 110.937 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.814 HG21 HG21 ' A' ' 33' ' ' VAL . 12.7 mt -68.0 -43.83 85.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 71.45 111.127 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -56.53 -34.85 67.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 72.34 110.794 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.98 -43.38 35.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 72.41 110.874 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.66 -49.01 77.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 70.31 112.476 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.6 mt -118.93 102.31 49.37 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.628 0.728 . . . . 74.15 110.944 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -15.03 36.87 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.701 2.268 . . . . 73.34 112.294 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -96.18 -10.21 28.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 63.4 110.862 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.477 ' CB ' ' HB3' ' A' ' 49' ' ' SER . . . -111.04 126.83 55.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 51.33 111.105 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.504 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 24.5 ttp180 -103.06 117.17 33.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 63.35 110.874 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.814 HG21 HG21 ' A' ' 24' ' ' ILE . 18.5 t -111.75 131.17 63.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 74.01 111.092 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -135.4 117.65 15.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 73.03 110.884 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 1.007 HG13 ' HB1' ' A' ' 17' ' ' ALA . 4.6 p -126.91 139.4 51.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 52.23 111.11 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -132.2 120.63 22.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 72.34 110.945 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 149.99 -139.45 7.37 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.751 -0.737 . . . . 52.32 112.467 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.402 ' OE1' ' HB2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -166.84 153.62 8.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.859 0.361 . . . . 74.44 110.906 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -58.61 147.48 32.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 74.24 110.893 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.29 -11.16 13.25 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.741 -0.742 . . . . 72.24 112.556 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 42' ' ' HIS . 20.5 t -118.14 164.05 14.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 73.35 111.099 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.556 ' N ' HG12 ' A' ' 41' ' ' VAL . 0.6 OUTLIER -75.79 107.67 8.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 73.34 110.889 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.819 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 3.6 p90 -119.37 167.22 12.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 74.03 110.824 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.418 ' OE2' ' C ' ' A' ' 45' ' ' ALA . 1.0 OUTLIER -113.52 135.19 54.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 63.23 110.902 -179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.418 ' C ' ' OE2' ' A' ' 44' ' ' GLU . . . -127.25 121.25 30.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 72.44 111.064 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.7 m -121.3 110.96 16.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 61.25 111.168 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.776 ' CG1' HG13 ' A' ' 33' ' ' VAL . 3.8 m -112.77 140.05 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 34.21 111.152 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.61 HG21 ' HB2' ' A' ' 89' ' ' ALA . 3.0 p -134.4 118.81 28.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 64.34 111.175 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.562 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 12.2 p -169.64 161.65 7.17 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.682 0.753 . . . . 70.32 110.859 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.578 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.6 Cg_endo -69.78 -23.4 30.74 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.664 2.242 . . . . 63.32 112.262 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.751 ' HB1' ' CD ' ' A' ' 60' ' ' ARG . . . -47.12 -41.59 17.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.307 -0.406 . . . . 54.12 111.085 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.695 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 1.6 m-85 -86.45 32.38 0.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 71.23 110.844 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.571 ' HA ' HG23 ' A' ' 85' ' ' THR . 10.8 p -52.38 146.79 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.491 . . . . 55.24 111.16 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 50.5 -88.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.747 -0.74 . . . . 73.34 112.424 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -121.06 112.25 18.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.792 0.33 . . . . 74.44 110.898 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.695 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -59.17 108.24 1.28 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.564 0.697 . . . . 74.05 111.101 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.64 162.43 42.05 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.66 2.24 . . . . 74.21 112.416 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -56.36 -26.12 51.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 64.24 110.966 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 63' ' ' MET . . . -59.82 -52.64 64.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 43.22 111.084 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.751 ' CD ' ' HB1' ' A' ' 51' ' ' ALA . 11.6 mmp_? -69.57 -42.77 74.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 75.14 110.889 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.529 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -58.59 -52.99 63.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 71.11 110.864 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -65.41 -36.49 84.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 52.32 110.903 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.475 ' O ' HG22 ' A' ' 67' ' ' THR . 0.3 OUTLIER -57.09 -48.25 79.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 65.35 110.889 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 61' ' ' HIS . 17.2 m -67.68 -40.88 84.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 53.23 111.146 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.514 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 14.8 m-85 -65.74 -33.39 75.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 75.52 110.897 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.36 -46.03 43.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.096 -0.502 . . . . 74.11 111.069 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.518 HG23 HD12 ' A' ' 68' ' ' LEU . 4.7 t -63.81 -33.66 76.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 51.4 111.161 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.751 ' HG ' HD13 ' A' ' 20' ' ' ILE . 3.4 mp -81.9 -1.95 49.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.447 . . . . 53.52 110.91 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 32.48 82.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.806 -0.711 . . . . 55.31 112.51 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.59 ' HG2' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -83.55 -20.17 34.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.357 . . . . 75.12 110.887 -179.876 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.59 HD22 ' HG2' ' A' ' 70' ' ' GLU . 4.0 mm? -87.96 9.36 22.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 64.34 110.871 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.87 -13.2 61.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 75.45 110.867 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.58 -33.15 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.772 -0.727 . . . . 51.11 112.511 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.93 102.36 0.27 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.694 -0.765 . . . . 74.42 112.497 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.467 ' C ' HD13 ' A' ' 76' ' ' ILE . . . -66.55 122.52 17.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.735 0.302 . . . . 75.43 111.116 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.467 HD13 ' C ' ' A' ' 75' ' ' ALA . 6.4 mm -114.11 157.46 14.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 72.22 111.115 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -73.97 41.39 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 63.44 110.843 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.543 ' HB3' ' HB3' ' A' ' 42' ' ' HIS . . . -135.04 29.36 3.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 70.53 111.12 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.819 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 3.7 mm? -97.02 143.67 27.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 72.12 110.888 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -118.79 115.25 24.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 72.01 110.919 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.514 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 0.4 OUTLIER -123.9 116.7 23.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 75.1 110.92 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.07 114.85 23.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 65.41 110.899 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.556 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 40.2 p -115.78 106.49 13.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.236 -0.438 . . . . 64.23 111.174 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.4 mt -131.68 162.82 29.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 61.13 110.894 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.571 HG23 ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -70.79 164.53 54.94 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.592 0.71 . . . . 64.2 111.128 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.578 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.4 Cg_endo -69.76 -24.53 29.58 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.726 2.284 . . . . 74.13 112.301 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.54 -36.0 82.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 70.23 110.882 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.63 -41.66 87.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 53.33 110.876 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.61 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 50.21 111.108 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.771 0.319 . . . . 72.33 110.867 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.483 ' O ' ' CG ' ' A' ' 11' ' ' ARG . 0.1 OUTLIER -132.73 106.23 7.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 70.35 110.872 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.418 ' O ' ' CG ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -116.95 115.76 26.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 74.33 110.884 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.418 ' CG ' ' O ' ' A' ' 12' ' ' LYS . 84.9 mtm180 -159.71 120.85 1.77 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.596 0.712 . . . . 74.52 110.9 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 153.6 68.52 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.729 2.286 . . . . 71.04 112.355 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.828 ' O ' HG23 ' A' ' 19' ' ' THR . 3.2 mm? -89.97 172.48 8.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 75.01 110.884 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -55.03 -70.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 73.35 110.801 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 35' ' ' VAL . . . -53.16 -26.19 16.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 72.22 111.075 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -70.69 -37.98 73.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 64.52 110.815 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.828 HG23 ' O ' ' A' ' 15' ' ' LEU . 6.2 p -59.21 -54.02 51.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 51.34 111.144 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.545 HD11 HG11 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -68.48 -47.34 77.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 74.31 111.152 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -53.29 -50.42 64.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 71.54 110.897 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 ptmm? -66.96 -35.39 79.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 62.02 110.868 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.32 -49.27 74.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.433 . . . . 73.4 110.908 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.721 HD11 ' OG1' ' A' ' 67' ' ' THR . 7.4 mm -72.79 -42.81 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 63.1 111.191 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -54.7 -37.19 65.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.075 -0.511 . . . . 73.53 110.858 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -82.88 -42.49 17.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 64.3 110.894 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.99 -47.58 90.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.688 -0.768 . . . . 64.32 112.463 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.738 ' CB ' ' HB3' ' A' ' 31' ' ' ALA . 2.5 mm? -76.19 157.06 83.51 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.57 0.7 . . . . 74.43 110.91 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -58.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.63 2.22 . . . . 64.22 112.377 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -134.99 20.81 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 44.41 110.942 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.738 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . . . -74.4 126.52 30.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 72.21 111.087 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.654 ' HB3' HG12 ' A' ' 48' ' ' VAL . 4.3 tpt180 -100.68 109.7 21.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 62.13 110.858 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.038 HG13 HG22 ' A' ' 47' ' ' VAL . 41.1 t -114.14 135.34 54.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 60.31 111.088 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -135.23 118.81 16.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 71.43 110.85 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.545 HG11 HD11 ' A' ' 20' ' ' ILE . 61.4 t -121.49 131.33 73.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 53.25 111.119 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -132.83 120.35 21.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 74.43 110.895 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 142.45 -163.68 27.12 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.809 -0.71 . . . . 53.15 112.514 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 41' ' ' VAL . 27.1 mt-10 -135.39 176.23 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.871 0.367 . . . . 73.34 110.888 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -78.65 146.52 34.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 62.13 110.841 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.4 ' HA2' ' CA ' ' A' ' 74' ' ' GLY . . . 72.73 18.43 78.75 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.763 -0.732 . . . . 75.52 112.402 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.586 HG22 ' N ' ' A' ' 42' ' ' HIS . 12.5 p -144.63 164.39 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 72.11 111.143 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.586 ' N ' HG22 ' A' ' 41' ' ' VAL . 8.1 p80 -75.52 108.09 8.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 52.41 110.935 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.81 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 9.7 p90 -114.96 167.11 11.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 73.34 110.926 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -116.59 126.76 53.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 64.13 110.844 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.447 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -128.33 125.35 38.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 35.44 111.132 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.3 m -121.21 111.17 17.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 70.03 111.132 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.038 HG22 HG13 ' A' ' 33' ' ' VAL . 92.7 t -112.13 138.01 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 74.52 111.166 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.746 HG21 ' HB2' ' A' ' 89' ' ' ALA . 9.9 p -136.21 121.8 28.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 71.14 111.111 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.43 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -170.25 166.01 5.34 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.588 0.708 . . . . 75.44 110.917 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.548 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.5 Cg_endo -69.72 -21.66 33.36 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.719 2.279 . . . . 74.13 112.327 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.801 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -46.73 -46.26 20.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 64.0 111.136 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.623 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.9 OUTLIER -84.72 35.14 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 73.43 110.873 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.547 ' HA ' HG23 ' A' ' 85' ' ' THR . 7.7 p -52.46 133.84 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 64.12 111.142 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.94 -88.88 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.761 -0.733 . . . . 72.14 112.484 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 0.3 OUTLIER -120.64 113.39 20.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.769 0.319 . . . . 74.14 110.922 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.623 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -58.3 107.8 1.08 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.544 0.688 . . . . 53.22 111.071 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.7 Cg_endo -69.83 164.9 32.88 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.623 2.215 . . . . 64.32 112.393 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.507 HD21 ' NE ' ' A' ' 62' ' ' ARG . 1.8 tt -59.66 -25.6 64.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 63.4 110.892 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.26 -52.15 65.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 74.14 111.146 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.801 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 20.4 mmt180 -69.69 -41.08 75.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 72.45 110.874 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.52 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -58.44 -53.49 57.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 72.41 110.848 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.507 ' NE ' HD21 ' A' ' 58' ' ' LEU . 51.8 mtt180 -66.47 -36.88 83.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 63.52 110.874 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.6 mmm -56.61 -47.56 79.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 70.14 110.819 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 61' ' ' HIS . 19.2 m -68.8 -40.78 81.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 70.22 111.065 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.497 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 12.0 m-85 -62.09 -36.09 80.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 75.04 110.953 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.18 -46.78 31.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 73.33 111.069 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.721 ' OG1' HD11 ' A' ' 24' ' ' ILE . 0.7 OUTLIER -61.7 -33.28 73.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 65.02 111.135 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.57 HD12 HG23 ' A' ' 67' ' ' THR . 4.0 mp -84.49 -6.25 59.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 64.4 110.904 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 34.46 85.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.672 -0.775 . . . . 43.11 112.534 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -96.09 -35.11 11.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.841 0.353 . . . . 71.53 110.882 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.496 ' C ' HD23 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -87.91 5.98 37.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 72.45 110.867 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.492 ' N ' HD23 ' A' ' 71' ' ' LEU . 1.5 tpt -71.93 -10.65 60.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.432 . . . . 72.12 110.942 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.83 -32.68 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.777 -0.725 . . . . 34.21 112.534 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.4 ' CA ' ' HA2' ' A' ' 40' ' ' GLY . . . 164.12 93.48 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.741 . . . . 61.34 112.478 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.48 123.48 30.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.72 0.295 . . . . 63.42 111.093 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.569 HG22 ' N ' ' A' ' 77' ' ' HIS . 3.8 mp -113.45 164.17 9.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 71.23 111.123 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.569 ' N ' HG22 ' A' ' 76' ' ' ILE . 1.7 t-80 -77.2 40.41 0.27 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 74.12 110.847 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.445 ' HB3' ' CB ' ' A' ' 42' ' ' HIS . . . -134.11 36.97 3.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 44.42 111.187 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.81 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 1.9 mm? -97.62 140.47 31.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 61.42 110.964 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -116.98 115.71 25.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 63.12 110.875 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.497 HD22 ' CZ ' ' A' ' 65' ' ' TYR . 5.2 tp -130.64 138.7 50.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 62.43 110.957 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -136.33 114.82 11.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 65.13 110.858 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.518 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 8.8 p -112.02 106.58 15.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.461 . . . . 75.22 111.119 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.0 mt -133.55 162.02 33.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 64.43 110.94 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.547 HG23 ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.72 164.53 57.42 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.642 0.734 . . . . 72.52 111.056 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.7 Cg_endo -69.78 -11.53 31.0 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.651 2.234 . . . . 74.3 112.339 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.47 -23.06 26.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 71.03 110.832 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -108.04 38.44 2.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 51.13 110.919 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.746 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 65.3 111.048 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 7.9 tpt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.746 0.308 . . . . 74.22 110.916 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -123.6 93.8 4.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 74.3 110.863 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -128.56 -49.28 1.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 71.3 110.848 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.451 ' C ' ' O ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER 34.34 54.97 1.71 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.542 0.687 . . . . 72.02 110.813 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.45 ' HD3' ' CG ' ' A' ' 12' ' ' LYS . 54.2 Cg_endo -69.67 -166.24 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.698 2.265 . . . . 74.42 112.39 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.641 HD22 ' N ' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -130.82 -3.8 4.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.421 . . . . 73.41 110.893 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.641 ' N ' HD22 ' A' ' 15' ' ' LEU . 68.3 m-20 -112.74 -74.85 0.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 70.22 110.865 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.689 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . -46.25 -28.4 1.27 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 55.13 111.129 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -74.06 -33.51 63.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 75.03 110.939 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.94 ' O ' HD23 ' A' ' 23' ' ' LEU . 18.6 p -57.55 -57.63 11.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 74.33 111.131 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.748 ' H ' HD13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -73.87 -35.26 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 64.21 111.135 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.409 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 68.7 ttt-85 -61.8 -45.07 95.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 71.43 110.895 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp -71.09 -41.09 71.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 65.21 110.933 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.94 HD23 ' O ' ' A' ' 19' ' ' THR . 3.4 mm? -55.63 -49.15 73.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 63.14 110.928 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.762 ' CG2' HG21 ' A' ' 33' ' ' VAL . 14.9 mt -69.28 -43.33 81.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 52.21 111.113 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -53.67 -38.26 63.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 54.43 110.897 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -78.28 -43.05 29.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 63.21 110.833 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.69 -51.11 60.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 64.23 112.454 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.512 HD23 HG23 ' A' ' 24' ' ' ILE . 4.2 mm? -78.69 158.17 76.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.623 0.725 . . . . 64.44 110.889 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -90.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.71 2.274 . . . . 73.12 112.337 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -107.28 33.2 4.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 60.44 110.885 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 49' ' ' SER . . . -84.05 125.84 32.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 72.34 111.112 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.519 ' HB2' ' CG1' ' A' ' 48' ' ' VAL . 3.7 mmt180 -92.8 108.92 20.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 61.53 110.862 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.762 HG21 ' CG2' ' A' ' 24' ' ' ILE . 76.3 t -109.76 122.74 64.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 51.31 111.116 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -134.07 118.38 17.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 53.43 110.822 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.689 HG13 ' HB1' ' A' ' 17' ' ' ALA . 2.4 p -128.25 132.78 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 61.15 111.17 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -132.89 120.45 21.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 74.42 110.92 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.413 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 150.29 -140.16 7.8 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 53.11 112.439 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -157.68 178.77 9.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.87 0.367 . . . . 64.43 110.887 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.07 142.47 30.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 54.52 110.866 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.85 17.81 78.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.731 . . . . 15.32 112.468 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 p -142.08 164.33 18.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.884 0.373 . . . . 75.34 111.117 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.49 ' CG ' ' O ' ' A' ' 42' ' ' HIS . 26.9 p-80 -75.7 107.05 7.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 75.12 110.865 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.779 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 4.7 p90 -119.06 167.25 11.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 63.44 110.863 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.409 ' HG3' ' CB ' ' A' ' 80' ' ' GLN . 26.5 tt0 -117.03 122.07 43.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 71.21 110.926 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.59 115.9 18.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 74.15 111.139 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.406 HG23 ' HB2' ' A' ' 82' ' ' LYS . 10.5 m -110.78 120.07 41.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 65.31 111.172 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.404 HG13 HG22 ' A' ' 33' ' ' VAL . 86.9 t -123.47 128.24 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 73.34 111.157 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 32' ' ' ARG . 4.9 p -125.33 122.67 63.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 75.11 111.115 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -163.33 168.01 10.67 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.655 0.74 . . . . 72.31 110.893 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.483 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.6 Cg_endo -69.82 -21.19 33.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.68 2.253 . . . . 73.04 112.314 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -46.48 -46.76 19.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 71.12 111.097 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.603 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.7 OUTLIER -86.1 36.41 0.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 74.21 110.93 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.503 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 6.9 p -52.24 124.27 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 72.31 111.12 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.46 -74.69 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.796 -0.716 . . . . 61.24 112.464 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 53' ' ' VAL . 22.9 pttm -119.89 140.47 50.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.761 0.315 . . . . 75.34 110.89 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.603 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -101.25 97.92 8.11 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.59 0.709 . . . . 71.13 111.054 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.6 Cg_endo -69.77 173.42 11.01 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.703 2.269 . . . . 72.54 112.348 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.79 -26.83 62.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 74.11 110.907 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.84 -52.94 63.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 64.32 111.162 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.597 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 11.6 mmt180 -69.51 -43.13 73.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 64.51 110.898 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.533 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.2 t-160 -58.34 -53.35 59.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 75.53 110.9 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.8 mtt180 -65.99 -35.82 81.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 73.43 110.887 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.9 ttt -57.91 -46.0 85.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 74.11 110.875 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 61' ' ' HIS . 15.8 m -69.61 -39.96 78.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 74.3 111.152 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -67.72 -34.99 77.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 64.21 111.028 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.18 -47.19 29.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 74.51 111.086 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.703 HG23 HD12 ' A' ' 68' ' ' LEU . 15.4 t -61.65 -39.59 91.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 72.24 111.138 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.703 HD12 HG23 ' A' ' 67' ' ' THR . 1.0 OUTLIER -82.0 0.73 38.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 41.21 110.975 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 35.04 91.22 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 62.34 112.416 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.524 ' HB3' ' HB2' ' A' ' 75' ' ' ALA . 5.5 mp0 -96.86 -32.26 12.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.902 0.382 . . . . 51.41 110.852 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.53 10.25 3.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 75.04 110.903 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 37.9 mtm -73.56 -13.19 60.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 62.44 110.937 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.12 -33.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 74.34 112.479 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.53 101.02 0.21 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.786 -0.721 . . . . 74.34 112.489 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . . . -82.5 123.68 29.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.805 0.336 . . . . 50.35 111.127 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.747 ' O ' HD23 ' A' ' 79' ' ' LEU . 2.2 mp -113.35 163.13 10.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 71.1 111.161 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.468 ' N ' HG22 ' A' ' 76' ' ' ILE . 0.6 OUTLIER -66.56 -3.84 7.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 75.23 110.902 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -87.37 29.83 0.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 70.34 111.105 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.779 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 3.6 mm? -97.79 133.86 41.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 62.21 110.972 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.409 ' CB ' ' HG3' ' A' ' 44' ' ' GLU . 25.9 mt-30 -109.7 115.6 30.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 72.41 110.906 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.4 ' C ' ' HD2' ' A' ' 82' ' ' LYS . 5.0 tp -133.46 139.63 46.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 64.1 110.852 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HB2' HG23 ' A' ' 46' ' ' THR . 0.6 OUTLIER -136.53 115.36 12.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 74.11 110.842 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.527 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 10.5 p -108.44 106.68 16.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 72.43 111.147 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.504 HD22 ' C ' ' A' ' 83' ' ' THR . 3.9 mm? -129.61 161.49 30.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 75.42 110.838 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.503 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.5 162.92 71.54 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.623 0.725 . . . . 73.13 111.089 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.6 Cg_endo -69.64 -19.18 37.05 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.733 2.289 . . . . 63.34 112.402 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -68.82 -35.99 77.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 74.35 110.899 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -66.53 -40.19 88.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 72.51 110.918 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 75.22 111.097 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.792 0.329 . . . . 72.31 110.845 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 63.39 54.27 2.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 70.14 110.864 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.13 48.28 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 60.23 110.889 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -141.57 143.35 29.23 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.56 0.695 . . . . 72.12 110.86 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 146.74 60.78 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.732 2.288 . . . . 62.45 112.297 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.562 HD22 ' CD ' ' A' ' 18' ' ' GLU . 4.3 mp -109.89 -175.6 2.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 73.15 110.93 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -129.76 -73.4 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 72.04 110.844 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.94 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . -59.26 -30.57 68.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 53.15 111.101 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.562 ' CD ' HD22 ' A' ' 15' ' ' LEU . 5.9 mt-10 -70.1 -38.45 75.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 60.44 110.84 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.9 ' O ' HD23 ' A' ' 23' ' ' LEU . 25.8 p -63.43 -53.57 50.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 72.31 111.139 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.935 HD12 ' N ' ' A' ' 21' ' ' ARG . 1.7 pp -65.06 -42.61 94.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 61.33 111.079 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.935 ' N ' HD12 ' A' ' 20' ' ' ILE . 39.9 ttp180 -60.37 -46.23 90.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 64.03 110.889 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.12 -42.4 99.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 75.12 110.969 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.9 HD23 ' O ' ' A' ' 19' ' ' THR . 4.2 mm? -58.08 -49.3 77.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 74.24 110.913 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.776 ' CG2' HG21 ' A' ' 33' ' ' VAL . 46.7 mm -63.31 -46.38 95.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 73.1 111.152 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -54.37 -43.71 71.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 74.15 110.851 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.31 -42.93 78.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 74.05 110.797 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.35 -57.04 12.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.725 -0.75 . . . . 14.42 112.45 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.477 ' CB ' ' HB3' ' A' ' 31' ' ' ALA . 3.3 mm? -72.65 155.86 90.57 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.537 0.684 . . . . 63.41 110.958 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -90.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.615 2.21 . . . . 73.51 112.352 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -103.32 31.89 4.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 70.33 110.902 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.477 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . . . -80.48 131.65 35.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 74.23 111.095 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.634 ' HB3' HG12 ' A' ' 48' ' ' VAL . 6.4 tpp180 -102.42 113.99 27.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 75.43 110.878 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.075 HG13 HG22 ' A' ' 47' ' ' VAL . 36.8 t -116.03 127.31 73.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 72.14 111.137 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -135.4 118.37 16.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.248 -0.433 . . . . 72.24 110.864 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.94 HG13 ' HB1' ' A' ' 17' ' ' ALA . 4.3 p -127.28 136.91 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 65.15 111.142 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.418 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 0.9 OUTLIER -133.05 120.4 21.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 61.55 110.918 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.435 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 142.37 -134.43 6.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.741 . . . . 55.44 112.469 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.412 ' OE2' ' CG ' ' A' ' 39' ' ' ASP . 5.3 tm-20 -170.2 166.53 8.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 72.22 110.866 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.412 ' CG ' ' OE2' ' A' ' 38' ' ' GLU . 7.8 p30 -72.95 153.55 40.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 70.34 110.905 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.432 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.84 -2.62 32.06 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 73.22 112.489 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.4 m -130.41 164.9 32.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.867 0.365 . . . . 62.52 111.124 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.419 ' CG ' ' O ' ' A' ' 42' ' ' HIS . 12.6 p80 -74.78 109.98 8.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 63.35 110.859 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.606 ' CE2' HD11 ' A' ' 79' ' ' LEU . 34.1 p90 -127.43 167.36 16.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 71.13 110.9 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -118.1 126.72 52.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 63.23 110.837 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.27 115.32 18.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 72.22 111.052 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.7 m -110.37 110.78 21.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.469 . . . . 55.2 111.108 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.075 HG22 HG13 ' A' ' 33' ' ' VAL . 91.5 t -110.68 140.8 28.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.49 . . . . 64.33 111.091 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.634 HG12 ' HB3' ' A' ' 32' ' ' ARG . 4.3 p -133.34 118.31 31.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 60.34 111.168 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.534 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 38.4 p -162.08 159.17 21.55 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.671 0.748 . . . . 72.11 110.853 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.574 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.1 Cg_endo -69.78 -14.67 36.34 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.643 2.229 . . . . 51.53 112.318 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.07 -48.45 22.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 74.0 111.134 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.77 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -84.19 35.07 0.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 64.33 110.874 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 p -50.84 131.1 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 54.13 111.099 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.73 -78.04 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.728 -0.749 . . . . 71.34 112.509 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -122.49 140.87 52.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.8 0.334 . . . . 75.44 110.849 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.77 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -104.19 99.11 15.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.606 0.717 . . . . 64.43 111.114 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 52.7 Cg_endo -69.81 169.4 19.05 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.677 2.251 . . . . 52.22 112.309 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.484 HD21 ' NE ' ' A' ' 62' ' ' ARG . 1.6 tt -56.43 -27.56 56.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 61.21 110.888 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.69 -52.75 63.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 73.25 111.097 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.458 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 3.4 mmm180 -69.84 -43.64 71.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 73.31 110.906 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.453 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.9 OUTLIER -56.57 -53.44 57.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.14 -0.482 . . . . 55.34 110.857 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.484 ' NE ' HD21 ' A' ' 58' ' ' LEU . 51.0 mtt180 -66.73 -37.93 85.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 64.1 110.852 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.5 mmt -54.13 -50.15 67.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 74.14 110.844 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.587 ' O ' HG22 ' A' ' 67' ' ' THR . 17.1 m -66.96 -42.91 89.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 60.02 111.154 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.889 ' CE1' HD13 ' A' ' 81' ' ' LEU . 15.2 m-85 -62.29 -36.82 83.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 71.15 110.936 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.2 -35.88 61.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 73.02 111.046 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.587 HG22 ' O ' ' A' ' 64' ' ' VAL . 0.6 OUTLIER -69.93 -31.22 68.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 73.32 111.122 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.657 ' C ' HD12 ' A' ' 68' ' ' LEU . 2.9 pp -88.03 -10.44 50.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 55.41 110.933 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.613 ' N ' HD12 ' A' ' 68' ' ' LEU . . . 46.86 87.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.681 -0.771 . . . . 52.5 112.506 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.638 ' HG2' HD11 ' A' ' 68' ' ' LEU . 8.2 pt-20 -111.02 -48.14 3.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.847 0.356 . . . . 73.23 110.868 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.73 HD13 ' O ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -78.88 -2.19 38.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.199 -0.455 . . . . 73.32 110.963 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.1 mmt -85.14 -13.7 49.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 54.03 110.888 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.6 -30.88 3.37 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.724 -0.75 . . . . 50.1 112.423 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.432 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . 103.53 53.25 0.88 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.785 -0.722 . . . . 64.0 112.527 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.84 157.91 19.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.843 0.354 . . . . 42.11 111.08 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.775 ' H ' HD12 ' A' ' 76' ' ' ILE . 2.2 mp -70.91 165.25 2.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 72.12 111.148 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.488 ' N ' HG22 ' A' ' 76' ' ' ILE . 19.3 m170 -74.22 49.37 0.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 63.33 110.814 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -131.37 51.85 2.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 70.41 111.068 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.606 HD11 ' CE2' ' A' ' 43' ' ' PHE . 4.1 mm? -97.44 131.83 43.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 63.53 110.943 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -112.58 114.94 27.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 75.22 110.896 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.889 HD13 ' CE1' ' A' ' 65' ' ' TYR . 6.7 tt -139.53 138.44 36.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 51.13 110.883 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -136.54 114.96 11.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 74.0 110.868 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.536 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 59.0 p -100.87 106.82 18.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 72.15 111.172 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 84' ' ' LEU . 2.5 mm? -125.27 162.5 24.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 74.4 110.92 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.408 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 0.6 OUTLIER -71.09 164.49 56.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.606 0.717 . . . . 64.03 111.131 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.2 Cg_endo -69.83 -18.25 36.78 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.613 2.209 . . . . 61.21 112.333 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -76.51 -29.56 56.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 63.2 110.885 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -80.28 5.37 14.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.172 -0.467 . . . . 75.42 110.87 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 63.03 111.118 179.925 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.45 ' O ' ' NH1' ' A' ' 11' ' ' ARG . 1.6 tpt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.705 0.288 . . . . 75.23 110.867 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.45 ' NH1' ' O ' ' A' ' 10' ' ' MET . 15.1 mmt-85 -127.31 159.0 35.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 64.43 110.805 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.403 ' O ' ' HD3' ' A' ' 14' ' ' PRO . 1.1 tppp? -83.8 144.38 29.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 74.15 110.876 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.425 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . 47.3 mtp180 -102.56 96.35 7.31 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.62 0.724 . . . . 73.23 110.853 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 13' ' ' ARG . 53.7 Cg_endo -69.73 160.56 49.26 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.731 2.287 . . . . 63.54 112.327 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.29 -75.13 0.5 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 71.41 110.934 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 20' ' ' ILE . 13.6 m-20 -128.77 -68.72 0.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 73.13 110.89 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 35' ' ' VAL . . . -67.4 -27.78 67.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 65.33 111.135 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.64 -47.19 49.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 62.01 110.967 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.403 HG23 ' N ' ' A' ' 20' ' ' ILE . 3.1 t -62.4 -45.14 94.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 43.4 111.155 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 16' ' ' ASP . 14.6 pt -69.91 -40.03 78.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 54.42 111.124 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.455 ' N ' HG13 ' A' ' 20' ' ' ILE . 32.5 ttt-85 -60.0 -48.23 82.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 51.2 110.861 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.449 ' HG3' ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -69.29 -39.62 78.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 73.32 110.917 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.449 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 17.8 mt -57.12 -49.32 76.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 73.42 110.881 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.803 ' CG2' HG21 ' A' ' 33' ' ' VAL . 5.7 mt -70.06 -45.86 74.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 61.3 111.127 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -53.96 -36.86 63.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 62.44 110.898 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -79.48 -40.82 28.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 74.24 110.861 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.92 -55.56 21.43 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.732 -0.747 . . . . 64.24 112.473 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.596 HD12 ' CG2' ' A' ' 24' ' ' ILE . 5.8 mt -76.5 159.62 79.17 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.572 0.701 . . . . 72.24 111.005 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -91.29 0.01 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.104 0 C-N-CA 122.73 2.286 . . . . 71.25 112.361 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -106.96 29.61 6.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 74.4 110.87 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.46 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -77.58 131.28 37.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 64.3 111.113 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.516 ' HB2' ' CG1' ' A' ' 48' ' ' VAL . 13.6 mmm-85 -97.11 114.42 26.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 74.44 110.881 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.872 HG13 HG22 ' A' ' 47' ' ' VAL . 56.3 t -117.98 126.05 74.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 63.33 111.179 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -135.28 118.63 16.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 73.35 110.822 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.568 HG21 ' CD1' ' A' ' 20' ' ' ILE . 43.2 t -125.01 135.21 64.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 72.34 111.108 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 -133.25 123.17 25.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 71.22 110.884 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.78 -134.48 6.23 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.698 -0.763 . . . . 62.24 112.511 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -163.67 160.23 22.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 54.42 110.896 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.453 ' OD2' ' C ' ' A' ' 72' ' ' MET . 24.5 t0 -67.49 147.63 52.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 65.41 110.901 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.0 -7.29 16.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.815 -0.707 . . . . 62.13 112.391 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.573 HG12 ' N ' ' A' ' 42' ' ' HIS . 14.6 t -118.81 165.8 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.871 0.367 . . . . 64.22 111.158 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.573 ' N ' HG12 ' A' ' 41' ' ' VAL . 22.9 p-80 -73.95 106.54 5.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 64.33 110.853 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.573 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 41.7 p90 -122.6 167.33 13.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 64.21 110.918 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -114.3 128.1 56.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 75.01 110.916 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.39 121.94 36.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 72.11 111.133 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.8 m -121.11 110.41 16.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 71.41 111.14 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.872 HG22 HG13 ' A' ' 33' ' ' VAL . 65.4 t -120.6 129.64 75.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 65.2 111.18 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.516 ' CG1' ' HB2' ' A' ' 32' ' ' ARG . 3.7 p -126.4 118.86 52.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 51.45 111.112 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.478 ' CB ' ' HD2' ' A' ' 50' ' ' PRO . 0.4 OUTLIER -161.84 169.36 9.63 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.657 0.741 . . . . 61.22 110.862 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.515 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 52.9 Cg_endo -69.79 -20.87 34.15 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.692 2.261 . . . . 72.35 112.326 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.68 ' HB1' ' NE ' ' A' ' 60' ' ' ARG . . . -43.74 -53.58 5.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 75.14 111.195 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.626 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.7 OUTLIER -81.55 38.46 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 72.11 110.884 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.514 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 2.9 p -51.37 127.23 7.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 64.31 111.118 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.39 -78.36 0.12 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.714 -0.755 . . . . 72.12 112.481 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -121.97 141.68 51.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.765 0.316 . . . . 72.25 110.91 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.626 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -99.67 99.28 8.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.575 0.702 . . . . 50.34 111.101 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.6 Cg_endo -69.74 165.75 29.91 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.696 2.264 . . . . 74.24 112.332 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.469 ' O ' HD23 ' A' ' 58' ' ' LEU . 2.8 tt -54.53 -24.09 19.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 63.02 110.916 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 63' ' ' MET . . . -61.36 -51.65 67.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 75.32 111.14 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.68 ' NE ' ' HB1' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -72.05 -37.45 69.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 71.12 110.918 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.514 ' CD2' ' CD2' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -61.46 -49.99 74.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 74.24 110.879 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.439 ' HD2' HD21 ' A' ' 58' ' ' LEU . 18.5 mtp180 -70.39 -39.8 74.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 63.45 110.95 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 10.1 tpt -54.58 -50.84 67.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 71.24 110.912 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.649 ' O ' HG22 ' A' ' 67' ' ' THR . 30.3 m -66.12 -44.21 91.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 70.3 111.142 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.65 ' CE1' HD13 ' A' ' 81' ' ' LEU . 10.0 m-85 -55.45 -40.17 71.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 62.34 110.943 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.32 -38.93 59.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 62.33 111.102 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.649 HG22 ' O ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -66.18 -24.03 66.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 74.23 111.123 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.597 ' C ' HD12 ' A' ' 68' ' ' LEU . 3.8 pp -95.47 -1.57 50.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 55.24 110.889 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.459 ' HA2' ' CG ' ' A' ' 72' ' ' MET . . . 82.06 66.01 1.6 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.773 -0.727 . . . . 73.43 112.446 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -74.75 -65.62 0.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.838 0.351 . . . . 73.24 110.914 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.6 tp -86.48 10.08 16.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 75.23 110.91 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' MET . . . . . 0.459 ' CG ' ' HA2' ' A' ' 69' ' ' GLY . 19.7 mmt -72.22 -14.08 61.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 53.33 110.854 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.423 ' HA3' ' CG ' ' A' ' 39' ' ' ASP . . . -149.46 -34.54 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.755 -0.736 . . . . 60.44 112.509 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 131.57 68.67 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 53.34 112.482 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.21 132.25 53.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.822 0.344 . . . . 42.33 111.059 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.753 ' O ' HD23 ' A' ' 79' ' ' LEU . 4.7 mp -110.69 163.25 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 50.53 111.178 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.595 ' N ' HG22 ' A' ' 76' ' ' ILE . 84.3 t60 -48.42 -18.8 0.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 70.43 110.891 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.01 44.79 0.58 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 62.33 111.096 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 76' ' ' ILE . 1.2 mm? -113.54 145.78 40.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 73.45 110.951 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -124.7 115.96 21.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 65.13 110.861 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.65 HD13 ' CE1' ' A' ' 65' ' ' TYR . 2.8 tp -123.94 141.67 51.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 75.22 110.895 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -133.13 114.39 13.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 75.22 110.916 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.527 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 24.7 p -118.5 106.12 12.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 54.13 111.145 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mp -134.62 161.23 35.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 64.15 110.934 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.514 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.48 163.59 66.52 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.639 0.733 . . . . 64.42 111.152 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.3 Cg_endo -69.76 -19.04 36.64 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.693 2.262 . . . . 71.04 112.328 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -68.87 -36.07 77.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 71.5 110.891 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -64.48 -38.12 89.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 62.53 110.925 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 54.13 111.136 179.893 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.833 0.349 . . . . 64.43 110.885 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.6 ttt85 -90.31 141.34 28.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 75.14 110.855 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.63 -62.91 1.41 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.31 110.914 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -47.45 115.46 3.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.656 0.741 . . . . 75.3 110.918 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 162.59 41.45 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.651 2.234 . . . . 65.5 112.407 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.695 ' O ' HG23 ' A' ' 19' ' ' THR . 28.1 mt -110.71 -68.01 0.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 75.11 110.924 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -61.88 -57.4 11.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 64.34 110.841 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.853 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . -59.38 -26.22 64.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 60.22 111.124 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -70.54 -39.13 74.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 74.31 110.879 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.695 HG23 ' O ' ' A' ' 15' ' ' LEU . 1.1 p -62.32 -53.55 53.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 75.2 111.104 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.073 HD12 HD22 ' A' ' 68' ' ' LEU . 9.1 pt -66.88 -45.9 86.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 74.51 111.147 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.435 ' N ' ' CG1' ' A' ' 20' ' ' ILE . 37.7 ttp85 -53.58 -51.45 62.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 73.13 110.828 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -67.43 -34.85 78.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 64.43 110.987 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.491 HD13 ' O ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -56.64 -49.65 74.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 55.22 110.885 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.663 HD12 HG11 ' A' ' 33' ' ' VAL . 46.8 mt -72.44 -43.05 64.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 74.42 111.109 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -54.61 -36.49 64.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 65.21 110.92 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -81.44 -43.14 19.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.487 . . . . 65.13 110.865 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 -37.88 95.45 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 55.24 112.485 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.801 HD23 ' CB ' ' A' ' 31' ' ' ALA . 8.2 mp -92.99 160.94 32.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.537 0.684 . . . . 72.11 110.937 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -90.99 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.657 2.238 . . . . 74.15 112.36 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -107.43 25.55 11.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 62.25 110.907 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.801 ' CB ' HD23 ' A' ' 28' ' ' LEU . . . -72.36 129.51 38.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 74.32 111.042 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.651 ' HB3' HG12 ' A' ' 48' ' ' VAL . 3.3 ttm180 -97.03 112.01 23.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 70.1 110.879 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.022 HG13 HG22 ' A' ' 47' ' ' VAL . 21.4 t -113.94 130.08 68.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 74.11 111.143 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -135.12 118.08 16.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 75.02 110.898 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.853 HG13 ' HB1' ' A' ' 17' ' ' ALA . 5.8 p -129.69 137.44 56.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 70.33 111.17 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.4 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 47.2 tt0 -133.25 120.3 20.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 74.22 110.868 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 144.12 -149.06 21.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 74.34 112.571 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -155.69 177.7 11.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 74.52 110.91 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.95 147.04 35.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 75.32 110.889 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.84 7.86 71.3 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.78 -0.724 . . . . 72.31 112.521 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.548 HG12 ' N ' ' A' ' 42' ' ' HIS . 17.7 t -134.87 163.87 35.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 52.14 111.105 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.548 ' N ' HG12 ' A' ' 41' ' ' VAL . 49.3 p-80 -75.9 106.85 7.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 75.42 110.879 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.654 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 7.4 p90 -119.76 166.76 12.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 75.32 110.866 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.02 129.59 56.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.02 110.899 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.05 116.28 19.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 62.32 111.108 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.691 HG23 ' HB2' ' A' ' 82' ' ' LYS . 12.0 m -121.29 112.11 18.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 71.33 111.132 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.022 HG22 HG13 ' A' ' 33' ' ' VAL . 79.6 t -114.06 138.92 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 45.22 111.143 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.651 HG12 ' HB3' ' A' ' 32' ' ' ARG . 8.6 p -132.08 123.84 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 73.21 111.126 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.44 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 0.6 OUTLIER -170.37 167.52 4.59 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.7 0.762 . . . . 60.12 110.855 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.518 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.4 Cg_endo -69.77 -22.78 31.55 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.693 2.262 . . . . 70.33 112.357 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HB1' ' NE ' ' A' ' 60' ' ' ARG . . . -44.27 -47.02 9.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 54.14 111.091 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.724 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -86.69 39.85 0.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 72.5 110.814 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.494 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 4.3 p -55.92 123.11 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 74.35 111.139 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.46 -91.68 0.86 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.75 -0.738 . . . . 52.25 112.41 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.485 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 11.8 mptt -118.06 108.88 15.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.797 0.332 . . . . 70.44 110.878 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.724 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -57.82 106.65 0.73 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.549 0.69 . . . . 63.44 111.1 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 54.5 Cg_endo -69.79 170.5 16.45 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.645 2.23 . . . . 73.24 112.381 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tp -63.54 -23.78 67.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 64.3 110.943 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.87 -54.14 49.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 64.3 111.116 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.583 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 8.2 mmm180 -71.83 -40.84 68.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 74.24 110.82 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.406 ' CD2' ' HE2' ' A' ' 65' ' ' TYR . 1.0 OUTLIER -58.25 -50.34 73.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 64.53 110.855 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -69.05 -40.18 78.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 71.23 110.819 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.812 ' O ' HG23 ' A' ' 67' ' ' THR . 10.5 tpt -53.47 -52.79 58.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 71.11 110.856 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.523 HG23 ' N ' ' A' ' 65' ' ' TYR . 16.6 m -61.75 -49.56 83.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 72.23 111.141 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.577 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 12.8 m-85 -55.61 -31.19 62.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 74.31 110.995 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.49 -43.33 56.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 74.14 111.151 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 63' ' ' MET . 1.1 p -64.44 -33.83 76.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 75.51 111.179 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.073 HD22 HD12 ' A' ' 20' ' ' ILE . 12.6 mt -81.74 7.07 13.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 74.12 110.925 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 31.58 73.14 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.7 -0.762 . . . . 70.11 112.48 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.427 ' CD ' ' HG ' ' A' ' 79' ' ' LEU . 26.7 mt-10 -77.34 -38.95 49.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.861 0.362 . . . . 51.32 110.894 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.4 tp -89.83 10.36 23.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 51.24 110.876 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.3 ttt -77.23 -13.52 59.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 72.11 110.904 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.1 -32.33 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.737 . . . . 53.12 112.508 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.88 100.53 0.17 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.718 -0.754 . . . . 32.24 112.528 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.28 122.81 28.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 44.11 111.079 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.535 ' O ' HD23 ' A' ' 79' ' ' LEU . 2.6 mp -114.02 163.82 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 71.32 111.205 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.5 ' N ' HG22 ' A' ' 76' ' ' ILE . 39.5 m-70 -76.9 41.52 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 52.23 110.867 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.415 ' HB3' ' HB3' ' A' ' 42' ' ' HIS . . . -135.01 33.21 3.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 74.34 111.123 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.654 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 4.0 mm? -97.61 146.54 25.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 64.42 110.954 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -121.3 115.79 23.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 72.34 110.901 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.577 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 0.4 OUTLIER -125.01 117.64 24.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 54.33 110.869 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.691 ' HB2' HG23 ' A' ' 46' ' ' THR . 2.3 mptp? -120.83 114.87 22.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 73.51 110.853 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.536 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 28.6 p -116.15 107.06 14.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 40.14 111.188 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.5 mt -132.48 161.42 33.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 72.24 110.935 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.494 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.1 163.04 70.27 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.608 0.718 . . . . 75.0 111.109 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.2 Cg_endo -69.77 -7.97 22.42 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.681 2.254 . . . . 72.2 112.354 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -86.62 -28.83 23.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.446 . . . . 74.43 110.824 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -84.53 18.31 2.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 71.5 110.894 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 63.12 111.118 179.93 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.4 mmt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.823 0.344 . . . . 73.02 110.856 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.0 mtm180 -104.74 -58.47 1.88 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 73.31 110.917 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.442 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -99.84 139.06 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 65.12 110.885 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -125.63 113.22 25.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.582 0.706 . . . . 73.4 110.898 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 87.22 0.55 Allowed 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.688 2.259 . . . . 62.34 112.312 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tp -132.23 -32.17 1.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.289 -0.414 . . . . 62.44 110.91 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.95 -175.28 3.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 70.02 110.853 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.77 ' HB1' ' CG1' ' A' ' 35' ' ' VAL . . . -46.55 -30.03 2.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 64.04 111.078 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -57.64 -37.1 72.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 62.01 110.898 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.56 ' CG2' ' N ' ' A' ' 20' ' ' ILE . 1.2 t -60.86 -47.53 85.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 44.51 111.045 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.857 HD13 ' HB2' ' A' ' 68' ' ' LEU . 9.4 pt -70.24 -30.8 44.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 74.2 111.086 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.556 ' N ' HG13 ' A' ' 20' ' ' ILE . 39.0 ttt-85 -65.22 -48.02 74.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 74.31 110.814 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -71.46 -39.74 70.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 72.24 110.92 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.0 mt -58.26 -50.21 74.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 75.41 110.899 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.778 HG21 HG21 ' A' ' 33' ' ' VAL . 6.6 mt -71.32 -45.78 68.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 62.32 111.176 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -54.2 -35.82 62.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 74.33 110.903 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.97 -43.15 22.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 75.31 110.852 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.79 -52.22 52.12 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.78 -0.724 . . . . 71.3 112.518 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.06 101.67 54.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 74.41 110.938 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.64 -14.76 36.95 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.723 2.282 . . . . 73.22 112.302 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -97.65 1.1 48.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 74.44 110.88 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' A' ' 49' ' ' SER . . . -119.24 135.89 54.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 61.45 111.123 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.609 ' HB2' HG13 ' A' ' 48' ' ' VAL . 9.8 mmt180 -106.85 114.32 28.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 74.12 110.878 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 24' ' ' ILE . 18.4 t -116.79 124.69 73.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 72.12 111.065 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.62 117.65 15.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 63.4 110.806 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.77 ' CG1' ' HB1' ' A' ' 17' ' ' ALA . 4.4 p -123.64 138.6 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 71.51 111.098 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 3.1 tp-100 -132.12 120.52 22.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 72.41 110.904 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.53 -150.81 23.1 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.667 -0.778 . . . . 74.44 112.474 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -150.94 165.68 32.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 75.24 110.883 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -68.56 142.75 55.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 64.35 110.851 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.421 ' C ' ' HA ' ' A' ' 75' ' ' ALA . . . 72.61 19.56 79.17 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 74.54 112.478 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 42' ' ' HIS . 9.8 t -144.1 164.98 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.853 0.359 . . . . 74.14 111.099 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.54 ' N ' HG12 ' A' ' 41' ' ' VAL . 17.3 p80 -74.81 107.73 7.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 71.11 110.923 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.928 ' CE2' HD11 ' A' ' 79' ' ' LEU . 7.7 p90 -119.43 167.43 11.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 72.21 110.904 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.1 pm0 -115.27 133.72 55.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 61.41 110.889 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.829 ' HB2' ' HE1' ' A' ' 43' ' ' PHE . . . -125.54 123.93 40.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 52.54 111.097 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.8 m -121.72 107.32 12.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 63.34 111.194 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.768 ' CG1' HG13 ' A' ' 33' ' ' VAL . 2.9 m -116.8 128.95 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 60.42 111.178 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.609 HG13 ' HB2' ' A' ' 32' ' ' ARG . 4.4 p -133.48 118.62 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 73.12 111.184 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.466 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -165.19 168.22 8.7 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.611 0.72 . . . . 74.22 110.828 -179.788 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.508 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.9 Cg_endo -69.7 -23.94 30.5 Favored 'Trans proline' 0 N--CA 1.465 -0.147 0 C-N-CA 122.747 2.298 . . . . 35.2 112.38 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -47.35 -44.45 23.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 72.54 111.053 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.635 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.7 OUTLIER -85.3 34.25 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 61.34 110.865 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.555 ' HA ' HG23 ' A' ' 85' ' ' THR . 14.6 p -52.3 144.67 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 71.44 111.109 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 50.7 -88.12 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.772 -0.728 . . . . 74.42 112.512 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -118.21 112.51 20.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 73.24 110.922 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.635 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -58.59 108.05 1.18 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.607 0.718 . . . . 63.33 111.136 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 52.9 Cg_endo -69.8 162.27 42.74 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.715 2.277 . . . . 73.42 112.317 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.8 tp -57.89 -25.95 61.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.225 -0.443 . . . . 74.23 110.831 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.22 -53.53 57.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 73.21 111.105 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.6 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 29.5 mmt180 -69.92 -44.97 68.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 75.24 110.885 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.485 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.5 t-160 -56.24 -53.77 53.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 61.44 110.821 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.9 mtp85 -65.33 -35.89 82.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 70.44 110.87 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.4 ttt -56.24 -48.38 76.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 65.13 110.835 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.594 HG21 HD21 ' A' ' 81' ' ' LEU . 11.4 m -67.83 -40.64 83.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 74.31 111.116 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.605 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 16.7 m-85 -67.35 -34.18 76.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 71.42 110.908 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.06 -44.46 26.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 64.02 111.114 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.505 HG22 ' O ' ' A' ' 64' ' ' VAL . 1.2 t -60.32 -40.99 92.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 72.52 111.158 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.048 HD22 ' O ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -88.66 -10.92 46.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 60.34 110.921 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 1.014 ' N ' HD13 ' A' ' 68' ' ' LEU . . . 31.32 87.82 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.757 -0.735 . . . . 75.04 112.506 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.456 ' HG2' HD23 ' A' ' 71' ' ' LEU . 1.1 pm0 -79.53 -35.25 40.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.993 0.425 . . . . 74.44 110.938 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.456 HD23 ' HG2' ' A' ' 70' ' ' GLU . 3.9 mm? -76.11 7.3 4.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 40.21 110.929 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 63.4 mtp -84.52 -13.05 52.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 71.11 110.854 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.39 -22.1 1.11 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.772 -0.728 . . . . 55.1 112.448 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.08 42.9 4.23 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.722 -0.751 . . . . 74.35 112.501 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.421 ' HA ' ' C ' ' A' ' 40' ' ' GLY . . . -58.78 156.09 11.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.766 0.317 . . . . 51.52 111.063 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.575 HG22 ' N ' ' A' ' 77' ' ' HIS . 21.5 mm -70.82 164.99 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 71.12 111.134 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.575 ' N ' HG22 ' A' ' 76' ' ' ILE . 30.2 m170 -74.48 46.46 0.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 72.14 110.839 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -134.95 58.63 1.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 61.0 111.107 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.928 HD11 ' CE2' ' A' ' 43' ' ' PHE . 3.9 mm? -97.66 132.49 43.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 63.23 110.882 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -111.46 114.94 28.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 71.11 110.935 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.605 HD22 ' CZ ' ' A' ' 65' ' ' TYR . 3.4 tp -133.65 124.72 27.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 64.12 110.915 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' A' ' 81' ' ' LEU . 9.4 mptt -126.48 114.47 18.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 72.05 110.834 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.583 ' HB ' ' CD2' ' A' ' 52' ' ' PHE . 66.8 p -109.39 107.19 17.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 72.3 111.189 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.412 HD12 ' C ' ' A' ' 83' ' ' THR . 6.6 mp -131.56 162.8 29.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 65.25 110.88 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.555 HG23 ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.11 164.1 59.8 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.59 0.71 . . . . 72.44 111.103 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.6 Cg_endo -69.79 -12.8 33.58 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.633 2.222 . . . . 74.54 112.374 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -78.66 -28.72 45.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 72.24 110.905 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -85.04 28.79 0.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 74.4 110.877 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 53.44 111.18 179.837 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.6 ptp . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.747 0.308 . . . . 72.01 110.944 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -113.85 90.91 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 74.13 110.876 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.74 43.94 2.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 65.53 110.933 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.506 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -71.35 -59.87 2.99 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.563 0.697 . . . . 74.2 110.852 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 13' ' ' ARG . 54.0 Cg_endo -69.8 165.32 31.4 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.662 2.241 . . . . 41.4 112.379 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 19' ' ' THR . 6.7 tp -121.22 -36.96 3.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 61.45 110.901 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.52 -49.25 6.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 74.55 110.911 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.869 ' HA ' HD11 ' A' ' 20' ' ' ILE . . . -63.37 -27.73 69.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 74.24 111.042 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' A' ' 19' ' ' THR . 4.0 pt-20 -71.49 -28.91 64.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.26 -0.427 . . . . 74.44 110.873 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 15' ' ' LEU . 17.1 p -59.07 -56.66 19.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 74.51 111.166 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.892 ' H ' HD13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -73.92 -35.29 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 74.15 111.098 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.52 ' N ' HG12 ' A' ' 20' ' ' ILE . 30.8 ttp180 -62.41 -48.57 79.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 73.23 110.862 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -69.56 -40.27 76.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 75.42 110.872 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.8 mt -56.18 -49.19 74.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.302 -0.408 . . . . 74.24 110.931 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.811 ' CG2' HG21 ' A' ' 33' ' ' VAL . 11.7 mt -68.07 -45.84 82.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 70.04 111.161 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -54.21 -36.8 63.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.116 -0.493 . . . . 74.34 110.898 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m -77.4 -43.02 34.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 40.15 110.881 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.47 -46.46 92.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.768 -0.729 . . . . 54.41 112.472 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.789 HD23 ' CB ' ' A' ' 31' ' ' ALA . 6.8 mp -85.61 161.09 52.02 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.567 0.699 . . . . 63.32 110.938 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -90.76 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.656 2.237 . . . . 74.12 112.373 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -107.26 25.89 10.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 72.41 110.909 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.789 ' CB ' HD23 ' A' ' 28' ' ' LEU . . . -71.64 125.71 27.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 73.01 111.118 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.717 ' HB3' HG12 ' A' ' 48' ' ' VAL . 2.2 tpm_? -93.71 108.75 20.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 71.22 110.865 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.071 HG22 HG13 ' A' ' 47' ' ' VAL . 41.7 t -113.28 127.46 70.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 73.04 111.196 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -135.22 118.56 16.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 70.12 110.828 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.683 HG13 ' HB1' ' A' ' 17' ' ' ALA . 3.9 p -126.26 136.7 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 64.33 111.089 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 24.7 mt-30 -132.69 120.1 21.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 73.44 110.912 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 149.18 -124.92 1.9 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 72.42 112.444 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.62 ' O ' HG12 ' A' ' 41' ' ' VAL . 2.2 tt0 -175.44 163.04 2.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 61.52 110.895 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.02 148.16 46.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 75.31 110.9 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.61 8.99 73.4 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.739 -0.743 . . . . 41.25 112.508 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 38' ' ' GLU . 14.7 p -139.14 165.17 23.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.827 0.346 . . . . 70.52 111.152 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.6 ' N ' HG22 ' A' ' 41' ' ' VAL . 32.6 p80 -74.49 110.7 9.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 73.22 110.851 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.536 ' CE2' HD11 ' A' ' 79' ' ' LEU . 4.9 p90 -126.91 167.65 15.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.273 -0.422 . . . . 71.21 110.866 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -113.5 124.98 53.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 64.15 110.873 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.22 119.99 26.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 64.51 111.148 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.4 m -118.26 114.99 23.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 74.51 111.117 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.071 HG13 HG22 ' A' ' 33' ' ' VAL . 24.7 t -113.47 141.25 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 74.13 111.128 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.717 HG12 ' HB3' ' A' ' 32' ' ' ARG . 5.1 p -134.95 122.2 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 70.24 111.133 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.449 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -167.61 166.26 7.97 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.704 0.764 . . . . 73.54 110.874 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.504 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.8 Cg_endo -69.74 -18.22 37.21 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.681 2.254 . . . . 74.03 112.317 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -43.76 -50.79 7.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 64.04 111.157 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.63 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -86.94 40.58 0.92 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.248 -0.433 . . . . 71.23 110.891 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.498 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 4.7 p -51.24 119.1 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 74.2 111.089 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.69 -72.88 1.01 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.748 -0.739 . . . . 70.55 112.495 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.404 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 23.3 mtpt -121.62 138.59 54.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.809 0.338 . . . . 72.23 110.876 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -99.73 100.11 10.33 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.538 0.685 . . . . 75.53 111.093 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.8 163.49 38.11 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.633 2.222 . . . . 75.23 112.374 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -56.49 -26.76 55.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 50.2 110.928 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 63' ' ' MET . . . -58.6 -49.95 75.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 63.41 111.13 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.605 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 21.6 mmt180 -71.7 -46.47 58.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.275 -0.42 . . . . 64.51 110.818 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.583 ' CD2' ' HH ' ' A' ' 65' ' ' TYR . 1.0 OUTLIER -58.0 -50.0 74.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 62.24 110.833 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 1.2 ttm180 -67.34 -39.65 85.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 55.34 110.883 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.407 ' CG ' ' O ' ' A' ' 59' ' ' ALA . 4.3 mmt -54.54 -48.02 72.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 75.41 110.898 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' A' ' 61' ' ' HIS . 13.5 m -65.43 -42.51 93.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 72.44 111.165 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.583 ' HH ' ' CD2' ' A' ' 61' ' ' HIS . 12.1 m-85 -54.8 -42.09 71.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 74.13 110.853 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.53 -44.37 62.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 54.2 111.109 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.569 HG21 HG12 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -69.64 -14.76 62.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 72.43 111.201 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.525 ' O ' HG21 ' A' ' 20' ' ' ILE . 18.0 mt -94.61 -10.54 31.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 72.32 110.929 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.71 72.71 0.47 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.712 -0.756 . . . . 43.04 112.505 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 71' ' ' LEU . 10.0 pt-20 -114.65 -38.47 3.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.869 0.366 . . . . 72.34 110.924 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.637 HD13 ' O ' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -88.38 -11.17 46.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 71.31 110.907 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.8 ptm -80.63 -13.14 59.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 75.24 110.921 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.36 -25.28 5.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 64.5 112.471 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.82 52.64 1.63 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.731 -0.747 . . . . 54.34 112.478 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.88 162.13 22.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 70.1 111.093 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.576 HG22 ' N ' ' A' ' 77' ' ' HIS . 10.9 mt -73.35 165.0 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 74.5 111.156 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.576 ' N ' HG22 ' A' ' 76' ' ' ILE . 1.6 t-80 -74.41 45.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 74.33 110.813 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -132.01 53.66 1.98 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 72.23 111.08 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.536 HD11 ' CE2' ' A' ' 43' ' ' PHE . 3.9 mm? -98.16 136.36 38.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 71.52 110.958 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -105.79 115.73 30.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 74.14 110.913 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.438 HD12 HG23 ' A' ' 83' ' ' THR . 0.2 OUTLIER -129.58 118.47 22.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 64.14 110.892 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 47' ' ' VAL . 2.2 mptp? -119.0 114.5 22.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.467 . . . . 75.4 110.953 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.539 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 33.5 p -109.79 107.32 17.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 62.0 111.163 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.6 mt -131.07 160.83 33.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 75.11 110.883 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.498 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.36 162.86 71.71 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.597 0.713 . . . . 62.3 111.128 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.7 Cg_endo -69.65 -17.94 37.81 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.689 2.259 . . . . 75.41 112.394 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -71.83 -34.76 69.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 73.43 110.904 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -68.32 -31.24 70.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.173 -0.467 . . . . 74.24 110.854 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 74.41 111.063 179.977 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.716 0.294 . . . . 74.319999999999993 111.046 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -71.5 -40.84 69.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 70.010000000000005 110.866 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.415 ' H ' HG23 ' A' ' 19' ' ' THR . 2.2 p -61.06 -52.86 63.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 71.439999999999998 111.134 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.561 HD11 HG11 ' A' ' 35' ' ' VAL . 4.6 pt -67.2 -45.07 87.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 73.420000000000002 111.148 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.1 ttt-85 -58.96 -45.06 91.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 72.340000000000003 110.846 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -65.37 -44.65 86.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 74.299999999999997 110.88 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.5 mt -56.01 -49.54 73.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 55.43 110.935 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.829 HG22 HD12 ' A' ' 28' ' ' LEU . 8.8 mt -67.33 -44.28 87.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 53.530000000000001 111.129 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -54.03 -39.1 65.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 55.539999999999999 110.852 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.78 -41.21 45.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 74.120000000000005 110.873 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.48 -58.33 10.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 63.109999999999999 112.502 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.829 HD12 HG22 ' A' ' 24' ' ' ILE . 32.0 mt -73.05 154.69 90.68 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.638 0.732 . . . . 75.010000000000005 110.896 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -90.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.267 . . . . 61.340000000000003 112.315 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -104.41 34.51 3.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 73.209999999999994 110.89 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.513 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -87.52 139.6 30.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 73.140000000000001 111.119 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.644 ' HB3' HG12 ' A' ' 48' ' ' VAL . 31.3 ttt180 -109.3 125.65 52.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 74.010000000000005 110.865 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.045 HG13 HG22 ' A' ' 47' ' ' VAL . 6.0 t -123.15 133.26 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 70.319999999999993 111.128 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -135.09 118.86 17.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 71.129999999999995 110.83 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.741 HG22 ' HB1' ' A' ' 45' ' ' ALA . 40.1 t -124.56 130.85 73.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 64.209999999999994 111.115 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 2.0 tp-100 -132.77 120.18 21.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 63.509999999999998 110.912 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.478 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 149.44 -122.75 1.49 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.757 -0.735 . . . . 65.519999999999996 112.516 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -175.32 160.71 2.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.783 0.325 . . . . 71.25 110.918 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -73.65 146.58 44.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 54.340000000000003 110.905 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.435 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.7 18.39 78.69 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.784 -0.722 . . . . 72.099999999999994 112.451 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 42' ' ' HIS . 21.0 t -149.23 165.44 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 74.439999999999998 111.168 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.574 ' N ' HG12 ' A' ' 41' ' ' VAL . 36.0 p-80 -74.21 112.27 10.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 74.230000000000004 110.849 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.765 ' CZ ' HD21 ' A' ' 79' ' ' LEU . 27.8 p90 -129.23 167.44 17.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 75.430000000000007 110.931 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -116.63 120.04 37.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 73.219999999999999 110.86 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.741 ' HB1' HG22 ' A' ' 35' ' ' VAL . . . -127.73 116.83 20.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 72.319999999999993 111.07 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.6 m -106.89 117.89 35.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 45.530000000000001 111.115 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.045 HG22 HG13 ' A' ' 33' ' ' VAL . 55.0 t -113.93 141.22 30.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 63.009999999999998 111.126 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.644 HG12 ' HB3' ' A' ' 32' ' ' ARG . 3.7 p -131.42 118.75 41.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 63.039999999999999 111.105 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.545 ' OG ' ' CE2' ' A' ' 52' ' ' PHE . 10.8 p -158.58 158.62 29.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.651 0.738 . . . . 62.439999999999998 110.862 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.577 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.1 Cg_endo -69.69 -22.71 32.01 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.697 2.265 . . . . 63.100000000000001 112.385 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.0 -39.2 40.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 73.420000000000002 111.116 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.596 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 3.3 m-85 -84.51 27.77 0.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 74.319999999999993 110.915 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 55' ' ' LYS . 2.1 p -52.25 138.65 10.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.113 -0.494 . . . . 44.130000000000003 111.147 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 54.85 -82.25 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.738 -0.744 . . . . 70.420000000000002 112.482 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 53' ' ' VAL . 16.6 pttm -119.23 135.69 54.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.328 . . . . 72.439999999999998 110.919 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.57 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -98.97 100.78 10.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.611 0.719 . . . . 70.540000000000006 111.068 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.5 Cg_endo -69.86 173.82 10.5 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.643 2.229 . . . . 63.340000000000003 112.339 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.38 -26.62 63.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 61.200000000000003 110.927 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.01 -52.96 63.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 53.210000000000001 111.128 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.596 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 3.7 mmt180 -71.57 -42.62 67.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 53.520000000000003 110.915 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.557 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 0.7 OUTLIER -57.92 -53.17 61.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.095 -0.502 . . . . 74.109999999999999 110.912 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 -67.35 -37.67 83.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 74.109999999999999 110.912 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 40.0 mmm -55.1 -47.71 74.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 63.229999999999997 110.935 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 61' ' ' HIS . 19.6 m -69.58 -42.66 80.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.435 . . . . 70.340000000000003 111.151 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.679 ' CE1' HD13 ' A' ' 81' ' ' LEU . 13.3 m-85 -62.41 -36.98 84.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 110.891 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.48 -45.71 44.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 74.510000000000005 111.125 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.624 HG23 HD12 ' A' ' 68' ' ' LEU . 1.2 t -66.5 -26.62 67.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 74.420000000000002 111.16 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.647 HD12 HD11 ' A' ' 24' ' ' ILE . 7.5 mp -86.91 4.49 41.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 70.140000000000001 110.886 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.53 78.68 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.791 -0.719 . . . . 52.219999999999999 112.479 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -99.44 -48.25 4.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 74.329999999999998 110.896 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.0 mp -85.96 1.0 51.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.16 -0.473 . . . . 55.240000000000002 110.947 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 tpt -80.86 -13.31 59.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 72.319999999999993 110.861 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -123.0 -28.29 1.4 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 63.219999999999999 112.501 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.435 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.332 0 C-N-CA 120.685 -0.769 . . . . 60.310000000000002 112.479 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.819 0.342 . . . . 73.239999999999995 111.08 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.765 HD21 ' CZ ' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -97.97 126.83 43.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.436 . . . . 51.240000000000002 110.902 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.4 ' N ' HD13 ' A' ' 79' ' ' LEU . 20.8 mp0 -106.75 114.76 29.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 72.409999999999997 110.917 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.679 HD13 ' CE1' ' A' ' 65' ' ' TYR . 9.0 tt -140.04 129.38 23.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 73.329999999999998 110.952 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -122.49 132.21 54.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 65.010000000000005 110.874 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.533 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 27.2 p -112.16 107.09 15.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 72.209999999999994 111.107 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.5 mt -124.04 162.07 24.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.26 -0.427 . . . . 34.409999999999997 110.959 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.414 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 0.5 OUTLIER -71.66 164.65 56.34 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.619 0.723 . . . . 43.520000000000003 111.111 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.577 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.0 Cg_endo -69.81 -18.85 36.53 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.67 2.247 . . . . 75.329999999999998 112.331 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -77.64 -25.64 49.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 71.150000000000006 110.91 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -83.01 18.77 1.55 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 62.450000000000003 110.891 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 63.020000000000003 111.104 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.76 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.796 0.331 . . . . 73.209999999999994 111.084 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -71.14 -31.06 67.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 72.140000000000001 110.911 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 19' ' ' THR . 1.3 p -67.22 -53.37 30.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 75.200000000000003 111.132 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.058 HD11 HG11 ' A' ' 35' ' ' VAL . 2.0 pp -70.06 -37.62 72.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 75.219999999999999 111.13 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.578 ' N ' HD12 ' A' ' 20' ' ' ILE . 38.0 ttp180 -61.32 -50.46 72.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 70.030000000000001 110.938 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.404 ' NZ ' ' HA ' ' A' ' 19' ' ' THR . 4.8 ptpp? -67.08 -40.0 86.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 64.219999999999999 110.878 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.8 mt -56.6 -49.86 73.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 75.030000000000001 110.893 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.714 ' CG2' HG21 ' A' ' 33' ' ' VAL . 12.3 mt -68.47 -43.8 83.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 75.450000000000003 111.113 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -55.58 -36.9 67.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 72.340000000000003 110.84 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.72 -43.0 32.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 71.219999999999999 110.845 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.8 -50.68 61.81 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.733 . . . . 63.219999999999999 112.463 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.501 HD13 ' CB ' ' A' ' 31' ' ' ALA . 5.0 mt -82.44 160.24 62.53 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.599 0.714 . . . . 64.340000000000003 110.884 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.424 ' HD2' ' CD2' ' A' ' 28' ' ' LEU . 54.3 Cg_endo -69.68 -91.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.729 2.286 . . . . 65.530000000000001 112.393 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -106.71 25.6 11.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 74.430000000000007 110.876 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.501 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -69.78 131.86 45.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 75.030000000000001 111.073 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.581 ' HB3' HG12 ' A' ' 48' ' ' VAL . 3.3 tpp85 -99.69 113.64 26.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 75.219999999999999 110.879 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.982 HG13 HG22 ' A' ' 47' ' ' VAL . 21.5 t -115.81 130.47 70.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 62.0 111.178 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -131.43 118.63 20.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 71.209999999999994 110.861 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.058 HG11 HD11 ' A' ' 20' ' ' ILE . 2.0 p -128.31 130.59 69.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 74.030000000000001 111.151 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.404 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 48.3 mt-30 -133.2 120.37 21.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 70.530000000000001 110.921 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 150.2 -125.14 1.88 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 64.310000000000002 112.505 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.647 ' O ' HG12 ' A' ' 41' ' ' VAL . 17.4 tt0 -175.1 162.48 3.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.817 0.342 . . . . 72.239999999999995 110.894 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -71.58 144.42 49.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 72.310000000000002 110.837 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.416 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.74 22.31 79.12 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.786 -0.721 . . . . 75.140000000000001 112.481 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -150.66 164.8 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.819 0.343 . . . . 72.349999999999994 111.173 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.402 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 45.8 p-80 -75.14 106.69 6.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 64.019999999999996 110.919 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.922 ' CE1' HD11 ' A' ' 79' ' ' LEU . 4.7 p90 -121.67 167.75 12.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 75.540000000000006 110.911 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -113.48 121.06 43.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 73.439999999999998 110.874 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.518 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -128.36 121.88 30.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 64.319999999999993 111.072 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.4 m -119.76 115.02 23.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 44.109999999999999 111.164 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.982 HG22 HG13 ' A' ' 33' ' ' VAL . 44.5 t -110.26 138.54 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 70.25 111.165 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.997 HG21 ' HB2' ' A' ' 89' ' ' ALA . 8.9 p -135.33 118.78 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 64.219999999999999 111.142 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.447 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.7 OUTLIER -161.19 165.72 16.44 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.614 0.721 . . . . 71.099999999999994 110.883 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.471 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.0 Cg_endo -69.74 -21.01 34.16 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.643 2.229 . . . . 54.210000000000001 112.362 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.723 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -47.31 -46.52 25.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 70.319999999999993 111.072 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.709 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -85.22 34.97 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.425 . . . . 75.430000000000007 110.889 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 55' ' ' LYS . 2.6 p -51.99 130.96 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 63.299999999999997 111.146 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 59.65 -76.08 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.804 -0.712 . . . . 60.549999999999997 112.498 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 53' ' ' VAL . 16.5 pttm -120.38 137.48 54.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 63.25 110.936 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.709 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -99.58 99.9 9.67 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.504 0.669 . . . . 73.530000000000001 111.118 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.82 171.25 14.87 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.695 2.263 . . . . 64.519999999999996 112.34 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.93 -27.97 61.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 72.340000000000003 110.945 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.459 ' O ' ' CG ' ' A' ' 63' ' ' MET . . . -58.15 -52.26 66.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 72.349999999999994 111.082 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.723 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 44.1 mmt-85 -70.37 -43.47 70.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 110.852 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.529 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.8 OUTLIER -57.74 -53.59 56.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 72.25 110.844 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -66.12 -36.15 82.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 71.209999999999994 110.864 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.459 ' CG ' ' O ' ' A' ' 59' ' ' ALA . 23.4 mmm -57.14 -46.49 82.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 74.129999999999995 110.881 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 61' ' ' HIS . 17.1 m -69.82 -40.21 78.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 74.400000000000006 111.152 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.58 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 13.7 m-85 -65.94 -34.44 78.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.145 -0.48 . . . . 72.109999999999999 110.882 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.14 -46.6 33.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 64.420000000000002 111.079 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.473 HG21 HG12 ' A' ' 24' ' ' ILE . 13.0 t -66.56 -28.46 68.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 74.340000000000003 111.14 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.621 ' HG ' HD13 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -82.47 -2.45 53.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 53.25 110.915 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.88 78.41 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.78 -0.724 . . . . 52.520000000000003 112.537 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 71' ' ' LEU . 12.1 pt-20 -90.02 -42.15 11.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.902 0.382 . . . . 74.430000000000007 110.883 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.469 ' N ' ' HG3' ' A' ' 70' ' ' GLU . 18.0 tp -89.45 7.94 33.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 72.329999999999998 110.9 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -13.02 60.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.446 . . . . 73.430000000000007 110.951 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.05 -30.27 0.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.708 -0.758 . . . . 35.030000000000001 112.446 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.416 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.362 0 C-N-CA 120.722 -0.751 . . . . 4.3300000000000001 112.499 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.83 0.348 . . . . 74.129999999999995 111.084 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.922 HD11 ' CE1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -98.77 128.48 45.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.318 -0.401 . . . . 74.519999999999996 110.934 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.406 ' N ' HD13 ' A' ' 79' ' ' LEU . 4.8 mt-30 -97.53 116.84 30.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 34.100000000000001 110.872 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.58 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 1.7 tm? -139.04 117.92 12.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 73.200000000000003 110.906 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.566 ' N ' HD13 ' A' ' 81' ' ' LEU . 4.0 mptp? -122.21 133.01 54.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 74.310000000000002 110.963 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.55 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 68.4 p -117.24 107.63 14.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 73.319999999999993 111.132 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.9 mt -127.76 161.04 29.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 62.420000000000002 110.903 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.483 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.15 163.8 64.28 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.631 0.729 . . . . 63.329999999999998 111.097 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.471 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.2 Cg_endo -69.81 -4.73 14.65 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.722 2.281 . . . . 74.109999999999999 112.304 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -94.18 -27.92 15.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 63.130000000000003 110.829 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -105.31 39.72 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 73.129999999999995 110.853 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.997 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 74.439999999999998 111.084 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.112 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.762 0.315 . . . . 52.509999999999998 111.145 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -40.53 94.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 73.329999999999998 110.872 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.577 ' CG2' ' N ' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -60.74 -47.89 84.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 43.140000000000001 111.118 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.794 HD11 HG11 ' A' ' 35' ' ' VAL . 43.6 pt -66.36 -39.26 83.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 52.340000000000003 111.122 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.484 ' N ' HG13 ' A' ' 20' ' ' ILE . 20.9 ttp85 -61.62 -42.22 98.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 63.219999999999999 110.85 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.62 -46.2 69.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 72.430000000000007 110.896 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -56.28 -49.06 75.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 74.409999999999997 110.957 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.813 ' CG2' HG21 ' A' ' 33' ' ' VAL . 7.9 mt -65.77 -45.31 92.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 74.239999999999995 111.117 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -53.86 -39.75 65.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 73.140000000000001 110.945 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -79.8 -32.47 40.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 70.310000000000002 110.798 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.24 -60.73 4.96 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.828 -0.701 . . . . 24.32 112.441 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.491 HD13 ' CB ' ' A' ' 31' ' ' ALA . 10.2 mt -72.65 159.29 85.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.569 0.7 . . . . 72.329999999999998 110.926 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -91.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.66 2.24 . . . . 54.350000000000001 112.347 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -105.38 38.9 1.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 64.329999999999998 110.846 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.491 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -91.35 125.75 36.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 71.5 111.072 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.624 ' HB3' HG12 ' A' ' 48' ' ' VAL . 8.0 tpp180 -95.67 109.65 21.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 71.340000000000003 110.881 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.027 HG22 HG13 ' A' ' 47' ' ' VAL . 39.0 t -109.12 125.4 66.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 62.409999999999997 111.101 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -135.35 117.53 15.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 64.129999999999995 110.831 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.112 HG13 ' HB1' ' A' ' 17' ' ' ALA . 5.1 p -126.88 139.78 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 74.519999999999996 111.13 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -129.19 120.99 26.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.461 . . . . 70.239999999999995 110.92 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.478 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 144.16 -135.07 6.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 72.530000000000001 112.488 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.517 ' O ' HG12 ' A' ' 41' ' ' VAL . 10.9 tt0 -168.67 172.05 8.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 71.430000000000007 110.915 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -77.15 150.63 35.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 73.109999999999999 110.861 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.58 1.25 52.28 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.741 -0.742 . . . . 71.439999999999998 112.442 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 38' ' ' GLU . 2.0 p -131.23 164.55 33.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.855 0.36 . . . . 65.319999999999993 111.151 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.525 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 10.0 p80 -75.21 107.35 7.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 73.219999999999999 110.876 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.513 ' CE2' HD11 ' A' ' 79' ' ' LEU . 48.8 p90 -125.37 167.52 14.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 74.239999999999995 110.884 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -114.02 124.61 52.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 42.109999999999999 110.887 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 81' ' ' LEU . . . -117.74 115.4 24.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 61.409999999999997 111.081 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 m -114.92 106.65 14.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 62.509999999999998 111.217 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.027 HG13 HG22 ' A' ' 33' ' ' VAL . 59.9 t -112.54 125.95 69.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 53.420000000000002 111.102 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 89' ' ' ALA . 3.9 p -114.4 118.57 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 75.299999999999997 111.173 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.499 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 14.9 p -159.33 158.66 28.38 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.663 0.744 . . . . 72.120000000000005 110.859 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.564 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.4 Cg_endo -69.68 -21.26 34.1 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.699 2.266 . . . . 75.019999999999996 112.352 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.53 -42.16 43.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 63.520000000000003 111.129 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.598 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 2.5 m-85 -84.04 30.18 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 74.510000000000005 110.838 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 55' ' ' LYS . 2.9 p -52.02 135.58 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 65.140000000000001 111.1 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.18 -82.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.745 -0.74 . . . . 53.409999999999997 112.46 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 53' ' ' VAL . 30.9 mmmt -115.62 135.97 53.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.824 0.345 . . . . 65.230000000000004 110.891 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.538 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -99.14 100.55 10.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.623 0.725 . . . . 75.310000000000002 111.092 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 54.3 Cg_endo -69.67 171.03 15.11 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.718 2.279 . . . . 75.430000000000007 112.333 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.491 HD21 ' NE ' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -55.62 -27.82 51.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 74.310000000000002 110.956 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.18 -52.64 64.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 74.209999999999994 111.135 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.598 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 7.7 mmt180 -70.98 -42.13 70.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 65.109999999999999 110.839 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.507 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 0.6 OUTLIER -57.61 -52.02 67.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 75.409999999999997 110.863 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.491 ' NE ' HD21 ' A' ' 58' ' ' LEU . 44.8 mtt180 -68.16 -37.48 81.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 64.519999999999996 110.801 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.1 mmt -55.51 -49.0 73.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 64.450000000000003 110.875 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.491 ' HA ' HG22 ' A' ' 67' ' ' THR . 18.6 m -67.89 -45.1 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 60.020000000000003 111.111 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.851 ' CE1' HD13 ' A' ' 81' ' ' LEU . 13.2 m-85 -57.75 -36.77 72.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.45 . . . . 73.219999999999999 110.894 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.55 -46.03 41.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 43.119999999999997 111.093 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.536 HG21 HG12 ' A' ' 24' ' ' ILE . 1.7 t -72.58 -12.89 61.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 72.120000000000005 111.136 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.741 HD23 HD12 ' A' ' 20' ' ' ILE . 27.1 mt -93.76 3.29 55.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 61.130000000000003 110.887 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 55.57 66.97 2.46 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 54.140000000000001 112.524 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -81.04 -39.41 25.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.912 0.387 . . . . 54.039999999999999 110.908 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.9 mt -90.18 10.08 25.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 73.219999999999999 110.894 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 22.9 mmt -71.79 -9.0 57.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 65.040000000000006 110.832 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.54 -31.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 75.129999999999995 112.52 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 C-N-CA 120.761 -0.733 . . . . 64.409999999999997 112.533 -179.923 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.851 0.358 . . . . 74.129999999999995 111.137 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.513 HD11 ' CE2' ' A' ' 43' ' ' PHE . 2.2 mm? -99.16 134.36 42.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 70.409999999999997 110.907 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -120.31 115.67 24.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 55.509999999999998 110.87 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.851 HD13 ' CE1' ' A' ' 65' ' ' TYR . 4.5 tt -127.94 140.61 51.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 74.200000000000003 110.957 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.39 115.69 12.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 61.219999999999999 110.979 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.542 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 11.8 p -105.46 106.87 17.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 64.120000000000005 111.086 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.5 mt -122.97 162.08 22.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 73.030000000000001 110.977 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.435 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 0.2 OUTLIER -71.33 165.82 44.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.61 0.719 . . . . 71.349999999999994 111.119 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.7 Cg_endo -69.69 -24.71 29.69 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.697 2.265 . . . . 74.019999999999996 112.393 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.28 -31.77 72.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 70.140000000000001 110.897 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -70.56 -32.39 69.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 72.219999999999999 110.903 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.664 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 71.510000000000005 111.134 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.581 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.803 0.335 . . . . 34.340000000000003 111.161 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -70.86 -47.94 56.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 73.109999999999999 110.844 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 1.9 t -61.34 -45.1 95.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 62.420000000000002 111.112 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.74 HD12 HD23 ' A' ' 68' ' ' LEU . 6.4 pt -71.55 -42.5 72.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 64.450000000000003 111.165 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 58.9 ttt180 -60.5 -48.0 83.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 73.430000000000007 110.855 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -66.08 -42.85 88.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 75.439999999999998 110.872 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 23' ' ' LEU . 12.1 mt -56.07 -48.31 76.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.452 . . . . 71.329999999999998 110.912 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.791 HG21 HG21 ' A' ' 33' ' ' VAL . 13.3 mt -68.41 -45.22 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 71.239999999999995 111.106 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -54.58 -37.12 65.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 70.219999999999999 110.879 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.91 -42.97 31.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 71.439999999999998 110.885 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.38 -49.9 73.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 65.209999999999994 112.499 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.608 HD13 ' CG2' ' A' ' 24' ' ' ILE . 5.8 mp -89.57 154.06 48.26 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.7 0.762 . . . . 70.439999999999998 110.845 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 -91.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.725 2.283 . . . . 63.329999999999998 112.317 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -100.16 54.74 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 72.5 110.897 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.97 137.66 42.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 54.420000000000002 111.143 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.645 ' HB3' HG12 ' A' ' 48' ' ' VAL . 4.7 tmm_? -106.43 117.38 33.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 74.439999999999998 110.852 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.948 HG13 HG22 ' A' ' 47' ' ' VAL . 38.0 t -122.2 130.27 74.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 64.400000000000006 111.181 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -135.26 118.52 16.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 71.319999999999993 110.949 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.884 HG13 ' HB2' ' A' ' 45' ' ' ALA . 7.6 t -122.79 131.55 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 65.230000000000004 111.124 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.403 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 1.9 tp60 -133.53 120.0 20.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 63.340000000000003 110.937 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.08 -141.62 9.81 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 53.219999999999999 112.47 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -155.05 179.95 8.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 74.239999999999995 110.832 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -86.96 144.25 27.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 63.329999999999998 110.85 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.425 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.69 22.3 79.1 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.757 -0.735 . . . . 73.219999999999999 112.455 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 42' ' ' HIS . 2.5 p -148.84 164.93 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.808 0.337 . . . . 63.5 111.166 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.43 ' CD2' ' O ' ' A' ' 42' ' ' HIS . 8.6 p-80 -74.95 106.75 6.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 64.329999999999998 110.862 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.418 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 8.1 p90 -120.5 167.39 12.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 63.119999999999997 110.881 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -118.29 119.18 33.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 73.140000000000001 110.836 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.884 ' HB2' HG13 ' A' ' 35' ' ' VAL . . . -128.99 115.57 18.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 63.350000000000001 111.148 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.461 HG23 ' HB2' ' A' ' 82' ' ' LYS . 38.7 m -103.86 125.64 50.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.479 . . . . 74.120000000000005 111.084 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.948 HG22 HG13 ' A' ' 33' ' ' VAL . 88.1 t -122.3 133.82 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 61.509999999999998 111.136 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.645 HG12 ' HB3' ' A' ' 32' ' ' ARG . 4.1 p -130.11 118.61 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 65.340000000000003 111.138 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.464 ' CB ' ' HD2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -158.64 168.06 13.19 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.629 0.728 . . . . 62.329999999999998 110.797 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.515 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.1 Cg_endo -69.75 -28.52 25.2 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.604 2.203 . . . . 71.450000000000003 112.388 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.731 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -48.65 -42.17 33.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 61.009999999999998 111.126 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.559 ' CD2' ' HB ' ' A' ' 83' ' ' THR . 1.4 m-85 -83.86 31.38 0.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 72.319999999999993 110.89 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.591 ' HA ' HG23 ' A' ' 85' ' ' THR . 1.8 p -54.36 132.1 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 61.539999999999999 111.177 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.93 -80.2 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.74 -0.743 . . . . 32.130000000000003 112.511 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -116.91 136.52 52.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.757 0.313 . . . . 51.509999999999998 110.92 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.426 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -99.07 100.5 10.15 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.579 0.704 . . . . 71.230000000000004 111.099 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.76 172.48 12.57 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.696 2.264 . . . . 65.230000000000004 112.309 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 tp -55.99 -25.07 42.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 71.120000000000005 110.909 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 63' ' ' MET . . . -59.26 -53.31 59.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 64.310000000000002 111.116 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.731 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 8.7 mmt180 -71.77 -40.43 69.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 73.319999999999993 110.915 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.555 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 0.8 OUTLIER -59.84 -51.91 67.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 74.239999999999995 110.885 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -67.4 -39.05 85.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 71.540000000000006 110.891 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 4.9 tmm? -54.89 -52.11 63.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 74.450000000000003 110.858 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.538 ' O ' HG22 ' A' ' 67' ' ' THR . 25.5 m -63.83 -44.9 98.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.303 -0.408 . . . . 72.129999999999995 111.072 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.555 ' OH ' ' CE1' ' A' ' 61' ' ' HIS . 12.8 m-85 -60.37 -31.24 70.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 73.0 110.885 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.04 -46.66 33.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 61.109999999999999 111.099 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.538 HG22 ' O ' ' A' ' 64' ' ' VAL . 3.8 t -67.12 -26.6 66.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 74.019999999999996 111.134 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.74 HD23 HD12 ' A' ' 20' ' ' ILE . 12.9 mt -83.0 8.88 11.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 72.150000000000006 110.887 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.14 66.94 1.33 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.736 . . . . 60.340000000000003 112.508 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.478 ' HG3' HD23 ' A' ' 71' ' ' LEU . 10.0 pt-20 -70.39 -42.8 71.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.875 0.369 . . . . 73.430000000000007 110.845 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.478 HD23 ' HG3' ' A' ' 70' ' ' GLU . 4.4 mm? -90.01 7.62 36.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 64.129999999999995 110.93 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.0 ttm -71.92 -12.99 61.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 74.209999999999994 110.877 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.26 -33.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.777 -0.725 . . . . 72.299999999999997 112.501 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.425 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . . . . . . 0 N--CA 1.452 -0.276 0 C-N-CA 120.643 -0.789 . . . . 63.140000000000001 112.449 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.754 0.311 . . . . 54.439999999999998 111.065 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 79' ' ' LEU . 8.8 mt -104.24 126.9 51.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 73.239999999999995 110.914 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -96.93 115.4 27.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.462 . . . . 61.030000000000001 110.903 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.44 HD23 ' HE1' ' A' ' 61' ' ' HIS . 3.8 tp -139.22 144.19 38.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 75.019999999999996 110.937 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HB2' HG23 ' A' ' 46' ' ' THR . 0.6 OUTLIER -136.27 114.48 11.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 64.109999999999999 110.901 179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.559 ' HB ' ' CD2' ' A' ' 52' ' ' PHE . 44.5 p -99.41 107.72 20.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 65.239999999999995 111.17 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.778 HD22 ' OE1' ' A' ' 88' ' ' GLU . 26.9 mt -130.78 160.35 34.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.176 -0.466 . . . . 71.010000000000005 110.915 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.591 HG23 ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -73.63 164.11 63.49 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.633 0.73 . . . . 71.209999999999994 111.142 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.8 Cg_endo -69.72 -8.79 24.5 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.689 2.259 . . . . 65.420000000000002 112.318 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -77.58 -35.96 52.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 63.520000000000003 110.918 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.778 ' OE1' HD22 ' A' ' 84' ' ' LEU . 18.0 mt-10 -70.36 -32.57 70.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 74.340000000000003 110.796 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 52.149999999999999 111.17 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.793 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.679 0.276 . . . . 71.030000000000001 111.093 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -71.61 -41.14 69.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 71.310000000000002 110.866 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.5 p -61.03 -53.0 62.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 73.549999999999997 111.15 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.714 HD11 HG11 ' A' ' 35' ' ' VAL . 12.3 pt -68.3 -42.72 84.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 72.530000000000001 111.155 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.501 ' N ' HG13 ' A' ' 20' ' ' ILE . 39.9 ttp85 -59.56 -46.49 88.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 75.540000000000006 110.88 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -66.82 -41.21 87.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 62.539999999999999 110.918 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.3 mt -56.64 -49.46 74.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 71.140000000000001 110.867 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.76 ' CG2' HG21 ' A' ' 33' ' ' VAL . 10.6 mt -67.56 -41.95 86.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 71.200000000000003 111.131 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -55.7 -41.1 73.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 73.109999999999999 110.913 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.72 -43.28 55.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 75.329999999999998 110.876 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.35 -51.86 53.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.747 . . . . 73.430000000000007 112.406 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.599 HD23 ' CB ' ' A' ' 31' ' ' ALA . 7.3 mp -80.71 156.31 72.92 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.594 0.712 . . . . 74.549999999999997 110.88 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -90.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.657 2.238 . . . . 64.439999999999998 112.375 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -105.96 27.36 8.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 74.150000000000006 110.863 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.599 ' CB ' HD23 ' A' ' 28' ' ' LEU . . . -75.81 144.45 41.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 74.439999999999998 111.048 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.692 ' HB3' HG12 ' A' ' 48' ' ' VAL . 58.2 ttt180 -110.96 124.83 52.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 74.439999999999998 110.849 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.1 HG13 HG22 ' A' ' 47' ' ' VAL . 5.9 t -124.17 129.44 74.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 62.340000000000003 111.153 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -131.44 118.98 20.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 53.130000000000003 110.846 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.793 HG13 ' HB1' ' A' ' 17' ' ' ALA . 1.6 p -126.73 134.34 66.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 64.120000000000005 111.105 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -133.45 120.3 20.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 74.129999999999995 110.897 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.56 -130.39 4.55 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.731 -0.747 . . . . 71.409999999999997 112.529 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -174.06 160.98 3.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.919 0.39 . . . . 72.510000000000005 110.871 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -67.69 151.95 46.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 70.530000000000001 110.887 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.419 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.74 10.12 75.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.752 -0.737 . . . . 75.430000000000007 112.533 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 42' ' ' HIS . 7.3 t -143.95 165.15 14.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.834 0.35 . . . . 54.140000000000001 111.159 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.524 ' N ' HG12 ' A' ' 41' ' ' VAL . 12.7 p80 -74.52 108.85 7.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 62.43 110.783 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.808 ' CE1' HD11 ' A' ' 79' ' ' LEU . 40.0 p90 -125.09 167.47 14.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 74.010000000000005 110.826 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -119.43 120.11 35.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 75.230000000000004 110.903 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.2 115.28 18.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 63.25 111.126 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.7 m -108.41 119.42 39.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 54.549999999999997 111.181 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.1 HG22 HG13 ' A' ' 33' ' ' VAL . 96.8 t -112.74 136.59 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 64.209999999999994 111.183 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.725 HG21 ' HB2' ' A' ' 89' ' ' ALA . 2.7 p -128.76 125.55 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 73.409999999999997 111.084 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.453 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.8 OUTLIER -172.45 164.84 3.81 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.648 0.737 . . . . 73.219999999999999 110.863 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.495 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.4 Cg_endo -69.74 -22.43 32.2 Favored 'Trans proline' 0 N--CA 1.466 -0.127 0 C-N-CA 122.705 2.27 . . . . 71.140000000000001 112.362 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.778 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -47.72 -41.99 24.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 73.219999999999999 111.043 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.768 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -89.27 35.9 0.82 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 63.130000000000003 110.904 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.5 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 6.7 p -52.41 139.33 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 64.140000000000001 111.138 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 56.38 -89.28 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.756 -0.735 . . . . 70.420000000000002 112.5 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HD2' ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -117.9 111.16 18.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.732 0.301 . . . . 70.219999999999999 110.919 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.768 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -60.03 108.48 1.43 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.635 0.731 . . . . 63.119999999999997 111.09 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 54.2 Cg_endo -69.71 160.76 48.52 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.67 2.247 . . . . 74.5 112.374 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tp -54.81 -26.76 36.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 74.109999999999999 110.86 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.02 -52.39 65.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 55.219999999999999 111.071 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.778 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 30.7 mmt-85 -69.46 -41.07 76.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 74.299999999999997 110.857 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.426 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.9 OUTLIER -59.07 -53.46 58.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 63.450000000000003 110.808 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 52.0 mtt-85 -67.1 -35.05 78.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 75.030000000000001 110.924 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.0 tpp -58.37 -51.6 69.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 65.450000000000003 110.875 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.659 ' O ' HG22 ' A' ' 67' ' ' THR . 20.7 m -64.05 -44.66 97.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 70.519999999999996 111.204 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.76 ' CE1' HD13 ' A' ' 81' ' ' LEU . 14.1 m-85 -59.17 -38.85 80.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 75.310000000000002 110.955 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.72 -32.85 60.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 70.040000000000006 111.096 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 64' ' ' VAL . 0.6 OUTLIER -71.57 -27.09 62.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 72.040000000000006 111.142 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.527 ' C ' HD12 ' A' ' 68' ' ' LEU . 3.5 pp -88.66 -10.5 48.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 72.209999999999994 110.95 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.523 ' N ' HD12 ' A' ' 68' ' ' LEU . . . 53.69 75.1 0.25 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.705 -0.76 . . . . 44.229999999999997 112.505 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.526 ' HG2' HD11 ' A' ' 68' ' ' LEU . 4.6 pt-20 -91.38 -42.51 10.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.858 0.361 . . . . 63.140000000000001 110.88 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.686 ' O ' HD13 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -84.44 -10.11 57.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 63.310000000000002 110.891 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.5 mmt -72.51 -13.72 61.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 53.409999999999997 110.896 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -126.72 -14.08 2.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.8 -0.714 . . . . 40.020000000000003 112.499 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.419 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.326 0 C-N-CA 120.689 -0.767 . . . . 74.540000000000006 112.475 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.847 0.356 . . . . 73.299999999999997 111.155 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.808 HD11 ' CE1' ' A' ' 43' ' ' PHE . 7.9 tp -105.0 133.14 50.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 64.310000000000002 110.912 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -111.47 115.46 29.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 74.400000000000006 110.929 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.76 HD13 ' CE1' ' A' ' 65' ' ' TYR . 8.4 tt -139.43 129.41 24.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 74.549999999999997 110.99 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -123.58 135.95 54.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 74.049999999999997 110.91 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.54 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 14.0 p -119.43 106.94 12.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.302 -0.408 . . . . 43.020000000000003 111.163 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.7 mp -124.9 161.59 26.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 74.310000000000002 110.902 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.5 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.3 OUTLIER -71.99 164.74 56.31 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.694 0.759 . . . . 65.530000000000001 111.035 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.4 Cg_endo -69.84 -12.32 32.5 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.684 2.256 . . . . 63.140000000000001 112.302 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -75.45 -35.81 60.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 72.120000000000005 110.876 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.45 -39.86 77.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 61.229999999999997 110.903 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.725 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 63.009999999999998 111.116 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.466 ' O ' ' CB ' ' A' ' 21' ' ' ARG . . . . . . . . 0 N--CA 1.457 -0.102 0 CA-C-O 120.743 0.306 . . . . 63.420000000000002 111.102 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -68.77 -48.69 63.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 75.040000000000006 110.883 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.454 HG23 ' N ' ' A' ' 20' ' ' ILE . 3.2 t -62.0 -48.32 80.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 74.25 111.181 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.706 HD12 ' N ' ' A' ' 21' ' ' ARG . 2.3 pp -69.3 -39.73 79.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 72.340000000000003 111.169 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.706 ' N ' HD12 ' A' ' 20' ' ' ILE . 33.0 ttp85 -59.39 -45.96 90.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 73.299999999999997 110.862 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -68.95 -41.26 78.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 62.539999999999999 110.86 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 23' ' ' LEU . 16.0 mt -56.3 -49.19 74.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 54.43 110.884 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.754 ' CG2' HG21 ' A' ' 33' ' ' VAL . 16.2 mt -69.88 -41.68 79.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 72.319999999999993 111.11 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -56.26 -37.03 69.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 75.310000000000002 110.851 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.31 -42.86 24.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 43.32 110.905 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.95 -52.03 51.06 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.776 -0.726 . . . . 62.350000000000001 112.453 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.517 HD23 ' CG2' ' A' ' 24' ' ' ILE . 4.1 mm? -79.53 158.02 74.15 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.645 0.736 . . . . 61.420000000000002 110.872 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -90.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.709 2.273 . . . . 73.129999999999995 112.354 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -105.18 27.71 7.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 65.030000000000001 110.873 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.485 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . . . -78.22 129.41 35.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 71.530000000000001 111.103 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.627 ' HB3' HG12 ' A' ' 48' ' ' VAL . 7.6 tpt180 -101.42 113.52 26.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 62.329999999999998 110.892 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.059 HG13 HG22 ' A' ' 47' ' ' VAL . 11.6 t -113.44 127.69 70.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 63.439999999999998 111.131 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -134.08 118.24 17.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 70.120000000000005 110.888 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.561 ' CG2' HD11 ' A' ' 20' ' ' ILE . 61.7 t -122.71 137.53 55.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 60.409999999999997 111.131 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 4.2 tt0 -133.9 119.39 19.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 71.120000000000005 110.987 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.466 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 146.1 -132.54 4.55 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 42.409999999999997 112.459 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.465 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 0.4 OUTLIER -171.68 162.37 6.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 74.030000000000001 110.915 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.41 145.7 53.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 51.32 110.817 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.9 -15.97 9.33 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.703 -0.761 . . . . 34.329999999999998 112.471 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' A' ' 38' ' ' GLU . 13.1 m -112.96 164.86 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.919 0.39 . . . . 71.319999999999993 111.112 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.606 ' CD2' ' O ' ' A' ' 78' ' ' ALA . 4.9 t-160 -74.94 106.9 6.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 74.129999999999995 110.886 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.788 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 4.4 p90 -120.94 167.21 12.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 75.209999999999994 110.85 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -119.47 123.62 44.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 73.540000000000006 110.836 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.594 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -117.66 115.97 26.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 74.150000000000006 111.085 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.2 m -110.8 108.05 17.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 72.409999999999997 111.17 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.059 HG22 HG13 ' A' ' 33' ' ' VAL . 95.2 t -109.76 141.27 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 72.319999999999993 111.152 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.747 HG21 ' HB2' ' A' ' 89' ' ' ALA . 5.1 p -134.65 118.49 26.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 60.43 111.117 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -164.03 165.98 12.67 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.67 0.748 . . . . 73.219999999999999 110.817 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.526 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.8 Cg_endo -69.78 -28.57 25.01 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.693 2.262 . . . . 72.319999999999993 112.33 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.663 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -51.27 -34.05 31.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 73.430000000000007 111.06 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.599 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 3.9 m-85 -90.78 31.06 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 75.299999999999997 110.893 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.681 ' HA ' HG23 ' A' ' 85' ' ' THR . 8.4 p -61.21 143.55 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 75.129999999999995 111.143 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 52.41 -90.99 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.728 -0.749 . . . . 71.299999999999997 112.496 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.9 OUTLIER -120.06 104.77 10.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.774 0.321 . . . . 62.100000000000001 110.934 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -59.49 109.22 1.76 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.624 0.726 . . . . 64.409999999999997 111.064 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.9 Cg_endo -69.81 168.81 20.56 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.67 2.247 . . . . 74.099999999999994 112.334 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tp -53.86 -26.62 25.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 71.299999999999997 110.925 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.35 -53.05 62.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 75.140000000000001 111.106 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.663 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 21.3 mmt180 -69.88 -41.67 74.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 64.549999999999997 110.926 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.557 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -59.49 -53.4 58.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 74.129999999999995 110.845 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.6 mtp180 -66.53 -35.85 81.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 72.409999999999997 110.837 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 10.9 tpt -58.35 -45.86 87.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 75.400000000000006 110.933 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.626 ' O ' HD13 ' A' ' 68' ' ' LEU . 19.6 m -70.19 -40.38 78.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 72.150000000000006 111.13 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.704 ' CE1' HD13 ' A' ' 81' ' ' LEU . 13.6 m-85 -65.71 -34.76 78.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 73.040000000000006 110.949 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.61 -46.29 32.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 71.239999999999995 111.045 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.562 HG23 HD11 ' A' ' 24' ' ' ILE . 3.5 t -66.91 -28.37 68.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 74.0 111.109 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.626 HD13 ' O ' ' A' ' 64' ' ' VAL . 3.8 mp -82.57 -8.82 59.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 63.450000000000003 110.91 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.27 80.01 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.687 -0.768 . . . . 53.450000000000003 112.552 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 56.1 mt-10 -91.22 -25.31 19.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.897 0.38 . . . . 72.030000000000001 110.889 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.1 mp -89.96 9.98 25.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.098 -0.501 . . . . 71.420000000000002 110.965 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 7.0 ptp -74.42 -13.22 60.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 74.010000000000005 110.83 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.3 -32.93 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.748 -0.739 . . . . 65.0 112.503 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.761 -0.733 . . . . 51.25 112.487 -179.869 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.606 ' O ' ' CD2' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.793 0.33 . . . . 70.329999999999998 111.091 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.788 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 1.1 mm? -115.47 133.85 55.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 72.030000000000001 110.97 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -114.35 115.61 27.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 75.099999999999994 110.883 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.704 HD13 ' CE1' ' A' ' 65' ' ' TYR . 1.4 tt -126.33 144.99 50.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 75.230000000000004 110.937 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -136.26 123.84 22.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 52.119999999999997 110.866 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.585 ' HB ' ' CD2' ' A' ' 52' ' ' PHE . 30.1 p -116.06 107.75 15.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 65.230000000000004 111.131 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mp -128.3 160.67 31.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 75.030000000000001 110.92 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.681 HG23 ' HA ' ' A' ' 53' ' ' VAL . 0.3 OUTLIER -72.5 164.94 55.91 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.606 0.717 . . . . 73.219999999999999 111.139 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.1 Cg_endo -69.77 -16.37 37.5 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 2.245 . . . . 71.420000000000002 112.375 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -73.03 -35.9 66.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 72.420000000000002 110.817 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -67.82 -38.03 82.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 75.109999999999999 110.839 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.747 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 71.239999999999995 111.144 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.473 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.794 0.331 . . . . 45.329999999999998 111.139 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -72.83 -48.04 41.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 72.5 110.906 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.462 HG23 ' N ' ' A' ' 20' ' ' ILE . 2.7 t -57.8 -50.15 74.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 64.150000000000006 111.139 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 21' ' ' ARG . 25.9 pt -68.01 -42.16 85.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 72.329999999999998 111.152 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.5 ' N ' HG13 ' A' ' 20' ' ' ILE . 54.3 ttt-85 -55.01 -53.16 59.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 74.329999999999998 110.834 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.5 mttt -66.15 -35.86 81.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 74.129999999999995 110.94 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -56.37 -49.18 75.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 53.439999999999998 110.945 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.825 ' CG2' HG21 ' A' ' 33' ' ' VAL . 5.8 mt -70.9 -44.34 76.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 61.530000000000001 111.135 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -53.89 -36.85 63.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 72.209999999999994 110.869 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.51 -41.48 21.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 75.109999999999999 110.818 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.61 -55.5 24.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.798 -0.715 . . . . 63.240000000000002 112.481 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 4.3 mm? -72.89 159.36 85.51 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.641 0.734 . . . . 75.340000000000003 110.945 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -90.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.649 2.233 . . . . 65.299999999999997 112.368 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -107.29 27.24 9.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.423 . . . . 73.219999999999999 110.895 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . . . -79.07 126.77 31.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 71.340000000000003 111.058 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.512 ' HB2' ' CG1' ' A' ' 48' ' ' VAL . 3.7 mmm180 -93.86 109.01 20.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 73.310000000000002 110.905 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.825 HG21 ' CG2' ' A' ' 24' ' ' ILE . 53.0 t -113.65 121.45 65.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 72.25 111.102 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -132.34 118.11 18.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 75.329999999999998 110.897 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.473 HG13 ' HB1' ' A' ' 17' ' ' ALA . 2.2 p -127.08 135.63 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 70.209999999999994 111.162 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -133.57 120.14 20.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 72.140000000000001 110.903 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.88 -128.19 2.92 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.727 -0.749 . . . . 23.399999999999999 112.436 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.439 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 11.8 pt-20 -175.27 171.17 2.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.811 0.339 . . . . 74.420000000000002 110.838 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -75.29 147.42 40.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.132 -0.485 . . . . 71.129999999999995 110.819 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.71 16.72 77.9 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.716 -0.754 . . . . 53.130000000000003 112.435 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.439 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 1.8 t -146.62 164.01 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 65.019999999999996 111.161 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 42' ' ' HIS . 19.7 p-80 -75.98 106.62 7.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 110.835 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.764 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 4.5 p90 -119.26 166.22 13.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 75.030000000000001 110.836 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -115.4 121.17 41.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 72.219999999999999 110.892 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 81' ' ' LEU . . . -128.17 115.09 17.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 72.120000000000005 111.072 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.1 m -111.81 116.16 30.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 73.450000000000003 111.1 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.771 ' CG2' HG13 ' A' ' 33' ' ' VAL . 28.6 t -120.58 126.11 74.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 74.239999999999995 111.148 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.512 ' CG1' ' HB2' ' A' ' 32' ' ' ARG . 6.4 p -124.06 118.8 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 75.040000000000006 111.174 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.446 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -160.61 166.63 15.17 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.611 0.719 . . . . 53.130000000000003 110.8 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.517 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.3 Cg_endo -69.82 -21.82 32.66 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.687 2.258 . . . . 74.340000000000003 112.297 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.67 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -46.65 -45.19 19.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 74.340000000000003 111.12 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.639 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -87.47 36.92 0.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 75.530000000000001 110.936 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.492 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 4.1 p -52.34 124.37 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 74.349999999999994 111.128 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.57 -89.05 0.73 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.791 -0.719 . . . . 34.350000000000001 112.47 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.426 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -119.52 111.24 17.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.82 0.343 . . . . 43.299999999999997 110.934 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.639 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -58.38 108.0 1.15 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.536 0.684 . . . . 60.0 111.149 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.5 Cg_endo -69.83 162.59 41.51 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.65 2.234 . . . . 74.299999999999997 112.366 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -58.0 -27.05 63.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 62.329999999999998 110.916 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.82 -52.39 65.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 71.230000000000004 111.079 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.67 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 16.5 mmt180 -69.09 -41.18 77.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.473 . . . . 71.549999999999997 110.908 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.467 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -60.66 -53.54 56.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 65.150000000000006 110.836 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.9 mtp85 -66.68 -33.35 75.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 75.25 110.87 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.3 mmt -60.81 -49.69 76.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 73.420000000000002 110.833 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.605 ' O ' HG22 ' A' ' 67' ' ' THR . 19.2 m -65.21 -43.0 95.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 75.120000000000005 111.166 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.98 ' CE1' HD13 ' A' ' 81' ' ' LEU . 15.0 m-85 -61.9 -37.92 86.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 75.109999999999999 110.887 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.24 -33.16 59.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 52.43 111.088 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 64' ' ' VAL . 0.6 OUTLIER -72.15 -29.63 64.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.264 -0.425 . . . . 73.150000000000006 111.115 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.565 HD21 ' HA ' ' A' ' 65' ' ' TYR . 3.9 pp -83.33 -6.78 59.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.448 . . . . 75.219999999999999 110.913 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.47 69.62 1.09 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.782 -0.723 . . . . 64.319999999999993 112.433 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.499 ' HB2' ' CD1' ' A' ' 68' ' ' LEU . 2.4 tp10 -98.75 -23.51 15.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.956 0.408 . . . . 75.099999999999994 110.957 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -90.31 3.39 53.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 74.209999999999994 110.916 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.7 mtp -71.93 -13.31 61.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 74.409999999999997 110.865 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.27 -31.5 0.12 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.738 -0.744 . . . . 64.340000000000003 112.505 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.399 0 C-N-CA 120.804 -0.712 . . . . 44.450000000000003 112.523 -179.931 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.82 0.343 . . . . 71.329999999999998 111.13 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.764 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 8.5 tp -97.58 133.25 42.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 73.120000000000005 110.937 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -111.35 115.18 28.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.519999999999996 110.946 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.98 HD13 ' CE1' ' A' ' 65' ' ' TYR . 7.4 tt -139.77 137.74 35.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 71.329999999999998 110.88 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 82' ' ' LYS . 2.3 mppt? -136.35 128.16 29.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 74.010000000000005 110.907 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.535 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 63.9 p -113.48 106.95 15.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 71.209999999999994 111.103 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.9 mt -125.99 161.69 26.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 73.219999999999999 110.946 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.492 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.94 163.99 62.29 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.608 0.718 . . . . 75.120000000000005 111.171 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.4 Cg_endo -69.66 -21.96 33.2 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.787 2.325 . . . . 74.450000000000003 112.288 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -70.66 -35.94 73.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 74.439999999999998 110.905 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.7 -33.89 76.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 63.149999999999999 110.916 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.47 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 62.43 111.106 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.092 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.767 0.318 . . . . 55.409999999999997 111.089 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -70.22 -48.43 57.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 72.140000000000001 110.888 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.489 HG23 ' N ' ' A' ' 20' ' ' ILE . 2.8 t -59.17 -51.13 71.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 63.229999999999997 111.143 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.025 HD11 HG11 ' A' ' 35' ' ' VAL . 2.6 pp -64.83 -40.7 89.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 72.450000000000003 111.187 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.632 ' N ' HD12 ' A' ' 20' ' ' ILE . 73.9 ttt180 -60.92 -46.26 91.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 63.539999999999999 110.87 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -63.51 -42.66 98.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 64.329999999999998 110.888 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 23' ' ' LEU . 16.5 mt -57.53 -49.11 77.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 74.200000000000003 110.939 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.792 ' CG2' HG21 ' A' ' 33' ' ' VAL . 49.2 mm -63.18 -46.71 95.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 72.409999999999997 111.147 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -55.11 -40.23 70.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 73.230000000000004 110.846 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.04 -43.24 71.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 72.400000000000006 110.867 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.99 -49.13 60.3 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.726 . . . . 73.439999999999998 112.525 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.55 157.16 72.77 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.53 0.681 . . . . 64.219999999999999 110.972 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -90.62 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.685 2.256 . . . . 54.329999999999998 112.323 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -107.41 29.57 7.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 64.420000000000002 110.882 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' A' ' 49' ' ' SER . . . -75.02 133.09 41.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 72.140000000000001 111.084 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.702 ' HB3' HG12 ' A' ' 48' ' ' VAL . 7.0 tpp180 -99.98 111.14 23.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 73.439999999999998 110.927 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.852 HG13 HG22 ' A' ' 47' ' ' VAL . 32.3 t -113.86 124.98 71.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 62.520000000000003 111.107 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -134.69 118.15 16.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 63.329999999999998 110.889 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.092 HG13 ' HB1' ' A' ' 17' ' ' ALA . 4.9 p -130.43 136.33 58.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 35.409999999999997 111.134 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -133.32 120.21 20.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.230000000000004 110.928 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.47 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 149.67 -145.19 13.09 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.703 -0.761 . . . . 72.209999999999994 112.461 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.403 ' O ' HG12 ' A' ' 41' ' ' VAL . 18.9 mt-10 -156.1 176.98 11.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.825 0.345 . . . . 71.0 110.939 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -80.06 139.87 36.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 74.030000000000001 110.895 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.432 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.67 25.7 73.38 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.772 -0.727 . . . . 54.020000000000003 112.463 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 38' ' ' GLU . 1.2 p -148.91 164.7 4.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.895 0.379 . . . . 75.540000000000006 111.079 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.423 ' CD2' ' O ' ' A' ' 42' ' ' HIS . 7.4 p-80 -74.97 107.44 7.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 71.230000000000004 110.853 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.83 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 4.4 p90 -123.88 167.14 14.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.3 -0.409 . . . . 74.140000000000001 110.92 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -118.75 121.73 40.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 53.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 81' ' ' LEU . . . -126.42 114.9 18.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 61.130000000000003 111.103 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 m -111.58 117.19 32.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 71.120000000000005 111.182 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.852 HG22 HG13 ' A' ' 33' ' ' VAL . 84.8 t -115.65 132.99 63.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 73.129999999999995 111.169 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.702 HG12 ' HB3' ' A' ' 32' ' ' ARG . 5.6 p -128.79 120.37 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 73.049999999999997 111.149 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.448 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.9 OUTLIER -167.31 164.82 9.31 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.711 0.767 . . . . 74.510000000000005 110.803 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.515 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.6 Cg_endo -69.78 -19.1 36.48 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.685 2.256 . . . . 63.200000000000003 112.363 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.798 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -47.19 -41.61 18.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 63.0 111.043 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.657 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -91.87 38.23 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 71.319999999999993 110.895 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.492 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 4.8 p -53.03 123.27 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 71.140000000000001 111.156 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.92 -90.61 0.68 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.689 -0.767 . . . . 75.310000000000002 112.532 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.452 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 1.3 mptp? -117.11 110.29 18.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.815 0.341 . . . . 72.019999999999996 110.855 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.657 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -58.52 107.44 0.95 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.526 0.679 . . . . 61.340000000000003 111.092 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.1 Cg_endo -69.85 166.01 29.15 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.676 2.251 . . . . 71.400000000000006 112.312 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.34 -26.75 65.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 74.519999999999996 110.929 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.61 -52.22 66.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 74.230000000000004 111.099 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.798 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 18.9 mmt180 -69.59 -41.09 76.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 72.329999999999998 110.829 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.498 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -58.78 -52.59 65.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.421 . . . . 74.209999999999994 110.836 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -66.42 -37.26 84.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 62.229999999999997 110.916 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 20.2 mmm -56.44 -52.07 66.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 71.120000000000005 110.895 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.632 ' O ' HG22 ' A' ' 67' ' ' THR . 17.4 m -62.95 -44.44 99.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 65.219999999999999 111.072 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 1.055 ' CE1' HD13 ' A' ' 81' ' ' LEU . 14.3 m-85 -60.98 -30.81 70.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 71.450000000000003 110.938 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.02 -46.76 32.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 73.409999999999997 111.08 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 64' ' ' VAL . 3.8 t -63.9 -28.8 70.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 60.119999999999997 111.115 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.863 HD23 HD13 ' A' ' 20' ' ' ILE . 9.9 mt -82.17 5.58 19.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 64.239999999999995 110.854 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 34.07 67.59 0.24 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 72.230000000000004 112.484 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.639 ' HG3' HD13 ' A' ' 71' ' ' LEU . 5.8 pt-20 -85.41 -39.48 17.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 72.310000000000002 110.847 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.639 HD13 ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -91.03 7.38 40.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 71.430000000000007 110.904 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.412 ' N ' HD22 ' A' ' 71' ' ' LEU . 19.8 mtt -73.06 -12.93 61.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 54.420000000000002 110.889 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.15 -32.15 0.1 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.725 -0.75 . . . . 74.010000000000005 112.49 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.432 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.778 -0.725 . . . . 31.34 112.514 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.801 0.334 . . . . 62.439999999999998 111.039 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.83 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 7.8 tp -107.96 128.18 54.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 72.209999999999994 110.902 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -102.45 115.0 29.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 73.450000000000003 110.957 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.055 HD13 ' CE1' ' A' ' 65' ' ' TYR . 8.6 tt -139.76 135.86 33.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.241 -0.436 . . . . 64.340000000000003 110.899 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -136.49 131.63 34.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 73.439999999999998 110.949 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.544 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 67.1 p -116.69 106.8 13.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 43.009999999999998 111.155 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.05 161.81 24.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 72.319999999999993 110.96 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.492 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -71.8 163.41 66.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.546 0.689 . . . . 72.409999999999997 111.175 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.2 Cg_endo -69.78 -10.32 28.25 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.749 2.3 . . . . 72.040000000000006 112.349 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -76.0 -35.89 59.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 63.450000000000003 110.821 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -68.19 -36.06 78.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.426 . . . . 71.329999999999998 110.898 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.452 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.154 -0.475 . . . . 71.140000000000001 111.122 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.736 0.303 . . . . 73.340000000000003 111.062 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.501 ' OE1' ' NE ' ' A' ' 21' ' ' ARG . 4.3 mm-40 -68.65 -26.55 65.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 73.310000000000002 110.854 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.7 p -61.4 -56.91 15.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 73.420000000000002 111.1 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.58 HG12 ' N ' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -74.06 -29.91 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 55.140000000000001 111.1 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.58 ' N ' HG12 ' A' ' 20' ' ' ILE . 23.7 ttp85 -63.37 -50.86 68.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 60.43 110.851 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -72.79 -36.13 67.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 71.409999999999997 110.897 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.648 HD13 ' O ' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -57.91 -51.04 71.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 71.239999999999995 110.851 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.795 HG21 HG21 ' A' ' 33' ' ' VAL . 8.6 mt -73.5 -44.16 54.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 72.040000000000006 111.17 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.444 ' CG ' ' O ' ' A' ' 21' ' ' ARG . 68.0 mt-10 -56.51 -32.22 64.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 71.430000000000007 110.874 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.27 -43.23 17.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 74.010000000000005 110.83 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.44 -41.89 97.29 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.737 -0.744 . . . . 73.420000000000002 112.548 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 28' ' ' LEU . 3.8 mm? -122.94 102.41 37.88 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.648 0.737 . . . . 64.230000000000004 110.915 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 28' ' ' LEU . 53.9 Cg_endo -69.7 -15.02 37.09 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.687 2.258 . . . . 71.209999999999994 112.3 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -100.16 0.83 41.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.411 . . . . 73.549999999999997 110.86 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.505 ' HB2' ' HB2' ' A' ' 49' ' ' SER . . . -120.58 135.7 55.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 64.430000000000007 111.108 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.476 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 47.1 ttt-85 -110.44 123.73 50.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 74.200000000000003 110.926 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.142 HG13 HG22 ' A' ' 47' ' ' VAL . 4.8 t -122.37 134.3 66.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 74.040000000000006 111.139 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.35 118.08 16.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 75.420000000000002 110.912 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.6 ' O ' ' HB1' ' A' ' 17' ' ' ALA . 43.4 t -123.62 130.4 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 75.510000000000005 111.104 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 20.8 mm100 -133.34 120.15 20.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 71.400000000000006 110.889 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.07 -119.97 1.12 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.712 -0.756 . . . . 73.340000000000003 112.437 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -172.19 170.43 5.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 74.420000000000002 110.903 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -80.35 145.55 32.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 72.120000000000005 110.908 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.474 ' CA ' ' O ' ' A' ' 73' ' ' GLY . . . 72.7 -0.94 40.69 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.747 -0.739 . . . . 65.230000000000004 112.487 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 42' ' ' HIS . 2.3 t -123.13 165.19 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 75.340000000000003 111.186 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.454 ' H ' HG12 ' A' ' 41' ' ' VAL . 53.9 p-80 -74.67 106.45 6.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 72.400000000000006 110.857 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.796 ' CE2' HD11 ' A' ' 79' ' ' LEU . 8.6 p90 -120.55 168.06 11.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 73.239999999999995 110.912 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -113.2 121.22 43.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 74.349999999999994 110.859 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.67 126.99 45.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.103 -0.499 . . . . 61.020000000000003 111.093 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.7 m -120.96 120.64 36.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 63.240000000000002 111.146 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.142 HG22 HG13 ' A' ' 33' ' ' VAL . 78.2 t -119.45 136.76 55.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 54.43 111.119 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.476 ' CG1' ' HB3' ' A' ' 32' ' ' ARG . 7.2 p -136.17 124.28 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 74.400000000000006 111.156 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -174.62 164.74 2.45 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.624 0.725 . . . . 55.119999999999997 110.879 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.524 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.2 Cg_endo -69.71 -19.96 35.68 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.653 2.236 . . . . 54.0 112.369 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.743 ' HB1' ' HD3' ' A' ' 60' ' ' ARG . . . -47.47 -40.51 18.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 111.08 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.748 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.5 OUTLIER -92.22 37.64 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 74.420000000000002 110.907 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.495 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 2.6 p -52.82 136.0 14.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 54.219999999999999 111.136 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 60.37 -89.09 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.765 -0.731 . . . . 64.109999999999999 112.455 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.431 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 3.6 mptp? -119.28 111.08 17.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.746 0.308 . . . . 70.310000000000002 110.932 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.748 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -58.46 107.99 1.15 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.607 0.718 . . . . 72.019999999999996 111.071 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.8 Cg_endo -69.76 164.23 35.33 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.665 2.244 . . . . 74.019999999999996 112.375 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 58' ' ' LEU . 1.6 tt -57.64 -24.85 58.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 63.100000000000001 110.887 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.406 ' O ' ' SD ' ' A' ' 63' ' ' MET . . . -61.91 -52.75 62.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 63.32 111.099 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.743 ' HD3' ' HB1' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -69.08 -40.7 78.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 74.450000000000003 110.875 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.561 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 1.1 t60 -58.85 -53.98 52.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 73.430000000000007 110.826 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -66.2 -35.53 80.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.209999999999994 110.868 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.609 ' O ' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -58.33 -46.22 86.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 44.310000000000002 110.88 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.715 HG21 HD21 ' A' ' 81' ' ' LEU . 17.1 m -69.15 -40.22 80.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 72.150000000000006 111.185 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 1.059 ' CE1' HD22 ' A' ' 81' ' ' LEU . 14.2 m-85 -64.93 -35.89 82.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 75.409999999999997 110.92 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.3 -46.63 39.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 71.530000000000001 111.115 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.62 HG23 HD13 ' A' ' 68' ' ' LEU . 6.0 t -66.04 -28.47 68.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 75.230000000000004 111.107 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.62 HD13 HG23 ' A' ' 67' ' ' THR . 5.2 mp -82.32 7.66 13.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 72.329999999999998 110.917 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 35.71 68.79 0.26 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.786 -0.721 . . . . 65.109999999999999 112.402 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.712 ' HG3' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -102.38 -24.62 13.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.879 0.371 . . . . 72.239999999999995 110.845 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.712 HD22 ' HG3' ' A' ' 70' ' ' GLU . 3.0 mm? -86.75 -21.0 26.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 63.25 110.902 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.2 ttm -76.22 -12.59 60.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 74.040000000000006 110.867 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.474 ' O ' ' CA ' ' A' ' 40' ' ' GLY . . . -120.47 -9.19 7.95 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.746 -0.74 . . . . 40.329999999999998 112.455 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.762 -0.733 . . . . 74.129999999999995 112.483 -179.903 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.85 0.357 . . . . 53.439999999999998 111.138 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.796 HD11 ' CE2' ' A' ' 43' ' ' PHE . 8.8 tp -110.2 138.43 46.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 75.519999999999996 110.928 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -104.62 117.07 33.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 61.509999999999998 110.891 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.059 HD22 ' CE1' ' A' ' 65' ' ' TYR . 1.9 tp -139.33 123.51 17.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 63.109999999999999 110.886 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -126.87 123.3 36.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 75.209999999999994 110.891 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.533 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 4.9 p -113.22 107.25 15.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 64.030000000000001 111.186 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.7 mp -129.81 161.59 30.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 51.539999999999999 110.924 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.495 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.9 164.04 61.8 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.614 0.721 . . . . 71.219999999999999 111.102 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.9 Cg_endo -69.71 -23.75 30.67 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.714 2.276 . . . . 63.210000000000001 112.296 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.44 -34.9 78.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 72.219999999999999 110.891 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.08 -33.18 75.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 71.219999999999999 110.876 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 64.239999999999995 111.09 179.941 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.732 0.301 . . . . 74.439999999999998 111.048 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -71.54 -48.01 51.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 70.409999999999997 110.92 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.572 ' O ' HD23 ' A' ' 23' ' ' LEU . 3.0 t -57.96 -51.7 68.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 52.32 111.177 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.866 HD12 ' HG ' ' A' ' 68' ' ' LEU . 16.2 pt -66.06 -41.9 90.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 73.010000000000005 111.168 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.425 ' N ' HG13 ' A' ' 20' ' ' ILE . 67.3 ttt180 -60.45 -53.58 55.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 73.430000000000007 110.912 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.456 ' CG ' ' N ' ' A' ' 23' ' ' LEU . 23.2 pttt -59.43 -44.83 92.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 75.310000000000002 110.861 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.572 HD23 ' O ' ' A' ' 19' ' ' THR . 2.1 mm? -55.96 -49.12 74.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 53.32 110.867 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.797 ' CG2' HG21 ' A' ' 33' ' ' VAL . 7.1 mt -68.17 -44.12 84.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 63.350000000000001 111.113 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -54.79 -37.85 66.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 75.439999999999998 110.874 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.1 -41.31 35.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 70.340000000000003 110.866 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.31 -53.82 33.7 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.701 -0.761 . . . . 72.230000000000004 112.483 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.402 ' CB ' ' HB3' ' A' ' 31' ' ' ALA . 4.2 mm? -76.94 159.13 79.29 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.533 0.682 . . . . 74.450000000000003 110.985 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -87.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.676 2.25 . . . . 71.430000000000007 112.369 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -111.02 26.12 11.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 75.200000000000003 110.889 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 49' ' ' SER . . . -73.31 125.85 28.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 54.039999999999999 111.085 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.61 ' HB2' HG13 ' A' ' 48' ' ' VAL . 2.4 mmt180 -91.77 107.52 19.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 65.129999999999995 110.984 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.814 HG13 HG22 ' A' ' 47' ' ' VAL . 61.6 t -109.83 121.33 62.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 55.329999999999998 111.132 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -132.38 118.88 19.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 73.230000000000004 110.876 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 44.8 t -126.79 136.98 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 72.310000000000002 111.146 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 34.9 mt-30 -130.67 120.5 24.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.159 -0.473 . . . . 71.409999999999997 110.886 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.438 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 140.63 -142.08 11.99 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.672 -0.775 . . . . 71.120000000000005 112.491 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.484 ' HG2' ' CG2' ' A' ' 41' ' ' VAL . 1.0 OUTLIER -165.29 156.04 13.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.886 0.374 . . . . 72.239999999999995 110.84 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -62.26 154.51 27.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 75.530000000000001 110.863 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.85 -2.59 40.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.676 -0.773 . . . . 75.120000000000005 112.524 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.484 ' CG2' ' HG2' ' A' ' 38' ' ' GLU . 1.3 t -132.52 164.76 34.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.328 . . . . 71.299999999999997 111.174 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.598 ' CD2' ' O ' ' A' ' 42' ' ' HIS . 0.6 OUTLIER -75.02 106.72 6.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 72.150000000000006 110.825 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.551 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 39.7 p90 -121.98 167.79 12.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 74.109999999999999 110.846 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -113.26 133.52 55.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 74.140000000000001 110.89 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.466 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -128.09 118.84 24.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 60.299999999999997 111.17 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.2 m -121.4 111.5 17.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 72.430000000000007 111.149 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.814 HG22 HG13 ' A' ' 33' ' ' VAL . 94.9 t -120.74 134.73 63.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 71.120000000000005 111.097 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.61 HG13 ' HB2' ' A' ' 32' ' ' ARG . 3.6 p -131.05 122.72 52.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 74.120000000000005 111.111 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -161.83 165.6 15.91 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.628 0.728 . . . . 73.5 110.874 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.515 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 52.9 Cg_endo -69.93 -22.14 31.7 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.728 2.285 . . . . 65.150000000000006 112.215 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.614 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -47.04 -44.29 20.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 43.109999999999999 111.079 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.676 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -87.11 35.56 0.7 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 73.420000000000002 110.902 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.481 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 12.4 p -52.26 125.86 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 73.25 111.138 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.5 -89.4 0.73 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.712 -0.756 . . . . 55.130000000000003 112.51 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.423 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 3.3 mptp? -120.3 110.23 16.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.809 0.338 . . . . 73.329999999999998 110.871 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.676 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -58.64 108.15 1.21 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.563 0.697 . . . . 62.420000000000002 111.08 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.8 Cg_endo -69.83 161.59 45.36 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.728 2.285 . . . . 62.43 112.36 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.87 -27.25 63.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.28 -0.418 . . . . 61.039999999999999 110.925 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.27 -52.16 66.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 54.420000000000002 111.092 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.614 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 23.2 mmt180 -69.18 -43.0 75.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 60.240000000000002 110.856 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.551 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.2 OUTLIER -59.17 -51.49 69.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 75.230000000000004 110.849 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.15 -38.64 88.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 74.439999999999998 110.902 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 21.8 mmt -56.29 -48.27 76.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 74.549999999999997 110.919 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 61' ' ' HIS . 16.3 m -65.31 -39.54 85.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 34.25 111.117 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.572 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 12.4 m-85 -59.58 -39.81 85.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 65.239999999999995 110.91 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.06 -46.96 31.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 74.450000000000003 111.133 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.556 HG23 HD12 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -61.66 -31.32 71.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 74.420000000000002 111.145 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.866 ' HG ' HD12 ' A' ' 20' ' ' ILE . 7.3 mp -83.04 -4.3 58.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 72.510000000000005 110.929 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.75 69.37 1.28 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.705 -0.76 . . . . 62.200000000000003 112.535 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -85.31 -40.5 16.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 64.209999999999994 110.911 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.4 mp -87.87 9.87 20.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 64.230000000000004 110.916 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.6 mmt -72.01 -13.14 61.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 65.329999999999998 110.909 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.92 -32.91 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.77 -0.729 . . . . 73.310000000000002 112.528 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.295 0 C-N-CA 120.745 -0.74 . . . . 64.230000000000004 112.465 -179.88 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.833 0.349 . . . . 43.140000000000001 111.075 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.551 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 1.6 mm? -97.83 140.43 32.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 71.310000000000002 110.939 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -118.21 115.62 25.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 75.019999999999996 111.016 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.572 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 0.6 OUTLIER -130.85 116.57 18.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 74.299999999999997 110.862 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -126.01 122.19 35.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 75.049999999999997 110.944 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.528 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 69.2 p -115.62 107.34 14.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.289 -0.414 . . . . 71.209999999999994 111.172 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 84' ' ' LEU . 1.6 mm? -127.75 162.06 27.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 63.149999999999999 110.894 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.481 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.02 163.29 68.17 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-O 121.639 0.733 . . . . 63.030000000000001 111.12 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.9 Cg_endo -69.72 -7.49 21.18 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.693 2.262 . . . . 74.540000000000006 112.363 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -84.58 -30.77 24.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 43.109999999999999 110.828 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -84.79 28.24 0.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 62.030000000000001 110.876 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 72.400000000000006 111.072 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.484 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . . . . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.67 0.271 . . . . 55.130000000000003 111.091 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -72.65 -48.8 36.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 72.340000000000003 110.856 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.438 HG23 ' N ' ' A' ' 20' ' ' ILE . 2.9 t -61.59 -47.63 84.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 51.310000000000002 111.151 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.491 HD11 HG11 ' A' ' 35' ' ' VAL . 10.8 pt -67.8 -43.13 86.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 72.540000000000006 111.149 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.403 ' N ' HG13 ' A' ' 20' ' ' ILE . 55.1 ttt-85 -54.97 -52.91 61.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 74.310000000000002 110.838 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.4 ptpt -65.42 -37.05 85.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 61.399999999999999 110.838 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.76 -50.26 72.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.47 . . . . 72.049999999999997 110.844 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.644 ' HB ' HG21 ' A' ' 33' ' ' VAL . 7.9 mt -72.51 -36.31 53.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 73.120000000000005 111.131 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.496 ' HG3' HG23 ' A' ' 33' ' ' VAL . 19.7 mt-10 -58.92 -38.3 78.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 70.430000000000007 110.845 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -80.84 -42.11 22.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 71.200000000000003 110.846 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.37 -42.48 99.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.738 . . . . 62.119999999999997 112.525 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.487 ' CB ' ' HB3' ' A' ' 31' ' ' ALA . 3.6 mm? -89.88 157.29 46.3 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.556 0.693 . . . . 73.329999999999998 110.962 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -91.22 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.662 2.241 . . . . 55.520000000000003 112.306 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -104.58 27.11 8.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.252 -0.431 . . . . 74.099999999999994 110.907 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 49' ' ' SER . . . -77.61 132.25 38.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 75.409999999999997 111.053 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.656 ' HB3' HG12 ' A' ' 48' ' ' VAL . 7.9 ttm-85 -101.35 112.12 24.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 75.540000000000006 110.873 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.707 HG12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -107.32 129.32 61.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.202 -0.454 . . . . 73.049999999999997 111.093 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.73 118.53 16.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 74.099999999999994 110.895 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.491 HG11 HD11 ' A' ' 20' ' ' ILE . 28.9 t -127.66 129.86 70.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 71.400000000000006 111.205 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.409 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 31.4 mt-30 -133.25 120.15 20.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 65.109999999999999 110.933 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.474 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 151.0 -125.97 2.01 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.726 -0.75 . . . . 42.229999999999997 112.483 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -174.66 157.76 2.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 74.099999999999994 110.909 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -68.41 144.16 54.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 74.430000000000007 110.854 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.76 22.26 79.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.759 . . . . 54.310000000000002 112.56 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -150.63 164.79 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.866 0.365 . . . . 71.329999999999998 111.111 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 28.1 p80 -75.09 106.66 6.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 74.439999999999998 110.831 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.895 ' CZ ' HD21 ' A' ' 79' ' ' LEU . 8.7 p90 -122.43 167.4 13.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 64.140000000000001 110.903 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -113.72 120.33 40.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 65.209999999999994 110.903 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.591 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -123.25 115.77 22.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 71.200000000000003 111.019 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.658 HG23 ' HB2' ' A' ' 82' ' ' LYS . 81.6 m -113.62 123.5 50.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 75.140000000000001 111.153 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.707 HG22 HG12 ' A' ' 33' ' ' VAL . 27.1 t -123.59 140.72 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 62.409999999999997 111.134 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.656 HG12 ' HB3' ' A' ' 32' ' ' ARG . 8.1 p -130.52 117.83 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 73.420000000000002 111.165 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.49 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -162.0 164.49 17.47 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.679 0.752 . . . . 72.349999999999994 110.855 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.544 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.3 Cg_endo -69.88 -22.05 32.06 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.631 2.221 . . . . 61.049999999999997 112.309 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.615 ' HB1' ' HE ' ' A' ' 60' ' ' ARG . . . -48.69 -44.53 38.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 61.119999999999997 111.133 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.659 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.5 OUTLIER -87.63 34.19 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 71.109999999999999 110.898 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 55' ' ' LYS . 7.6 p -52.41 131.63 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 71.329999999999998 111.109 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 56.08 -81.02 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.726 -0.75 . . . . 74.439999999999998 112.517 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 53' ' ' VAL . 69.6 mmtt -113.3 134.27 54.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.796 0.331 . . . . 62.009999999999998 110.876 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.659 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -99.56 99.96 9.77 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.608 0.718 . . . . 73.319999999999993 111.1 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.4 Cg_endo -69.71 172.58 12.32 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.695 2.263 . . . . 51.119999999999997 112.333 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tp -57.01 -27.49 61.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 52.149999999999999 110.913 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 63' ' ' MET . . . -57.3 -53.35 59.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 60.119999999999997 111.016 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.615 ' HE ' ' HB1' ' A' ' 51' ' ' ALA . 12.2 mmm180 -70.57 -42.24 71.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 60.240000000000002 110.838 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.516 ' CE1' HD23 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -57.12 -53.1 61.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 71.540000000000006 110.874 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -67.49 -38.86 84.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 73.239999999999995 110.903 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.463 ' C ' ' SD ' ' A' ' 63' ' ' MET . 0.7 OUTLIER -54.08 -48.02 71.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 75.209999999999994 110.853 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.772 ' O ' HD13 ' A' ' 68' ' ' LEU . 24.4 m -68.77 -40.64 81.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 62.210000000000001 111.156 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.891 ' CE1' HD13 ' A' ' 81' ' ' LEU . 10.5 m-85 -64.93 -34.84 79.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 65.239999999999995 110.936 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.75 -46.24 32.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 75.329999999999998 111.193 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.604 HG21 HG12 ' A' ' 24' ' ' ILE . 3.8 t -67.58 -25.67 65.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 54.009999999999998 111.108 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.772 HD13 ' O ' ' A' ' 64' ' ' VAL . 5.9 mp -82.48 -0.47 46.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.246 -0.434 . . . . 73.239999999999995 110.919 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.6 68.37 1.02 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.75 -0.738 . . . . 70.120000000000005 112.439 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.845 ' HG3' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -88.06 -25.57 22.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.339 . . . . 73.209999999999994 110.817 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.845 HD23 ' HG3' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -89.64 7.12 38.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 73.049999999999997 110.963 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.4 mmt -73.15 -7.18 50.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 72.409999999999997 110.899 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.94 -35.04 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.703 -0.761 . . . . 73.200000000000003 112.492 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.767 -0.73 . . . . 71.319999999999993 112.517 -179.924 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.79 0.329 . . . . 64.519999999999996 111.092 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.895 HD21 ' CZ ' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -97.68 134.41 40.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 73.310000000000002 110.894 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.511 ' N ' HD13 ' A' ' 79' ' ' LEU . 8.5 mm-40 -106.95 118.67 37.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 71.430000000000007 110.984 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.891 HD13 ' CE1' ' A' ' 65' ' ' TYR . 4.5 tp -123.05 138.9 54.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 74.5 110.873 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.658 ' HB2' HG23 ' A' ' 46' ' ' THR . 2.5 mptt -132.36 118.46 19.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 64.420000000000002 110.933 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.53 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 11.8 p -118.91 107.35 13.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 54.109999999999999 111.133 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.537 HD23 ' N ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -127.22 161.42 28.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.92 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.479 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -76.35 164.92 56.81 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.545 0.688 . . . . 74.519999999999996 111.166 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.5 Cg_endo -69.8 -0.15 6.52 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.695 2.264 . . . . 71.540000000000006 112.36 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.09 -27.43 26.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 73.010000000000005 110.869 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -82.2 24.81 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 60.420000000000002 110.884 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 65.200000000000003 111.137 179.918 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.687 0.28 . . . . 63.240000000000002 111.096 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.557 ' CD ' ' N ' ' A' ' 19' ' ' THR . 3.0 pp20? -66.77 -48.14 69.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 50.329999999999998 110.83 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.557 ' N ' ' CD ' ' A' ' 18' ' ' GLU . 3.7 t -57.74 -52.45 65.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 74.349999999999994 111.089 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.526 ' N ' HG23 ' A' ' 19' ' ' THR . 5.9 pt -67.84 -41.95 85.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 72.040000000000006 111.176 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 54.4 ttp180 -58.67 -51.47 69.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 53.439999999999998 110.868 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.1 pttp -63.79 -40.24 96.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.499 . . . . 64.409999999999997 110.892 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 20.6 mt -56.32 -50.27 71.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 71.230000000000004 110.898 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.662 HD11 ' CG2' ' A' ' 67' ' ' THR . 10.5 mt -69.53 -43.86 80.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 52.130000000000003 111.112 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -55.64 -35.07 65.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.462 . . . . 71.439999999999998 110.868 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -79.18 -43.2 24.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 55.020000000000003 110.905 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.65 -34.38 88.77 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.695 -0.764 . . . . 73.209999999999994 112.524 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.63 158.98 32.76 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.545 0.688 . . . . 52.119999999999997 110.924 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -90.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.695 2.263 . . . . 64.329999999999998 112.4 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -107.87 33.46 4.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 55.310000000000002 110.912 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.67 133.87 34.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 72.239999999999995 111.138 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.654 ' HB3' HG12 ' A' ' 48' ' ' VAL . 39.8 ttt-85 -106.4 125.56 51.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 72.230000000000004 110.845 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.035 HG13 HG22 ' A' ' 47' ' ' VAL . 3.9 t -124.0 135.45 63.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 74.329999999999998 111.149 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -135.26 118.46 16.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 72.010000000000005 110.889 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.437 ' O ' ' HB1' ' A' ' 17' ' ' ALA . 39.6 t -125.85 136.7 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 73.299999999999997 111.143 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 50.3 mm-40 -133.33 120.36 20.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 53.240000000000002 110.893 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.84 -143.21 13.46 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 64.120000000000005 112.461 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.422 ' HB2' HG21 ' A' ' 41' ' ' VAL . 17.8 mt-10 -151.19 -174.98 4.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.889 0.376 . . . . 75.219999999999999 110.845 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -87.77 146.79 25.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 73.209999999999994 110.888 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.437 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 73.24 1.14 56.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.73 . . . . 62.310000000000002 112.476 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' A' ' 38' ' ' GLU . 2.6 m -125.21 165.19 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 71.450000000000003 111.1 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.454 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 23.6 p80 -74.86 107.01 6.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 53.340000000000003 110.821 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.833 ' CE1' HD11 ' A' ' 79' ' ' LEU . 39.6 p90 -121.99 167.75 12.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 74.120000000000005 110.898 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -113.48 124.74 53.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 63.539999999999999 110.86 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.18 115.88 19.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 44.329999999999998 111.099 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.8 m -117.72 112.71 20.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 72.209999999999994 111.131 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.035 HG22 HG13 ' A' ' 33' ' ' VAL . 22.6 t -110.5 141.44 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 71.099999999999994 111.133 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.753 HG21 ' HB2' ' A' ' 89' ' ' ALA . 4.0 p -130.42 118.95 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 74.409999999999997 111.127 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.539 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 24.1 p -168.7 160.01 8.4 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.654 0.74 . . . . 74.430000000000007 110.923 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.581 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.4 Cg_endo -69.74 -18.65 36.96 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.659 2.239 . . . . 71.200000000000003 112.383 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.878 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -49.83 -38.47 35.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 61.240000000000002 111.077 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.811 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 1.3 m-85 -90.86 33.5 0.93 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 73.510000000000005 110.904 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.539 ' HA ' HG23 ' A' ' 85' ' ' THR . 10.9 p -52.18 146.82 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 74.299999999999997 111.122 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 52.17 -89.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.719 . . . . 60.409999999999997 112.467 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -121.62 111.03 16.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.333 . . . . 74.209999999999994 110.87 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.811 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -59.67 108.28 1.33 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.58 0.705 . . . . 52.329999999999998 111.097 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.6 Cg_endo -69.76 161.55 45.48 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.695 2.263 . . . . 63.5 112.344 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -55.14 -24.76 27.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 61.439999999999998 110.921 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.33 -52.57 64.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 51.219999999999999 111.06 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.878 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 21.1 mmt180 -69.78 -41.01 75.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 75.420000000000002 110.84 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.557 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 1.0 OUTLIER -59.77 -53.01 62.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 73.530000000000001 110.908 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -66.2 -35.64 80.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 71.25 110.813 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.2 ttt -59.09 -49.86 76.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 65.420000000000002 110.852 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.587 ' O ' HG22 ' A' ' 67' ' ' THR . 22.1 m -65.08 -41.43 91.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 71.439999999999998 111.136 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.595 ' HD1' HD21 ' A' ' 68' ' ' LEU . 12.8 m-85 -62.83 -36.89 84.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 72.120000000000005 110.921 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.73 -35.27 60.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 51.149999999999999 111.107 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.662 ' CG2' HD11 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -70.95 -30.17 66.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 74.230000000000004 111.121 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.595 HD21 ' HD1' ' A' ' 65' ' ' TYR . 4.0 pp -83.6 -3.79 58.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 73.230000000000004 110.912 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.68 63.4 3.72 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.799 -0.715 . . . . 74.340000000000003 112.422 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -70.03 -57.43 5.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.387 . . . . 72.129999999999995 110.875 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -84.79 8.65 16.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 73.140000000000001 110.888 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.7 ttt -78.17 -13.2 59.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 72.540000000000006 110.89 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.47 -32.2 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.708 -0.758 . . . . 51.229999999999997 112.506 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.437 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.349 0 C-N-CA 120.764 -0.731 . . . . 74.120000000000005 112.533 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.815 0.341 . . . . 65.409999999999997 111.082 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.833 HD11 ' CE1' ' A' ' 43' ' ' PHE . 8.3 tp -113.04 147.53 37.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 74.129999999999995 110.99 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -113.71 119.33 37.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 72.549999999999997 110.837 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.58 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 0.5 OUTLIER -128.61 117.62 21.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 75.0 110.889 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.419 ' N ' HD13 ' A' ' 81' ' ' LEU . 15.4 mmtp -119.33 114.52 22.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 72.099999999999994 110.874 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.532 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 17.3 p -117.1 106.54 13.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 40.340000000000003 111.147 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mp -132.42 162.76 30.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 75.519999999999996 110.973 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.539 HG23 ' HA ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -71.12 165.39 48.34 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.615 0.721 . . . . 72.25 111.147 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.1 Cg_endo -69.8 -24.8 29.09 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.729 2.286 . . . . 71.329999999999998 112.285 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -65.77 -32.31 73.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 63.520000000000003 110.83 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -70.03 -35.03 74.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 71.430000000000007 110.874 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.753 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 61.32 111.071 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 1.007 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.744 0.306 . . . . 41.549999999999997 111.122 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -72.01 -47.83 49.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 74.219999999999999 110.934 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.833 ' O ' HD23 ' A' ' 23' ' ' LEU . 2.7 t -61.68 -47.04 87.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 75.010000000000005 111.115 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.937 HD11 HG11 ' A' ' 35' ' ' VAL . 2.0 pp -69.51 -36.84 73.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 73.109999999999999 111.119 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.447 ' N ' HD12 ' A' ' 20' ' ' ILE . 35.9 ttt180 -63.58 -49.99 71.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.329999999999998 110.871 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.408 ' CG ' ' N ' ' A' ' 23' ' ' LEU . 34.1 pttt -64.45 -41.99 96.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 71.420000000000002 110.929 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.833 HD23 ' O ' ' A' ' 19' ' ' THR . 3.2 mm? -56.48 -50.79 70.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 72.409999999999997 110.937 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.814 HG21 HG21 ' A' ' 33' ' ' VAL . 12.7 mt -68.0 -43.83 85.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 71.450000000000003 111.127 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -56.53 -34.85 67.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 72.340000000000003 110.794 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.98 -43.38 35.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 72.409999999999997 110.874 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.66 -49.01 77.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 70.310000000000002 112.476 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.6 mt -118.93 102.31 49.37 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.628 0.728 . . . . 74.150000000000006 110.944 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -15.03 36.87 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.701 2.268 . . . . 73.340000000000003 112.294 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -96.18 -10.21 28.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 63.399999999999999 110.862 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.477 ' CB ' ' HB3' ' A' ' 49' ' ' SER . . . -111.04 126.83 55.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 51.329999999999998 111.105 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.504 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 24.5 ttp180 -103.06 117.17 33.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 63.350000000000001 110.874 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.814 HG21 HG21 ' A' ' 24' ' ' ILE . 18.5 t -111.75 131.17 63.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 74.010000000000005 111.092 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -135.4 117.65 15.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 73.030000000000001 110.884 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 1.007 HG13 ' HB1' ' A' ' 17' ' ' ALA . 4.6 p -126.91 139.4 51.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 52.229999999999997 111.11 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -132.2 120.63 22.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 72.340000000000003 110.945 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 149.99 -139.45 7.37 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.751 -0.737 . . . . 52.32 112.467 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.84 153.62 8.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.859 0.361 . . . . 74.439999999999998 110.906 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -58.61 147.48 32.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 74.239999999999995 110.893 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.29 -11.16 13.25 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.741 -0.742 . . . . 72.239999999999995 112.556 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 42' ' ' HIS . 20.5 t -118.14 164.05 14.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 73.349999999999994 111.099 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.556 ' N ' HG12 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -75.79 107.67 8.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 73.340000000000003 110.889 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.819 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 3.6 p90 -119.37 167.22 12.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 74.030000000000001 110.824 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.418 ' OE2' ' C ' ' A' ' 45' ' ' ALA . 1.0 OUTLIER -113.52 135.19 54.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 63.229999999999997 110.902 -179.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.418 ' C ' ' OE2' ' A' ' 44' ' ' GLU . . . -127.25 121.25 30.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 72.439999999999998 111.064 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.7 m -121.3 110.96 16.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 61.25 111.168 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.776 ' CG1' HG13 ' A' ' 33' ' ' VAL . 3.8 m -112.77 140.05 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 34.210000000000001 111.152 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.61 HG21 ' HB2' ' A' ' 89' ' ' ALA . 3.0 p -134.4 118.81 28.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 64.340000000000003 111.175 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.562 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 12.2 p -169.64 161.65 7.17 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.682 0.753 . . . . 70.319999999999993 110.859 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.578 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.6 Cg_endo -69.78 -23.4 30.74 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.664 2.242 . . . . 63.32 112.262 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.751 ' HB1' ' CD ' ' A' ' 60' ' ' ARG . . . -47.12 -41.59 17.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.307 -0.406 . . . . 54.119999999999997 111.085 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.695 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 1.6 m-85 -86.45 32.38 0.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 71.230000000000004 110.844 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.571 ' HA ' HG23 ' A' ' 85' ' ' THR . 10.8 p -52.38 146.79 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.491 . . . . 55.240000000000002 111.16 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 50.5 -88.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.747 -0.74 . . . . 73.340000000000003 112.424 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -121.06 112.25 18.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.792 0.33 . . . . 74.439999999999998 110.898 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.695 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -59.17 108.24 1.28 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.564 0.697 . . . . 74.049999999999997 111.101 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.64 162.43 42.05 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.66 2.24 . . . . 74.209999999999994 112.416 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -56.36 -26.12 51.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 64.239999999999995 110.966 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 63' ' ' MET . . . -59.82 -52.64 64.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 43.219999999999999 111.084 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.751 ' CD ' ' HB1' ' A' ' 51' ' ' ALA . 11.6 mmp_? -69.57 -42.77 74.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 75.140000000000001 110.889 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.529 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -58.59 -52.99 63.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 71.109999999999999 110.864 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -65.41 -36.49 84.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 52.32 110.903 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.475 ' O ' HG22 ' A' ' 67' ' ' THR . 0.3 OUTLIER -57.09 -48.25 79.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 65.349999999999994 110.889 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 61' ' ' HIS . 17.2 m -67.68 -40.88 84.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 53.229999999999997 111.146 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.514 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 14.8 m-85 -65.74 -33.39 75.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 75.519999999999996 110.897 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.36 -46.03 43.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.096 -0.502 . . . . 74.109999999999999 111.069 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.518 HG23 HD12 ' A' ' 68' ' ' LEU . 4.7 t -63.81 -33.66 76.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 51.399999999999999 111.161 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.751 ' HG ' HD13 ' A' ' 20' ' ' ILE . 3.4 mp -81.9 -1.95 49.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.447 . . . . 53.520000000000003 110.91 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 32.48 82.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.806 -0.711 . . . . 55.310000000000002 112.51 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.59 ' HG2' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -83.55 -20.17 34.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.357 . . . . 75.120000000000005 110.887 -179.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.59 HD22 ' HG2' ' A' ' 70' ' ' GLU . 4.0 mm? -87.96 9.36 22.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 64.340000000000003 110.871 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.87 -13.2 61.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 75.450000000000003 110.867 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.58 -33.15 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.772 -0.727 . . . . 51.109999999999999 112.511 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.267 0 C-N-CA 120.694 -0.765 . . . . 74.420000000000002 112.497 -179.94 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.543 ' HB3' ' HB3' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.865 0.364 . . . . 70.530000000000001 111.12 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.819 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 3.7 mm? -97.02 143.67 27.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 72.120000000000005 110.888 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -118.79 115.25 24.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 72.010000000000005 110.919 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.514 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 0.4 OUTLIER -123.9 116.7 23.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 75.099999999999994 110.92 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.07 114.85 23.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 65.409999999999997 110.899 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.556 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 40.2 p -115.78 106.49 13.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.236 -0.438 . . . . 64.230000000000004 111.174 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.4 mt -131.68 162.82 29.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 61.130000000000003 110.894 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.571 HG23 ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -70.79 164.53 54.94 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.592 0.71 . . . . 64.200000000000003 111.128 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.578 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.4 Cg_endo -69.76 -24.53 29.58 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.726 2.284 . . . . 74.129999999999995 112.301 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.54 -36.0 82.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 70.230000000000004 110.882 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.63 -41.66 87.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 53.329999999999998 110.876 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.61 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 50.210000000000001 111.108 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.793 0.33 . . . . 72.219999999999999 111.075 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -70.69 -37.98 73.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 64.519999999999996 110.815 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 19' ' ' THR . 6.2 p -59.21 -54.02 51.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 51.340000000000003 111.144 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.545 HD11 HG11 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -68.48 -47.34 77.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 74.310000000000002 111.152 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -53.29 -50.42 64.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 71.540000000000006 110.897 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 ptmm? -66.96 -35.39 79.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 62.020000000000003 110.868 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.32 -49.27 74.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.433 . . . . 73.400000000000006 110.908 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.721 HD11 ' OG1' ' A' ' 67' ' ' THR . 7.4 mm -72.79 -42.81 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 63.100000000000001 111.191 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -54.7 -37.19 65.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.075 -0.511 . . . . 73.530000000000001 110.858 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -82.88 -42.49 17.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 64.299999999999997 110.894 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.99 -47.58 90.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.688 -0.768 . . . . 64.319999999999993 112.463 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.738 ' CB ' ' HB3' ' A' ' 31' ' ' ALA . 2.5 mm? -76.19 157.06 83.51 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.57 0.7 . . . . 74.430000000000007 110.91 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -58.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.63 2.22 . . . . 64.219999999999999 112.377 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -134.99 20.81 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 44.409999999999997 110.942 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.738 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . . . -74.4 126.52 30.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 72.209999999999994 111.087 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.654 ' HB3' HG12 ' A' ' 48' ' ' VAL . 4.3 tpt180 -100.68 109.7 21.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 62.130000000000003 110.858 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.038 HG13 HG22 ' A' ' 47' ' ' VAL . 41.1 t -114.14 135.34 54.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 60.310000000000002 111.088 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -135.23 118.81 16.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 71.430000000000007 110.85 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.545 HG11 HD11 ' A' ' 20' ' ' ILE . 61.4 t -121.49 131.33 73.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 53.25 111.119 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -132.83 120.35 21.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 74.430000000000007 110.895 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 142.45 -163.68 27.12 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.809 -0.71 . . . . 53.149999999999999 112.514 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 41' ' ' VAL . 27.1 mt-10 -135.39 176.23 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.871 0.367 . . . . 73.340000000000003 110.888 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -78.65 146.52 34.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 62.130000000000003 110.841 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.4 ' HA2' ' CA ' ' A' ' 74' ' ' GLY . . . 72.73 18.43 78.75 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.763 -0.732 . . . . 75.519999999999996 112.402 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.586 HG22 ' N ' ' A' ' 42' ' ' HIS . 12.5 p -144.63 164.39 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 72.109999999999999 111.143 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.586 ' N ' HG22 ' A' ' 41' ' ' VAL . 8.1 p80 -75.52 108.09 8.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 52.409999999999997 110.935 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.81 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 9.7 p90 -114.96 167.11 11.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 73.340000000000003 110.926 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -116.59 126.76 53.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 64.129999999999995 110.844 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.447 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -128.33 125.35 38.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 35.439999999999998 111.132 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.3 m -121.21 111.17 17.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 70.030000000000001 111.132 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.038 HG22 HG13 ' A' ' 33' ' ' VAL . 92.7 t -112.13 138.01 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 74.519999999999996 111.166 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.746 HG21 ' HB2' ' A' ' 89' ' ' ALA . 9.9 p -136.21 121.8 28.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 71.140000000000001 111.111 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.43 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -170.25 166.01 5.34 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.588 0.708 . . . . 75.439999999999998 110.917 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.548 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.5 Cg_endo -69.72 -21.66 33.36 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.719 2.279 . . . . 74.129999999999995 112.327 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.801 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -46.73 -46.26 20.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 64.0 111.136 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.623 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.9 OUTLIER -84.72 35.14 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 73.430000000000007 110.873 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.547 ' HA ' HG23 ' A' ' 85' ' ' THR . 7.7 p -52.46 133.84 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 64.120000000000005 111.142 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.94 -88.88 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.761 -0.733 . . . . 72.140000000000001 112.484 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 0.3 OUTLIER -120.64 113.39 20.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.769 0.319 . . . . 74.140000000000001 110.922 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.623 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -58.3 107.8 1.08 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.544 0.688 . . . . 53.219999999999999 111.071 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.7 Cg_endo -69.83 164.9 32.88 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.623 2.215 . . . . 64.319999999999993 112.393 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.507 HD21 ' NE ' ' A' ' 62' ' ' ARG . 1.8 tt -59.66 -25.6 64.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 63.399999999999999 110.892 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.26 -52.15 65.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 74.140000000000001 111.146 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.801 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 20.4 mmt180 -69.69 -41.08 75.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 72.450000000000003 110.874 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.52 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -58.44 -53.49 57.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 72.409999999999997 110.848 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.507 ' NE ' HD21 ' A' ' 58' ' ' LEU . 51.8 mtt180 -66.47 -36.88 83.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 63.520000000000003 110.874 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.6 mmm -56.61 -47.56 79.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 70.140000000000001 110.819 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 61' ' ' HIS . 19.2 m -68.8 -40.78 81.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 70.219999999999999 111.065 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.497 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 12.0 m-85 -62.09 -36.09 80.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 75.040000000000006 110.953 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.18 -46.78 31.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 73.329999999999998 111.069 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.721 ' OG1' HD11 ' A' ' 24' ' ' ILE . 0.7 OUTLIER -61.7 -33.28 73.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 65.019999999999996 111.135 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.57 HD12 HG23 ' A' ' 67' ' ' THR . 4.0 mp -84.49 -6.25 59.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 64.400000000000006 110.904 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 34.46 85.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.672 -0.775 . . . . 43.109999999999999 112.534 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -96.09 -35.11 11.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.841 0.353 . . . . 71.530000000000001 110.882 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.496 HD23 ' C ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -87.91 5.98 37.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 72.450000000000003 110.867 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.492 ' N ' HD23 ' A' ' 71' ' ' LEU . 1.5 tpt -71.93 -10.65 60.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.432 . . . . 72.120000000000005 110.942 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.83 -32.68 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.777 -0.725 . . . . 34.210000000000001 112.534 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.4 ' CA ' ' HA2' ' A' ' 40' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.741 . . . . 61.340000000000003 112.478 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.445 ' HB3' ' CB ' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.891 0.376 . . . . 44.420000000000002 111.187 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.81 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 1.9 mm? -97.62 140.47 31.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 61.420000000000002 110.964 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -116.98 115.71 25.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 63.119999999999997 110.875 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.497 HD22 ' CZ ' ' A' ' 65' ' ' TYR . 5.2 tp -130.64 138.7 50.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 62.43 110.957 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -136.33 114.82 11.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 65.129999999999995 110.858 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.518 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 8.8 p -112.02 106.58 15.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.461 . . . . 75.219999999999999 111.119 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.0 mt -133.55 162.02 33.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 64.430000000000007 110.94 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.547 HG23 ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.72 164.53 57.42 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.642 0.734 . . . . 72.519999999999996 111.056 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.7 Cg_endo -69.78 -11.53 31.0 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.651 2.234 . . . . 74.299999999999997 112.339 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.47 -23.06 26.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 71.030000000000001 110.832 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -108.04 38.44 2.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 51.130000000000003 110.919 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.746 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 65.299999999999997 111.048 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.689 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.757 0.313 . . . . 55.130000000000003 111.129 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -74.06 -33.51 63.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 75.030000000000001 110.939 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.94 ' O ' HD23 ' A' ' 23' ' ' LEU . 18.6 p -57.55 -57.63 11.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 74.329999999999998 111.131 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.748 ' H ' HD13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -73.87 -35.26 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 64.209999999999994 111.135 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.409 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 68.7 ttt-85 -61.8 -45.07 95.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 71.430000000000007 110.895 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp -71.09 -41.09 71.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 65.209999999999994 110.933 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.94 HD23 ' O ' ' A' ' 19' ' ' THR . 3.4 mm? -55.63 -49.15 73.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 63.140000000000001 110.928 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.762 ' CG2' HG21 ' A' ' 33' ' ' VAL . 14.9 mt -69.28 -43.33 81.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 52.210000000000001 111.113 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -53.67 -38.26 63.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 54.43 110.897 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -78.28 -43.05 29.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 63.210000000000001 110.833 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.69 -51.11 60.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 64.230000000000004 112.454 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.512 HD23 HG23 ' A' ' 24' ' ' ILE . 4.2 mm? -78.69 158.17 76.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.623 0.725 . . . . 64.439999999999998 110.889 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -90.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.71 2.274 . . . . 73.120000000000005 112.337 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -107.28 33.2 4.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 60.439999999999998 110.885 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 49' ' ' SER . . . -84.05 125.84 32.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 72.340000000000003 111.112 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.519 ' HB2' ' CG1' ' A' ' 48' ' ' VAL . 3.7 mmt180 -92.8 108.92 20.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 61.530000000000001 110.862 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.762 HG21 ' CG2' ' A' ' 24' ' ' ILE . 76.3 t -109.76 122.74 64.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 51.310000000000002 111.116 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -134.07 118.38 17.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 53.43 110.822 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.689 HG13 ' HB1' ' A' ' 17' ' ' ALA . 2.4 p -128.25 132.78 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 61.149999999999999 111.17 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -132.89 120.45 21.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 74.420000000000002 110.92 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.413 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 150.29 -140.16 7.8 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 53.109999999999999 112.439 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -157.68 178.77 9.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.87 0.367 . . . . 64.430000000000007 110.887 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.07 142.47 30.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 54.520000000000003 110.866 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.85 17.81 78.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.731 . . . . 15.32 112.468 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 p -142.08 164.33 18.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.884 0.373 . . . . 75.340000000000003 111.117 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.49 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 5.9 p80 -75.7 107.05 7.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 75.120000000000005 110.865 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.779 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 4.7 p90 -119.06 167.25 11.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 63.439999999999998 110.863 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.409 ' HG3' ' CB ' ' A' ' 80' ' ' GLN . 26.5 tt0 -117.03 122.07 43.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 71.209999999999994 110.926 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.59 115.9 18.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 74.150000000000006 111.139 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.406 HG23 ' HB2' ' A' ' 82' ' ' LYS . 10.5 m -110.78 120.07 41.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 65.310000000000002 111.172 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.404 HG13 HG22 ' A' ' 33' ' ' VAL . 86.9 t -123.47 128.24 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 73.340000000000003 111.157 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 32' ' ' ARG . 4.9 p -125.33 122.67 63.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 75.109999999999999 111.115 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -163.33 168.01 10.67 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.655 0.74 . . . . 72.310000000000002 110.893 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.483 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.6 Cg_endo -69.82 -21.19 33.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.68 2.253 . . . . 73.040000000000006 112.314 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -46.48 -46.76 19.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 71.120000000000005 111.097 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.603 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.7 OUTLIER -86.1 36.41 0.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 74.209999999999994 110.93 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.503 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 6.9 p -52.24 124.27 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 72.310000000000002 111.12 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.46 -74.69 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.796 -0.716 . . . . 61.240000000000002 112.464 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 53' ' ' VAL . 22.9 pttm -119.89 140.47 50.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.761 0.315 . . . . 75.340000000000003 110.89 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.603 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -101.25 97.92 8.11 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.59 0.709 . . . . 71.129999999999995 111.054 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.6 Cg_endo -69.77 173.42 11.01 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.703 2.269 . . . . 72.540000000000006 112.348 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.79 -26.83 62.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 74.109999999999999 110.907 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.84 -52.94 63.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 64.319999999999993 111.162 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.597 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 11.6 mmt180 -69.51 -43.13 73.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 64.510000000000005 110.898 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.553 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -58.34 -53.35 59.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 75.530000000000001 110.9 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.8 mtt180 -65.99 -35.82 81.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 73.430000000000007 110.887 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.9 ttt -57.91 -46.0 85.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 74.109999999999999 110.875 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 61' ' ' HIS . 15.8 m -69.61 -39.96 78.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 74.299999999999997 111.152 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.553 ' OH ' ' CE1' ' A' ' 61' ' ' HIS . 15.8 m-85 -67.72 -34.99 77.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 64.209999999999994 111.028 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.18 -47.19 29.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 74.510000000000005 111.086 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.703 HG23 HD12 ' A' ' 68' ' ' LEU . 15.4 t -61.65 -39.59 91.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 72.239999999999995 111.138 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.703 HD12 HG23 ' A' ' 67' ' ' THR . 1.0 OUTLIER -82.0 0.73 38.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 41.210000000000001 110.975 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 35.04 91.22 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 62.340000000000003 112.416 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -96.86 -32.26 12.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.902 0.382 . . . . 51.409999999999997 110.852 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.53 10.25 3.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 75.040000000000006 110.903 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 37.9 mtm -73.56 -13.19 60.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 62.439999999999998 110.937 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.12 -33.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 74.340000000000003 112.479 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 C-N-CA 120.786 -0.721 . . . . 74.340000000000003 112.489 -179.921 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.207 0 CA-C-O 120.806 0.336 . . . . 70.340000000000003 111.105 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.779 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 3.6 mm? -97.79 133.86 41.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 62.210000000000001 110.972 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.409 ' CB ' ' HG3' ' A' ' 44' ' ' GLU . 25.9 mt-30 -109.7 115.6 30.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 72.409999999999997 110.906 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.498 HD23 ' HE1' ' A' ' 61' ' ' HIS . 5.0 tp -133.46 139.63 46.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 64.099999999999994 110.852 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HB2' HG23 ' A' ' 46' ' ' THR . 0.6 OUTLIER -136.53 115.36 12.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 74.109999999999999 110.842 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.527 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 10.5 p -108.44 106.68 16.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 72.430000000000007 111.147 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.504 HD22 ' C ' ' A' ' 83' ' ' THR . 3.9 mm? -129.61 161.49 30.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 75.420000000000002 110.838 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.503 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.5 162.92 71.54 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.623 0.725 . . . . 73.129999999999995 111.089 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.6 Cg_endo -69.64 -19.18 37.05 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.733 2.289 . . . . 63.340000000000003 112.402 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -68.82 -35.99 77.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 74.349999999999994 110.899 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -66.53 -40.19 88.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 72.510000000000005 110.918 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 75.219999999999999 111.097 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.94 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.755 0.312 . . . . 53.149999999999999 111.101 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -70.1 -38.45 75.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 60.439999999999998 110.84 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.9 ' O ' HD23 ' A' ' 23' ' ' LEU . 25.8 p -63.43 -53.57 50.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 72.310000000000002 111.139 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.935 HD12 ' N ' ' A' ' 21' ' ' ARG . 1.7 pp -65.06 -42.61 94.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 61.329999999999998 111.079 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.935 ' N ' HD12 ' A' ' 20' ' ' ILE . 39.9 ttp180 -60.37 -46.23 90.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 64.030000000000001 110.889 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.12 -42.4 99.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 75.120000000000005 110.969 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.9 HD23 ' O ' ' A' ' 19' ' ' THR . 4.2 mm? -58.08 -49.3 77.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 74.239999999999995 110.913 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.776 ' CG2' HG21 ' A' ' 33' ' ' VAL . 46.7 mm -63.31 -46.38 95.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 73.099999999999994 111.152 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -54.37 -43.71 71.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 74.150000000000006 110.851 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.31 -42.93 78.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 74.049999999999997 110.797 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.35 -57.04 12.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.725 -0.75 . . . . 14.42 112.45 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.477 ' CB ' ' HB3' ' A' ' 31' ' ' ALA . 3.3 mm? -72.65 155.86 90.57 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.537 0.684 . . . . 63.409999999999997 110.958 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -90.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.615 2.21 . . . . 73.510000000000005 112.352 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -103.32 31.89 4.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 70.329999999999998 110.902 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.477 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . . . -80.48 131.65 35.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 74.230000000000004 111.095 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.634 ' HB3' HG12 ' A' ' 48' ' ' VAL . 6.4 tpp180 -102.42 113.99 27.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 75.430000000000007 110.878 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.075 HG13 HG22 ' A' ' 47' ' ' VAL . 36.8 t -116.03 127.31 73.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 72.140000000000001 111.137 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -135.4 118.37 16.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.248 -0.433 . . . . 72.239999999999995 110.864 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.94 HG13 ' HB1' ' A' ' 17' ' ' ALA . 4.3 p -127.28 136.91 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 65.150000000000006 111.142 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.418 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 0.9 OUTLIER -133.05 120.4 21.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 61.549999999999997 110.918 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.435 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 142.37 -134.43 6.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.741 . . . . 55.439999999999998 112.469 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.412 ' OE2' ' CG ' ' A' ' 39' ' ' ASP . 5.3 tm-20 -170.2 166.53 8.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 72.219999999999999 110.866 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.412 ' CG ' ' OE2' ' A' ' 38' ' ' GLU . 7.8 p30 -72.95 153.55 40.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 70.340000000000003 110.905 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.432 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.84 -2.62 32.06 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 73.219999999999999 112.489 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.4 m -130.41 164.9 32.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.867 0.365 . . . . 62.520000000000003 111.124 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.419 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 12.6 p80 -74.78 109.98 8.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 63.350000000000001 110.859 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.606 ' CE2' HD11 ' A' ' 79' ' ' LEU . 34.1 p90 -127.43 167.36 16.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 71.129999999999995 110.9 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -118.1 126.72 52.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 63.229999999999997 110.837 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.27 115.32 18.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 72.219999999999999 111.052 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.7 m -110.37 110.78 21.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.469 . . . . 55.200000000000003 111.108 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.075 HG22 HG13 ' A' ' 33' ' ' VAL . 91.5 t -110.68 140.8 28.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.49 . . . . 64.329999999999998 111.091 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.634 HG12 ' HB3' ' A' ' 32' ' ' ARG . 4.3 p -133.34 118.31 31.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 60.340000000000003 111.168 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.534 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 38.4 p -162.08 159.17 21.55 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.671 0.748 . . . . 72.109999999999999 110.853 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.574 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.1 Cg_endo -69.78 -14.67 36.34 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.643 2.229 . . . . 51.530000000000001 112.318 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.07 -48.45 22.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 74.0 111.134 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.77 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -84.19 35.07 0.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 64.329999999999998 110.874 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 p -50.84 131.1 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 54.130000000000003 111.099 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.73 -78.04 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.728 -0.749 . . . . 71.340000000000003 112.509 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -122.49 140.87 52.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.8 0.334 . . . . 75.439999999999998 110.849 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.77 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -104.19 99.11 15.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.606 0.717 . . . . 64.430000000000007 111.114 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 52.7 Cg_endo -69.81 169.4 19.05 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.677 2.251 . . . . 52.219999999999999 112.309 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.484 HD21 ' NE ' ' A' ' 62' ' ' ARG . 1.6 tt -56.43 -27.56 56.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 61.210000000000001 110.888 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.69 -52.75 63.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 73.25 111.097 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.458 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 3.4 mmm180 -69.84 -43.64 71.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 73.310000000000002 110.906 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.453 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.9 OUTLIER -56.57 -53.44 57.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.14 -0.482 . . . . 55.340000000000003 110.857 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.484 ' NE ' HD21 ' A' ' 58' ' ' LEU . 51.0 mtt180 -66.73 -37.93 85.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 64.099999999999994 110.852 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.5 mmt -54.13 -50.15 67.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 74.140000000000001 110.844 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.587 ' O ' HG22 ' A' ' 67' ' ' THR . 17.1 m -66.96 -42.91 89.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 60.020000000000003 111.154 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.889 ' CE1' HD13 ' A' ' 81' ' ' LEU . 15.2 m-85 -62.29 -36.82 83.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 71.150000000000006 110.936 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.2 -35.88 61.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 73.019999999999996 111.046 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.587 HG22 ' O ' ' A' ' 64' ' ' VAL . 0.6 OUTLIER -69.93 -31.22 68.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 73.319999999999993 111.122 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.657 ' C ' HD12 ' A' ' 68' ' ' LEU . 2.9 pp -88.03 -10.44 50.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 55.409999999999997 110.933 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.613 ' N ' HD12 ' A' ' 68' ' ' LEU . . . 46.86 87.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.681 -0.771 . . . . 52.5 112.506 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.638 ' HG2' HD11 ' A' ' 68' ' ' LEU . 8.2 pt-20 -111.02 -48.14 3.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.847 0.356 . . . . 73.230000000000004 110.868 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.73 ' O ' HD13 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -78.88 -2.19 38.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.199 -0.455 . . . . 73.319999999999993 110.963 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.1 mmt -85.14 -13.7 49.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 54.030000000000001 110.888 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.6 -30.88 3.37 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.724 -0.75 . . . . 50.100000000000001 112.423 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.432 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . . . . . . 0 N--CA 1.451 -0.357 0 C-N-CA 120.785 -0.722 . . . . 64.0 112.527 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.833 0.349 . . . . 70.409999999999997 111.068 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.606 HD11 ' CE2' ' A' ' 43' ' ' PHE . 4.1 mm? -97.44 131.83 43.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 63.530000000000001 110.943 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -112.58 114.94 27.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 75.219999999999999 110.896 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.889 HD13 ' CE1' ' A' ' 65' ' ' TYR . 6.7 tt -139.53 138.44 36.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 51.130000000000003 110.883 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -136.54 114.96 11.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 74.0 110.868 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.536 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 59.0 p -100.87 106.82 18.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 72.150000000000006 111.172 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 84' ' ' LEU . 2.5 mm? -125.27 162.5 24.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 74.400000000000006 110.92 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.408 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 0.6 OUTLIER -71.09 164.49 56.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.606 0.717 . . . . 64.030000000000001 111.131 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.2 Cg_endo -69.83 -18.25 36.78 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.613 2.209 . . . . 61.210000000000001 112.333 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -76.51 -29.56 56.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 63.200000000000003 110.885 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -80.28 5.37 14.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.172 -0.467 . . . . 75.420000000000002 110.87 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 63.030000000000001 111.118 179.925 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 35' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.108 0 CA-C-O 120.716 0.293 . . . . 65.329999999999998 111.135 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.64 -47.19 49.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 62.009999999999998 110.967 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.403 HG23 ' N ' ' A' ' 20' ' ' ILE . 3.1 t -62.4 -45.14 94.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 43.399999999999999 111.155 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.568 ' CD1' HG21 ' A' ' 35' ' ' VAL . 14.6 pt -69.91 -40.03 78.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 54.420000000000002 111.124 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.455 ' N ' HG13 ' A' ' 20' ' ' ILE . 32.5 ttt-85 -60.0 -48.23 82.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 51.200000000000003 110.861 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.449 ' HG3' ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -69.29 -39.62 78.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 73.319999999999993 110.917 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.449 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 17.8 mt -57.12 -49.32 76.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 73.420000000000002 110.881 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.803 ' CG2' HG21 ' A' ' 33' ' ' VAL . 5.7 mt -70.06 -45.86 74.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 61.299999999999997 111.127 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -53.96 -36.86 63.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 62.439999999999998 110.898 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -79.48 -40.82 28.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 74.239999999999995 110.861 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.92 -55.56 21.43 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.732 -0.747 . . . . 64.239999999999995 112.473 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.596 HD12 ' CG2' ' A' ' 24' ' ' ILE . 5.8 mt -76.5 159.62 79.17 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.572 0.701 . . . . 72.239999999999995 111.005 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -91.29 0.01 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.104 0 C-N-CA 122.73 2.286 . . . . 71.25 112.361 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -106.96 29.61 6.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 74.400000000000006 110.87 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.46 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -77.58 131.28 37.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 64.299999999999997 111.113 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.516 ' HB2' ' CG1' ' A' ' 48' ' ' VAL . 13.6 mmm-85 -97.11 114.42 26.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 74.439999999999998 110.881 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.872 HG13 HG22 ' A' ' 47' ' ' VAL . 56.3 t -117.98 126.05 74.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 63.329999999999998 111.179 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -135.28 118.63 16.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 73.349999999999994 110.822 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.568 HG21 ' CD1' ' A' ' 20' ' ' ILE . 43.2 t -125.01 135.21 64.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 72.340000000000003 111.108 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 -133.25 123.17 25.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 71.219999999999999 110.884 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.78 -134.48 6.23 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.698 -0.763 . . . . 62.240000000000002 112.511 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -163.67 160.23 22.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 54.420000000000002 110.896 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.453 ' OD2' ' C ' ' A' ' 72' ' ' MET . 24.5 t0 -67.49 147.63 52.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 65.409999999999997 110.901 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.0 -7.29 16.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.815 -0.707 . . . . 62.130000000000003 112.391 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.573 HG12 ' N ' ' A' ' 42' ' ' HIS . 14.6 t -118.81 165.8 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.871 0.367 . . . . 64.219999999999999 111.158 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.573 ' N ' HG12 ' A' ' 41' ' ' VAL . 5.3 p80 -73.95 106.54 5.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 64.329999999999998 110.853 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.573 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 41.7 p90 -122.6 167.33 13.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 64.209999999999994 110.918 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -114.3 128.1 56.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 75.010000000000005 110.916 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.39 121.94 36.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 72.109999999999999 111.133 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.8 m -121.11 110.41 16.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 71.409999999999997 111.14 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.872 HG22 HG13 ' A' ' 33' ' ' VAL . 65.4 t -120.6 129.64 75.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 65.200000000000003 111.18 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.516 ' CG1' ' HB2' ' A' ' 32' ' ' ARG . 3.7 p -126.4 118.86 52.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 51.450000000000003 111.112 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.478 ' CB ' ' HD2' ' A' ' 50' ' ' PRO . 0.4 OUTLIER -161.84 169.36 9.63 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.657 0.741 . . . . 61.219999999999999 110.862 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.515 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 52.9 Cg_endo -69.79 -20.87 34.15 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.692 2.261 . . . . 72.349999999999994 112.326 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.68 ' HB1' ' NE ' ' A' ' 60' ' ' ARG . . . -43.74 -53.58 5.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 75.140000000000001 111.195 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.626 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.7 OUTLIER -81.55 38.46 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 72.109999999999999 110.884 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.514 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 2.9 p -51.37 127.23 7.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 64.310000000000002 111.118 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.39 -78.36 0.12 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.714 -0.755 . . . . 72.120000000000005 112.481 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -121.97 141.68 51.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.765 0.316 . . . . 72.25 110.91 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.626 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -99.67 99.28 8.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.575 0.702 . . . . 50.340000000000003 111.101 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.6 Cg_endo -69.74 165.75 29.91 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.696 2.264 . . . . 74.239999999999995 112.332 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 58' ' ' LEU . 2.8 tt -54.53 -24.09 19.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 63.020000000000003 110.916 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 63' ' ' MET . . . -61.36 -51.65 67.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 75.319999999999993 111.14 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.68 ' NE ' ' HB1' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -72.05 -37.45 69.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 71.120000000000005 110.918 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.514 ' CD2' ' CD2' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -61.46 -49.99 74.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 74.239999999999995 110.879 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.439 ' HD2' HD21 ' A' ' 58' ' ' LEU . 18.5 mtp180 -70.39 -39.8 74.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 63.450000000000003 110.95 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 10.1 tpt -54.58 -50.84 67.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 71.239999999999995 110.912 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.649 ' O ' HG22 ' A' ' 67' ' ' THR . 30.3 m -66.12 -44.21 91.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 70.299999999999997 111.142 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.65 ' CE1' HD13 ' A' ' 81' ' ' LEU . 10.0 m-85 -55.45 -40.17 71.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 62.340000000000003 110.943 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.32 -38.93 59.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 62.329999999999998 111.102 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.649 HG22 ' O ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -66.18 -24.03 66.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 74.230000000000004 111.123 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.597 ' C ' HD12 ' A' ' 68' ' ' LEU . 3.8 pp -95.47 -1.57 50.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 55.240000000000002 110.889 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.459 ' HA2' ' CG ' ' A' ' 72' ' ' MET . . . 82.06 66.01 1.6 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.773 -0.727 . . . . 73.430000000000007 112.446 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -74.75 -65.62 0.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.838 0.351 . . . . 73.239999999999995 110.914 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.6 tp -86.48 10.08 16.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 75.230000000000004 110.91 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . 0.459 ' CG ' ' HA2' ' A' ' 69' ' ' GLY . 19.7 mmt -72.22 -14.08 61.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 53.329999999999998 110.854 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.423 ' HA3' ' CG ' ' A' ' 39' ' ' ASP . . . -149.46 -34.54 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.755 -0.736 . . . . 60.439999999999998 112.509 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 53.340000000000003 112.482 -179.892 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.82 0.343 . . . . 62.329999999999998 111.096 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.573 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 1.2 mm? -113.54 145.78 40.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 73.450000000000003 110.951 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -124.7 115.96 21.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 65.129999999999995 110.861 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.65 HD13 ' CE1' ' A' ' 65' ' ' TYR . 2.8 tp -123.94 141.67 51.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 75.219999999999999 110.895 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -133.13 114.39 13.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 75.219999999999999 110.916 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.527 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 24.7 p -118.5 106.12 12.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 54.130000000000003 111.145 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mp -134.62 161.23 35.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 64.150000000000006 110.934 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.514 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.48 163.59 66.52 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.639 0.733 . . . . 64.420000000000002 111.152 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.3 Cg_endo -69.76 -19.04 36.64 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.693 2.262 . . . . 71.040000000000006 112.328 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -68.87 -36.07 77.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 71.5 110.891 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -64.48 -38.12 89.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 62.530000000000001 110.925 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 54.130000000000003 111.136 179.893 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.853 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.797 0.332 . . . . 60.219999999999999 111.124 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -70.54 -39.13 74.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 74.310000000000002 110.879 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.442 ' H ' HG23 ' A' ' 19' ' ' THR . 1.1 p -62.32 -53.55 53.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 75.200000000000003 111.104 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.073 HD12 HD22 ' A' ' 68' ' ' LEU . 9.1 pt -66.88 -45.9 86.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 74.510000000000005 111.147 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.435 ' N ' ' CG1' ' A' ' 20' ' ' ILE . 37.7 ttp85 -53.58 -51.45 62.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 73.129999999999995 110.828 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -67.43 -34.85 78.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 64.430000000000007 110.987 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.491 HD13 ' O ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -56.64 -49.65 74.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 55.219999999999999 110.885 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.663 HD12 HG11 ' A' ' 33' ' ' VAL . 46.8 mt -72.44 -43.05 64.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 74.420000000000002 111.109 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -54.61 -36.49 64.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 65.209999999999994 110.92 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -81.44 -43.14 19.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.487 . . . . 65.129999999999995 110.865 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 -37.88 95.45 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 55.240000000000002 112.485 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.801 HD23 ' CB ' ' A' ' 31' ' ' ALA . 8.2 mp -92.99 160.94 32.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.537 0.684 . . . . 72.109999999999999 110.937 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -90.99 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.657 2.238 . . . . 74.150000000000006 112.36 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -107.43 25.55 11.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 62.25 110.907 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.801 ' CB ' HD23 ' A' ' 28' ' ' LEU . . . -72.36 129.51 38.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 74.319999999999993 111.042 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.651 ' HB3' HG12 ' A' ' 48' ' ' VAL . 3.3 ttm180 -97.03 112.01 23.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 70.099999999999994 110.879 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.022 HG13 HG22 ' A' ' 47' ' ' VAL . 21.4 t -113.94 130.08 68.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 74.109999999999999 111.143 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -135.12 118.08 16.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 75.019999999999996 110.898 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.853 HG13 ' HB1' ' A' ' 17' ' ' ALA . 5.8 p -129.69 137.44 56.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 70.329999999999998 111.17 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.4 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 47.2 tt0 -133.25 120.3 20.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 74.219999999999999 110.868 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 144.12 -149.06 21.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 74.340000000000003 112.571 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -155.69 177.7 11.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 74.519999999999996 110.91 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.95 147.04 35.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 75.319999999999993 110.889 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.84 7.86 71.3 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.78 -0.724 . . . . 72.310000000000002 112.521 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.548 HG12 ' N ' ' A' ' 42' ' ' HIS . 17.7 t -134.87 163.87 35.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 52.140000000000001 111.105 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.548 ' N ' HG12 ' A' ' 41' ' ' VAL . 49.3 p-80 -75.9 106.85 7.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 75.420000000000002 110.879 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.654 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 7.4 p90 -119.76 166.76 12.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 75.319999999999993 110.866 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.02 129.59 56.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.019999999999996 110.899 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.05 116.28 19.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 62.32 111.108 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.691 HG23 ' HB2' ' A' ' 82' ' ' LYS . 12.0 m -121.29 112.11 18.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 71.329999999999998 111.132 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.022 HG22 HG13 ' A' ' 33' ' ' VAL . 79.6 t -114.06 138.92 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 45.219999999999999 111.143 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.651 HG12 ' HB3' ' A' ' 32' ' ' ARG . 8.6 p -132.08 123.84 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 73.209999999999994 111.126 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.44 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 0.6 OUTLIER -170.37 167.52 4.59 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.7 0.762 . . . . 60.119999999999997 110.855 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.518 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.4 Cg_endo -69.77 -22.78 31.55 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.693 2.262 . . . . 70.329999999999998 112.357 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HB1' ' NE ' ' A' ' 60' ' ' ARG . . . -44.27 -47.02 9.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 54.140000000000001 111.091 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.724 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -86.69 39.85 0.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 72.5 110.814 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.494 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 4.3 p -55.92 123.11 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 74.349999999999994 111.139 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.46 -91.68 0.86 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.75 -0.738 . . . . 52.25 112.41 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.485 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 11.8 mptt -118.06 108.88 15.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.797 0.332 . . . . 70.439999999999998 110.878 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.724 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -57.82 106.65 0.73 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.549 0.69 . . . . 63.439999999999998 111.1 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 54.5 Cg_endo -69.79 170.5 16.45 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.645 2.23 . . . . 73.239999999999995 112.381 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tp -63.54 -23.78 67.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 64.299999999999997 110.943 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.87 -54.14 49.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 64.299999999999997 111.116 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.583 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 8.2 mmm180 -71.83 -40.84 68.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 74.239999999999995 110.82 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.406 ' CD2' ' HE2' ' A' ' 65' ' ' TYR . 1.0 OUTLIER -58.25 -50.34 73.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 64.530000000000001 110.855 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -69.05 -40.18 78.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 71.230000000000004 110.819 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.812 ' O ' HG23 ' A' ' 67' ' ' THR . 10.5 tpt -53.47 -52.79 58.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 71.109999999999999 110.856 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.523 HG23 ' N ' ' A' ' 65' ' ' TYR . 16.6 m -61.75 -49.56 83.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 72.230000000000004 111.141 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.577 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 12.8 m-85 -55.61 -31.19 62.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 74.310000000000002 110.995 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.49 -43.33 56.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 74.140000000000001 111.151 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 63' ' ' MET . 1.1 p -64.44 -33.83 76.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 75.510000000000005 111.179 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.073 HD22 HD12 ' A' ' 20' ' ' ILE . 12.6 mt -81.74 7.07 13.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 74.120000000000005 110.925 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 31.58 73.14 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.7 -0.762 . . . . 70.109999999999999 112.48 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.427 ' CD ' ' HG ' ' A' ' 79' ' ' LEU . 26.7 mt-10 -77.34 -38.95 49.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.861 0.362 . . . . 51.32 110.894 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.4 tp -89.83 10.36 23.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 51.240000000000002 110.876 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.3 ttt -77.23 -13.52 59.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 72.109999999999999 110.904 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.1 -32.33 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.737 . . . . 53.119999999999997 112.508 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.311 0 C-N-CA 120.718 -0.754 . . . . 32.240000000000002 112.528 -179.918 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.415 ' HB3' ' HB3' ' A' ' 42' ' ' HIS . . . . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.798 0.332 . . . . 74.340000000000003 111.123 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.654 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 4.0 mm? -97.61 146.54 25.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 64.420000000000002 110.954 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -121.3 115.79 23.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 72.340000000000003 110.901 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.577 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 0.4 OUTLIER -125.01 117.64 24.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 54.329999999999998 110.869 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.691 ' HB2' HG23 ' A' ' 46' ' ' THR . 2.3 mptp? -120.83 114.87 22.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 73.510000000000005 110.853 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.536 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 28.6 p -116.15 107.06 14.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 40.140000000000001 111.188 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.5 mt -132.48 161.42 33.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 72.239999999999995 110.935 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.494 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.1 163.04 70.27 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.608 0.718 . . . . 75.0 111.109 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.2 Cg_endo -69.77 -7.97 22.42 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.681 2.254 . . . . 72.200000000000003 112.354 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -86.62 -28.83 23.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.446 . . . . 74.430000000000007 110.824 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -84.53 18.31 2.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 71.5 110.894 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 63.119999999999997 111.118 179.93 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.77 ' HB1' ' CG1' ' A' ' 35' ' ' VAL . . . . . . . . 0 N--CA 1.457 -0.076 0 CA-C-O 120.736 0.303 . . . . 64.040000000000006 111.078 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -57.64 -37.1 72.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 62.009999999999998 110.898 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.56 ' CG2' ' N ' ' A' ' 20' ' ' ILE . 1.2 t -60.86 -47.53 85.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 44.509999999999998 111.045 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.857 HD13 ' HB2' ' A' ' 68' ' ' LEU . 9.4 pt -70.24 -30.8 44.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 74.200000000000003 111.086 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.556 ' N ' HG13 ' A' ' 20' ' ' ILE . 39.0 ttt-85 -65.22 -48.02 74.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 74.310000000000002 110.814 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -71.46 -39.74 70.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 72.239999999999995 110.92 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.0 mt -58.26 -50.21 74.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 75.409999999999997 110.899 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.778 HG21 HG21 ' A' ' 33' ' ' VAL . 6.6 mt -71.32 -45.78 68.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 62.32 111.176 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -54.2 -35.82 62.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 74.329999999999998 110.903 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.97 -43.15 22.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 75.310000000000002 110.852 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.79 -52.22 52.12 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.78 -0.724 . . . . 71.299999999999997 112.518 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.06 101.67 54.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 74.409999999999997 110.938 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.64 -14.76 36.95 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.723 2.282 . . . . 73.219999999999999 112.302 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -97.65 1.1 48.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 74.439999999999998 110.88 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' A' ' 49' ' ' SER . . . -119.24 135.89 54.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 61.450000000000003 111.123 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.609 ' HB2' HG13 ' A' ' 48' ' ' VAL . 9.8 mmt180 -106.85 114.32 28.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 74.120000000000005 110.878 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 24' ' ' ILE . 18.4 t -116.79 124.69 73.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 72.120000000000005 111.065 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.62 117.65 15.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 63.399999999999999 110.806 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.77 ' CG1' ' HB1' ' A' ' 17' ' ' ALA . 4.4 p -123.64 138.6 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 71.510000000000005 111.098 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 3.1 tp-100 -132.12 120.52 22.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 72.409999999999997 110.904 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.53 -150.81 23.1 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.667 -0.778 . . . . 74.439999999999998 112.474 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -150.94 165.68 32.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 75.239999999999995 110.883 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -68.56 142.75 55.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 64.349999999999994 110.851 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.61 19.56 79.17 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 74.540000000000006 112.478 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 42' ' ' HIS . 9.8 t -144.1 164.98 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.853 0.359 . . . . 74.140000000000001 111.099 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.54 ' N ' HG12 ' A' ' 41' ' ' VAL . 17.3 p80 -74.81 107.73 7.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 71.109999999999999 110.923 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.928 ' CE2' HD11 ' A' ' 79' ' ' LEU . 7.7 p90 -119.43 167.43 11.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 72.209999999999994 110.904 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.1 pm0 -115.27 133.72 55.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 61.409999999999997 110.889 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.829 ' HB2' ' HE1' ' A' ' 43' ' ' PHE . . . -125.54 123.93 40.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 52.539999999999999 111.097 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.8 m -121.72 107.32 12.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 63.340000000000003 111.194 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.768 ' CG1' HG13 ' A' ' 33' ' ' VAL . 2.9 m -116.8 128.95 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 60.420000000000002 111.178 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.609 HG13 ' HB2' ' A' ' 32' ' ' ARG . 4.4 p -133.48 118.62 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 73.120000000000005 111.184 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.466 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -165.19 168.22 8.7 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.611 0.72 . . . . 74.219999999999999 110.828 -179.788 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.508 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.9 Cg_endo -69.7 -23.94 30.5 Favored 'Trans proline' 0 N--CA 1.465 -0.147 0 C-N-CA 122.747 2.298 . . . . 35.200000000000003 112.38 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -47.35 -44.45 23.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 72.540000000000006 111.053 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.635 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.7 OUTLIER -85.3 34.25 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 61.340000000000003 110.865 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.555 ' HA ' HG23 ' A' ' 85' ' ' THR . 14.6 p -52.3 144.67 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 71.439999999999998 111.109 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 50.7 -88.12 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.772 -0.728 . . . . 74.420000000000002 112.512 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -118.21 112.51 20.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 73.239999999999995 110.922 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.635 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -58.59 108.05 1.18 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.607 0.718 . . . . 63.329999999999998 111.136 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 52.9 Cg_endo -69.8 162.27 42.74 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.715 2.277 . . . . 73.420000000000002 112.317 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.8 tp -57.89 -25.95 61.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.225 -0.443 . . . . 74.230000000000004 110.831 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.22 -53.53 57.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 73.209999999999994 111.105 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.6 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 29.5 mmt180 -69.92 -44.97 68.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 75.239999999999995 110.885 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.485 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.5 t-160 -56.24 -53.77 53.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 61.439999999999998 110.821 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.9 mtp85 -65.33 -35.89 82.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 70.439999999999998 110.87 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.4 ttt -56.24 -48.38 76.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 65.129999999999995 110.835 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.594 HG21 HD21 ' A' ' 81' ' ' LEU . 11.4 m -67.83 -40.64 83.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 74.310000000000002 111.116 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.605 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 16.7 m-85 -67.35 -34.18 76.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 71.420000000000002 110.908 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.06 -44.46 26.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 64.019999999999996 111.114 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.505 HG22 ' O ' ' A' ' 64' ' ' VAL . 1.2 t -60.32 -40.99 92.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 72.519999999999996 111.158 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.048 ' O ' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -88.66 -10.92 46.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 60.340000000000003 110.921 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 1.014 ' N ' HD13 ' A' ' 68' ' ' LEU . . . 31.32 87.82 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.757 -0.735 . . . . 75.040000000000006 112.506 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.456 ' HG2' HD23 ' A' ' 71' ' ' LEU . 1.1 pm0 -79.53 -35.25 40.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.993 0.425 . . . . 74.439999999999998 110.938 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.456 HD23 ' HG2' ' A' ' 70' ' ' GLU . 3.9 mm? -76.11 7.3 4.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 40.210000000000001 110.929 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 63.4 mtp -84.52 -13.05 52.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 71.109999999999999 110.854 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.39 -22.1 1.11 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.772 -0.728 . . . . 55.100000000000001 112.448 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.323 0 C-N-CA 120.722 -0.751 . . . . 74.349999999999994 112.501 -179.881 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.812 0.339 . . . . 61.0 111.107 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.928 HD11 ' CE2' ' A' ' 43' ' ' PHE . 3.9 mm? -97.66 132.49 43.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 63.229999999999997 110.882 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -111.46 114.94 28.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 71.109999999999999 110.935 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.605 HD22 ' CZ ' ' A' ' 65' ' ' TYR . 3.4 tp -133.65 124.72 27.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 64.120000000000005 110.915 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' A' ' 81' ' ' LEU . 9.4 mptt -126.48 114.47 18.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 72.049999999999997 110.834 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.583 ' HB ' ' CD2' ' A' ' 52' ' ' PHE . 66.8 p -109.39 107.19 17.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 72.299999999999997 111.189 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.412 HD12 ' C ' ' A' ' 83' ' ' THR . 6.6 mp -131.56 162.8 29.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 65.25 110.88 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.555 HG23 ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.11 164.1 59.8 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.59 0.71 . . . . 72.439999999999998 111.103 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.6 Cg_endo -69.79 -12.8 33.58 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.633 2.222 . . . . 74.540000000000006 112.374 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -78.66 -28.72 45.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 72.239999999999995 110.905 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -85.04 28.79 0.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 74.400000000000006 110.877 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 53.439999999999998 111.18 179.837 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.869 ' HA ' HD11 ' A' ' 20' ' ' ILE . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.704 0.288 . . . . 74.239999999999995 111.042 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' A' ' 19' ' ' THR . 4.0 pt-20 -71.49 -28.91 64.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.26 -0.427 . . . . 74.439999999999998 110.873 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.421 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 17.1 p -59.07 -56.66 19.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 74.510000000000005 111.166 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.892 ' H ' HD13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -73.92 -35.29 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 74.150000000000006 111.098 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.52 ' N ' HG12 ' A' ' 20' ' ' ILE . 30.8 ttp180 -62.41 -48.57 79.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 73.230000000000004 110.862 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -69.56 -40.27 76.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 75.420000000000002 110.872 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.8 mt -56.18 -49.19 74.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.302 -0.408 . . . . 74.239999999999995 110.931 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.811 ' CG2' HG21 ' A' ' 33' ' ' VAL . 11.7 mt -68.07 -45.84 82.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 70.040000000000006 111.161 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -54.21 -36.8 63.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.116 -0.493 . . . . 74.340000000000003 110.898 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m -77.4 -43.02 34.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 40.149999999999999 110.881 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.47 -46.46 92.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.768 -0.729 . . . . 54.409999999999997 112.472 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.789 HD23 ' CB ' ' A' ' 31' ' ' ALA . 6.8 mp -85.61 161.09 52.02 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.567 0.699 . . . . 63.32 110.938 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -90.76 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.656 2.237 . . . . 74.120000000000005 112.373 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -107.26 25.89 10.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 72.409999999999997 110.909 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.789 ' CB ' HD23 ' A' ' 28' ' ' LEU . . . -71.64 125.71 27.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 73.010000000000005 111.118 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.717 ' HB3' HG12 ' A' ' 48' ' ' VAL . 2.2 tpm_? -93.71 108.75 20.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 71.219999999999999 110.865 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 1.071 HG22 HG13 ' A' ' 47' ' ' VAL . 41.7 t -113.28 127.46 70.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 73.040000000000006 111.196 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -135.22 118.56 16.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 70.120000000000005 110.828 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.683 HG13 ' HB1' ' A' ' 17' ' ' ALA . 3.9 p -126.26 136.7 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 64.329999999999998 111.089 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 63.6 mt-30 -132.69 120.1 21.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 73.439999999999998 110.912 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 149.18 -124.92 1.9 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 72.420000000000002 112.444 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.62 ' O ' HG12 ' A' ' 41' ' ' VAL . 2.2 tt0 -175.44 163.04 2.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 61.520000000000003 110.895 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.02 148.16 46.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 75.310000000000002 110.9 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.61 8.99 73.4 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.739 -0.743 . . . . 41.25 112.508 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 38' ' ' GLU . 14.7 p -139.14 165.17 23.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.827 0.346 . . . . 70.519999999999996 111.152 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.6 ' N ' HG22 ' A' ' 41' ' ' VAL . 32.6 p80 -74.49 110.7 9.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 73.219999999999999 110.851 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.536 ' CE2' HD11 ' A' ' 79' ' ' LEU . 4.9 p90 -126.91 167.65 15.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.273 -0.422 . . . . 71.209999999999994 110.866 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -113.5 124.98 53.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 64.150000000000006 110.873 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.22 119.99 26.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 64.510000000000005 111.148 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.4 m -118.26 114.99 23.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 74.510000000000005 111.117 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.071 HG13 HG22 ' A' ' 33' ' ' VAL . 24.7 t -113.47 141.25 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 74.129999999999995 111.128 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.717 HG12 ' HB3' ' A' ' 32' ' ' ARG . 5.1 p -134.95 122.2 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 70.239999999999995 111.133 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.449 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -167.61 166.26 7.97 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.704 0.764 . . . . 73.540000000000006 110.874 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.504 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.8 Cg_endo -69.74 -18.22 37.21 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.681 2.254 . . . . 74.030000000000001 112.317 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -43.76 -50.79 7.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 64.040000000000006 111.157 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.63 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -86.94 40.58 0.92 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.248 -0.433 . . . . 71.230000000000004 110.891 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.498 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 4.7 p -51.24 119.1 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 74.200000000000003 111.089 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.69 -72.88 1.01 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.748 -0.739 . . . . 70.549999999999997 112.495 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.404 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 23.3 mtpt -121.62 138.59 54.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.809 0.338 . . . . 72.230000000000004 110.876 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -99.73 100.11 10.33 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.538 0.685 . . . . 75.530000000000001 111.093 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.8 163.49 38.11 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.633 2.222 . . . . 75.230000000000004 112.374 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -56.49 -26.76 55.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 50.200000000000003 110.928 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 63' ' ' MET . . . -58.6 -49.95 75.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 63.409999999999997 111.13 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.605 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 21.6 mmt180 -71.7 -46.47 58.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.275 -0.42 . . . . 64.510000000000005 110.818 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.583 ' CD2' ' HH ' ' A' ' 65' ' ' TYR . 1.0 OUTLIER -58.0 -50.0 74.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 62.240000000000002 110.833 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 1.2 ttm180 -67.34 -39.65 85.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 55.340000000000003 110.883 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' MET . . . . . 0.407 ' CG ' ' O ' ' A' ' 59' ' ' ALA . 4.3 mmt -54.54 -48.02 72.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 75.409999999999997 110.898 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' A' ' 61' ' ' HIS . 13.5 m -65.43 -42.51 93.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 72.439999999999998 111.165 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . 0.583 ' HH ' ' CD2' ' A' ' 61' ' ' HIS . 12.1 m-85 -54.8 -42.09 71.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 74.129999999999995 110.853 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.53 -44.37 62.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 54.200000000000003 111.109 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.569 HG21 HG12 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -69.64 -14.76 62.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 72.430000000000007 111.201 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.525 ' O ' HG21 ' A' ' 20' ' ' ILE . 18.0 mt -94.61 -10.54 31.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 72.319999999999993 110.929 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.71 72.71 0.47 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.712 -0.756 . . . . 43.039999999999999 112.505 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 71' ' ' LEU . 10.0 pt-20 -114.65 -38.47 3.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.869 0.366 . . . . 72.340000000000003 110.924 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.637 ' O ' HD13 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -88.38 -11.17 46.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 71.310000000000002 110.907 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.8 ptm -80.63 -13.14 59.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 75.239999999999995 110.921 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.36 -25.28 5.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 64.5 112.471 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.368 0 C-N-CA 120.731 -0.747 . . . . 54.340000000000003 112.478 -179.91 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.84 0.353 . . . . 72.230000000000004 111.08 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.536 HD11 ' CE2' ' A' ' 43' ' ' PHE . 3.9 mm? -98.16 136.36 38.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 71.519999999999996 110.958 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -105.79 115.73 30.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 74.140000000000001 110.913 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.438 HD12 HG23 ' A' ' 83' ' ' THR . 0.2 OUTLIER -129.58 118.47 22.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 64.140000000000001 110.892 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 47' ' ' VAL . 2.2 mptp? -119.0 114.5 22.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.467 . . . . 75.400000000000006 110.953 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.539 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 33.5 p -109.79 107.32 17.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 62.0 111.163 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.6 mt -131.07 160.83 33.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 75.109999999999999 110.883 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.498 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.36 162.86 71.71 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.597 0.713 . . . . 62.299999999999997 111.128 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.7 Cg_endo -69.65 -17.94 37.81 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.689 2.259 . . . . 75.409999999999997 112.394 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -71.83 -34.76 69.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 73.430000000000007 110.904 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -68.32 -31.24 70.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.173 -0.467 . . . . 74.239999999999995 110.854 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 74.409999999999997 111.063 179.977 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 39.1 mtt . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.788 0.328 . . . . 73.239999999999995 110.892 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.84 -35.88 3.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 72.239999999999995 110.853 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -148.98 111.58 4.77 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 55.039999999999999 110.922 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.498 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 7.2 ttt180 -47.25 -59.67 5.1 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.571 0.7 . . . . 74.439999999999998 110.844 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 13' ' ' ARG . 54.3 Cg_endo -69.72 176.75 6.32 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.649 2.232 . . . . 73.340000000000003 112.363 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.708 ' O ' HG23 ' A' ' 19' ' ' THR . 8.9 tp -173.5 157.14 3.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.439 . . . . 53.439999999999998 110.923 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -58.99 -63.82 1.16 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.239 -0.437 . . . . 72.209999999999994 110.896 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.52 -25.7 17.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 74.319999999999993 111.046 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -71.5 -40.84 69.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.44 . . . . 70.010000000000005 110.866 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 15' ' ' LEU . 2.2 p -61.06 -52.86 63.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 71.439999999999998 111.134 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.561 HD11 HG11 ' A' ' 35' ' ' VAL . 4.6 pt -67.2 -45.07 87.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 73.420000000000002 111.148 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.1 ttt-85 -58.96 -45.06 91.42 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.143 -0.481 . . . . 72.340000000000003 110.846 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 mtmt -65.37 -44.65 86.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 74.299999999999997 110.88 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 18.5 mt -56.01 -49.54 73.36 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 55.43 110.935 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.829 HG22 HD12 ' A' ' 28' ' ' LEU . 8.8 mt -67.33 -44.28 87.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.176 -0.466 . . . . 53.530000000000001 111.129 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -54.03 -39.1 65.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.095 -0.502 . . . . 55.539999999999999 110.852 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.78 -41.21 45.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 74.120000000000005 110.873 -179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.48 -58.33 10.59 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.737 -0.744 . . . . 63.109999999999999 112.502 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.829 HD12 HG22 ' A' ' 24' ' ' ILE . 32.0 mt -73.05 154.69 90.68 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.638 0.732 . . . . 75.010000000000005 110.896 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -90.98 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.701 2.267 . . . . 61.340000000000003 112.315 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -104.41 34.51 3.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.202 -0.454 . . . . 73.209999999999994 110.89 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.513 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -87.52 139.6 30.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.1 -0.5 . . . . 73.140000000000001 111.119 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.644 ' HB3' HG12 ' A' ' 48' ' ' VAL . 31.3 ttt180 -109.3 125.65 52.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 74.010000000000005 110.865 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.045 HG13 HG22 ' A' ' 47' ' ' VAL . 6.0 t -123.15 133.26 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 70.319999999999993 111.128 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -135.09 118.86 17.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 71.129999999999995 110.83 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.741 HG22 ' HB1' ' A' ' 45' ' ' ALA . 40.1 t -124.56 130.85 73.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 64.209999999999994 111.115 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 2.0 tp-100 -132.77 120.18 21.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 63.509999999999998 110.912 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.478 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 149.44 -122.75 1.49 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.757 -0.735 . . . . 65.519999999999996 112.516 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -175.32 160.71 2.67 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.783 0.325 . . . . 71.25 110.918 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -73.65 146.58 44.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.112 -0.495 . . . . 54.340000000000003 110.905 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.435 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.7 18.39 78.69 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.784 -0.722 . . . . 72.099999999999994 112.451 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 42' ' ' HIS . 21.0 t -149.23 165.44 3.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 74.439999999999998 111.168 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.574 ' N ' HG12 ' A' ' 41' ' ' VAL . 36.0 p-80 -74.21 112.27 10.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.197 -0.456 . . . . 74.230000000000004 110.849 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.765 ' CZ ' HD21 ' A' ' 79' ' ' LEU . 27.8 p90 -129.23 167.44 17.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 75.430000000000007 110.931 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -116.63 120.04 37.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 73.219999999999999 110.86 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.741 ' HB1' HG22 ' A' ' 35' ' ' VAL . . . -127.73 116.83 20.85 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.127 -0.488 . . . . 72.319999999999993 111.07 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.6 m -106.89 117.89 35.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.184 -0.462 . . . . 45.530000000000001 111.115 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.045 HG22 HG13 ' A' ' 33' ' ' VAL . 55.0 t -113.93 141.22 30.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 63.009999999999998 111.126 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.644 HG12 ' HB3' ' A' ' 32' ' ' ARG . 3.7 p -131.42 118.75 41.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 63.039999999999999 111.105 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.545 ' OG ' ' CE2' ' A' ' 52' ' ' PHE . 10.8 p -158.58 158.62 29.59 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.651 0.738 . . . . 62.439999999999998 110.862 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.577 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.1 Cg_endo -69.69 -22.71 32.01 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 122.697 2.265 . . . . 63.100000000000001 112.385 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.0 -39.2 40.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.256 -0.429 . . . . 73.420000000000002 111.116 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.596 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 3.3 m-85 -84.51 27.77 0.69 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.171 -0.468 . . . . 74.319999999999993 110.915 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.505 ' O ' ' N ' ' A' ' 55' ' ' LYS . 2.1 p -52.25 138.65 10.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.113 -0.494 . . . . 44.130000000000003 111.147 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 54.85 -82.25 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.738 -0.744 . . . . 70.420000000000002 112.482 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 53' ' ' VAL . 16.6 pttm -119.23 135.69 54.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.79 0.328 . . . . 72.439999999999998 110.919 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.57 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -98.97 100.78 10.55 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.611 0.719 . . . . 70.540000000000006 111.068 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.5 Cg_endo -69.86 173.82 10.5 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.643 2.229 . . . . 63.340000000000003 112.339 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tp -58.38 -26.62 63.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 61.200000000000003 110.927 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.01 -52.96 63.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 53.210000000000001 111.128 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.596 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 3.7 mmt180 -71.57 -42.62 67.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.466 . . . . 53.520000000000003 110.915 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.557 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 0.7 OUTLIER -57.92 -53.17 61.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.095 -0.502 . . . . 74.109999999999999 110.912 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 -67.35 -37.67 83.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 74.109999999999999 110.912 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 40.0 mmm -55.1 -47.71 74.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 63.229999999999997 110.935 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 61' ' ' HIS . 19.6 m -69.58 -42.66 80.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.435 . . . . 70.340000000000003 111.151 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.679 ' CE1' HD13 ' A' ' 81' ' ' LEU . 13.3 m-85 -62.41 -36.98 84.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 74.230000000000004 110.891 -179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.48 -45.71 44.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 74.510000000000005 111.125 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.624 HG23 HD12 ' A' ' 68' ' ' LEU . 1.2 t -66.5 -26.62 67.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.212 -0.449 . . . . 74.420000000000002 111.16 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.647 HD12 HD11 ' A' ' 24' ' ' ILE . 7.5 mp -86.91 4.49 41.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 70.140000000000001 110.886 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.53 78.68 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.791 -0.719 . . . . 52.219999999999999 112.479 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -99.44 -48.25 4.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 74.329999999999998 110.896 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 10.0 mp -85.96 1.0 51.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.16 -0.473 . . . . 55.240000000000002 110.947 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.6 tpt -80.86 -13.31 59.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 72.319999999999993 110.861 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -123.0 -28.29 1.4 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.73 -0.748 . . . . 63.219999999999999 112.501 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.435 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . 106.62 35.3 2.87 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.685 -0.769 . . . . 60.310000000000002 112.479 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.69 155.67 15.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.73 0.3 . . . . 61.329999999999998 111.09 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 77' ' ' HIS . 7.9 mt -84.33 163.28 2.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 64.530000000000001 111.181 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.55 ' N ' HG22 ' A' ' 76' ' ' ILE . 66.0 m80 -60.16 -9.34 3.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 71.230000000000004 110.909 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.524 ' HB3' ' HB3' ' A' ' 42' ' ' HIS . . . -77.43 45.72 0.49 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 73.239999999999995 111.08 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.765 HD21 ' CZ ' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -97.97 126.83 43.56 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.24 -0.436 . . . . 51.240000000000002 110.902 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.4 ' N ' HD13 ' A' ' 79' ' ' LEU . 20.8 mp0 -106.75 114.76 29.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 72.409999999999997 110.917 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.679 HD13 ' CE1' ' A' ' 65' ' ' TYR . 9.0 tt -140.04 129.38 23.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.209 -0.45 . . . . 73.329999999999998 110.952 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.7 mmtp -122.49 132.21 54.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 65.010000000000005 110.874 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.533 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 27.2 p -112.16 107.09 15.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 72.209999999999994 111.107 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 29.5 mt -124.04 162.07 24.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.26 -0.427 . . . . 34.409999999999997 110.959 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.414 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 0.5 OUTLIER -71.66 164.65 56.34 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.619 0.723 . . . . 43.520000000000003 111.111 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.577 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.0 Cg_endo -69.81 -18.85 36.53 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.67 2.247 . . . . 75.329999999999998 112.331 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -77.64 -25.64 49.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 71.150000000000006 110.91 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -83.01 18.77 1.55 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.161 -0.472 . . . . 62.450000000000003 110.891 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.119 -0.491 . . . . 63.020000000000003 111.104 179.94 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 18.3 mtt . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.766 0.317 . . . . 71.239999999999995 110.856 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 86.5 mtt-85 -58.16 176.64 0.16 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.231 -0.44 . . . . 74.219999999999999 110.882 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -156.02 175.33 14.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 71.299999999999997 110.926 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.0 mmm180 -118.7 153.96 52.48 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.58 0.705 . . . . 71.030000000000001 110.844 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.84 -172.72 0.61 Allowed 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.651 2.234 . . . . 65.200000000000003 112.331 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.774 ' O ' HG23 ' A' ' 19' ' ' THR . 1.6 mp -104.05 -35.66 8.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 64.049999999999997 110.872 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -38.7 -71.08 0.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.234 -0.439 . . . . 74.319999999999993 110.84 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.76 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . -56.72 -28.59 61.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.268 -0.424 . . . . 73.209999999999994 111.084 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -71.14 -31.06 67.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 72.140000000000001 110.911 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.774 HG23 ' O ' ' A' ' 15' ' ' LEU . 1.3 p -67.22 -53.37 30.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.127 -0.488 . . . . 75.200000000000003 111.132 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.058 HD11 HG11 ' A' ' 35' ' ' VAL . 2.0 pp -70.06 -37.62 72.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 75.219999999999999 111.13 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.578 ' N ' HD12 ' A' ' 20' ' ' ILE . 38.0 ttp180 -61.32 -50.46 72.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 70.030000000000001 110.938 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.404 ' NZ ' ' HA ' ' A' ' 19' ' ' THR . 4.8 ptpp? -67.08 -40.0 86.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 64.219999999999999 110.878 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 25.8 mt -56.6 -49.86 73.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 75.030000000000001 110.893 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.714 ' CG2' HG21 ' A' ' 33' ' ' VAL . 12.3 mt -68.47 -43.8 83.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.195 -0.457 . . . . 75.450000000000003 111.113 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -55.58 -36.9 67.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.249 -0.432 . . . . 72.340000000000003 110.84 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.72 -43.0 32.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 71.219999999999999 110.845 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.8 -50.68 61.81 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.733 . . . . 63.219999999999999 112.463 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.501 HD13 ' CB ' ' A' ' 31' ' ' ALA . 5.0 mt -82.44 160.24 62.53 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.599 0.714 . . . . 64.340000000000003 110.884 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.424 ' HD2' ' CD2' ' A' ' 28' ' ' LEU . 54.3 Cg_endo -69.68 -91.27 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.729 2.286 . . . . 65.530000000000001 112.393 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.5 tt0 -106.71 25.6 11.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.45 . . . . 74.430000000000007 110.876 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.501 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -69.78 131.86 45.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 75.030000000000001 111.073 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.581 ' HB3' HG12 ' A' ' 48' ' ' VAL . 3.3 tpp85 -99.69 113.64 26.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 75.219999999999999 110.879 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.982 HG13 HG22 ' A' ' 47' ' ' VAL . 21.5 t -115.81 130.47 70.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.215 -0.448 . . . . 62.0 111.178 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -131.43 118.63 20.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 71.209999999999994 110.861 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.058 HG11 HD11 ' A' ' 20' ' ' ILE . 2.0 p -128.31 130.59 69.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.224 -0.444 . . . . 74.030000000000001 111.151 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.404 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 48.3 mt-30 -133.2 120.37 21.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 70.530000000000001 110.921 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 150.2 -125.14 1.88 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.761 -0.733 . . . . 64.310000000000002 112.505 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.647 ' O ' HG12 ' A' ' 41' ' ' VAL . 17.4 tt0 -175.1 162.48 3.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.817 0.342 . . . . 72.239999999999995 110.894 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 9.0 p30 -71.58 144.42 49.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 72.310000000000002 110.837 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.416 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.74 22.31 79.12 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.786 -0.721 . . . . 75.140000000000001 112.481 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 38' ' ' GLU . 1.0 OUTLIER -150.66 164.8 2.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.819 0.343 . . . . 72.349999999999994 111.173 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.402 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 45.8 p-80 -75.14 106.69 6.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.233 -0.44 . . . . 64.019999999999996 110.919 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.922 ' CE1' HD11 ' A' ' 79' ' ' LEU . 4.7 p90 -121.67 167.75 12.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 75.540000000000006 110.911 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -113.48 121.06 43.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 73.439999999999998 110.874 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.518 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -128.36 121.88 30.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 64.319999999999993 111.072 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.4 m -119.76 115.02 23.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 44.109999999999999 111.164 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.982 HG22 HG13 ' A' ' 33' ' ' VAL . 44.5 t -110.26 138.54 37.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.166 -0.47 . . . . 70.25 111.165 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.997 HG21 ' HB2' ' A' ' 89' ' ' ALA . 8.9 p -135.33 118.78 24.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 64.219999999999999 111.142 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.447 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.7 OUTLIER -161.19 165.72 16.44 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.614 0.721 . . . . 71.099999999999994 110.883 -179.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.471 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.0 Cg_endo -69.74 -21.01 34.16 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.643 2.229 . . . . 54.210000000000001 112.362 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.723 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -47.31 -46.52 25.23 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 70.319999999999993 111.072 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.709 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -85.22 34.97 0.57 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.266 -0.425 . . . . 75.430000000000007 110.889 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 55' ' ' LYS . 2.6 p -51.99 130.96 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.216 -0.447 . . . . 63.299999999999997 111.146 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 59.65 -76.08 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.804 -0.712 . . . . 60.549999999999997 112.498 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 53' ' ' VAL . 16.5 pttm -120.38 137.48 54.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.795 0.331 . . . . 63.25 110.936 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.709 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -99.58 99.9 9.67 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.504 0.669 . . . . 73.530000000000001 111.118 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.82 171.25 14.87 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.695 2.263 . . . . 64.519999999999996 112.34 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.93 -27.97 61.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.182 -0.463 . . . . 72.340000000000003 110.945 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.459 ' O ' ' CG ' ' A' ' 63' ' ' MET . . . -58.15 -52.26 66.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.182 -0.463 . . . . 72.349999999999994 111.082 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.723 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 44.1 mmt-85 -70.37 -43.47 70.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 73.109999999999999 110.852 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.529 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.8 OUTLIER -57.74 -53.59 56.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 72.25 110.844 179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -66.12 -36.15 82.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.166 -0.47 . . . . 71.209999999999994 110.864 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.459 ' CG ' ' O ' ' A' ' 59' ' ' ALA . 23.4 mmm -57.14 -46.49 82.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.44 . . . . 74.129999999999995 110.881 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 61' ' ' HIS . 17.1 m -69.82 -40.21 78.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 74.400000000000006 111.152 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.58 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 13.7 m-85 -65.94 -34.44 78.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.145 -0.48 . . . . 72.109999999999999 110.882 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.14 -46.6 33.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.134 -0.485 . . . . 64.420000000000002 111.079 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.473 HG21 HG12 ' A' ' 24' ' ' ILE . 13.0 t -66.56 -28.46 68.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 74.340000000000003 111.14 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.621 ' HG ' HD13 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -82.47 -2.45 53.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 53.25 110.915 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.88 78.41 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.78 -0.724 . . . . 52.520000000000003 112.537 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.469 ' HG3' ' N ' ' A' ' 71' ' ' LEU . 12.1 pt-20 -90.02 -42.15 11.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.902 0.382 . . . . 74.430000000000007 110.883 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.469 ' N ' ' HG3' ' A' ' 70' ' ' GLU . 18.0 tp -89.45 7.94 33.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 72.329999999999998 110.9 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -13.02 60.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.446 . . . . 73.430000000000007 110.951 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -139.05 -30.27 0.21 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.708 -0.758 . . . . 35.030000000000001 112.446 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.416 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . 130.27 48.86 0.12 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.722 -0.751 . . . . 4.3300000000000001 112.499 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.53 140.87 55.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.828 0.347 . . . . 40.450000000000003 111.132 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.52 HG22 ' N ' ' A' ' 77' ' ' HIS . 4.0 mp -99.77 160.46 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 42.299999999999997 111.092 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.52 ' N ' HG22 ' A' ' 76' ' ' ILE . 52.6 t60 -53.66 -14.81 0.97 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 73.420000000000002 110.897 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.94 40.06 0.52 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 74.129999999999995 111.084 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.922 HD11 ' CE1' ' A' ' 43' ' ' PHE . 0.1 OUTLIER -98.77 128.48 45.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.318 -0.401 . . . . 74.519999999999996 110.934 -179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.406 ' N ' HD13 ' A' ' 79' ' ' LEU . 4.8 mt-30 -97.53 116.84 30.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 34.100000000000001 110.872 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.58 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 1.7 tm? -139.04 117.92 12.4 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.16 -0.473 . . . . 73.200000000000003 110.906 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.566 ' N ' HD13 ' A' ' 81' ' ' LEU . 4.0 mptp? -122.21 133.01 54.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 74.310000000000002 110.963 179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.55 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 68.4 p -117.24 107.63 14.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 73.319999999999993 111.132 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 21.9 mt -127.76 161.04 29.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 62.420000000000002 110.903 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.483 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.15 163.8 64.28 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.631 0.729 . . . . 63.329999999999998 111.097 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.471 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.2 Cg_endo -69.81 -4.73 14.65 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.722 2.281 . . . . 74.109999999999999 112.304 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -94.18 -27.92 15.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 63.130000000000003 110.829 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -105.31 39.72 1.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 73.129999999999995 110.853 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.997 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.178 -0.464 . . . . 74.439999999999998 111.084 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.728 0.299 . . . . 74.420000000000002 110.836 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 8.5 mpt_? -105.01 -55.67 2.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 74.329999999999998 110.964 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 4.6 mmpt? -105.11 137.38 42.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.476 . . . . 62.229999999999997 110.901 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.2 mmm180 -129.27 144.66 53.63 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.584 0.706 . . . . 63.530000000000001 110.951 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.78 -164.64 0.13 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.634 2.223 . . . . 72.049999999999997 112.341 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.485 ' C ' HD12 ' A' ' 15' ' ' LEU . 2.8 pp -106.35 24.0 13.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.231 -0.44 . . . . 63.329999999999998 110.958 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -66.8 179.69 1.04 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 75.400000000000006 110.864 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.112 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . -46.52 -26.03 0.8 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 52.509999999999998 111.145 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -40.53 94.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.439 . . . . 73.329999999999998 110.872 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.577 ' CG2' ' N ' ' A' ' 20' ' ' ILE . 0.8 OUTLIER -60.74 -47.89 84.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.486 . . . . 43.140000000000001 111.118 -179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.794 HD11 HG11 ' A' ' 35' ' ' VAL . 43.6 pt -66.36 -39.26 83.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 52.340000000000003 111.122 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.484 ' N ' HG13 ' A' ' 20' ' ' ILE . 20.9 ttp85 -61.62 -42.22 98.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 63.219999999999999 110.85 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.62 -46.2 69.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 72.430000000000007 110.896 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -56.28 -49.06 75.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 74.409999999999997 110.957 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.813 ' CG2' HG21 ' A' ' 33' ' ' VAL . 7.9 mt -65.77 -45.31 92.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 74.239999999999995 111.117 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -53.86 -39.75 65.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 73.140000000000001 110.945 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -79.8 -32.47 40.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.107 -0.497 . . . . 70.310000000000002 110.798 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -69.24 -60.73 4.96 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.828 -0.701 . . . . 24.32 112.441 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.491 HD13 ' CB ' ' A' ' 31' ' ' ALA . 10.2 mt -72.65 159.29 85.73 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.569 0.7 . . . . 72.329999999999998 110.926 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.81 -91.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.34 0.129 0 C-N-CA 122.66 2.24 . . . . 54.350000000000001 112.347 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -105.38 38.9 1.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 64.329999999999998 110.846 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.491 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -91.35 125.75 36.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.242 -0.435 . . . . 71.5 111.072 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.624 ' HB3' HG12 ' A' ' 48' ' ' VAL . 8.0 tpp180 -95.67 109.65 21.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 71.340000000000003 110.881 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.027 HG22 HG13 ' A' ' 47' ' ' VAL . 39.0 t -109.12 125.4 66.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.217 -0.447 . . . . 62.409999999999997 111.101 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -135.35 117.53 15.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 64.129999999999995 110.831 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.112 HG13 ' HB1' ' A' ' 17' ' ' ALA . 5.1 p -126.88 139.78 50.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.139 -0.482 . . . . 74.519999999999996 111.13 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -129.19 120.99 26.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.187 -0.461 . . . . 70.239999999999995 110.92 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.478 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 144.16 -135.07 6.03 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.785 -0.721 . . . . 72.530000000000001 112.488 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.517 ' O ' HG12 ' A' ' 41' ' ' VAL . 10.9 tt0 -168.67 172.05 8.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 71.430000000000007 110.915 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -77.15 150.63 35.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.461 . . . . 73.109999999999999 110.861 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.58 1.25 52.28 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.741 -0.742 . . . . 71.439999999999998 112.442 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 38' ' ' GLU . 2.0 p -131.23 164.55 33.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.855 0.36 . . . . 65.319999999999993 111.151 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.525 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 10.0 p80 -75.21 107.35 7.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.453 . . . . 73.219999999999999 110.876 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.513 ' CE2' HD11 ' A' ' 79' ' ' LEU . 48.8 p90 -125.37 167.52 14.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 74.239999999999995 110.884 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -114.02 124.61 52.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 42.109999999999999 110.887 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.41 ' O ' ' HA ' ' A' ' 81' ' ' LEU . . . -117.74 115.4 24.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.214 -0.448 . . . . 61.409999999999997 111.081 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.0 m -114.92 106.65 14.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 62.509999999999998 111.217 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.027 HG13 HG22 ' A' ' 33' ' ' VAL . 59.9 t -112.54 125.95 69.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.152 -0.476 . . . . 53.420000000000002 111.102 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.664 HG21 ' HB2' ' A' ' 89' ' ' ALA . 3.9 p -114.4 118.57 58.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 75.299999999999997 111.173 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.499 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 14.9 p -159.33 158.66 28.38 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.663 0.744 . . . . 72.120000000000005 110.859 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.564 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.4 Cg_endo -69.68 -21.26 34.1 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.699 2.266 . . . . 75.019999999999996 112.352 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.53 -42.16 43.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.177 -0.465 . . . . 63.520000000000003 111.129 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.598 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 2.5 m-85 -84.04 30.18 0.53 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.449 . . . . 74.510000000000005 110.838 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.489 ' O ' ' N ' ' A' ' 55' ' ' LYS . 2.9 p -52.02 135.58 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 65.140000000000001 111.1 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.18 -82.88 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.745 -0.74 . . . . 53.409999999999997 112.46 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.489 ' N ' ' O ' ' A' ' 53' ' ' VAL . 30.9 mmmt -115.62 135.97 53.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.824 0.345 . . . . 65.230000000000004 110.891 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.538 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -99.14 100.55 10.36 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.623 0.725 . . . . 75.310000000000002 111.092 179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 54.3 Cg_endo -69.67 171.03 15.11 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.718 2.279 . . . . 75.430000000000007 112.333 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.491 HD21 ' NE ' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -55.62 -27.82 51.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.178 -0.464 . . . . 74.310000000000002 110.956 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.18 -52.64 64.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 74.209999999999994 111.135 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.598 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 7.7 mmt180 -70.98 -42.13 70.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.464 . . . . 65.109999999999999 110.839 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.507 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 0.6 OUTLIER -57.61 -52.02 67.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 75.409999999999997 110.863 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.491 ' NE ' HD21 ' A' ' 58' ' ' LEU . 44.8 mtt180 -68.16 -37.48 81.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.161 -0.472 . . . . 64.519999999999996 110.801 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 14.1 mmt -55.51 -49.0 73.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 64.450000000000003 110.875 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.491 ' HA ' HG22 ' A' ' 67' ' ' THR . 18.6 m -67.89 -45.1 84.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 60.020000000000003 111.111 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.851 ' CE1' HD13 ' A' ' 81' ' ' LEU . 13.2 m-85 -57.75 -36.77 72.53 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.45 . . . . 73.219999999999999 110.894 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.55 -46.03 41.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.478 . . . . 43.119999999999997 111.093 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.536 HG21 HG12 ' A' ' 24' ' ' ILE . 1.7 t -72.58 -12.89 61.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 72.120000000000005 111.136 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.741 HD23 HD12 ' A' ' 20' ' ' ILE . 27.1 mt -93.76 3.29 55.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 61.130000000000003 110.887 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 55.57 66.97 2.46 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.704 -0.76 . . . . 54.140000000000001 112.524 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -81.04 -39.41 25.84 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.912 0.387 . . . . 54.039999999999999 110.908 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.9 mt -90.18 10.08 25.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 73.219999999999999 110.894 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 22.9 mmt -71.79 -9.0 57.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 65.040000000000006 110.832 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -162.54 -31.8 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 75.129999999999995 112.52 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 142.85 107.3 0.61 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.761 -0.733 . . . . 64.409999999999997 112.533 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -83.16 123.58 29.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.725 0.297 . . . . 63.420000000000002 111.156 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.571 ' O ' HD23 ' A' ' 79' ' ' LEU . 3.7 mp -113.24 163.16 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 65.25 111.102 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.536 ' N ' HG22 ' A' ' 76' ' ' ILE . 25.6 p-80 -60.47 -9.45 3.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 71.340000000000003 110.872 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.52 26.84 0.76 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 74.129999999999995 111.137 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 76' ' ' ILE . 2.2 mm? -99.16 134.36 42.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 70.409999999999997 110.907 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -120.31 115.67 24.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 55.509999999999998 110.87 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.851 HD13 ' CE1' ' A' ' 65' ' ' TYR . 4.5 tt -127.94 140.61 51.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 74.200000000000003 110.957 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -136.39 115.69 12.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 61.219999999999999 110.979 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.542 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 11.8 p -105.46 106.87 17.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 64.120000000000005 111.086 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 45.5 mt -122.97 162.08 22.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.2 -0.455 . . . . 73.030000000000001 110.977 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.435 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 0.2 OUTLIER -71.33 165.82 44.74 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.61 0.719 . . . . 71.349999999999994 111.119 179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.7 Cg_endo -69.69 -24.71 29.69 Favored 'Trans proline' 0 C--O 1.231 0.16 0 C-N-CA 122.697 2.265 . . . . 74.019999999999996 112.393 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -67.28 -31.77 72.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 70.140000000000001 110.897 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.9 mm-40 -70.56 -32.39 69.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 72.219999999999999 110.903 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.664 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.114 -0.494 . . . . 71.510000000000005 111.134 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 7.2 mtm . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.811 0.339 . . . . 63.399999999999999 110.891 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -45.59 140.44 3.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.23 -0.441 . . . . 75.150000000000006 110.838 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 34.5 mttp -142.9 111.78 6.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 72.409999999999997 110.84 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.5 mtt180 -105.1 93.8 7.0 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.563 0.697 . . . . 73.129999999999995 110.866 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.83 101.97 0.98 Allowed 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.647 2.231 . . . . 63.049999999999997 112.311 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.1 mt -88.98 168.62 12.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 72.310000000000002 110.957 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.441 ' O ' ' CG2' ' A' ' 19' ' ' THR . 11.6 t0 -53.53 -53.5 50.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.191 -0.458 . . . . 73.510000000000005 110.832 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.581 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -67.91 -24.77 65.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.424 . . . . 34.340000000000003 111.161 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -70.86 -47.94 56.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.202 -0.454 . . . . 73.109999999999999 110.844 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.441 ' CG2' ' O ' ' A' ' 16' ' ' ASP . 1.9 t -61.34 -45.1 95.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.219 -0.446 . . . . 62.420000000000002 111.112 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.74 HD12 HD23 ' A' ' 68' ' ' LEU . 6.4 pt -71.55 -42.5 72.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 64.450000000000003 111.165 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 17' ' ' ALA . 58.9 ttt180 -60.5 -48.0 83.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 73.430000000000007 110.855 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -66.08 -42.85 88.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.185 -0.461 . . . . 75.439999999999998 110.872 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 23' ' ' LEU . 12.1 mt -56.07 -48.31 76.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.452 . . . . 71.329999999999998 110.912 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.791 HG21 HG21 ' A' ' 33' ' ' VAL . 13.3 mt -68.41 -45.22 82.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.484 . . . . 71.239999999999995 111.106 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -54.58 -37.12 65.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.104 -0.498 . . . . 70.219999999999999 110.879 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -77.91 -42.97 31.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 71.439999999999998 110.885 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.38 -49.9 73.54 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.799 -0.715 . . . . 65.209999999999994 112.499 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.608 HD13 ' CG2' ' A' ' 24' ' ' ILE . 5.8 mp -89.57 154.06 48.26 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.7 0.762 . . . . 70.439999999999998 110.845 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.69 -91.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.725 2.283 . . . . 63.329999999999998 112.317 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -100.16 54.74 0.91 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 72.5 110.897 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -104.97 137.66 42.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 54.420000000000002 111.143 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.645 ' HB3' HG12 ' A' ' 48' ' ' VAL . 4.7 tmm_? -106.43 117.38 33.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 74.439999999999998 110.852 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.948 HG13 HG22 ' A' ' 47' ' ' VAL . 38.0 t -122.2 130.27 74.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 64.400000000000006 111.181 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -135.26 118.52 16.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.454 . . . . 71.319999999999993 110.949 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.884 HG13 ' HB2' ' A' ' 45' ' ' ALA . 7.6 t -122.79 131.55 73.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 65.230000000000004 111.124 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.403 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 1.9 tp60 -133.53 120.0 20.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 63.340000000000003 110.937 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.08 -141.62 9.81 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.708 -0.758 . . . . 53.219999999999999 112.47 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -155.05 179.95 8.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 74.239999999999995 110.832 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -86.96 144.25 27.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.155 -0.475 . . . . 63.329999999999998 110.85 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.425 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.69 22.3 79.1 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.757 -0.735 . . . . 73.219999999999999 112.455 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.415 HG22 ' H ' ' A' ' 42' ' ' HIS . 2.5 p -148.84 164.93 4.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.808 0.337 . . . . 63.5 111.166 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.43 ' CD2' ' O ' ' A' ' 42' ' ' HIS . 8.6 p-80 -74.95 106.75 6.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.179 -0.464 . . . . 64.329999999999998 110.862 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.418 ' CD1' ' C ' ' A' ' 43' ' ' PHE . 8.1 p90 -120.5 167.39 12.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 63.119999999999997 110.881 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -118.29 119.18 33.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.114 -0.494 . . . . 73.140000000000001 110.836 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.884 ' HB2' HG13 ' A' ' 35' ' ' VAL . . . -128.99 115.57 18.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.095 -0.502 . . . . 63.350000000000001 111.148 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.461 HG23 ' HB2' ' A' ' 82' ' ' LYS . 38.7 m -103.86 125.64 50.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.145 -0.479 . . . . 74.120000000000005 111.084 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.948 HG22 HG13 ' A' ' 33' ' ' VAL . 88.1 t -122.3 133.82 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 61.509999999999998 111.136 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.645 HG12 ' HB3' ' A' ' 32' ' ' ARG . 4.1 p -130.11 118.61 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 65.340000000000003 111.138 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.464 ' CB ' ' HD2' ' A' ' 50' ' ' PRO . 0.5 OUTLIER -158.64 168.06 13.19 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.629 0.728 . . . . 62.329999999999998 110.797 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.515 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.1 Cg_endo -69.75 -28.52 25.2 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.604 2.203 . . . . 71.450000000000003 112.388 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.731 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -48.65 -42.17 33.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.227 -0.442 . . . . 61.009999999999998 111.126 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.559 ' CD2' ' HB ' ' A' ' 83' ' ' THR . 1.4 m-85 -83.86 31.38 0.48 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 72.319999999999993 110.89 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.591 ' HA ' HG23 ' A' ' 85' ' ' THR . 1.8 p -54.36 132.1 17.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.133 -0.485 . . . . 61.539999999999999 111.177 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.93 -80.2 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.74 -0.743 . . . . 32.130000000000003 112.511 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -116.91 136.52 52.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.757 0.313 . . . . 51.509999999999998 110.92 -179.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.426 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -99.07 100.5 10.15 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.579 0.704 . . . . 71.230000000000004 111.099 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.76 172.48 12.57 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.696 2.264 . . . . 65.230000000000004 112.309 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 tp -55.99 -25.07 42.56 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 71.120000000000005 110.909 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 63' ' ' MET . . . -59.26 -53.31 59.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 64.310000000000002 111.116 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.731 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 8.7 mmt180 -71.77 -40.43 69.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 73.319999999999993 110.915 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.555 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 0.8 OUTLIER -59.84 -51.91 67.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 74.239999999999995 110.885 179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 25.5 mtp180 -67.4 -39.05 85.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 71.540000000000006 110.891 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 4.9 tmm? -54.89 -52.11 63.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 74.450000000000003 110.858 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.538 ' O ' HG22 ' A' ' 67' ' ' THR . 25.5 m -63.83 -44.9 98.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.303 -0.408 . . . . 72.129999999999995 111.072 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.555 ' OH ' ' CE1' ' A' ' 61' ' ' HIS . 12.8 m-85 -60.37 -31.24 70.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.202 -0.454 . . . . 73.0 110.885 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.04 -46.66 33.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 61.109999999999999 111.099 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.538 HG22 ' O ' ' A' ' 64' ' ' VAL . 3.8 t -67.12 -26.6 66.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 74.019999999999996 111.134 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.74 HD23 HD12 ' A' ' 20' ' ' ILE . 12.9 mt -83.0 8.88 11.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.23 -0.441 . . . . 72.150000000000006 110.887 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.14 66.94 1.33 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.736 . . . . 60.340000000000003 112.508 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.478 ' HG3' HD23 ' A' ' 71' ' ' LEU . 10.0 pt-20 -70.39 -42.8 71.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.875 0.369 . . . . 73.430000000000007 110.845 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.478 HD23 ' HG3' ' A' ' 70' ' ' GLU . 4.4 mm? -90.01 7.62 36.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.17 -0.468 . . . . 64.129999999999995 110.93 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.0 ttm -71.92 -12.99 61.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 74.209999999999994 110.877 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -153.26 -33.12 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.777 -0.725 . . . . 72.299999999999997 112.501 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.425 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . 130.3 59.3 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.643 -0.789 . . . . 63.140000000000001 112.449 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.02 147.17 35.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.73 0.3 . . . . 74.209999999999994 111.097 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.423 ' N ' HD12 ' A' ' 76' ' ' ILE . 4.0 mp -113.11 152.91 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 51.420000000000002 111.111 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -46.38 -20.36 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.201 -0.454 . . . . 74.299999999999997 110.877 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.63 47.73 0.42 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 54.439999999999998 111.065 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 79' ' ' LEU . 8.8 mt -104.24 126.9 51.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 73.239999999999995 110.914 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -96.93 115.4 27.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.462 . . . . 61.030000000000001 110.903 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.44 HD23 ' HE1' ' A' ' 61' ' ' HIS . 3.8 tp -139.22 144.19 38.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.28 -0.418 . . . . 75.019999999999996 110.937 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.461 ' HB2' HG23 ' A' ' 46' ' ' THR . 0.6 OUTLIER -136.27 114.48 11.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.455 . . . . 64.109999999999999 110.901 179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.559 ' HB ' ' CD2' ' A' ' 52' ' ' PHE . 44.5 p -99.41 107.72 20.02 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.232 -0.44 . . . . 65.239999999999995 111.17 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.778 HD22 ' OE1' ' A' ' 88' ' ' GLU . 26.9 mt -130.78 160.35 34.62 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.176 -0.466 . . . . 71.010000000000005 110.915 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.591 HG23 ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -73.63 164.11 63.49 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.633 0.73 . . . . 71.209999999999994 111.142 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.8 Cg_endo -69.72 -8.79 24.5 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.689 2.259 . . . . 65.420000000000002 112.318 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -77.58 -35.96 52.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 63.520000000000003 110.918 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.778 ' OE1' HD22 ' A' ' 84' ' ' LEU . 18.0 mt-10 -70.36 -32.57 70.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 74.340000000000003 110.796 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 52.149999999999999 111.17 179.914 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 14.2 mtt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.838 0.351 . . . . 62.43 110.906 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 14.4 ttp180 -53.54 -51.91 61.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 55.43 110.849 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.04 100.49 7.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.174 -0.466 . . . . 74.409999999999997 110.881 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -115.39 80.73 7.94 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.653 0.739 . . . . 63.530000000000001 110.893 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.7 -172.67 0.59 Allowed 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.711 2.274 . . . . 63.539999999999999 112.431 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 pp -117.31 25.04 10.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.286 -0.415 . . . . 64.120000000000005 110.94 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -120.72 -70.56 0.78 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.155 -0.475 . . . . 75.310000000000002 110.914 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.793 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . -67.18 -32.58 73.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 71.030000000000001 111.093 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -71.61 -41.14 69.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 71.310000000000002 110.866 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.5 p -61.03 -53.0 62.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 73.549999999999997 111.15 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.714 HD11 HG11 ' A' ' 35' ' ' VAL . 12.3 pt -68.3 -42.72 84.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 72.530000000000001 111.155 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.501 ' N ' HG13 ' A' ' 20' ' ' ILE . 39.9 ttp85 -59.56 -46.49 88.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.176 -0.465 . . . . 75.540000000000006 110.88 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.8 mtpt -66.82 -41.21 87.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.236 -0.438 . . . . 62.539999999999999 110.918 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.3 mt -56.64 -49.46 74.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.153 -0.476 . . . . 71.140000000000001 110.867 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.76 ' CG2' HG21 ' A' ' 33' ' ' VAL . 10.6 mt -67.56 -41.95 86.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.276 -0.42 . . . . 71.200000000000003 111.131 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -55.7 -41.1 73.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 73.109999999999999 110.913 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -74.72 -43.28 55.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 75.329999999999998 110.876 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.35 -51.86 53.42 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.732 -0.747 . . . . 73.430000000000007 112.406 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.599 HD23 ' CB ' ' A' ' 31' ' ' ALA . 7.3 mp -80.71 156.31 72.92 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.594 0.712 . . . . 74.549999999999997 110.88 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.78 -90.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.657 2.238 . . . . 64.439999999999998 112.375 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -105.96 27.36 8.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 74.150000000000006 110.863 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.599 ' CB ' HD23 ' A' ' 28' ' ' LEU . . . -75.81 144.45 41.32 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 74.439999999999998 111.048 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.692 ' HB3' HG12 ' A' ' 48' ' ' VAL . 58.2 ttt180 -110.96 124.83 52.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 74.439999999999998 110.849 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.1 HG13 HG22 ' A' ' 47' ' ' VAL . 5.9 t -124.17 129.44 74.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 62.340000000000003 111.153 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -131.44 118.98 20.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 53.130000000000003 110.846 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.793 HG13 ' HB1' ' A' ' 17' ' ' ALA . 1.6 p -126.73 134.34 66.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.213 -0.449 . . . . 64.120000000000005 111.105 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -133.45 120.3 20.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 74.129999999999995 110.897 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 140.56 -130.39 4.55 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.731 -0.747 . . . . 71.409999999999997 112.529 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -174.06 160.98 3.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.919 0.39 . . . . 72.510000000000005 110.871 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -67.69 151.95 46.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 70.530000000000001 110.887 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.419 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.74 10.12 75.97 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.752 -0.737 . . . . 75.430000000000007 112.533 -179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.524 HG12 ' N ' ' A' ' 42' ' ' HIS . 7.3 t -143.95 165.15 14.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.834 0.35 . . . . 54.140000000000001 111.159 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.524 ' N ' HG12 ' A' ' 41' ' ' VAL . 12.7 p80 -74.52 108.85 7.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 62.43 110.783 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.808 ' CE1' HD11 ' A' ' 79' ' ' LEU . 40.0 p90 -125.09 167.47 14.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 74.010000000000005 110.826 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -119.43 120.11 35.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.132 -0.486 . . . . 75.230000000000004 110.903 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.2 115.28 18.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.179 -0.464 . . . . 63.25 111.126 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 23.7 m -108.41 119.42 39.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.232 -0.44 . . . . 54.549999999999997 111.181 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.1 HG22 HG13 ' A' ' 33' ' ' VAL . 96.8 t -112.74 136.59 48.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 64.209999999999994 111.183 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.725 HG21 ' HB2' ' A' ' 89' ' ' ALA . 2.7 p -128.76 125.55 63.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 73.409999999999997 111.084 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.453 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.8 OUTLIER -172.45 164.84 3.81 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.648 0.737 . . . . 73.219999999999999 110.863 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.495 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.4 Cg_endo -69.74 -22.43 32.2 Favored 'Trans proline' 0 N--CA 1.466 -0.127 0 C-N-CA 122.705 2.27 . . . . 71.140000000000001 112.362 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.778 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -47.72 -41.99 24.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 73.219999999999999 111.043 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.768 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -89.27 35.9 0.82 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 63.130000000000003 110.904 -179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.5 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 6.7 p -52.41 139.33 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 64.140000000000001 111.138 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 56.38 -89.28 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.756 -0.735 . . . . 70.420000000000002 112.5 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HD2' ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -117.9 111.16 18.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.732 0.301 . . . . 70.219999999999999 110.919 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.768 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -60.03 108.48 1.43 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.635 0.731 . . . . 63.119999999999997 111.09 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 54.2 Cg_endo -69.71 160.76 48.52 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.67 2.247 . . . . 74.5 112.374 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tp -54.81 -26.76 36.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.206 -0.452 . . . . 74.109999999999999 110.86 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.02 -52.39 65.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.212 -0.449 . . . . 55.219999999999999 111.071 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.778 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 30.7 mmt-85 -69.46 -41.07 76.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 74.299999999999997 110.857 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.426 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.9 OUTLIER -59.07 -53.46 58.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.197 -0.456 . . . . 63.450000000000003 110.808 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 52.0 mtt-85 -67.1 -35.05 78.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 75.030000000000001 110.924 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.0 tpp -58.37 -51.6 69.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 65.450000000000003 110.875 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.659 ' O ' HG22 ' A' ' 67' ' ' THR . 20.7 m -64.05 -44.66 97.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.257 -0.429 . . . . 70.519999999999996 111.204 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.76 ' CE1' HD13 ' A' ' 81' ' ' LEU . 14.1 m-85 -59.17 -38.85 80.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.121 -0.491 . . . . 75.310000000000002 110.955 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.72 -32.85 60.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.49 . . . . 70.040000000000006 111.096 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.659 HG22 ' O ' ' A' ' 64' ' ' VAL . 0.6 OUTLIER -71.57 -27.09 62.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 72.040000000000006 111.142 -179.867 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.527 ' C ' HD12 ' A' ' 68' ' ' LEU . 3.5 pp -88.66 -10.5 48.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.221 -0.445 . . . . 72.209999999999994 110.95 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.523 ' N ' HD12 ' A' ' 68' ' ' LEU . . . 53.69 75.1 0.25 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.705 -0.76 . . . . 44.229999999999997 112.505 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.526 ' HG2' HD11 ' A' ' 68' ' ' LEU . 4.6 pt-20 -91.38 -42.51 10.29 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.858 0.361 . . . . 63.140000000000001 110.88 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.686 ' O ' HD13 ' A' ' 71' ' ' LEU . 0.3 OUTLIER -84.44 -10.11 57.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 63.310000000000002 110.891 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 4.5 mmt -72.51 -13.72 61.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.197 -0.456 . . . . 53.409999999999997 110.896 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -126.72 -14.08 2.91 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.8 -0.714 . . . . 40.020000000000003 112.499 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.419 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . 99.52 35.81 4.54 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.689 -0.767 . . . . 74.540000000000006 112.475 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -59.76 142.31 53.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.732 0.301 . . . . 74.310000000000002 111.11 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.709 ' H ' HD12 ' A' ' 76' ' ' ILE . 3.6 mp -82.66 160.83 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 65.400000000000006 111.168 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.544 ' CD2' ' O ' ' A' ' 77' ' ' HIS . 15.2 t60 -58.19 -10.67 2.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 73.040000000000006 110.852 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.73 47.61 0.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.214 -0.448 . . . . 73.299999999999997 111.155 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.808 HD11 ' CE1' ' A' ' 43' ' ' PHE . 7.9 tp -105.0 133.14 50.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 64.310000000000002 110.912 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.8 mm-40 -111.47 115.46 29.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 74.400000000000006 110.929 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.76 HD13 ' CE1' ' A' ' 65' ' ' TYR . 8.4 tt -139.43 129.41 24.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 74.549999999999997 110.99 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.5 mmtp -123.58 135.95 54.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.246 -0.434 . . . . 74.049999999999997 110.91 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.54 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 14.0 p -119.43 106.94 12.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.302 -0.408 . . . . 43.020000000000003 111.163 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.7 mp -124.9 161.59 26.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 74.310000000000002 110.902 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.5 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.3 OUTLIER -71.99 164.74 56.31 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.694 0.759 . . . . 65.530000000000001 111.035 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.495 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.4 Cg_endo -69.84 -12.32 32.5 Favored 'Trans proline' 0 C--N 1.342 0.233 0 C-N-CA 122.684 2.256 . . . . 63.140000000000001 112.302 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -75.45 -35.81 60.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 72.120000000000005 110.876 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -69.45 -39.86 77.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 61.229999999999997 110.903 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.725 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 63.009999999999998 111.116 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.472 ' O ' ' C ' ' A' ' 11' ' ' ARG . 22.3 ptp . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.735 0.302 . . . . 74.200000000000003 110.869 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.472 ' C ' ' O ' ' A' ' 10' ' ' MET . 0.0 OUTLIER 32.45 41.0 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 74.409999999999997 110.873 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.485 ' HB2' HD13 ' A' ' 15' ' ' LEU . 29.6 mtpt -78.15 98.34 5.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 65.430000000000007 110.889 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.648 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 6.3 ttt85 -68.34 -51.52 24.37 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.582 0.706 . . . . 75.530000000000001 110.831 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.648 ' HD2' ' N ' ' A' ' 13' ' ' ARG . 53.3 Cg_endo -69.79 14.43 0.26 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.693 2.262 . . . . 74.219999999999999 112.311 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.485 HD13 ' HB2' ' A' ' 12' ' ' LYS . 5.9 tp -39.26 161.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.251 -0.431 . . . . 40.219999999999999 110.865 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -85.24 -50.01 7.72 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.479 . . . . 52.119999999999997 110.922 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.466 ' O ' ' CB ' ' A' ' 21' ' ' ARG . . . -68.37 -30.47 69.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.133 -0.485 . . . . 63.420000000000002 111.102 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.401 ' CB ' ' HB3' ' A' ' 15' ' ' LEU . 7.2 tp10 -68.77 -48.69 63.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 75.040000000000006 110.883 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.469 HG22 ' O ' ' A' ' 15' ' ' LEU . 3.2 t -62.0 -48.32 80.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 74.25 111.181 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.706 HD12 ' N ' ' A' ' 21' ' ' ARG . 2.3 pp -69.3 -39.73 79.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 72.340000000000003 111.169 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.706 ' N ' HD12 ' A' ' 20' ' ' ILE . 33.0 ttp85 -59.39 -45.96 90.02 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 73.299999999999997 110.862 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 26.1 mtpt -68.95 -41.26 78.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 62.539999999999999 110.86 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.412 HD23 ' HA ' ' A' ' 23' ' ' LEU . 16.0 mt -56.3 -49.19 74.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 54.43 110.884 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.754 ' CG2' HG21 ' A' ' 33' ' ' VAL . 16.2 mt -69.88 -41.68 79.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.234 -0.439 . . . . 72.319999999999993 111.11 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -56.26 -37.03 69.25 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 75.310000000000002 110.851 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.31 -42.86 24.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 43.32 110.905 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.95 -52.03 51.06 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.776 -0.726 . . . . 62.350000000000001 112.453 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.517 HD23 ' CG2' ' A' ' 24' ' ' ILE . 4.1 mm? -79.53 158.02 74.15 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.645 0.736 . . . . 61.420000000000002 110.872 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.78 -90.74 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.709 2.273 . . . . 73.129999999999995 112.354 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -105.18 27.71 7.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 65.030000000000001 110.873 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.485 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . . . -78.22 129.41 35.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 71.530000000000001 111.103 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.627 ' HB3' HG12 ' A' ' 48' ' ' VAL . 7.6 tpt180 -101.42 113.52 26.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 62.329999999999998 110.892 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.059 HG13 HG22 ' A' ' 47' ' ' VAL . 11.6 t -113.44 127.69 70.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 63.439999999999998 111.131 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -134.08 118.24 17.53 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.208 -0.451 . . . . 70.120000000000005 110.888 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.561 ' CG2' HD11 ' A' ' 20' ' ' ILE . 61.7 t -122.71 137.53 55.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.255 -0.43 . . . . 60.409999999999997 111.131 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 4.2 tt0 -133.9 119.39 19.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 71.120000000000005 110.987 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.466 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 146.1 -132.54 4.55 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 42.409999999999997 112.459 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.465 ' O ' ' CG2' ' A' ' 41' ' ' VAL . 0.4 OUTLIER -171.68 162.37 6.3 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 74.030000000000001 110.915 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -68.41 145.7 53.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.133 -0.485 . . . . 51.32 110.817 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 78.9 -15.97 9.33 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.703 -0.761 . . . . 34.329999999999998 112.471 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.465 ' CG2' ' O ' ' A' ' 38' ' ' GLU . 13.1 m -112.96 164.86 8.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.919 0.39 . . . . 71.319999999999993 111.112 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.606 ' CD2' ' O ' ' A' ' 78' ' ' ALA . 4.9 t-160 -74.94 106.9 6.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 74.129999999999995 110.886 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.788 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 4.4 p90 -120.94 167.21 12.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 75.209999999999994 110.85 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -119.47 123.62 44.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.069 -0.514 . . . . 73.540000000000006 110.836 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.594 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -117.66 115.97 26.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 74.150000000000006 111.085 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 15.2 m -110.8 108.05 17.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.248 -0.433 . . . . 72.409999999999997 111.17 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.059 HG22 HG13 ' A' ' 33' ' ' VAL . 95.2 t -109.76 141.27 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 72.319999999999993 111.152 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.747 HG21 ' HB2' ' A' ' 89' ' ' ALA . 5.1 p -134.65 118.49 26.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 60.43 111.117 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -164.03 165.98 12.67 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.67 0.748 . . . . 73.219999999999999 110.817 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.526 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.8 Cg_endo -69.78 -28.57 25.01 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.693 2.262 . . . . 72.319999999999993 112.33 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.663 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -51.27 -34.05 31.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 73.430000000000007 111.06 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.599 ' CE2' ' HB3' ' A' ' 60' ' ' ARG . 3.9 m-85 -90.78 31.06 1.09 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 75.299999999999997 110.893 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.681 ' HA ' HG23 ' A' ' 85' ' ' THR . 8.4 p -61.21 143.55 14.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 75.129999999999995 111.143 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 52.41 -90.99 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.728 -0.749 . . . . 71.299999999999997 112.496 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.9 OUTLIER -120.06 104.77 10.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.774 0.321 . . . . 62.100000000000001 110.934 179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -59.49 109.22 1.76 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.624 0.726 . . . . 64.409999999999997 111.064 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.9 Cg_endo -69.81 168.81 20.56 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.67 2.247 . . . . 74.099999999999994 112.334 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tp -53.86 -26.62 25.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 71.299999999999997 110.925 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.35 -53.05 62.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 75.140000000000001 111.106 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.663 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 21.3 mmt180 -69.88 -41.67 74.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 64.549999999999997 110.926 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.557 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -59.49 -53.4 58.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 74.129999999999995 110.845 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 24.6 mtp180 -66.53 -35.85 81.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 72.409999999999997 110.837 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 10.9 tpt -58.35 -45.86 87.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 75.400000000000006 110.933 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.626 ' O ' HD13 ' A' ' 68' ' ' LEU . 19.6 m -70.19 -40.38 78.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.125 -0.489 . . . . 72.150000000000006 111.13 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.704 ' CE1' HD13 ' A' ' 81' ' ' LEU . 13.6 m-85 -65.71 -34.76 78.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.183 -0.462 . . . . 73.040000000000006 110.949 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.61 -46.29 32.58 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 71.239999999999995 111.045 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.562 HG23 HD11 ' A' ' 24' ' ' ILE . 3.5 t -66.91 -28.37 68.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 74.0 111.109 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.626 HD13 ' O ' ' A' ' 64' ' ' VAL . 3.8 mp -82.57 -8.82 59.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 63.450000000000003 110.91 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.27 80.01 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.687 -0.768 . . . . 53.450000000000003 112.552 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.443 ' C ' ' HB2' ' A' ' 75' ' ' ALA . 56.1 mt-10 -91.22 -25.31 19.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.897 0.38 . . . . 72.030000000000001 110.889 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.1 mp -89.96 9.98 25.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.098 -0.501 . . . . 71.420000000000002 110.965 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 7.0 ptp -74.42 -13.22 60.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 74.010000000000005 110.83 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.3 -32.93 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.748 -0.739 . . . . 65.0 112.503 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.88 73.9 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.761 -0.733 . . . . 51.25 112.487 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.443 ' HB2' ' C ' ' A' ' 70' ' ' GLU . . . -59.35 123.54 17.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.828 0.346 . . . . 55.420000000000002 111.061 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.55 HG22 ' N ' ' A' ' 77' ' ' HIS . 18.6 mm -113.56 163.42 10.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.145 -0.479 . . . . 74.450000000000003 111.102 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.55 ' N ' HG22 ' A' ' 76' ' ' ILE . 74.0 m80 -65.2 -4.88 5.66 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.186 -0.461 . . . . 62.409999999999997 110.823 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.606 ' O ' ' CD2' ' A' ' 42' ' ' HIS . . . -88.47 47.21 1.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.248 -0.433 . . . . 70.329999999999998 111.091 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.788 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 1.1 mm? -115.47 133.85 55.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 72.030000000000001 110.97 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -114.35 115.61 27.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 75.099999999999994 110.883 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.704 HD13 ' CE1' ' A' ' 65' ' ' TYR . 1.4 tt -126.33 144.99 50.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 75.230000000000004 110.937 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -136.26 123.84 22.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 52.119999999999997 110.866 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.585 ' HB ' ' CD2' ' A' ' 52' ' ' PHE . 30.1 p -116.06 107.75 15.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 65.230000000000004 111.131 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mp -128.3 160.67 31.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 75.030000000000001 110.92 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.681 HG23 ' HA ' ' A' ' 53' ' ' VAL . 0.3 OUTLIER -72.5 164.94 55.91 Favored Pre-proline 0 C--N 1.33 -0.249 0 CA-C-O 121.606 0.717 . . . . 73.219999999999999 111.139 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.1 Cg_endo -69.77 -16.37 37.5 Favored 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.667 2.245 . . . . 71.420000000000002 112.375 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -73.03 -35.9 66.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 72.420000000000002 110.817 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -67.82 -38.03 82.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 75.109999999999999 110.839 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.747 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.109 -0.496 . . . . 71.239999999999995 111.144 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 14.9 ptp . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.761 0.315 . . . . 74.25 110.941 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 -84.01 145.05 28.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 71.349999999999994 110.894 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 15.9 mtpt -98.75 35.6 1.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 73.239999999999995 110.874 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? -115.15 65.37 1.9 Allowed Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.596 0.713 . . . . 74.400000000000006 110.876 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 150.92 68.69 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.668 2.245 . . . . 53.039999999999999 112.319 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.1 mt -128.15 -69.73 0.72 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 73.109999999999999 110.927 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -125.83 -69.05 0.8 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.469 . . . . 73.430000000000007 110.914 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.473 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . -68.61 -31.9 71.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.164 -0.471 . . . . 45.329999999999998 111.139 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -72.83 -48.04 41.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 72.5 110.906 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.462 HG23 ' N ' ' A' ' 20' ' ' ILE . 2.7 t -57.8 -50.15 74.24 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.18 -0.464 . . . . 64.150000000000006 111.139 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.5 HG13 ' N ' ' A' ' 21' ' ' ARG . 25.9 pt -68.01 -42.16 85.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 72.329999999999998 111.152 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.5 ' N ' HG13 ' A' ' 20' ' ' ILE . 54.3 ttt-85 -55.01 -53.16 59.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.078 -0.51 . . . . 74.329999999999998 110.834 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.5 mttt -66.15 -35.86 81.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 74.129999999999995 110.94 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -56.37 -49.18 75.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 53.439999999999998 110.945 179.88 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.825 ' CG2' HG21 ' A' ' 33' ' ' VAL . 5.8 mt -70.9 -44.34 76.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 61.530000000000001 111.135 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -53.89 -36.85 63.14 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.455 . . . . 72.209999999999994 110.869 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -81.51 -41.48 21.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 75.109999999999999 110.818 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.61 -55.5 24.83 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.798 -0.715 . . . . 63.240000000000002 112.481 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 4.3 mm? -72.89 159.36 85.51 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.641 0.734 . . . . 75.340000000000003 110.945 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -90.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.649 2.233 . . . . 65.299999999999997 112.368 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -107.29 27.24 9.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.423 . . . . 73.219999999999999 110.895 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HB3' ' HB3' ' A' ' 28' ' ' LEU . . . -79.07 126.77 31.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.168 -0.469 . . . . 71.340000000000003 111.058 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.512 ' HB2' ' CG1' ' A' ' 48' ' ' VAL . 3.7 mmm180 -93.86 109.01 20.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 73.310000000000002 110.905 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.825 HG21 ' CG2' ' A' ' 24' ' ' ILE . 53.0 t -113.65 121.45 65.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.47 . . . . 72.25 111.102 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -132.34 118.11 18.99 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.193 -0.458 . . . . 75.329999999999998 110.897 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.473 HG13 ' HB1' ' A' ' 17' ' ' ALA . 2.2 p -127.08 135.63 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 70.209999999999994 111.162 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 30.5 mm-40 -133.57 120.14 20.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 72.140000000000001 110.903 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 146.88 -128.19 2.92 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.727 -0.749 . . . . 23.399999999999999 112.436 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.439 ' HG3' ' CG2' ' A' ' 41' ' ' VAL . 11.8 pt-20 -175.27 171.17 2.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.811 0.339 . . . . 74.420000000000002 110.838 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -75.29 147.42 40.22 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.132 -0.485 . . . . 71.129999999999995 110.819 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.71 16.72 77.9 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.716 -0.754 . . . . 53.130000000000003 112.435 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.439 ' CG2' ' HG3' ' A' ' 38' ' ' GLU . 1.8 t -146.62 164.01 8.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.831 0.348 . . . . 65.019999999999996 111.161 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.589 ' CD2' ' O ' ' A' ' 42' ' ' HIS . 19.7 p-80 -75.98 106.62 7.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 110.835 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.764 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 4.5 p90 -119.26 166.22 13.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 75.030000000000001 110.836 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -115.4 121.17 41.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.137 -0.483 . . . . 72.219999999999999 110.892 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 81' ' ' LEU . . . -128.17 115.09 17.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.186 -0.461 . . . . 72.120000000000005 111.072 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.1 m -111.81 116.16 30.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.28 -0.418 . . . . 73.450000000000003 111.1 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.771 ' CG2' HG13 ' A' ' 33' ' ' VAL . 28.6 t -120.58 126.11 74.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.46 . . . . 74.239999999999995 111.148 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.512 ' CG1' ' HB2' ' A' ' 32' ' ' ARG . 6.4 p -124.06 118.8 55.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.464 . . . . 75.040000000000006 111.174 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.446 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.8 OUTLIER -160.61 166.63 15.17 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.611 0.719 . . . . 53.130000000000003 110.8 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.517 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.3 Cg_endo -69.82 -21.82 32.66 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.687 2.258 . . . . 74.340000000000003 112.297 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.67 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -46.65 -45.19 19.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 74.340000000000003 111.12 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.639 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -87.47 36.92 0.76 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.237 -0.438 . . . . 75.530000000000001 110.936 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.492 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 4.1 p -52.34 124.37 4.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 74.349999999999994 111.128 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.57 -89.05 0.73 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.791 -0.719 . . . . 34.350000000000001 112.47 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.426 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -119.52 111.24 17.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.82 0.343 . . . . 43.299999999999997 110.934 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.639 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -58.38 108.0 1.15 Allowed Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.536 0.684 . . . . 60.0 111.149 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.437 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.5 Cg_endo -69.83 162.59 41.51 Favored 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.65 2.234 . . . . 74.299999999999997 112.366 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -58.0 -27.05 63.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.242 -0.435 . . . . 62.329999999999998 110.916 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.82 -52.39 65.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.454 . . . . 71.230000000000004 111.079 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.67 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 16.5 mmt180 -69.09 -41.18 77.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.473 . . . . 71.549999999999997 110.908 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.467 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -60.66 -53.54 56.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.118 -0.492 . . . . 65.150000000000006 110.836 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.9 mtp85 -66.68 -33.35 75.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 75.25 110.87 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.3 mmt -60.81 -49.69 76.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.217 -0.447 . . . . 73.420000000000002 110.833 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.605 ' O ' HG22 ' A' ' 67' ' ' THR . 19.2 m -65.21 -43.0 95.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 75.120000000000005 111.166 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.98 ' CE1' HD13 ' A' ' 81' ' ' LEU . 15.0 m-85 -61.9 -37.92 86.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 75.109999999999999 110.887 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.24 -33.16 59.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 52.43 111.088 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 64' ' ' VAL . 0.6 OUTLIER -72.15 -29.63 64.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.264 -0.425 . . . . 73.150000000000006 111.115 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.565 HD21 ' HA ' ' A' ' 65' ' ' TYR . 3.9 pp -83.33 -6.78 59.58 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.213 -0.448 . . . . 75.219999999999999 110.913 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.47 69.62 1.09 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.782 -0.723 . . . . 64.319999999999993 112.433 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.726 ' HG3' ' HB2' ' A' ' 75' ' ' ALA . 2.4 tp10 -98.75 -23.51 15.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.956 0.408 . . . . 75.099999999999994 110.957 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.729 HD22 ' HB2' ' A' ' 75' ' ' ALA . 4.6 mm? -90.31 3.39 53.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.118 -0.492 . . . . 74.209999999999994 110.916 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 81.7 mtp -71.93 -13.31 61.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.217 -0.447 . . . . 74.409999999999997 110.865 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -142.27 -31.5 0.12 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.738 -0.744 . . . . 64.340000000000003 112.505 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 154.26 109.14 0.34 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.804 -0.712 . . . . 44.450000000000003 112.523 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.729 ' HB2' HD22 ' A' ' 71' ' ' LEU . . . -87.56 123.19 32.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.774 0.321 . . . . 60.140000000000001 111.088 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 77' ' ' HIS . 4.5 mp -113.89 163.25 11.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.193 -0.458 . . . . 72.329999999999998 111.109 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.574 ' N ' HG22 ' A' ' 76' ' ' ILE . 35.4 p-80 -72.11 2.76 5.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.329999999999998 110.848 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 42' ' ' HIS . . . -88.94 21.52 3.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.226 -0.443 . . . . 71.329999999999998 111.13 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.764 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 8.5 tp -97.58 133.25 42.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.454 . . . . 73.120000000000005 110.937 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -111.35 115.18 28.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.241 -0.436 . . . . 72.519999999999996 110.946 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.98 HD13 ' CE1' ' A' ' 65' ' ' TYR . 7.4 tt -139.77 137.74 35.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 71.329999999999998 110.88 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.449 ' HD3' ' N ' ' A' ' 82' ' ' LYS . 2.3 mppt? -136.35 128.16 29.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 74.010000000000005 110.907 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.535 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 63.9 p -113.48 106.95 15.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.26 -0.427 . . . . 71.209999999999994 111.103 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 28.9 mt -125.99 161.69 26.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 73.219999999999999 110.946 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.492 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.94 163.99 62.29 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.608 0.718 . . . . 75.120000000000005 111.171 179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.4 Cg_endo -69.66 -21.96 33.2 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.787 2.325 . . . . 74.450000000000003 112.288 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -70.66 -35.94 73.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 74.439999999999998 110.905 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.7 -33.89 76.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 63.149999999999999 110.916 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.47 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 62.43 111.106 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.3 tpt . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.714 0.292 . . . . 75.109999999999999 110.926 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -81.52 -49.85 10.09 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 70.040000000000006 110.86 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -161.22 146.5 13.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 72.209999999999994 110.908 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 67.6 mtm180 -120.7 81.99 33.71 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.577 0.703 . . . . 70.329999999999998 110.91 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.73 -51.4 0.39 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.663 2.242 . . . . 63.520000000000003 112.335 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.0 tp 61.53 53.12 3.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 75.430000000000007 110.956 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -134.94 -70.01 0.5 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.228 -0.442 . . . . 72.219999999999999 110.905 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.092 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . -68.29 -34.5 76.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 55.409999999999997 111.089 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -70.22 -48.43 57.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 72.140000000000001 110.888 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.489 HG23 ' N ' ' A' ' 20' ' ' ILE . 2.8 t -59.17 -51.13 71.34 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 63.229999999999997 111.143 -179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.025 HD11 HG11 ' A' ' 35' ' ' VAL . 2.6 pp -64.83 -40.7 89.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 72.450000000000003 111.187 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.632 ' N ' HD12 ' A' ' 20' ' ' ILE . 73.9 ttt180 -60.92 -46.26 91.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 63.539999999999999 110.87 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -63.51 -42.66 98.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.17 -0.468 . . . . 64.329999999999998 110.888 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.413 HD23 ' HA ' ' A' ' 23' ' ' LEU . 16.5 mt -57.53 -49.11 77.42 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.208 -0.451 . . . . 74.200000000000003 110.939 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.792 ' CG2' HG21 ' A' ' 33' ' ' VAL . 49.2 mm -63.18 -46.71 95.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 72.409999999999997 111.147 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -55.11 -40.23 70.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 73.230000000000004 110.846 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.04 -43.24 71.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 72.400000000000006 110.867 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.99 -49.13 60.3 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.776 -0.726 . . . . 73.439999999999998 112.525 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -80.55 157.16 72.77 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.53 0.681 . . . . 64.219999999999999 110.972 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.76 -90.62 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.685 2.256 . . . . 54.329999999999998 112.323 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -107.41 29.57 7.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 64.420000000000002 110.882 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.411 ' HB2' ' HB2' ' A' ' 49' ' ' SER . . . -75.02 133.09 41.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 72.140000000000001 111.084 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.702 ' HB3' HG12 ' A' ' 48' ' ' VAL . 7.0 tpp180 -99.98 111.14 23.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 73.439999999999998 110.927 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.852 HG13 HG22 ' A' ' 47' ' ' VAL . 32.3 t -113.86 124.98 71.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 62.520000000000003 111.107 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -134.69 118.15 16.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 63.329999999999998 110.889 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.092 HG13 ' HB1' ' A' ' 17' ' ' ALA . 4.9 p -130.43 136.33 58.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 35.409999999999997 111.134 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -133.32 120.21 20.72 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.172 -0.467 . . . . 71.230000000000004 110.928 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.47 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 149.67 -145.19 13.09 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.703 -0.761 . . . . 72.209999999999994 112.461 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.403 ' O ' HG12 ' A' ' 41' ' ' VAL . 18.9 mt-10 -156.1 176.98 11.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.825 0.345 . . . . 71.0 110.939 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -80.06 139.87 36.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 74.030000000000001 110.895 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.432 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.67 25.7 73.38 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.772 -0.727 . . . . 54.020000000000003 112.463 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.471 ' HA ' ' CD1' ' A' ' 76' ' ' ILE . 1.2 p -148.91 164.7 4.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.895 0.379 . . . . 75.540000000000006 111.079 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.423 ' CD2' ' O ' ' A' ' 42' ' ' HIS . 7.4 p-80 -74.97 107.44 7.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 71.230000000000004 110.853 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.83 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 4.4 p90 -123.88 167.14 14.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.3 -0.409 . . . . 74.140000000000001 110.92 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -118.75 121.73 40.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 53.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 81' ' ' LEU . . . -126.42 114.9 18.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 61.130000000000003 111.103 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 m -111.58 117.19 32.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.218 -0.446 . . . . 71.120000000000005 111.182 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.852 HG22 HG13 ' A' ' 33' ' ' VAL . 84.8 t -115.65 132.99 63.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 73.129999999999995 111.169 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.702 HG12 ' HB3' ' A' ' 32' ' ' ARG . 5.6 p -128.79 120.37 52.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 73.049999999999997 111.149 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.448 ' C ' ' HD3' ' A' ' 86' ' ' PRO . 0.9 OUTLIER -167.31 164.82 9.31 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.711 0.767 . . . . 74.510000000000005 110.803 -179.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.515 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.6 Cg_endo -69.78 -19.1 36.48 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.685 2.256 . . . . 63.200000000000003 112.363 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.798 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -47.19 -41.61 18.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.221 -0.445 . . . . 63.0 111.043 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.657 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -91.87 38.23 0.99 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 71.319999999999993 110.895 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.492 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 4.8 p -53.03 123.27 3.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 71.140000000000001 111.156 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.92 -90.61 0.68 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.689 -0.767 . . . . 75.310000000000002 112.532 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.452 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 1.3 mptp? -117.11 110.29 18.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.815 0.341 . . . . 72.019999999999996 110.855 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.657 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -58.52 107.44 0.95 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.526 0.679 . . . . 61.340000000000003 111.092 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.1 Cg_endo -69.85 166.01 29.15 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.676 2.251 . . . . 71.400000000000006 112.312 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tp -59.34 -26.75 65.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.185 -0.461 . . . . 74.519999999999996 110.929 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.61 -52.22 66.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 74.230000000000004 111.099 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.798 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 18.9 mmt180 -69.59 -41.09 76.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 72.329999999999998 110.829 -179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.498 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -58.78 -52.59 65.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.275 -0.421 . . . . 74.209999999999994 110.836 179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -66.42 -37.26 84.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 62.229999999999997 110.916 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 20.2 mmm -56.44 -52.07 66.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.121 -0.49 . . . . 71.120000000000005 110.895 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.632 ' O ' HG22 ' A' ' 67' ' ' THR . 17.4 m -62.95 -44.44 99.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 65.219999999999999 111.072 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 1.055 ' CE1' HD13 ' A' ' 81' ' ' LEU . 14.3 m-85 -60.98 -30.81 70.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 71.450000000000003 110.938 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.02 -46.76 32.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.089 -0.505 . . . . 73.409999999999997 111.08 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.632 HG22 ' O ' ' A' ' 64' ' ' VAL . 3.8 t -63.9 -28.8 70.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 60.119999999999997 111.115 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.863 HD23 HD13 ' A' ' 20' ' ' ILE . 9.9 mt -82.17 5.58 19.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.241 -0.436 . . . . 64.239999999999995 110.854 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 34.07 67.59 0.24 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.736 -0.745 . . . . 72.230000000000004 112.484 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.639 ' HG3' HD13 ' A' ' 71' ' ' LEU . 5.8 pt-20 -85.41 -39.48 17.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.892 0.377 . . . . 72.310000000000002 110.847 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.639 HD13 ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -91.03 7.38 40.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 71.430000000000007 110.904 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.412 ' N ' HD22 ' A' ' 71' ' ' LEU . 19.8 mtt -73.06 -12.93 61.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.176 -0.465 . . . . 54.420000000000002 110.889 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -143.15 -32.15 0.1 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.725 -0.75 . . . . 74.010000000000005 112.49 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.432 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . 135.52 54.48 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.778 -0.725 . . . . 31.34 112.514 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 70' ' ' GLU . . . -58.81 145.16 41.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.715 0.293 . . . . 70.239999999999995 111.104 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.494 ' H ' HD12 ' A' ' 76' ' ' ILE . 3.0 mp -97.11 148.42 5.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 64.010000000000005 111.164 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -48.07 -17.34 0.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 74.409999999999997 110.843 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.417 ' N ' ' C ' ' A' ' 76' ' ' ILE . . . -74.78 48.7 0.38 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.26 -0.427 . . . . 62.439999999999998 111.039 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.83 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 7.8 tp -107.96 128.18 54.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.272 -0.422 . . . . 72.209999999999994 110.902 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -102.45 115.0 29.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 73.450000000000003 110.957 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.055 HD13 ' CE1' ' A' ' 65' ' ' TYR . 8.6 tt -139.76 135.86 33.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.241 -0.436 . . . . 64.340000000000003 110.899 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 11.2 mptt -136.49 131.63 34.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 73.439999999999998 110.949 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.544 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 67.1 p -116.69 106.8 13.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 43.009999999999998 111.155 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.2 mp -124.05 161.81 24.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.247 -0.433 . . . . 72.319999999999993 110.96 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.492 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -71.8 163.41 66.78 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.546 0.689 . . . . 72.409999999999997 111.175 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.2 Cg_endo -69.78 -10.32 28.25 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.749 2.3 . . . . 72.040000000000006 112.349 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -76.0 -35.89 59.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 63.450000000000003 110.821 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -68.19 -36.06 78.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.264 -0.426 . . . . 71.329999999999998 110.898 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.452 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.154 -0.475 . . . . 71.140000000000001 111.122 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 2.8 ttt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.739 0.304 . . . . 71.329999999999998 110.913 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -151.96 116.86 5.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 60.130000000000003 110.897 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -63.51 111.8 2.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.447 . . . . 64.519999999999996 110.876 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 29.3 ttp180 -76.13 114.86 41.62 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.619 0.723 . . . . 75.519999999999996 110.843 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 174.0 10.12 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.658 2.239 . . . . 75.219999999999999 112.389 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.401 HD23 ' H ' ' A' ' 15' ' ' LEU . 1.3 pt? -121.18 -11.51 8.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.272 -0.422 . . . . 63.43 110.918 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 52.5 m-20 -102.78 -53.61 2.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 72.430000000000007 110.874 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 35' ' ' VAL . . . -63.23 -27.95 69.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.196 -0.456 . . . . 73.340000000000003 111.062 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.501 ' OE1' ' NE ' ' A' ' 21' ' ' ARG . 4.3 mm-40 -68.65 -26.55 65.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 73.310000000000002 110.854 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 15.7 p -61.4 -56.91 15.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 73.420000000000002 111.1 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.58 HG12 ' N ' ' A' ' 21' ' ' ARG . 0.2 OUTLIER -74.06 -29.91 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.248 -0.433 . . . . 55.140000000000001 111.1 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.58 ' N ' HG12 ' A' ' 20' ' ' ILE . 23.7 ttp85 -63.37 -50.86 68.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 60.43 110.851 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 30.5 mtmt -72.79 -36.13 67.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 71.409999999999997 110.897 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.648 HD13 ' O ' ' A' ' 23' ' ' LEU . 0.6 OUTLIER -57.91 -51.04 71.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 71.239999999999995 110.851 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.795 HG21 HG21 ' A' ' 33' ' ' VAL . 8.6 mt -73.5 -44.16 54.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 72.040000000000006 111.17 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.444 ' CG ' ' O ' ' A' ' 21' ' ' ARG . 68.0 mt-10 -56.51 -32.22 64.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 71.430000000000007 110.874 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.27 -43.23 17.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 74.010000000000005 110.83 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.44 -41.89 97.29 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.737 -0.744 . . . . 73.420000000000002 112.548 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.459 ' HA ' HD13 ' A' ' 28' ' ' LEU . 3.8 mm? -122.94 102.41 37.88 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.648 0.737 . . . . 64.230000000000004 110.915 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 28' ' ' LEU . 53.9 Cg_endo -69.7 -15.02 37.09 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.687 2.258 . . . . 71.209999999999994 112.3 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -100.16 0.83 41.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.297 -0.411 . . . . 73.549999999999997 110.86 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.505 ' HB2' ' HB2' ' A' ' 49' ' ' SER . . . -120.58 135.7 55.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 64.430000000000007 111.108 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.476 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 47.1 ttt-85 -110.44 123.73 50.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.261 -0.427 . . . . 74.200000000000003 110.926 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.142 HG13 HG22 ' A' ' 47' ' ' VAL . 4.8 t -122.37 134.3 66.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.281 -0.418 . . . . 74.040000000000006 111.139 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -135.35 118.08 16.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 75.420000000000002 110.912 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.6 ' O ' ' HB1' ' A' ' 17' ' ' ALA . 43.4 t -123.62 130.4 74.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.451 . . . . 75.510000000000005 111.104 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.401 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 20.8 mm100 -133.34 120.15 20.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 71.400000000000006 110.889 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 149.07 -119.97 1.12 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.712 -0.756 . . . . 73.340000000000003 112.437 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -172.19 170.43 5.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.808 0.337 . . . . 74.420000000000002 110.903 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -80.35 145.55 32.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.236 -0.438 . . . . 72.120000000000005 110.908 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.474 ' CA ' ' O ' ' A' ' 73' ' ' GLY . . . 72.7 -0.94 40.69 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.747 -0.739 . . . . 65.230000000000004 112.487 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 42' ' ' HIS . 2.3 t -123.13 165.19 19.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.852 0.358 . . . . 75.340000000000003 111.186 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.454 ' H ' HG12 ' A' ' 41' ' ' VAL . 53.9 p-80 -74.67 106.45 6.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 72.400000000000006 110.857 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.796 ' CE2' HD11 ' A' ' 79' ' ' LEU . 8.6 p90 -120.55 168.06 11.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 73.239999999999995 110.912 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -113.2 121.22 43.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 74.349999999999994 110.859 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -125.67 126.99 45.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.103 -0.499 . . . . 61.020000000000003 111.093 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 60.7 m -120.96 120.64 36.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 63.240000000000002 111.146 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.142 HG22 HG13 ' A' ' 33' ' ' VAL . 78.2 t -119.45 136.76 55.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 54.43 111.119 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.476 ' CG1' ' HB3' ' A' ' 32' ' ' ARG . 7.2 p -136.17 124.28 35.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 74.400000000000006 111.156 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.505 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -174.62 164.74 2.45 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.624 0.725 . . . . 55.119999999999997 110.879 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.524 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.2 Cg_endo -69.71 -19.96 35.68 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.653 2.236 . . . . 54.0 112.369 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.743 ' HB1' ' HD3' ' A' ' 60' ' ' ARG . . . -47.47 -40.51 18.53 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 111.08 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.748 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.5 OUTLIER -92.22 37.64 0.99 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 74.420000000000002 110.907 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.495 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 2.6 p -52.82 136.0 14.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 54.219999999999999 111.136 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 60.37 -89.09 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.765 -0.731 . . . . 64.109999999999999 112.455 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.431 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 3.6 mptp? -119.28 111.08 17.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.746 0.308 . . . . 70.310000000000002 110.932 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.748 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -58.46 107.99 1.15 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.607 0.718 . . . . 72.019999999999996 111.071 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.8 Cg_endo -69.76 164.23 35.33 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.665 2.244 . . . . 74.019999999999996 112.375 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.415 HD23 ' O ' ' A' ' 58' ' ' LEU . 1.6 tt -57.64 -24.85 58.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.289 -0.414 . . . . 63.100000000000001 110.887 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.406 ' O ' ' SD ' ' A' ' 63' ' ' MET . . . -61.91 -52.75 62.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 63.32 111.099 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.743 ' HD3' ' HB1' ' A' ' 51' ' ' ALA . 0.5 OUTLIER -69.08 -40.7 78.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 74.450000000000003 110.875 -179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.561 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 1.1 t60 -58.85 -53.98 52.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.444 . . . . 73.430000000000007 110.826 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 27.3 mtp180 -66.2 -35.53 80.69 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 74.209999999999994 110.868 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.609 ' O ' HG22 ' A' ' 67' ' ' THR . 0.0 OUTLIER -58.33 -46.22 86.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 44.310000000000002 110.88 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.715 HG21 HD21 ' A' ' 81' ' ' LEU . 17.1 m -69.15 -40.22 80.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 72.150000000000006 111.185 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 1.059 ' CE1' HD22 ' A' ' 81' ' ' LEU . 14.2 m-85 -64.93 -35.89 82.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 75.409999999999997 110.92 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.3 -46.63 39.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 71.530000000000001 111.115 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.62 HG23 HD13 ' A' ' 68' ' ' LEU . 6.0 t -66.04 -28.47 68.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 75.230000000000004 111.107 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.62 HD13 HG23 ' A' ' 67' ' ' THR . 5.2 mp -82.32 7.66 13.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.247 -0.433 . . . . 72.329999999999998 110.917 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 35.71 68.79 0.26 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.786 -0.721 . . . . 65.109999999999999 112.402 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.712 ' HG3' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -102.38 -24.62 13.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.879 0.371 . . . . 72.239999999999995 110.845 -179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.712 HD22 ' HG3' ' A' ' 70' ' ' GLU . 3.0 mm? -86.75 -21.0 26.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 63.25 110.902 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 10.2 ttm -76.22 -12.59 60.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 74.040000000000006 110.867 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.474 ' O ' ' CA ' ' A' ' 40' ' ' GLY . . . -120.47 -9.19 7.95 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.746 -0.74 . . . . 40.329999999999998 112.455 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 79.53 43.03 10.69 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.762 -0.733 . . . . 74.129999999999995 112.483 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.89 127.6 33.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.732 0.301 . . . . 62.140000000000001 111.096 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.584 HG22 ' N ' ' A' ' 77' ' ' HIS . 26.1 mm -71.25 163.32 3.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 75.129999999999995 111.077 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.584 ' N ' HG22 ' A' ' 76' ' ' ILE . 80.3 m-70 -55.69 -12.63 1.31 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.09 -0.505 . . . . 73.010000000000005 110.897 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.31 47.94 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.458 . . . . 53.439999999999998 111.138 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.796 HD11 ' CE2' ' A' ' 43' ' ' PHE . 8.8 tp -110.2 138.43 46.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 75.519999999999996 110.928 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.9 mm100 -104.62 117.07 33.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 61.509999999999998 110.891 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.059 HD22 ' CE1' ' A' ' 65' ' ' TYR . 1.9 tp -139.33 123.51 17.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.183 -0.462 . . . . 63.109999999999999 110.886 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -126.87 123.3 36.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 75.209999999999994 110.891 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.533 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 4.9 p -113.22 107.25 15.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 64.030000000000001 111.186 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.7 mp -129.81 161.59 30.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 51.539999999999999 110.924 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.495 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.9 164.04 61.8 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-O 121.614 0.721 . . . . 71.219999999999999 111.102 179.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.524 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.9 Cg_endo -69.71 -23.75 30.67 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.714 2.276 . . . . 63.210000000000001 112.296 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -67.44 -34.9 78.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 72.219999999999999 110.891 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -65.08 -33.18 75.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.206 -0.452 . . . . 71.219999999999999 110.876 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 64.239999999999995 111.09 179.941 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.714 0.292 . . . . 73.349999999999994 110.863 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.404 ' HD3' ' N ' ' A' ' 11' ' ' ARG . 1.7 mpp_? -109.02 163.59 13.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.256 -0.429 . . . . 73.420000000000002 110.864 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -169.03 177.91 4.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.162 -0.472 . . . . 74.099999999999994 110.94 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.449 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 11.8 mmp_? 51.5 53.45 13.36 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.616 0.722 . . . . 73.409999999999997 110.864 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.449 ' CD ' ' N ' ' A' ' 13' ' ' ARG . 54.0 Cg_endo -69.7 108.22 2.02 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.71 2.274 . . . . 73.319999999999993 112.411 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.2 tp -113.5 -72.53 0.7 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 74.409999999999997 110.915 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.463 ' O ' HG23 ' A' ' 20' ' ' ILE . 12.0 m-20 -128.63 -66.54 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 42.020000000000003 110.87 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.1 -36.28 79.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 74.439999999999998 111.048 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.4 ' HB2' ' HA ' ' A' ' 14' ' ' PRO . 50.2 mm-40 -71.54 -48.01 51.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.243 -0.435 . . . . 70.409999999999997 110.92 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.572 ' O ' HD23 ' A' ' 23' ' ' LEU . 3.0 t -57.96 -51.7 68.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 52.32 111.177 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.866 HD12 ' HG ' ' A' ' 68' ' ' LEU . 16.2 pt -66.06 -41.9 90.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 73.010000000000005 111.168 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.425 ' N ' HG13 ' A' ' 20' ' ' ILE . 67.3 ttt180 -60.45 -53.58 55.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.113 -0.494 . . . . 73.430000000000007 110.912 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.456 ' CG ' ' N ' ' A' ' 23' ' ' LEU . 23.2 pttt -59.43 -44.83 92.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.171 -0.468 . . . . 75.310000000000002 110.861 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.572 HD23 ' O ' ' A' ' 19' ' ' THR . 2.1 mm? -55.96 -49.12 74.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.242 -0.435 . . . . 53.32 110.867 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.797 ' CG2' HG21 ' A' ' 33' ' ' VAL . 7.1 mt -68.17 -44.12 84.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 63.350000000000001 111.113 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -54.79 -37.85 66.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.196 -0.456 . . . . 75.439999999999998 110.874 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -78.1 -41.31 35.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 70.340000000000003 110.866 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.31 -53.82 33.7 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.701 -0.761 . . . . 72.230000000000004 112.483 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.402 ' CB ' ' HB3' ' A' ' 31' ' ' ALA . 4.2 mm? -76.94 159.13 79.29 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.533 0.682 . . . . 74.450000000000003 110.985 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.78 -87.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.676 2.25 . . . . 71.430000000000007 112.369 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -111.02 26.12 11.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 75.200000000000003 110.889 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.492 ' HB2' ' HB2' ' A' ' 49' ' ' SER . . . -73.31 125.85 28.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 54.039999999999999 111.085 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.61 ' HB2' HG13 ' A' ' 48' ' ' VAL . 2.4 mmt180 -91.77 107.52 19.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 65.129999999999995 110.984 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.814 HG13 HG22 ' A' ' 47' ' ' VAL . 61.6 t -109.83 121.33 62.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.228 -0.442 . . . . 55.329999999999998 111.132 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -132.38 118.88 19.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 73.230000000000004 110.876 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 44.8 t -126.79 136.98 59.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 72.310000000000002 111.146 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 34.9 mt-30 -130.67 120.5 24.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.159 -0.473 . . . . 71.409999999999997 110.886 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.438 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 140.63 -142.08 11.99 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.672 -0.775 . . . . 71.120000000000005 112.491 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.484 ' HG2' ' CG2' ' A' ' 41' ' ' VAL . 1.0 OUTLIER -165.29 156.04 13.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.886 0.374 . . . . 72.239999999999995 110.84 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -62.26 154.51 27.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.092 -0.504 . . . . 75.530000000000001 110.863 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.85 -2.59 40.61 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.676 -0.773 . . . . 75.120000000000005 112.524 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.484 ' CG2' ' HG2' ' A' ' 38' ' ' GLU . 1.3 t -132.52 164.76 34.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.328 . . . . 71.299999999999997 111.174 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.598 ' CD2' ' O ' ' A' ' 42' ' ' HIS . 0.6 OUTLIER -75.02 106.72 6.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 72.150000000000006 110.825 179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.551 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 39.7 p90 -121.98 167.79 12.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 74.109999999999999 110.846 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -113.26 133.52 55.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 74.140000000000001 110.89 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.466 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -128.09 118.84 24.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 60.299999999999997 111.17 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.2 m -121.4 111.5 17.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 72.430000000000007 111.149 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.814 HG22 HG13 ' A' ' 33' ' ' VAL . 94.9 t -120.74 134.73 63.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 71.120000000000005 111.097 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.61 HG13 ' HB2' ' A' ' 32' ' ' ARG . 3.6 p -131.05 122.72 52.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.15 -0.477 . . . . 74.120000000000005 111.111 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.492 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -161.83 165.6 15.91 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.628 0.728 . . . . 73.5 110.874 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.515 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 52.9 Cg_endo -69.93 -22.14 31.7 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.728 2.285 . . . . 65.150000000000006 112.215 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.614 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -47.04 -44.29 20.52 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 43.109999999999999 111.079 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.676 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -87.11 35.56 0.7 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 73.420000000000002 110.902 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.481 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 12.4 p -52.26 125.86 6.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.073 -0.512 . . . . 73.25 111.138 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.5 -89.4 0.73 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.712 -0.756 . . . . 55.130000000000003 112.51 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.423 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 3.3 mptp? -120.3 110.23 16.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.809 0.338 . . . . 73.329999999999998 110.871 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.676 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -58.64 108.15 1.21 Allowed Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.563 0.697 . . . . 62.420000000000002 111.08 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.8 Cg_endo -69.83 161.59 45.36 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.728 2.285 . . . . 62.43 112.36 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.87 -27.25 63.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.28 -0.418 . . . . 61.039999999999999 110.925 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.27 -52.16 66.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.144 -0.48 . . . . 54.420000000000002 111.092 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.614 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 23.2 mmt180 -69.18 -43.0 75.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 60.240000000000002 110.856 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.551 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.2 OUTLIER -59.17 -51.49 69.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.457 . . . . 75.230000000000004 110.849 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -66.15 -38.64 88.6 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 74.439999999999998 110.902 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 21.8 mmt -56.29 -48.27 76.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 74.549999999999997 110.919 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 61' ' ' HIS . 16.3 m -65.31 -39.54 85.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 34.25 111.117 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.572 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 12.4 m-85 -59.58 -39.81 85.31 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 65.239999999999995 110.91 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.06 -46.96 31.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 74.450000000000003 111.133 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.556 HG23 HD12 ' A' ' 68' ' ' LEU . 0.9 OUTLIER -61.66 -31.32 71.42 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.238 -0.437 . . . . 74.420000000000002 111.145 -179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.866 ' HG ' HD12 ' A' ' 20' ' ' ILE . 7.3 mp -83.04 -4.3 58.18 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 72.510000000000005 110.929 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.75 69.37 1.28 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.705 -0.76 . . . . 62.200000000000003 112.535 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -85.31 -40.5 16.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.824 0.345 . . . . 64.209999999999994 110.911 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.408 ' N ' HD12 ' A' ' 71' ' ' LEU . 8.4 mp -87.87 9.87 20.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 64.230000000000004 110.916 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 11.6 mmt -72.01 -13.14 61.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.178 -0.464 . . . . 65.329999999999998 110.909 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.92 -32.91 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.77 -0.729 . . . . 73.310000000000002 112.528 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.76 106.23 0.31 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.745 -0.74 . . . . 64.230000000000004 112.465 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -85.69 123.76 31.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.718 0.294 . . . . 70.5 111.113 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.582 HG22 ' N ' ' A' ' 77' ' ' HIS . 4.7 mp -113.36 163.26 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.258 -0.428 . . . . 54.149999999999999 111.083 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.582 ' N ' HG22 ' A' ' 76' ' ' ILE . 43.8 m-70 -60.86 -9.07 3.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.088 -0.506 . . . . 73.349999999999994 110.871 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' A' ' 42' ' ' HIS . . . -83.86 27.1 0.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 43.140000000000001 111.075 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.551 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 1.6 mm? -97.83 140.43 32.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.256 -0.429 . . . . 71.310000000000002 110.939 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -118.21 115.62 25.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 75.019999999999996 111.016 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.572 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 0.6 OUTLIER -130.85 116.57 18.1 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 74.299999999999997 110.862 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -126.01 122.19 35.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 75.049999999999997 110.944 179.788 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.528 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 69.2 p -115.62 107.34 14.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.289 -0.414 . . . . 71.209999999999994 111.172 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 84' ' ' LEU . 1.6 mm? -127.75 162.06 27.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 63.149999999999999 110.894 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.481 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.02 163.29 68.17 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-O 121.639 0.733 . . . . 63.030000000000001 111.12 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.9 Cg_endo -69.72 -7.49 21.18 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.693 2.262 . . . . 74.540000000000006 112.363 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 45.6 t0 -84.58 -30.77 24.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.19 -0.459 . . . . 43.109999999999999 110.828 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -84.79 28.24 0.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.224 -0.444 . . . . 62.030000000000001 110.876 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 72.400000000000006 111.072 179.934 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.771 0.32 . . . . 60.520000000000003 110.905 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.483 ' CZ ' ' HB2' ' A' ' 22' ' ' LYS . 18.8 ptt180 -119.1 93.3 4.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.27 -0.423 . . . . 65.519999999999996 110.864 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 45.9 mmtt -99.58 -48.93 4.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 70.349999999999994 110.923 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.472 ' O ' ' CD2' ' A' ' 15' ' ' LEU . 8.8 ptt-85 -116.21 86.25 17.03 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.639 0.733 . . . . 74.239999999999995 110.918 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.556 ' C ' HD22 ' A' ' 15' ' ' LEU . 53.8 Cg_endo -69.74 136.4 32.96 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.628 2.219 . . . . 64.530000000000001 112.362 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.556 HD22 ' C ' ' A' ' 14' ' ' PRO . 3.7 mm? -116.5 -68.22 0.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.202 -0.454 . . . . 72.340000000000003 110.948 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -133.29 -68.06 0.6 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 70.099999999999994 110.814 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.484 ' HA ' ' CD1' ' A' ' 20' ' ' ILE . . . -68.0 -25.06 65.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.443 . . . . 55.130000000000003 111.091 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.432 ' CB ' ' HA ' ' A' ' 14' ' ' PRO . 12.6 mt-10 -72.65 -48.8 36.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 72.340000000000003 110.856 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.438 HG23 ' N ' ' A' ' 20' ' ' ILE . 2.9 t -61.59 -47.63 84.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 51.310000000000002 111.151 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.491 HD11 HG11 ' A' ' 35' ' ' VAL . 10.8 pt -67.8 -43.13 86.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.48 . . . . 72.540000000000006 111.149 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.403 ' N ' HG13 ' A' ' 20' ' ' ILE . 55.1 ttt-85 -54.97 -52.91 61.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 74.310000000000002 110.838 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 11' ' ' ARG . 13.4 ptpt -65.42 -37.05 85.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 61.399999999999999 110.838 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.76 -50.26 72.82 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.167 -0.47 . . . . 72.049999999999997 110.844 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.644 ' HB ' HG21 ' A' ' 33' ' ' VAL . 7.9 mt -72.51 -36.31 53.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.197 -0.456 . . . . 73.120000000000005 111.131 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.496 ' HG3' HG23 ' A' ' 33' ' ' VAL . 19.7 mt-10 -58.92 -38.3 78.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 70.430000000000007 110.845 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -80.84 -42.11 22.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.107 -0.497 . . . . 71.200000000000003 110.846 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.37 -42.48 99.12 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.751 -0.738 . . . . 62.119999999999997 112.525 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.487 ' CB ' ' HB3' ' A' ' 31' ' ' ALA . 3.6 mm? -89.88 157.29 46.3 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.556 0.693 . . . . 73.329999999999998 110.962 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -91.22 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.662 2.241 . . . . 55.520000000000003 112.306 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -104.58 27.11 8.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.252 -0.431 . . . . 74.099999999999994 110.907 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.49 ' HB2' ' HB2' ' A' ' 49' ' ' SER . . . -77.61 132.25 38.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.18 -0.464 . . . . 75.409999999999997 111.053 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.656 ' HB3' HG12 ' A' ' 48' ' ' VAL . 7.9 ttm-85 -101.35 112.12 24.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.142 -0.481 . . . . 75.540000000000006 110.873 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.707 HG12 HG22 ' A' ' 47' ' ' VAL . 0.0 OUTLIER -107.32 129.32 61.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.202 -0.454 . . . . 73.049999999999997 111.093 179.998 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -135.73 118.53 16.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 74.099999999999994 110.895 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.491 HG11 HD11 ' A' ' 20' ' ' ILE . 28.9 t -127.66 129.86 70.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 71.400000000000006 111.205 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.409 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 31.4 mt-30 -133.25 120.15 20.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 65.109999999999999 110.933 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.474 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 151.0 -125.97 2.01 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.726 -0.75 . . . . 42.229999999999997 112.483 -179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -174.66 157.76 2.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.843 0.354 . . . . 74.099999999999994 110.909 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -68.41 144.16 54.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 74.430000000000007 110.854 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.76 22.26 79.16 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.705 -0.759 . . . . 54.310000000000002 112.56 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 1.5 t -150.63 164.79 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.866 0.365 . . . . 71.329999999999998 111.111 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 78' ' ' ALA . 28.1 p80 -75.09 106.66 6.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 74.439999999999998 110.831 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.895 ' CZ ' HD21 ' A' ' 79' ' ' LEU . 8.7 p90 -122.43 167.4 13.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.241 -0.436 . . . . 64.140000000000001 110.903 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -113.72 120.33 40.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 65.209999999999994 110.903 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.591 ' HB1' HD21 ' A' ' 68' ' ' LEU . . . -123.25 115.77 22.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 71.200000000000003 111.019 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.658 HG23 ' HB2' ' A' ' 82' ' ' LYS . 81.6 m -113.62 123.5 50.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 75.140000000000001 111.153 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.707 HG22 HG12 ' A' ' 33' ' ' VAL . 27.1 t -123.59 140.72 46.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 62.409999999999997 111.134 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.656 HG12 ' HB3' ' A' ' 32' ' ' ARG . 8.1 p -130.52 117.83 40.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 73.420000000000002 111.165 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.49 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -162.0 164.49 17.47 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.679 0.752 . . . . 72.349999999999994 110.855 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.544 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.3 Cg_endo -69.88 -22.05 32.06 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.631 2.221 . . . . 61.049999999999997 112.309 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.615 ' HB1' ' HE ' ' A' ' 60' ' ' ARG . . . -48.69 -44.53 38.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 61.119999999999997 111.133 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.659 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.5 OUTLIER -87.63 34.19 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 71.109999999999999 110.898 -179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 55' ' ' LYS . 7.6 p -52.41 131.63 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.102 -0.499 . . . . 71.329999999999998 111.109 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 56.08 -81.02 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.726 -0.75 . . . . 74.439999999999998 112.517 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.494 ' N ' ' O ' ' A' ' 53' ' ' VAL . 69.6 mmtt -113.3 134.27 54.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.796 0.331 . . . . 62.009999999999998 110.876 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.659 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -99.56 99.96 9.77 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.608 0.718 . . . . 73.319999999999993 111.1 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.4 Cg_endo -69.71 172.58 12.32 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.695 2.263 . . . . 51.119999999999997 112.333 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 tp -57.01 -27.49 61.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 52.149999999999999 110.913 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 63' ' ' MET . . . -57.3 -53.35 59.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 60.119999999999997 111.016 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.615 ' HE ' ' HB1' ' A' ' 51' ' ' ALA . 12.2 mmm180 -70.57 -42.24 71.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 60.240000000000002 110.838 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.516 ' CE1' HD23 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -57.12 -53.1 61.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 71.540000000000006 110.874 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 57.1 mtt180 -67.49 -38.86 84.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 73.239999999999995 110.903 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.463 ' C ' ' SD ' ' A' ' 63' ' ' MET . 0.7 OUTLIER -54.08 -48.02 71.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 75.209999999999994 110.853 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.772 ' O ' HD13 ' A' ' 68' ' ' LEU . 24.4 m -68.77 -40.64 81.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.172 -0.467 . . . . 62.210000000000001 111.156 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.891 ' CE1' HD13 ' A' ' 81' ' ' LEU . 10.5 m-85 -64.93 -34.84 79.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.206 -0.452 . . . . 65.239999999999995 110.936 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.75 -46.24 32.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.139 -0.482 . . . . 75.329999999999998 111.193 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.604 HG21 HG12 ' A' ' 24' ' ' ILE . 3.8 t -67.58 -25.67 65.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.193 -0.458 . . . . 54.009999999999998 111.108 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.772 HD13 ' O ' ' A' ' 64' ' ' VAL . 5.9 mp -82.48 -0.47 46.57 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.246 -0.434 . . . . 73.239999999999995 110.919 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 45.6 68.37 1.02 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.75 -0.738 . . . . 70.120000000000005 112.439 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.845 ' HG3' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -88.06 -25.57 22.99 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.813 0.339 . . . . 73.209999999999994 110.817 -179.864 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.845 HD23 ' HG3' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -89.64 7.12 38.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 73.049999999999997 110.963 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 3.4 mmt -73.15 -7.18 50.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 72.409999999999997 110.899 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.94 -35.04 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.703 -0.761 . . . . 73.200000000000003 112.492 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 131.63 64.26 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.767 -0.73 . . . . 71.319999999999993 112.517 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.475 ' CB ' ' HB2' ' A' ' 70' ' ' GLU . . . -59.0 129.1 40.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 52.020000000000003 111.109 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 77' ' ' HIS . 4.3 mp -88.89 163.22 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 74.040000000000006 111.094 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.574 ' N ' HG22 ' A' ' 76' ' ' ILE . 11.5 m80 -57.08 -12.27 2.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 73.25 110.822 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.468 ' HB3' ' HB3' ' A' ' 42' ' ' HIS . . . -82.79 39.61 0.63 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.263 -0.426 . . . . 64.519999999999996 111.092 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.895 HD21 ' CZ ' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -97.68 134.41 40.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.197 -0.456 . . . . 73.310000000000002 110.894 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.511 ' N ' HD13 ' A' ' 79' ' ' LEU . 8.5 mm-40 -106.95 118.67 37.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 71.430000000000007 110.984 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.891 HD13 ' CE1' ' A' ' 65' ' ' TYR . 4.5 tp -123.05 138.9 54.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.239 -0.437 . . . . 74.5 110.873 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.658 ' HB2' HG23 ' A' ' 46' ' ' THR . 2.5 mptt -132.36 118.46 19.42 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.164 -0.471 . . . . 64.420000000000002 110.933 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.53 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 11.8 p -118.91 107.35 13.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.466 . . . . 54.109999999999999 111.133 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.537 HD23 ' N ' ' A' ' 84' ' ' LEU . 0.1 OUTLIER -127.22 161.42 28.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.212 -0.449 . . . . 74.329999999999998 110.92 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.479 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -76.35 164.92 56.81 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.545 0.688 . . . . 74.519999999999996 111.166 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.5 Cg_endo -69.8 -0.15 6.52 Favored 'Trans proline' 0 C--N 1.341 0.142 0 C-N-CA 122.695 2.264 . . . . 71.540000000000006 112.36 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.09 -27.43 26.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.147 -0.479 . . . . 73.010000000000005 110.869 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -82.2 24.81 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 60.420000000000002 110.884 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.113 -0.494 . . . . 65.200000000000003 111.137 179.918 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.0 mtt . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.769 0.318 . . . . 75.239999999999995 110.827 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -124.03 32.21 5.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.301 -0.409 . . . . 72.420000000000002 110.83 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 19.3 tptt -80.59 42.56 0.61 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 75.319999999999993 110.919 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.479 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 15.5 mtt85 -72.54 -60.45 2.06 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.597 0.713 . . . . 74.439999999999998 110.885 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.563 ' C ' HD22 ' A' ' 15' ' ' LEU . 53.2 Cg_endo -69.73 -173.92 0.8 Allowed 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.683 2.256 . . . . 64.340000000000003 112.317 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.563 HD22 ' C ' ' A' ' 14' ' ' PRO . 4.0 mm? -120.99 -58.18 1.82 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.244 -0.435 . . . . 73.129999999999995 110.931 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.524 ' O ' HG23 ' A' ' 20' ' ' ILE . 17.6 t0 -78.55 -34.65 46.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 72.530000000000001 110.88 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 35' ' ' VAL . . . -68.43 -42.96 78.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 63.240000000000002 111.096 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.557 ' CD ' ' N ' ' A' ' 19' ' ' THR . 3.0 pp20? -66.77 -48.14 69.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 50.329999999999998 110.83 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.557 ' N ' ' CD ' ' A' ' 18' ' ' GLU . 3.7 t -57.74 -52.45 65.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 74.349999999999994 111.089 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.526 ' N ' HG23 ' A' ' 19' ' ' THR . 5.9 pt -67.84 -41.95 85.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 72.040000000000006 111.176 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.413 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 54.4 ttp180 -58.67 -51.47 69.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.129 -0.487 . . . . 53.439999999999998 110.868 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.1 pttp -63.79 -40.24 96.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.101 -0.499 . . . . 64.409999999999997 110.892 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 20.6 mt -56.32 -50.27 71.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.44 . . . . 71.230000000000004 110.898 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.662 HD11 ' CG2' ' A' ' 67' ' ' THR . 10.5 mt -69.53 -43.86 80.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.446 . . . . 52.130000000000003 111.112 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -55.64 -35.07 65.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.462 . . . . 71.439999999999998 110.868 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -79.18 -43.2 24.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 55.020000000000003 110.905 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.65 -34.38 88.77 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.695 -0.764 . . . . 73.209999999999994 112.524 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -96.63 158.98 32.76 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.545 0.688 . . . . 52.119999999999997 110.924 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.73 -90.52 0.0 OUTLIER 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.695 2.263 . . . . 64.329999999999998 112.4 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -107.87 33.46 4.08 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.204 -0.453 . . . . 55.310000000000002 110.912 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -83.67 133.87 34.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.134 -0.485 . . . . 72.239999999999995 111.138 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.654 ' HB3' HG12 ' A' ' 48' ' ' VAL . 39.8 ttt-85 -106.4 125.56 51.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 72.230000000000004 110.845 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.035 HG13 HG22 ' A' ' 47' ' ' VAL . 3.9 t -124.0 135.45 63.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 74.329999999999998 111.149 179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -135.26 118.46 16.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 72.010000000000005 110.889 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.437 ' O ' ' HB1' ' A' ' 17' ' ' ALA . 39.6 t -125.85 136.7 60.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 73.299999999999997 111.143 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 50.3 mm-40 -133.33 120.36 20.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.198 -0.456 . . . . 53.240000000000002 110.893 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 139.84 -143.21 13.46 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 64.120000000000005 112.461 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.422 ' HB2' HG21 ' A' ' 41' ' ' VAL . 17.8 mt-10 -151.19 -174.98 4.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.889 0.376 . . . . 75.219999999999999 110.845 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -87.77 146.79 25.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 73.209999999999994 110.888 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.437 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 73.24 1.14 56.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.766 -0.73 . . . . 62.310000000000002 112.476 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.422 HG21 ' HB2' ' A' ' 38' ' ' GLU . 2.6 m -125.21 165.19 22.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.864 0.364 . . . . 71.450000000000003 111.1 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.454 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 23.6 p80 -74.86 107.01 6.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 53.340000000000003 110.821 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.833 ' CE1' HD11 ' A' ' 79' ' ' LEU . 39.6 p90 -121.99 167.75 12.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.194 -0.457 . . . . 74.120000000000005 110.898 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -113.48 124.74 53.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 63.539999999999999 110.86 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -127.18 115.88 19.77 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.135 -0.484 . . . . 44.329999999999998 111.099 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.8 m -117.72 112.71 20.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 72.209999999999994 111.131 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.035 HG22 HG13 ' A' ' 33' ' ' VAL . 22.6 t -110.5 141.44 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.196 -0.457 . . . . 71.099999999999994 111.133 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.753 HG21 ' HB2' ' A' ' 89' ' ' ALA . 4.0 p -130.42 118.95 44.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 74.409999999999997 111.127 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.539 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 24.1 p -168.7 160.01 8.4 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.654 0.74 . . . . 74.430000000000007 110.923 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.581 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.4 Cg_endo -69.74 -18.65 36.96 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.659 2.239 . . . . 71.200000000000003 112.383 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.878 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -49.83 -38.47 35.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 61.240000000000002 111.077 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.811 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 1.3 m-85 -90.86 33.5 0.93 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 73.510000000000005 110.904 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.539 ' HA ' HG23 ' A' ' 85' ' ' THR . 10.9 p -52.18 146.82 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 74.299999999999997 111.122 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 52.17 -89.27 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.791 -0.719 . . . . 60.409999999999997 112.467 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -121.62 111.03 16.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.333 . . . . 74.209999999999994 110.87 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.811 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -59.67 108.28 1.33 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.58 0.705 . . . . 52.329999999999998 111.097 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.6 Cg_endo -69.76 161.55 45.48 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.695 2.263 . . . . 63.5 112.344 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -55.14 -24.76 27.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 61.439999999999998 110.921 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.33 -52.57 64.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 51.219999999999999 111.06 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.878 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 21.1 mmt180 -69.78 -41.01 75.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 75.420000000000002 110.84 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.557 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 1.0 OUTLIER -59.77 -53.01 62.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 73.530000000000001 110.908 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 -66.2 -35.64 80.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 71.25 110.813 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 13.2 ttt -59.09 -49.86 76.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.213 -0.449 . . . . 65.420000000000002 110.852 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.587 ' O ' HG22 ' A' ' 67' ' ' THR . 22.1 m -65.08 -41.43 91.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.257 -0.429 . . . . 71.439999999999998 111.136 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.595 ' HD1' HD21 ' A' ' 68' ' ' LEU . 12.8 m-85 -62.83 -36.89 84.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 72.120000000000005 110.921 -179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.73 -35.27 60.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 51.149999999999999 111.107 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.662 ' CG2' HD11 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -70.95 -30.17 66.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 74.230000000000004 111.121 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.595 HD21 ' HD1' ' A' ' 65' ' ' TYR . 4.0 pp -83.6 -3.79 58.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 73.230000000000004 110.912 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.68 63.4 3.72 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.799 -0.715 . . . . 74.340000000000003 112.422 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -70.03 -57.43 5.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.912 0.387 . . . . 72.129999999999995 110.875 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -84.79 8.65 16.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.115 -0.493 . . . . 73.140000000000001 110.888 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 20.7 ttt -78.17 -13.2 59.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 72.540000000000006 110.89 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.47 -32.2 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.708 -0.758 . . . . 51.229999999999997 112.506 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.437 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . 121.67 48.85 0.27 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.764 -0.731 . . . . 74.120000000000005 112.533 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -58.87 124.43 19.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.754 0.311 . . . . 71.120000000000005 111.115 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.523 HG22 ' N ' ' A' ' 77' ' ' HIS . 14.9 mm -83.29 163.29 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.447 . . . . 54.100000000000001 111.165 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.523 ' N ' HG22 ' A' ' 76' ' ' ILE . 5.2 p80 -50.61 -16.96 0.44 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 73.25 110.874 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.38 48.3 0.42 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 65.409999999999997 111.082 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.833 HD11 ' CE1' ' A' ' 43' ' ' PHE . 8.3 tp -113.04 147.53 37.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.235 -0.439 . . . . 74.129999999999995 110.99 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -113.71 119.33 37.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 72.549999999999997 110.837 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.58 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 0.5 OUTLIER -128.61 117.62 21.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.443 . . . . 75.0 110.889 179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.419 ' N ' HD13 ' A' ' 81' ' ' LEU . 15.4 mmtp -119.33 114.52 22.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 72.099999999999994 110.874 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.532 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 17.3 p -117.1 106.54 13.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 40.340000000000003 111.147 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mp -132.42 162.76 30.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 75.519999999999996 110.973 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.539 HG23 ' HA ' ' A' ' 53' ' ' VAL . 0.4 OUTLIER -71.12 165.39 48.34 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.615 0.721 . . . . 72.25 111.147 179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.1 Cg_endo -69.8 -24.8 29.09 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.729 2.286 . . . . 71.329999999999998 112.285 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -65.77 -32.31 73.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 63.520000000000003 110.83 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -70.03 -35.03 74.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.201 -0.454 . . . . 71.430000000000007 110.874 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.753 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 61.32 111.071 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.792 0.329 . . . . 73.409999999999997 110.884 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -141.14 105.91 4.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.16 -0.473 . . . . 70.450000000000003 110.873 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -107.71 -41.09 5.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 74.120000000000005 110.926 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.434 ' N ' ' CD ' ' A' ' 14' ' ' PRO . 12.4 mmt85 58.09 55.0 6.36 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.562 0.696 . . . . 72.340000000000003 110.815 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.434 ' CD ' ' N ' ' A' ' 13' ' ' ARG . 53.9 Cg_endo -69.84 170.68 16.1 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.673 2.249 . . . . 73.219999999999999 112.374 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.44 ' O ' HD12 ' A' ' 15' ' ' LEU . 3.3 pp -109.98 36.28 3.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 74.010000000000005 110.915 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.405 ' O ' HG23 ' A' ' 20' ' ' ILE . 1.3 m-20 -127.6 -74.04 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.177 -0.465 . . . . 74.530000000000001 110.906 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 1.007 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . -68.08 -26.61 65.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 41.549999999999997 111.122 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -72.01 -47.83 49.09 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 74.219999999999999 110.934 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.833 ' O ' HD23 ' A' ' 23' ' ' LEU . 2.7 t -61.68 -47.04 87.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.157 -0.474 . . . . 75.010000000000005 111.115 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.937 HD11 HG11 ' A' ' 35' ' ' VAL . 2.0 pp -69.51 -36.84 73.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 73.109999999999999 111.119 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.447 ' N ' HD12 ' A' ' 20' ' ' ILE . 35.9 ttt180 -63.58 -49.99 71.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.181 -0.463 . . . . 74.329999999999998 110.871 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.408 ' CG ' ' N ' ' A' ' 23' ' ' LEU . 34.1 pttt -64.45 -41.99 96.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 71.420000000000002 110.929 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.833 HD23 ' O ' ' A' ' 19' ' ' THR . 3.2 mm? -56.48 -50.79 70.72 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.261 -0.427 . . . . 72.409999999999997 110.937 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.814 HG21 HG21 ' A' ' 33' ' ' VAL . 12.7 mt -68.0 -43.83 85.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.157 -0.474 . . . . 71.450000000000003 111.127 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -56.53 -34.85 67.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 72.340000000000003 110.794 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.98 -43.38 35.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 72.409999999999997 110.874 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -57.66 -49.01 77.54 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.758 -0.734 . . . . 70.310000000000002 112.476 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.6 mt -118.93 102.31 49.37 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.628 0.728 . . . . 74.150000000000006 110.944 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.77 -15.03 36.87 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.701 2.268 . . . . 73.340000000000003 112.294 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -96.18 -10.21 28.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 63.399999999999999 110.862 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.477 ' CB ' ' HB3' ' A' ' 49' ' ' SER . . . -111.04 126.83 55.22 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 51.329999999999998 111.105 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.504 ' HB3' ' CG1' ' A' ' 48' ' ' VAL . 24.5 ttp180 -103.06 117.17 33.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 63.350000000000001 110.874 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.814 HG21 HG21 ' A' ' 24' ' ' ILE . 18.5 t -111.75 131.17 63.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 74.010000000000005 111.092 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -135.4 117.65 15.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 73.030000000000001 110.884 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 1.007 HG13 ' HB1' ' A' ' 17' ' ' ALA . 4.6 p -126.91 139.4 51.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.444 . . . . 52.229999999999997 111.11 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -132.2 120.63 22.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 72.340000000000003 110.945 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 149.99 -139.45 7.37 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.751 -0.737 . . . . 52.32 112.467 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.402 ' OE1' ' HB2' ' A' ' 14' ' ' PRO . 0.3 OUTLIER -166.84 153.62 8.77 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.859 0.361 . . . . 74.439999999999998 110.906 -179.856 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -58.61 147.48 32.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 74.239999999999995 110.893 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.29 -11.16 13.25 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.741 -0.742 . . . . 72.239999999999995 112.556 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 42' ' ' HIS . 20.5 t -118.14 164.05 14.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.816 0.341 . . . . 73.349999999999994 111.099 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.556 ' N ' HG12 ' A' ' 41' ' ' VAL . 0.2 OUTLIER -75.79 107.67 8.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 73.340000000000003 110.889 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.819 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 3.6 p90 -119.37 167.22 12.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 74.030000000000001 110.824 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.418 ' OE2' ' C ' ' A' ' 45' ' ' ALA . 1.0 OUTLIER -113.52 135.19 54.17 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 63.229999999999997 110.902 -179.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.418 ' C ' ' OE2' ' A' ' 44' ' ' GLU . . . -127.25 121.25 30.66 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 72.439999999999998 111.064 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.7 m -121.3 110.96 16.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.128 -0.487 . . . . 61.25 111.168 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.776 ' CG1' HG13 ' A' ' 33' ' ' VAL . 3.8 m -112.77 140.05 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 34.210000000000001 111.152 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.61 HG21 ' HB2' ' A' ' 89' ' ' ALA . 3.0 p -134.4 118.81 28.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 64.340000000000003 111.175 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.562 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 12.2 p -169.64 161.65 7.17 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.682 0.753 . . . . 70.319999999999993 110.859 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.578 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.6 Cg_endo -69.78 -23.4 30.74 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.664 2.242 . . . . 63.32 112.262 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.751 ' HB1' ' CD ' ' A' ' 60' ' ' ARG . . . -47.12 -41.59 17.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.307 -0.406 . . . . 54.119999999999997 111.085 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.695 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 1.6 m-85 -86.45 32.38 0.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 71.230000000000004 110.844 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.571 ' HA ' HG23 ' A' ' 85' ' ' THR . 10.8 p -52.38 146.79 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.121 -0.491 . . . . 55.240000000000002 111.16 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 50.5 -88.22 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.747 -0.74 . . . . 73.340000000000003 112.424 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -121.06 112.25 18.48 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.792 0.33 . . . . 74.439999999999998 110.898 -179.926 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.695 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -59.17 108.24 1.28 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.564 0.697 . . . . 74.049999999999997 111.101 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 54.0 Cg_endo -69.64 162.43 42.05 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.66 2.24 . . . . 74.209999999999994 112.416 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -56.36 -26.12 51.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.256 -0.429 . . . . 64.239999999999995 110.966 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 63' ' ' MET . . . -59.82 -52.64 64.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.141 -0.481 . . . . 43.219999999999999 111.084 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.751 ' CD ' ' HB1' ' A' ' 51' ' ' ALA . 11.6 mmp_? -69.57 -42.77 74.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 75.140000000000001 110.889 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.529 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -58.59 -52.99 63.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.139 -0.482 . . . . 71.109999999999999 110.864 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 18.5 mtp180 -65.41 -36.49 84.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.26 -0.427 . . . . 52.32 110.903 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.475 ' O ' HG22 ' A' ' 67' ' ' THR . 0.3 OUTLIER -57.09 -48.25 79.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 65.349999999999994 110.889 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.529 HG22 ' O ' ' A' ' 61' ' ' HIS . 17.2 m -67.68 -40.88 84.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.47 . . . . 53.229999999999997 111.146 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.514 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 14.8 m-85 -65.74 -33.39 75.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 75.519999999999996 110.897 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.36 -46.03 43.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.096 -0.502 . . . . 74.109999999999999 111.069 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.518 HG23 HD12 ' A' ' 68' ' ' LEU . 4.7 t -63.81 -33.66 76.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 51.399999999999999 111.161 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.751 ' HG ' HD13 ' A' ' 20' ' ' ILE . 3.4 mp -81.9 -1.95 49.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.447 . . . . 53.520000000000003 110.91 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.467 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 32.48 82.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.806 -0.711 . . . . 55.310000000000002 112.51 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.59 ' HG2' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -83.55 -20.17 34.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.849 0.357 . . . . 75.120000000000005 110.887 -179.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.59 HD22 ' HG2' ' A' ' 70' ' ' GLU . 4.0 mm? -87.96 9.36 22.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.144 -0.48 . . . . 64.340000000000003 110.871 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.87 -13.2 61.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 75.450000000000003 110.867 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -148.58 -33.15 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.772 -0.727 . . . . 51.109999999999999 112.511 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 148.93 102.36 0.27 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.694 -0.765 . . . . 74.420000000000002 112.497 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.467 ' C ' HD13 ' A' ' 76' ' ' ILE . . . -66.55 122.52 17.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.735 0.302 . . . . 75.430000000000007 111.116 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.467 HD13 ' C ' ' A' ' 75' ' ' ALA . 6.4 mm -114.11 157.46 14.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.244 -0.435 . . . . 72.219999999999999 111.115 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . . . . . . . . . 27.6 m170 -73.97 41.39 0.13 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 63.439999999999998 110.843 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.543 ' HB3' ' HB3' ' A' ' 42' ' ' HIS . . . -135.04 29.36 3.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 70.530000000000001 111.12 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.819 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 3.7 mm? -97.02 143.67 27.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 72.120000000000005 110.888 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -118.79 115.25 24.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 72.010000000000005 110.919 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.514 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 0.4 OUTLIER -123.9 116.7 23.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.186 -0.461 . . . . 75.099999999999994 110.92 -180.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.07 114.85 23.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 65.409999999999997 110.899 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.556 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 40.2 p -115.78 106.49 13.91 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.236 -0.438 . . . . 64.230000000000004 111.174 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.4 mt -131.68 162.82 29.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.458 . . . . 61.130000000000003 110.894 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.571 HG23 ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -70.79 164.53 54.94 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.592 0.71 . . . . 64.200000000000003 111.128 179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.578 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.4 Cg_endo -69.76 -24.53 29.58 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.726 2.284 . . . . 74.129999999999995 112.301 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -64.54 -36.0 82.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.29 -0.414 . . . . 70.230000000000004 110.882 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -66.63 -41.66 87.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 53.329999999999998 110.876 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.61 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 50.210000000000001 111.108 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.4 mpp? . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.771 0.319 . . . . 72.329999999999998 110.867 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.483 ' O ' ' CG ' ' A' ' 11' ' ' ARG . 0.1 OUTLIER -132.73 106.23 7.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.237 -0.438 . . . . 70.349999999999994 110.872 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.418 ' O ' ' CG ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -116.95 115.76 26.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.26 -0.427 . . . . 74.329999999999998 110.884 179.973 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.418 ' CG ' ' O ' ' A' ' 12' ' ' LYS . 84.9 mtm180 -159.71 120.85 1.77 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.596 0.712 . . . . 74.519999999999996 110.9 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 153.6 68.52 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.729 2.286 . . . . 71.040000000000006 112.355 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.828 ' O ' HG23 ' A' ' 19' ' ' THR . 3.2 mm? -89.97 172.48 8.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.254 -0.43 . . . . 75.010000000000005 110.884 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -55.03 -70.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 73.349999999999994 110.801 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.415 ' HB1' ' O ' ' A' ' 35' ' ' VAL . . . -53.16 -26.19 16.17 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 72.219999999999999 111.075 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -70.69 -37.98 73.64 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 64.519999999999996 110.815 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.828 HG23 ' O ' ' A' ' 15' ' ' LEU . 6.2 p -59.21 -54.02 51.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 51.340000000000003 111.144 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.545 HD11 HG11 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -68.48 -47.34 77.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 74.310000000000002 111.152 179.91 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 27.2 ttt180 -53.29 -50.42 64.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.48 . . . . 71.540000000000006 110.897 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.6 ptmm? -66.96 -35.39 79.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 62.020000000000003 110.868 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.32 -49.27 74.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.433 . . . . 73.400000000000006 110.908 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.721 HD11 ' OG1' ' A' ' 67' ' ' THR . 7.4 mm -72.79 -42.81 61.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 63.100000000000001 111.191 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -54.7 -37.19 65.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.075 -0.511 . . . . 73.530000000000001 110.858 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -82.88 -42.49 17.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 64.299999999999997 110.894 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.99 -47.58 90.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.688 -0.768 . . . . 64.319999999999993 112.463 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.738 ' CB ' ' HB3' ' A' ' 31' ' ' ALA . 2.5 mm? -76.19 157.06 83.51 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.57 0.7 . . . . 74.430000000000007 110.91 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.77 -58.43 0.1 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.63 2.22 . . . . 64.219999999999999 112.377 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.3 mt-10 -134.99 20.81 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 44.409999999999997 110.942 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.738 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . . . -74.4 126.52 30.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 72.209999999999994 111.087 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.654 ' HB3' HG12 ' A' ' 48' ' ' VAL . 4.3 tpt180 -100.68 109.7 21.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 62.130000000000003 110.858 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.038 HG13 HG22 ' A' ' 47' ' ' VAL . 41.1 t -114.14 135.34 54.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 60.310000000000002 111.088 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -135.23 118.81 16.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.21 -0.45 . . . . 71.430000000000007 110.85 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.545 HG11 HD11 ' A' ' 20' ' ' ILE . 61.4 t -121.49 131.33 73.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 53.25 111.119 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -132.83 120.35 21.44 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 74.430000000000007 110.895 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 142.45 -163.68 27.12 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.809 -0.71 . . . . 53.149999999999999 112.514 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.493 ' O ' HG12 ' A' ' 41' ' ' VAL . 27.1 mt-10 -135.39 176.23 8.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.871 0.367 . . . . 73.340000000000003 110.888 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -78.65 146.52 34.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.156 -0.475 . . . . 62.130000000000003 110.841 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.4 ' HA2' ' CA ' ' A' ' 74' ' ' GLY . . . 72.73 18.43 78.75 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.763 -0.732 . . . . 75.519999999999996 112.402 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.586 HG22 ' N ' ' A' ' 42' ' ' HIS . 12.5 p -144.63 164.39 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.86 0.362 . . . . 72.109999999999999 111.143 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.586 ' N ' HG22 ' A' ' 41' ' ' VAL . 8.1 p80 -75.52 108.09 8.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 52.409999999999997 110.935 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.81 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 9.7 p90 -114.96 167.11 11.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 73.340000000000003 110.926 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -116.59 126.76 53.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 64.129999999999995 110.844 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.447 ' CB ' HD21 ' A' ' 68' ' ' LEU . . . -128.33 125.35 38.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 35.439999999999998 111.132 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.3 m -121.21 111.17 17.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.224 -0.444 . . . . 70.030000000000001 111.132 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.038 HG22 HG13 ' A' ' 33' ' ' VAL . 92.7 t -112.13 138.01 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 74.519999999999996 111.166 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.746 HG21 ' HB2' ' A' ' 89' ' ' ALA . 9.9 p -136.21 121.8 28.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.12 -0.491 . . . . 71.140000000000001 111.111 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.43 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 0.7 OUTLIER -170.25 166.01 5.34 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.588 0.708 . . . . 75.439999999999998 110.917 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.548 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.5 Cg_endo -69.72 -21.66 33.36 Favored 'Trans proline' 0 C--N 1.341 0.135 0 C-N-CA 122.719 2.279 . . . . 74.129999999999995 112.327 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.801 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -46.73 -46.26 20.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.223 -0.444 . . . . 64.0 111.136 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.623 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.9 OUTLIER -84.72 35.14 0.55 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 73.430000000000007 110.873 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.547 ' HA ' HG23 ' A' ' 85' ' ' THR . 7.7 p -52.46 133.84 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 64.120000000000005 111.142 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.94 -88.88 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.761 -0.733 . . . . 72.140000000000001 112.484 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 0.3 OUTLIER -120.64 113.39 20.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.769 0.319 . . . . 74.140000000000001 110.922 179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.623 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -58.3 107.8 1.08 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.544 0.688 . . . . 53.219999999999999 111.071 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.7 Cg_endo -69.83 164.9 32.88 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.623 2.215 . . . . 64.319999999999993 112.393 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.507 HD21 ' NE ' ' A' ' 62' ' ' ARG . 1.8 tt -59.66 -25.6 64.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.27 -0.423 . . . . 63.399999999999999 110.892 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.26 -52.15 65.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 74.140000000000001 111.146 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.801 ' HD2' ' HB1' ' A' ' 51' ' ' ALA . 20.4 mmt180 -69.69 -41.08 75.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 72.450000000000003 110.874 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.52 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.0 OUTLIER -58.44 -53.49 57.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 72.409999999999997 110.848 -179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.507 ' NE ' HD21 ' A' ' 58' ' ' LEU . 51.8 mtt180 -66.47 -36.88 83.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 63.520000000000003 110.874 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 37.6 mmm -56.61 -47.56 79.36 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 70.140000000000001 110.819 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.52 HG22 ' O ' ' A' ' 61' ' ' HIS . 19.2 m -68.8 -40.78 81.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 70.219999999999999 111.065 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.497 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 12.0 m-85 -62.09 -36.09 80.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 75.040000000000006 110.953 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.18 -46.78 31.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 73.329999999999998 111.069 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.721 ' OG1' HD11 ' A' ' 24' ' ' ILE . 0.7 OUTLIER -61.7 -33.28 73.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 65.019999999999996 111.135 -179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.57 HD12 HG23 ' A' ' 67' ' ' THR . 4.0 mp -84.49 -6.25 59.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 64.400000000000006 110.904 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.442 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 34.46 85.31 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.672 -0.775 . . . . 43.109999999999999 112.534 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.421 ' HG2' ' N ' ' A' ' 71' ' ' LEU . 0.8 OUTLIER -96.09 -35.11 11.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.841 0.353 . . . . 71.530000000000001 110.882 -179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.496 HD23 ' C ' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -87.91 5.98 37.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 72.450000000000003 110.867 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.492 ' N ' HD23 ' A' ' 71' ' ' LEU . 1.5 tpt -71.93 -10.65 60.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.432 . . . . 72.120000000000005 110.942 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -145.83 -32.68 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.777 -0.725 . . . . 34.210000000000001 112.534 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.4 ' CA ' ' HA2' ' A' ' 40' ' ' GLY . . . 164.12 93.48 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.741 . . . . 61.340000000000003 112.478 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -84.48 123.48 30.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.72 0.295 . . . . 63.420000000000002 111.093 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.569 HG22 ' N ' ' A' ' 77' ' ' HIS . 3.8 mp -113.45 164.17 9.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.196 -0.456 . . . . 71.230000000000004 111.123 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.569 ' N ' HG22 ' A' ' 76' ' ' ILE . 1.7 t-80 -77.2 40.41 0.27 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.118 -0.492 . . . . 74.120000000000005 110.847 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.445 ' HB3' ' CB ' ' A' ' 42' ' ' HIS . . . -134.11 36.97 3.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 44.420000000000002 111.187 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.81 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 1.9 mm? -97.62 140.47 31.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.475 . . . . 61.420000000000002 110.964 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -116.98 115.71 25.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 63.119999999999997 110.875 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.497 HD22 ' CZ ' ' A' ' 65' ' ' TYR . 5.2 tp -130.64 138.7 50.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 62.43 110.957 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.3 mptt -136.33 114.82 11.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.153 -0.476 . . . . 65.129999999999995 110.858 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.518 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 8.8 p -112.02 106.58 15.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.187 -0.461 . . . . 75.219999999999999 111.119 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 58.0 mt -133.55 162.02 33.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.234 -0.439 . . . . 64.430000000000007 110.94 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.547 HG23 ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.72 164.53 57.42 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.642 0.734 . . . . 72.519999999999996 111.056 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.7 Cg_endo -69.78 -11.53 31.0 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.651 2.234 . . . . 74.299999999999997 112.339 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -86.47 -23.06 26.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 71.030000000000001 110.832 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -108.04 38.44 2.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.46 . . . . 51.130000000000003 110.919 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.746 ' HB2' HG21 ' A' ' 48' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.486 . . . . 65.299999999999997 111.048 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 7.9 tpt . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.746 0.308 . . . . 74.219999999999999 110.916 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -123.6 93.8 4.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 74.299999999999997 110.863 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 13' ' ' ARG . 0.0 OUTLIER -128.56 -49.28 1.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 71.299999999999997 110.848 179.973 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.451 ' C ' ' O ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER 34.34 54.97 1.71 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.542 0.687 . . . . 72.019999999999996 110.813 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.45 ' HD3' ' CG ' ' A' ' 12' ' ' LYS . 54.2 Cg_endo -69.67 -166.24 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.698 2.265 . . . . 74.420000000000002 112.39 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.641 HD22 ' N ' ' A' ' 16' ' ' ASP . 0.0 OUTLIER -130.82 -3.8 4.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.273 -0.421 . . . . 73.409999999999997 110.893 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.641 ' N ' HD22 ' A' ' 15' ' ' LEU . 68.3 m-20 -112.74 -74.85 0.62 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 70.219999999999999 110.865 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.689 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . -46.25 -28.4 1.27 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 55.130000000000003 111.129 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -74.06 -33.51 63.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 75.030000000000001 110.939 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.94 ' O ' HD23 ' A' ' 23' ' ' LEU . 18.6 p -57.55 -57.63 11.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 74.329999999999998 111.131 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.748 ' H ' HD13 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -73.87 -35.26 42.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.44 . . . . 64.209999999999994 111.135 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.409 ' CB ' ' O ' ' A' ' 17' ' ' ALA . 68.7 ttt-85 -61.8 -45.07 95.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 71.430000000000007 110.895 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp -71.09 -41.09 71.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 65.209999999999994 110.933 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.94 HD23 ' O ' ' A' ' 19' ' ' THR . 3.4 mm? -55.63 -49.15 73.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 63.140000000000001 110.928 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.762 ' CG2' HG21 ' A' ' 33' ' ' VAL . 14.9 mt -69.28 -43.33 81.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.215 -0.448 . . . . 52.210000000000001 111.113 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -53.67 -38.26 63.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.248 -0.433 . . . . 54.43 110.897 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -78.28 -43.05 29.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.148 -0.478 . . . . 63.210000000000001 110.833 -179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -60.69 -51.11 60.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.733 -0.746 . . . . 64.230000000000004 112.454 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.512 HD23 HG23 ' A' ' 24' ' ' ILE . 4.2 mm? -78.69 158.17 76.07 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.623 0.725 . . . . 64.439999999999998 110.889 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -90.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.71 2.274 . . . . 73.120000000000005 112.337 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -107.28 33.2 4.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.2 -0.455 . . . . 60.439999999999998 110.885 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.456 ' HB2' ' HB2' ' A' ' 49' ' ' SER . . . -84.05 125.84 32.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.173 -0.467 . . . . 72.340000000000003 111.112 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.519 ' HB2' ' CG1' ' A' ' 48' ' ' VAL . 3.7 mmt180 -92.8 108.92 20.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 61.530000000000001 110.862 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.762 HG21 ' CG2' ' A' ' 24' ' ' ILE . 76.3 t -109.76 122.74 64.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 51.310000000000002 111.116 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -134.07 118.38 17.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.484 . . . . 53.43 110.822 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.689 HG13 ' HB1' ' A' ' 17' ' ' ALA . 2.4 p -128.25 132.78 67.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 61.149999999999999 111.17 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -132.89 120.45 21.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 74.420000000000002 110.92 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.413 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 150.29 -140.16 7.8 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 53.109999999999999 112.439 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -157.68 178.77 9.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.87 0.367 . . . . 64.430000000000007 110.887 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -84.07 142.47 30.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 54.520000000000003 110.866 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.85 17.81 78.58 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.766 -0.731 . . . . 15.32 112.468 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.0 p -142.08 164.33 18.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.884 0.373 . . . . 75.340000000000003 111.117 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.49 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 5.9 p80 -75.7 107.05 7.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.164 -0.471 . . . . 75.120000000000005 110.865 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.779 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 4.7 p90 -119.06 167.25 11.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.19 -0.459 . . . . 63.439999999999998 110.863 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.409 ' HG3' ' CB ' ' A' ' 80' ' ' GLN . 26.5 tt0 -117.03 122.07 43.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 71.209999999999994 110.926 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.59 115.9 18.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 74.150000000000006 111.139 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.406 HG23 ' HB2' ' A' ' 82' ' ' LYS . 10.5 m -110.78 120.07 41.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 65.310000000000002 111.172 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.404 HG13 HG22 ' A' ' 33' ' ' VAL . 86.9 t -123.47 128.24 74.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 73.340000000000003 111.157 179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.519 ' CG1' ' HB2' ' A' ' 32' ' ' ARG . 4.9 p -125.33 122.67 63.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.155 -0.475 . . . . 75.109999999999999 111.115 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -163.33 168.01 10.67 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.655 0.74 . . . . 72.310000000000002 110.893 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.483 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.6 Cg_endo -69.82 -21.19 33.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.68 2.253 . . . . 73.040000000000006 112.314 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -46.48 -46.76 19.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 71.120000000000005 111.097 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.603 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.7 OUTLIER -86.1 36.41 0.68 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 74.209999999999994 110.93 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.503 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 6.9 p -52.24 124.27 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 72.310000000000002 111.12 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 63.46 -74.69 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.796 -0.716 . . . . 61.240000000000002 112.464 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 53' ' ' VAL . 22.9 pttm -119.89 140.47 50.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.761 0.315 . . . . 75.340000000000003 110.89 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.603 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -101.25 97.92 8.11 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.59 0.709 . . . . 71.129999999999995 111.054 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 53.6 Cg_endo -69.77 173.42 11.01 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.703 2.269 . . . . 72.540000000000006 112.348 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 tp -57.79 -26.83 62.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 74.109999999999999 110.907 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.84 -52.94 63.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.472 . . . . 64.319999999999993 111.162 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.597 ' HB3' ' CE1' ' A' ' 52' ' ' PHE . 11.6 mmt180 -69.51 -43.13 73.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 64.510000000000005 110.898 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.553 ' CE1' ' OH ' ' A' ' 65' ' ' TYR . 0.9 OUTLIER -58.34 -53.35 59.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 75.530000000000001 110.9 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 43.8 mtt180 -65.99 -35.82 81.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 73.430000000000007 110.887 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 2.9 ttt -57.91 -46.0 85.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.467 . . . . 74.109999999999999 110.875 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 61' ' ' HIS . 15.8 m -69.61 -39.96 78.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 74.299999999999997 111.152 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.553 ' OH ' ' CE1' ' A' ' 61' ' ' HIS . 15.8 m-85 -67.72 -34.99 77.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 64.209999999999994 111.028 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.18 -47.19 29.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.11 -0.495 . . . . 74.510000000000005 111.086 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.703 HG23 HD12 ' A' ' 68' ' ' LEU . 15.4 t -61.65 -39.59 91.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.19 -0.459 . . . . 72.239999999999995 111.138 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.703 HD12 HG23 ' A' ' 67' ' ' THR . 1.0 OUTLIER -82.0 0.73 38.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 41.210000000000001 110.975 179.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 35.04 91.22 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 62.340000000000003 112.416 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.524 ' HB3' ' HB2' ' A' ' 75' ' ' ALA . 5.5 mp0 -96.86 -32.26 12.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.902 0.382 . . . . 51.409999999999997 110.852 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -78.53 10.25 3.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.46 . . . . 75.040000000000006 110.903 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 37.9 mtm -73.56 -13.19 60.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.225 -0.443 . . . . 62.439999999999998 110.937 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -150.12 -33.5 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.717 -0.754 . . . . 74.340000000000003 112.479 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 151.53 101.02 0.21 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.786 -0.721 . . . . 74.340000000000003 112.489 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . . . -82.5 123.68 29.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.805 0.336 . . . . 50.350000000000001 111.127 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.747 ' O ' HD23 ' A' ' 79' ' ' LEU . 2.2 mp -113.35 163.13 10.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 71.099999999999994 111.161 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.468 ' N ' HG22 ' A' ' 76' ' ' ILE . 0.1 OUTLIER -66.56 -3.84 7.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.125 -0.489 . . . . 75.230000000000004 110.902 179.853 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -87.37 29.83 0.83 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.258 -0.428 . . . . 70.340000000000003 111.105 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.779 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 3.6 mm? -97.79 133.86 41.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 62.210000000000001 110.972 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.409 ' CB ' ' HG3' ' A' ' 44' ' ' GLU . 25.9 mt-30 -109.7 115.6 30.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 72.409999999999997 110.906 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.498 HD23 ' HE1' ' A' ' 61' ' ' HIS . 5.0 tp -133.46 139.63 46.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.239 -0.437 . . . . 64.099999999999994 110.852 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.406 ' HB2' HG23 ' A' ' 46' ' ' THR . 0.6 OUTLIER -136.53 115.36 12.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 74.109999999999999 110.842 179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.527 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 10.5 p -108.44 106.68 16.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 72.430000000000007 111.147 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.504 HD22 ' C ' ' A' ' 83' ' ' THR . 3.9 mm? -129.61 161.49 30.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 75.420000000000002 110.838 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.503 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.5 162.92 71.54 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.623 0.725 . . . . 73.129999999999995 111.089 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.6 Cg_endo -69.64 -19.18 37.05 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.733 2.289 . . . . 63.340000000000003 112.402 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -68.82 -35.99 77.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.246 -0.434 . . . . 74.349999999999994 110.899 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -66.53 -40.19 88.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 72.510000000000005 110.918 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.168 -0.469 . . . . 75.219999999999999 111.097 179.957 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.792 0.329 . . . . 72.310000000000002 110.845 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 63.39 54.27 2.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 70.140000000000001 110.864 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -105.13 48.28 0.84 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 60.229999999999997 110.889 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -141.57 143.35 29.23 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.56 0.695 . . . . 72.120000000000005 110.86 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 146.74 60.78 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.732 2.288 . . . . 62.450000000000003 112.297 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.562 HD22 ' CD ' ' A' ' 18' ' ' GLU . 4.3 mp -109.89 -175.6 2.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 73.150000000000006 110.93 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -129.76 -73.4 0.56 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 72.040000000000006 110.844 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.94 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . -59.26 -30.57 68.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 53.149999999999999 111.101 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.562 ' CD ' HD22 ' A' ' 15' ' ' LEU . 5.9 mt-10 -70.1 -38.45 75.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 60.439999999999998 110.84 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.9 ' O ' HD23 ' A' ' 23' ' ' LEU . 25.8 p -63.43 -53.57 50.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.492 . . . . 72.310000000000002 111.139 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.935 HD12 ' N ' ' A' ' 21' ' ' ARG . 1.7 pp -65.06 -42.61 94.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 61.329999999999998 111.079 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.935 ' N ' HD12 ' A' ' 20' ' ' ILE . 39.9 ttp180 -60.37 -46.23 90.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.47 . . . . 64.030000000000001 110.889 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.12 -42.4 99.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 75.120000000000005 110.969 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.9 HD23 ' O ' ' A' ' 19' ' ' THR . 4.2 mm? -58.08 -49.3 77.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.228 -0.442 . . . . 74.239999999999995 110.913 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.776 ' CG2' HG21 ' A' ' 33' ' ' VAL . 46.7 mm -63.31 -46.38 95.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 73.099999999999994 111.152 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.1 mm-40 -54.37 -43.71 71.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 74.150000000000006 110.851 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.31 -42.93 78.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 74.049999999999997 110.797 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -65.35 -57.04 12.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.725 -0.75 . . . . 14.42 112.45 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.477 ' CB ' ' HB3' ' A' ' 31' ' ' ALA . 3.3 mm? -72.65 155.86 90.57 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.537 0.684 . . . . 63.409999999999997 110.958 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.79 -90.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.138 0 C-N-CA 122.615 2.21 . . . . 73.510000000000005 112.352 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -103.32 31.89 4.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 70.329999999999998 110.902 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.477 ' HB3' ' CB ' ' A' ' 28' ' ' LEU . . . -80.48 131.65 35.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.165 -0.471 . . . . 74.230000000000004 111.095 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.634 ' HB3' HG12 ' A' ' 48' ' ' VAL . 6.4 tpp180 -102.42 113.99 27.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 75.430000000000007 110.878 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.075 HG13 HG22 ' A' ' 47' ' ' VAL . 36.8 t -116.03 127.31 73.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 72.140000000000001 111.137 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -135.4 118.37 16.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.248 -0.433 . . . . 72.239999999999995 110.864 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.94 HG13 ' HB1' ' A' ' 17' ' ' ALA . 4.3 p -127.28 136.91 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 65.150000000000006 111.142 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.418 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 0.9 OUTLIER -133.05 120.4 21.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 61.549999999999997 110.918 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.435 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 142.37 -134.43 6.09 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.743 -0.741 . . . . 55.439999999999998 112.469 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.412 ' OE2' ' CG ' ' A' ' 39' ' ' ASP . 5.3 tm-20 -170.2 166.53 8.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.846 0.355 . . . . 72.219999999999999 110.866 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.412 ' CG ' ' OE2' ' A' ' 38' ' ' GLU . 7.8 p30 -72.95 153.55 40.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.103 -0.499 . . . . 70.340000000000003 110.905 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.432 ' HA2' ' C ' ' A' ' 74' ' ' GLY . . . 72.84 -2.62 32.06 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.75 -0.738 . . . . 73.219999999999999 112.489 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 17.4 m -130.41 164.9 32.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.867 0.365 . . . . 62.520000000000003 111.124 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.419 ' O ' ' CG ' ' A' ' 42' ' ' HIS . 12.6 p80 -74.78 109.98 8.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 63.350000000000001 110.859 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.606 ' CE2' HD11 ' A' ' 79' ' ' LEU . 34.1 p90 -127.43 167.36 16.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.219 -0.446 . . . . 71.129999999999995 110.9 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -118.1 126.72 52.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 63.229999999999997 110.837 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.27 115.32 18.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.129 -0.487 . . . . 72.219999999999999 111.052 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.7 m -110.37 110.78 21.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.469 . . . . 55.200000000000003 111.108 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.075 HG22 HG13 ' A' ' 33' ' ' VAL . 91.5 t -110.68 140.8 28.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.123 -0.49 . . . . 64.329999999999998 111.091 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.634 HG12 ' HB3' ' A' ' 32' ' ' ARG . 4.3 p -133.34 118.31 31.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.172 -0.467 . . . . 60.340000000000003 111.168 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.534 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 38.4 p -162.08 159.17 21.55 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.671 0.748 . . . . 72.109999999999999 110.853 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.574 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.1 Cg_endo -69.78 -14.67 36.34 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.643 2.229 . . . . 51.530000000000001 112.318 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.07 -48.45 22.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 74.0 111.134 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.77 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.2 OUTLIER -84.19 35.07 0.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.292 -0.413 . . . . 64.329999999999998 110.874 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.5 p -50.84 131.1 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.119 -0.491 . . . . 54.130000000000003 111.099 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.73 -78.04 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.728 -0.749 . . . . 71.340000000000003 112.509 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -122.49 140.87 52.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.8 0.334 . . . . 75.439999999999998 110.849 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.77 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -104.19 99.11 15.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.606 0.717 . . . . 64.430000000000007 111.114 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 52.7 Cg_endo -69.81 169.4 19.05 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.677 2.251 . . . . 52.219999999999999 112.309 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.484 HD21 ' NE ' ' A' ' 62' ' ' ARG . 1.6 tt -56.43 -27.56 56.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 61.210000000000001 110.888 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.69 -52.75 63.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 73.25 111.097 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.458 ' N ' ' HD2' ' A' ' 60' ' ' ARG . 3.4 mmm180 -69.84 -43.64 71.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 73.310000000000002 110.906 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.453 ' O ' HG22 ' A' ' 64' ' ' VAL . 0.9 OUTLIER -56.57 -53.44 57.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.14 -0.482 . . . . 55.340000000000003 110.857 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.484 ' NE ' HD21 ' A' ' 58' ' ' LEU . 51.0 mtt180 -66.73 -37.93 85.65 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.217 -0.447 . . . . 64.099999999999994 110.852 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 11.5 mmt -54.13 -50.15 67.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 74.140000000000001 110.844 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.587 ' O ' HG22 ' A' ' 67' ' ' THR . 17.1 m -66.96 -42.91 89.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 60.020000000000003 111.154 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.889 ' CE1' HD13 ' A' ' 81' ' ' LEU . 15.2 m-85 -62.29 -36.82 83.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 71.150000000000006 110.936 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.2 -35.88 61.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.16 -0.473 . . . . 73.019999999999996 111.046 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.587 HG22 ' O ' ' A' ' 64' ' ' VAL . 0.6 OUTLIER -69.93 -31.22 68.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 73.319999999999993 111.122 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.657 ' C ' HD12 ' A' ' 68' ' ' LEU . 2.9 pp -88.03 -10.44 50.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 55.409999999999997 110.933 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.613 ' N ' HD12 ' A' ' 68' ' ' LEU . . . 46.86 87.0 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.681 -0.771 . . . . 52.5 112.506 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.638 ' HG2' HD11 ' A' ' 68' ' ' LEU . 8.2 pt-20 -111.02 -48.14 3.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.847 0.356 . . . . 73.230000000000004 110.868 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.73 ' O ' HD13 ' A' ' 71' ' ' LEU . 0.4 OUTLIER -78.88 -2.19 38.68 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.199 -0.455 . . . . 73.319999999999993 110.963 179.974 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 9.1 mmt -85.14 -13.7 49.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 54.030000000000001 110.888 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.6 -30.88 3.37 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.724 -0.75 . . . . 50.100000000000001 112.423 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.432 ' C ' ' HA2' ' A' ' 40' ' ' GLY . . . 103.53 53.25 0.88 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.785 -0.722 . . . . 64.0 112.527 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -86.84 157.91 19.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.843 0.354 . . . . 42.109999999999999 111.08 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.775 ' H ' HD12 ' A' ' 76' ' ' ILE . 2.2 mp -70.91 165.25 2.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 72.120000000000005 111.148 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.488 ' N ' HG22 ' A' ' 76' ' ' ILE . 19.3 m170 -74.22 49.37 0.35 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 63.329999999999998 110.814 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -131.37 51.85 2.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.48 . . . . 70.409999999999997 111.068 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.606 HD11 ' CE2' ' A' ' 43' ' ' PHE . 4.1 mm? -97.44 131.83 43.71 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.212 -0.449 . . . . 63.530000000000001 110.943 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -112.58 114.94 27.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.254 -0.43 . . . . 75.219999999999999 110.896 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.889 HD13 ' CE1' ' A' ' 65' ' ' TYR . 6.7 tt -139.53 138.44 36.3 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.136 -0.484 . . . . 51.130000000000003 110.883 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -136.54 114.96 11.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 74.0 110.868 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.536 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 59.0 p -100.87 106.82 18.22 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 72.150000000000006 111.172 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.466 HD13 ' HA ' ' A' ' 84' ' ' LEU . 2.5 mm? -125.27 162.5 24.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 74.400000000000006 110.92 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.408 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 0.6 OUTLIER -71.09 164.49 56.37 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.606 0.717 . . . . 64.030000000000001 111.131 179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.2 Cg_endo -69.83 -18.25 36.78 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.613 2.209 . . . . 61.210000000000001 112.333 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -76.51 -29.56 56.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.234 -0.439 . . . . 63.200000000000003 110.885 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -80.28 5.37 14.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.172 -0.467 . . . . 75.420000000000002 110.87 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 63.030000000000001 111.118 179.925 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.45 ' O ' ' NH1' ' A' ' 11' ' ' ARG . 1.6 tpt . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.705 0.288 . . . . 75.230000000000004 110.867 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.45 ' NH1' ' O ' ' A' ' 10' ' ' MET . 15.1 mmt-85 -127.31 159.0 35.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.233 -0.439 . . . . 64.430000000000007 110.805 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.403 ' O ' ' HD3' ' A' ' 14' ' ' PRO . 1.1 tppp? -83.8 144.38 29.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 74.150000000000006 110.876 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.425 ' HA ' ' HD2' ' A' ' 14' ' ' PRO . 47.3 mtp180 -102.56 96.35 7.31 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.62 0.724 . . . . 73.230000000000004 110.853 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 13' ' ' ARG . 53.7 Cg_endo -69.73 160.56 49.26 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.731 2.287 . . . . 63.539999999999999 112.327 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.29 -75.13 0.5 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.451 . . . . 71.409999999999997 110.934 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 20' ' ' ILE . 13.6 m-20 -128.77 -68.72 0.74 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.175 -0.466 . . . . 73.129999999999995 110.89 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 35' ' ' VAL . . . -67.4 -27.78 67.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.15 -0.477 . . . . 65.329999999999998 111.135 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.64 -47.19 49.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.184 -0.462 . . . . 62.009999999999998 110.967 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.403 HG23 ' N ' ' A' ' 20' ' ' ILE . 3.1 t -62.4 -45.14 94.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.119 -0.491 . . . . 43.399999999999999 111.155 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 16' ' ' ASP . 14.6 pt -69.91 -40.03 78.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 54.420000000000002 111.124 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.455 ' N ' HG13 ' A' ' 20' ' ' ILE . 32.5 ttt-85 -60.0 -48.23 82.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 51.200000000000003 110.861 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.449 ' HG3' ' N ' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -69.29 -39.62 78.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 73.319999999999993 110.917 179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.449 ' N ' ' HG3' ' A' ' 22' ' ' LYS . 17.8 mt -57.12 -49.32 76.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 73.420000000000002 110.881 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.803 ' CG2' HG21 ' A' ' 33' ' ' VAL . 5.7 mt -70.06 -45.86 74.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 61.299999999999997 111.127 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -53.96 -36.86 63.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 62.439999999999998 110.898 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -79.48 -40.82 28.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 74.239999999999995 110.861 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -64.92 -55.56 21.43 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.732 -0.747 . . . . 64.239999999999995 112.473 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.596 HD12 ' CG2' ' A' ' 24' ' ' ILE . 5.8 mt -76.5 159.62 79.17 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.572 0.701 . . . . 72.239999999999995 111.005 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 -91.29 0.01 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.104 0 C-N-CA 122.73 2.286 . . . . 71.25 112.361 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -106.96 29.61 6.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 74.400000000000006 110.87 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.46 ' CB ' HD13 ' A' ' 28' ' ' LEU . . . -77.58 131.28 37.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.15 -0.477 . . . . 64.299999999999997 111.113 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.516 ' HB2' ' CG1' ' A' ' 48' ' ' VAL . 13.6 mmm-85 -97.11 114.42 26.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.278 -0.419 . . . . 74.439999999999998 110.881 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.872 HG13 HG22 ' A' ' 47' ' ' VAL . 56.3 t -117.98 126.05 74.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 63.329999999999998 111.179 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -135.28 118.63 16.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 73.349999999999994 110.822 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.568 HG21 ' CD1' ' A' ' 20' ' ' ILE . 43.2 t -125.01 135.21 64.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 72.340000000000003 111.108 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 -133.25 123.17 25.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.114 -0.494 . . . . 71.219999999999999 110.884 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 141.78 -134.48 6.23 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.698 -0.763 . . . . 62.240000000000002 112.511 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -163.67 160.23 22.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.849 0.357 . . . . 54.420000000000002 110.896 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.453 ' OD2' ' C ' ' A' ' 72' ' ' MET . 24.5 t0 -67.49 147.63 52.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 65.409999999999997 110.901 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.0 -7.29 16.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.815 -0.707 . . . . 62.130000000000003 112.391 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.573 HG12 ' N ' ' A' ' 42' ' ' HIS . 14.6 t -118.81 165.8 13.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.871 0.367 . . . . 64.219999999999999 111.158 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.573 ' N ' HG12 ' A' ' 41' ' ' VAL . 5.3 p80 -73.95 106.54 5.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 64.329999999999998 110.853 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.573 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 41.7 p90 -122.6 167.33 13.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 64.209999999999994 110.918 -179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -114.3 128.1 56.19 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.135 -0.484 . . . . 75.010000000000005 110.916 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -124.39 121.94 36.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 72.109999999999999 111.133 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 38.8 m -121.11 110.41 16.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 71.409999999999997 111.14 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.872 HG22 HG13 ' A' ' 33' ' ' VAL . 65.4 t -120.6 129.64 75.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 65.200000000000003 111.18 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.516 ' CG1' ' HB2' ' A' ' 32' ' ' ARG . 3.7 p -126.4 118.86 52.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 51.450000000000003 111.112 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.478 ' CB ' ' HD2' ' A' ' 50' ' ' PRO . 0.4 OUTLIER -161.84 169.36 9.63 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.657 0.741 . . . . 61.219999999999999 110.862 -179.859 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.515 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 52.9 Cg_endo -69.79 -20.87 34.15 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.692 2.261 . . . . 72.349999999999994 112.326 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.68 ' HB1' ' NE ' ' A' ' 60' ' ' ARG . . . -43.74 -53.58 5.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 75.140000000000001 111.195 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.626 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.7 OUTLIER -81.55 38.46 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 72.109999999999999 110.884 -179.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.514 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 2.9 p -51.37 127.23 7.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 64.310000000000002 111.118 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.39 -78.36 0.12 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.714 -0.755 . . . . 72.120000000000005 112.481 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.417 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 0.0 OUTLIER -121.97 141.68 51.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.765 0.316 . . . . 72.25 110.91 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.626 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -99.67 99.28 8.47 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.575 0.702 . . . . 50.340000000000003 111.101 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.6 Cg_endo -69.74 165.75 29.91 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.696 2.264 . . . . 74.239999999999995 112.332 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 58' ' ' LEU . 2.8 tt -54.53 -24.09 19.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 63.020000000000003 110.916 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 63' ' ' MET . . . -61.36 -51.65 67.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 75.319999999999993 111.14 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.68 ' NE ' ' HB1' ' A' ' 51' ' ' ALA . 0.1 OUTLIER -72.05 -37.45 69.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 71.120000000000005 110.918 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.514 ' CD2' ' CD2' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -61.46 -49.99 74.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 74.239999999999995 110.879 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.439 ' HD2' HD21 ' A' ' 58' ' ' LEU . 18.5 mtp180 -70.39 -39.8 74.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.158 -0.474 . . . . 63.450000000000003 110.95 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 59' ' ' ALA . 10.1 tpt -54.58 -50.84 67.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 71.239999999999995 110.912 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.649 ' O ' HG22 ' A' ' 67' ' ' THR . 30.3 m -66.12 -44.21 91.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 70.299999999999997 111.142 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.65 ' CE1' HD13 ' A' ' 81' ' ' LEU . 10.0 m-85 -55.45 -40.17 71.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 62.340000000000003 110.943 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.32 -38.93 59.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.166 -0.47 . . . . 62.329999999999998 111.102 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.649 HG22 ' O ' ' A' ' 64' ' ' VAL . 0.7 OUTLIER -66.18 -24.03 66.56 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 74.230000000000004 111.123 -179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.597 ' C ' HD12 ' A' ' 68' ' ' LEU . 3.8 pp -95.47 -1.57 50.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 55.240000000000002 110.889 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.459 ' HA2' ' CG ' ' A' ' 72' ' ' MET . . . 82.06 66.01 1.6 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.773 -0.727 . . . . 73.430000000000007 112.446 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -74.75 -65.62 0.85 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.838 0.351 . . . . 73.239999999999995 110.914 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.6 tp -86.48 10.08 16.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.164 -0.471 . . . . 75.230000000000004 110.91 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . 0.459 ' CG ' ' HA2' ' A' ' 69' ' ' GLY . 19.7 mmt -72.22 -14.08 61.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 53.329999999999998 110.854 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.423 ' HA3' ' CG ' ' A' ' 39' ' ' ASP . . . -149.46 -34.54 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.755 -0.736 . . . . 60.439999999999998 112.509 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 131.57 68.67 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.739 -0.743 . . . . 53.340000000000003 112.482 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.21 132.25 53.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.822 0.344 . . . . 42.329999999999998 111.059 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.753 ' O ' HD23 ' A' ' 79' ' ' LEU . 4.7 mp -110.69 163.25 7.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 50.530000000000001 111.178 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.595 ' N ' HG22 ' A' ' 76' ' ' ILE . 84.3 t60 -48.42 -18.8 0.26 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 70.430000000000007 110.891 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.01 44.79 0.58 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.157 -0.474 . . . . 62.329999999999998 111.096 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 76' ' ' ILE . 1.2 mm? -113.54 145.78 40.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 73.450000000000003 110.951 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 mm100 -124.7 115.96 21.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 65.129999999999995 110.861 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.65 HD13 ' CE1' ' A' ' 65' ' ' TYR . 2.8 tp -123.94 141.67 51.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.223 -0.444 . . . . 75.219999999999999 110.895 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 5.7 mptt -133.13 114.39 13.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 75.219999999999999 110.916 179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.527 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 24.7 p -118.5 106.12 12.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.451 . . . . 54.130000000000003 111.145 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.7 mp -134.62 161.23 35.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.188 -0.46 . . . . 64.150000000000006 110.934 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.514 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.48 163.59 66.52 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.639 0.733 . . . . 64.420000000000002 111.152 179.921 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.3 Cg_endo -69.76 -19.04 36.64 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.693 2.262 . . . . 71.040000000000006 112.328 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -68.87 -36.07 77.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 71.5 110.891 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -64.48 -38.12 89.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.49 . . . . 62.530000000000001 110.925 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.183 -0.462 . . . . 54.130000000000003 111.136 179.893 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.833 0.349 . . . . 64.430000000000007 110.885 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.6 ttt85 -90.31 141.34 28.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 75.140000000000001 110.855 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.63 -62.91 1.41 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.166 -0.47 . . . . 73.310000000000002 110.914 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -47.45 115.46 3.69 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.656 0.741 . . . . 75.299999999999997 110.918 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 162.59 41.45 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.651 2.234 . . . . 65.5 112.407 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.695 ' O ' HG23 ' A' ' 19' ' ' THR . 28.1 mt -110.71 -68.01 0.96 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 75.109999999999999 110.924 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -61.88 -57.4 11.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 64.340000000000003 110.841 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.853 ' HB1' HG13 ' A' ' 35' ' ' VAL . . . -59.38 -26.22 64.93 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 60.219999999999999 111.124 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -70.54 -39.13 74.18 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 74.310000000000002 110.879 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.695 HG23 ' O ' ' A' ' 15' ' ' LEU . 1.1 p -62.32 -53.55 53.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 75.200000000000003 111.104 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.073 HD12 HD22 ' A' ' 68' ' ' LEU . 9.1 pt -66.88 -45.9 86.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 74.510000000000005 111.147 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.435 ' N ' ' CG1' ' A' ' 20' ' ' ILE . 37.7 ttp85 -53.58 -51.45 62.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 73.129999999999995 110.828 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -67.43 -34.85 78.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 64.430000000000007 110.987 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.491 HD13 ' O ' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -56.64 -49.65 74.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 55.219999999999999 110.885 179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.663 HD12 HG11 ' A' ' 33' ' ' VAL . 46.8 mt -72.44 -43.05 64.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.455 . . . . 74.420000000000002 111.109 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -54.61 -36.49 64.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 65.209999999999994 110.92 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -81.44 -43.14 19.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.13 -0.487 . . . . 65.129999999999995 110.865 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -62.56 -37.88 95.45 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.753 -0.737 . . . . 55.240000000000002 112.485 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.801 HD23 ' CB ' ' A' ' 31' ' ' ALA . 8.2 mp -92.99 160.94 32.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.537 0.684 . . . . 72.109999999999999 110.937 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.75 -90.99 0.01 OUTLIER 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.657 2.238 . . . . 74.150000000000006 112.36 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -107.43 25.55 11.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.206 -0.452 . . . . 62.25 110.907 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.801 ' CB ' HD23 ' A' ' 28' ' ' LEU . . . -72.36 129.51 38.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 74.319999999999993 111.042 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.651 ' HB3' HG12 ' A' ' 48' ' ' VAL . 3.3 ttm180 -97.03 112.01 23.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 70.099999999999994 110.879 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.022 HG13 HG22 ' A' ' 47' ' ' VAL . 21.4 t -113.94 130.08 68.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.455 . . . . 74.109999999999999 111.143 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -135.12 118.08 16.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 75.019999999999996 110.898 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.853 HG13 ' HB1' ' A' ' 17' ' ' ALA . 5.8 p -129.69 137.44 56.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 70.329999999999998 111.17 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.4 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 47.2 tt0 -133.25 120.3 20.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 74.219999999999999 110.868 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 144.12 -149.06 21.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.746 -0.74 . . . . 74.340000000000003 112.571 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -155.69 177.7 11.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 74.519999999999996 110.91 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -77.95 147.04 35.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 75.319999999999993 110.889 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.84 7.86 71.3 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.78 -0.724 . . . . 72.310000000000002 112.521 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.548 HG12 ' N ' ' A' ' 42' ' ' HIS . 17.7 t -134.87 163.87 35.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 52.140000000000001 111.105 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.548 ' N ' HG12 ' A' ' 41' ' ' VAL . 49.3 p-80 -75.9 106.85 7.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 75.420000000000002 110.879 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.654 ' CZ ' HD11 ' A' ' 79' ' ' LEU . 7.4 p90 -119.76 166.76 12.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.213 -0.449 . . . . 75.319999999999993 110.866 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -114.02 129.59 56.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 74.019999999999996 110.899 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.05 116.28 19.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 62.32 111.108 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.691 HG23 ' HB2' ' A' ' 82' ' ' LYS . 12.0 m -121.29 112.11 18.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 71.329999999999998 111.132 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.022 HG22 HG13 ' A' ' 33' ' ' VAL . 79.6 t -114.06 138.92 42.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.198 -0.456 . . . . 45.219999999999999 111.143 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.651 HG12 ' HB3' ' A' ' 32' ' ' ARG . 8.6 p -132.08 123.84 51.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.148 -0.478 . . . . 73.209999999999994 111.126 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.44 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 0.6 OUTLIER -170.37 167.52 4.59 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.7 0.762 . . . . 60.119999999999997 110.855 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.518 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 54.4 Cg_endo -69.77 -22.78 31.55 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.693 2.262 . . . . 70.329999999999998 112.357 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.503 ' HB1' ' NE ' ' A' ' 60' ' ' ARG . . . -44.27 -47.02 9.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 54.140000000000001 111.091 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.724 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -86.69 39.85 0.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 72.5 110.814 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.494 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 4.3 p -55.92 123.11 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 74.349999999999994 111.139 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.46 -91.68 0.86 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.75 -0.738 . . . . 52.25 112.41 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.485 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 11.8 mptt -118.06 108.88 15.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.797 0.332 . . . . 70.439999999999998 110.878 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.724 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -57.82 106.65 0.73 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.549 0.69 . . . . 63.439999999999998 111.1 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 54.5 Cg_endo -69.79 170.5 16.45 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.645 2.23 . . . . 73.239999999999995 112.381 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 tp -63.54 -23.78 67.53 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.211 -0.45 . . . . 64.299999999999997 110.943 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.87 -54.14 49.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 64.299999999999997 111.116 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.583 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 8.2 mmm180 -71.83 -40.84 68.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 74.239999999999995 110.82 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.406 ' CD2' ' HE2' ' A' ' 65' ' ' TYR . 1.0 OUTLIER -58.25 -50.34 73.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 64.530000000000001 110.855 179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -69.05 -40.18 78.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 71.230000000000004 110.819 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.812 ' O ' HG23 ' A' ' 67' ' ' THR . 10.5 tpt -53.47 -52.79 58.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.173 -0.467 . . . . 71.109999999999999 110.856 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.523 HG23 ' N ' ' A' ' 65' ' ' TYR . 16.6 m -61.75 -49.56 83.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 72.230000000000004 111.141 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.577 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 12.8 m-85 -55.61 -31.19 62.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.212 -0.449 . . . . 74.310000000000002 110.995 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -74.49 -43.33 56.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.102 -0.499 . . . . 74.140000000000001 111.151 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 63' ' ' MET . 1.1 p -64.44 -33.83 76.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 75.510000000000005 111.179 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.073 HD22 HD12 ' A' ' 20' ' ' ILE . 12.6 mt -81.74 7.07 13.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 74.120000000000005 110.925 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.484 ' C ' ' O ' ' A' ' 68' ' ' LEU . . . 31.58 73.14 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.7 -0.762 . . . . 70.109999999999999 112.48 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.427 ' CD ' ' HG ' ' A' ' 79' ' ' LEU . 26.7 mt-10 -77.34 -38.95 49.25 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.861 0.362 . . . . 51.32 110.894 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 19.4 tp -89.83 10.36 23.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 51.240000000000002 110.876 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 1.3 ttt -77.23 -13.52 59.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.184 -0.462 . . . . 72.109999999999999 110.904 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -147.1 -32.33 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.753 -0.737 . . . . 53.119999999999997 112.508 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.88 100.53 0.17 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.718 -0.754 . . . . 32.240000000000002 112.528 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -82.28 122.81 28.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 44.109999999999999 111.079 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.535 ' O ' HD23 ' A' ' 79' ' ' LEU . 2.6 mp -114.02 163.82 10.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 71.319999999999993 111.205 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.5 ' N ' HG22 ' A' ' 76' ' ' ILE . 39.5 m-70 -76.9 41.52 0.28 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.14 -0.482 . . . . 52.229999999999997 110.867 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.415 ' HB3' ' HB3' ' A' ' 42' ' ' HIS . . . -135.01 33.21 3.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 74.340000000000003 111.123 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.654 HD11 ' CZ ' ' A' ' 43' ' ' PHE . 4.0 mm? -97.61 146.54 25.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.25 -0.432 . . . . 64.420000000000002 110.954 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -121.3 115.79 23.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 72.340000000000003 110.901 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.577 ' HG ' ' CE1' ' A' ' 65' ' ' TYR . 0.4 OUTLIER -125.01 117.64 24.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 54.329999999999998 110.869 -179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.691 ' HB2' HG23 ' A' ' 46' ' ' THR . 2.3 mptp? -120.83 114.87 22.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.173 -0.467 . . . . 73.510000000000005 110.853 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.536 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 28.6 p -116.15 107.06 14.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 40.140000000000001 111.188 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 43.5 mt -132.48 161.42 33.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 72.239999999999995 110.935 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.494 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.1 163.04 70.27 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.608 0.718 . . . . 75.0 111.109 179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.2 Cg_endo -69.77 -7.97 22.42 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.681 2.254 . . . . 72.200000000000003 112.354 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -86.62 -28.83 23.0 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.22 -0.446 . . . . 74.430000000000007 110.824 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -84.53 18.31 2.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 71.5 110.894 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 63.119999999999997 111.118 179.93 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 8.4 mmt . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.823 0.344 . . . . 73.019999999999996 110.856 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 60.0 mtm180 -104.74 -58.47 1.88 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 73.310000000000002 110.917 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.442 ' HD2' ' N ' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -99.84 139.06 36.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 65.120000000000005 110.885 179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -125.63 113.22 25.17 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.582 0.706 . . . . 73.400000000000006 110.898 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.69 87.22 0.55 Allowed 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.688 2.259 . . . . 62.340000000000003 112.312 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tp -132.23 -32.17 1.39 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.289 -0.414 . . . . 62.439999999999998 110.91 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -76.95 -175.28 3.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.201 -0.454 . . . . 70.019999999999996 110.853 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.77 ' HB1' ' CG1' ' A' ' 35' ' ' VAL . . . -46.55 -30.03 2.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 64.040000000000006 111.078 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -57.64 -37.1 72.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 62.009999999999998 110.898 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.56 ' CG2' ' N ' ' A' ' 20' ' ' ILE . 1.2 t -60.86 -47.53 85.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.153 -0.476 . . . . 44.509999999999998 111.045 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.857 HD13 ' HB2' ' A' ' 68' ' ' LEU . 9.4 pt -70.24 -30.8 44.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 74.200000000000003 111.086 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.556 ' N ' HG13 ' A' ' 20' ' ' ILE . 39.0 ttt-85 -65.22 -48.02 74.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 74.310000000000002 110.814 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.4 pttm -71.46 -39.74 70.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 72.239999999999995 110.92 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 16.0 mt -58.26 -50.21 74.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.254 -0.43 . . . . 75.409999999999997 110.899 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.778 HG21 HG21 ' A' ' 33' ' ' VAL . 6.6 mt -71.32 -45.78 68.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 62.32 111.176 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -54.2 -35.82 62.78 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 74.329999999999998 110.903 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -79.97 -43.15 22.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 75.310000000000002 110.852 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -56.79 -52.22 52.12 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.78 -0.724 . . . . 71.299999999999997 112.518 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.06 101.67 54.58 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.583 0.706 . . . . 74.409999999999997 110.938 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.64 -14.76 36.95 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.723 2.282 . . . . 73.219999999999999 112.302 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -97.65 1.1 48.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 74.439999999999998 110.88 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' A' ' 49' ' ' SER . . . -119.24 135.89 54.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 61.450000000000003 111.123 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.609 ' HB2' HG13 ' A' ' 48' ' ' VAL . 9.8 mmt180 -106.85 114.32 28.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.445 . . . . 74.120000000000005 110.878 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.778 HG21 HG21 ' A' ' 24' ' ' ILE . 18.4 t -116.79 124.69 73.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.192 -0.458 . . . . 72.120000000000005 111.065 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -135.62 117.65 15.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.19 -0.459 . . . . 63.399999999999999 110.806 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.77 ' CG1' ' HB1' ' A' ' 17' ' ' ALA . 4.4 p -123.64 138.6 52.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 71.510000000000005 111.098 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 3.1 tp-100 -132.12 120.52 22.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 72.409999999999997 110.904 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.53 -150.81 23.1 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.667 -0.778 . . . . 74.439999999999998 112.474 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -150.94 165.68 32.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 75.239999999999995 110.883 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -68.56 142.75 55.11 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 64.349999999999994 110.851 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.421 ' C ' ' HA ' ' A' ' 75' ' ' ALA . . . 72.61 19.56 79.17 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.745 -0.74 . . . . 74.540000000000006 112.478 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.54 HG12 ' N ' ' A' ' 42' ' ' HIS . 9.8 t -144.1 164.98 14.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.853 0.359 . . . . 74.140000000000001 111.099 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.54 ' N ' HG12 ' A' ' 41' ' ' VAL . 17.3 p80 -74.81 107.73 7.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 71.109999999999999 110.923 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.928 ' CE2' HD11 ' A' ' 79' ' ' LEU . 7.7 p90 -119.43 167.43 11.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.238 -0.437 . . . . 72.209999999999994 110.904 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.1 pm0 -115.27 133.72 55.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 61.409999999999997 110.889 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.829 ' HB2' ' HE1' ' A' ' 43' ' ' PHE . . . -125.54 123.93 40.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 52.539999999999999 111.097 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 62.8 m -121.72 107.32 12.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 63.340000000000003 111.194 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.768 ' CG1' HG13 ' A' ' 33' ' ' VAL . 2.9 m -116.8 128.95 74.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.475 . . . . 60.420000000000002 111.178 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.609 HG13 ' HB2' ' A' ' 32' ' ' ARG . 4.4 p -133.48 118.62 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 73.120000000000005 111.184 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.466 ' HB2' ' HB2' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -165.19 168.22 8.7 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.611 0.72 . . . . 74.219999999999999 110.828 -179.788 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.508 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.9 Cg_endo -69.7 -23.94 30.5 Favored 'Trans proline' 0 N--CA 1.465 -0.147 0 C-N-CA 122.747 2.298 . . . . 35.200000000000003 112.38 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.581 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -47.35 -44.45 23.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 72.540000000000006 111.053 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.635 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.7 OUTLIER -85.3 34.25 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 61.340000000000003 110.865 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.555 ' HA ' HG23 ' A' ' 85' ' ' THR . 14.6 p -52.3 144.67 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 71.439999999999998 111.109 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 50.7 -88.12 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.772 -0.728 . . . . 74.420000000000002 112.512 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.467 ' N ' ' O ' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -118.21 112.51 20.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.8 0.333 . . . . 73.239999999999995 110.922 179.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.635 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -58.59 108.05 1.18 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.607 0.718 . . . . 63.329999999999998 111.136 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 52.9 Cg_endo -69.8 162.27 42.74 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.715 2.277 . . . . 73.420000000000002 112.317 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.8 tp -57.89 -25.95 61.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.225 -0.443 . . . . 74.230000000000004 110.831 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.22 -53.53 57.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.272 -0.422 . . . . 73.209999999999994 111.105 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.6 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 29.5 mmt180 -69.92 -44.97 68.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.148 -0.478 . . . . 75.239999999999995 110.885 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.485 ' O ' HG22 ' A' ' 64' ' ' VAL . 1.5 t-160 -56.24 -53.77 53.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.133 -0.485 . . . . 61.439999999999998 110.821 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 20.9 mtp85 -65.33 -35.89 82.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 70.439999999999998 110.87 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 3.4 ttt -56.24 -48.38 76.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 65.129999999999995 110.835 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.594 HG21 HD21 ' A' ' 81' ' ' LEU . 11.4 m -67.83 -40.64 83.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 74.310000000000002 111.116 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.605 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 16.7 m-85 -67.35 -34.18 76.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 71.420000000000002 110.908 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.06 -44.46 26.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 64.019999999999996 111.114 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.505 HG22 ' O ' ' A' ' 64' ' ' VAL . 1.2 t -60.32 -40.99 92.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 72.519999999999996 111.158 -179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.048 ' O ' HD22 ' A' ' 68' ' ' LEU . 0.0 OUTLIER -88.66 -10.92 46.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 60.340000000000003 110.921 179.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 1.014 ' N ' HD13 ' A' ' 68' ' ' LEU . . . 31.32 87.82 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.757 -0.735 . . . . 75.040000000000006 112.506 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.456 ' HG2' HD23 ' A' ' 71' ' ' LEU . 1.1 pm0 -79.53 -35.25 40.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.993 0.425 . . . . 74.439999999999998 110.938 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.456 HD23 ' HG2' ' A' ' 70' ' ' GLU . 3.9 mm? -76.11 7.3 4.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 40.210000000000001 110.929 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 63.4 mtp -84.52 -13.05 52.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 71.109999999999999 110.854 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -130.39 -22.1 1.11 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.772 -0.728 . . . . 55.100000000000001 112.448 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 93.08 42.9 4.23 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.722 -0.751 . . . . 74.349999999999994 112.501 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.421 ' HA ' ' C ' ' A' ' 40' ' ' GLY . . . -58.78 156.09 11.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.766 0.317 . . . . 51.520000000000003 111.063 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.575 HG22 ' N ' ' A' ' 77' ' ' HIS . 21.5 mm -70.82 164.99 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 71.120000000000005 111.134 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.575 ' N ' HG22 ' A' ' 76' ' ' ILE . 30.2 m170 -74.48 46.46 0.27 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 72.140000000000001 110.839 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -134.95 58.63 1.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 61.0 111.107 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.928 HD11 ' CE2' ' A' ' 43' ' ' PHE . 3.9 mm? -97.66 132.49 43.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.266 -0.424 . . . . 63.229999999999997 110.882 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -111.46 114.94 28.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 71.109999999999999 110.935 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.605 HD22 ' CZ ' ' A' ' 65' ' ' TYR . 3.4 tp -133.65 124.72 27.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 64.120000000000005 110.915 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.418 ' HD2' ' C ' ' A' ' 81' ' ' LEU . 9.4 mptt -126.48 114.47 18.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.139 -0.482 . . . . 72.049999999999997 110.834 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.583 ' HB ' ' CD2' ' A' ' 52' ' ' PHE . 66.8 p -109.39 107.19 17.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 72.299999999999997 111.189 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.412 HD12 ' C ' ' A' ' 83' ' ' THR . 6.6 mp -131.56 162.8 29.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 65.25 110.88 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.555 HG23 ' HA ' ' A' ' 53' ' ' VAL . 0.5 OUTLIER -71.11 164.1 59.8 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.59 0.71 . . . . 72.439999999999998 111.103 179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 53.6 Cg_endo -69.79 -12.8 33.58 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.633 2.222 . . . . 74.540000000000006 112.374 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 -78.66 -28.72 45.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 72.239999999999995 110.905 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -85.04 28.79 0.68 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 74.400000000000006 110.877 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.151 -0.477 . . . . 53.439999999999998 111.18 179.837 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 4.6 ptp . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.747 0.308 . . . . 72.010000000000005 110.944 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.3 ttm180 -113.85 90.91 3.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 74.129999999999995 110.876 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.74 43.94 2.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.08 -0.509 . . . . 65.530000000000001 110.933 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.506 ' N ' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -71.35 -59.87 2.99 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.563 0.697 . . . . 74.200000000000003 110.852 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 13' ' ' ARG . 54.0 Cg_endo -69.8 165.32 31.4 Favored 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.662 2.241 . . . . 41.399999999999999 112.379 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.433 ' O ' HG23 ' A' ' 19' ' ' THR . 6.7 tp -121.22 -36.96 3.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 61.450000000000003 110.901 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.52 -49.25 6.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 74.549999999999997 110.911 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.869 ' HA ' HD11 ' A' ' 20' ' ' ILE . . . -63.37 -27.73 69.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.445 . . . . 74.239999999999995 111.042 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.421 ' HG3' ' N ' ' A' ' 19' ' ' THR . 4.0 pt-20 -71.49 -28.91 64.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.26 -0.427 . . . . 74.439999999999998 110.873 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.433 HG23 ' O ' ' A' ' 15' ' ' LEU . 17.1 p -59.07 -56.66 19.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 74.510000000000005 111.166 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.892 ' H ' HD13 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -73.92 -35.29 42.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 74.150000000000006 111.098 179.897 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.52 ' N ' HG12 ' A' ' 20' ' ' ILE . 30.8 ttp180 -62.41 -48.57 79.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.229 -0.441 . . . . 73.230000000000004 110.862 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 15.0 mmtp -69.56 -40.27 76.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.208 -0.451 . . . . 75.420000000000002 110.872 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 22.8 mt -56.18 -49.19 74.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.302 -0.408 . . . . 74.239999999999995 110.931 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.811 ' CG2' HG21 ' A' ' 33' ' ' VAL . 11.7 mt -68.07 -45.84 82.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 70.040000000000006 111.161 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -54.21 -36.8 63.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.116 -0.493 . . . . 74.340000000000003 110.898 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m -77.4 -43.02 34.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 40.149999999999999 110.881 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -63.47 -46.46 92.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.768 -0.729 . . . . 54.409999999999997 112.472 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.789 HD23 ' CB ' ' A' ' 31' ' ' ALA . 6.8 mp -85.61 161.09 52.02 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.567 0.699 . . . . 63.32 110.938 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.68 -90.76 0.0 OUTLIER 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.656 2.237 . . . . 74.120000000000005 112.373 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -107.26 25.89 10.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 72.409999999999997 110.909 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.789 ' CB ' HD23 ' A' ' 28' ' ' LEU . . . -71.64 125.71 27.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.172 -0.467 . . . . 73.010000000000005 111.118 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.717 ' HB3' HG12 ' A' ' 48' ' ' VAL . 2.2 tpm_? -93.71 108.75 20.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 71.219999999999999 110.865 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.071 HG22 HG13 ' A' ' 47' ' ' VAL . 41.7 t -113.28 127.46 70.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.269 -0.423 . . . . 73.040000000000006 111.196 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -135.22 118.56 16.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.465 . . . . 70.120000000000005 110.828 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.683 HG13 ' HB1' ' A' ' 17' ' ' ALA . 3.9 p -126.26 136.7 60.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.161 -0.472 . . . . 64.329999999999998 111.089 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 43' ' ' PHE . 63.6 mt-30 -132.69 120.1 21.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 73.439999999999998 110.912 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.429 ' HA3' ' CB ' ' A' ' 43' ' ' PHE . . . 149.18 -124.92 1.9 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.765 -0.731 . . . . 72.420000000000002 112.444 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.62 ' O ' HG12 ' A' ' 41' ' ' VAL . 2.2 tt0 -175.44 163.04 2.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.816 0.341 . . . . 61.520000000000003 110.895 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -72.02 148.16 46.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 75.310000000000002 110.9 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.61 8.99 73.4 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.739 -0.743 . . . . 41.25 112.508 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.62 HG12 ' O ' ' A' ' 38' ' ' GLU . 14.7 p -139.14 165.17 23.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.827 0.346 . . . . 70.519999999999996 111.152 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.6 ' N ' HG22 ' A' ' 41' ' ' VAL . 32.6 p80 -74.49 110.7 9.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 73.219999999999999 110.851 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.536 ' CE2' HD11 ' A' ' 79' ' ' LEU . 4.9 p90 -126.91 167.65 15.56 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.273 -0.422 . . . . 71.209999999999994 110.866 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -113.5 124.98 53.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 64.150000000000006 110.873 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -128.22 119.99 26.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 64.510000000000005 111.148 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.4 m -118.26 114.99 23.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.171 -0.468 . . . . 74.510000000000005 111.117 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.071 HG13 HG22 ' A' ' 33' ' ' VAL . 24.7 t -113.47 141.25 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 74.129999999999995 111.128 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.717 HG12 ' HB3' ' A' ' 32' ' ' ARG . 5.1 p -134.95 122.2 36.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 70.239999999999995 111.133 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.449 ' HB2' ' HD2' ' A' ' 50' ' ' PRO . 0.9 OUTLIER -167.61 166.26 7.97 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.704 0.764 . . . . 73.540000000000006 110.874 -179.885 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.504 ' N ' ' HD3' ' A' ' 86' ' ' PRO . 53.8 Cg_endo -69.74 -18.22 37.21 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.681 2.254 . . . . 74.030000000000001 112.317 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.579 ' HB1' ' HD2' ' A' ' 60' ' ' ARG . . . -43.76 -50.79 7.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 64.040000000000006 111.157 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.63 ' HB3' ' HB2' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -86.94 40.58 0.92 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.248 -0.433 . . . . 71.230000000000004 110.891 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.498 ' HA ' ' CG2' ' A' ' 85' ' ' THR . 4.7 p -51.24 119.1 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.182 -0.463 . . . . 74.200000000000003 111.089 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.69 -72.88 1.01 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.748 -0.739 . . . . 70.549999999999997 112.495 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.404 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 23.3 mtpt -121.62 138.59 54.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.809 0.338 . . . . 72.230000000000004 110.876 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.63 ' HB2' ' HB3' ' A' ' 52' ' ' PHE . . . -99.73 100.11 10.33 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.538 0.685 . . . . 75.530000000000001 111.093 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 55' ' ' LYS . 53.8 Cg_endo -69.8 163.49 38.11 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.633 2.222 . . . . 75.230000000000004 112.374 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -56.49 -26.76 55.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 50.200000000000003 110.928 179.975 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.407 ' O ' ' CG ' ' A' ' 63' ' ' MET . . . -58.6 -49.95 75.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.19 -0.459 . . . . 63.409999999999997 111.13 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.605 ' HB3' ' CE2' ' A' ' 52' ' ' PHE . 21.6 mmt180 -71.7 -46.47 58.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.275 -0.42 . . . . 64.510000000000005 110.818 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.583 ' CD2' ' HH ' ' A' ' 65' ' ' TYR . 1.0 OUTLIER -58.0 -50.0 74.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 62.240000000000002 110.833 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 1.2 ttm180 -67.34 -39.65 85.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.192 -0.458 . . . . 55.340000000000003 110.883 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.407 ' CG ' ' O ' ' A' ' 59' ' ' ALA . 4.3 mmt -54.54 -48.02 72.5 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 75.409999999999997 110.898 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.513 ' CG2' ' O ' ' A' ' 61' ' ' HIS . 13.5 m -65.43 -42.51 93.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 72.439999999999998 111.165 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.583 ' HH ' ' CD2' ' A' ' 61' ' ' HIS . 12.1 m-85 -54.8 -42.09 71.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.13 -0.486 . . . . 74.129999999999995 110.853 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.53 -44.37 62.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 54.200000000000003 111.109 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.569 HG21 HG12 ' A' ' 24' ' ' ILE . 0.6 OUTLIER -69.64 -14.76 62.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.163 -0.471 . . . . 72.430000000000007 111.201 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.525 ' O ' HG21 ' A' ' 20' ' ' ILE . 18.0 mt -94.61 -10.54 31.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.24 -0.437 . . . . 72.319999999999993 110.929 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.71 72.71 0.47 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.712 -0.756 . . . . 43.039999999999999 112.505 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.416 ' HG3' ' N ' ' A' ' 71' ' ' LEU . 10.0 pt-20 -114.65 -38.47 3.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.869 0.366 . . . . 72.340000000000003 110.924 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.637 ' O ' HD13 ' A' ' 71' ' ' LEU . 0.2 OUTLIER -88.38 -11.17 46.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.141 -0.481 . . . . 71.310000000000002 110.907 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' MET . . . . . . . . . . . . . 19.8 ptm -80.63 -13.14 59.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 75.239999999999995 110.921 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -109.36 -25.28 5.59 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.756 -0.735 . . . . 64.5 112.471 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.82 52.64 1.63 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.731 -0.747 . . . . 54.340000000000003 112.478 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -81.88 162.13 22.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 70.099999999999994 111.093 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.576 HG22 ' N ' ' A' ' 77' ' ' HIS . 10.9 mt -73.35 165.0 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 74.5 111.156 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.576 ' N ' HG22 ' A' ' 76' ' ' ILE . 1.6 t-80 -74.41 45.64 0.24 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 74.329999999999998 110.813 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -132.01 53.66 1.98 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 72.230000000000004 111.08 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.536 HD11 ' CE2' ' A' ' 43' ' ' PHE . 3.9 mm? -98.16 136.36 38.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 71.519999999999996 110.958 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -105.79 115.73 30.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.455 . . . . 74.140000000000001 110.913 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.438 HD12 HG23 ' A' ' 83' ' ' THR . 0.2 OUTLIER -129.58 118.47 22.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.239 -0.437 . . . . 64.140000000000001 110.892 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.403 ' O ' ' O ' ' A' ' 47' ' ' VAL . 2.2 mptp? -119.0 114.5 22.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.467 . . . . 75.400000000000006 110.953 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.539 ' HB ' ' CG ' ' A' ' 52' ' ' PHE . 33.5 p -109.79 107.32 17.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 62.0 111.163 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.6 mt -131.07 160.83 33.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.13 -0.486 . . . . 75.109999999999999 110.883 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.498 ' CG2' ' HA ' ' A' ' 53' ' ' VAL . 0.6 OUTLIER -72.36 162.86 71.71 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.597 0.713 . . . . 62.299999999999997 111.128 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 50' ' ' PRO . 54.7 Cg_endo -69.65 -17.94 37.81 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.689 2.259 . . . . 75.409999999999997 112.394 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -71.83 -34.76 69.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 73.430000000000007 110.904 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 24.9 mm-40 -68.32 -31.24 70.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.173 -0.467 . . . . 74.239999999999995 110.854 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 74.409999999999997 111.063 179.977 . . . . . . . . 0 0 . 1 stop_ save_